data_1qnd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qnd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.593 0.711 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.55 82.49 0.34 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -169.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -153.22 140.02 19.03 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.815 1.246 . . . . 0.0 107.743 -166.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -59.24 -29.58 67.64 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.899 0.318 . . . . 0.0 110.963 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.61 -11.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.527 1.931 . . . . 0.0 114.74 169.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.421 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 19.8 t-20 -57.69 -36.93 72.63 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 120.279 1.399 . . . . 0.0 111.677 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.79 -38.24 67.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.158 172.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -56.04 -46.11 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.911 1.284 . . . . 0.0 110.868 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -68.65 -24.64 64.56 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.175 -0.328 . . . . 0.0 111.822 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -75.22 -27.15 59.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 121.292 -0.88 . . . . 0.0 111.62 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.88 -46.46 89.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.229 0.468 . . . . 0.0 110.349 169.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.46 -48.72 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.499 1.12 . . . . 0.0 108.158 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -55.75 -43.09 76.34 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.466 0.706 . . . . 0.0 111.342 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.45 -47.46 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -57.42 -45.48 84.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.568 172.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -42.45 76.98 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.84 -53.23 53.96 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.083 0.953 . . . . 0.0 110.984 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.14 -45.57 92.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 119.214 0.915 . . . . 0.0 111.947 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -161.97 58.19 0.25 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.431 1.092 . . . . 0.0 111.669 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.57 -12.99 43.12 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 120.015 -1.678 . . . . 0.0 113.213 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.85 -40.47 63.42 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.256 1.528 . . . . 0.0 111.828 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.06 -26.65 43.07 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.913 -1.117 . . . . 0.0 112.294 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.2 m-85 -74.98 -33.68 61.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.037 1.335 . . . . 0.0 108.571 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -54.94 -52.68 41.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -59.53 -14.25 12.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -85.82 -42.06 14.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.98 1.718 . . . . 0.0 111.977 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.23 -59.49 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.72 65.58 2.82 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 124.286 0.946 . . . . 0.0 111.451 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.74 171.51 43.32 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.15 132.33 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 157.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.48 166.93 18.63 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.363 0.602 . . . . 0.0 111.651 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.19 145.3 38.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.584 1.154 . . . . 0.0 108.898 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -94.67 93.49 7.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.737 1.215 . . . . 0.0 108.451 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -77.62 109.39 11.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.652 1.115 . . . . 0.0 109.444 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.22 104.95 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.63 -179.64 5.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.42 1.088 . . . . 0.0 108.208 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t0 58.76 48.13 11.84 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.58 1.152 . . . . 0.0 113.479 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.8 -173.79 11.85 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.998 1.285 . . . . 0.0 115.373 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.95 78.1 0.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.588 2.859 . . . . 0.0 108.62 161.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.38 -17.63 4.49 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.367 1.937 . . . . 0.0 112.794 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.72 -11.57 68.1 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 126.013 1.768 . . . . 0.0 112.471 170.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.13 -176.46 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.057 1.743 . . . . 0.0 110.675 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.28 152.46 51.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 112.315 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.11 174.94 6.03 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.345 2.258 . . . . 0.0 107.977 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.9 m -147.73 153.89 39.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 147.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -120.74 136.97 54.73 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 162.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.59 144.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.8 113.52 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.23 112.15 18.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 164.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.23 48.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 167.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -137.07 -50.16 0.64 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.034 0.934 . . . . 0.0 110.236 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -79.87 131.11 35.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 -122.7 14.37 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.418 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 8.25 28.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.769 1.628 . . . . 0.0 110.751 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.53 158.7 30.6 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.841 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -171.14 147.63 2.58 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.865 2.466 . . . . 0.0 109.585 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -80.87 153.9 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 mt -136.43 86.19 24.39 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -169.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.45 142.22 48.7 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.609 1.54 . . . . 0.0 109.768 -174.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 45.75 34.95 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 129.278 3.031 . . . . 0.0 111.955 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.8 152.67 25.57 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.622 0.769 . . . . 0.0 110.578 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 -3.92 59.02 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.266 1.026 . . . . 0.0 111.178 161.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.97 128.95 22.68 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -73.92 -176.76 2.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.16 141.58 30.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.362 1.865 . . . . 0.0 108.092 -172.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.75 -29.17 58.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 m -150.41 165.27 33.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.013 1.725 . . . . 0.0 108.348 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.547 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 86.5 m -147.26 119.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.16 -0.962 . . . . 0.0 108.962 -170.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.94 138.46 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.9 m -108.99 131.21 55.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.022 1.283 . . . . 0.0 107.739 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -139.88 -101.22 0.16 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 161.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.08 159.06 0.15 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.503 3.121 . . . . 0.0 106.873 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.3 -48.87 79.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.73 0.812 . . . . 0.0 111.861 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -71.31 1.45 6.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.052 1.341 . . . . 0.0 111.188 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -105.3 -44.55 4.71 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.924 -1.11 . . . . 0.0 112.856 158.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -60.04 -60.79 3.27 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.223 1.409 . . . . 0.0 111.184 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tp -44.5 -61.22 1.62 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.477 1.111 . . . . 0.0 109.304 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.77 -18.2 29.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.792 -172.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -67.13 -68.69 0.36 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.477 1.111 . . . . 0.0 110.675 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.333 -0.146 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.547 ' CG2' ' H ' ' A' ' 72' ' ' THR . 1.2 mp . . . . . 0 C--N 1.312 -1.048 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.288 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.11 -3.85 28.97 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 169.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -150.13 44.74 0.89 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.176 1.79 . . . . 0.0 111.393 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.6 mt . . . . . 0 N--CA 1.467 0.42 0 C-N-CA 128.174 2.59 . . . . 0.0 116.018 -169.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.02 78.06 0.28 Allowed Glycine 0 C--N 1.336 0.544 0 O-C-N 120.67 -1.269 . . . . 0.0 113.088 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -153.68 160.69 42.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.629 1.572 . . . . 0.0 110.263 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm -65.48 -9.56 26.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.81 -6.24 5.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.994 0.815 . . . . 0.0 113.144 166.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.11 -37.93 81.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.681 1.128 . . . . 0.0 112.342 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -37.88 77.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.701 1.201 . . . . 0.0 110.734 174.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -52.71 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.627 1.571 . . . . 0.0 111.228 -175.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -70.15 -21.63 63.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.015 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -75.06 -27.5 60.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.774 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -49.46 72.96 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.353 1.433 . . . . 0.0 110.596 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mt -53.56 -47.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.42 1.088 . . . . 0.0 108.204 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -61.21 -53.39 57.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.634 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -51.76 -53.72 36.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.766 1.166 . . . . 0.0 108.42 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -57.12 -46.58 82.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.974 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -35.48 68.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -70.18 -52.24 24.95 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.27 -44.42 95.33 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.347 2.259 . . . . 0.0 112.763 -171.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -154.76 55.16 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.739 1.616 . . . . 0.0 111.072 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.31 -30.93 56.22 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-O 117.741 -1.589 . . . . 0.0 113.529 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.75 -38.91 67.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.898 1.849 . . . . 0.0 111.118 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -81.07 -19.26 44.14 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.279 -0.888 . . . . 0.0 112.429 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.42 -31.5 20.03 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 109.929 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.37 -55.03 6.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 126.682 1.993 . . . . 0.0 108.252 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -61.77 -16.0 45.97 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -79.68 -58.85 2.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.716 0.806 . . . . 0.0 110.52 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.45 -63.46 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.961 1.704 . . . . 0.0 107.155 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.66 72.39 0.69 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.243 1.402 . . . . 0.0 112.32 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.25 153.7 6.46 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.525 -1.153 . . . . 0.0 110.767 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.99 134.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -128.41 162.94 25.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.712 0.768 . . . . 0.0 109.131 162.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.59 157.72 22.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.561 164.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -105.79 96.29 6.39 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.322 1.449 . . . . 0.0 109.469 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.77 108.95 7.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.317 -1.489 . . . . 0.0 109.799 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.93 94.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 174.45 7.11 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 61.57 40.69 13.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 0.0 111.917 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 77' ' ' ASP . . . -61.16 173.08 6.65 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.396 0.998 . . . . 0.0 113.52 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.01 86.61 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.009 2.473 . . . . 0.0 107.085 166.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.81 -57.98 0.41 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -163.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.96 -23.87 7.63 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 125.945 1.736 . . . . 0.0 110.483 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -71.58 -172.48 0.79 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 111.221 168.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.58 149.03 50.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.934 1.694 . . . . 0.0 113.666 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.42 167.14 10.58 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.367 2.267 . . . . 0.0 109.966 166.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.9 m -155.23 114.59 3.64 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.005 0.907 . . . . 0.0 109.854 150.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -88.46 162.35 16.52 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 168.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.88 145.33 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.71 109.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.54 122.57 29.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.5 50.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 126.136 1.775 . . . . 0.0 106.961 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -40.5 0.07 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.401 1.08 . . . . 0.0 110.279 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -95.2 131.54 41.13 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 -145.24 42.72 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -83.16 8.29 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.455 -1.259 . . . . 0.0 113.744 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.78 156.77 8.66 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 120.586 1.539 . . . . 0.0 110.579 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -171.28 144.6 2.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.96 2.104 . . . . 0.0 108.524 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.4 t -74.56 152.05 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 168.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.37 88.6 12.69 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 127.843 2.457 . . . . 0.0 104.501 -164.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.39 138.94 62.76 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.587 1.525 . . . . 0.0 109.479 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 54.49 24.09 5.04 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.301 1.841 . . . . 0.0 112.742 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 t -76.77 145.31 38.64 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.915 0.864 . . . . 0.0 111.424 -159.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.37 -11.12 55.3 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.264 2.226 . . . . 0.0 112.64 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -66.11 164.84 14.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.681 0.673 . . . . 0.0 109.541 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -169.91 0.94 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.51 -0.744 . . . . 0.0 110.106 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.9 178.28 7.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.257 1.423 . . . . 0.0 107.767 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.1 -52.14 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 159.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -149.05 -172.78 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.563 1.545 . . . . 0.0 110.985 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -129.31 178.83 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 tt -125.24 178.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 159.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.6 m -125.29 161.97 25.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 160.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -50.01 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 158.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.08 161.41 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 130.912 3.685 . . . . 0.0 109.961 -166.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 16.6 t70 -62.37 -56.06 22.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.025 -169.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.81 -34.24 62.5 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 125.6 1.812 . . . . 0.0 108.781 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -58.39 5.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 111.626 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -53.97 -50.7 65.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.196 0.598 . . . . 0.0 109.968 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -26.98 66.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.036 1.734 . . . . 0.0 112.519 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.12 -25.93 55.86 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.286 0.948 . . . . 0.0 112.782 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.68 -72.54 0.2 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 11.9 ptp . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 125.015 1.326 . . . . 0.0 113.581 -171.028 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.0 mm . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 177.597 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.1 m120 . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.83 -17.36 55.99 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.668 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -127.38 45.68 2.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.091 1.314 . . . . 0.0 109.785 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.308 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.526 1 C-N-CA 132.041 4.136 . . . . 0.0 115.964 170.993 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.15 65.87 0.24 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 126.578 2.037 . . . . 0.0 109.731 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -154.07 167.74 28.8 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.694 2.398 . . . . 0.0 107.283 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -62.33 -30.01 70.86 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.079 -0.388 . . . . 0.0 110.515 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.06 -28.13 0.67 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 128.218 2.607 . . . . 0.0 114.885 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.81 -44.1 73.51 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 123.789 0.835 . . . . 0.0 109.859 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.19 -42.7 99.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.683 1.593 . . . . 0.0 110.028 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -81.96 -51.22 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.593 1.557 . . . . 0.0 111.246 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.36 -23.32 67.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.056 0.844 . . . . 0.0 110.733 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -71.53 -36.4 70.99 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.846 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -55.43 -39.87 70.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 119.902 1.228 . . . . 0.0 112.32 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -62.43 -48.98 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -56.23 -53.84 52.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.016 1.326 . . . . 0.0 111.068 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -51.74 28.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.824 1.65 . . . . 0.0 109.092 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -59.26 -48.04 83.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.053 0.541 . . . . 0.0 111.211 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -36.09 68.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.13 -52.13 38.31 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.765 -1.209 . . . . 0.0 108.646 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.35 -47.11 82.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 110.569 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -165.35 64.7 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.411 1.084 . . . . 0.0 111.459 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.75 -15.01 81.78 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.46 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.82 -40.21 60.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.896 1.348 . . . . 0.0 111.994 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -17.99 49.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.654 0.782 . . . . 0.0 112.159 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -14.62 26.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.05 -62.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 126.733 2.013 . . . . 0.0 106.425 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -58.27 -18.71 28.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -66.3 -50.67 62.88 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.53 -53.19 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.45 47.63 76.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.361 0.981 . . . . 0.0 112.674 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.22 171.03 39.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.76 134.01 30.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 159.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -128.34 177.91 6.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.957 0.798 . . . . 0.0 109.211 163.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.42 51.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.412 0.685 . . . . 0.0 109.937 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -103.58 101.76 11.64 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.556 1.142 . . . . 0.0 107.997 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 106.84 6.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 121.092 1.769 . . . . 0.0 108.533 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.3 t -122.43 99.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -166.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -111.05 176.94 4.82 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 121.038 -1.039 . . . . 0.0 108.57 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.9 t0 60.24 60.02 2.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.476 1.91 . . . . 0.0 112.022 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.43 -167.29 32.56 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.83 1.681 . . . . 0.0 111.815 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.31 67.71 6.13 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.797 2.998 . . . . 0.0 109.644 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 -43.69 0.39 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.215 1.388 . . . . 0.0 110.636 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.64 -0.18 45.98 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.032 1.301 . . . . 0.0 112.369 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -65.84 -175.13 0.27 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.11 1.364 . . . . 0.0 111.576 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -132.3 132.75 43.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.221 1.008 . . . . 0.0 111.019 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.76 165.29 12.97 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.343 2.657 . . . . 0.0 107.304 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 m -148.38 117.64 6.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 155.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -83.69 128.02 34.21 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 165.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.92 146.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.86 104.84 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.78 106.4 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.11 47.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -129.25 -54.5 1.19 Allowed 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.319 0.647 . . . . 0.0 109.643 165.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -93.35 140.51 29.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -158.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 -124.54 11.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.23 5.76 35.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.523 1.529 . . . . 0.0 112.116 164.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.01 156.98 9.15 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -171.37 153.53 3.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.916 2.486 . . . . 0.0 107.832 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.66 114.86 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.75 117.44 59.78 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -169.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.01 140.12 15.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 -171.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 45.39 29.37 0.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.347 1.859 . . . . 0.0 114.057 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -64.83 141.37 58.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.156 0.889 . . . . 0.0 110.569 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.52 -20.19 60.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.412 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -54.51 126.7 24.63 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -63.16 -176.97 0.15 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.155 0.982 . . . . 0.0 110.034 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.95 159.19 42.74 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.098 1.359 . . . . 0.0 111.113 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -54.37 47.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.133 0.968 . . . . 0.0 109.191 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.0 m -146.41 169.8 18.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.366 2.266 . . . . 0.0 107.387 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.592 HG21 ' H ' ' A' ' 73' ' ' ILE . 10.3 m -114.32 -164.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.592 ' H ' HG21 ' A' ' 72' ' ' THR . 3.9 tt -148.93 178.1 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.495 -1.378 . . . . 0.0 108.13 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.7 m -143.11 138.81 30.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.856 1.662 . . . . 0.0 109.092 167.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -134.99 -12.56 2.2 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.7 143.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.348 2.659 . . . . 0.0 111.588 -146.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.7 -45.61 67.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 126.877 2.071 . . . . 0.0 112.376 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -54.43 -44.99 72.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.858 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.17 -51.24 56.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.717 1.207 . . . . 0.0 110.877 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.48 -50.99 51.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.392 2.277 . . . . 0.0 111.433 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.7 tp -53.8 -64.64 0.76 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.985 1.714 . . . . 0.0 108.633 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.21 -42.4 51.43 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.872 1.269 . . . . 0.0 111.385 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.72 -68.51 0.18 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.727 1.611 . . . . 0.0 109.912 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 73' ' ' ILE . 3.1 mp . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.1 t30 . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -92.7 8.36 39.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.66 2.027 . . . . 0.0 110.493 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -153.9 44.69 0.58 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.658 2.783 . . . . 0.0 110.4 -172.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 123.818 1.77 . . . . 0.0 115.44 -173.076 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.46 16.37 26.76 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 120.4 -1.438 . . . . 0.0 112.533 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.2 173.33 10.48 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.863 1.265 . . . . 0.0 109.905 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 49.1 mttp -74.76 -5.56 44.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.247 169.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.41 -23.04 62.28 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.764 1.225 . . . . 0.0 113.021 167.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -57.01 -52.71 64.17 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.078 0.854 . . . . 0.0 111.232 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -68.8 -32.47 72.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.239 0.616 . . . . 0.0 111.154 178.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.35 -54.59 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.078 0.951 . . . . 0.0 110.755 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -64.53 -27.14 68.76 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.606 0.639 . . . . 0.0 110.646 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.09 -30.51 65.17 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.077 -1.015 . . . . 0.0 112.701 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -59.8 -31.92 70.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 119.301 0.955 . . . . 0.0 112.081 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.0 mt -75.0 -46.56 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -50.86 -50.25 57.34 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.68 1.192 . . . . 0.0 111.306 172.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -58.35 -38.57 77.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.92 0.782 . . . . 0.0 109.942 -166.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -65.06 -47.92 75.63 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 173.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -35.16 65.52 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.048 0.939 . . . . 0.0 112.444 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.2 -53.15 40.81 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.831 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.35 -45.43 91.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.33 0.968 . . . . 0.0 112.686 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -155.72 58.48 0.61 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.746 1.26 . . . . 0.0 110.841 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.79 86.3 Favored Glycine 0 C--O 1.219 -0.79 0 CA-C-O 118.569 -1.129 . . . . 0.0 111.844 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.94 -40.14 42.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.357 1.578 . . . . 0.0 112.581 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -84.37 -18.68 35.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.359 -0.838 . . . . 0.0 111.778 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.94 -38.7 19.02 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.502 1.921 . . . . 0.0 109.246 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 t -54.07 -46.3 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 127.637 2.375 . . . . 0.0 108.755 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.54 -13.02 7.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -92.74 -63.09 1.27 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 120.077 1.308 . . . . 0.0 110.577 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.89 -38.36 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.2 1.0 . . . . 0.0 110.469 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 47.85 59.03 6.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.428 1.489 . . . . 0.0 112.526 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.49 -176.79 39.62 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.272 1.536 . . . . 0.0 110.509 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.6 131.77 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 159.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -121.98 167.26 13.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 111.939 166.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.8 146.02 34.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.832 1.653 . . . . 0.0 108.997 164.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -95.42 100.3 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -77.09 99.56 5.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.049 1.295 . . . . 0.0 109.059 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.12 133.81 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 170.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.48 175.46 5.51 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.607 -1.308 . . . . 0.0 108.706 154.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 55.42 52.52 11.17 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.112 160.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 44' ' ' GLY . . . -66.01 174.74 20.07 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.425 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.8 6.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.455 3.437 . . . . 0.0 115.088 169.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' GLY . . . -125.58 -22.06 1.89 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.403 1.478 . . . . 0.0 114.052 163.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.68 -13.43 17.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 119.515 1.657 . . . . 0.0 111.792 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -66.16 -175.5 0.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.938 1.695 . . . . 0.0 111.177 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.87 167.09 13.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.466 1.506 . . . . 0.0 110.225 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.45 173.37 12.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.547 1.939 . . . . 0.0 107.109 169.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 84.3 m -143.91 143.99 31.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 161.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.41 137.09 49.64 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 161.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.48 144.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.51 107.95 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -75.39 124.5 27.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.67 44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 105.852 -1.906 . . . . 0.0 105.852 172.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -134.5 -46.0 0.75 Allowed 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 125.09 1.356 . . . . 0.0 110.107 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -92.28 103.21 15.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -159.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.34 -113.83 4.51 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.278 -0.889 . . . . 0.0 111.638 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -84.81 -5.72 59.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.073 0.949 . . . . 0.0 112.757 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.75 -97.49 0.72 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 128.722 3.058 . . . . 0.0 110.383 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.7 m 98.89 151.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 1 C-N-CA 135.548 5.539 . . . . 0.0 111.733 -172.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.75 148.64 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 163.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.33 122.5 19.06 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.15 138.52 16.23 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 -177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.64 24.54 3.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.562 1.945 . . . . 0.0 111.958 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 t -74.65 144.76 43.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.264 1.031 . . . . 0.0 111.064 -153.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.4 7.08 23.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 111.882 164.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 tttm -61.99 129.29 40.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 153.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -68.06 -176.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.24 156.45 47.07 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.565 1.546 . . . . 0.0 109.286 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.31 -45.15 41.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.681 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -134.22 177.3 7.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.363 0.665 . . . . 0.0 110.887 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -138.81 -177.78 5.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.475 1.51 . . . . 0.0 107.688 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.27 152.93 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 119.543 -1.973 . . . . 0.0 105.694 166.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.7 m -108.24 122.74 47.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.409 1.459 . . . . 0.0 112.185 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.7 mtm -156.6 119.24 4.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.4 165.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.643 163.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 79' ' ' ASP . 15.6 t70 -56.09 -54.4 45.47 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 121.256 -0.902 . . . . 0.0 109.817 163.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.9 1.69 1.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.839 1.256 . . . . 0.0 112.305 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -100.0 -63.38 1.13 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.466 2.306 . . . . 0.0 108.613 164.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -60.94 -40.01 91.63 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.327 2.251 . . . . 0.0 113.503 -174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -35.37 71.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.934 1.293 . . . . 0.0 110.038 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.28 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.733 1.213 . . . . 0.0 110.674 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 tt -46.83 -75.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.82 2.448 . . . . 0.0 109.717 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 123.851 0.86 . . . . 0.0 112.992 172.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.498 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.49 -4.87 42.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.383 0.992 . . . . 0.0 111.874 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -163.23 44.26 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.712 1.205 . . . . 0.0 112.172 -165.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 125.214 2.435 . . . . 0.0 114.055 -165.502 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t0 . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.01 77.58 0.39 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 126.725 2.107 . . . . 0.0 108.6 -175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -153.25 151.93 30.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.682 2.393 . . . . 0.0 106.852 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -61.98 -26.55 68.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.838 0.744 . . . . 0.0 110.272 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.89 -14.35 1.42 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.051 0.94 . . . . 0.0 113.443 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 19.0 t-20 -55.9 -52.19 64.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.574 1.079 . . . . 0.0 111.454 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.183 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.6 t -54.69 -54.62 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.454 1.502 . . . . 0.0 110.723 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -71.1 -23.59 62.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.602 0.637 . . . . 0.0 112.199 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -75.29 -26.96 59.15 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.79 -50.0 75.57 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.211 0.46 . . . . 0.0 110.546 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.3 mt -51.39 -47.9 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.92 -50.72 72.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.988 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -55.42 -48.85 73.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.77 0.714 . . . . 0.0 109.213 -170.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.5 -45.57 93.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.181 0.592 . . . . 0.0 109.881 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -34.1 66.04 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.353 1.461 . . . . 0.0 114.355 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.258 7.8 mm-40 -63.67 -52.13 62.07 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.197 -0.939 . . . . 0.0 111.665 171.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.69 -45.54 93.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.071 1.305 . . . . 0.0 113.233 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -157.75 63.55 0.47 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.674 1.59 . . . . 0.0 108.446 -170.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -25.96 74.04 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 121.073 -1.017 . . . . 0.0 112.749 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -52.89 -36.54 59.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 112.195 -171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -77.05 -35.87 56.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.302 1.041 . . . . 0.0 110.005 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.03 -27.76 57.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.08 -55.6 9.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 167.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -63.8 -15.95 60.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.391 0.996 . . . . 0.0 113.472 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 119.634 1.106 . . . . 0.0 110.82 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.65 -50.29 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.279 1.031 . . . . 0.0 109.047 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.52 65.35 3.63 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.652 1.12 . . . . 0.0 112.775 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.06 144.76 4.64 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.31 138.28 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 168.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -138.88 162.66 34.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.046 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.3 144.56 40.29 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.749 1.22 . . . . 0.0 109.253 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -92.94 90.06 6.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.951 1.301 . . . . 0.0 108.945 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -74.62 107.56 6.82 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.717 -1.239 . . . . 0.0 109.526 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.67 110.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -115.77 -175.29 2.69 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 165.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t0 65.19 38.18 6.14 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.685 1.994 . . . . 0.0 112.578 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.44 -155.13 24.38 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.962 1.268 . . . . 0.0 111.801 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.75 110.06 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.658 2.239 . . . . 0.0 106.448 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.32 -70.5 0.23 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.028 0.823 . . . . 0.0 111.141 -166.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.92 21.44 36.2 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 118.476 1.138 . . . . 0.0 110.843 -162.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -75.52 -176.12 3.09 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 156.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.25 153.33 29.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.553 1.141 . . . . 0.0 108.363 166.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.69 170.85 13.29 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.36 1.864 . . . . 0.0 107.626 163.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.6 m -152.77 145.78 24.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 163.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -112.61 149.36 32.91 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 102.134 -3.284 . . . . 0.0 102.134 166.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 141.72 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 167.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.17 113.0 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -82.19 114.01 20.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.42 51.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -141.63 -54.22 0.46 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.4 153.02 34.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.729 0.812 . . . . 0.0 109.914 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.96 -134.37 11.65 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.366 0.984 . . . . 0.0 111.144 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.66 3.3 50.34 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.186 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.95 156.19 20.38 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -173.02 157.67 3.57 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 129.505 3.122 . . . . 0.0 107.599 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.15 153.62 3.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.0 mt -140.32 79.29 21.4 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -161.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.9 144.27 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.502 2.135 . . . . 0.0 110.331 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 47.09 24.47 0.4 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.761 2.024 . . . . 0.0 115.138 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -71.77 161.45 30.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.359 1.076 . . . . 0.0 111.479 -161.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.46 -15.73 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.632 1.973 . . . . 0.0 110.71 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -53.83 130.24 36.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.05 -176.03 2.82 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 165.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.54 152.45 45.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.82 0.848 . . . . 0.0 109.447 -174.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.15 -41.02 59.15 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.306 1.042 . . . . 0.0 109.516 -174.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -136.18 174.81 10.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.833 2.053 . . . . 0.0 107.889 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.49 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 23.7 m -155.35 122.71 5.55 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 tt -83.52 152.31 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.8 m -120.71 141.7 50.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.888 -1.133 . . . . 0.0 108.998 159.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.56 -103.41 0.2 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 163.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.21 159.25 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 130.56 3.544 . . . . 0.0 105.473 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.61 -41.2 69.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.834 0.854 . . . . 0.0 111.211 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 t -60.81 -21.23 62.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.632 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.32 -64.06 1.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.788 0.835 . . . . 0.0 109.387 172.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -55.85 -53.32 58.2 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.861 0.865 . . . . 0.0 110.299 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 tp -55.1 -54.72 39.6 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.54 -41.91 77.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.108 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -54.84 -65.02 0.65 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.776 0.716 . . . . 0.0 110.144 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . 0.275 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.49 ' CG2' ' H ' ' A' ' 72' ' ' THR 0.314 1.2 mp . . . . . 0 N--CA 1.433 -1.279 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 165.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.893 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.7 tp -77.92 -30.71 50.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.725 1.21 . . . . 0.0 110.789 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -134.99 44.48 2.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.508 1.923 . . . . 0.0 108.987 -165.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.307 0.4 OUTLIER . . . . . 0 CA--C 1.547 0.844 0 C-N-CA 129.494 3.118 . . . . 0.0 114.121 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 122.193 0.997 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 3.66 58.23 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.871 1.701 . . . . 0.0 112.031 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 2.3 m-30 -68.0 148.68 50.7 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 108.926 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -60.19 -21.99 62.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.308 0.643 . . . . 0.0 112.663 169.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -2.58 0.11 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 114.505 170.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -54.75 -51.87 64.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.931 1.242 . . . . 0.0 111.352 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -58.9 -36.34 74.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.325 1.05 . . . . 0.0 112.241 178.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.15 -51.76 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.493 1.042 . . . . 0.0 110.848 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -74.94 -14.72 60.67 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.989 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -74.62 -35.84 62.93 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 117.611 -1.185 . . . . 0.0 111.635 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -57.36 -29.06 63.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.995 1.27 . . . . 0.0 112.795 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.48 -56.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.453 1.901 . . . . 0.0 108.603 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.57 -47.44 63.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 110.609 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.71 -38.98 93.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.088 1.355 . . . . 0.0 109.825 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -69.32 -36.81 77.35 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.435 -0.79 . . . . 0.0 110.445 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -33.17 75.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.706 1.202 . . . . 0.0 112.188 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.83 -53.35 52.13 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.806 -1.184 . . . . 0.0 110.16 167.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.64 -42.55 83.66 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 112.648 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -160.27 40.34 0.18 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.0 -18.77 80.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.979 -172.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.28 -52.83 2.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.941 1.371 . . . . 0.0 111.529 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.16 77.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.456 0.646 . . . . 0.0 109.798 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.16 -29.25 67.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -53.75 -52.51 33.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.398 0.999 . . . . 0.0 108.699 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -62.18 -24.22 67.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.45 1.477 . . . . 0.0 113.641 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.64 -29.92 69.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.039 1.291 . . . . 0.0 112.175 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.34 -61.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.739 1.216 . . . . 0.0 108.533 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.54 64.48 3.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 125.79 1.662 . . . . 0.0 109.794 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.29 45.34 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.955 0.878 . . . . 0.0 113.809 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.37 138.29 24.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 158.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -135.37 164.49 27.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.858 0.299 . . . . 0.0 110.726 163.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.0 167.75 9.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 109.715 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.8 99.23 4.54 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -170.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -87.34 94.02 9.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.215 1.371 . . . . 0.0 110.607 -165.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.82 115.0 38.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.375 0.607 . . . . 0.0 109.787 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -115.29 174.14 6.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.922 1.289 . . . . 0.0 109.464 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.7 t0 44.13 47.23 7.49 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.165 0.916 . . . . 0.0 112.879 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 7' ' ' PHE . . . -69.71 173.27 37.97 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-O 118.564 -1.131 . . . . 0.0 111.834 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.25 94.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.818 3.012 . . . . 0.0 109.894 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.77 -3.48 14.89 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 126.674 2.083 . . . . 0.0 114.116 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.35 13.8 70.07 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.368 2.084 . . . . 0.0 112.284 160.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -85.79 -167.14 1.74 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.09 2.156 . . . . 0.0 108.502 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -134.11 147.76 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.854 1.661 . . . . 0.0 107.679 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.14 174.86 11.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.161 1.784 . . . . 0.0 108.122 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -155.54 155.83 34.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.116 1.366 . . . . 0.0 108.655 169.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.31 154.68 36.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 t -122.49 114.61 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.8 t -95.38 112.55 27.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.83 115.37 20.29 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.65 47.31 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 168.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.97 -49.92 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.513 1.525 . . . . 0.0 109.715 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.27 151.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.303 1.041 . . . . 0.0 108.208 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.11 -131.09 44.86 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -111.79 13.14 21.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.429 1.892 . . . . 0.0 109.717 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 156.66 29.45 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -172.62 161.56 4.92 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 128.182 2.593 . . . . 0.0 105.776 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.29 127.7 58.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -107.6 93.37 10.04 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 125.539 1.535 . . . . 0.0 108.061 -162.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.58 137.55 64.9 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.727 1.618 . . . . 0.0 110.297 -165.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.24 44.6 15.96 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.597 3.159 . . . . 0.0 109.06 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.69 147.01 53.9 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.916 0.865 . . . . 0.0 111.205 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.29 -24.68 39.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.547 158.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -60.43 117.12 4.86 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.157 0.979 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -72.21 -177.17 2.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.996 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.15 163.95 30.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.553 1.168 . . . . 0.0 111.542 -163.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -37.19 59.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.115 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.17 -178.85 5.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.273 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -139.03 -176.01 4.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.272 1.429 . . . . 0.0 108.123 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt -142.62 157.37 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 120.911 -1.118 . . . . 0.0 109.285 159.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 m -98.03 124.4 42.51 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 mtt -152.03 124.31 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 163.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 155.74 4.12 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.982 -0.449 . . . . 0.0 110.931 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -52.47 -49.59 64.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 110.871 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 t -65.4 -9.87 28.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.812 1.645 . . . . 0.0 111.603 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.17 -54.67 3.34 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.757 168.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -48.16 -54.34 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.081 0.855 . . . . 0.0 110.061 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.04 -51.08 62.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 125.818 1.647 . . . . 0.0 110.292 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.98 -24.77 66.36 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.052 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -67.91 -82.16 0.03 OUTLIER 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 ptm . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 126.295 1.838 . . . . 0.0 114.321 -163.842 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.273 21.8 mm . . . . . 0 C--N 1.316 -0.872 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.7 tp -57.47 -53.97 52.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.44 52.69 0.88 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.681 1.592 . . . . 0.0 110.666 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 122.221 1.01 . . . . 0.0 111.053 -170.06 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.52 62.67 0.3 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 119.606 -1.933 . . . . 0.0 111.965 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.431 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 32.5 m-85 -152.32 143.47 23.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.017 1.408 . . . . 0.0 110.938 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -17.7 62.54 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.637 167.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.33 -13.47 0.9 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.857 1.663 . . . . 0.0 113.706 167.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -56.26 -34.09 66.07 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.541 1.064 . . . . 0.0 112.208 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -31.53 25.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.56 -0.733 . . . . 0.0 112.088 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.87 -62.97 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 124.286 1.034 . . . . 0.0 108.907 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -67.51 -25.97 66.11 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.346 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -73.03 -34.33 66.26 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.537 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.66 -30.2 70.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 120.406 1.457 . . . . 0.0 112.588 172.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.3 mt -65.91 -52.99 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -56.38 -45.71 80.4 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.318 1.047 . . . . 0.0 112.303 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -59.81 -46.54 88.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -65.33 -39.34 92.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.795 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.35 -37.43 70.0 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 113.63 171.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.1 -53.4 50.24 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.205 1.002 . . . . 0.0 110.542 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -59.43 -46.02 89.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.307 1.412 . . . . 0.0 111.369 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -164.9 65.06 0.13 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.457 1.123 . . . . 0.0 113.341 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.57 79.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.048 1.309 . . . . 0.0 113.272 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.45 -36.93 67.1 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.811 1.305 . . . . 0.0 111.64 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.841 -1.162 . . . . 0.0 111.43 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.06 -25.8 61.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.432 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.24 -51.17 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.449 -0.786 . . . . 0.0 108.997 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.64 -37.34 75.73 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.801 1.182 . . . . 0.0 111.319 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -61.24 -65.76 0.64 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.626 0.77 . . . . 0.0 110.006 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mt -74.84 -66.87 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.51 66.24 2.53 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.819 1.2 . . . . 0.0 111.051 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.79 37.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 171.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.93 134.62 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 158.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -137.18 167.52 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 171.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 141.15 47.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.921 0.782 . . . . 0.0 112.864 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -87.26 103.78 15.77 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.142 0.977 . . . . 0.0 109.832 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -74.09 95.79 2.61 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 119.54 1.064 . . . . 0.0 109.764 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.14 108.9 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.28 179.25 4.21 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.679 1.191 . . . . 0.0 108.322 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 t70 49.51 42.79 23.28 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.631 1.172 . . . . 0.0 110.724 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 7' ' ' PHE . . . -66.86 168.63 36.19 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.148 -1.362 . . . . 0.0 110.413 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 92.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.829 3.019 . . . . 0.0 113.324 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.93 3.34 51.99 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.718 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.02 40.99 1.34 Allowed Glycine 0 C--N 1.339 0.734 0 CA-C-N 120.61 2.205 . . . . 0.0 111.307 164.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.04 -176.98 6.18 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.535 -0.979 . . . . 0.0 111.086 174.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -147.67 140.65 24.96 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.589 2.355 . . . . 0.0 107.381 163.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.25 166.33 30.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.3 m -143.88 147.73 34.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -122.44 132.81 54.53 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.97 151.29 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -126.66 104.84 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.85 105.16 15.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.34 55.18 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.839 0.745 . . . . 0.0 109.391 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -155.12 -43.66 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.674 1.19 . . . . 0.0 111.194 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -95.92 110.26 22.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.41 1.484 . . . . 0.0 107.557 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.49 -153.6 39.15 Favored Glycine 0 N--CA 1.46 0.261 0 O-C-N 119.882 -1.761 . . . . 0.0 111.618 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -5.45 57.02 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.771 0.828 . . . . 0.0 112.614 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.28 157.68 30.12 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-O 122.238 0.91 . . . . 0.0 110.973 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.84 165.41 6.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.125 3.37 . . . . 0.0 107.905 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.89 89.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 120.747 -1.221 . . . . 0.0 107.945 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.66 103.58 0.88 Allowed Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -164.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.94 143.83 41.73 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.678 1.585 . . . . 0.0 110.14 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 47.7 23.77 0.47 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.941 2.496 . . . . 0.0 113.427 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -78.49 149.21 33.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.405 0.621 . . . . 0.0 110.211 -153.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.55 -2.47 58.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.625 1.97 . . . . 0.0 111.183 168.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.09 130.57 46.7 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 155.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -177.28 1.9 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.28 159.34 39.39 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.983 1.713 . . . . 0.0 107.722 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -35.87 73.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.61 -167.19 2.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.519 1.528 . . . . 0.0 110.794 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 m -133.28 -176.62 4.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.766 1.226 . . . . 0.0 109.578 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tt -142.37 143.55 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.065 -1.022 . . . . 0.0 108.774 151.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 m -84.64 138.91 32.42 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.6 tpp -136.17 -57.88 0.75 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.308 1.413 . . . . 0.0 110.466 149.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.69 152.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 130.433 3.493 . . . . 0.0 111.634 -157.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.13 -48.62 75.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 123.717 0.807 . . . . 0.0 110.403 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 p -66.29 -5.34 10.16 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.751 1.22 . . . . 0.0 111.688 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 -47.87 3.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 161.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -55.81 -52.12 65.08 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.813 1.642 . . . . 0.0 110.179 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tp -55.12 -41.9 72.28 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.187 1.795 . . . . 0.0 112.606 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.82 79.92 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.776 0.43 . . . . 0.0 111.578 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -68.59 -76.14 0.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.055 1.742 . . . . 0.0 110.757 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptm . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 125.071 1.349 . . . . 0.0 113.902 -173.574 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -172.711 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.95 -21.53 59.99 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 120.931 -1.105 . . . . 0.0 110.418 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.82 53.1 1.49 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.064 0.945 . . . . 0.0 109.648 -167.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 126.044 1.737 . . . . 0.0 112.568 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 122.111 0.957 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.57 35.48 0.38 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.761 1.172 . . . . 0.0 112.512 -174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.317 1.058 . . . . 0.0 110.349 173.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -54.15 -34.85 61.39 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.718 -0.614 . . . . 0.0 110.525 164.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.21 -10.96 1.42 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.206 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -60.61 -26.67 67.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.984 1.72 . . . . 0.0 110.969 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -81.56 -38.38 26.24 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.243 1.383 . . . . 0.0 112.039 169.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.81 -53.47 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 119.39 0.995 . . . . 0.0 110.591 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -67.91 -22.59 65.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.136 -0.625 . . . . 0.0 111.353 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -75.1 -30.33 60.87 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.58 -46.52 83.89 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.375 0.534 . . . . 0.0 109.72 170.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.54 -50.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -52.62 -55.68 20.74 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 124.374 1.07 . . . . 0.0 111.5 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -55.19 -48.65 73.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.546 1.138 . . . . 0.0 108.375 -171.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -48.96 79.16 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.642 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.19 70.22 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.328 59.2 mm-40 -66.2 -51.22 59.83 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 124.434 1.094 . . . . 0.0 110.828 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.37 -46.5 80.03 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.19 -0.944 . . . . 0.0 111.856 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -165.63 61.75 0.11 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.969 1.307 . . . . 0.0 109.456 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -24.01 72.58 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.963 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.43 -28.82 65.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.765 1.783 . . . . 0.0 113.596 -165.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.29 -25.47 16.32 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.488 2.715 . . . . 0.0 110.95 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -73.77 -28.85 61.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.724 2.01 . . . . 0.0 110.39 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -53.23 -44.34 52.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.585 1.154 . . . . 0.0 109.029 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.87 -27.78 69.04 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -71.04 -28.85 64.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.844 1.202 . . . . 0.0 112.277 -167.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.76 -59.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.3 73.96 0.51 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.739 1.161 . . . . 0.0 110.343 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.56 177.09 45.27 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.896 0.848 . . . . 0.0 112.148 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.56 147.36 6.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 144.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -138.27 176.25 8.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 154.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.24 174.53 7.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.551 156.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -116.38 122.69 45.58 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.588 1.555 . . . . 0.0 107.836 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -100.05 104.93 16.54 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 121.12 1.782 . . . . 0.0 106.628 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.58 94.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -162.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -94.53 177.73 5.83 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.869 -1.145 . . . . 0.0 108.414 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.8 t0 60.31 33.3 20.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.344 1.057 . . . . 0.0 111.601 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.46 174.6 38.25 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 118.409 -1.217 . . . . 0.0 111.381 170.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.7 95.66 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.508 2.805 . . . . 0.0 110.528 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.69 -16.57 4.78 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.122 2.296 . . . . 0.0 112.871 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.28 3.72 88.65 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 118.919 1.359 . . . . 0.0 112.086 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -69.5 -174.78 0.73 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.312 2.645 . . . . 0.0 109.444 170.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -126.91 168.74 14.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.079 0.552 . . . . 0.0 110.829 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.39 175.07 10.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.881 1.672 . . . . 0.0 109.338 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.0 m -149.75 149.09 30.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.256 1.022 . . . . 0.0 109.917 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.7 151.63 40.29 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 t -120.55 133.94 65.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 126.853 2.061 . . . . 0.0 105.985 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.85 114.5 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.15 114.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.97 54.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.34 -45.41 0.05 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.166 1.386 . . . . 0.0 109.106 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -74.91 135.44 41.48 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.37 -133.19 11.0 Favored Glycine 0 C--N 1.333 0.362 0 O-C-N 123.69 0.618 . . . . 0.0 111.885 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.46 4.15 47.57 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.418 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.24 156.89 28.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-O 123.22 1.456 . . . . 0.0 110.212 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -172.31 144.4 1.56 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.005 2.922 . . . . 0.0 109.689 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.97 157.01 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mt -134.71 79.23 53.41 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -166.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.87 132.83 38.82 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.122 2.548 . . . . 0.0 110.81 -166.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.2 23.77 4.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.539 1.936 . . . . 0.0 111.891 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -82.69 145.91 29.35 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.449 -0.782 . . . . 0.0 110.104 -162.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -85.16 -9.45 57.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.748 1.619 . . . . 0.0 111.791 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -53.4 142.36 22.01 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.945 -1.097 . . . . 0.0 110.435 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -71.02 -175.58 1.18 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 111.779 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.58 165.09 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.22 -62.49 1.55 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.562 1.145 . . . . 0.0 112.157 157.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -154.54 166.91 31.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.871 1.669 . . . . 0.0 108.991 -170.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -138.61 126.65 22.58 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 tt -82.53 165.48 2.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 m -102.35 126.37 49.34 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -157.82 132.07 8.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 158.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.21 154.39 39.94 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.456 1.102 . . . . 0.0 110.081 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -49.69 -48.59 49.56 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.535 1.534 . . . . 0.0 112.389 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -59.04 -24.99 63.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 110.948 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.38 -26.44 11.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.465 0.706 . . . . 0.0 110.89 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.48 ' CZ ' ' HG3' ' A' ' 75' ' ' MET . 66.1 m-85 -57.85 -57.97 10.44 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 158.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.47 -35.82 53.51 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.547 -0.72 . . . . 0.0 111.977 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.92 94.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mt -69.94 -67.1 0.51 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 110.107 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.341 0.225 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -167.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt . . . . . 0 N--CA 1.441 -0.895 0 N-CA-C 101.974 -3.343 . . . . 0.0 101.974 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.0 mm . . . . . 0 C--N 1.312 -1.044 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -157.679 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.07 -5.01 32.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.339 0.972 . . . . 0.0 111.671 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -149.49 44.46 0.94 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 128.639 2.775 . . . . 0.0 109.58 -170.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.379 0.2 OUTLIER . . . . . 0 C--N 1.352 0.681 0 C-N-CA 127.348 2.259 . . . . 0.0 112.756 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.06 68.56 0.42 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 125.225 1.393 . . . . 0.0 111.025 -163.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -153.42 159.87 42.47 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.727 2.011 . . . . 0.0 107.34 -168.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.71 -34.6 73.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 167.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.21 -10.5 0.37 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.805 2.042 . . . . 0.0 114.607 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -55.16 -52.52 63.05 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 120.347 1.43 . . . . 0.0 111.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -65.22 -33.63 76.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.434 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.66 -54.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.144 0.884 . . . . 0.0 110.248 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -68.95 -23.19 64.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.261 0.482 . . . . 0.0 111.646 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -37.57 80.99 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 116.591 -1.671 . . . . 0.0 111.835 173.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -65.45 -38.16 89.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.678 1.581 . . . . 0.0 111.256 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 60.0 mt -52.86 -47.91 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -64.51 -43.04 95.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.886 0.474 . . . . 0.0 111.826 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -63.18 -42.95 99.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -60.16 -35.71 75.94 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.142 -0.974 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.29 -27.26 62.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -63.86 -54.05 41.07 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.19 -0.944 . . . . 0.0 109.079 163.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.06 -43.81 98.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.648 0.779 . . . . 0.0 110.05 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -165.09 64.9 0.12 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.408 1.483 . . . . 0.0 109.064 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.89 -17.28 79.3 Favored Glycine 0 CA--C 1.519 0.334 0 O-C-N 120.959 -1.088 . . . . 0.0 113.166 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' CB ' ' HE3' ' A' ' 58' ' ' LYS . 5.9 pt-20 -58.21 -33.98 69.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.99 0.895 . . . . 0.0 112.197 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -79.98 -39.35 30.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.775 1.63 . . . . 0.0 109.463 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.39 -29.53 70.82 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.27 -52.25 53.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 119.214 0.916 . . . . 0.0 110.6 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -68.41 -18.04 64.35 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.299 -0.876 . . . . 0.0 112.621 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -72.55 -69.49 0.4 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 120.333 1.424 . . . . 0.0 109.195 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.32 -54.84 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -171.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.29 65.01 3.43 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.06 158.07 21.91 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 167.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.27 137.51 22.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 159.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -132.41 168.81 17.49 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.661 -0.649 . . . . 0.0 109.426 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.06 158.87 26.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.09 113.39 26.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.503 1.521 . . . . 0.0 108.629 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.27 117.3 23.46 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.34 1.882 . . . . 0.0 114.181 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.67 101.28 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -109.45 -169.96 1.57 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 165.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t0 54.12 39.28 30.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.822 2.049 . . . . 0.0 111.917 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.22 176.55 17.68 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.721 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.88 -8.04 12.77 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.451 2.1 . . . . 0.0 114.119 -174.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.69 4.84 19.1 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.629 1.585 . . . . 0.0 114.617 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.61 77.57 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 120.179 1.989 . . . . 0.0 112.805 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -85.57 -171.77 3.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.062 2.945 . . . . 0.0 110.164 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.45 150.5 39.1 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.87 162.77 28.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 131.528 3.931 . . . . 0.0 107.498 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 m -154.91 140.94 18.36 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 161.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -112.19 154.72 25.11 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 170.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.1 t -118.93 122.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.13 109.97 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 107.681 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -85.4 48.52 1.59 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.077 1.351 . . . . 0.0 112.242 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 m -75.74 53.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 119.998 -1.689 . . . . 0.0 110.977 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.06 -46.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.226 1.81 . . . . 0.0 108.908 174.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.4 143.19 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -168.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.54 -131.57 51.18 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HE3' ' CB ' ' A' ' 25' ' ' GLU . 2.8 mmmt -97.94 5.18 49.2 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.351 1.06 . . . . 0.0 111.346 168.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.77 157.8 20.33 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 119.885 1.22 . . . . 0.0 110.637 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.8 m -171.54 162.49 6.52 Favored 'General case' 0 N--CA 1.442 -0.844 1 C-N-CA 132.386 4.274 . . . . 0.0 105.201 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.94 157.41 10.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 mt -129.03 122.55 21.34 Favored Pre-proline 0 N--CA 1.441 -0.897 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -89.74 145.45 4.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.787 2.991 . . . . 0.0 108.849 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 35.49 41.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.088 1.755 . . . . 0.0 114.039 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -68.25 148.9 50.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.722 0.809 . . . . 0.0 109.098 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -86.19 -20.24 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.402 1.081 . . . . 0.0 111.303 163.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -52.3 125.06 14.84 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -62.44 -177.45 0.14 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.165 0.983 . . . . 0.0 109.036 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.36 149.06 33.05 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.609 1.164 . . . . 0.0 109.997 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -43.45 51.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.812 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -127.27 174.23 9.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.511 1.924 . . . . 0.0 109.136 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 73' ' ' ILE . 1.9 m -133.75 -169.68 2.35 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.445 ' H ' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER -155.37 154.67 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 169.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -121.64 128.4 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.6 mtm -136.27 -29.15 1.0 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 117.367 -1.301 . . . . 0.0 111.718 165.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.81 153.6 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.872 1.269 . . . . 0.0 109.517 -166.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.47 -44.06 72.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.382 1.473 . . . . 0.0 111.216 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.0 t -56.81 -39.31 73.91 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.068 2.547 . . . . 0.0 109.925 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.19 -42.39 10.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.522 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.39 -52.32 62.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.34 1.056 . . . . 0.0 110.489 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.39 -53.45 56.49 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.68 -19.26 15.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.612 0.765 . . . . 0.0 113.054 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -79.81 0.05 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.6 pttp . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.321 33.4 mm . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.722 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p30 . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.47 -56.19 18.98 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.728 0.811 . . . . 0.0 109.294 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.12 44.88 1.21 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.976 0.51 . . . . 0.0 110.49 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--O 1.235 0.324 0 C-N-CA 125.571 1.548 . . . . 0.0 112.933 -170.14 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.271 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.27 74.87 0.29 Allowed Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.243 -1.535 . . . . 0.0 111.492 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -153.87 158.74 41.22 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.606 1.562 . . . . 0.0 109.955 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -75.05 -13.34 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.841 165.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.86 -30.25 5.59 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.585 1.084 . . . . 0.0 112.575 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 127.135 2.174 . . . . 0.0 110.479 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.83 -31.43 71.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.191 1.396 . . . . 0.0 110.859 -174.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 t -90.63 -45.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.222 2.609 . . . . 0.0 110.989 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -65.14 -37.34 87.1 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.093 0.861 . . . . 0.0 111.797 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -52.25 -37.1 54.4 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 170.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.69 -41.27 96.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.921 0.782 . . . . 0.0 110.906 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.17 -51.68 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.29 -43.71 83.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.807 1.643 . . . . 0.0 112.768 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -65.32 -51.46 60.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -59.58 -38.97 82.59 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.317 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -37.95 71.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.52 -53.38 43.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.29 -0.881 . . . . 0.0 111.938 165.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -55.21 -43.93 74.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.041 1.336 . . . . 0.0 112.136 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -165.42 65.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.621 2.768 . . . . 0.0 108.525 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.89 -25.66 75.36 Favored Glycine 0 CA--C 1.518 0.224 0 O-C-N 120.691 -1.256 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -44.22 62.44 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.952 0.876 . . . . 0.0 111.58 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -77.43 -22.66 51.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 121.426 -0.796 . . . . 0.0 110.815 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.17 -29.04 54.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -55.47 -38.83 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.153 0.888 . . . . 0.0 109.417 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -69.48 -11.17 60.61 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.53 -1.356 . . . . 0.0 114.013 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -78.07 -61.7 1.91 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 121.405 1.911 . . . . 0.0 111.199 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.77 -58.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.02 62.64 4.55 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 126.756 2.122 . . . . 0.0 112.724 -170.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.54 164.38 34.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 125.275 1.417 . . . . 0.0 110.657 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.03 128.36 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 159.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -129.82 159.36 36.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 110.899 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.74 166.67 10.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 109.212 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.09 91.92 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -172.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -78.84 104.41 9.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.307 0.958 . . . . 0.0 109.073 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.59 103.5 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -92.83 -171.03 2.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 170.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.8 t0 62.22 51.62 3.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 123.23 1.491 . . . . 0.0 111.333 148.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.87 -162.64 11.78 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 126.849 2.166 . . . . 0.0 109.627 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.9 85.84 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 124.053 3.169 . . . . 0.0 110.619 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.13 -20.87 4.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.826 1.679 . . . . 0.0 113.467 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.07 22.67 65.22 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 120.035 1.917 . . . . 0.0 111.285 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -79.06 -169.58 1.88 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.318 1.447 . . . . 0.0 108.409 168.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.0 141.67 50.72 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.573 0.749 . . . . 0.0 109.378 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.97 160.98 14.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.016 2.527 . . . . 0.0 107.721 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.5 m -140.05 142.56 36.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 147.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.1 140.83 47.54 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 161.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.13 142.16 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.51 113.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 42.49 1.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.848 1.659 . . . . 0.0 112.197 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 m -74.63 60.37 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.822 1.249 . . . . 0.0 111.117 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -148.99 -46.14 0.14 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.234 1.814 . . . . 0.0 109.584 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -82.08 142.31 32.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.12 -127.71 25.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.953 0.797 . . . . 0.0 113.119 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -92.55 1.44 57.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.606 1.162 . . . . 0.0 111.909 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.12 157.83 15.33 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 120.185 1.357 . . . . 0.0 110.263 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -171.17 165.64 7.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 129.461 3.104 . . . . 0.0 108.509 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -107.96 156.12 8.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.086 1.754 . . . . 0.0 109.039 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -142.23 75.08 20.34 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 -162.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -63.18 140.07 75.83 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.357 2.038 . . . . 0.0 109.531 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 51.43 23.56 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.709 1.603 . . . . 0.0 114.132 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 t -79.22 144.5 34.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.485 0.659 . . . . 0.0 111.406 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.52 8.36 3.59 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 126.021 1.728 . . . . 0.0 111.057 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.91 135.22 57.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.437 -2.039 . . . . 0.0 109.546 162.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -66.95 -173.34 0.24 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.535 1.534 . . . . 0.0 109.482 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 165.85 33.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.293 1.037 . . . . 0.0 109.907 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.08 -50.32 16.78 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.068 160.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.4 m -134.83 -178.65 5.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.891 0.769 . . . . 0.0 111.461 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.564 HG21 ' H ' ' A' ' 73' ' ' ILE . 14.1 m -149.2 -164.66 2.08 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.564 ' H ' HG21 ' A' ' 72' ' ' THR . 5.6 tt -150.75 165.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 125.566 1.546 . . . . 0.0 107.159 161.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.457 ' H ' ' HA ' ' A' ' 100' ' ' LYS . 72.9 m -121.48 136.23 54.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.181 161.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.05 -98.33 0.15 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 152.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 178.0 152.24 0.27 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.755 3.222 . . . . 0.0 106.992 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.17 -40.59 90.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.796 1.638 . . . . 0.0 110.159 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.4 p -58.68 -22.77 57.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.771 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -105.72 -40.79 5.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.661 1.184 . . . . 0.0 109.982 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -53.99 50.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.342 1.457 . . . . 0.0 111.904 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -54.66 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.03 -12.9 58.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.896 -1.526 . . . . 0.0 114.043 -168.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.55 -76.33 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.765 1.626 . . . . 0.0 108.996 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.241 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HA ' ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -176.466 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -15.39 25.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.535 0.734 . . . . 0.0 112.283 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -128.17 49.34 2.18 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.495 1.518 . . . . 0.0 109.104 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 C--N 1.344 0.354 0 C-N-CA 125.8 1.64 . . . . 0.0 111.823 -172.611 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.88 4.46 6.95 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.714 1.149 . . . . 0.0 112.483 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -65.51 160.2 22.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.583 1.191 . . . . 0.0 109.092 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -7.18 14.6 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.21 0.45 7.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 113.192 165.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -53.15 -53.62 47.76 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.482 1.492 . . . . 0.0 111.311 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -57.29 -35.72 70.16 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.346 1.059 . . . . 0.0 113.439 173.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -47.81 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.565 1.546 . . . . 0.0 110.463 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -72.73 -33.62 66.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.332 0.969 . . . . 0.0 111.057 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -71.37 -24.57 62.11 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.421 -0.799 . . . . 0.0 112.777 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.08 -49.24 72.17 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.72 -0.613 . . . . 0.0 112.338 164.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -57.45 -48.85 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -58.15 -54.39 47.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.244 1.417 . . . . 0.0 110.984 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -36.31 81.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.406 1.003 . . . . 0.0 109.547 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -67.38 -39.71 85.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.568 1.147 . . . . 0.0 110.67 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -31.29 72.1 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.26 -51.69 65.11 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.677 173.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.31 -46.47 88.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 118.547 -1.261 . . . . 0.0 111.81 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -160.6 42.49 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.986 1.374 . . . . 0.0 112.306 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -52.57 -20.43 7.59 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.978 1.275 . . . . 0.0 114.856 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -58.0 -23.46 54.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.774 1.787 . . . . 0.0 113.866 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.35 -23.97 16.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.93 0.786 . . . . 0.0 109.145 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.23 -31.27 60.81 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.511 -1.368 . . . . 0.0 108.555 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -52.11 -41.33 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.297 1.839 . . . . 0.0 109.6 163.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -70.89 -37.52 73.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.723 1.147 . . . . 0.0 110.985 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -60.2 -61.56 2.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.069 0.85 . . . . 0.0 110.055 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.06 -57.05 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -172.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.31 52.85 36.68 Favored Glycine 0 CA--C 1.525 0.715 0 O-C-N 121.143 -0.973 . . . . 0.0 112.566 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.82 143.33 4.28 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.44 144.22 12.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -140.64 168.57 19.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.967 -0.458 . . . . 0.0 110.507 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.84 131.48 54.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.231 . . . . 0.0 109.787 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -84.91 104.26 14.7 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.808 1.243 . . . . 0.0 108.08 172.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -78.82 100.96 7.39 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 120.815 1.643 . . . . 0.0 110.408 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.48 93.54 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 175.09 6.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.272 -0.892 . . . . 0.0 111.274 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 59.37 24.31 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.695 2.398 . . . . 0.0 113.634 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 177.82 3.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.004 -167.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.52 91.67 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.15 2.566 . . . . 0.0 109.489 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.67 -72.87 0.44 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.052 1.31 . . . . 0.0 112.888 -156.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.04 -7.64 7.21 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.56 1.552 . . . . 0.0 112.894 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -69.47 -174.31 0.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.907 1.283 . . . . 0.0 110.837 170.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.7 147.3 49.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 108.474 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.22 167.62 17.37 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.251 2.62 . . . . 0.0 107.8 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 m -155.57 144.57 20.69 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.307 -0.871 . . . . 0.0 109.136 170.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.64 118.95 30.44 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -78.96 128.52 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.08 107.65 23.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -82.12 110.67 17.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.36 48.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 172.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -133.54 -49.34 0.84 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 165.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -90.41 136.49 33.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.7 -142.26 41.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -80.22 -3.76 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.334 1.453 . . . . 0.0 114.351 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.47 156.58 6.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.654 1.116 . . . . 0.0 111.526 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m -172.62 151.85 2.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 129.123 2.969 . . . . 0.0 107.958 169.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.35 126.07 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt -103.4 99.74 16.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.45 147.87 53.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.852 2.368 . . . . 0.0 108.937 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 47.49 23.48 0.39 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.362 1.865 . . . . 0.0 113.683 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 t -81.88 155.87 25.11 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.408 1.099 . . . . 0.0 111.424 -156.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -25.45 27.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.408 1.083 . . . . 0.0 109.946 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -74.28 129.44 37.81 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.802 0.728 . . . . 0.0 109.153 -166.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -73.11 -177.83 2.62 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.797 1.239 . . . . 0.0 112.41 -163.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.05 174.62 5.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.336 -165.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -57.08 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.002 -1.686 . . . . 0.0 108.353 148.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.41 -177.74 5.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.568 1.947 . . . . 0.0 109.413 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 m -131.15 -173.72 3.18 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.841 -1.162 . . . . 0.0 107.958 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 tt -155.17 146.7 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.3 m -111.19 132.02 54.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 117.122 -1.418 . . . . 0.0 107.68 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.9 mtm -137.08 -48.5 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.854 -1.07 . . . . 0.0 111.993 166.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.54 153.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.362 3.065 . . . . 0.0 110.81 -161.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.93 -39.99 93.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.142 0.901 . . . . 0.0 108.67 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.74 68.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.077 0.465 . . . . 0.0 110.362 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.51 -49.45 6.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.556 -1.212 . . . . 0.0 107.812 -168.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -56.98 -40.53 76.69 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.471 1.108 . . . . 0.0 110.977 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.4 tp -64.28 -60.52 3.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.49 -35.59 65.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.248 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.34 -70.53 0.09 Allowed 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.107 1.763 . . . . 0.0 108.143 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptp . . . . . 0 CA--C 1.53 0.198 0 CA-C-N 118.565 0.62 . . . . 0.0 111.906 -172.657 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -166.789 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 C--O 1.227 -0.127 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tp 48.85 -61.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.728 2.011 . . . . 0.0 111.384 -152.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -135.11 62.88 1.63 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 127.372 2.269 . . . . 0.0 109.895 -163.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.31 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 126.608 1.963 . . . . 0.0 113.175 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 122.34 1.067 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.86 84.4 0.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -164.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -153.8 170.59 20.6 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 128.83 2.852 . . . . 0.0 104.501 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -29.77 70.76 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.299 -0.875 . . . . 0.0 110.078 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.86 -11.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.316 1.846 . . . . 0.0 114.815 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -53.7 -40.55 66.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.675 1.579 . . . . 0.0 110.856 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -65.47 -36.68 84.61 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.757 176.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.77 -59.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.179 0.992 . . . . 0.0 110.839 -173.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -63.71 -23.99 67.59 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.982 0.81 . . . . 0.0 110.923 -171.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -70.34 -25.46 63.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -67.59 -40.8 84.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.602 0.637 . . . . 0.0 110.939 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.68 -48.64 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.384 1.474 . . . . 0.0 107.56 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -51.26 -49.93 60.23 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.053 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -58.68 -40.65 84.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -47.41 76.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.73 1.212 . . . . 0.0 111.707 173.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -33.1 63.83 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.427 0.691 . . . . 0.0 112.009 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.94 -52.59 55.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.828 -1.17 . . . . 0.0 110.22 169.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -53.7 -45.98 70.58 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.949 1.25 . . . . 0.0 111.315 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -162.36 49.76 0.18 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.859 0.838 . . . . 0.0 112.349 -170.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.36 -28.3 61.75 Favored Glycine 0 C--O 1.223 -0.585 0 O-C-N 120.496 -1.378 . . . . 0.0 113.273 -174.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.85 -24.65 64.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -78.31 -41.7 32.96 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.716 -1.24 . . . . 0.0 110.138 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.1 -36.05 81.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 108.659 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 t -51.01 -42.11 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 127.834 2.453 . . . . 0.0 111.018 169.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -72.29 -23.77 61.23 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.458 -1.401 . . . . 0.0 111.052 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -89.57 -14.17 35.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -173.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.9 -55.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.484 1.514 . . . . 0.0 107.535 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.39 59.85 7.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 124.85 1.214 . . . . 0.0 111.888 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.04 -177.96 43.6 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.25 138.38 31.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 160.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -129.03 164.72 22.63 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.331 0.586 . . . . 0.0 110.255 165.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.33 166.18 11.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.1 163.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -123.18 98.36 5.84 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.588 1.555 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 109.21 7.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 120.218 1.372 . . . . 0.0 109.282 172.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.41 93.48 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -96.55 177.89 5.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.959 1.704 . . . . 0.0 109.923 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 65.01 24.52 12.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.081 1.352 . . . . 0.0 112.482 162.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.56 -168.38 33.68 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.835 1.683 . . . . 0.0 112.394 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.71 96.12 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.305 2.67 . . . . 0.0 110.079 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.09 -13.05 10.52 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 127.663 2.554 . . . . 0.0 112.582 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.59 21.08 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 126.108 1.813 . . . . 0.0 112.537 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -51.03 -175.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 129.251 3.02 . . . . 0.0 111.809 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.07 161.46 33.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.834 0.826 . . . . 0.0 110.964 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.37 173.63 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.745 2.418 . . . . 0.0 107.862 161.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.7 m -140.73 156.58 46.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -124.73 149.82 46.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 164.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.96 143.02 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.3 110.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.48 122.26 24.98 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 164.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.78 46.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -138.83 -46.53 0.49 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.101 0.961 . . . . 0.0 110.639 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.68 103.13 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -156.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.03 -118.29 7.16 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.884 -1.135 . . . . 0.0 111.123 -170.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -74.82 -5.12 41.78 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 171.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.98 -103.4 0.77 Allowed Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 127.774 2.606 . . . . 0.0 108.232 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 m 97.39 157.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 135.444 5.497 . . . . 0.0 110.147 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.5 t -77.09 157.97 5.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.9 mt -143.72 84.88 9.58 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 -169.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.1 152.52 76.34 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 N-CA-C 108.202 -1.499 . . . . 0.0 108.202 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.3 23.52 4.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.196 1.398 . . . . 0.0 112.188 170.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -82.65 146.49 29.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.267 -0.896 . . . . 0.0 110.86 -154.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.45 -0.34 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.634 163.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -59.16 139.75 56.6 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.997 1.272 . . . . 0.0 108.061 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -69.43 -176.43 0.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.23 159.59 43.47 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.401 0.68 . . . . 0.0 111.03 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -36.6 65.34 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.354 1.062 . . . . 0.0 111.494 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.21 -177.05 6.07 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.09 1.756 . . . . 0.0 109.018 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 m -133.35 -172.7 3.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.87 146.64 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.7 m -103.76 131.08 51.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 mtp -137.09 -48.88 0.61 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.83 160.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 129.948 3.299 . . . . 0.0 109.57 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.01 -46.89 71.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.389 1.876 . . . . 0.0 109.693 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -62.65 -18.77 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 112.281 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -105.97 -37.15 6.74 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.699 0.8 . . . . 0.0 112.143 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -65.79 -54.17 30.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.687 1.195 . . . . 0.0 110.674 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.21 -36.09 80.88 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.76 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -48.22 -38.33 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.541 1.136 . . . . 0.0 112.546 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -74.12 0.06 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 174.568 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.503 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 174.637 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.57 -3.55 57.77 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.26 -0.9 . . . . 0.0 110.872 170.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -164.79 48.27 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.883 1.273 . . . . 0.0 111.76 -164.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.474 0.729 0 C-N-CA 127.362 2.265 . . . . 0.0 114.595 -175.776 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.317 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.48 10.29 33.03 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 119.255 -2.153 . . . . 0.0 114.335 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.7 171.37 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.576 1.15 . . . . 0.0 112.856 -160.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.35 -23.77 51.0 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.727 -1.233 . . . . 0.0 111.62 163.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.17 -20.58 42.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.784 1.174 . . . . 0.0 113.496 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -73.23 -19.16 61.14 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.927 1.691 . . . . 0.0 111.146 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.51 -63.45 1.37 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.167 1.787 . . . . 0.0 106.289 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 84' ' ' MET . 4.6 t -59.58 -56.87 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.085 1.354 . . . . 0.0 112.518 -167.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.49 -21.68 64.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.248 0.931 . . . . 0.0 110.986 -173.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -67.06 -34.01 76.76 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.495 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -59.02 -33.84 71.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.642 1.11 . . . . 0.0 112.163 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -72.18 -46.75 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -55.6 -49.5 72.62 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.323 1.049 . . . . 0.0 111.48 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.082 0.953 . . . . 0.0 109.388 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -70.07 -39.37 75.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.482 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -43.15 79.95 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.645 1.111 . . . . 0.0 113.034 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -63.71 -51.99 62.57 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.278 1.431 . . . . 0.0 110.186 173.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.65 -46.24 87.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.4 -1.438 . . . . 0.0 112.755 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -166.34 62.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.41 1.484 . . . . 0.0 111.976 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.97 -20.19 79.73 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 125.36 1.457 . . . . 0.0 113.528 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -33.79 24.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.681 1.24 . . . . 0.0 112.996 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.451 ' OE1' ' HE2' ' A' ' 30' ' ' LYS . 1.1 tm0? -91.71 -35.25 14.27 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.454 1.502 . . . . 0.0 110.702 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.53 -34.77 71.35 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 108.967 168.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -57.64 -62.35 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 119.824 1.193 . . . . 0.0 108.612 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.79 -20.06 60.75 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.451 ' HE2' ' OE1' ' A' ' 26' ' ' GLN . 53.1 mttm -67.93 -67.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.905 1.282 . . . . 0.0 111.44 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.6 -60.53 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 109.196 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.05 9.91 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.072 1.796 . . . . 0.0 113.817 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.73 176.51 44.19 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 117.955 0.878 . . . . 0.0 111.493 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 mt -102.14 138.16 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 162.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -135.86 157.84 45.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.79 167.19 10.04 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.293 1.037 . . . . 0.0 109.865 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -129.57 105.78 8.3 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.917 1.687 . . . . 0.0 108.644 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -74.38 121.57 21.6 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 168.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 t -119.23 110.69 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -114.03 174.79 5.76 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t0 61.59 24.8 14.84 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.504 1.522 . . . . 0.0 112.478 173.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.87 -176.81 23.15 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.859 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.67 44.3 0.32 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.625 3.55 . . . . 0.0 113.428 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.24 -19.76 0.02 OUTLIER Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.288 2.375 . . . . 0.0 112.698 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.48 -7.71 81.36 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 120.853 2.326 . . . . 0.0 113.351 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -69.19 -173.28 0.51 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.608 157.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.22 158.73 36.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.564 1.945 . . . . 0.0 108.697 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.9 174.69 6.3 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.156 2.182 . . . . 0.0 107.51 166.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.6 m -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.145 0.978 . . . . 0.0 108.989 161.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -118.73 152.96 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 170.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.1 t -115.62 135.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 171.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.5 t -116.6 120.79 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.63 116.71 28.73 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.0 52.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -145.31 -49.5 0.24 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.638 1.175 . . . . 0.0 110.371 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -90.61 139.46 30.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -164.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.83 -135.48 46.33 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -89.79 6.62 40.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.053 1.741 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.24 158.14 27.33 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -172.13 145.64 1.8 Allowed 'General case' 0 C--O 1.237 0.447 0 C-N-CA 127.006 2.122 . . . . 0.0 105.588 159.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 157.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mt -136.28 80.57 39.83 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.34 145.17 87.9 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.234 1.956 . . . . 0.0 109.043 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.91 23.95 3.1 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.582 2.353 . . . . 0.0 112.2 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -89.95 140.5 29.57 Favored 'General case' 0 CA--C 1.524 -0.052 0 O-C-N 120.417 -1.427 . . . . 0.0 109.489 -163.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.8 -22.63 65.16 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.374 0.67 . . . . 0.0 111.345 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -58.27 130.3 46.06 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.372 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -60.78 -176.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.235 1.414 . . . . 0.0 111.316 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.26 173.2 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 110.567 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -49.18 19.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 163.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.3 m -146.6 -179.43 6.76 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.641 1.576 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.539 ' CG2' ' H ' ' A' ' 73' ' ' ILE . 15.0 m -132.51 -165.93 1.67 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.488 1.115 . . . . 0.0 108.194 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.539 ' H ' ' CG2' ' A' ' 72' ' ' THR . 4.0 tt -150.54 172.75 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.937 -1.102 . . . . 0.0 109.593 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.5 m -122.31 124.07 42.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 163.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.408 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 1.9 mtm -151.73 120.79 6.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 166.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.09 164.07 1.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.426 . . . . 0.0 110.106 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -58.9 -54.24 49.34 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.875 0.87 . . . . 0.0 109.405 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -67.59 1.22 2.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.37 1.068 . . . . 0.0 112.691 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -60.85 1.5 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.259 1.824 . . . . 0.0 108.883 168.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 75' ' ' MET . 21.4 m-85 -56.18 -41.04 74.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.965 1.306 . . . . 0.0 112.893 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.42 -44.37 62.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.658 0.783 . . . . 0.0 109.417 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -27.77 64.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.739 . . . . 0.0 112.153 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.2 -78.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 C-N-CA 126.365 1.866 . . . . 0.0 109.718 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 12' ' ' VAL . 6.0 ptp . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.1 mm . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.241 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--O 1.232 0.147 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mp -71.66 -7.07 45.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 117.806 -1.092 . . . . 0.0 110.894 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.3 46.92 2.27 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 120.26 1.391 . . . . 0.0 112.938 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.4 mt . . . . . 0 C--N 1.347 0.489 0 CA-C-O 123.603 1.668 . . . . 0.0 110.544 -176.596 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 120.763 0.316 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.63 39.83 0.64 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.936 1.732 . . . . 0.0 109.874 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -85.54 177.87 7.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -66.42 -22.66 66.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.522 -1.362 . . . . 0.0 111.037 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.24 -5.07 1.38 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.37 -47.33 85.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.081 1.31 . . . . 0.0 112.422 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.266 0.0 OUTLIER -68.97 -33.11 73.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.547 0.739 . . . . 0.0 111.53 176.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.25 -53.19 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.969 1.708 . . . . 0.0 110.396 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -67.5 -21.91 65.48 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.728 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -75.46 -26.41 58.23 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.494 -1.241 . . . . 0.0 112.768 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -57.09 -41.09 78.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.46 1.482 . . . . 0.0 110.773 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.69 -47.72 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.18 -51.32 70.52 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.378 0.671 . . . . 0.0 110.775 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -53.0 -50.83 63.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.171 2.188 . . . . 0.0 108.639 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -34.38 73.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.198 . . . . 0.0 111.349 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -32.6 61.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 0.0 112.811 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -63.35 -53.81 46.84 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.834 0.854 . . . . 0.0 109.994 170.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -62.74 -45.82 90.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 110.863 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -159.41 58.0 0.4 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.208 1.004 . . . . 0.0 109.217 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.22 -23.06 66.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.315 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -59.38 -43.11 92.94 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.715 1.757 . . . . 0.0 111.6 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.14 -32.4 73.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.627 -0.671 . . . . 0.0 111.465 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -75.62 -34.35 60.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 108.619 -171.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.37 -48.73 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.704 1.202 . . . . 0.0 109.208 164.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -70.99 -10.68 60.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.805 -1.185 . . . . 0.0 113.437 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -86.02 -30.53 22.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.368 1.44 . . . . 0.0 113.603 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.56 -54.11 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.696 1.198 . . . . 0.0 108.772 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.73 57.11 11.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.669 2.08 . . . . 0.0 114.786 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.74 -171.18 37.29 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.348 1.574 . . . . 0.0 111.738 -176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.24 124.55 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 158.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -120.93 173.76 7.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.22 142.82 51.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.087 0.955 . . . . 0.0 109.411 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -88.27 91.53 8.82 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 124.969 1.308 . . . . 0.0 110.259 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -74.88 89.08 2.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.577 -1.327 . . . . 0.0 112.241 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -93.58 123.41 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -115.78 174.89 5.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.384 1.474 . . . . 0.0 110.357 158.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.53 61.17 2.06 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.803 1.641 . . . . 0.0 114.82 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.8 -152.44 8.85 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 126.329 1.919 . . . . 0.0 111.933 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.65 5.9 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.185 3.257 . . . . 0.0 114.605 -169.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.45 -49.13 0.21 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 159.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.94 -24.16 4.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.575 1.188 . . . . 0.0 111.402 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -62.16 -175.65 0.08 Allowed 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.087 1.755 . . . . 0.0 111.279 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -127.42 147.65 50.29 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -172.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.87 170.76 15.4 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.675 1.99 . . . . 0.0 108.087 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -155.9 149.42 24.88 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.62 133.1 55.4 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 166.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.95 142.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.68 113.27 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.54 123.96 30.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 165.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.15 39.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 126.365 1.866 . . . . 0.0 107.76 173.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -124.67 -39.31 2.3 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.574 1.15 . . . . 0.0 109.674 162.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -95.04 115.88 27.99 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -155.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.98 49.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -2.68 27.76 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.123 173.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.31 157.1 14.11 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -168.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 m -171.46 133.28 0.8 Allowed 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 128.507 2.723 . . . . 0.0 106.137 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.96 147.93 8.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -125.53 93.54 44.52 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.79 150.75 44.98 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.278 1.985 . . . . 0.0 109.381 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.13 22.85 0.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.941 2.497 . . . . 0.0 114.507 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.48 147.79 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.419 -155.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.49 -5.09 46.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.96 0.904 . . . . 0.0 111.279 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -44.9 129.12 7.27 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.868 1.667 . . . . 0.0 108.736 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -69.06 -176.0 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.919 0.866 . . . . 0.0 109.04 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.2 151.77 37.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.205 1.002 . . . . 0.0 108.956 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -75.82 -31.01 59.19 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.932 0.493 . . . . 0.0 112.156 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.1 m -148.37 173.02 13.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.822 2.449 . . . . 0.0 107.689 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -155.48 114.7 3.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.129 -1.607 . . . . 0.0 108.063 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.13 146.18 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.0 m -122.55 131.27 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.122 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 mmm -138.73 -12.56 1.3 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.703 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 67.5 151.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.419 1.888 . . . . 0.0 111.107 -164.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.37 -35.41 79.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.342 -0.837 . . . . 0.0 111.929 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -58.09 2.72 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.73 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -51.21 -55.69 16.76 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.232 1.013 . . . . 0.0 112.139 -173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -54.14 -58.47 7.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.297 0.953 . . . . 0.0 109.331 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.38 -39.48 73.0 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.878 0.736 . . . . 0.0 112.149 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 tt -55.69 -56.61 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.769 2.428 . . . . 0.0 110.306 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.6 pttm . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.268 2.5 mp . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 115.05 7.5 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 70.06 44.9 0.74 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.221 1.008 . . . . 0.0 110.624 -172.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--N 1.345 0.41 0 C-N-CA 125.497 1.519 . . . . 0.0 111.896 -177.52 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 121.392 0.615 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.39 22.39 0.75 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.352 1.453 . . . . 0.0 113.722 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -82.6 177.69 8.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.875 1.337 . . . . 0.0 109.827 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -66.15 -23.42 66.47 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 118.023 -1.471 . . . . 0.0 111.468 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.84 -18.68 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 114.35 169.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -53.09 -44.64 67.73 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.825 0.85 . . . . 0.0 111.024 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.286 0.0 OUTLIER -85.05 -30.22 24.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.573 0.749 . . . . 0.0 111.769 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.55 -54.23 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.593 1.157 . . . . 0.0 110.656 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.15 -20.9 63.13 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.244 -0.91 . . . . 0.0 111.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' HE3' ' A' ' 14' ' ' LYS . 22.2 ttmt -75.9 -28.14 57.94 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 118.016 -0.992 . . . . 0.0 113.535 175.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -58.73 -49.91 75.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 119.742 1.155 . . . . 0.0 110.386 163.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.6 -43.5 78.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -51.7 68.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.229 1.012 . . . . 0.0 111.967 170.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -58.98 -41.02 86.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -169.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -65.1 -31.71 73.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.704 2.002 . . . . 0.0 111.861 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -29.61 59.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.518 1.054 . . . . 0.0 113.787 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.5 -53.29 54.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 119.45 1.023 . . . . 0.0 109.053 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -45.37 93.9 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -161.49 51.55 0.24 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 123.433 1.587 . . . . 0.0 109.862 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.77 -17.49 14.8 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 117.525 -1.708 . . . . 0.0 114.91 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.77 -51.12 58.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.669 2.235 . . . . 0.0 110.852 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -68.08 -28.25 67.19 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.773 -1.205 . . . . 0.0 111.37 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -73.7 -35.75 65.18 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.772 -1.205 . . . . 0.0 108.659 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.4 t -55.97 -42.03 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.867 1.267 . . . . 0.0 109.459 165.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.516 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 4.1 mmpt? -69.31 -29.9 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.55 1.523 . . . . 0.0 113.185 174.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -68.46 -49.33 60.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.591 1.542 . . . . 0.0 111.893 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.06 -48.43 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.003 1.274 . . . . 0.0 109.67 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.08 47.19 84.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.646 -1.641 . . . . 0.0 113.935 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.52 171.0 37.41 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.567 1.684 . . . . 0.0 110.728 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.36 131.1 54.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 162.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -129.4 165.57 21.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.991 0.424 . . . . 0.0 111.279 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.8 137.62 52.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.073 1.749 . . . . 0.0 108.722 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.62 109.15 20.13 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.532 1.133 . . . . 0.0 108.668 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HE2' HG22 ' A' ' 72' ' ' THR . 15.4 mttm -87.37 103.32 15.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 121.03 1.741 . . . . 0.0 107.626 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 t -112.14 94.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.611 -0.681 . . . . 0.0 109.335 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 174.43 6.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.383 -1.448 . . . . 0.0 110.294 171.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 59.34 43.81 16.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.205 1.802 . . . . 0.0 112.105 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 77' ' ' ASP . . . -78.1 -167.96 31.57 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.082 -1.011 . . . . 0.0 113.862 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.28 -11.5 10.85 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.025 3.15 . . . . 0.0 114.05 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.25 -5.19 8.85 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.535 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.04 74.73 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.21 1.505 . . . . 0.0 112.084 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.7 -175.66 0.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.271 1.828 . . . . 0.0 109.768 165.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -135.79 150.71 49.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.145 1.778 . . . . 0.0 109.205 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.87 172.09 13.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.829 2.052 . . . . 0.0 109.065 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.5 m -145.91 147.3 31.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 108.32 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -117.59 142.84 46.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 163.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.03 143.61 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.31 118.67 50.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.93 110.45 18.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 165.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.44 43.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.308 168.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -132.51 -44.9 0.9 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.377 -0.827 . . . . 0.0 111.611 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -95.84 148.12 22.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.734 0.646 . . . . 0.0 109.451 -172.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.95 -130.55 51.04 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.657 ' HE3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.02 4.3 34.32 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.08 1.352 . . . . 0.0 112.383 173.146 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.35 157.73 18.86 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.8 m -172.26 153.01 2.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 128.447 2.699 . . . . 0.0 108.028 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -88.09 156.16 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mt -132.79 96.4 18.31 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 -173.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.98 140.32 41.57 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.04 1.827 . . . . 0.0 109.025 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.9 22.79 4.51 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.047 2.139 . . . . 0.0 112.957 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.47 133.95 35.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.419 0.628 . . . . 0.0 110.177 -157.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.36 -7.16 51.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.633 1.173 . . . . 0.0 110.594 165.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -52.48 132.92 35.57 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -74.64 -177.09 3.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.085 0.945 . . . . 0.0 109.651 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.03 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.968 1.707 . . . . 0.0 108.824 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.56 -25.15 56.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.48 -176.22 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.197 0.999 . . . . 0.0 109.47 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.413 HG22 ' HE2' ' A' ' 38' ' ' LYS . 21.4 m -137.66 -175.77 4.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.932 0.893 . . . . 0.0 108.764 -171.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 tt -145.83 142.5 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 154.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.19 146.2 24.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 157.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.434 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 31.4 mtt -134.19 -51.29 0.82 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 157.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.93 161.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.143 3.377 . . . . 0.0 107.966 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 6.0 t70 -66.72 -47.04 73.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 122.96 0.504 . . . . 0.0 110.863 -171.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.6 m -55.29 -36.25 65.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.448 0.699 . . . . 0.0 110.326 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.11 -59.43 2.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.307 1.843 . . . . 0.0 109.849 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 75' ' ' MET . 10.7 m-85 -50.83 -58.75 5.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.39 1.876 . . . . 0.0 111.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -42.87 99.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.956 0.902 . . . . 0.0 109.81 -172.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -23.24 65.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.87 -173.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mt -67.77 -51.5 48.26 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.496 1.118 . . . . 0.0 110.882 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.189 0 CA-C-N 119.191 0.905 . . . . 0.0 112.556 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 pttt . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 166.904 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.4 m120 . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.85 -10.98 53.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.359 1.064 . . . . 0.0 112.947 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -137.88 54.72 1.8 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.501 1.521 . . . . 0.0 107.106 166.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER . . . . . 0 C--N 1.348 0.535 0 C-N-CA 128.752 2.821 . . . . 0.0 113.387 -175.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.277 0.561 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.05 42.52 1.27 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.434 1.016 . . . . 0.0 112.535 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -85.1 -176.54 6.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.426 1.613 . . . . 0.0 110.583 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -72.36 -17.15 61.86 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.033 -1.042 . . . . 0.0 111.394 164.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.32 -23.98 4.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.2 1.0 . . . . 0.0 112.903 170.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -45.63 77.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.117 1.367 . . . . 0.0 110.32 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.24 -48.77 76.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.171 1.388 . . . . 0.0 109.67 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 t -58.65 -54.29 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.725 1.21 . . . . 0.0 111.421 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -64.31 -26.22 68.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.911 1.232 . . . . 0.0 111.88 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -75.06 -23.65 58.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.506 -0.746 . . . . 0.0 112.589 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.52 -52.62 53.79 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.434 0.459 . . . . 0.0 109.932 166.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -58.64 -48.28 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.186 1.395 . . . . 0.0 107.83 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -55.78 -51.1 68.59 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.759 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -57.99 -47.56 82.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.948 0.795 . . . . 0.0 109.425 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -38.8 88.83 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.559 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -38.99 72.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 113.814 172.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.12 -52.94 56.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.29 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.54 -45.74 90.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.828 1.194 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -162.73 56.1 0.21 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.138 0.97 . . . . 0.0 111.893 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.51 -16.01 69.04 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 120.905 -1.122 . . . . 0.0 113.103 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -43.3 68.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.764 1.282 . . . . 0.0 112.165 -171.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.77 -32.02 59.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.566 0.746 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.76 -26.8 60.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -60.31 -28.3 41.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -66.08 -21.91 66.39 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.319 -0.863 . . . . 0.0 111.405 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -73.0 -70.82 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.266 1.394 . . . . 0.0 111.241 -172.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.65 -59.98 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 56.76 13.05 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.807 1.194 . . . . 0.0 113.146 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.81 42.57 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.38 146.68 7.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 149.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -141.33 177.19 8.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 118.969 -1.093 . . . . 0.0 109.581 158.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.73 164.15 20.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.502 1.121 . . . . 0.0 108.897 171.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -121.98 106.99 11.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.174 1.79 . . . . 0.0 108.832 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -73.71 110.49 8.04 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 120.282 1.401 . . . . 0.0 112.107 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.07 98.25 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.407 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -93.94 174.69 7.04 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 166.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 49.75 53.19 13.19 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.982 2.113 . . . . 0.0 113.737 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.64 176.54 2.23 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.399 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.01 84.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.448 3.432 . . . . 0.0 108.433 158.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.17 -76.46 0.3 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -167.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.54 -12.27 3.21 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.506 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -70.18 -171.58 0.47 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.774 1.787 . . . . 0.0 110.978 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.1 160.64 20.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.222 1.809 . . . . 0.0 108.772 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.41 166.05 30.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.545 2.338 . . . . 0.0 106.296 173.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 m -150.81 128.88 11.83 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.78 0.832 . . . . 0.0 109.996 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -94.3 127.34 40.1 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 167.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.18 149.59 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.2 119.97 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.26 106.78 18.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 172.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.17 56.78 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 121.611 -0.681 . . . . 0.0 110.474 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -139.91 -53.63 0.53 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.307 1.043 . . . . 0.0 109.683 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -78.39 140.9 38.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.942 1.697 . . . . 0.0 108.152 -172.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 -137.57 32.85 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -104.88 8.26 34.64 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.015 1.726 . . . . 0.0 111.724 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.44 157.34 29.85 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -173.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.9 m -172.52 161.35 4.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.621 3.968 . . . . 0.0 105.991 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -109.96 154.38 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.9 mt -134.25 70.35 73.37 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -158.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.99 142.65 62.82 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.539 2.159 . . . . 0.0 109.28 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 54.88 23.22 4.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.766 2.427 . . . . 0.0 112.437 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 t -87.61 138.32 31.57 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.042 1.292 . . . . 0.0 110.26 -164.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.65 -4.87 58.4 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.48 1.912 . . . . 0.0 111.223 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -60.56 145.18 49.67 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 118.399 -1.32 . . . . 0.0 108.324 170.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -69.6 -173.6 0.61 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.221 1.808 . . . . 0.0 110.378 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.11 133.88 16.79 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.135 -0.353 . . . . 0.0 111.562 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.29 -52.89 4.35 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.933 2.493 . . . . 0.0 111.053 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.3 m -149.42 168.99 21.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.994 2.518 . . . . 0.0 106.767 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.9 m -121.83 -171.07 2.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.05 167.61 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 158.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.77 159.68 16.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.748 1.613 . . . . 0.0 106.756 160.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -150.57 -38.86 0.13 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.817 158.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HA ' ' H ' ' A' ' 40' ' ' LYS . . . 95.57 157.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.545 2.338 . . . . 0.0 110.035 -173.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -59.78 -46.77 88.15 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.802 0.841 . . . . 0.0 111.134 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -44.01 73.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.338 -175.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.03 -65.22 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 128.326 2.65 . . . . 0.0 112.06 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 75' ' ' MET . 43.3 m-85 -51.09 -45.36 61.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 110.401 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 tp -60.77 -69.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.616 0.644 . . . . 0.0 109.322 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.37 75.08 Favored 'General case' 0 CA--C 1.524 -0.057 0 C-N-CA 124.244 1.018 . . . . 0.0 113.269 -165.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 tp -52.01 -66.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.677 1.191 . . . . 0.0 109.654 -176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.4 ptm . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.74 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.339 0 CA-C-O 121.942 0.877 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.444 -0.773 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.488 -173.526 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 m120 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tp -85.08 9.73 13.98 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 122.032 2.197 . . . . 0.0 111.827 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.96 48.81 0.85 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.251 2.22 . . . . 0.0 110.466 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 129.738 3.215 . . . . 0.0 114.83 178.264 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 119.971 3.323 . . . . 0.0 119.971 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.75 82.88 0.18 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 126.573 2.035 . . . . 0.0 108.16 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -153.42 160.78 42.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.628 1.571 . . . . 0.0 108.449 -166.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -24.97 50.49 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.3 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.35 -10.69 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.378 1.871 . . . . 0.0 114.624 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.424 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 1.5 t-20 -51.35 -44.21 61.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.409 0.684 . . . . 0.0 110.943 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -38.35 65.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.351 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.34 -60.78 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 125.005 1.322 . . . . 0.0 109.969 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -66.78 -19.63 65.79 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.746 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -75.56 -28.6 59.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.533 172.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.2 mt -68.56 -52.42 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.37 -54.78 12.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 125.176 1.39 . . . . 0.0 109.895 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -44.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.214 1.005 . . . . 0.0 110.944 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -44.96 79.12 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.168 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -35.15 66.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 112.635 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.48 -52.9 55.55 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.78 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.52 -45.69 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.408 -1.433 . . . . 0.0 114.189 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -153.22 64.94 0.76 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.925 1.69 . . . . 0.0 109.461 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.41 70.52 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-O 118.333 -1.259 . . . . 0.0 111.177 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -52.48 -38.09 58.65 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.721 1.26 . . . . 0.0 111.429 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.22 -42.97 44.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.735 1.214 . . . . 0.0 109.225 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -20.81 63.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.598 -0.689 . . . . 0.0 111.442 -176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.27 -38.9 64.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 119.131 0.878 . . . . 0.0 110.213 168.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -74.84 -5.03 41.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.884 -1.135 . . . . 0.0 113.103 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -69.27 0.68 Allowed 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.936 1.244 . . . . 0.0 110.353 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.54 -62.97 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.33 9.39 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.728 1.156 . . . . 0.0 113.28 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.97 -169.24 29.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.77 125.89 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 157.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -121.42 172.65 7.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.03 131.32 49.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.994 1.717 . . . . 0.0 108.578 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -82.05 93.86 7.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -74.71 101.13 4.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.252 1.842 . . . . 0.0 109.834 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.2 t -104.22 121.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -115.77 179.7 3.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.363 1.465 . . . . 0.0 109.421 162.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t70 54.69 53.86 10.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.391 1.091 . . . . 0.0 112.273 164.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.43 -154.91 10.65 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.534 1.54 . . . . 0.0 109.784 168.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -48.74 114.91 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.236 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.9 -8.07 17.58 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.265 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.27 16.49 62.48 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 120.547 2.173 . . . . 0.0 112.083 169.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -61.66 -175.12 0.05 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.18 1.392 . . . . 0.0 111.007 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -150.47 111.58 4.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.336 -171.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 174.65 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.77 2.028 . . . . 0.0 110.416 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -147.75 149.43 32.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 109.018 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -116.7 117.12 28.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 166.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.79 128.59 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.2 t -112.07 110.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.63 129.83 34.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.16 30.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -140.09 -25.9 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 120.981 -1.074 . . . . 0.0 112.775 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -84.71 111.67 19.8 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.63 -117.86 7.96 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -85.99 0.34 53.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.157 0.978 . . . . 0.0 112.566 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.23 156.66 3.81 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -157.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.7 m -172.23 149.59 2.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.418 2.287 . . . . 0.0 106.327 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.72 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mt -127.22 81.61 69.68 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 -170.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.12 144.94 65.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.057 1.838 . . . . 0.0 109.728 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 37.47 44.05 0.46 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.308 2.643 . . . . 0.0 111.292 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -85.8 142.74 28.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.693 1.235 . . . . 0.0 109.615 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.26 -17.9 59.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 111.182 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -57.46 133.05 54.87 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -60.96 -175.75 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.998 1.38 . . . . 0.0 109.778 167.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.45 155.49 48.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.152 166.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.41 -27.74 64.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.535 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.7 p -145.62 -175.92 4.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.551 0.74 . . . . 0.0 112.856 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.525 HG21 ' H ' ' A' ' 73' ' ' ILE . 1.4 m -136.14 -171.99 3.02 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.525 ' H ' HG21 ' A' ' 72' ' ' THR . 3.6 tt -142.27 175.6 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 161.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.2 m -141.73 137.44 31.66 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 119.335 -2.103 . . . . 0.0 108.373 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.1 ptp -148.65 -28.83 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.528 -1.669 . . . . 0.0 115.217 161.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.43 147.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.972 3.309 . . . . 0.0 110.618 -162.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.99 -47.95 84.06 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 127.215 2.206 . . . . 0.0 110.443 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.8 m -66.43 -11.46 52.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.3 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.93 -40.24 5.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 168.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -47.42 -54.03 12.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.683 1.193 . . . . 0.0 109.987 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.47 -62.26 1.44 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.593 1.957 . . . . 0.0 108.383 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.56 -39.94 77.79 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.693 0.797 . . . . 0.0 112.435 -174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -65.75 0.51 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.479 0.712 . . . . 0.0 110.482 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -175.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.38 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.681 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.51 -5.62 20.54 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -166.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -136.82 55.6 1.83 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.221 1.408 . . . . 0.0 107.324 167.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--N 1.35 0.615 0 C-N-CA 125.071 1.348 . . . . 0.0 114.369 179.862 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 11.77 0.06 OUTLIER Glycine 0 N--CA 1.466 0.671 0 O-C-N 120.782 -1.199 . . . . 0.0 115.442 -162.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -80.21 178.51 8.22 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.823 1.249 . . . . 0.0 108.671 -173.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -69.65 -17.92 63.54 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.735 -1.853 . . . . 0.0 111.378 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.37 17.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.265 1.026 . . . . 0.0 112.815 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -58.6 -40.05 82.11 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.516 1.527 . . . . 0.0 110.275 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -61.53 -51.89 66.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.307 1.843 . . . . 0.0 109.79 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.55 -43.61 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.493 2.317 . . . . 0.0 111.943 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.18 -26.94 61.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.168 0.894 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -71.48 -24.77 62.05 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 118.977 0.808 . . . . 0.0 112.619 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.13 -46.31 91.09 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 165.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.8 -45.44 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.04 -55.22 33.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.824 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -52.48 -50.51 62.57 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -168.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -65.56 -27.11 68.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.666 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -33.45 66.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.075 0.852 . . . . 0.0 112.006 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.17 -52.3 59.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 170.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.58 -45.2 85.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.534 1.134 . . . . 0.0 111.795 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -165.54 62.79 0.11 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.954 0.902 . . . . 0.0 110.897 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.01 -29.18 71.87 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 116.869 -2.073 . . . . 0.0 114.486 -172.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -36.97 3.59 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.99 2.395 . . . . 0.0 112.918 172.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -81.38 -16.84 51.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -93.49 -34.91 13.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.088 1.355 . . . . 0.0 108.212 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.2 -46.09 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 126.151 1.78 . . . . 0.0 109.036 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -64.39 -23.94 67.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.562 1.528 . . . . 0.0 113.776 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -74.13 -29.21 61.71 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.411 -0.806 . . . . 0.0 111.828 -166.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mp -117.36 -49.76 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.557 2.343 . . . . 0.0 110.321 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.19 49.26 58.69 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.861 1.696 . . . . 0.0 116.245 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.55 27.36 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.758 1.779 . . . . 0.0 108.759 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.95 139.14 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 3.6 p90 -127.15 164.55 21.37 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.978 -1.076 . . . . 0.0 109.961 158.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 156.31 21.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 35' ' ' PHE . 6.6 m-85 -114.72 108.34 16.65 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.464 1.506 . . . . 0.0 108.734 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -87.09 95.9 10.11 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -85.09 116.6 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -107.91 176.63 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 119.07 0.85 . . . . 0.0 109.152 162.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t0 46.42 50.79 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.573 1.549 . . . . 0.0 113.776 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.5 165.55 27.94 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.977 167.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.46 98.43 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.656 3.571 . . . . 0.0 112.648 172.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.81 -41.3 1.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.237 1.875 . . . . 0.0 111.765 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.59 -8.35 3.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.701 -1.61 . . . . 0.0 114.574 163.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -67.61 -175.26 0.5 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.191 1.796 . . . . 0.0 112.782 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -125.15 146.23 49.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.935 1.694 . . . . 0.0 111.221 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.93 162.08 34.25 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.716 3.207 . . . . 0.0 106.832 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 m -139.25 148.13 42.64 Favored 'General case' 0 C--O 1.228 -0.053 0 CA-C-N 119.082 0.856 . . . . 0.0 110.059 166.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -117.65 156.81 27.54 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.42 134.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.41 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 57.6 t -123.41 112.75 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -91.98 80.28 5.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.43 53.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -146.62 -54.18 0.24 Allowed 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.18 0.992 . . . . 0.0 110.042 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -95.36 140.45 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.016 0.823 . . . . 0.0 109.586 -164.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.9 -140.9 43.76 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -84.84 -0.1 52.8 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.506 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 157.07 15.97 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 120.795 1.634 . . . . 0.0 111.873 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m -171.77 166.08 6.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.913 3.285 . . . . 0.0 108.87 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.33 93.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 127.941 2.496 . . . . 0.0 107.254 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.9 101.28 0.48 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 127.231 2.212 . . . . 0.0 107.001 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -70.5 131.22 19.77 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.372 2.714 . . . . 0.0 111.308 -166.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 47.24 24.56 0.44 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.317 2.247 . . . . 0.0 112.591 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.54 143.79 40.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -160.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -73.59 -15.79 61.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.575 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -57.92 145.11 36.76 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.708 -1.597 . . . . 0.0 110.429 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.79 -176.18 0.05 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.861 1.315 . . . . 0.0 109.895 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.95 168.06 20.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.638 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -37.48 55.6 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.395 0.678 . . . . 0.0 111.391 171.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m -150.93 -173.14 4.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.084 2.153 . . . . 0.0 109.307 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -133.95 -172.92 3.11 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.062 -1.024 . . . . 0.0 108.736 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -147.44 165.07 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 155.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -126.48 124.29 39.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 165.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.71 136.62 17.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.15 163.59 1.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 168.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.04 -52.01 62.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.057 1.343 . . . . 0.0 111.005 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.66 -33.77 61.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.3 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.87 -35.26 14.88 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.33 2.252 . . . . 0.0 111.381 -169.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.92 -54.77 33.37 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.482 1.113 . . . . 0.0 108.357 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -31.48 68.59 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.555 0.742 . . . . 0.0 110.361 -175.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.55 -41.76 10.21 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.048 1.339 . . . . 0.0 113.727 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.01 -75.51 0.05 Allowed 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -170.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.242 0.663 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.54 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -13.91 32.76 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 171.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -141.69 62.83 1.44 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.042 0.937 . . . . 0.0 109.514 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.329 0.1 OUTLIER . . . . . 0 C--N 1.353 0.753 0 C-N-CA 124.421 1.089 . . . . 0.0 113.596 170.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 123.039 1.4 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.4 84.41 0.36 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 129.349 3.356 . . . . 0.0 108.414 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -152.83 149.74 28.61 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.675 2.39 . . . . 0.0 107.824 -167.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -6.67 51.13 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.846 -1.159 . . . . 0.0 111.782 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.28 -16.46 53.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.883 0.873 . . . . 0.0 112.975 160.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -59.09 -58.41 8.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.844 1.202 . . . . 0.0 111.019 -168.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -64.77 -31.37 72.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.36 -55.92 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.813 2.445 . . . . 0.0 110.618 171.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -65.83 -29.34 69.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.683 1.128 . . . . 0.0 111.119 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -70.09 -24.93 63.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.771 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -44.17 73.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 176.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -52.02 -54.33 14.23 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.33 -48.48 78.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.965 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -56.59 -46.85 80.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -66.11 -42.28 89.43 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.69 177.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -32.54 62.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.307 6.5 mm-40 -70.11 -52.31 24.7 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.877 171.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.06 -40.69 96.64 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -161.04 60.44 0.29 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.833 1.253 . . . . 0.0 109.858 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.12 -29.69 70.32 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-O 118.185 -1.341 . . . . 0.0 111.47 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.44 -29.5 24.86 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.838 1.319 . . . . 0.0 112.694 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -79.93 -34.98 38.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.911 -1.118 . . . . 0.0 111.678 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -80.31 -19.46 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.643 1.111 . . . . 0.0 108.997 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.07 -45.59 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.151 0.887 . . . . 0.0 109.467 169.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.49 -17.67 62.34 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -71.53 -65.17 0.79 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.365 -0.834 . . . . 0.0 109.845 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mm -78.32 -56.07 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.0 1.32 . . . . 0.0 108.713 -166.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 50.61 63.29 4.55 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.253 -167.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 173.0 39.55 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 119.376 1.588 . . . . 0.0 111.941 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.19 121.36 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 102.936 -2.986 . . . . 0.0 102.936 159.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -130.42 166.01 21.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 123.659 0.6 . . . . 0.0 109.724 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.12 168.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.889 0.852 . . . . 0.0 112.063 173.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.49 98.5 6.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.932 . . . . 0.0 108.529 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -83.9 89.55 7.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.987 0.812 . . . . 0.0 110.904 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.18 124.03 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -115.11 -175.05 2.61 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.899 -1.126 . . . . 0.0 108.728 158.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t0 47.8 58.23 5.23 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 127.236 2.214 . . . . 0.0 111.881 169.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 44' ' ' GLY . . . -63.89 -177.2 4.58 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.393 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -60.23 7.49 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 1 C-N-CA 125.389 4.059 . . . . 0.0 113.188 159.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 42' ' ' GLY . . . -135.71 -31.79 0.3 Allowed Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.282 -1.511 . . . . 0.0 112.075 155.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -2.68 7.61 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 118.805 1.303 . . . . 0.0 114.018 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -62.04 -175.57 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.958 1.379 . . . . 0.0 110.791 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -120.97 165.38 15.33 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 166.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.13 164.94 34.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.498 1.919 . . . . 0.0 107.43 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.0 m -147.07 144.15 28.86 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -115.67 133.05 56.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 103.595 -2.743 . . . . 0.0 103.595 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -101.35 136.16 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.69 117.29 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.63 117.07 28.24 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 165.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.65 51.55 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -133.4 -53.61 0.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.123 0.969 . . . . 0.0 108.824 160.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.79 111.24 13.39 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.03 -151.93 50.66 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 121.673 0.596 . . . . 0.0 111.648 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.02 9.49 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 127.94 2.496 . . . . 0.0 114.205 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.14 157.76 33.9 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.0 m -172.87 158.12 3.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.49 2.316 . . . . 0.0 106.99 152.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.74 160.37 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -141.51 87.57 10.28 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -160.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.53 147.99 18.02 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.012 2.475 . . . . 0.0 109.963 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.53 25.8 3.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.995 1.718 . . . . 0.0 111.468 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -92.41 146.84 23.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.524 1.154 . . . . 0.0 109.377 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.84 -26.7 25.54 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 111.909 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -50.33 120.98 5.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.512 1.125 . . . . 0.0 108.648 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -178.04 1.52 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 122.798 1.285 . . . . 0.0 108.804 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.21 156.65 46.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.507 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.2 -32.57 71.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.733 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.76 173.83 15.89 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.101 1.36 . . . . 0.0 110.619 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 101' ' ' ILE . 5.0 m -155.23 119.98 4.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -172.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.447 HG13 ' H ' ' A' ' 101' ' ' ILE . 15.8 tt -83.96 155.11 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 118.661 0.664 . . . . 0.0 109.449 -173.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.4 m -100.73 126.32 47.27 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 118.203 -0.904 . . . . 0.0 109.245 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.06 126.74 2.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 157.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.08 166.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 0.0 112.149 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -53.0 63.06 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t -65.32 -4.53 5.56 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.307 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.23 -53.96 2.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.141 1.776 . . . . 0.0 108.998 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.77 -56.72 10.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.205 1.82 . . . . 0.0 111.37 171.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 tp -54.16 -51.66 63.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.46 1.504 . . . . 0.0 107.852 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.62 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -66.02 0.88 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.183 0.993 . . . . 0.0 108.965 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 O-C-N 121.351 -0.843 . . . . 0.0 112.464 -171.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 N--CA 1.47 0.539 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.44 -31.78 73.14 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 166.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -123.43 47.56 1.99 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.421 1.888 . . . . 0.0 111.244 -166.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.351 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.849 0 C-N-CA 128.219 2.608 . . . . 0.0 112.051 -175.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t0 . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 122.304 1.05 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.57 20.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.508 1.051 . . . . 0.0 112.711 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -79.89 171.08 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 120.8 -1.412 . . . . 0.0 108.503 169.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -69.82 -19.36 63.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.879 1.218 . . . . 0.0 110.471 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.72 -22.13 3.27 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.146 0.978 . . . . 0.0 112.798 165.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 27.7 t-20 -55.58 -47.26 76.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.608 0.64 . . . . 0.0 110.725 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.28 -38.97 91.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.57 1.148 . . . . 0.0 112.142 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.15 -57.81 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.192 1.397 . . . . 0.0 109.412 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.95 -23.29 66.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.928 -0.482 . . . . 0.0 111.495 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.25 -48.99 54.46 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -51.34 -39.09 56.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 118.845 0.748 . . . . 0.0 112.885 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.47 -51.66 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.27 -54.33 48.02 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 123.973 0.909 . . . . 0.0 111.783 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -57.3 -38.29 73.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.888 1.222 . . . . 0.0 110.135 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.59 -43.89 71.88 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.605 1.162 . . . . 0.0 110.39 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -38.51 69.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.525 1.53 . . . . 0.0 114.071 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.59 -50.7 68.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.287 -0.863 . . . . 0.0 108.682 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.0 -46.99 85.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.593 1.542 . . . . 0.0 114.749 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -153.66 55.44 0.74 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 123.513 1.625 . . . . 0.0 111.089 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.51 -16.1 80.18 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.078 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -60.34 -40.47 90.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.161 1.481 . . . . 0.0 111.485 -168.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.609 ' NE2' ' HZ1' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -77.75 -27.49 50.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.313 -0.867 . . . . 0.0 110.857 176.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -32.99 70.25 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.0 -42.77 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.142 166.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.63 74.48 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.957 -1.09 . . . . 0.0 111.267 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.609 ' HZ1' ' NE2' ' A' ' 26' ' ' GLN . 10.0 mmtp -71.92 -41.99 67.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 117.554 -1.212 . . . . 0.0 113.462 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.3 mp -95.18 -64.21 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 121.911 2.141 . . . . 0.0 107.176 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 77.03 0.28 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.433 1.016 . . . . 0.0 110.671 -169.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.85 145.78 4.2 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 118.312 -1.271 . . . . 0.0 110.636 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -73.37 137.35 23.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -135.28 168.17 19.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 110.155 170.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.57 137.2 52.36 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.534 1.133 . . . . 0.0 109.83 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -88.22 97.2 10.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -74.56 111.94 10.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.532 1.06 . . . . 0.0 109.475 168.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.79 106.79 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.28 177.44 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 159.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.5 t0 55.96 61.45 2.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.065 1.346 . . . . 0.0 111.903 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.55 -160.98 36.19 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.947 1.737 . . . . 0.0 112.442 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.59 4.95 0.39 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 124.567 3.511 . . . . 0.0 114.869 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.74 2.17 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 120.653 -1.279 . . . . 0.0 113.839 164.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.55 5.59 53.87 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 120.515 2.158 . . . . 0.0 113.244 163.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.41 -175.14 0.76 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.174 1.389 . . . . 0.0 109.802 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -118.87 138.0 53.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.098 1.359 . . . . 0.0 108.818 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.56 166.23 12.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.749 1.62 . . . . 0.0 107.64 164.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.0 m -146.35 148.69 32.63 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 160.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -119.64 133.77 55.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.88 114.07 40.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.91 105.12 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.28 116.58 18.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 163.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.25 52.01 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -144.4 -48.98 0.27 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.609 1.164 . . . . 0.0 109.885 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -80.9 126.01 30.83 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -173.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.17 -142.29 44.72 Favored Glycine 0 N--CA 1.439 -1.112 0 O-C-N 121.391 -0.818 . . . . 0.0 111.632 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -82.74 3.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.686 -1.15 . . . . 0.0 112.286 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.25 158.02 27.14 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 120.782 1.628 . . . . 0.0 109.512 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -171.72 137.27 1.0 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.551 2.74 . . . . 0.0 106.565 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -76.53 111.64 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 166.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -87.0 122.14 71.31 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.78 130.6 10.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 41.49 45.79 2.85 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.339 1.856 . . . . 0.0 113.465 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.98 137.5 58.03 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -9.07 59.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.404 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -57.72 140.76 50.63 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -177.03 1.85 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.13 157.22 45.86 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 125.085 1.354 . . . . 0.0 108.549 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -33.24 67.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 p -153.24 175.72 12.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.454 2.301 . . . . 0.0 109.034 -170.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.4 m -140.25 -172.73 3.49 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.25 152.0 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 159.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.5 m -120.47 133.97 55.34 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.4 -38.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.184 1.356 . . . . 0.0 113.439 170.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 96.88 155.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 131.179 3.792 . . . . 0.0 111.516 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -62.72 -44.35 96.46 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.158 0.583 . . . . 0.0 110.571 -173.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -62.97 -21.41 66.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.123 -0.942 . . . . 0.0 111.595 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.28 -67.0 0.82 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 117.884 -1.055 . . . . 0.0 108.537 166.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -49.69 -45.41 48.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.92 1.688 . . . . 0.0 111.97 -168.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tp -59.89 -65.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.96 -36.43 62.84 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.189 0.996 . . . . 0.0 112.34 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.3 tp -48.6 -71.17 0.07 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.507 2.323 . . . . 0.0 109.123 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 10.1 ptp . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 175.495 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 pttt . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 164.225 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.82 3.98 31.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.715 1.143 . . . . 0.0 110.021 169.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -139.42 45.27 1.95 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.529 2.331 . . . . 0.0 108.249 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.379 0.1 OUTLIER . . . . . 0 C--O 1.238 0.462 0 C-N-CA 125.617 1.567 . . . . 0.0 113.389 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -65.14 143.09 58.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.454 0.57 . . . . 0.0 109.571 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.8 67.34 1.02 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.124 1.77 . . . . 0.0 110.9 -167.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.4 m -95.2 -82.59 0.37 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.665 1.986 . . . . 0.0 109.885 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.53 23.56 5.93 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.593 0.711 . . . . 0.0 112.099 163.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.55 82.49 0.34 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -169.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -153.22 140.02 19.03 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.815 1.246 . . . . 0.0 107.743 -166.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -59.24 -29.58 67.64 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.899 0.318 . . . . 0.0 110.963 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.61 -11.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.527 1.931 . . . . 0.0 114.74 169.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.421 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 19.8 t-20 -57.69 -36.93 72.63 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 120.279 1.399 . . . . 0.0 111.677 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.79 -38.24 67.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.158 172.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -56.04 -46.11 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.911 1.284 . . . . 0.0 110.868 -171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -68.65 -24.64 64.56 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.175 -0.328 . . . . 0.0 111.822 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -75.22 -27.15 59.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 121.292 -0.88 . . . . 0.0 111.62 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.88 -46.46 89.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.229 0.468 . . . . 0.0 110.349 169.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.46 -48.72 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.499 1.12 . . . . 0.0 108.158 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -55.75 -43.09 76.34 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.466 0.706 . . . . 0.0 111.342 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.45 -47.46 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -57.42 -45.48 84.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.568 172.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -42.45 76.98 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.84 -53.23 53.96 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.083 0.953 . . . . 0.0 110.984 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.14 -45.57 92.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 119.214 0.915 . . . . 0.0 111.947 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -161.97 58.19 0.25 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.431 1.092 . . . . 0.0 111.669 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.57 -12.99 43.12 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 120.015 -1.678 . . . . 0.0 113.213 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.85 -40.47 63.42 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.256 1.528 . . . . 0.0 111.828 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.06 -26.65 43.07 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.913 -1.117 . . . . 0.0 112.294 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.2 m-85 -74.98 -33.68 61.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.037 1.335 . . . . 0.0 108.571 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -54.94 -52.68 41.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -59.53 -14.25 12.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -85.82 -42.06 14.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.98 1.718 . . . . 0.0 111.977 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.23 -59.49 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.72 65.58 2.82 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 124.286 0.946 . . . . 0.0 111.451 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.74 171.51 43.32 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.15 132.33 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 157.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.48 166.93 18.63 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.363 0.602 . . . . 0.0 111.651 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.19 145.3 38.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.584 1.154 . . . . 0.0 108.898 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -94.67 93.49 7.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.737 1.215 . . . . 0.0 108.451 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -77.62 109.39 11.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.652 1.115 . . . . 0.0 109.444 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.22 104.95 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.63 -179.64 5.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.42 1.088 . . . . 0.0 108.208 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t0 58.76 48.13 11.84 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.58 1.152 . . . . 0.0 113.479 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.8 -173.79 11.85 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.998 1.285 . . . . 0.0 115.373 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.95 78.1 0.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.588 2.859 . . . . 0.0 108.62 161.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.38 -17.63 4.49 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.367 1.937 . . . . 0.0 112.794 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.72 -11.57 68.1 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 126.013 1.768 . . . . 0.0 112.471 170.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.13 -176.46 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.057 1.743 . . . . 0.0 110.675 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.28 152.46 51.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 112.315 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.11 174.94 6.03 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.345 2.258 . . . . 0.0 107.977 174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.9 m -147.73 153.89 39.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 147.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -120.74 136.97 54.73 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 162.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.59 144.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.8 113.52 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.23 112.15 18.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 164.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.23 48.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 167.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -137.07 -50.16 0.64 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.034 0.934 . . . . 0.0 110.236 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -79.87 131.11 35.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 -122.7 14.37 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.418 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 8.25 28.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.769 1.628 . . . . 0.0 110.751 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.53 158.7 30.6 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.841 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -171.14 147.63 2.58 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.865 2.466 . . . . 0.0 109.585 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -80.87 153.9 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 mt -136.43 86.19 24.39 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -169.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.45 142.22 48.7 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.609 1.54 . . . . 0.0 109.768 -174.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 45.75 34.95 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 129.278 3.031 . . . . 0.0 111.955 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.8 152.67 25.57 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.622 0.769 . . . . 0.0 110.578 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 -3.92 59.02 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.266 1.026 . . . . 0.0 111.178 161.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.97 128.95 22.68 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -73.92 -176.76 2.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.16 141.58 30.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.362 1.865 . . . . 0.0 108.092 -172.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.75 -29.17 58.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 m -150.41 165.27 33.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.013 1.725 . . . . 0.0 108.348 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.547 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 86.5 m -147.26 119.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.16 -0.962 . . . . 0.0 108.962 -170.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.94 138.46 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.9 m -108.99 131.21 55.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.022 1.283 . . . . 0.0 107.739 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -139.88 -101.22 0.16 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 161.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.08 159.06 0.15 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.503 3.121 . . . . 0.0 106.873 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.3 -48.87 79.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.73 0.812 . . . . 0.0 111.861 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -71.31 1.45 6.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.052 1.341 . . . . 0.0 111.188 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -105.3 -44.55 4.71 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.924 -1.11 . . . . 0.0 112.856 158.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -60.04 -60.79 3.27 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.223 1.409 . . . . 0.0 111.184 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tp -44.5 -61.22 1.62 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.477 1.111 . . . . 0.0 109.304 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.77 -18.2 29.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.792 -172.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -67.13 -68.69 0.36 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.477 1.111 . . . . 0.0 110.675 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -21.94 59.02 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.2 m -74.57 -19.51 60.3 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.685 -1.259 . . . . 0.0 111.003 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.15 36.76 90.75 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.666 1.121 . . . . 0.0 112.158 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -69.1 -36.17 77.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.421 1.11 . . . . 0.0 111.462 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 18.3 mtt -163.44 160.44 23.39 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.634 2.774 . . . . 0.0 106.233 166.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -36.89 99.4 0.18 Allowed Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 127.147 2.179 . . . . 0.0 111.554 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.43 116.5 1.7 Allowed 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 123.364 2.709 . . . . 0.0 110.74 -162.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -166.64 71.12 0.12 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.48 0.712 . . . . 0.0 111.397 -171.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.4 t -59.2 -33.3 70.8 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.734 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.93 -87.88 0.0 OUTLIER 'General case' 0 C--N 1.353 0.721 0 CA-C-N 120.207 1.367 . . . . 0.0 112.819 162.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.2 t80 33.89 -135.14 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.501 2.32 . . . . 0.0 112.753 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -7.68 59.63 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.467 1.507 . . . . 0.0 113.007 175.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -66.05 -39.8 90.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.936 1.244 . . . . 0.0 108.416 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.12 49.54 21.14 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 123.828 0.728 . . . . 0.0 111.938 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -63.09 -9.0 8.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 117.873 -1.06 . . . . 0.0 113.705 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.1 tp 54.32 45.2 27.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 122.012 0.911 . . . . 0.0 108.751 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 124.33 21.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.547 ' CG2' ' H ' ' A' ' 72' ' ' THR . 1.2 mp -73.74 166.99 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.288 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -154.83 138.8 16.36 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.922 1.289 . . . . 0.0 107.571 -171.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.37 -15.28 66.79 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.134 -1.37 . . . . 0.0 113.603 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 174.88 -172.34 0.06 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.291 3.036 . . . . 0.0 106.841 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.2 mtp -65.69 -166.79 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.531 1.532 . . . . 0.0 111.214 158.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.88 -63.29 4.09 Favored Glycine 0 C--N 1.338 0.677 0 O-C-N 120.58 -1.325 . . . . 0.0 110.224 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 pp -52.96 -13.34 0.42 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.407 1.883 . . . . 0.0 115.759 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.58 -73.65 0.21 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.978 1.263 . . . . 0.0 110.319 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -159.19 48.21 0.31 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.002 1.273 . . . . 0.0 111.039 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -72.88 -8.11 54.04 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.723 -1.235 . . . . 0.0 113.243 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -165.06 -164.92 0.82 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.451 1.9 . . . . 0.0 108.443 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.9 -30.96 6.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.258 1.023 . . . . 0.0 113.307 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -68.47 -14.1 62.77 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.373 -1.454 . . . . 0.0 113.714 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.11 -3.85 28.97 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 169.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -150.13 44.74 0.89 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.176 1.79 . . . . 0.0 111.393 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.6 mt 50.22 159.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 128.174 2.59 . . . . 0.0 116.018 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.15 130.01 90.06 Favored Pre-proline 0 C--O 1.235 0.338 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.43 164.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.32 174.44 11.97 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.596 2.197 . . . . 0.0 111.123 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.87 83.26 0.15 Allowed Glycine 0 C--N 1.333 0.396 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -168.23 126.94 1.18 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.783 1.233 . . . . 0.0 108.591 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.73 104.19 11.09 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 168.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -80.97 98.82 8.1 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.653 0.781 . . . . 0.0 110.6 -171.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tp . . . . . 0 C--O 1.247 0.951 0 C-N-CA 126.403 1.881 . . . . 0.0 110.252 -168.624 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.411 ' CB ' ' HZ1' ' A' ' 38' ' ' LYS . 73.0 m -165.89 112.84 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.514 1.126 . . . . 0.0 110.755 -174.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.84 49.38 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.125 1.77 . . . . 0.0 110.328 151.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 t -95.42 -16.38 22.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -169.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.49 24.96 3.27 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 155.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.02 78.06 0.28 Allowed Glycine 0 C--N 1.336 0.544 0 O-C-N 120.67 -1.269 . . . . 0.0 113.088 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -153.68 160.69 42.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.629 1.572 . . . . 0.0 110.263 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm -65.48 -9.56 26.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.81 -6.24 5.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.994 0.815 . . . . 0.0 113.144 166.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.11 -37.93 81.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.681 1.128 . . . . 0.0 112.342 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -37.88 77.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.701 1.201 . . . . 0.0 110.734 174.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -52.71 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.627 1.571 . . . . 0.0 111.228 -175.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -70.15 -21.63 63.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.015 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -75.06 -27.5 60.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.774 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -49.46 72.96 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.353 1.433 . . . . 0.0 110.596 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mt -53.56 -47.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.42 1.088 . . . . 0.0 108.204 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -61.21 -53.39 57.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.634 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -51.76 -53.72 36.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.766 1.166 . . . . 0.0 108.42 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -57.12 -46.58 82.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.974 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -35.48 68.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -70.18 -52.24 24.95 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.27 -44.42 95.33 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.347 2.259 . . . . 0.0 112.763 -171.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -154.76 55.16 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.739 1.616 . . . . 0.0 111.072 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.31 -30.93 56.22 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-O 117.741 -1.589 . . . . 0.0 113.529 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.75 -38.91 67.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.898 1.849 . . . . 0.0 111.118 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -81.07 -19.26 44.14 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.279 -0.888 . . . . 0.0 112.429 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.42 -31.5 20.03 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 109.929 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.37 -55.03 6.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 126.682 1.993 . . . . 0.0 108.252 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -61.77 -16.0 45.97 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -79.68 -58.85 2.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.716 0.806 . . . . 0.0 110.52 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.45 -63.46 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.961 1.704 . . . . 0.0 107.155 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.66 72.39 0.69 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.243 1.402 . . . . 0.0 112.32 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.25 153.7 6.46 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.525 -1.153 . . . . 0.0 110.767 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.99 134.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -128.41 162.94 25.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.712 0.768 . . . . 0.0 109.131 162.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.59 157.72 22.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.561 164.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -105.79 96.29 6.39 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.322 1.449 . . . . 0.0 109.469 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HZ1' ' CB ' ' A' ' 2' ' ' SER . 10.2 tppt? -74.77 108.95 7.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.317 -1.489 . . . . 0.0 109.799 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.93 94.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 174.45 7.11 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 61.57 40.69 13.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 0.0 111.917 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 77' ' ' ASP . . . -61.16 173.08 6.65 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.396 0.998 . . . . 0.0 113.52 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.01 86.61 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.009 2.473 . . . . 0.0 107.085 166.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.81 -57.98 0.41 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -163.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.96 -23.87 7.63 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 125.945 1.736 . . . . 0.0 110.483 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -71.58 -172.48 0.79 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 111.221 168.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.58 149.03 50.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.934 1.694 . . . . 0.0 113.666 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.42 167.14 10.58 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.367 2.267 . . . . 0.0 109.966 166.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.9 m -155.23 114.59 3.64 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.005 0.907 . . . . 0.0 109.854 150.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -88.46 162.35 16.52 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 168.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.88 145.33 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.71 109.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.54 122.57 29.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.5 50.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 126.136 1.775 . . . . 0.0 106.961 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -40.5 0.07 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.401 1.08 . . . . 0.0 110.279 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -95.2 131.54 41.13 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 -145.24 42.72 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -83.16 8.29 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.455 -1.259 . . . . 0.0 113.744 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.78 156.77 8.66 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 120.586 1.539 . . . . 0.0 110.579 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -171.28 144.6 2.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.96 2.104 . . . . 0.0 108.524 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.4 t -74.56 152.05 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 168.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.37 88.6 12.69 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 127.843 2.457 . . . . 0.0 104.501 -164.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.39 138.94 62.76 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.587 1.525 . . . . 0.0 109.479 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 54.49 24.09 5.04 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.301 1.841 . . . . 0.0 112.742 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 t -76.77 145.31 38.64 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.915 0.864 . . . . 0.0 111.424 -159.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.37 -11.12 55.3 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.264 2.226 . . . . 0.0 112.64 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -66.11 164.84 14.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.681 0.673 . . . . 0.0 109.541 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -169.91 0.94 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.51 -0.744 . . . . 0.0 110.106 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.9 178.28 7.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.257 1.423 . . . . 0.0 107.767 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.1 -52.14 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 159.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -149.05 -172.78 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.563 1.545 . . . . 0.0 110.985 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -129.31 178.83 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 tt -125.24 178.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 159.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.6 m -125.29 161.97 25.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 160.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -50.01 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 158.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.08 161.41 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 130.912 3.685 . . . . 0.0 109.961 -166.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 16.6 t70 -62.37 -56.06 22.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.025 -169.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.81 -34.24 62.5 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 125.6 1.812 . . . . 0.0 108.781 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -58.39 5.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 111.626 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -53.97 -50.7 65.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.196 0.598 . . . . 0.0 109.968 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -26.98 66.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.036 1.734 . . . . 0.0 112.519 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.12 -25.93 55.86 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.286 0.948 . . . . 0.0 112.782 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.68 -72.54 0.2 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 11.9 ptp -76.51 53.25 0.85 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.015 1.326 . . . . 0.0 113.581 -171.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.2 p -155.76 -17.45 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 129.177 2.991 . . . . 0.0 110.082 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.14 37.34 91.41 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -164.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -99.4 22.94 9.95 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.509 1.655 . . . . 0.0 110.223 171.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.24 98.77 0.05 OUTLIER 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.521 1.929 . . . . 0.0 111.683 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -139.05 68.4 41.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 O-C-N 121.87 -0.519 . . . . 0.0 112.134 167.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -68.77 77.12 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 125.111 3.874 . . . . 0.0 112.072 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 56.69 37.98 29.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.911 1.285 . . . . 0.0 112.298 170.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.1 t -53.58 -17.69 2.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.757 1.623 . . . . 0.0 112.596 174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.01 -28.72 25.39 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.697 1.599 . . . . 0.0 112.682 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.61 -66.59 0.86 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.174 0.99 . . . . 0.0 108.955 166.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -50.02 -51.52 41.42 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.736 1.615 . . . . 0.0 112.049 -163.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -67.48 -8.92 37.35 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.85 30.69 46.71 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 119.575 1.079 . . . . 0.0 111.135 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -93.81 -4.51 50.06 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.229 1.514 . . . . 0.0 113.123 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.5 tp 54.49 84.79 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.364 2.265 . . . . 0.0 113.657 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 168.15 6.93 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.0 mm -132.3 -172.16 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -97.4 153.94 17.78 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 119.991 -1.693 . . . . 0.0 109.876 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -163.61 -7.75 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.748 -1.029 . . . . 0.0 114.403 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -164.53 -95.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 158.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 40.3 ttm -150.95 -105.48 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.297 0.953 . . . . 0.0 109.618 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.34 48.25 3.76 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 125.847 1.689 . . . . 0.0 110.371 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.33 -10.58 59.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.365 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.4 67.26 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.508 1.049 . . . . 0.0 112.445 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -100.45 -31.74 11.15 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -165.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -76.11 42.54 0.26 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 119.763 -1.836 . . . . 0.0 112.515 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.87 -14.17 62.61 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 119.872 -1.767 . . . . 0.0 113.068 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -35.53 -80.77 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.609 2.364 . . . . 0.0 115.272 -171.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -95.85 -48.12 5.87 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.559 1.143 . . . . 0.0 110.533 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.83 -17.36 55.99 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.668 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -127.38 45.68 2.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.091 1.314 . . . . 0.0 109.785 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.308 0.2 OUTLIER 46.68 156.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 1 C-N-CA 132.041 4.136 . . . . 0.0 115.964 170.993 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.78 135.58 59.51 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 120.611 -1.305 . . . . 0.0 110.901 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.45 -176.73 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.271 3.314 . . . . 0.0 113.307 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.91 147.41 22.31 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.993 1.759 . . . . 0.0 109.671 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.08 88.15 0.08 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.128 1.771 . . . . 0.0 109.678 -162.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.27 -60.74 2.99 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.556 1.542 . . . . 0.0 110.85 -172.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -162.3 108.19 1.25 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 103.36 -2.829 . . . . 0.0 103.36 156.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 C--O 1.249 1.057 0 O-C-N 124.473 1.108 . . . . 0.0 109.699 -172.139 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 m -54.44 -60.05 3.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.385 1.074 . . . . 0.0 112.392 -168.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 34.44 57.39 0.68 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.371 2.268 . . . . 0.0 112.687 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.8 m -143.36 -156.65 0.7 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.341 1.456 . . . . 0.0 107.685 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 45.34 22.44 0.09 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.15 65.87 0.24 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 126.578 2.037 . . . . 0.0 109.731 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -154.07 167.74 28.8 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.694 2.398 . . . . 0.0 107.283 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -62.33 -30.01 70.86 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.079 -0.388 . . . . 0.0 110.515 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.06 -28.13 0.67 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 128.218 2.607 . . . . 0.0 114.885 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.81 -44.1 73.51 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 123.789 0.835 . . . . 0.0 109.859 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.19 -42.7 99.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.683 1.593 . . . . 0.0 110.028 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -81.96 -51.22 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.593 1.557 . . . . 0.0 111.246 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.36 -23.32 67.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.056 0.844 . . . . 0.0 110.733 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -71.53 -36.4 70.99 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.846 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -55.43 -39.87 70.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 119.902 1.228 . . . . 0.0 112.32 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -62.43 -48.98 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -56.23 -53.84 52.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.016 1.326 . . . . 0.0 111.068 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -51.74 28.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.824 1.65 . . . . 0.0 109.092 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -59.26 -48.04 83.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.053 0.541 . . . . 0.0 111.211 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -36.09 68.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.13 -52.13 38.31 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.765 -1.209 . . . . 0.0 108.646 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.35 -47.11 82.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 110.569 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -165.35 64.7 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.411 1.084 . . . . 0.0 111.459 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.75 -15.01 81.78 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.46 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.82 -40.21 60.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.896 1.348 . . . . 0.0 111.994 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -17.99 49.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.654 0.782 . . . . 0.0 112.159 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -14.62 26.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.05 -62.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 126.733 2.013 . . . . 0.0 106.425 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -58.27 -18.71 28.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' HE3' HD23 ' A' ' 111' ' ' LEU . 30.2 mttm -66.3 -50.67 62.88 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 174.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.53 -53.19 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.45 47.63 76.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.361 0.981 . . . . 0.0 112.674 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.22 171.03 39.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.76 134.01 30.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 159.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -128.34 177.91 6.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.957 0.798 . . . . 0.0 109.211 163.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.42 51.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.412 0.685 . . . . 0.0 109.937 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -103.58 101.76 11.64 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.556 1.142 . . . . 0.0 107.997 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 106.84 6.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 121.092 1.769 . . . . 0.0 108.533 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.3 t -122.43 99.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -166.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -111.05 176.94 4.82 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 121.038 -1.039 . . . . 0.0 108.57 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.9 t0 60.24 60.02 2.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.476 1.91 . . . . 0.0 112.022 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.43 -167.29 32.56 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.83 1.681 . . . . 0.0 111.815 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.31 67.71 6.13 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.797 2.998 . . . . 0.0 109.644 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 -43.69 0.39 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.215 1.388 . . . . 0.0 110.636 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.64 -0.18 45.98 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.032 1.301 . . . . 0.0 112.369 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -65.84 -175.13 0.27 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.11 1.364 . . . . 0.0 111.576 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -132.3 132.75 43.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.221 1.008 . . . . 0.0 111.019 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.76 165.29 12.97 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.343 2.657 . . . . 0.0 107.304 171.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 m -148.38 117.64 6.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 155.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -83.69 128.02 34.21 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 165.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.92 146.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.86 104.84 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.78 106.4 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.11 47.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -129.25 -54.5 1.19 Allowed 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.319 0.647 . . . . 0.0 109.643 165.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -93.35 140.51 29.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -158.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 -124.54 11.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.23 5.76 35.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.523 1.529 . . . . 0.0 112.116 164.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.01 156.98 9.15 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -171.37 153.53 3.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.916 2.486 . . . . 0.0 107.832 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.66 114.86 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.75 117.44 59.78 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -169.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.01 140.12 15.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 -171.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 45.39 29.37 0.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.347 1.859 . . . . 0.0 114.057 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -64.83 141.37 58.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.156 0.889 . . . . 0.0 110.569 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.52 -20.19 60.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.412 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -54.51 126.7 24.63 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -63.16 -176.97 0.15 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.155 0.982 . . . . 0.0 110.034 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.95 159.19 42.74 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.098 1.359 . . . . 0.0 111.113 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -54.37 47.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.133 0.968 . . . . 0.0 109.191 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.0 m -146.41 169.8 18.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.366 2.266 . . . . 0.0 107.387 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.592 HG21 ' H ' ' A' ' 73' ' ' ILE . 10.3 m -114.32 -164.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.592 ' H ' HG21 ' A' ' 72' ' ' THR . 3.9 tt -148.93 178.1 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.495 -1.378 . . . . 0.0 108.13 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.7 m -143.11 138.81 30.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.856 1.662 . . . . 0.0 109.092 167.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -134.99 -12.56 2.2 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.7 143.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.348 2.659 . . . . 0.0 111.588 -146.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.7 -45.61 67.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 126.877 2.071 . . . . 0.0 112.376 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -54.43 -44.99 72.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.858 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.17 -51.24 56.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.717 1.207 . . . . 0.0 110.877 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -50.48 -50.99 51.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.392 2.277 . . . . 0.0 111.433 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.7 tp -53.8 -64.64 0.76 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.985 1.714 . . . . 0.0 108.633 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.21 -42.4 51.43 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.872 1.269 . . . . 0.0 111.385 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.72 -68.51 0.18 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.727 1.611 . . . . 0.0 109.912 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.47 -25.15 57.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.9 m -73.64 -11.33 60.38 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.005 0.82 . . . . 0.0 110.238 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.62 33.83 3.01 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.305 0.955 . . . . 0.0 112.033 163.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -106.4 -29.39 9.75 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.069 -168.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 14.7 ptm -154.35 179.16 9.25 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.817 1.19 . . . . 0.0 111.873 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -46.27 140.87 5.09 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.909 2.084 . . . . 0.0 111.1 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.11 43.12 1.23 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.92 3.08 . . . . 0.0 112.923 -176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -158.79 78.21 0.77 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.217 1.407 . . . . 0.0 109.384 -171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -25.35 63.65 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.0 -89.76 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.341 166.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.1 t80 48.05 -153.63 0.09 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.004 1.275 . . . . 0.0 112.196 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -63.0 -3.46 1.67 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.038 2.135 . . . . 0.0 113.665 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -78.92 -104.06 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.7 1.591 . . . . 0.0 107.961 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.14 28.27 0.02 OUTLIER Glycine 0 CA--C 1.531 1.048 0 N-CA-C 116.701 1.44 . . . . 0.0 116.701 -170.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -64.91 7.0 0.19 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 121.061 2.43 . . . . 0.0 115.394 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.6 tp 35.03 60.75 0.65 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.703 2.001 . . . . 0.0 109.89 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 160.33 28.58 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 73' ' ' ILE . 3.1 mp -100.09 169.82 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.9 p -75.04 -170.82 1.2 Allowed 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.198 -1.564 . . . . 0.0 110.484 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.39 -104.87 0.19 Allowed Glycine 0 C--N 1.337 0.614 0 O-C-N 119.483 -2.011 . . . . 0.0 112.369 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -147.41 -94.04 0.08 Allowed 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.64 1.176 . . . . 0.0 108.041 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.4 ttt -150.19 155.79 40.42 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.499 1.045 . . . . 0.0 110.92 -164.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.02 -83.63 1.61 Allowed Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 mt 49.72 -79.33 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.828 2.851 . . . . 0.0 113.971 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.45 -17.24 62.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.556 1.142 . . . . 0.0 112.063 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.4 ttt -133.48 31.21 3.75 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.176 1.79 . . . . 0.0 109.47 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 115' ' ' GLN . 3.3 pttt -68.94 44.92 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.175 2.59 . . . . 0.0 115.13 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.418 HD23 ' HE3' ' A' ' 30' ' ' LYS . 0.7 OUTLIER 52.37 -176.64 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.362 2.665 . . . . 0.0 113.377 177.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -86.51 -56.96 3.18 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -63.91 -2.94 2.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -170.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -92.7 8.36 39.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.66 2.027 . . . . 0.0 110.493 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.435 ' CG ' ' HE2' ' A' ' 110' ' ' LYS . 30.4 mt-30 -153.9 44.69 0.58 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.658 2.783 . . . . 0.0 110.4 -172.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.0 mt 50.48 -177.08 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 123.818 1.77 . . . . 0.0 115.44 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -134.76 169.81 12.88 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 125.87 1.668 . . . . 0.0 107.174 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -78.2 176.35 10.05 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.527 2.151 . . . . 0.0 110.054 167.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.02 70.9 0.78 Allowed Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.867 1.222 . . . . 0.0 111.735 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -144.58 152.31 40.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.935 0.868 . . . . 0.0 108.809 171.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 53.18 90.85 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.479 1.912 . . . . 0.0 111.576 -166.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -141.9 166.51 24.52 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.426 1.091 . . . . 0.0 109.555 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.979 2.112 . . . . 0.0 110.516 -170.818 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.474 ' HG ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 p . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.4 m -55.2 155.56 4.78 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.812 1.187 . . . . 0.0 109.759 162.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.99 163.4 14.7 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.84 0.856 . . . . 0.0 109.843 170.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.0 p -144.9 -26.92 0.49 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.29 22.54 2.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.018 1.727 . . . . 0.0 115.41 161.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.46 16.37 26.76 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 120.4 -1.438 . . . . 0.0 112.533 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.2 173.33 10.48 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.863 1.265 . . . . 0.0 109.905 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 49.1 mttp -74.76 -5.56 44.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.247 169.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.41 -23.04 62.28 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.764 1.225 . . . . 0.0 113.021 167.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -57.01 -52.71 64.17 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.078 0.854 . . . . 0.0 111.232 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -68.8 -32.47 72.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.239 0.616 . . . . 0.0 111.154 178.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.35 -54.59 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.078 0.951 . . . . 0.0 110.755 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -64.53 -27.14 68.76 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.606 0.639 . . . . 0.0 110.646 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.09 -30.51 65.17 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.077 -1.015 . . . . 0.0 112.701 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -59.8 -31.92 70.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 119.301 0.955 . . . . 0.0 112.081 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.0 mt -75.0 -46.56 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -50.86 -50.25 57.34 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.68 1.192 . . . . 0.0 111.306 172.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -58.35 -38.57 77.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.92 0.782 . . . . 0.0 109.942 -166.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -65.06 -47.92 75.63 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 173.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -35.16 65.52 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.048 0.939 . . . . 0.0 112.444 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.2 -53.15 40.81 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.831 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.35 -45.43 91.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.33 0.968 . . . . 0.0 112.686 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -155.72 58.48 0.61 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.746 1.26 . . . . 0.0 110.841 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.79 86.3 Favored Glycine 0 C--O 1.219 -0.79 0 CA-C-O 118.569 -1.129 . . . . 0.0 111.844 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.94 -40.14 42.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.357 1.578 . . . . 0.0 112.581 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -84.37 -18.68 35.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.359 -0.838 . . . . 0.0 111.778 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.94 -38.7 19.02 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.502 1.921 . . . . 0.0 109.246 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 t -54.07 -46.3 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 127.637 2.375 . . . . 0.0 108.755 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.54 -13.02 7.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -92.74 -63.09 1.27 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 120.077 1.308 . . . . 0.0 110.577 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.89 -38.36 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.2 1.0 . . . . 0.0 110.469 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 47.85 59.03 6.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.428 1.489 . . . . 0.0 112.526 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.49 -176.79 39.62 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.272 1.536 . . . . 0.0 110.509 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.6 131.77 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 159.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -121.98 167.26 13.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 111.939 166.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.8 146.02 34.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.832 1.653 . . . . 0.0 108.997 164.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -95.42 100.3 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -77.09 99.56 5.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.049 1.295 . . . . 0.0 109.059 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.12 133.81 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 170.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.48 175.46 5.51 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.607 -1.308 . . . . 0.0 108.706 154.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 55.42 52.52 11.17 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.112 160.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 44' ' ' GLY . . . -66.01 174.74 20.07 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.425 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.8 6.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.455 3.437 . . . . 0.0 115.088 169.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' GLY . . . -125.58 -22.06 1.89 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.403 1.478 . . . . 0.0 114.052 163.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.68 -13.43 17.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 119.515 1.657 . . . . 0.0 111.792 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -66.16 -175.5 0.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.938 1.695 . . . . 0.0 111.177 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' HG2' ' HG ' ' A' ' 1' ' ' SER . 4.0 pt-20 -121.87 167.09 13.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.466 1.506 . . . . 0.0 110.225 172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.45 173.37 12.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.547 1.939 . . . . 0.0 107.109 169.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 84.3 m -143.91 143.99 31.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 161.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.41 137.09 49.64 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 161.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.48 144.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.51 107.95 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -75.39 124.5 27.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.67 44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 105.852 -1.906 . . . . 0.0 105.852 172.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -134.5 -46.0 0.75 Allowed 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 125.09 1.356 . . . . 0.0 110.107 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -92.28 103.21 15.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -159.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.34 -113.83 4.51 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.278 -0.889 . . . . 0.0 111.638 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -84.81 -5.72 59.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.073 0.949 . . . . 0.0 112.757 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.75 -97.49 0.72 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 128.722 3.058 . . . . 0.0 110.383 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.7 m 98.89 151.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 1 C-N-CA 135.548 5.539 . . . . 0.0 111.733 -172.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.75 148.64 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 163.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.33 122.5 19.06 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.15 138.52 16.23 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 -177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.64 24.54 3.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.562 1.945 . . . . 0.0 111.958 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 t -74.65 144.76 43.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.264 1.031 . . . . 0.0 111.064 -153.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.4 7.08 23.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 111.882 164.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 tttm -61.99 129.29 40.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 153.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -68.06 -176.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.24 156.45 47.07 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.565 1.546 . . . . 0.0 109.286 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.31 -45.15 41.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.681 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -134.22 177.3 7.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.363 0.665 . . . . 0.0 110.887 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -138.81 -177.78 5.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.475 1.51 . . . . 0.0 107.688 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.27 152.93 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 119.543 -1.973 . . . . 0.0 105.694 166.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.7 m -108.24 122.74 47.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.409 1.459 . . . . 0.0 112.185 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.7 mtm -156.6 119.24 4.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.4 165.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.643 163.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 79' ' ' ASP . 15.6 t70 -56.09 -54.4 45.47 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 121.256 -0.902 . . . . 0.0 109.817 163.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.9 1.69 1.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.839 1.256 . . . . 0.0 112.305 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -100.0 -63.38 1.13 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.466 2.306 . . . . 0.0 108.613 164.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -60.94 -40.01 91.63 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.327 2.251 . . . . 0.0 113.503 -174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -35.37 71.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.934 1.293 . . . . 0.0 110.038 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.28 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.733 1.213 . . . . 0.0 110.674 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 tt -46.83 -75.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.82 2.448 . . . . 0.0 109.717 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.02 54.43 0.85 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.851 0.86 . . . . 0.0 112.992 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 p -137.81 -5.07 1.74 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.488 1.115 . . . . 0.0 112.267 155.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.0 73.45 1.0 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -168.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -140.7 -21.63 0.81 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.021 -0.693 . . . . 0.0 111.952 175.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 ptm -136.36 87.45 2.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -62.25 -55.61 38.67 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.871 -1.062 . . . . 0.0 109.715 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.03 148.19 75.24 Favored 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-N 121.371 1.525 . . . . 0.0 110.252 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -56.2 112.98 1.37 Allowed 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.324 0.65 . . . . 0.0 109.643 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -54.77 -48.26 72.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.175 0.99 . . . . 0.0 111.696 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.553 ' HA ' HE21 ' A' ' 96' ' ' GLN . . . -65.26 -40.55 94.1 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 121.482 1.947 . . . . 0.0 113.186 -170.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.9 -47.39 80.78 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 173.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -58.33 -58.95 6.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.239 1.816 . . . . 0.0 111.978 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.553 HE21 ' HA ' ' A' ' 93' ' ' ALA . 6.3 pt20 -68.53 -28.09 66.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.7 1.137 . . . . 0.0 111.191 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.43 12.98 53.18 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 116.617 -2.213 . . . . 0.0 114.987 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -64.3 -84.35 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.991 2.396 . . . . 0.0 110.335 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 tp -165.38 69.95 0.14 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.222 1.009 . . . . 0.0 109.456 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.58 164.03 27.05 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 175.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.2 mm -136.91 172.97 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.3 m 64.11 174.75 0.18 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.33 2.252 . . . . 0.0 111.468 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -165.7 16.6 0.09 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 120.444 -1.41 . . . . 0.0 114.225 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -82.86 40.68 0.7 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.58 1.69 . . . . 0.0 113.298 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.4 mpp? 25.73 60.82 0.07 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.482 2.713 . . . . 0.0 113.902 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.71 -18.98 0.04 OUTLIER Glycine 0 C--N 1.337 0.593 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -14.94 60.0 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.048 1.424 . . . . 0.0 111.671 164.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.16 -83.22 0.11 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.663 1.185 . . . . 0.0 108.444 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.0 ttt -142.76 88.77 2.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.419 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -76.4 -61.5 1.93 Allowed 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.093 -1.004 . . . . 0.0 112.804 175.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -149.7 -148.2 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.284 0.634 . . . . 0.0 109.504 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -89.76 -60.22 2.0 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.36 1.064 . . . . 0.0 109.734 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -57.02 -21.23 29.27 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.49 -4.87 42.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.383 0.992 . . . . 0.0 111.874 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -163.23 44.26 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.712 1.205 . . . . 0.0 112.172 -165.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.0 mt 48.74 160.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 125.214 2.435 . . . . 0.0 114.055 -165.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -80.68 171.91 11.13 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.871 172.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.1 178.89 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.675 2.25 . . . . 0.0 111.741 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.45 175.35 47.2 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.754 1.645 . . . . 0.0 109.646 165.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -52.29 3.95 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.561 1.544 . . . . 0.0 111.456 168.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 48.29 77.28 0.1 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.096 2.158 . . . . 0.0 114.278 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 97.36 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 1 C-N-CA 134.292 5.037 . . . . 0.0 107.706 -155.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--O 1.245 0.848 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 160.908 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.45 173.1 0.19 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.838 2.055 . . . . 0.0 113.669 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.26 147.13 37.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.116 1.367 . . . . 0.0 107.944 164.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.2 p -147.36 -153.33 0.48 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 127.426 2.29 . . . . 0.0 107.403 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t0 64.28 24.16 13.25 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 163.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.01 77.58 0.39 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 126.725 2.107 . . . . 0.0 108.6 -175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -153.25 151.93 30.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.682 2.393 . . . . 0.0 106.852 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -61.98 -26.55 68.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.838 0.744 . . . . 0.0 110.272 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.89 -14.35 1.42 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.051 0.94 . . . . 0.0 113.443 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 19.0 t-20 -55.9 -52.19 64.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.574 1.079 . . . . 0.0 111.454 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.183 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.6 t -54.69 -54.62 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.454 1.502 . . . . 0.0 110.723 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -71.1 -23.59 62.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.602 0.637 . . . . 0.0 112.199 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -75.29 -26.96 59.15 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.79 -50.0 75.57 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.211 0.46 . . . . 0.0 110.546 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.3 mt -51.39 -47.9 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.92 -50.72 72.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.988 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -55.42 -48.85 73.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.77 0.714 . . . . 0.0 109.213 -170.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.5 -45.57 93.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.181 0.592 . . . . 0.0 109.881 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -34.1 66.04 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.353 1.461 . . . . 0.0 114.355 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.258 7.8 mm-40 -63.67 -52.13 62.07 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.197 -0.939 . . . . 0.0 111.665 171.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.69 -45.54 93.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.071 1.305 . . . . 0.0 113.233 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -157.75 63.55 0.47 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.674 1.59 . . . . 0.0 108.446 -170.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -25.96 74.04 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 121.073 -1.017 . . . . 0.0 112.749 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -52.89 -36.54 59.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 112.195 -171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -77.05 -35.87 56.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.302 1.041 . . . . 0.0 110.005 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.03 -27.76 57.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.08 -55.6 9.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 167.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -63.8 -15.95 60.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.391 0.996 . . . . 0.0 113.472 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 119.634 1.106 . . . . 0.0 110.82 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.65 -50.29 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.279 1.031 . . . . 0.0 109.047 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.52 65.35 3.63 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.652 1.12 . . . . 0.0 112.775 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.06 144.76 4.64 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.31 138.28 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 168.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -138.88 162.66 34.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.046 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.3 144.56 40.29 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.749 1.22 . . . . 0.0 109.253 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -92.94 90.06 6.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.951 1.301 . . . . 0.0 108.945 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -74.62 107.56 6.82 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.717 -1.239 . . . . 0.0 109.526 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.67 110.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -115.77 -175.29 2.69 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 165.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t0 65.19 38.18 6.14 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.685 1.994 . . . . 0.0 112.578 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.44 -155.13 24.38 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.962 1.268 . . . . 0.0 111.801 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.75 110.06 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.658 2.239 . . . . 0.0 106.448 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.32 -70.5 0.23 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.028 0.823 . . . . 0.0 111.141 -166.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.92 21.44 36.2 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 118.476 1.138 . . . . 0.0 110.843 -162.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -75.52 -176.12 3.09 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 156.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.25 153.33 29.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.553 1.141 . . . . 0.0 108.363 166.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.69 170.85 13.29 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.36 1.864 . . . . 0.0 107.626 163.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.6 m -152.77 145.78 24.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 163.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -112.61 149.36 32.91 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 102.134 -3.284 . . . . 0.0 102.134 166.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 141.72 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 167.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.17 113.0 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -82.19 114.01 20.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.42 51.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -141.63 -54.22 0.46 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.4 153.02 34.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.729 0.812 . . . . 0.0 109.914 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.96 -134.37 11.65 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.366 0.984 . . . . 0.0 111.144 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.66 3.3 50.34 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.186 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.95 156.19 20.38 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -173.02 157.67 3.57 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 129.505 3.122 . . . . 0.0 107.599 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.15 153.62 3.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.0 mt -140.32 79.29 21.4 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -161.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.9 144.27 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.502 2.135 . . . . 0.0 110.331 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 47.09 24.47 0.4 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.761 2.024 . . . . 0.0 115.138 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -71.77 161.45 30.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.359 1.076 . . . . 0.0 111.479 -161.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.46 -15.73 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.632 1.973 . . . . 0.0 110.71 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -53.83 130.24 36.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.05 -176.03 2.82 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 165.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.54 152.45 45.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.82 0.848 . . . . 0.0 109.447 -174.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.15 -41.02 59.15 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.306 1.042 . . . . 0.0 109.516 -174.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -136.18 174.81 10.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.833 2.053 . . . . 0.0 107.889 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.49 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 23.7 m -155.35 122.71 5.55 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 tt -83.52 152.31 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.8 m -120.71 141.7 50.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.888 -1.133 . . . . 0.0 108.998 159.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.56 -103.41 0.2 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 163.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.21 159.25 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 130.56 3.544 . . . . 0.0 105.473 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.61 -41.2 69.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.834 0.854 . . . . 0.0 111.211 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 t -60.81 -21.23 62.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.632 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.32 -64.06 1.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.788 0.835 . . . . 0.0 109.387 172.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -55.85 -53.32 58.2 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.861 0.865 . . . . 0.0 110.299 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 tp -55.1 -54.72 39.6 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.54 -41.91 77.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.108 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -54.84 -65.02 0.65 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.776 0.716 . . . . 0.0 110.144 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . 0.275 0.0 OUTLIER -69.34 -28.36 66.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.7 m -74.47 -12.21 60.43 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.599 1.091 . . . . 0.0 112.102 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.04 19.97 29.47 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 119.589 1.086 . . . . 0.0 113.656 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -106.23 -24.3 12.35 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.428 1.491 . . . . 0.0 112.768 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.1 ttm 48.0 178.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 128.64 2.776 . . . . 0.0 114.86 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.91 154.89 29.68 Favored Pre-proline 0 C--O 1.241 0.625 0 C-N-CA 127.483 2.313 . . . . 0.0 105.732 173.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.64 43.2 1.48 Allowed 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.084 2.522 . . . . 0.0 112.699 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 48.68 78.43 0.09 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 128.547 2.739 . . . . 0.0 112.091 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.53 -43.13 1.24 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.188 2.595 . . . . 0.0 113.22 -172.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.91 -48.41 11.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 126.722 2.009 . . . . 0.0 112.955 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.7 t80 37.33 -150.81 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 130.128 3.371 . . . . 0.0 115.141 164.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -68.42 -7.16 29.22 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.396 1.078 . . . . 0.0 112.045 162.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -72.14 -47.07 53.78 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.107 0.867 . . . . 0.0 108.942 -169.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.46 66.47 1.51 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -75.11 49.25 0.44 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.255 1.022 . . . . 0.0 108.425 164.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.3 pt? 36.77 32.74 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.447 2.699 . . . . 0.0 113.447 -167.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.48 138.18 57.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -165.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.49 ' CG2' ' H ' ' A' ' 72' ' ' THR 0.314 1.2 mp -106.55 178.15 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 165.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.5 p -147.03 160.35 42.48 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 127.527 2.331 . . . . 0.0 105.135 162.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.25 -13.05 12.47 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.905 167.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -146.67 157.62 43.74 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.125 1.462 . . . . 0.0 109.172 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.5 mmm -62.71 134.51 56.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.415 1.886 . . . . 0.0 108.202 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.29 21.41 68.34 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.826 -0.43 . . . . 0.0 113.347 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.74 -21.96 65.26 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.613 1.206 . . . . 0.0 113.052 -172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.09 -38.95 18.51 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.61 0.764 . . . . 0.0 110.425 -172.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.05 63.69 1.35 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HA ' ' HE2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -76.28 -66.5 0.79 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.052 -1.03 . . . . 0.0 110.442 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.38 161.75 19.12 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.414 1.886 . . . . 0.0 108.989 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -71.6 -42.23 67.95 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -11.8 51.09 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.463 -1.398 . . . . 0.0 113.945 -173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.7 tp -77.92 -30.71 50.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.725 1.21 . . . . 0.0 110.789 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -134.99 44.48 2.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.508 1.923 . . . . 0.0 108.987 -165.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.307 0.4 OUTLIER 37.73 -175.83 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 129.494 3.118 . . . . 0.0 114.121 -178.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -134.42 143.43 46.79 Favored Pre-proline 0 N--CA 1.447 -0.619 0 O-C-N 119.012 -2.305 . . . . 0.0 108.823 -158.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.41 174.05 13.2 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.218 1.279 . . . . 0.0 109.767 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.45 -161.92 8.99 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 124.319 0.961 . . . . 0.0 111.019 -168.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -85.72 -29.1 24.18 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.123 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 39.83 -151.22 0.01 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 127.452 2.301 . . . . 0.0 113.159 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -175.46 160.31 2.54 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 130.865 3.666 . . . . 0.0 106.097 145.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . 0.28 1.3 pt? . . . . . 0 C--O 1.26 1.61 0 C-N-CA 127.812 2.445 . . . . 0.0 111.834 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 120.754 0.312 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 m -98.43 -172.2 2.28 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.321 1.448 . . . . 0.0 109.731 -174.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 35.02 69.73 0.16 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.12 2.168 . . . . 0.0 113.259 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 t -81.5 -44.89 16.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.896 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 48.48 23.0 0.54 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.114 2.165 . . . . 0.0 113.109 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 3.66 58.23 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.871 1.701 . . . . 0.0 112.031 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 2.3 m-30 -68.0 148.68 50.7 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 108.926 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -60.19 -21.99 62.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.308 0.643 . . . . 0.0 112.663 169.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -2.58 0.11 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 114.505 170.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -54.75 -51.87 64.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.931 1.242 . . . . 0.0 111.352 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -58.9 -36.34 74.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.325 1.05 . . . . 0.0 112.241 178.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.15 -51.76 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.493 1.042 . . . . 0.0 110.848 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -74.94 -14.72 60.67 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.989 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -74.62 -35.84 62.93 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 117.611 -1.185 . . . . 0.0 111.635 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -57.36 -29.06 63.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.995 1.27 . . . . 0.0 112.795 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.48 -56.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.453 1.901 . . . . 0.0 108.603 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.57 -47.44 63.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 110.609 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.71 -38.98 93.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.088 1.355 . . . . 0.0 109.825 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -69.32 -36.81 77.35 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.435 -0.79 . . . . 0.0 110.445 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -33.17 75.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.706 1.202 . . . . 0.0 112.188 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.83 -53.35 52.13 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.806 -1.184 . . . . 0.0 110.16 167.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.64 -42.55 83.66 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 112.648 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -160.27 40.34 0.18 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.0 -18.77 80.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.979 -172.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.28 -52.83 2.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.941 1.371 . . . . 0.0 111.529 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.16 77.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.456 0.646 . . . . 0.0 109.798 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.16 -29.25 67.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -53.75 -52.51 33.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.398 0.999 . . . . 0.0 108.699 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -62.18 -24.22 67.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.45 1.477 . . . . 0.0 113.641 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.64 -29.92 69.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.039 1.291 . . . . 0.0 112.175 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.34 -61.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.739 1.216 . . . . 0.0 108.533 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.54 64.48 3.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 125.79 1.662 . . . . 0.0 109.794 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.29 45.34 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.955 0.878 . . . . 0.0 113.809 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.37 138.29 24.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 158.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -135.37 164.49 27.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.858 0.299 . . . . 0.0 110.726 163.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.0 167.75 9.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 109.715 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.8 99.23 4.54 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -170.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -87.34 94.02 9.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.215 1.371 . . . . 0.0 110.607 -165.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.82 115.0 38.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.375 0.607 . . . . 0.0 109.787 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -115.29 174.14 6.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.922 1.289 . . . . 0.0 109.464 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.7 t0 44.13 47.23 7.49 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.165 0.916 . . . . 0.0 112.879 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 7' ' ' PHE . . . -69.71 173.27 37.97 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-O 118.564 -1.131 . . . . 0.0 111.834 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.25 94.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.818 3.012 . . . . 0.0 109.894 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.77 -3.48 14.89 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 126.674 2.083 . . . . 0.0 114.116 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.35 13.8 70.07 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.368 2.084 . . . . 0.0 112.284 160.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -85.79 -167.14 1.74 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.09 2.156 . . . . 0.0 108.502 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -134.11 147.76 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.854 1.661 . . . . 0.0 107.679 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.14 174.86 11.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.161 1.784 . . . . 0.0 108.122 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -155.54 155.83 34.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.116 1.366 . . . . 0.0 108.655 169.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.31 154.68 36.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 t -122.49 114.61 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.8 t -95.38 112.55 27.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.83 115.37 20.29 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.65 47.31 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 168.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.97 -49.92 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.513 1.525 . . . . 0.0 109.715 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.27 151.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.303 1.041 . . . . 0.0 108.208 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.11 -131.09 44.86 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -111.79 13.14 21.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.429 1.892 . . . . 0.0 109.717 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 156.66 29.45 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -172.62 161.56 4.92 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 128.182 2.593 . . . . 0.0 105.776 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.29 127.7 58.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -107.6 93.37 10.04 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 125.539 1.535 . . . . 0.0 108.061 -162.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.58 137.55 64.9 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.727 1.618 . . . . 0.0 110.297 -165.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.24 44.6 15.96 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.597 3.159 . . . . 0.0 109.06 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.69 147.01 53.9 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.916 0.865 . . . . 0.0 111.205 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.29 -24.68 39.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.547 158.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -60.43 117.12 4.86 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.157 0.979 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -72.21 -177.17 2.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.996 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.15 163.95 30.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.553 1.168 . . . . 0.0 111.542 -163.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -37.19 59.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.115 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.17 -178.85 5.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.273 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -139.03 -176.01 4.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.272 1.429 . . . . 0.0 108.123 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt -142.62 157.37 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 120.911 -1.118 . . . . 0.0 109.285 159.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 m -98.03 124.4 42.51 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 mtt -152.03 124.31 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 163.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 155.74 4.12 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.982 -0.449 . . . . 0.0 110.931 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -52.47 -49.59 64.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 110.871 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 t -65.4 -9.87 28.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.812 1.645 . . . . 0.0 111.603 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.17 -54.67 3.34 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.757 168.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -48.16 -54.34 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.081 0.855 . . . . 0.0 110.061 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.04 -51.08 62.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 125.818 1.647 . . . . 0.0 110.292 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.98 -24.77 66.36 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.052 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -67.91 -82.16 0.03 OUTLIER 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 ptm -75.89 53.15 0.74 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.295 1.838 . . . . 0.0 114.321 -163.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.8 m -154.53 -19.57 0.12 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.371 2.668 . . . . 0.0 108.799 170.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.15 80.46 1.31 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -125.48 -66.33 0.95 Allowed 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 44.9 mtt -143.05 -6.66 0.84 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 38.27 63.61 3.75 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 119.577 1.081 . . . . 0.0 111.911 -165.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -68.82 -175.76 1.03 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.163 2.575 . . . . 0.0 110.884 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -142.52 91.56 2.33 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 168.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.31 -48.26 62.38 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.46 -33.43 14.22 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -90.33 -61.29 1.71 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -61.92 -63.55 1.22 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.241 1.417 . . . . 0.0 111.695 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.55 -34.54 78.13 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.74 37.58 61.34 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 11.24 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.191 1.796 . . . . 0.0 115.72 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 tp 49.76 82.35 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.734 2.414 . . . . 0.0 109.994 -166.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.18 141.69 55.92 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.859 166.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.273 21.8 mm -78.95 169.74 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.4 p -89.93 -154.31 0.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.759 2.024 . . . . 0.0 107.96 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.92 -51.2 0.82 Allowed Glycine 0 CA--C 1.507 -0.445 0 O-C-N 120.608 -1.307 . . . . 0.0 110.232 162.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -144.52 110.74 5.5 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 101.857 -3.386 . . . . 0.0 101.857 168.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 25.7 ptp -67.05 158.46 31.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.7 -2.09 87.85 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 117.84 -1.533 . . . . 0.0 114.108 172.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . 0.268 1.4 pp -75.08 61.38 1.09 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.664 2.232 . . . . 0.0 110.006 162.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.84 -81.58 0.19 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 162.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -150.46 34.42 0.63 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.164 0.893 . . . . 0.0 110.858 -168.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -75.8 -32.18 59.75 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.892 0.877 . . . . 0.0 113.313 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 163.54 12.47 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.86 0.864 . . . . 0.0 108.899 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . 0.267 0.6 OUTLIER -115.92 -85.37 0.62 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 118.164 -0.922 . . . . 0.0 109.256 -178.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -56.71 -3.77 0.13 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.445 2.298 . . . . 0.0 115.893 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.7 tp -57.47 -53.97 52.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.44 52.69 0.88 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.681 1.592 . . . . 0.0 110.666 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.0 mt 57.57 -174.84 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 122.221 1.01 . . . . 0.0 111.053 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -105.8 137.15 19.25 Favored Pre-proline 0 N--CA 1.441 -0.88 0 C-N-CA 125.493 1.517 . . . . 0.0 111.578 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.14 174.53 12.29 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.536 2.157 . . . . 0.0 111.64 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -137.6 134.09 6.78 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-O 118.761 -1.022 . . . . 0.0 110.673 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -168.59 65.26 0.07 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.333 1.053 . . . . 0.0 111.144 171.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.2 97.85 3.07 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 120.669 -1.27 . . . . 0.0 108.804 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.17 78.91 0.39 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.253 1.277 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -149.606 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.239 0.532 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -73.8 60.95 0.74 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.355 1.862 . . . . 0.0 110.8 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.56 175.09 10.21 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.952 1.701 . . . . 0.0 109.003 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.7 p -143.47 -155.98 0.65 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -163.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.4 t0 61.43 27.04 16.7 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.52 62.67 0.3 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 119.606 -1.933 . . . . 0.0 111.965 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.431 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 32.5 m-85 -152.32 143.47 23.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.017 1.408 . . . . 0.0 110.938 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -17.7 62.54 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.637 167.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.33 -13.47 0.9 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.857 1.663 . . . . 0.0 113.706 167.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -56.26 -34.09 66.07 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.541 1.064 . . . . 0.0 112.208 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -31.53 25.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.56 -0.733 . . . . 0.0 112.088 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.87 -62.97 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 124.286 1.034 . . . . 0.0 108.907 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -67.51 -25.97 66.11 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.346 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -73.03 -34.33 66.26 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.537 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.66 -30.2 70.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 120.406 1.457 . . . . 0.0 112.588 172.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.3 mt -65.91 -52.99 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -56.38 -45.71 80.4 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.318 1.047 . . . . 0.0 112.303 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -59.81 -46.54 88.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -65.33 -39.34 92.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.795 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.35 -37.43 70.0 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 113.63 171.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.1 -53.4 50.24 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.205 1.002 . . . . 0.0 110.542 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -59.43 -46.02 89.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.307 1.412 . . . . 0.0 111.369 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -164.9 65.06 0.13 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.457 1.123 . . . . 0.0 113.341 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.57 79.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.048 1.309 . . . . 0.0 113.272 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.45 -36.93 67.1 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.811 1.305 . . . . 0.0 111.64 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.841 -1.162 . . . . 0.0 111.43 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.06 -25.8 61.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.432 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.24 -51.17 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.449 -0.786 . . . . 0.0 108.997 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.64 -37.34 75.73 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.801 1.182 . . . . 0.0 111.319 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -61.24 -65.76 0.64 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.626 0.77 . . . . 0.0 110.006 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mt -74.84 -66.87 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.51 66.24 2.53 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.819 1.2 . . . . 0.0 111.051 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.79 37.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 171.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.93 134.62 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 158.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -137.18 167.52 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 171.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 141.15 47.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.921 0.782 . . . . 0.0 112.864 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -87.26 103.78 15.77 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.142 0.977 . . . . 0.0 109.832 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -74.09 95.79 2.61 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 119.54 1.064 . . . . 0.0 109.764 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.14 108.9 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.28 179.25 4.21 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.679 1.191 . . . . 0.0 108.322 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 t70 49.51 42.79 23.28 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.631 1.172 . . . . 0.0 110.724 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 7' ' ' PHE . . . -66.86 168.63 36.19 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.148 -1.362 . . . . 0.0 110.413 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 92.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.829 3.019 . . . . 0.0 113.324 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.93 3.34 51.99 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.718 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.02 40.99 1.34 Allowed Glycine 0 C--N 1.339 0.734 0 CA-C-N 120.61 2.205 . . . . 0.0 111.307 164.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.04 -176.98 6.18 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.535 -0.979 . . . . 0.0 111.086 174.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -147.67 140.65 24.96 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.589 2.355 . . . . 0.0 107.381 163.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.25 166.33 30.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.3 m -143.88 147.73 34.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -122.44 132.81 54.53 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.97 151.29 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -126.66 104.84 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.85 105.16 15.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.34 55.18 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.839 0.745 . . . . 0.0 109.391 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -155.12 -43.66 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.674 1.19 . . . . 0.0 111.194 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -95.92 110.26 22.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.41 1.484 . . . . 0.0 107.557 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.49 -153.6 39.15 Favored Glycine 0 N--CA 1.46 0.261 0 O-C-N 119.882 -1.761 . . . . 0.0 111.618 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -5.45 57.02 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.771 0.828 . . . . 0.0 112.614 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.28 157.68 30.12 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-O 122.238 0.91 . . . . 0.0 110.973 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.84 165.41 6.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.125 3.37 . . . . 0.0 107.905 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.89 89.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 120.747 -1.221 . . . . 0.0 107.945 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.66 103.58 0.88 Allowed Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -164.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.94 143.83 41.73 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.678 1.585 . . . . 0.0 110.14 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 47.7 23.77 0.47 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.941 2.496 . . . . 0.0 113.427 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -78.49 149.21 33.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.405 0.621 . . . . 0.0 110.211 -153.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.55 -2.47 58.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.625 1.97 . . . . 0.0 111.183 168.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.09 130.57 46.7 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 155.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -177.28 1.9 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.28 159.34 39.39 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.983 1.713 . . . . 0.0 107.722 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -35.87 73.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.61 -167.19 2.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.519 1.528 . . . . 0.0 110.794 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 m -133.28 -176.62 4.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.766 1.226 . . . . 0.0 109.578 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tt -142.37 143.55 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.065 -1.022 . . . . 0.0 108.774 151.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 m -84.64 138.91 32.42 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.6 tpp -136.17 -57.88 0.75 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.308 1.413 . . . . 0.0 110.466 149.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.69 152.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 130.433 3.493 . . . . 0.0 111.634 -157.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.13 -48.62 75.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 123.717 0.807 . . . . 0.0 110.403 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 p -66.29 -5.34 10.16 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.751 1.22 . . . . 0.0 111.688 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 -47.87 3.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 161.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -55.81 -52.12 65.08 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.813 1.642 . . . . 0.0 110.179 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tp -55.12 -41.9 72.28 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.187 1.795 . . . . 0.0 112.606 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.82 79.92 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.776 0.43 . . . . 0.0 111.578 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -68.59 -76.14 0.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.055 1.742 . . . . 0.0 110.757 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptm -76.7 54.53 0.98 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.071 1.349 . . . . 0.0 113.902 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.0 p -155.25 -33.64 0.09 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.469 1.908 . . . . 0.0 110.446 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.85 78.04 1.19 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 125.986 1.755 . . . . 0.0 109.824 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -108.85 -46.01 3.7 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.313 1.445 . . . . 0.0 110.539 156.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -146.92 177.11 9.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.876 1.27 . . . . 0.0 113.603 -153.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -62.74 151.73 83.84 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.085 1.354 . . . . 0.0 112.056 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.17 163.97 22.31 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.385 2.723 . . . . 0.0 114.082 -171.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 59.63 80.84 0.19 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.821 2.048 . . . . 0.0 111.43 -165.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.4 m -41.28 -52.93 3.35 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.252 1.021 . . . . 0.0 113.033 170.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.17 67.76 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.817 -1.177 . . . . 0.0 113.956 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -64.63 -38.62 91.63 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -71.16 -78.22 0.08 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.4 1.88 . . . . 0.0 110.389 168.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -70.78 -18.9 62.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -157.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.97 49.33 72.24 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 120.564 -1.335 . . . . 0.0 112.896 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -105.21 56.03 0.69 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 128.264 2.626 . . . . 0.0 109.597 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.4 tp 33.53 73.06 0.07 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.686 2.394 . . . . 0.0 112.48 167.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 166.6 16.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 171.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.6 mp -129.83 159.56 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -172.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 46.54 -166.34 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.252 1.021 . . . . 0.0 111.775 -161.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 177.98 -24.88 0.05 OUTLIER Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.39 -1.444 . . . . 0.0 112.272 174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.8 t30 52.41 -174.69 0.03 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.088 2.155 . . . . 0.0 110.624 -170.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -72.5 80.82 1.07 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 164.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.0 73.24 0.38 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 126.452 1.977 . . . . 0.0 111.645 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -64.17 -40.24 95.71 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 118.194 0.997 . . . . 0.0 111.399 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.02 -61.53 2.48 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 118.403 -0.808 . . . . 0.0 108.874 -166.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 68.9 mmm 24.87 -70.37 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 130.081 3.353 . . . . 0.0 117.004 167.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -71.04 -49.58 43.3 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.082 1.31 . . . . 0.0 110.787 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.252 2.2 pp 34.8 4.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.948 1 C-N-CA 134.123 4.969 . . . . 0.0 119.753 177.599 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -88.92 -87.66 0.16 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 121.024 1.738 . . . . 0.0 106.704 -166.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -70.34 -3.89 19.59 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.582 -1.323 . . . . 0.0 112.561 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.95 -21.53 59.99 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 120.931 -1.105 . . . . 0.0 110.418 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.82 53.1 1.49 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.064 0.945 . . . . 0.0 109.648 -167.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER 43.79 -173.46 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.044 1.737 . . . . 0.0 112.568 178.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -142.55 165.62 25.76 Favored Pre-proline 0 C--O 1.24 0.576 0 O-C-N 119.574 -1.954 . . . . 0.0 109.152 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.58 -170.71 0.86 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.795 2.33 . . . . 0.0 109.682 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.57 -94.2 1.59 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 105.56 -3.016 . . . . 0.0 105.56 -165.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.3 t30 55.35 76.75 0.25 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.372 1.069 . . . . 0.0 108.206 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.76 101.47 2.1 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -155.97 143.68 19.54 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.246 0.891 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 158.253 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.513 ' HG ' ' HB3' ' A' ' 47' ' ' GLU . 13.4 p . . . . . 0 C--O 1.238 0.474 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.6 168.74 8.89 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 154.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.76 175.16 1.55 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.809 1.244 . . . . 0.0 111.02 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.8 m -154.01 -83.1 0.08 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 76.85 40.55 0.19 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.053 1.741 . . . . 0.0 109.034 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.57 35.48 0.38 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.761 1.172 . . . . 0.0 112.512 -174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.317 1.058 . . . . 0.0 110.349 173.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -54.15 -34.85 61.39 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.718 -0.614 . . . . 0.0 110.525 164.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.21 -10.96 1.42 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.206 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -60.61 -26.67 67.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.984 1.72 . . . . 0.0 110.969 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -81.56 -38.38 26.24 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.243 1.383 . . . . 0.0 112.039 169.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.81 -53.47 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 119.39 0.995 . . . . 0.0 110.591 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -67.91 -22.59 65.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.136 -0.625 . . . . 0.0 111.353 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -75.1 -30.33 60.87 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.58 -46.52 83.89 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.375 0.534 . . . . 0.0 109.72 170.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.54 -50.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -52.62 -55.68 20.74 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 124.374 1.07 . . . . 0.0 111.5 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -55.19 -48.65 73.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.546 1.138 . . . . 0.0 108.375 -171.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -48.96 79.16 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.642 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.19 70.22 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.328 59.2 mm-40 -66.2 -51.22 59.83 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 124.434 1.094 . . . . 0.0 110.828 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.37 -46.5 80.03 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.19 -0.944 . . . . 0.0 111.856 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -165.63 61.75 0.11 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.969 1.307 . . . . 0.0 109.456 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -24.01 72.58 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.963 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.43 -28.82 65.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.765 1.783 . . . . 0.0 113.596 -165.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.29 -25.47 16.32 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.488 2.715 . . . . 0.0 110.95 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -73.77 -28.85 61.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.724 2.01 . . . . 0.0 110.39 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -53.23 -44.34 52.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.585 1.154 . . . . 0.0 109.029 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.87 -27.78 69.04 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.42 ' HE3' HD11 ' A' ' 111' ' ' LEU . 57.6 mmtt -71.04 -28.85 64.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.844 1.202 . . . . 0.0 112.277 -167.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.76 -59.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.3 73.96 0.51 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.739 1.161 . . . . 0.0 110.343 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.56 177.09 45.27 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.896 0.848 . . . . 0.0 112.148 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.56 147.36 6.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 144.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -138.27 176.25 8.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 154.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.24 174.53 7.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.551 156.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -116.38 122.69 45.58 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.588 1.555 . . . . 0.0 107.836 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -100.05 104.93 16.54 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 121.12 1.782 . . . . 0.0 106.628 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.58 94.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -162.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -94.53 177.73 5.83 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.869 -1.145 . . . . 0.0 108.414 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.8 t0 60.31 33.3 20.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.344 1.057 . . . . 0.0 111.601 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.46 174.6 38.25 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 118.409 -1.217 . . . . 0.0 111.381 170.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.7 95.66 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.508 2.805 . . . . 0.0 110.528 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.69 -16.57 4.78 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.122 2.296 . . . . 0.0 112.871 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.28 3.72 88.65 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 118.919 1.359 . . . . 0.0 112.086 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -69.5 -174.78 0.73 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.312 2.645 . . . . 0.0 109.444 170.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.513 ' HB3' ' HG ' ' A' ' 1' ' ' SER . 14.5 pt-20 -126.91 168.74 14.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.079 0.552 . . . . 0.0 110.829 170.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.39 175.07 10.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.881 1.672 . . . . 0.0 109.338 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.0 m -149.75 149.09 30.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.256 1.022 . . . . 0.0 109.917 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.7 151.63 40.29 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 t -120.55 133.94 65.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 126.853 2.061 . . . . 0.0 105.985 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.85 114.5 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.15 114.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.97 54.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.34 -45.41 0.05 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.166 1.386 . . . . 0.0 109.106 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -74.91 135.44 41.48 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.37 -133.19 11.0 Favored Glycine 0 C--N 1.333 0.362 0 O-C-N 123.69 0.618 . . . . 0.0 111.885 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.46 4.15 47.57 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.418 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.24 156.89 28.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-O 123.22 1.456 . . . . 0.0 110.212 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -172.31 144.4 1.56 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.005 2.922 . . . . 0.0 109.689 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.97 157.01 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mt -134.71 79.23 53.41 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -166.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.87 132.83 38.82 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.122 2.548 . . . . 0.0 110.81 -166.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.2 23.77 4.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.539 1.936 . . . . 0.0 111.891 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -82.69 145.91 29.35 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.449 -0.782 . . . . 0.0 110.104 -162.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -85.16 -9.45 57.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.748 1.619 . . . . 0.0 111.791 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -53.4 142.36 22.01 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.945 -1.097 . . . . 0.0 110.435 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -71.02 -175.58 1.18 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 111.779 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.58 165.09 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.22 -62.49 1.55 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.562 1.145 . . . . 0.0 112.157 157.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -154.54 166.91 31.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.871 1.669 . . . . 0.0 108.991 -170.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -138.61 126.65 22.58 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 tt -82.53 165.48 2.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 m -102.35 126.37 49.34 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -157.82 132.07 8.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 158.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.21 154.39 39.94 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.456 1.102 . . . . 0.0 110.081 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -49.69 -48.59 49.56 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.535 1.534 . . . . 0.0 112.389 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -59.04 -24.99 63.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 110.948 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.38 -26.44 11.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.465 0.706 . . . . 0.0 110.89 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' CZ ' ' HG3' ' A' ' 75' ' ' MET . 66.1 m-85 -57.85 -57.97 10.44 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 158.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.47 -35.82 53.51 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.547 -0.72 . . . . 0.0 111.977 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.92 94.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mt -69.94 -67.1 0.51 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 110.107 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -50.7 15.18 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -167.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.1 m -74.43 -26.65 60.2 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.719 -1.238 . . . . 0.0 109.536 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.02 18.41 19.98 Favored Glycine 0 C--O 1.222 -0.595 0 CA-C-O 118.539 -1.145 . . . . 0.0 113.378 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -64.35 -8.09 11.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.216 2.008 . . . . 0.0 114.607 -171.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 32.0 mtp 64.4 112.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.642 2.377 . . . . 0.0 111.877 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -154.71 142.49 14.05 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.92 -178.89 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.863 1.709 . . . . 0.0 110.923 171.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -57.48 92.76 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.048 1.339 . . . . 0.0 112.4 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -35.17 78.64 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -164.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.0 72.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.603 1.161 . . . . 0.0 111.499 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -76.06 -44.11 40.59 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.785 0.834 . . . . 0.0 110.268 170.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -43.49 67.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.153 0.981 . . . . 0.0 111.667 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -85.21 10.59 11.94 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 118.947 0.794 . . . . 0.0 112.454 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.33 -24.73 1.37 Allowed Glycine 0 C--N 1.339 0.705 0 C-N-CA 126.467 1.984 . . . . 0.0 114.379 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -64.78 -15.7 62.02 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.942 1.297 . . . . 0.0 113.36 -167.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 100' ' ' LYS . 13.6 tp 66.62 -172.06 0.19 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.934 1.693 . . . . 0.0 108.657 -166.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.537 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 17.5 ptmt -143.12 129.91 20.42 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 130.631 3.573 . . . . 0.0 101.974 -162.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.546 HG21 ' H ' ' A' ' 102' ' ' THR . 3.0 mm -102.61 -154.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -157.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.546 ' H ' HG21 ' A' ' 101' ' ' ILE . 14.1 p 50.42 -134.41 1.53 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -174.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 168.29 -69.76 0.16 Allowed Glycine 0 C--O 1.225 -0.458 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 166.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 41.11 57.72 2.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.201 1.801 . . . . 0.0 112.295 163.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 51.6 ttm 48.01 63.16 2.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.161 2.184 . . . . 0.0 111.05 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.41 -26.94 1.04 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.628 2.061 . . . . 0.0 114.469 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 40.93 18.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 131.133 3.773 . . . . 0.0 116.575 -176.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.05 -71.63 0.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.554 1.07 . . . . 0.0 110.771 -160.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 ttt -151.73 61.18 0.87 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -70.19 -5.68 29.09 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.136 0.974 . . . . 0.0 112.88 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.42 HD11 ' HE3' ' A' ' 30' ' ' LYS . 1.1 pt? -158.93 135.42 9.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.13 2.172 . . . . 0.0 105.617 166.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -59.94 -35.42 74.9 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -54.91 -28.52 51.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.124 0.97 . . . . 0.0 113.371 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.07 -5.01 32.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.339 0.972 . . . . 0.0 111.671 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -149.49 44.46 0.94 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 128.639 2.775 . . . . 0.0 109.58 -170.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.379 0.2 OUTLIER 44.45 -173.55 0.01 OUTLIER 'General case' 0 C--N 1.352 0.681 0 C-N-CA 127.348 2.259 . . . . 0.0 112.756 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -92.2 115.21 64.28 Favored Pre-proline 0 CA--C 1.538 0.493 0 O-C-N 118.941 -2.349 . . . . 0.0 109.025 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.96 -179.9 5.43 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.262 2.642 . . . . 0.0 111.099 170.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.63 72.38 0.96 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.576 1.56 . . . . 0.0 109.838 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.06 145.94 29.83 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.91 101.13 2.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.453 1.479 . . . . 0.0 111.075 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt 44.65 -151.83 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.235 1.814 . . . . 0.0 111.305 173.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.819 0 CA-C-O 117.002 -1.475 . . . . 0.0 107.051 151.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 120.599 0.238 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 p 78.45 155.97 0.16 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 130.333 3.453 . . . . 0.0 112.583 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.57 95.8 0.01 OUTLIER 'General case' 0 C--N 1.345 0.37 0 C-N-CA 127.963 2.505 . . . . 0.0 111.798 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -135.77 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.112 2.565 . . . . 0.0 111.905 -173.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.55 22.58 13.02 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 119.452 -2.03 . . . . 0.0 113.544 167.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.06 68.56 0.42 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 125.225 1.393 . . . . 0.0 111.025 -163.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -153.42 159.87 42.47 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.727 2.011 . . . . 0.0 107.34 -168.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.71 -34.6 73.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 167.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.21 -10.5 0.37 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.805 2.042 . . . . 0.0 114.607 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -55.16 -52.52 63.05 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 120.347 1.43 . . . . 0.0 111.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -65.22 -33.63 76.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.434 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.66 -54.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.144 0.884 . . . . 0.0 110.248 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -68.95 -23.19 64.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.261 0.482 . . . . 0.0 111.646 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -37.57 80.99 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 116.591 -1.671 . . . . 0.0 111.835 173.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -65.45 -38.16 89.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.678 1.581 . . . . 0.0 111.256 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 60.0 mt -52.86 -47.91 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -64.51 -43.04 95.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.886 0.474 . . . . 0.0 111.826 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -63.18 -42.95 99.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -60.16 -35.71 75.94 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.142 -0.974 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.29 -27.26 62.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -63.86 -54.05 41.07 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.19 -0.944 . . . . 0.0 109.079 163.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.06 -43.81 98.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.648 0.779 . . . . 0.0 110.05 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -165.09 64.9 0.12 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.408 1.483 . . . . 0.0 109.064 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.89 -17.28 79.3 Favored Glycine 0 CA--C 1.519 0.334 0 O-C-N 120.959 -1.088 . . . . 0.0 113.166 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' CB ' ' HE3' ' A' ' 58' ' ' LYS . 5.9 pt-20 -58.21 -33.98 69.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.99 0.895 . . . . 0.0 112.197 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -79.98 -39.35 30.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.775 1.63 . . . . 0.0 109.463 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.39 -29.53 70.82 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.27 -52.25 53.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 119.214 0.916 . . . . 0.0 110.6 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -68.41 -18.04 64.35 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.299 -0.876 . . . . 0.0 112.621 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -72.55 -69.49 0.4 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 120.333 1.424 . . . . 0.0 109.195 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.32 -54.84 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -171.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.29 65.01 3.43 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.06 158.07 21.91 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 167.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.27 137.51 22.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 159.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -132.41 168.81 17.49 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.661 -0.649 . . . . 0.0 109.426 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.06 158.87 26.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.09 113.39 26.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.503 1.521 . . . . 0.0 108.629 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.27 117.3 23.46 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.34 1.882 . . . . 0.0 114.181 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.67 101.28 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -109.45 -169.96 1.57 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 165.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t0 54.12 39.28 30.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.822 2.049 . . . . 0.0 111.917 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.22 176.55 17.68 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.721 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.88 -8.04 12.77 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.451 2.1 . . . . 0.0 114.119 -174.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.69 4.84 19.1 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.629 1.585 . . . . 0.0 114.617 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.61 77.57 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 120.179 1.989 . . . . 0.0 112.805 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -85.57 -171.77 3.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.062 2.945 . . . . 0.0 110.164 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.45 150.5 39.1 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.87 162.77 28.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 131.528 3.931 . . . . 0.0 107.498 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 m -154.91 140.94 18.36 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 161.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -112.19 154.72 25.11 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 170.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.1 t -118.93 122.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.13 109.97 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 107.681 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -85.4 48.52 1.59 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.077 1.351 . . . . 0.0 112.242 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 m -75.74 53.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 119.998 -1.689 . . . . 0.0 110.977 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.06 -46.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.226 1.81 . . . . 0.0 108.908 174.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.4 143.19 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -168.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.54 -131.57 51.18 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HE3' ' CB ' ' A' ' 25' ' ' GLU . 2.8 mmmt -97.94 5.18 49.2 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.351 1.06 . . . . 0.0 111.346 168.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.77 157.8 20.33 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 119.885 1.22 . . . . 0.0 110.637 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.8 m -171.54 162.49 6.52 Favored 'General case' 0 N--CA 1.442 -0.844 1 C-N-CA 132.386 4.274 . . . . 0.0 105.201 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.94 157.41 10.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 mt -129.03 122.55 21.34 Favored Pre-proline 0 N--CA 1.441 -0.897 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -89.74 145.45 4.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.787 2.991 . . . . 0.0 108.849 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 35.49 41.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.088 1.755 . . . . 0.0 114.039 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -68.25 148.9 50.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.722 0.809 . . . . 0.0 109.098 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -86.19 -20.24 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.402 1.081 . . . . 0.0 111.303 163.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -52.3 125.06 14.84 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -62.44 -177.45 0.14 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.165 0.983 . . . . 0.0 109.036 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.36 149.06 33.05 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.609 1.164 . . . . 0.0 109.997 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -43.45 51.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.812 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -127.27 174.23 9.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.511 1.924 . . . . 0.0 109.136 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 73' ' ' ILE . 1.9 m -133.75 -169.68 2.35 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.445 ' H ' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER -155.37 154.67 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 169.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -121.64 128.4 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.6 mtm -136.27 -29.15 1.0 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 117.367 -1.301 . . . . 0.0 111.718 165.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.81 153.6 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.872 1.269 . . . . 0.0 109.517 -166.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.47 -44.06 72.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.382 1.473 . . . . 0.0 111.216 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.0 t -56.81 -39.31 73.91 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.068 2.547 . . . . 0.0 109.925 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.19 -42.39 10.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.522 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.39 -52.32 62.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.34 1.056 . . . . 0.0 110.489 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.39 -53.45 56.49 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.68 -19.26 15.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.612 0.765 . . . . 0.0 113.054 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -79.81 0.05 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -30.33 59.85 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -166.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.1 m -74.71 -12.58 60.46 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.188 1.358 . . . . 0.0 110.542 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.06 73.56 1.18 Allowed Glycine 0 C--N 1.34 0.771 0 O-C-N 120.995 -1.066 . . . . 0.0 112.132 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -136.35 -25.37 1.18 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.492 0.717 . . . . 0.0 112.677 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.4 mmt -128.89 161.0 30.88 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.968 1.307 . . . . 0.0 109.327 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.14 128.88 58.26 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 124.621 1.168 . . . . 0.0 108.527 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.49 44.56 1.73 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.349 2.7 . . . . 0.0 112.324 -167.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -149.55 41.09 0.86 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.481 1.113 . . . . 0.0 110.248 -165.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -53.7 34.9 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.906 -1.122 . . . . 0.0 111.21 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . . . -51.68 -12.62 0.19 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -101.23 -57.14 2.15 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.666 2.387 . . . . 0.0 109.576 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -70.58 -60.43 2.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.075 1.75 . . . . 0.0 110.756 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -40.04 94.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.689 1.595 . . . . 0.0 109.759 170.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.87 17.58 79.99 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 121.336 -0.853 . . . . 0.0 113.621 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -64.01 -6.68 6.67 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.31 1.555 . . . . 0.0 113.657 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.8 tp 44.59 62.33 2.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.863 1.265 . . . . 0.0 109.417 -163.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 93' ' ' ALA . 10.6 pttp -64.41 139.9 58.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 168.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.561 ' CG2' ' H ' ' A' ' 102' ' ' THR 0.321 33.4 mm -77.45 -172.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.722 -176.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.561 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -153.09 153.09 32.12 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.269 1.828 . . . . 0.0 106.488 -167.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.38 -90.65 1.2 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -159.63 172.89 16.97 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.062 0.945 . . . . 0.0 109.731 169.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 47.84 89.67 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.819 2.447 . . . . 0.0 113.92 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.12 -65.93 2.25 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.755 1.645 . . . . 0.0 113.192 160.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.526 ' HG ' ' H ' ' A' ' 108' ' ' ALA 0.276 1.2 pp 34.01 -78.41 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.109 1 C-N-CA 132.346 4.258 . . . . 0.0 114.48 174.96 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.526 ' H ' ' HG ' ' A' ' 107' ' ' LEU . . . -58.1 -46.17 85.98 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 128.701 2.8 . . . . 0.0 110.234 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.2 ttm -82.1 -34.32 29.36 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 124.307 1.004 . . . . 0.0 111.133 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.75 46.05 0.35 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.877 1.671 . . . . 0.0 111.397 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.15 79.87 5.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.067 1.347 . . . . 0.0 109.572 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . 0.252 2.6 mt-30 -116.25 -68.06 0.95 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -98.53 -51.4 3.95 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.579 1.552 . . . . 0.0 114.76 166.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.47 -56.19 18.98 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.728 0.811 . . . . 0.0 109.294 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.12 44.88 1.21 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.976 0.51 . . . . 0.0 110.49 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.6 mt 49.88 -177.32 0.01 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.571 1.548 . . . . 0.0 112.933 -170.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.32 115.48 63.77 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 126.68 1.992 . . . . 0.0 109.265 -170.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.16 174.63 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.034 2.49 . . . . 0.0 112.909 -169.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.39 88.68 0.52 Allowed Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.002 1.287 . . . . 0.0 111.012 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -64.37 151.76 43.16 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 162.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 35.63 82.08 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.23 2.212 . . . . 0.0 113.336 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -143.25 175.97 9.49 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.059 1.344 . . . . 0.0 108.267 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 C--O 1.254 1.299 0 C-N-CA 123.838 0.855 . . . . 0.0 110.277 177.299 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -152.22 -179.76 7.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.507 1.523 . . . . 0.0 109.403 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.06 148.07 26.6 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.025 1.33 . . . . 0.0 107.888 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m -150.61 -16.24 0.23 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.271 0.1 OUTLIER 57.51 23.99 9.79 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.27 74.87 0.29 Allowed Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.243 -1.535 . . . . 0.0 111.492 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -153.87 158.74 41.22 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.606 1.562 . . . . 0.0 109.955 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -75.05 -13.34 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.841 165.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.86 -30.25 5.59 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.585 1.084 . . . . 0.0 112.575 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 127.135 2.174 . . . . 0.0 110.479 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.83 -31.43 71.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.191 1.396 . . . . 0.0 110.859 -174.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 t -90.63 -45.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.222 2.609 . . . . 0.0 110.989 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -65.14 -37.34 87.1 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.093 0.861 . . . . 0.0 111.797 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -52.25 -37.1 54.4 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 170.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.69 -41.27 96.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.921 0.782 . . . . 0.0 110.906 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.17 -51.68 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.29 -43.71 83.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.807 1.643 . . . . 0.0 112.768 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -65.32 -51.46 60.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -59.58 -38.97 82.59 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.317 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -37.95 71.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.52 -53.38 43.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.29 -0.881 . . . . 0.0 111.938 165.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -55.21 -43.93 74.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.041 1.336 . . . . 0.0 112.136 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -165.42 65.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.621 2.768 . . . . 0.0 108.525 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.89 -25.66 75.36 Favored Glycine 0 CA--C 1.518 0.224 0 O-C-N 120.691 -1.256 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -44.22 62.44 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.952 0.876 . . . . 0.0 111.58 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -77.43 -22.66 51.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 121.426 -0.796 . . . . 0.0 110.815 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.17 -29.04 54.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -55.47 -38.83 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.153 0.888 . . . . 0.0 109.417 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -69.48 -11.17 60.61 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.53 -1.356 . . . . 0.0 114.013 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -78.07 -61.7 1.91 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 121.405 1.911 . . . . 0.0 111.199 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.77 -58.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.02 62.64 4.55 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 126.756 2.122 . . . . 0.0 112.724 -170.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.54 164.38 34.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 125.275 1.417 . . . . 0.0 110.657 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.03 128.36 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 159.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -129.82 159.36 36.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 110.899 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.74 166.67 10.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 109.212 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.09 91.92 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -172.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -78.84 104.41 9.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.307 0.958 . . . . 0.0 109.073 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.59 103.5 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -92.83 -171.03 2.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 170.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.8 t0 62.22 51.62 3.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 123.23 1.491 . . . . 0.0 111.333 148.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.87 -162.64 11.78 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 126.849 2.166 . . . . 0.0 109.627 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.9 85.84 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 124.053 3.169 . . . . 0.0 110.619 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.13 -20.87 4.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.826 1.679 . . . . 0.0 113.467 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.07 22.67 65.22 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 120.035 1.917 . . . . 0.0 111.285 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -79.06 -169.58 1.88 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.318 1.447 . . . . 0.0 108.409 168.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.0 141.67 50.72 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.573 0.749 . . . . 0.0 109.378 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.97 160.98 14.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.016 2.527 . . . . 0.0 107.721 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.5 m -140.05 142.56 36.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 147.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.1 140.83 47.54 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 161.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.13 142.16 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.51 113.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 42.49 1.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.848 1.659 . . . . 0.0 112.197 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 m -74.63 60.37 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.822 1.249 . . . . 0.0 111.117 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -148.99 -46.14 0.14 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.234 1.814 . . . . 0.0 109.584 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -82.08 142.31 32.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.12 -127.71 25.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.953 0.797 . . . . 0.0 113.119 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -92.55 1.44 57.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.606 1.162 . . . . 0.0 111.909 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.12 157.83 15.33 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 120.185 1.357 . . . . 0.0 110.263 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -171.17 165.64 7.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 129.461 3.104 . . . . 0.0 108.509 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -107.96 156.12 8.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.086 1.754 . . . . 0.0 109.039 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -142.23 75.08 20.34 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 -162.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -63.18 140.07 75.83 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.357 2.038 . . . . 0.0 109.531 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 51.43 23.56 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.709 1.603 . . . . 0.0 114.132 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 t -79.22 144.5 34.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.485 0.659 . . . . 0.0 111.406 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.52 8.36 3.59 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 126.021 1.728 . . . . 0.0 111.057 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.91 135.22 57.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.437 -2.039 . . . . 0.0 109.546 162.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -66.95 -173.34 0.24 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.535 1.534 . . . . 0.0 109.482 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 165.85 33.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.293 1.037 . . . . 0.0 109.907 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.08 -50.32 16.78 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.068 160.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.4 m -134.83 -178.65 5.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.891 0.769 . . . . 0.0 111.461 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.564 HG21 ' H ' ' A' ' 73' ' ' ILE . 14.1 m -149.2 -164.66 2.08 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.564 ' H ' HG21 ' A' ' 72' ' ' THR . 5.6 tt -150.75 165.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 125.566 1.546 . . . . 0.0 107.159 161.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.457 ' H ' ' HA ' ' A' ' 100' ' ' LYS . 72.9 m -121.48 136.23 54.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.181 161.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.05 -98.33 0.15 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 152.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 178.0 152.24 0.27 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.755 3.222 . . . . 0.0 106.992 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.17 -40.59 90.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.796 1.638 . . . . 0.0 110.159 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.4 p -58.68 -22.77 57.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.771 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -105.72 -40.79 5.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.661 1.184 . . . . 0.0 109.982 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -53.99 50.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.342 1.457 . . . . 0.0 111.904 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -54.66 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.03 -12.9 58.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.896 -1.526 . . . . 0.0 114.043 -168.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.55 -76.33 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.765 1.626 . . . . 0.0 108.996 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -34.97 79.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 m -74.52 -10.76 59.87 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.681 -0.637 . . . . 0.0 109.881 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.8 20.47 61.37 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-O 118.494 -1.17 . . . . 0.0 114.116 154.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -100.29 -64.97 1.0 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.705 1.253 . . . . 0.0 111.246 -169.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 11.4 mtt -155.82 102.37 2.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 108.139 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -134.31 54.66 12.48 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 125.63 1.572 . . . . 0.0 109.709 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -62.67 149.07 92.37 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.798 2.332 . . . . 0.0 109.982 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -34.85 92.73 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.705 2.402 . . . . 0.0 112.064 -172.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.87 -91.76 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 119.595 1.089 . . . . 0.0 110.733 -160.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 100' ' ' LYS . . . -63.64 -21.24 66.27 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.604 1.093 . . . . 0.0 111.169 175.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -64.64 -48.36 75.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.796 1.638 . . . . 0.0 110.775 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -75.6 -53.7 8.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.264 0.938 . . . . 0.0 108.862 171.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -71.4 -25.59 62.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.33 -159.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.66 27.85 70.53 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.899 1.227 . . . . 0.0 114.309 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -67.02 -86.84 0.02 OUTLIER 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.965 1.382 . . . . 0.0 110.262 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.6 tp -165.36 55.28 0.11 Allowed 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.96 -0.462 . . . . 0.0 111.02 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -80.17 169.2 18.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 120.995 -1.065 . . . . 0.0 108.263 174.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -135.85 171.23 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.5 p -150.42 -179.01 6.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.607 1.963 . . . . 0.0 107.977 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 172.6 50.29 0.04 OUTLIER Glycine 0 C--N 1.336 0.544 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 167.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -166.8 -67.86 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.716 0.806 . . . . 0.0 109.135 -166.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.2 ptm 177.46 -106.23 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.851 2.86 . . . . 0.0 107.806 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -138.13 80.87 0.28 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 121.08 1.764 . . . . 0.0 109.636 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.18 20.15 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.815 2.046 . . . . 0.0 115.817 -170.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.91 -94.09 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.668 1.187 . . . . 0.0 112.887 -167.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.0 mtt -105.59 7.39 32.78 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.392 1.477 . . . . 0.0 111.145 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.3 32.32 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.675 2.39 . . . . 0.0 111.833 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.02 164.38 38.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.212 1.805 . . . . 0.0 110.27 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.65 -81.59 0.61 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -53.75 -33.97 57.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.164 1.347 . . . . 0.0 113.317 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -15.39 25.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.535 0.734 . . . . 0.0 112.283 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -128.17 49.34 2.18 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.495 1.518 . . . . 0.0 109.104 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.4 mt 47.86 -176.02 0.01 OUTLIER 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.8 1.64 . . . . 0.0 111.823 -172.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.63 166.6 11.05 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 124.134 0.974 . . . . 0.0 111.343 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.73 174.63 5.3 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.15 2.567 . . . . 0.0 111.284 166.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.08 77.07 1.15 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -156.05 -73.2 0.11 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.25 1.02 . . . . 0.0 110.212 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 43.35 44.89 4.98 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.345 1.858 . . . . 0.0 114.512 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -134.37 154.72 51.2 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 120.452 -1.405 . . . . 0.0 108.61 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.249 1.045 0 C-N-CA 125.742 1.617 . . . . 0.0 110.463 -178.853 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 t 154.17 -82.03 0.0 OUTLIER 'General case' 0 C--O 1.237 0.42 1 C-N-CA 132.169 4.187 . . . . 0.0 105.324 169.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.8 179.91 7.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.003 2.121 . . . . 0.0 108.638 175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.1 m -144.65 -83.26 0.15 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.714 1.205 . . . . 0.0 109.949 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 63.06 32.48 15.32 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 110.378 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.88 4.46 6.95 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.714 1.149 . . . . 0.0 112.483 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -65.51 160.2 22.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.583 1.191 . . . . 0.0 109.092 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -7.18 14.6 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.21 0.45 7.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 113.192 165.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -53.15 -53.62 47.76 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.482 1.492 . . . . 0.0 111.311 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -57.29 -35.72 70.16 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.346 1.059 . . . . 0.0 113.439 173.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -47.81 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.565 1.546 . . . . 0.0 110.463 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -72.73 -33.62 66.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.332 0.969 . . . . 0.0 111.057 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -71.37 -24.57 62.11 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.421 -0.799 . . . . 0.0 112.777 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.08 -49.24 72.17 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.72 -0.613 . . . . 0.0 112.338 164.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -57.45 -48.85 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -58.15 -54.39 47.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.244 1.417 . . . . 0.0 110.984 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -36.31 81.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.406 1.003 . . . . 0.0 109.547 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -67.38 -39.71 85.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.568 1.147 . . . . 0.0 110.67 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -31.29 72.1 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.26 -51.69 65.11 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.677 173.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.31 -46.47 88.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 118.547 -1.261 . . . . 0.0 111.81 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -160.6 42.49 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.986 1.374 . . . . 0.0 112.306 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -52.57 -20.43 7.59 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.978 1.275 . . . . 0.0 114.856 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -58.0 -23.46 54.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.774 1.787 . . . . 0.0 113.866 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.35 -23.97 16.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.93 0.786 . . . . 0.0 109.145 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.23 -31.27 60.81 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.511 -1.368 . . . . 0.0 108.555 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -52.11 -41.33 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.297 1.839 . . . . 0.0 109.6 163.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -70.89 -37.52 73.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.723 1.147 . . . . 0.0 110.985 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -60.2 -61.56 2.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.069 0.85 . . . . 0.0 110.055 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.06 -57.05 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -172.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.31 52.85 36.68 Favored Glycine 0 CA--C 1.525 0.715 0 O-C-N 121.143 -0.973 . . . . 0.0 112.566 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.82 143.33 4.28 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.44 144.22 12.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -140.64 168.57 19.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.967 -0.458 . . . . 0.0 110.507 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.84 131.48 54.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.231 . . . . 0.0 109.787 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -84.91 104.26 14.7 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.808 1.243 . . . . 0.0 108.08 172.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -78.82 100.96 7.39 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 120.815 1.643 . . . . 0.0 110.408 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.48 93.54 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 175.09 6.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.272 -0.892 . . . . 0.0 111.274 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 59.37 24.31 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.695 2.398 . . . . 0.0 113.634 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 177.82 3.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.004 -167.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.52 91.67 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.15 2.566 . . . . 0.0 109.489 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.67 -72.87 0.44 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.052 1.31 . . . . 0.0 112.888 -156.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.04 -7.64 7.21 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.56 1.552 . . . . 0.0 112.894 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -69.47 -174.31 0.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.907 1.283 . . . . 0.0 110.837 170.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.7 147.3 49.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 108.474 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.22 167.62 17.37 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.251 2.62 . . . . 0.0 107.8 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 m -155.57 144.57 20.69 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.307 -0.871 . . . . 0.0 109.136 170.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.64 118.95 30.44 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -78.96 128.52 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.08 107.65 23.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -82.12 110.67 17.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 m -133.36 48.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 172.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -133.54 -49.34 0.84 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 165.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -90.41 136.49 33.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.7 -142.26 41.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -80.22 -3.76 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.334 1.453 . . . . 0.0 114.351 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.47 156.58 6.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.654 1.116 . . . . 0.0 111.526 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m -172.62 151.85 2.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 129.123 2.969 . . . . 0.0 107.958 169.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.35 126.07 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt -103.4 99.74 16.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.45 147.87 53.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.852 2.368 . . . . 0.0 108.937 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 47.49 23.48 0.39 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.362 1.865 . . . . 0.0 113.683 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 t -81.88 155.87 25.11 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.408 1.099 . . . . 0.0 111.424 -156.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -25.45 27.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.408 1.083 . . . . 0.0 109.946 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -74.28 129.44 37.81 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.802 0.728 . . . . 0.0 109.153 -166.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -73.11 -177.83 2.62 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.797 1.239 . . . . 0.0 112.41 -163.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.05 174.62 5.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.336 -165.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -57.08 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.002 -1.686 . . . . 0.0 108.353 148.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.41 -177.74 5.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.568 1.947 . . . . 0.0 109.413 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 m -131.15 -173.72 3.18 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.841 -1.162 . . . . 0.0 107.958 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 tt -155.17 146.7 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.3 m -111.19 132.02 54.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 117.122 -1.418 . . . . 0.0 107.68 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.9 mtm -137.08 -48.5 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.854 -1.07 . . . . 0.0 111.993 166.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.54 153.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.362 3.065 . . . . 0.0 110.81 -161.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.93 -39.99 93.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.142 0.901 . . . . 0.0 108.67 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.74 68.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.077 0.465 . . . . 0.0 110.362 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.51 -49.45 6.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.556 -1.212 . . . . 0.0 107.812 -168.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -56.98 -40.53 76.69 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.471 1.108 . . . . 0.0 110.977 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.4 tp -64.28 -60.52 3.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.49 -35.59 65.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.248 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.34 -70.53 0.09 Allowed 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.107 1.763 . . . . 0.0 108.143 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.4 ptp -69.4 -33.88 73.66 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.565 0.62 . . . . 0.0 111.906 -172.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.8 m -74.22 -8.06 54.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.826 1.251 . . . . 0.0 111.502 -171.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.9 72.01 0.73 Allowed Glycine 0 C--N 1.335 0.48 0 O-C-N 120.805 -1.184 . . . . 0.0 110.305 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -144.79 -47.5 0.24 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.38 1.072 . . . . 0.0 108.795 166.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.0 mmt -126.34 103.32 7.58 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.485 1.114 . . . . 0.0 108.7 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -44.92 69.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 117.632 -1.175 . . . . 0.0 113.103 169.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -83.6 -158.68 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.522 2.148 . . . . 0.0 111.627 -170.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -60.47 84.12 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.569 1.548 . . . . 0.0 110.496 173.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 t -57.9 -34.43 69.81 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.873 -1.142 . . . . 0.0 111.234 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.31 -15.97 63.08 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.807 -1.183 . . . . 0.0 113.539 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -75.19 -43.11 53.95 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 125.128 1.371 . . . . 0.0 110.227 171.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -61.82 -53.23 58.67 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.62 1.568 . . . . 0.0 110.383 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.7 -18.81 65.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.796 1.18 . . . . 0.0 111.888 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.67 37.49 14.05 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 127.398 2.427 . . . . 0.0 115.019 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -74.32 -101.46 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.985 1.314 . . . . 0.0 109.263 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.65 71.09 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.97 1.308 . . . . 0.0 109.285 -171.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 154.28 23.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -104.88 165.23 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -166.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.7 p -87.55 -165.07 1.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.39 116.35 4.05 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.75 115.93 0.02 OUTLIER 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.656 2.382 . . . . 0.0 111.667 -169.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.8 105.12 0.11 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.457 1.503 . . . . 0.0 110.346 174.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.36 63.64 4.21 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.529 2.014 . . . . 0.0 113.481 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -70.69 4.03 2.76 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.49 -79.04 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.425 1.466 . . . . 0.0 111.435 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -83.13 2.41 35.54 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.098 -1.001 . . . . 0.0 113.31 -167.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -7.88 54.2 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.929 -1.107 . . . . 0.0 113.202 -170.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -176.78 2.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.011 1.724 . . . . 0.0 111.436 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -115.05 -67.03 1.02 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 166.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -81.34 -96.64 0.04 OUTLIER 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tp 48.85 -61.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.728 2.011 . . . . 0.0 111.384 -152.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -135.11 62.88 1.63 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 127.372 2.269 . . . . 0.0 109.895 -163.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.31 0.1 OUTLIER 50.78 -175.48 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.608 1.963 . . . . 0.0 113.175 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.09 175.32 3.25 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.459 1.504 . . . . 0.0 109.508 167.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.67 174.94 11.86 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.922 1.748 . . . . 0.0 112.043 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -157.49 -75.34 0.02 OUTLIER Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -144.34 81.52 1.67 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.707 1.203 . . . . 0.0 108.608 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.28 163.1 16.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 158.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.93 104.64 4.72 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 165.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.181 0 C-N-CA 128.255 2.622 . . . . 0.0 111.089 -163.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 p -151.55 -152.37 0.43 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.373 1.869 . . . . 0.0 107.374 -166.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.9 151.68 49.35 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 152.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 m -144.3 -15.25 0.58 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.302 1.041 . . . . 0.0 111.641 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 51.25 32.5 8.25 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.727 1.211 . . . . 0.0 110.622 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.86 84.4 0.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -164.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -153.8 170.59 20.6 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 128.83 2.852 . . . . 0.0 104.501 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -29.77 70.76 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.299 -0.875 . . . . 0.0 110.078 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.86 -11.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.316 1.846 . . . . 0.0 114.815 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -53.7 -40.55 66.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.675 1.579 . . . . 0.0 110.856 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -65.47 -36.68 84.61 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.757 176.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.77 -59.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.179 0.992 . . . . 0.0 110.839 -173.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -63.71 -23.99 67.59 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.982 0.81 . . . . 0.0 110.923 -171.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -70.34 -25.46 63.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -67.59 -40.8 84.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.602 0.637 . . . . 0.0 110.939 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.68 -48.64 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.384 1.474 . . . . 0.0 107.56 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -51.26 -49.93 60.23 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.053 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -58.68 -40.65 84.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -47.41 76.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.73 1.212 . . . . 0.0 111.707 173.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -33.1 63.83 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.427 0.691 . . . . 0.0 112.009 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.94 -52.59 55.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.828 -1.17 . . . . 0.0 110.22 169.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -53.7 -45.98 70.58 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.949 1.25 . . . . 0.0 111.315 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -162.36 49.76 0.18 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.859 0.838 . . . . 0.0 112.349 -170.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.36 -28.3 61.75 Favored Glycine 0 C--O 1.223 -0.585 0 O-C-N 120.496 -1.378 . . . . 0.0 113.273 -174.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.85 -24.65 64.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -78.31 -41.7 32.96 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.716 -1.24 . . . . 0.0 110.138 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.1 -36.05 81.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 108.659 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 t -51.01 -42.11 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 127.834 2.453 . . . . 0.0 111.018 169.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -72.29 -23.77 61.23 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.458 -1.401 . . . . 0.0 111.052 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -89.57 -14.17 35.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -173.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.9 -55.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.484 1.514 . . . . 0.0 107.535 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.39 59.85 7.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 124.85 1.214 . . . . 0.0 111.888 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.04 -177.96 43.6 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.25 138.38 31.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 160.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -129.03 164.72 22.63 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.331 0.586 . . . . 0.0 110.255 165.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.33 166.18 11.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.1 163.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -123.18 98.36 5.84 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.588 1.555 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 109.21 7.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 120.218 1.372 . . . . 0.0 109.282 172.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.41 93.48 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -96.55 177.89 5.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.959 1.704 . . . . 0.0 109.923 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 65.01 24.52 12.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.081 1.352 . . . . 0.0 112.482 162.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.56 -168.38 33.68 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.835 1.683 . . . . 0.0 112.394 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.71 96.12 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.305 2.67 . . . . 0.0 110.079 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.09 -13.05 10.52 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 127.663 2.554 . . . . 0.0 112.582 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.59 21.08 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 126.108 1.813 . . . . 0.0 112.537 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -51.03 -175.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 129.251 3.02 . . . . 0.0 111.809 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.07 161.46 33.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.834 0.826 . . . . 0.0 110.964 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.37 173.63 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.745 2.418 . . . . 0.0 107.862 161.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.7 m -140.73 156.58 46.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -124.73 149.82 46.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 164.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.96 143.02 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.3 110.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.48 122.26 24.98 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 164.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.78 46.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -138.83 -46.53 0.49 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.101 0.961 . . . . 0.0 110.639 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.68 103.13 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -156.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.03 -118.29 7.16 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.884 -1.135 . . . . 0.0 111.123 -170.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -74.82 -5.12 41.78 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 171.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.98 -103.4 0.77 Allowed Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 127.774 2.606 . . . . 0.0 108.232 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 m 97.39 157.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 135.444 5.497 . . . . 0.0 110.147 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.5 t -77.09 157.97 5.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.9 mt -143.72 84.88 9.58 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 -169.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.1 152.52 76.34 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 N-CA-C 108.202 -1.499 . . . . 0.0 108.202 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.3 23.52 4.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.196 1.398 . . . . 0.0 112.188 170.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -82.65 146.49 29.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.267 -0.896 . . . . 0.0 110.86 -154.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.45 -0.34 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.634 163.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -59.16 139.75 56.6 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.997 1.272 . . . . 0.0 108.061 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -69.43 -176.43 0.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.23 159.59 43.47 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.401 0.68 . . . . 0.0 111.03 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -36.6 65.34 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.354 1.062 . . . . 0.0 111.494 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.21 -177.05 6.07 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.09 1.756 . . . . 0.0 109.018 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.3 m -133.35 -172.7 3.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.87 146.64 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.7 m -103.76 131.08 51.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 mtp -137.09 -48.88 0.61 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.83 160.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 129.948 3.299 . . . . 0.0 109.57 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.01 -46.89 71.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.389 1.876 . . . . 0.0 109.693 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -62.65 -18.77 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 112.281 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -105.97 -37.15 6.74 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.699 0.8 . . . . 0.0 112.143 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -65.79 -54.17 30.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.687 1.195 . . . . 0.0 110.674 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.21 -36.09 80.88 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.76 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -48.22 -38.33 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.541 1.136 . . . . 0.0 112.546 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -74.12 0.06 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.3 ptp -76.49 52.47 0.79 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.2 p -142.94 2.29 1.33 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.985 1.714 . . . . 0.0 110.173 156.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.21 86.47 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 118.324 -1.265 . . . . 0.0 113.951 174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -64.73 -59.4 4.28 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.625 1.713 . . . . 0.0 108.15 166.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . 0.25 8.2 ptt? 44.34 47.23 7.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.873 2.469 . . . . 0.0 115.719 168.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -60.54 133.7 91.41 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -72.25 124.71 10.18 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.14 2.56 . . . . 0.0 111.999 -162.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 39.34 57.78 2.01 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.924 2.09 . . . . 0.0 110.9 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -33.83 75.57 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.899 1.28 . . . . 0.0 112.274 -167.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.41 -21.62 60.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.06 1.3 . . . . 0.0 111.626 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -74.68 -42.81 57.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.969 0.908 . . . . 0.0 110.388 166.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.08 -66.27 0.56 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.353 1.061 . . . . 0.0 110.093 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.91 -21.7 65.98 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.992 0.917 . . . . 0.0 111.399 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.12 41.06 99.34 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.428 -0.651 . . . . 0.0 113.011 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -64.39 -76.6 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.774 1.287 . . . . 0.0 109.166 -177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.07 52.84 0.09 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.619 1.568 . . . . 0.0 109.931 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 162.91 28.64 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.814 -1.179 . . . . 0.0 108.585 -172.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.98 167.84 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.1 p -87.99 171.65 10.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.415 1.086 . . . . 0.0 109.62 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -159.03 -20.12 0.03 OUTLIER Glycine 0 C--N 1.336 0.544 0 CA-C-O 117.615 -1.658 . . . . 0.0 115.689 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 174.79 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.506 1.922 . . . . 0.0 108.299 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 16.9 mtt -158.09 -91.94 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.767 2.427 . . . . 0.0 106.507 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -91.2 36.44 3.63 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 119.408 1.004 . . . . 0.0 113.718 -167.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -44.51 65.42 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.683 1.193 . . . . 0.0 111.971 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.69 0.87 13.78 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 32.9 ttm -164.9 47.01 0.1 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.309 1.413 . . . . 0.0 111.315 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -68.35 -50.65 51.71 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.996 -1.065 . . . . 0.0 111.631 -171.639 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.13 178.07 7.26 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.187 1.395 . . . . 0.0 108.981 174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -71.72 0.06 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 124.629 1.171 . . . . 0.0 111.051 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -67.11 -3.92 8.73 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -168.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.57 -3.55 57.77 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.26 -0.9 . . . . 0.0 110.872 170.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -164.79 48.27 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.883 1.273 . . . . 0.0 111.76 -164.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.6 mt 53.85 177.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.362 2.265 . . . . 0.0 114.595 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.36 153.37 85.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -66.65 176.08 4.62 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.46 1.44 . . . . 0.0 110.425 165.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 160.37 58.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -61.95 119.02 8.05 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 35.45 55.39 0.86 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.069 2.148 . . . . 0.0 112.269 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -77.55 70.02 3.88 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.456 -0.777 . . . . 0.0 110.223 -172.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.243 0.748 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 146.731 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.51 168.39 0.58 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.852 1.661 . . . . 0.0 112.102 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 80.81 -10.39 1.24 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.837 2.855 . . . . 0.0 115.033 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.4 m -73.96 -84.88 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 116.994 -1.479 . . . . 0.0 109.203 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.317 0.0 OUTLIER 47.11 24.27 0.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 157.13 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.48 10.29 33.03 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 119.255 -2.153 . . . . 0.0 114.335 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.7 171.37 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.576 1.15 . . . . 0.0 112.856 -160.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.35 -23.77 51.0 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.727 -1.233 . . . . 0.0 111.62 163.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.17 -20.58 42.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.784 1.174 . . . . 0.0 113.496 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -73.23 -19.16 61.14 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.927 1.691 . . . . 0.0 111.146 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.51 -63.45 1.37 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.167 1.787 . . . . 0.0 106.289 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 84' ' ' MET . 4.6 t -59.58 -56.87 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.085 1.354 . . . . 0.0 112.518 -167.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.49 -21.68 64.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.248 0.931 . . . . 0.0 110.986 -173.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -67.06 -34.01 76.76 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.495 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -59.02 -33.84 71.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.642 1.11 . . . . 0.0 112.163 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -72.18 -46.75 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -55.6 -49.5 72.62 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.323 1.049 . . . . 0.0 111.48 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.082 0.953 . . . . 0.0 109.388 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -70.07 -39.37 75.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.482 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -43.15 79.95 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.645 1.111 . . . . 0.0 113.034 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -63.71 -51.99 62.57 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.278 1.431 . . . . 0.0 110.186 173.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.65 -46.24 87.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.4 -1.438 . . . . 0.0 112.755 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -166.34 62.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.41 1.484 . . . . 0.0 111.976 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.97 -20.19 79.73 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 125.36 1.457 . . . . 0.0 113.528 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -33.79 24.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.681 1.24 . . . . 0.0 112.996 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.451 ' OE1' ' HE2' ' A' ' 30' ' ' LYS . 1.1 tm0? -91.71 -35.25 14.27 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.454 1.502 . . . . 0.0 110.702 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.53 -34.77 71.35 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 108.967 168.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -57.64 -62.35 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 119.824 1.193 . . . . 0.0 108.612 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.79 -20.06 60.75 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.451 ' HE2' ' OE1' ' A' ' 26' ' ' GLN . 53.1 mttm -67.93 -67.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.905 1.282 . . . . 0.0 111.44 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.6 -60.53 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 109.196 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.05 9.91 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.072 1.796 . . . . 0.0 113.817 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.73 176.51 44.19 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 117.955 0.878 . . . . 0.0 111.493 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 mt -102.14 138.16 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 162.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -135.86 157.84 45.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.79 167.19 10.04 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.293 1.037 . . . . 0.0 109.865 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -129.57 105.78 8.3 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.917 1.687 . . . . 0.0 108.644 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -74.38 121.57 21.6 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 168.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 t -119.23 110.69 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -114.03 174.79 5.76 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t0 61.59 24.8 14.84 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.504 1.522 . . . . 0.0 112.478 173.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.87 -176.81 23.15 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.859 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.67 44.3 0.32 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.625 3.55 . . . . 0.0 113.428 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.24 -19.76 0.02 OUTLIER Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.288 2.375 . . . . 0.0 112.698 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.48 -7.71 81.36 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 120.853 2.326 . . . . 0.0 113.351 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -69.19 -173.28 0.51 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.608 157.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.22 158.73 36.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.564 1.945 . . . . 0.0 108.697 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.9 174.69 6.3 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.156 2.182 . . . . 0.0 107.51 166.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.6 m -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.145 0.978 . . . . 0.0 108.989 161.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -118.73 152.96 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 170.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.1 t -115.62 135.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 171.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.5 t -116.6 120.79 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.63 116.71 28.73 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.0 52.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -145.31 -49.5 0.24 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.638 1.175 . . . . 0.0 110.371 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -90.61 139.46 30.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -164.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.83 -135.48 46.33 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -89.79 6.62 40.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.053 1.741 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.24 158.14 27.33 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -172.13 145.64 1.8 Allowed 'General case' 0 C--O 1.237 0.447 0 C-N-CA 127.006 2.122 . . . . 0.0 105.588 159.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 157.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mt -136.28 80.57 39.83 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.34 145.17 87.9 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.234 1.956 . . . . 0.0 109.043 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.91 23.95 3.1 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.582 2.353 . . . . 0.0 112.2 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -89.95 140.5 29.57 Favored 'General case' 0 CA--C 1.524 -0.052 0 O-C-N 120.417 -1.427 . . . . 0.0 109.489 -163.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.8 -22.63 65.16 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.374 0.67 . . . . 0.0 111.345 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -58.27 130.3 46.06 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.372 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -60.78 -176.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.235 1.414 . . . . 0.0 111.316 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.26 173.2 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 110.567 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -49.18 19.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 163.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.3 m -146.6 -179.43 6.76 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.641 1.576 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.539 ' CG2' ' H ' ' A' ' 73' ' ' ILE . 15.0 m -132.51 -165.93 1.67 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.488 1.115 . . . . 0.0 108.194 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.539 ' H ' ' CG2' ' A' ' 72' ' ' THR . 4.0 tt -150.54 172.75 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.937 -1.102 . . . . 0.0 109.593 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.5 m -122.31 124.07 42.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 163.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.408 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 1.9 mtm -151.73 120.79 6.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 166.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.09 164.07 1.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.426 . . . . 0.0 110.106 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -58.9 -54.24 49.34 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.875 0.87 . . . . 0.0 109.405 175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -67.59 1.22 2.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.37 1.068 . . . . 0.0 112.691 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -60.85 1.5 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.259 1.824 . . . . 0.0 108.883 168.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 75' ' ' MET . 21.4 m-85 -56.18 -41.04 74.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.965 1.306 . . . . 0.0 112.893 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.42 -44.37 62.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.658 0.783 . . . . 0.0 109.417 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -27.77 64.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.739 . . . . 0.0 112.153 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.2 -78.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 C-N-CA 126.365 1.866 . . . . 0.0 109.718 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 12' ' ' VAL . 6.0 ptp -77.24 51.46 0.84 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.1 p -150.04 14.54 0.81 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.465 1.906 . . . . 0.0 109.857 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.31 1.98 17.33 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.575 1.084 . . . . 0.0 113.883 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -81.31 -32.0 33.29 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 119.556 1.678 . . . . 0.0 110.064 -172.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.8 mmt -114.89 178.21 4.37 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.158 1.383 . . . . 0.0 108.394 166.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -98.26 154.4 37.66 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.217 1.407 . . . . 0.0 110.135 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.79 166.17 25.29 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.525 2.15 . . . . 0.0 109.734 171.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.94 63.07 2.33 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.96 1.362 . . . . 0.0 109.4 -158.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -72.13 -48.74 41.38 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.012 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.413 ' HA ' HE21 ' A' ' 96' ' ' GLN . . . -50.22 -33.85 20.92 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 121.01 1.732 . . . . 0.0 114.49 172.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -64.31 -53.14 53.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -56.48 -66.89 0.36 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.873 1.669 . . . . 0.0 112.177 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.413 HE21 ' HA ' ' A' ' 93' ' ' ALA . 0.9 OUTLIER -64.32 -17.02 63.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.143 1.338 . . . . 0.0 112.635 -173.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.98 4.26 54.6 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 121.026 1.739 . . . . 0.0 114.054 172.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -69.16 24.49 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.538 2.735 . . . . 0.0 114.248 -174.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.7 tp 41.7 75.6 0.08 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 127.845 2.458 . . . . 0.0 111.36 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 145.82 55.82 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.1 mm -74.78 162.38 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 67.2 p -82.74 -170.31 2.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.454 0.701 . . . . 0.0 109.282 -174.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.75 -57.88 0.23 Allowed Glycine 0 N--CA 1.444 -0.807 0 O-C-N 120.687 -1.258 . . . . 0.0 110.592 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -145.37 151.59 38.53 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.923 1.362 . . . . 0.0 111.028 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 11.7 mmt -57.87 -71.59 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.114 1.366 . . . . 0.0 110.948 -165.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.06 25.53 6.06 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.418 1.008 . . . . 0.0 112.187 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -35.72 75.36 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.311 1.556 . . . . 0.0 110.87 177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.04 1.65 23.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.264 1.425 . . . . 0.0 112.42 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.8 ttp -105.86 -37.83 6.56 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.694 1.198 . . . . 0.0 112.556 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -77.4 -58.89 3.02 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.404 -1.435 . . . . 0.0 112.388 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 pt? 38.45 15.88 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.917 1 C-N-CA 131.893 4.077 . . . . 0.0 117.511 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -44.89 -86.01 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 121.725 2.057 . . . . 0.0 112.083 -154.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.58 -6.93 44.48 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 127.334 2.254 . . . . 0.0 113.269 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mp -71.66 -7.07 45.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 117.806 -1.092 . . . . 0.0 110.894 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.3 46.92 2.27 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 120.26 1.391 . . . . 0.0 112.938 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.4 mt 56.3 -172.45 0.07 Allowed 'General case' 0 C--N 1.347 0.489 0 CA-C-O 123.603 1.668 . . . . 0.0 110.544 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.9 125.9 19.45 Favored Pre-proline 0 N--CA 1.43 -1.444 0 C-N-CA 127.678 2.391 . . . . 0.0 106.206 178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.19 173.39 11.43 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.487 1.458 . . . . 0.0 109.696 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -125.37 -161.57 11.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 123.991 0.805 . . . . 0.0 111.634 -171.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.03 63.31 4.5 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.741 1.216 . . . . 0.0 109.304 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.53 155.47 25.72 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.262 1.425 . . . . 0.0 112.724 -163.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -158.83 131.6 7.01 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.586 1.555 . . . . 0.0 108.257 173.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.247 0.95 0 C-N-CA 127.571 2.348 . . . . 0.0 112.987 173.594 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 119.471 -0.299 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t 64.59 -59.92 0.22 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 129.819 3.247 . . . . 0.0 114.125 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.19 111.15 0.02 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.917 2.087 . . . . 0.0 110.986 -170.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.5 m -143.4 -45.08 0.28 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.72 1.208 . . . . 0.0 109.242 -170.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.92 33.99 23.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.482 0.489 . . . . 0.0 111.63 150.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.63 39.83 0.64 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.936 1.732 . . . . 0.0 109.874 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -85.54 177.87 7.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -66.42 -22.66 66.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.522 -1.362 . . . . 0.0 111.037 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.24 -5.07 1.38 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.37 -47.33 85.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.081 1.31 . . . . 0.0 112.422 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.266 0.0 OUTLIER -68.97 -33.11 73.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.547 0.739 . . . . 0.0 111.53 176.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.25 -53.19 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.969 1.708 . . . . 0.0 110.396 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -67.5 -21.91 65.48 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.728 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -75.46 -26.41 58.23 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.494 -1.241 . . . . 0.0 112.768 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -57.09 -41.09 78.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.46 1.482 . . . . 0.0 110.773 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.69 -47.72 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.18 -51.32 70.52 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.378 0.671 . . . . 0.0 110.775 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -53.0 -50.83 63.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.171 2.188 . . . . 0.0 108.639 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -34.38 73.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.198 . . . . 0.0 111.349 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -32.6 61.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 0.0 112.811 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -63.35 -53.81 46.84 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.834 0.854 . . . . 0.0 109.994 170.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -62.74 -45.82 90.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 110.863 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -159.41 58.0 0.4 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.208 1.004 . . . . 0.0 109.217 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.22 -23.06 66.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.315 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -59.38 -43.11 92.94 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.715 1.757 . . . . 0.0 111.6 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.14 -32.4 73.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.627 -0.671 . . . . 0.0 111.465 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -75.62 -34.35 60.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 108.619 -171.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.37 -48.73 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.704 1.202 . . . . 0.0 109.208 164.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -70.99 -10.68 60.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.805 -1.185 . . . . 0.0 113.437 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -86.02 -30.53 22.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.368 1.44 . . . . 0.0 113.603 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.56 -54.11 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.696 1.198 . . . . 0.0 108.772 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.73 57.11 11.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.669 2.08 . . . . 0.0 114.786 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.74 -171.18 37.29 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.348 1.574 . . . . 0.0 111.738 -176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.24 124.55 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 158.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -120.93 173.76 7.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.22 142.82 51.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.087 0.955 . . . . 0.0 109.411 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -88.27 91.53 8.82 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 124.969 1.308 . . . . 0.0 110.259 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -74.88 89.08 2.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.577 -1.327 . . . . 0.0 112.241 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -93.58 123.41 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -115.78 174.89 5.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.384 1.474 . . . . 0.0 110.357 158.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.53 61.17 2.06 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.803 1.641 . . . . 0.0 114.82 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.8 -152.44 8.85 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 126.329 1.919 . . . . 0.0 111.933 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.65 5.9 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.185 3.257 . . . . 0.0 114.605 -169.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.45 -49.13 0.21 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 159.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.94 -24.16 4.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.575 1.188 . . . . 0.0 111.402 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -62.16 -175.65 0.08 Allowed 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.087 1.755 . . . . 0.0 111.279 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -127.42 147.65 50.29 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -172.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.87 170.76 15.4 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.675 1.99 . . . . 0.0 108.087 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -155.9 149.42 24.88 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.62 133.1 55.4 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 166.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.95 142.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.68 113.27 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.54 123.96 30.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 165.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.15 39.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 126.365 1.866 . . . . 0.0 107.76 173.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -124.67 -39.31 2.3 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.574 1.15 . . . . 0.0 109.674 162.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -95.04 115.88 27.99 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -155.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.98 49.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -2.68 27.76 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.123 173.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.31 157.1 14.11 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -168.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 m -171.46 133.28 0.8 Allowed 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 128.507 2.723 . . . . 0.0 106.137 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.96 147.93 8.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -125.53 93.54 44.52 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.79 150.75 44.98 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.278 1.985 . . . . 0.0 109.381 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.13 22.85 0.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.941 2.497 . . . . 0.0 114.507 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.48 147.79 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.419 -155.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.49 -5.09 46.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.96 0.904 . . . . 0.0 111.279 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -44.9 129.12 7.27 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.868 1.667 . . . . 0.0 108.736 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -69.06 -176.0 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.919 0.866 . . . . 0.0 109.04 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.2 151.77 37.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.205 1.002 . . . . 0.0 108.956 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -75.82 -31.01 59.19 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.932 0.493 . . . . 0.0 112.156 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.1 m -148.37 173.02 13.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.822 2.449 . . . . 0.0 107.689 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -155.48 114.7 3.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.129 -1.607 . . . . 0.0 108.063 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.13 146.18 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.0 m -122.55 131.27 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.122 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 mmm -138.73 -12.56 1.3 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.703 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 67.5 151.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.419 1.888 . . . . 0.0 111.107 -164.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.37 -35.41 79.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.342 -0.837 . . . . 0.0 111.929 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -58.09 2.72 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.73 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -51.21 -55.69 16.76 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.232 1.013 . . . . 0.0 112.139 -173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -54.14 -58.47 7.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.297 0.953 . . . . 0.0 109.331 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.38 -39.48 73.0 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.878 0.736 . . . . 0.0 112.149 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 tt -55.69 -56.61 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.769 2.428 . . . . 0.0 110.306 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -26.92 60.29 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.4 m -74.53 -15.5 60.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.83 -1.169 . . . . 0.0 113.304 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 57.61 3.37 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -168.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.9 tttt -145.21 -32.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.979 1.712 . . . . 0.0 111.034 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 11.6 mtt 58.14 165.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.165 2.586 . . . . 0.0 112.567 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -142.7 158.18 60.34 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 151.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -59.51 125.91 19.21 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.526 2.15 . . . . 0.0 109.387 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -34.74 101.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.207 0 C-N-CA 129.486 3.114 . . . . 0.0 112.518 -167.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -52.6 46.54 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.073 -172.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.09 -19.17 1.76 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -82.49 -74.42 0.35 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.057 0.943 . . . . 0.0 108.49 166.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -61.19 -40.44 93.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.215 1.406 . . . . 0.0 113.961 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -14.23 60.79 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.48 1.112 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.66 -7.97 0.22 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.898 1.714 . . . . 0.0 115.135 -172.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -64.42 -0.93 1.47 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -163.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.7 tp 54.43 90.71 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.233 1.813 . . . . 0.0 110.496 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -66.65 171.65 4.95 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.605 ' CG2' ' H ' ' A' ' 102' ' ' THR 0.268 2.5 mp -127.96 -162.65 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -176.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.605 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 18.3 p 57.73 -171.21 0.1 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.286 2.234 . . . . 0.0 112.53 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.7 120.11 1.51 Allowed Glycine 0 CA--C 1.527 0.826 0 O-C-N 120.796 -1.19 . . . . 0.0 112.286 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.78 -60.59 1.61 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.086 1.355 . . . . 0.0 111.526 156.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.2 ttm -170.24 74.52 0.07 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.963 2.105 . . . . 0.0 111.072 175.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.39 65.05 1.83 Allowed Glycine 0 CA--C 1.531 1.065 0 O-C-N 120.428 -1.42 . . . . 0.0 113.436 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . 0.274 0.2 OUTLIER -86.92 36.75 0.73 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.73 -80.31 0.21 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.627 1.558 . . . . 0.0 108.787 168.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 68.0 mtm -134.1 27.86 3.83 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.446 1.099 . . . . 0.0 109.857 -169.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -75.17 -43.29 53.08 Favored 'General case' 0 CA--C 1.527 0.061 0 O-C-N 121.187 -0.946 . . . . 0.0 109.726 167.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.27 156.13 29.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.075 2.15 . . . . 0.0 111.917 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.73 -47.96 2.59 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -166.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -98.13 -39.3 8.96 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.771 0.829 . . . . 0.0 112.864 168.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 115.05 7.5 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 70.06 44.9 0.74 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.221 1.008 . . . . 0.0 110.624 -172.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.8 mt 48.35 -173.39 0.01 OUTLIER 'General case' 0 C--N 1.345 0.41 0 C-N-CA 125.497 1.519 . . . . 0.0 111.896 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.92 113.76 62.04 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.348 -177.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.52 174.67 11.28 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.154 1.903 . . . . 0.0 111.025 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.4 95.77 1.29 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -54.22 116.43 2.6 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.366 1.467 . . . . 0.0 112.066 -168.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.49 164.82 15.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.477 2.311 . . . . 0.0 112.326 -161.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.16 139.67 35.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 160.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 C--O 1.25 1.105 0 C-N-CA 128.075 2.55 . . . . 0.0 110.606 -170.585 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 t -152.38 114.54 4.45 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.697 -1.252 . . . . 0.0 109.87 168.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.43 63.12 1.42 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 161.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 t -70.19 -82.5 0.04 OUTLIER 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 124.768 1.227 . . . . 0.0 108.546 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.26 50.04 6.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.392 0.615 . . . . 0.0 111.006 167.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.39 22.39 0.75 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.352 1.453 . . . . 0.0 113.722 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -82.6 177.69 8.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.875 1.337 . . . . 0.0 109.827 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -66.15 -23.42 66.47 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 118.023 -1.471 . . . . 0.0 111.468 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.84 -18.68 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 114.35 169.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -53.09 -44.64 67.73 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.825 0.85 . . . . 0.0 111.024 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.286 0.0 OUTLIER -85.05 -30.22 24.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.573 0.749 . . . . 0.0 111.769 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.55 -54.23 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.593 1.157 . . . . 0.0 110.656 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.15 -20.9 63.13 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.244 -0.91 . . . . 0.0 111.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' HE3' ' A' ' 14' ' ' LYS . 22.2 ttmt -75.9 -28.14 57.94 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 118.016 -0.992 . . . . 0.0 113.535 175.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -58.73 -49.91 75.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 119.742 1.155 . . . . 0.0 110.386 163.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.6 -43.5 78.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -51.7 68.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.229 1.012 . . . . 0.0 111.967 170.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -58.98 -41.02 86.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -169.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -65.1 -31.71 73.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.704 2.002 . . . . 0.0 111.861 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -29.61 59.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.518 1.054 . . . . 0.0 113.787 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.5 -53.29 54.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 119.45 1.023 . . . . 0.0 109.053 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -45.37 93.9 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -161.49 51.55 0.24 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 123.433 1.587 . . . . 0.0 109.862 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.77 -17.49 14.8 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 117.525 -1.708 . . . . 0.0 114.91 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.77 -51.12 58.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.669 2.235 . . . . 0.0 110.852 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -68.08 -28.25 67.19 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.773 -1.205 . . . . 0.0 111.37 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -73.7 -35.75 65.18 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.772 -1.205 . . . . 0.0 108.659 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.4 t -55.97 -42.03 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.867 1.267 . . . . 0.0 109.459 165.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.516 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 4.1 mmpt? -69.31 -29.9 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.55 1.523 . . . . 0.0 113.185 174.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -68.46 -49.33 60.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.591 1.542 . . . . 0.0 111.893 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.06 -48.43 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.003 1.274 . . . . 0.0 109.67 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.08 47.19 84.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.646 -1.641 . . . . 0.0 113.935 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.52 171.0 37.41 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.567 1.684 . . . . 0.0 110.728 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.36 131.1 54.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 162.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -129.4 165.57 21.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.991 0.424 . . . . 0.0 111.279 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.8 137.62 52.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.073 1.749 . . . . 0.0 108.722 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.62 109.15 20.13 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.532 1.133 . . . . 0.0 108.668 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HE2' HG22 ' A' ' 72' ' ' THR . 15.4 mttm -87.37 103.32 15.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 121.03 1.741 . . . . 0.0 107.626 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 t -112.14 94.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.611 -0.681 . . . . 0.0 109.335 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 174.43 6.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.383 -1.448 . . . . 0.0 110.294 171.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 59.34 43.81 16.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.205 1.802 . . . . 0.0 112.105 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 77' ' ' ASP . . . -78.1 -167.96 31.57 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.082 -1.011 . . . . 0.0 113.862 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.28 -11.5 10.85 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.025 3.15 . . . . 0.0 114.05 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.25 -5.19 8.85 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.535 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.04 74.73 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.21 1.505 . . . . 0.0 112.084 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.7 -175.66 0.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.271 1.828 . . . . 0.0 109.768 165.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -135.79 150.71 49.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.145 1.778 . . . . 0.0 109.205 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.87 172.09 13.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.829 2.052 . . . . 0.0 109.065 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.5 m -145.91 147.3 31.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 108.32 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -117.59 142.84 46.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 163.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.03 143.61 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.31 118.67 50.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.93 110.45 18.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 165.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.44 43.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.308 168.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -132.51 -44.9 0.9 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.377 -0.827 . . . . 0.0 111.611 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -95.84 148.12 22.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.734 0.646 . . . . 0.0 109.451 -172.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.95 -130.55 51.04 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.657 ' HE3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.02 4.3 34.32 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.08 1.352 . . . . 0.0 112.383 173.146 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.35 157.73 18.86 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.8 m -172.26 153.01 2.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 128.447 2.699 . . . . 0.0 108.028 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -88.09 156.16 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mt -132.79 96.4 18.31 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 -173.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.98 140.32 41.57 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.04 1.827 . . . . 0.0 109.025 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.9 22.79 4.51 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.047 2.139 . . . . 0.0 112.957 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.47 133.95 35.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.419 0.628 . . . . 0.0 110.177 -157.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.36 -7.16 51.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.633 1.173 . . . . 0.0 110.594 165.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -52.48 132.92 35.57 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -74.64 -177.09 3.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.085 0.945 . . . . 0.0 109.651 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.03 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.968 1.707 . . . . 0.0 108.824 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.56 -25.15 56.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.48 -176.22 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.197 0.999 . . . . 0.0 109.47 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.413 HG22 ' HE2' ' A' ' 38' ' ' LYS . 21.4 m -137.66 -175.77 4.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.932 0.893 . . . . 0.0 108.764 -171.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 tt -145.83 142.5 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 154.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.19 146.2 24.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 157.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.434 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 31.4 mtt -134.19 -51.29 0.82 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 157.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.93 161.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.143 3.377 . . . . 0.0 107.966 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 6.0 t70 -66.72 -47.04 73.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 122.96 0.504 . . . . 0.0 110.863 -171.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.6 m -55.29 -36.25 65.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.448 0.699 . . . . 0.0 110.326 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.478 ' CG ' ' HG ' ' A' ' 92' ' ' SER . 4.9 t70 -76.11 -59.43 2.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.307 1.843 . . . . 0.0 109.849 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 75' ' ' MET . 10.7 m-85 -50.83 -58.75 5.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.39 1.876 . . . . 0.0 111.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -42.87 99.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.956 0.902 . . . . 0.0 109.81 -172.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -23.24 65.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.87 -173.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mt -67.77 -51.5 48.26 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.496 1.118 . . . . 0.0 110.882 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -49.76 18.32 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.191 0.905 . . . . 0.0 112.556 176.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.1 m -74.53 2.13 10.38 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.594 1.157 . . . . 0.0 112.039 -174.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.53 15.78 64.42 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 120.097 -1.627 . . . . 0.0 113.147 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -72.33 -3.53 24.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.457 1.129 . . . . 0.0 111.552 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 8.5 ttm 85.05 91.18 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.22 2.208 . . . . 0.0 110.914 164.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -139.63 123.34 10.79 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 161.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.76 -173.96 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.314 2.676 . . . . 0.0 111.251 158.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -48.51 143.64 4.8 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.576 -0.703 . . . . 0.0 109.271 161.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.478 ' HG ' ' CG ' ' A' ' 79' ' ' ASP . 3.2 m -65.78 -29.74 70.28 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.26 0.552 . . . . 0.0 110.294 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.7 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.456 1.902 . . . . 0.0 111.235 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.66 -143.76 0.31 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.709 1.203 . . . . 0.0 111.886 171.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -1.23 56.78 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.602 1.092 . . . . 0.0 112.471 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -71.8 -60.66 2.12 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.985 1.714 . . . . 0.0 109.645 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.87 61.68 2.36 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 125.7 1.619 . . . . 0.0 111.091 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -64.84 -2.32 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 167.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.5 tp 42.28 70.12 0.31 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.384 1.874 . . . . 0.0 111.821 -163.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -68.69 175.97 3.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.791 160.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.09 172.45 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 166.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.3 p 44.72 -161.53 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.134 2.173 . . . . 0.0 113.816 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.05 27.02 0.03 OUTLIER Glycine 0 C--N 1.338 0.688 0 O-C-N 120.828 -1.17 . . . . 0.0 114.25 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -66.46 148.37 51.97 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.207 1.004 . . . . 0.0 112.001 -166.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 39.8 tpp -60.09 101.07 0.11 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.581 1.952 . . . . 0.0 109.116 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.26 -85.62 0.22 Allowed Glycine 0 C--O 1.224 -0.482 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 pp -51.55 -22.27 3.11 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.82 68.31 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.693 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.43 -22.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.976 1.31 . . . . 0.0 113.225 173.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.99 71.13 2.76 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 119.754 -1.841 . . . . 0.0 111.591 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.39 160.68 37.15 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.064 2.145 . . . . 0.0 108.397 169.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -117.28 -79.88 0.6 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 160.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -54.32 -26.74 31.37 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.515 1.126 . . . . 0.0 113.527 -171.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.85 -10.98 53.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.359 1.064 . . . . 0.0 112.947 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -137.88 54.72 1.8 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.501 1.521 . . . . 0.0 107.106 166.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER 38.49 -173.85 0.0 OUTLIER 'General case' 0 C--N 1.348 0.535 0 C-N-CA 128.752 2.821 . . . . 0.0 113.387 -175.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -104.56 129.46 24.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 120.13 -1.606 . . . . 0.0 107.858 -169.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.56 174.09 13.2 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.059 1.839 . . . . 0.0 111.63 -167.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 171.05 141.98 3.5 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -74.68 119.89 19.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 167.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.37 147.98 34.11 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.013 1.725 . . . . 0.0 109.151 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -93.13 141.5 28.34 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.611 0.641 . . . . 0.0 111.081 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.981 0 C-N-CA 128.413 2.685 . . . . 0.0 110.276 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 121.819 0.819 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 p -95.59 -62.27 1.32 Allowed 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.57 -0.706 . . . . 0.0 109.474 163.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.9 152.03 23.8 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.85 1.26 . . . . 0.0 112.488 -175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 m -176.0 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.241 2.616 . . . . 0.0 106.093 -164.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 67.95 44.48 1.51 Allowed 'General case' 0 C--N 1.347 0.479 0 CA-C-O 121.277 0.561 . . . . 0.0 111.978 165.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.05 42.52 1.27 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.434 1.016 . . . . 0.0 112.535 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -85.1 -176.54 6.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.426 1.613 . . . . 0.0 110.583 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -72.36 -17.15 61.86 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.033 -1.042 . . . . 0.0 111.394 164.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.32 -23.98 4.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.2 1.0 . . . . 0.0 112.903 170.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -45.63 77.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.117 1.367 . . . . 0.0 110.32 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.24 -48.77 76.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.171 1.388 . . . . 0.0 109.67 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 t -58.65 -54.29 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.725 1.21 . . . . 0.0 111.421 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -64.31 -26.22 68.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.911 1.232 . . . . 0.0 111.88 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -75.06 -23.65 58.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.506 -0.746 . . . . 0.0 112.589 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.52 -52.62 53.79 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.434 0.459 . . . . 0.0 109.932 166.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -58.64 -48.28 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.186 1.395 . . . . 0.0 107.83 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -55.78 -51.1 68.59 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.759 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -57.99 -47.56 82.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.948 0.795 . . . . 0.0 109.425 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -38.8 88.83 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.559 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -38.99 72.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 113.814 172.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.12 -52.94 56.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.29 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.54 -45.74 90.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.828 1.194 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -162.73 56.1 0.21 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.138 0.97 . . . . 0.0 111.893 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.51 -16.01 69.04 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 120.905 -1.122 . . . . 0.0 113.103 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -43.3 68.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.764 1.282 . . . . 0.0 112.165 -171.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.77 -32.02 59.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.566 0.746 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.76 -26.8 60.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -60.31 -28.3 41.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -66.08 -21.91 66.39 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.319 -0.863 . . . . 0.0 111.405 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -73.0 -70.82 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.266 1.394 . . . . 0.0 111.241 -172.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.65 -59.98 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 56.76 13.05 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.807 1.194 . . . . 0.0 113.146 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.81 42.57 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.38 146.68 7.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 149.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -141.33 177.19 8.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 118.969 -1.093 . . . . 0.0 109.581 158.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.73 164.15 20.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.502 1.121 . . . . 0.0 108.897 171.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -121.98 106.99 11.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.174 1.79 . . . . 0.0 108.832 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -73.71 110.49 8.04 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 120.282 1.401 . . . . 0.0 112.107 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.07 98.25 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.407 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -93.94 174.69 7.04 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 166.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 49.75 53.19 13.19 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.982 2.113 . . . . 0.0 113.737 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.64 176.54 2.23 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.399 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.01 84.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.448 3.432 . . . . 0.0 108.433 158.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.17 -76.46 0.3 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -167.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.54 -12.27 3.21 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.506 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -70.18 -171.58 0.47 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.774 1.787 . . . . 0.0 110.978 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.1 160.64 20.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.222 1.809 . . . . 0.0 108.772 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.41 166.05 30.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.545 2.338 . . . . 0.0 106.296 173.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 m -150.81 128.88 11.83 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.78 0.832 . . . . 0.0 109.996 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -94.3 127.34 40.1 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 167.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.18 149.59 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.2 119.97 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.26 106.78 18.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 172.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 m -138.17 56.78 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 121.611 -0.681 . . . . 0.0 110.474 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -139.91 -53.63 0.53 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.307 1.043 . . . . 0.0 109.683 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -78.39 140.9 38.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.942 1.697 . . . . 0.0 108.152 -172.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 -137.57 32.85 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -104.88 8.26 34.64 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.015 1.726 . . . . 0.0 111.724 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.44 157.34 29.85 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -173.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.9 m -172.52 161.35 4.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.621 3.968 . . . . 0.0 105.991 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -109.96 154.38 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.9 mt -134.25 70.35 73.37 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -158.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.99 142.65 62.82 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.539 2.159 . . . . 0.0 109.28 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 54.88 23.22 4.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.766 2.427 . . . . 0.0 112.437 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 t -87.61 138.32 31.57 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.042 1.292 . . . . 0.0 110.26 -164.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.65 -4.87 58.4 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.48 1.912 . . . . 0.0 111.223 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -60.56 145.18 49.67 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 118.399 -1.32 . . . . 0.0 108.324 170.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -69.6 -173.6 0.61 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.221 1.808 . . . . 0.0 110.378 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.11 133.88 16.79 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.135 -0.353 . . . . 0.0 111.562 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.29 -52.89 4.35 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.933 2.493 . . . . 0.0 111.053 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.3 m -149.42 168.99 21.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.994 2.518 . . . . 0.0 106.767 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.9 m -121.83 -171.07 2.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.05 167.61 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 158.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.77 159.68 16.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.748 1.613 . . . . 0.0 106.756 160.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -150.57 -38.86 0.13 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.817 158.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HA ' ' H ' ' A' ' 40' ' ' LYS . . . 95.57 157.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.545 2.338 . . . . 0.0 110.035 -173.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -59.78 -46.77 88.15 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.802 0.841 . . . . 0.0 111.134 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -44.01 73.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.338 -175.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.03 -65.22 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 128.326 2.65 . . . . 0.0 112.06 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 75' ' ' MET . 43.3 m-85 -51.09 -45.36 61.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 110.401 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 tp -60.77 -69.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.616 0.644 . . . . 0.0 109.322 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.37 75.08 Favored 'General case' 0 CA--C 1.524 -0.057 0 C-N-CA 124.244 1.018 . . . . 0.0 113.269 -165.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 tp -52.01 -66.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.677 1.191 . . . . 0.0 109.654 -176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.4 ptm -76.36 -19.48 58.14 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.8 m -77.25 12.35 1.53 Allowed 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.385 -1.447 . . . . 0.0 111.883 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.46 48.1 86.07 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.102 -1.624 . . . . 0.0 110.477 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -134.28 25.75 3.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.844 1.657 . . . . 0.0 110.153 -177.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 89.0 mtp 71.99 -74.56 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 129.225 3.01 . . . . 0.0 112.223 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.294 0.6 OUTLIER 33.78 89.11 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 127.254 2.222 . . . . 0.0 112.643 -136.37 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.68 100.86 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.671 2.247 . . . . 0.0 109.893 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 71.26 123.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.532 2.333 . . . . 0.0 110.191 -167.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.9 m -74.36 -103.17 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.552 ' HA ' HE21 ' A' ' 96' ' ' GLN . . . -73.99 -17.77 60.95 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 118.479 -2.638 . . . . 0.0 112.688 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -38.65 91.69 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 117.759 -1.115 . . . . 0.0 109.385 175.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -55.23 -60.54 3.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.969 1.259 . . . . 0.0 110.034 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.552 HE21 ' HA ' ' A' ' 93' ' ' ALA . 6.9 pt20 -69.72 -27.41 64.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.62 24.71 76.11 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 118.852 0.751 . . . . 0.0 113.441 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.62 41.22 0.25 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.084 1.442 . . . . 0.0 110.859 175.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 35.2 73.48 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.772 2.429 . . . . 0.0 113.239 168.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 138.74 58.6 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.109 -0.995 . . . . 0.0 109.07 -172.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.46 159.23 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.488 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 p -139.7 172.53 12.66 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.287 1.435 . . . . 0.0 109.682 -167.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.15 -56.27 0.71 Allowed Glycine 0 N--CA 1.466 0.685 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -60.93 -17.33 50.55 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.806 0.842 . . . . 0.0 112.37 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 58.2 mtm 47.87 -168.98 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.175 2.19 . . . . 0.0 111.198 -166.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.57 -111.62 2.23 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 124.979 1.276 . . . . 0.0 111.06 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.406 HD21 ' HE3' ' A' ' 110' ' ' LYS . 11.1 mt 63.69 -36.48 0.16 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 129.252 3.021 . . . . 0.0 114.217 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.49 -70.96 0.17 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.923 1.689 . . . . 0.0 110.158 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.7 mtt -76.3 65.8 2.28 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.353 0.978 . . . . 0.0 111.7 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HE3' HD21 ' A' ' 107' ' ' LEU . 27.4 mttt -75.72 36.99 0.14 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.004 1.722 . . . . 0.0 112.728 167.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 46.34 -155.19 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.016 1.726 . . . . 0.0 110.683 -175.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.49 -50.48 4.72 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.55 1.068 . . . . 0.0 110.493 164.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -54.82 -28.04 46.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.404 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 3.1 tp -85.08 9.73 13.98 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 122.032 2.197 . . . . 0.0 111.827 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.96 48.81 0.85 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.251 2.22 . . . . 0.0 110.466 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.3 mt 56.41 163.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 129.738 3.215 . . . . 0.0 114.83 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 134.48 88.07 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.788 163.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.78 173.55 10.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.204 1.269 . . . . 0.0 109.317 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.22 81.99 1.63 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -144.35 -179.39 6.5 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.169 2.187 . . . . 0.0 105.522 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.92 -52.4 0.29 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.219 1.008 . . . . 0.0 109.655 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? 71.16 103.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 128.788 2.835 . . . . 0.0 112.053 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 C--O 1.251 1.135 0 C-N-CA 129.803 3.241 . . . . 0.0 111.948 168.854 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t -153.82 -155.44 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.061 -2.199 . . . . 0.0 105.061 165.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.99 168.99 5.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.23 1.014 . . . . 0.0 110.98 163.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -96.63 -134.13 0.22 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 127.451 2.3 . . . . 0.0 108.755 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 44.29 23.53 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 119.971 3.323 . . . . 0.0 119.971 129.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.75 82.88 0.18 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 126.573 2.035 . . . . 0.0 108.16 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -153.42 160.78 42.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.628 1.571 . . . . 0.0 108.449 -166.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -24.97 50.49 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.3 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.35 -10.69 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.378 1.871 . . . . 0.0 114.624 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.424 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 1.5 t-20 -51.35 -44.21 61.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.409 0.684 . . . . 0.0 110.943 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -38.35 65.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.351 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.34 -60.78 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 125.005 1.322 . . . . 0.0 109.969 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -66.78 -19.63 65.79 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.746 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -75.56 -28.6 59.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.533 172.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.2 mt -68.56 -52.42 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.37 -54.78 12.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 125.176 1.39 . . . . 0.0 109.895 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -44.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.214 1.005 . . . . 0.0 110.944 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -44.96 79.12 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.168 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -35.15 66.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 112.635 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.48 -52.9 55.55 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.78 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.52 -45.69 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.408 -1.433 . . . . 0.0 114.189 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -153.22 64.94 0.76 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.925 1.69 . . . . 0.0 109.461 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.41 70.52 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-O 118.333 -1.259 . . . . 0.0 111.177 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -52.48 -38.09 58.65 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.721 1.26 . . . . 0.0 111.429 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.22 -42.97 44.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.735 1.214 . . . . 0.0 109.225 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -20.81 63.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.598 -0.689 . . . . 0.0 111.442 -176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.27 -38.9 64.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 119.131 0.878 . . . . 0.0 110.213 168.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -74.84 -5.03 41.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.884 -1.135 . . . . 0.0 113.103 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -69.27 0.68 Allowed 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.936 1.244 . . . . 0.0 110.353 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.54 -62.97 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.33 9.39 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.728 1.156 . . . . 0.0 113.28 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.97 -169.24 29.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.77 125.89 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 157.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -121.42 172.65 7.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.03 131.32 49.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.994 1.717 . . . . 0.0 108.578 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -82.05 93.86 7.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -74.71 101.13 4.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.252 1.842 . . . . 0.0 109.834 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.2 t -104.22 121.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -115.77 179.7 3.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.363 1.465 . . . . 0.0 109.421 162.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t70 54.69 53.86 10.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.391 1.091 . . . . 0.0 112.273 164.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.43 -154.91 10.65 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.534 1.54 . . . . 0.0 109.784 168.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -48.74 114.91 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.236 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.9 -8.07 17.58 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.265 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.27 16.49 62.48 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 120.547 2.173 . . . . 0.0 112.083 169.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -61.66 -175.12 0.05 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.18 1.392 . . . . 0.0 111.007 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -150.47 111.58 4.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.336 -171.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 174.65 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.77 2.028 . . . . 0.0 110.416 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -147.75 149.43 32.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 109.018 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -116.7 117.12 28.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 166.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.79 128.59 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.2 t -112.07 110.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.63 129.83 34.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.16 30.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -140.09 -25.9 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 120.981 -1.074 . . . . 0.0 112.775 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -84.71 111.67 19.8 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.63 -117.86 7.96 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -85.99 0.34 53.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.157 0.978 . . . . 0.0 112.566 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.23 156.66 3.81 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -157.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.7 m -172.23 149.59 2.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.418 2.287 . . . . 0.0 106.327 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.72 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mt -127.22 81.61 69.68 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 -170.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.12 144.94 65.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.057 1.838 . . . . 0.0 109.728 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 37.47 44.05 0.46 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.308 2.643 . . . . 0.0 111.292 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -85.8 142.74 28.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.693 1.235 . . . . 0.0 109.615 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.26 -17.9 59.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 111.182 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -57.46 133.05 54.87 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -60.96 -175.75 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.998 1.38 . . . . 0.0 109.778 167.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.45 155.49 48.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.152 166.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.41 -27.74 64.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.535 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.7 p -145.62 -175.92 4.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.551 0.74 . . . . 0.0 112.856 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.525 HG21 ' H ' ' A' ' 73' ' ' ILE . 1.4 m -136.14 -171.99 3.02 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.525 ' H ' HG21 ' A' ' 72' ' ' THR . 3.6 tt -142.27 175.6 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 161.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.2 m -141.73 137.44 31.66 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 119.335 -2.103 . . . . 0.0 108.373 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.1 ptp -148.65 -28.83 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.528 -1.669 . . . . 0.0 115.217 161.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.43 147.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.972 3.309 . . . . 0.0 110.618 -162.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.99 -47.95 84.06 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 127.215 2.206 . . . . 0.0 110.443 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.8 m -66.43 -11.46 52.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.3 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.93 -40.24 5.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 168.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -47.42 -54.03 12.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.683 1.193 . . . . 0.0 109.987 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.47 -62.26 1.44 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.593 1.957 . . . . 0.0 108.383 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.56 -39.94 77.79 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.693 0.797 . . . . 0.0 112.435 -174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -65.75 0.51 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.479 0.712 . . . . 0.0 110.482 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.68 -26.62 54.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.3 m -73.95 -3.65 30.33 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 120.507 -1.371 . . . . 0.0 110.838 -175.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.89 62.85 1.8 Allowed Glycine 0 C--N 1.338 0.67 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -145.76 -9.35 0.54 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.121 1.368 . . . . 0.0 112.195 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 6.2 mtt -151.33 149.94 29.93 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.708 1.14 . . . . 0.0 112.846 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -75.61 160.88 78.27 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.454 0.701 . . . . 0.0 110.087 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.5 165.5 31.55 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.67 1.58 . . . . 0.0 113.014 -165.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.39 97.86 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.182 2.193 . . . . 0.0 110.362 -161.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.3 t -54.55 -61.72 2.13 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 123.887 0.875 . . . . 0.0 109.81 172.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.69 -63.33 1.21 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 116.922 -1.513 . . . . 0.0 111.891 -162.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.2 t80 22.87 -89.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 127.853 2.461 . . . . 0.0 113.91 161.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -62.12 1.51 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.917 1.687 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -64.24 -10.93 26.63 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.67 28.05 62.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.524 1.059 . . . . 0.0 114.667 165.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -65.98 17.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.522 2.329 . . . . 0.0 115.493 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 tp 47.09 61.84 2.67 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.053 1.741 . . . . 0.0 109.063 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.47 142.44 57.55 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 173.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.76 164.62 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.87 131.28 40.61 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.995 -1.065 . . . . 0.0 108.533 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.91 60.87 0.59 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.38 -150.71 0.43 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.194 0.998 . . . . 0.0 108.556 -161.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.9 ttp -138.38 148.17 44.22 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.251 1.42 . . . . 0.0 107.563 -168.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.64 8.91 49.46 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.398 0.999 . . . . 0.0 113.699 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.6 -36.18 75.78 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.847 1.259 . . . . 0.0 113.658 -164.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.94 -88.5 0.08 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -170.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.6 mmt 29.1 -83.0 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.26 2.624 . . . . 0.0 114.02 169.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -76.27 33.48 0.13 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.031 1.332 . . . . 0.0 113.225 -175.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.76 102.33 3.97 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.79 -55.54 2.42 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -97.6 -23.82 15.81 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 161.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.51 -5.62 20.54 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -166.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -136.82 55.6 1.83 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.221 1.408 . . . . 0.0 107.324 167.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.5 mt 51.05 -174.01 0.02 OUTLIER 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.071 1.348 . . . . 0.0 114.369 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -146.05 129.22 8.21 Favored Pre-proline 0 N--CA 1.452 -0.343 0 O-C-N 121.527 -0.733 . . . . 0.0 111.599 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -69.2 173.9 9.8 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.743 1.628 . . . . 0.0 110.291 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.81 62.13 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 107.884 -2.087 . . . . 0.0 107.884 -170.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.63 167.84 22.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.336 1.054 . . . . 0.0 109.446 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.96 15.18 0.41 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -169.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -134.28 151.32 51.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.9 1.227 . . . . 0.0 110.82 -168.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.989 0 C-N-CA 129.536 3.134 . . . . 0.0 111.852 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t -53.58 93.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.487 1.915 . . . . 0.0 112.874 -158.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.43 -22.59 0.33 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.79 1.236 . . . . 0.0 113.164 -171.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 m -157.76 -155.48 0.51 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.794 1.238 . . . . 0.0 108.581 -156.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.67 22.91 13.63 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 149.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 11.77 0.06 OUTLIER Glycine 0 N--CA 1.466 0.671 0 O-C-N 120.782 -1.199 . . . . 0.0 115.442 -162.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -80.21 178.51 8.22 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.823 1.249 . . . . 0.0 108.671 -173.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -69.65 -17.92 63.54 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.735 -1.853 . . . . 0.0 111.378 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.37 17.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.265 1.026 . . . . 0.0 112.815 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -58.6 -40.05 82.11 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.516 1.527 . . . . 0.0 110.275 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -61.53 -51.89 66.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.307 1.843 . . . . 0.0 109.79 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.55 -43.61 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.493 2.317 . . . . 0.0 111.943 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.18 -26.94 61.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.168 0.894 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -71.48 -24.77 62.05 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 118.977 0.808 . . . . 0.0 112.619 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.13 -46.31 91.09 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 165.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.8 -45.44 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.04 -55.22 33.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.824 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -52.48 -50.51 62.57 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -168.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -65.56 -27.11 68.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.666 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -33.45 66.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.075 0.852 . . . . 0.0 112.006 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.17 -52.3 59.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 170.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.58 -45.2 85.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.534 1.134 . . . . 0.0 111.795 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -165.54 62.79 0.11 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.954 0.902 . . . . 0.0 110.897 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.01 -29.18 71.87 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 116.869 -2.073 . . . . 0.0 114.486 -172.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -36.97 3.59 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.99 2.395 . . . . 0.0 112.918 172.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -81.38 -16.84 51.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -93.49 -34.91 13.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.088 1.355 . . . . 0.0 108.212 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.2 -46.09 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 126.151 1.78 . . . . 0.0 109.036 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -64.39 -23.94 67.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.562 1.528 . . . . 0.0 113.776 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -74.13 -29.21 61.71 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.411 -0.806 . . . . 0.0 111.828 -166.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mp -117.36 -49.76 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.557 2.343 . . . . 0.0 110.321 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.19 49.26 58.69 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.861 1.696 . . . . 0.0 116.245 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.55 27.36 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.758 1.779 . . . . 0.0 108.759 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.95 139.14 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 3.6 p90 -127.15 164.55 21.37 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.978 -1.076 . . . . 0.0 109.961 158.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 156.31 21.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 35' ' ' PHE . 6.6 m-85 -114.72 108.34 16.65 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.464 1.506 . . . . 0.0 108.734 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -87.09 95.9 10.11 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -85.09 116.6 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -107.91 176.63 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 119.07 0.85 . . . . 0.0 109.152 162.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t0 46.42 50.79 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.573 1.549 . . . . 0.0 113.776 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.5 165.55 27.94 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.977 167.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.46 98.43 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.656 3.571 . . . . 0.0 112.648 172.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.81 -41.3 1.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.237 1.875 . . . . 0.0 111.765 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.59 -8.35 3.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.701 -1.61 . . . . 0.0 114.574 163.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -67.61 -175.26 0.5 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.191 1.796 . . . . 0.0 112.782 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -125.15 146.23 49.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.935 1.694 . . . . 0.0 111.221 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.93 162.08 34.25 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.716 3.207 . . . . 0.0 106.832 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 m -139.25 148.13 42.64 Favored 'General case' 0 C--O 1.228 -0.053 0 CA-C-N 119.082 0.856 . . . . 0.0 110.059 166.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -117.65 156.81 27.54 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.42 134.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.41 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 57.6 t -123.41 112.75 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -91.98 80.28 5.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.43 53.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -146.62 -54.18 0.24 Allowed 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.18 0.992 . . . . 0.0 110.042 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -95.36 140.45 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.016 0.823 . . . . 0.0 109.586 -164.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.9 -140.9 43.76 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -84.84 -0.1 52.8 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.506 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 157.07 15.97 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 120.795 1.634 . . . . 0.0 111.873 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m -171.77 166.08 6.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.913 3.285 . . . . 0.0 108.87 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.33 93.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 127.941 2.496 . . . . 0.0 107.254 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.9 101.28 0.48 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 127.231 2.212 . . . . 0.0 107.001 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -70.5 131.22 19.77 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.372 2.714 . . . . 0.0 111.308 -166.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 47.24 24.56 0.44 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.317 2.247 . . . . 0.0 112.591 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.54 143.79 40.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -160.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -73.59 -15.79 61.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.575 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -57.92 145.11 36.76 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.708 -1.597 . . . . 0.0 110.429 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.79 -176.18 0.05 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.861 1.315 . . . . 0.0 109.895 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.95 168.06 20.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.638 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -37.48 55.6 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.395 0.678 . . . . 0.0 111.391 171.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m -150.93 -173.14 4.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.084 2.153 . . . . 0.0 109.307 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -133.95 -172.92 3.11 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.062 -1.024 . . . . 0.0 108.736 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -147.44 165.07 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 155.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -126.48 124.29 39.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 165.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.71 136.62 17.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.15 163.59 1.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 168.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.04 -52.01 62.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.057 1.343 . . . . 0.0 111.005 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.66 -33.77 61.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.3 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.87 -35.26 14.88 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.33 2.252 . . . . 0.0 111.381 -169.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.92 -54.77 33.37 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.482 1.113 . . . . 0.0 108.357 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -31.48 68.59 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.555 0.742 . . . . 0.0 110.361 -175.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.55 -41.76 10.21 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.048 1.339 . . . . 0.0 113.727 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.01 -75.51 0.05 Allowed 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -170.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.56 52.22 0.79 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.2 p -152.78 -35.91 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.144 -0.973 . . . . 0.0 110.833 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 132.83 -6.64 5.17 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 118.8 -1.0 . . . . 0.0 115.144 167.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -69.19 -52.81 24.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.124 1.962 . . . . 0.0 109.153 161.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 3.3 mtm 54.55 169.71 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.264 1.825 . . . . 0.0 112.574 -162.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -177.42 53.99 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 127.559 2.344 . . . . 0.0 107.695 160.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -67.48 147.3 76.84 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.89 1.726 . . . . 0.0 109.007 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.48 -25.87 0.06 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.301 1.841 . . . . 0.0 114.907 -173.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 t -50.61 -24.26 3.15 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.029 2.132 . . . . 0.0 112.226 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.09 -26.12 68.1 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.14 -0.975 . . . . 0.0 111.713 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -83.02 -51.99 7.06 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.877 1.217 . . . . 0.0 109.615 164.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -58.09 -51.5 69.44 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.192 1.397 . . . . 0.0 110.863 -161.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -71.28 -70.38 0.32 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.561 1.544 . . . . 0.0 107.652 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 150.06 61.25 0.01 OUTLIER Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -99.79 -6.65 26.6 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.796 163.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.4 tp 49.31 80.56 0.06 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 126.722 2.009 . . . . 0.0 110.565 -168.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 174.83 5.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.38 168.84 17.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -152.7 -139.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 130.198 3.399 . . . . 0.0 105.783 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.34 -53.64 0.58 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 120.618 1.554 . . . . 0.0 110.836 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -65.82 -29.28 69.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.901 0.85 . . . . 0.0 111.909 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 57.44 -165.36 0.16 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -160.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.57 -50.49 4.07 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.752 -1.218 . . . . 0.0 113.264 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -48.09 -61.75 1.82 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.001 1.72 . . . . 0.0 111.766 -171.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.0 -0.62 40.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.851 0.861 . . . . 0.0 112.929 -170.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.27 -48.42 8.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -75.82 -72.97 0.29 Allowed 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.399 -0.813 . . . . 0.0 112.155 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 34.63 38.84 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 130.799 3.64 . . . . 0.0 115.542 -166.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -106.7 -96.19 0.36 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.121 1.328 . . . . 0.0 108.774 -167.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -19.33 64.34 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.904 1.684 . . . . 0.0 110.223 174.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -13.91 32.76 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 171.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -141.69 62.83 1.44 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.042 0.937 . . . . 0.0 109.514 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.329 0.1 OUTLIER 49.77 -173.48 0.02 OUTLIER 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.421 1.089 . . . . 0.0 113.596 170.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.95 121.84 4.14 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 119.876 -1.765 . . . . 0.0 112.156 170.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.69 173.54 13.75 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.288 1.992 . . . . 0.0 110.289 172.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.33 -175.93 30.12 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 123.71 0.671 . . . . 0.0 111.455 -173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -158.22 123.69 4.47 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.409 1.484 . . . . 0.0 107.776 168.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 50.37 97.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.997 2.919 . . . . 0.0 113.432 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.48 155.03 0.14 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.303 2.241 . . . . 0.0 108.633 -174.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.507 HD22 ' H ' ' A' ' 123' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.397 1.079 . . . . 0.0 109.264 174.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t -143.34 89.57 2.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 171.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.61 179.34 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.469 2.308 . . . . 0.0 112.881 -165.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -177.17 -36.22 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.416 1.087 . . . . 0.0 111.046 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.39 25.95 6.82 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.039 1.4 . . . . 0.0 112.022 154.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.4 84.41 0.36 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 129.349 3.356 . . . . 0.0 108.414 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -152.83 149.74 28.61 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.675 2.39 . . . . 0.0 107.824 -167.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -6.67 51.13 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.846 -1.159 . . . . 0.0 111.782 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.28 -16.46 53.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.883 0.873 . . . . 0.0 112.975 160.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -59.09 -58.41 8.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.844 1.202 . . . . 0.0 111.019 -168.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -64.77 -31.37 72.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.36 -55.92 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.813 2.445 . . . . 0.0 110.618 171.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -65.83 -29.34 69.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.683 1.128 . . . . 0.0 111.119 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -70.09 -24.93 63.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.771 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -44.17 73.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 176.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -52.02 -54.33 14.23 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.33 -48.48 78.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.965 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -56.59 -46.85 80.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -66.11 -42.28 89.43 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.69 177.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -32.54 62.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.307 6.5 mm-40 -70.11 -52.31 24.7 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.877 171.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.06 -40.69 96.64 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -161.04 60.44 0.29 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.833 1.253 . . . . 0.0 109.858 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.12 -29.69 70.32 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-O 118.185 -1.341 . . . . 0.0 111.47 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.44 -29.5 24.86 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.838 1.319 . . . . 0.0 112.694 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -79.93 -34.98 38.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.911 -1.118 . . . . 0.0 111.678 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -80.31 -19.46 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.643 1.111 . . . . 0.0 108.997 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.07 -45.59 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.151 0.887 . . . . 0.0 109.467 169.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.49 -17.67 62.34 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -71.53 -65.17 0.79 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.365 -0.834 . . . . 0.0 109.845 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mm -78.32 -56.07 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.0 1.32 . . . . 0.0 108.713 -166.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 50.61 63.29 4.55 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.253 -167.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 173.0 39.55 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 119.376 1.588 . . . . 0.0 111.941 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.19 121.36 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 102.936 -2.986 . . . . 0.0 102.936 159.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -130.42 166.01 21.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 123.659 0.6 . . . . 0.0 109.724 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.12 168.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.889 0.852 . . . . 0.0 112.063 173.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.49 98.5 6.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.932 . . . . 0.0 108.529 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -83.9 89.55 7.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.987 0.812 . . . . 0.0 110.904 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.18 124.03 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -115.11 -175.05 2.61 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.899 -1.126 . . . . 0.0 108.728 158.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t0 47.8 58.23 5.23 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 127.236 2.214 . . . . 0.0 111.881 169.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 44' ' ' GLY . . . -63.89 -177.2 4.58 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.393 -177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -60.23 7.49 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 1 C-N-CA 125.389 4.059 . . . . 0.0 113.188 159.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 42' ' ' GLY . . . -135.71 -31.79 0.3 Allowed Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.282 -1.511 . . . . 0.0 112.075 155.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -2.68 7.61 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 118.805 1.303 . . . . 0.0 114.018 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -62.04 -175.57 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.958 1.379 . . . . 0.0 110.791 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -120.97 165.38 15.33 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 166.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.13 164.94 34.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.498 1.919 . . . . 0.0 107.43 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.0 m -147.07 144.15 28.86 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -115.67 133.05 56.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 103.595 -2.743 . . . . 0.0 103.595 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -101.35 136.16 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.69 117.29 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.63 117.07 28.24 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 165.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.65 51.55 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -133.4 -53.61 0.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.123 0.969 . . . . 0.0 108.824 160.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.79 111.24 13.39 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.03 -151.93 50.66 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 121.673 0.596 . . . . 0.0 111.648 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.02 9.49 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 127.94 2.496 . . . . 0.0 114.205 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.14 157.76 33.9 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.0 m -172.87 158.12 3.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.49 2.316 . . . . 0.0 106.99 152.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.74 160.37 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -141.51 87.57 10.28 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -160.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.53 147.99 18.02 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.012 2.475 . . . . 0.0 109.963 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.53 25.8 3.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.995 1.718 . . . . 0.0 111.468 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -92.41 146.84 23.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.524 1.154 . . . . 0.0 109.377 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.84 -26.7 25.54 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 111.909 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -50.33 120.98 5.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.512 1.125 . . . . 0.0 108.648 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -178.04 1.52 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 122.798 1.285 . . . . 0.0 108.804 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.21 156.65 46.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.507 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.2 -32.57 71.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.733 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.76 173.83 15.89 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.101 1.36 . . . . 0.0 110.619 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 101' ' ' ILE . 5.0 m -155.23 119.98 4.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -172.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.447 HG13 ' H ' ' A' ' 101' ' ' ILE . 15.8 tt -83.96 155.11 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 118.661 0.664 . . . . 0.0 109.449 -173.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.4 m -100.73 126.32 47.27 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 118.203 -0.904 . . . . 0.0 109.245 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.06 126.74 2.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 157.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.08 166.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 0.0 112.149 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -53.0 63.06 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t -65.32 -4.53 5.56 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.307 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.23 -53.96 2.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.141 1.776 . . . . 0.0 108.998 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.77 -56.72 10.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.205 1.82 . . . . 0.0 111.37 171.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 tp -54.16 -51.66 63.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.46 1.504 . . . . 0.0 107.852 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.62 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -66.02 0.88 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.183 0.993 . . . . 0.0 108.965 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -32.52 61.64 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.351 -0.843 . . . . 0.0 112.464 -171.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.81 1.75 11.8 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.946 -1.096 . . . . 0.0 110.971 169.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.32 45.0 94.64 Favored Glycine 0 C--N 1.341 0.832 0 O-C-N 120.705 -1.247 . . . . 0.0 112.53 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -80.63 -36.46 32.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.702 1.251 . . . . 0.0 110.457 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.6 ptp -142.77 -173.73 3.97 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.507 0.594 . . . . 0.0 112.534 -162.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -53.55 116.0 8.96 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.974 1.709 . . . . 0.0 109.978 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -81.46 44.19 1.69 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.828 3.019 . . . . 0.0 112.822 -163.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -156.61 33.67 0.31 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.084 1.353 . . . . 0.0 109.459 170.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.7 t -52.77 -34.03 51.24 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.777 0.717 . . . . 0.0 112.81 -166.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.95 -37.14 68.61 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.58 1.082 . . . . 0.0 111.905 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -86.59 -44.66 11.72 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.718 1.607 . . . . 0.0 112.362 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -59.33 -43.58 92.7 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.356 0.662 . . . . 0.0 110.349 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.62 -16.41 58.58 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.607 -0.683 . . . . 0.0 111.371 172.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.79 45.54 95.59 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.583 1.087 . . . . 0.0 111.693 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -84.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.757 0.778 . . . . 0.0 110.64 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -165.78 57.32 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 127.481 2.312 . . . . 0.0 106.949 167.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.85 148.8 44.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.746 -1.221 . . . . 0.0 107.954 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -130.27 173.04 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 p -154.91 145.14 21.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.426 1.891 . . . . 0.0 107.24 -169.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.91 -23.96 50.68 Favored Glycine 0 N--CA 1.467 0.709 0 CA-C-N 120.173 1.351 . . . . 0.0 111.452 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -156.46 147.89 22.49 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.572 2.349 . . . . 0.0 105.761 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.6 mtm -62.98 130.16 43.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.959 1.254 . . . . 0.0 109.407 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.85 -144.46 15.63 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -168.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 46.32 17.59 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 129.795 3.238 . . . . 0.0 117.25 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.94 -67.95 0.45 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.802 0.728 . . . . 0.0 110.139 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 34.1 ttm -133.65 -3.43 2.95 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.371 -0.83 . . . . 0.0 111.848 -168.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -68.62 -35.24 77.04 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.052 -1.655 . . . . 0.0 112.658 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.74 119.84 25.29 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -110.82 -78.45 0.59 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 123.829 0.851 . . . . 0.0 108.785 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -62.41 -8.74 6.56 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.44 -31.78 73.14 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 166.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -123.43 47.56 1.99 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.421 1.888 . . . . 0.0 111.244 -166.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.351 0.2 OUTLIER 49.27 172.17 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.219 2.608 . . . . 0.0 112.051 -175.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -105.52 141.96 23.73 Favored Pre-proline 0 CA--C 1.533 0.311 0 O-C-N 119.098 -2.251 . . . . 0.0 111.788 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -79.62 179.54 6.24 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.139 2.559 . . . . 0.0 110.387 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.63 74.57 1.25 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 -171.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -144.29 145.58 32.1 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.19 0.996 . . . . 0.0 109.211 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.67 -63.47 0.18 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 43.05 74.98 0.1 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.89 2.076 . . . . 0.0 110.396 -169.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--O 1.244 0.797 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -156.697 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.56 175.09 13.66 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.08 1.352 . . . . 0.0 107.842 155.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.88 145.71 29.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 155.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 t -144.63 -81.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t0 63.49 62.17 0.97 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.304 1.05 . . . . 0.0 111.938 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.57 20.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.508 1.051 . . . . 0.0 112.711 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -79.89 171.08 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 120.8 -1.412 . . . . 0.0 108.503 169.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -69.82 -19.36 63.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.879 1.218 . . . . 0.0 110.471 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.72 -22.13 3.27 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.146 0.978 . . . . 0.0 112.798 165.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 27.7 t-20 -55.58 -47.26 76.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.608 0.64 . . . . 0.0 110.725 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.28 -38.97 91.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.57 1.148 . . . . 0.0 112.142 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.15 -57.81 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.192 1.397 . . . . 0.0 109.412 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.95 -23.29 66.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.928 -0.482 . . . . 0.0 111.495 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.25 -48.99 54.46 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -51.34 -39.09 56.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 118.845 0.748 . . . . 0.0 112.885 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.47 -51.66 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.27 -54.33 48.02 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 123.973 0.909 . . . . 0.0 111.783 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -57.3 -38.29 73.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.888 1.222 . . . . 0.0 110.135 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.59 -43.89 71.88 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.605 1.162 . . . . 0.0 110.39 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -38.51 69.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.525 1.53 . . . . 0.0 114.071 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.59 -50.7 68.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.287 -0.863 . . . . 0.0 108.682 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.0 -46.99 85.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.593 1.542 . . . . 0.0 114.749 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -153.66 55.44 0.74 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 123.513 1.625 . . . . 0.0 111.089 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.51 -16.1 80.18 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.078 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -60.34 -40.47 90.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.161 1.481 . . . . 0.0 111.485 -168.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.609 ' NE2' ' HZ1' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -77.75 -27.49 50.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.313 -0.867 . . . . 0.0 110.857 176.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -32.99 70.25 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.0 -42.77 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.142 166.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.63 74.48 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.957 -1.09 . . . . 0.0 111.267 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.609 ' HZ1' ' NE2' ' A' ' 26' ' ' GLN . 10.0 mmtp -71.92 -41.99 67.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 117.554 -1.212 . . . . 0.0 113.462 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.447 ' CD1' ' HE2' ' A' ' 110' ' ' LYS . 1.3 mp -95.18 -64.21 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 121.911 2.141 . . . . 0.0 107.176 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 77.03 0.28 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.433 1.016 . . . . 0.0 110.671 -169.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.85 145.78 4.2 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 118.312 -1.271 . . . . 0.0 110.636 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -73.37 137.35 23.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -135.28 168.17 19.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 110.155 170.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.57 137.2 52.36 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.534 1.133 . . . . 0.0 109.83 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -88.22 97.2 10.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -74.56 111.94 10.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.532 1.06 . . . . 0.0 109.475 168.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.79 106.79 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.28 177.44 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 159.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.5 t0 55.96 61.45 2.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.065 1.346 . . . . 0.0 111.903 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.55 -160.98 36.19 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.947 1.737 . . . . 0.0 112.442 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.59 4.95 0.39 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 124.567 3.511 . . . . 0.0 114.869 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.74 2.17 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 120.653 -1.279 . . . . 0.0 113.839 164.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.55 5.59 53.87 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 120.515 2.158 . . . . 0.0 113.244 163.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.41 -175.14 0.76 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.174 1.389 . . . . 0.0 109.802 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -118.87 138.0 53.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.098 1.359 . . . . 0.0 108.818 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.56 166.23 12.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.749 1.62 . . . . 0.0 107.64 164.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.0 m -146.35 148.69 32.63 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 160.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -119.64 133.77 55.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.88 114.07 40.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.91 105.12 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.28 116.58 18.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 163.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.25 52.01 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -144.4 -48.98 0.27 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.609 1.164 . . . . 0.0 109.885 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -80.9 126.01 30.83 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -173.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.17 -142.29 44.72 Favored Glycine 0 N--CA 1.439 -1.112 0 O-C-N 121.391 -0.818 . . . . 0.0 111.632 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -82.74 3.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.686 -1.15 . . . . 0.0 112.286 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.25 158.02 27.14 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 120.782 1.628 . . . . 0.0 109.512 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -171.72 137.27 1.0 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.551 2.74 . . . . 0.0 106.565 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -76.53 111.64 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 166.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -87.0 122.14 71.31 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.78 130.6 10.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 41.49 45.79 2.85 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.339 1.856 . . . . 0.0 113.465 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.98 137.5 58.03 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -9.07 59.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.404 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -57.72 140.76 50.63 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.89 -177.03 1.85 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.13 157.22 45.86 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 125.085 1.354 . . . . 0.0 108.549 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -33.24 67.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 p -153.24 175.72 12.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.454 2.301 . . . . 0.0 109.034 -170.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.4 m -140.25 -172.73 3.49 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.25 152.0 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 159.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.5 m -120.47 133.97 55.34 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.4 -38.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.184 1.356 . . . . 0.0 113.439 170.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 96.88 155.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 131.179 3.792 . . . . 0.0 111.516 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -62.72 -44.35 96.46 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.158 0.583 . . . . 0.0 110.571 -173.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -62.97 -21.41 66.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.123 -0.942 . . . . 0.0 111.595 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.28 -67.0 0.82 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 117.884 -1.055 . . . . 0.0 108.537 166.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -49.69 -45.41 48.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.92 1.688 . . . . 0.0 111.97 -168.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tp -59.89 -65.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.96 -36.43 62.84 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.189 0.996 . . . . 0.0 112.34 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.3 tp -48.6 -71.17 0.07 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.507 2.323 . . . . 0.0 109.123 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 10.1 ptp -75.78 -37.16 59.48 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.0 m -75.75 22.78 0.13 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.224 1.374 . . . . 0.0 111.832 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.99 18.1 59.56 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 124.748 1.166 . . . . 0.0 113.614 167.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -100.25 12.86 36.08 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.932 1.366 . . . . 0.0 111.855 -171.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.0 ttt 76.2 79.51 0.09 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 127.188 2.195 . . . . 0.0 112.882 162.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.77 123.86 21.36 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 169.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.11 169.4 4.92 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.142 1.895 . . . . 0.0 110.132 162.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -63.84 104.79 0.73 Allowed 'General case' 0 C--O 1.238 0.475 0 O-C-N 120.663 -1.273 . . . . 0.0 109.329 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.486 ' HB3' HE21 ' A' ' 96' ' ' GLN . 42.3 m -51.23 -38.74 54.21 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 118.423 -0.798 . . . . 0.0 112.739 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.25 -39.29 20.92 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -85.9 -64.99 1.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.417 1.087 . . . . 0.0 109.647 172.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -54.92 -50.74 68.05 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.12 1.368 . . . . 0.0 113.025 -168.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.486 HE21 ' HB3' ' A' ' 92' ' ' SER . 6.7 mt-30 -76.48 -42.88 42.06 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.29 22.78 46.7 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -9.96 22.6 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.247 -1.359 . . . . 0.0 113.615 177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.4 tp 55.83 95.47 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.282 1.833 . . . . 0.0 110.506 -173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -66.69 175.56 2.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.998 0.919 . . . . 0.0 108.844 169.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.79 159.66 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 164.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 m 61.24 166.48 0.09 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.332 2.653 . . . . 0.0 114.342 -176.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -133.87 -64.74 0.07 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.765 1.65 . . . . 0.0 109.49 172.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 57.61 -173.18 0.08 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.372 1.869 . . . . 0.0 111.004 -172.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -64.1 6.23 0.19 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.692 1.597 . . . . 0.0 113.813 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.14 89.61 0.86 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 125.358 1.456 . . . . 0.0 109.687 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.39 -29.81 65.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.929 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 110' ' ' LYS . . . -84.67 -64.03 1.23 Allowed 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 124.002 0.814 . . . . 0.0 109.452 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.04 29.3 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.158 2.583 . . . . 0.0 114.114 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.447 ' HE2' ' CD1' ' A' ' 31' ' ' ILE . 41.0 tptt -61.67 -72.13 0.13 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.633 2.773 . . . . 0.0 110.715 -169.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -164.23 165.31 22.07 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.111 2.165 . . . . 0.0 106.974 168.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.25 -47.37 86.36 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -72.34 -14.91 61.85 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -165.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.82 3.98 31.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.715 1.143 . . . . 0.0 110.021 169.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -139.42 45.27 1.95 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.529 2.331 . . . . 0.0 108.249 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.379 0.1 OUTLIER 57.06 -176.13 0.06 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.617 1.567 . . . . 0.0 113.389 174.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.91 135.31 19.44 Favored Pre-proline 0 CA--C 1.538 0.513 0 O-C-N 120.566 -1.334 . . . . 0.0 109.376 170.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.19 -175.68 2.84 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.296 2.664 . . . . 0.0 111.737 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.78 83.67 0.52 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.141 1.353 . . . . 0.0 109.75 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 53.95 157.15 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 130.148 3.379 . . . . 0.0 114.416 -173.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.84 -105.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -145.28 124.12 12.67 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.634 1.106 . . . . 0.0 109.328 174.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.504 -0.794 0 C-N-CA 129.519 3.127 . . . . 0.0 105.771 -162.793 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.593 0.711 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.55 82.49 0.34 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -169.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.53 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 98.0 m-85 -153.22 140.02 19.03 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.815 1.246 . . . . 0.0 107.743 -166.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -59.24 -29.58 67.64 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.899 0.318 . . . . 0.0 110.963 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.61 -11.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.527 1.931 . . . . 0.0 114.74 169.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.432 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 19.8 t-20 -57.69 -36.93 72.63 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 120.279 1.399 . . . . 0.0 111.677 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.637 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -72.79 -38.24 67.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.158 172.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG13 ' HG3' ' A' ' 84' ' ' MET . 2.4 t -56.04 -46.11 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.911 1.284 . . . . 0.0 110.868 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 16' ' ' ILE . 72.1 m-85 -68.65 -24.64 64.56 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.175 -0.328 . . . . 0.0 111.822 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -75.22 -27.15 59.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 121.292 -0.88 . . . . 0.0 111.62 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.88 -46.46 89.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.229 0.468 . . . . 0.0 110.349 169.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 13' ' ' PHE . 64.8 mt -59.46 -48.72 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.499 1.12 . . . . 0.0 108.158 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -55.75 -43.09 76.34 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.466 0.706 . . . . 0.0 111.342 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.45 -47.46 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -57.42 -45.48 84.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.568 172.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -42.45 76.98 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.84 -53.23 53.96 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.083 0.953 . . . . 0.0 110.984 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.14 -45.57 92.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 119.214 0.915 . . . . 0.0 111.947 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -161.97 58.19 0.25 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.431 1.092 . . . . 0.0 111.669 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.57 -12.99 43.12 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 120.015 -1.678 . . . . 0.0 113.213 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.85 -40.47 63.42 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.256 1.528 . . . . 0.0 111.828 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.06 -26.65 43.07 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.913 -1.117 . . . . 0.0 112.294 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.2 m-85 -74.98 -33.68 61.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.037 1.335 . . . . 0.0 108.571 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -54.94 -52.68 41.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -59.53 -14.25 12.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -85.82 -42.06 14.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.98 1.718 . . . . 0.0 111.977 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.23 -59.49 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.72 65.58 2.82 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 124.286 0.946 . . . . 0.0 111.451 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.74 171.51 43.32 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.15 132.33 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 157.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.48 166.93 18.63 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.363 0.602 . . . . 0.0 111.651 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.19 145.3 38.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.584 1.154 . . . . 0.0 108.898 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -94.67 93.49 7.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.737 1.215 . . . . 0.0 108.451 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -77.62 109.39 11.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.652 1.115 . . . . 0.0 109.444 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.526 HG22 ' CE2' ' A' ' 80' ' ' PHE . 2.9 t -118.22 104.95 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.63 -179.64 5.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.42 1.088 . . . . 0.0 108.208 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t0 58.76 48.13 11.84 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.58 1.152 . . . . 0.0 113.479 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.8 -173.79 11.85 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.998 1.285 . . . . 0.0 115.373 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.95 78.1 0.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.588 2.859 . . . . 0.0 108.62 161.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.38 -17.63 4.49 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.367 1.937 . . . . 0.0 112.794 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.72 -11.57 68.1 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 126.013 1.768 . . . . 0.0 112.471 170.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.13 -176.46 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.057 1.743 . . . . 0.0 110.675 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.28 152.46 51.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 112.315 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HB2' ' CD2' ' A' ' 7' ' ' PHE . . . -119.11 174.94 6.03 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.345 2.258 . . . . 0.0 107.977 174.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.9 m -147.73 153.89 39.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 147.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.432 ' CH2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -120.74 136.97 54.73 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 162.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.59 144.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.8 113.52 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.23 112.15 18.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 164.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.23 48.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 167.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -137.07 -50.16 0.64 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.034 0.934 . . . . 0.0 110.236 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -79.87 131.11 35.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 -122.7 14.37 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.418 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 8.25 28.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.769 1.628 . . . . 0.0 110.751 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.53 158.7 30.6 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.841 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -171.14 147.63 2.58 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.865 2.466 . . . . 0.0 109.585 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -80.87 153.9 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 mt -136.43 86.19 24.39 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -169.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.45 142.22 48.7 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.609 1.54 . . . . 0.0 109.768 -174.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 45.75 34.95 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 129.278 3.031 . . . . 0.0 111.955 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.8 152.67 25.57 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.622 0.769 . . . . 0.0 110.578 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 -3.92 59.02 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.266 1.026 . . . . 0.0 111.178 161.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.97 128.95 22.68 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -73.92 -176.76 2.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.16 141.58 30.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.362 1.865 . . . . 0.0 108.092 -172.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.75 -29.17 58.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 m -150.41 165.27 33.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.013 1.725 . . . . 0.0 108.348 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.558 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 86.5 m -147.26 119.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.16 -0.962 . . . . 0.0 108.962 -170.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.94 138.46 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.9 m -108.99 131.21 55.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.022 1.283 . . . . 0.0 107.739 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -139.88 -101.22 0.16 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 161.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.08 159.06 0.15 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.503 3.121 . . . . 0.0 106.873 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.3 -48.87 79.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.73 0.812 . . . . 0.0 111.861 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -71.31 1.45 6.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.052 1.341 . . . . 0.0 111.188 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -105.3 -44.55 4.71 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.924 -1.11 . . . . 0.0 112.856 158.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CE2' HG22 ' A' ' 39' ' ' VAL . 3.8 m-85 -60.04 -60.79 3.27 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.223 1.409 . . . . 0.0 111.184 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tp -44.5 -61.22 1.62 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.477 1.111 . . . . 0.0 109.304 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.77 -18.2 29.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.792 -172.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -67.13 -68.69 0.36 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.477 1.111 . . . . 0.0 110.675 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.419 ' HG3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.333 -0.146 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.558 ' CG2' ' H ' ' A' ' 72' ' ' THR . 1.2 mp . . . . . 0 C--N 1.312 -1.048 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.288 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.476 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -73.11 -3.85 28.97 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 169.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -150.13 44.74 0.89 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.176 1.79 . . . . 0.0 111.393 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.6 mt . . . . . 0 N--CA 1.467 0.42 0 C-N-CA 128.174 2.59 . . . . 0.0 116.018 -169.871 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.02 78.06 0.28 Allowed Glycine 0 C--N 1.336 0.544 0 O-C-N 120.67 -1.269 . . . . 0.0 113.088 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -153.68 160.69 42.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.629 1.572 . . . . 0.0 110.263 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm -65.48 -9.56 26.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.81 -6.24 5.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.994 0.815 . . . . 0.0 113.144 166.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.11 -37.93 81.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.681 1.128 . . . . 0.0 112.342 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -69.53 -37.88 77.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.701 1.201 . . . . 0.0 110.734 174.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.648 HG13 ' SD ' ' A' ' 84' ' ' MET . 0.9 OUTLIER -58.84 -52.71 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.627 1.571 . . . . 0.0 111.228 -175.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 67.4 m-85 -70.15 -21.63 63.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.015 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -75.06 -27.5 60.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.774 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.509 ' CB ' HD22 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -55.71 -49.46 72.96 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.353 1.433 . . . . 0.0 110.596 171.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mt -53.56 -47.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.42 1.088 . . . . 0.0 108.204 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -61.21 -53.39 57.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.634 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -51.76 -53.72 36.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.766 1.166 . . . . 0.0 108.42 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -57.12 -46.58 82.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.974 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -35.48 68.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -70.18 -52.24 24.95 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.27 -44.42 95.33 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.347 2.259 . . . . 0.0 112.763 -171.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -154.76 55.16 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.739 1.616 . . . . 0.0 111.072 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.31 -30.93 56.22 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-O 117.741 -1.589 . . . . 0.0 113.529 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.75 -38.91 67.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.898 1.849 . . . . 0.0 111.118 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -81.07 -19.26 44.14 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.279 -0.888 . . . . 0.0 112.429 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.42 -31.5 20.03 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 109.929 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.37 -55.03 6.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 126.682 1.993 . . . . 0.0 108.252 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -61.77 -16.0 45.97 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -79.68 -58.85 2.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.716 0.806 . . . . 0.0 110.52 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.45 -63.46 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.961 1.704 . . . . 0.0 107.155 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.66 72.39 0.69 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.243 1.402 . . . . 0.0 112.32 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.25 153.7 6.46 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.525 -1.153 . . . . 0.0 110.767 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.99 134.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -128.41 162.94 25.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.712 0.768 . . . . 0.0 109.131 162.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.59 157.72 22.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.561 164.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -105.79 96.29 6.39 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.322 1.449 . . . . 0.0 109.469 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.77 108.95 7.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.317 -1.489 . . . . 0.0 109.799 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG22 ' CE1' ' A' ' 80' ' ' PHE . 21.9 t -124.93 94.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 174.45 7.11 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 61.57 40.69 13.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 0.0 111.917 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -61.16 173.08 6.65 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.396 0.998 . . . . 0.0 113.52 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.01 86.61 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.009 2.473 . . . . 0.0 107.085 166.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.81 -57.98 0.41 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -163.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.96 -23.87 7.63 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 125.945 1.736 . . . . 0.0 110.483 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -71.58 -172.48 0.79 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 111.221 168.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.58 149.03 50.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.934 1.694 . . . . 0.0 113.666 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.42 167.14 10.58 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.367 2.267 . . . . 0.0 109.966 166.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.9 m -155.23 114.59 3.64 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.005 0.907 . . . . 0.0 109.854 150.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -88.46 162.35 16.52 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 168.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.88 145.33 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.71 109.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.54 122.57 29.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.5 50.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 126.136 1.775 . . . . 0.0 106.961 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -40.5 0.07 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.401 1.08 . . . . 0.0 110.279 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -95.2 131.54 41.13 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 -145.24 42.72 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -83.16 8.29 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.455 -1.259 . . . . 0.0 113.744 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.78 156.77 8.66 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 120.586 1.539 . . . . 0.0 110.579 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -171.28 144.6 2.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.96 2.104 . . . . 0.0 108.524 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.4 t -74.56 152.05 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 168.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.37 88.6 12.69 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 127.843 2.457 . . . . 0.0 104.501 -164.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.39 138.94 62.76 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.587 1.525 . . . . 0.0 109.479 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 54.49 24.09 5.04 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.301 1.841 . . . . 0.0 112.742 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 t -76.77 145.31 38.64 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.915 0.864 . . . . 0.0 111.424 -159.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.37 -11.12 55.3 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.264 2.226 . . . . 0.0 112.64 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -66.11 164.84 14.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.681 0.673 . . . . 0.0 109.541 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -169.91 0.94 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.51 -0.744 . . . . 0.0 110.106 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.9 178.28 7.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.257 1.423 . . . . 0.0 107.767 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.1 -52.14 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 159.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -149.05 -172.78 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.563 1.545 . . . . 0.0 110.985 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -129.31 178.83 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 tt -125.24 178.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 159.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.6 m -125.29 161.97 25.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 160.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -50.01 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 158.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.08 161.41 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 130.912 3.685 . . . . 0.0 109.961 -166.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 16.6 t70 -62.37 -56.06 22.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.025 -169.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.81 -34.24 62.5 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 125.6 1.812 . . . . 0.0 108.781 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -58.39 5.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 111.626 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.706 ' CE1' HG22 ' A' ' 39' ' ' VAL . 11.9 m-85 -53.97 -50.7 65.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.196 0.598 . . . . 0.0 109.968 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -26.98 66.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.036 1.734 . . . . 0.0 112.519 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.12 -25.93 55.86 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.286 0.948 . . . . 0.0 112.782 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.68 -72.54 0.2 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.654 ' SD ' HD21 ' A' ' 116' ' ' LEU . 11.9 ptp . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 125.015 1.326 . . . . 0.0 113.581 -171.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.0 mm . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 177.597 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.1 m120 . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.83 -17.36 55.99 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.668 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -127.38 45.68 2.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.091 1.314 . . . . 0.0 109.785 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.654 HD21 ' SD ' ' A' ' 84' ' ' MET 0.308 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.526 1 C-N-CA 132.041 4.136 . . . . 0.0 115.964 170.993 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.15 65.87 0.24 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 126.578 2.037 . . . . 0.0 109.731 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.685 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 10.2 m-85 -154.07 167.74 28.8 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.694 2.398 . . . . 0.0 107.283 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -62.33 -30.01 70.86 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.079 -0.388 . . . . 0.0 110.515 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.06 -28.13 0.67 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 128.218 2.607 . . . . 0.0 114.885 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.81 -44.1 73.51 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 123.789 0.835 . . . . 0.0 109.859 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.19 -42.7 99.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.683 1.593 . . . . 0.0 110.028 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -81.96 -51.22 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.593 1.557 . . . . 0.0 111.246 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 16' ' ' ILE . 33.8 m-85 -64.36 -23.32 67.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.056 0.844 . . . . 0.0 110.733 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -71.53 -36.4 70.99 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.846 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.804 ' HG3' HD21 ' A' ' 116' ' ' LEU . 34.1 mm-40 -55.43 -39.87 70.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 119.902 1.228 . . . . 0.0 112.32 172.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 13' ' ' PHE . 62.7 mt -62.43 -48.98 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 61' ' ' VAL . 16.9 tt0 -56.23 -53.84 52.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.016 1.326 . . . . 0.0 111.068 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -51.74 28.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.824 1.65 . . . . 0.0 109.092 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -59.26 -48.04 83.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.053 0.541 . . . . 0.0 111.211 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -36.09 68.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.13 -52.13 38.31 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.765 -1.209 . . . . 0.0 108.646 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.35 -47.11 82.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 110.569 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -165.35 64.7 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.411 1.084 . . . . 0.0 111.459 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.75 -15.01 81.78 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.46 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.82 -40.21 60.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.896 1.348 . . . . 0.0 111.994 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -17.99 49.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.654 0.782 . . . . 0.0 112.159 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -14.62 26.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.05 -62.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 126.733 2.013 . . . . 0.0 106.425 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -58.27 -18.71 28.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -66.3 -50.67 62.88 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.53 -53.19 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.45 47.63 76.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.361 0.981 . . . . 0.0 112.674 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.22 171.03 39.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.76 134.01 30.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 159.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -128.34 177.91 6.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.957 0.798 . . . . 0.0 109.211 163.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.42 51.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.412 0.685 . . . . 0.0 109.937 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 39' ' ' VAL . 69.5 m-85 -103.58 101.76 11.64 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.556 1.142 . . . . 0.0 107.997 175.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 106.84 6.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 121.092 1.769 . . . . 0.0 108.533 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.71 HG22 ' CE2' ' A' ' 80' ' ' PHE . 76.3 t -122.43 99.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -166.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -111.05 176.94 4.82 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 121.038 -1.039 . . . . 0.0 108.57 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.9 t0 60.24 60.02 2.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.476 1.91 . . . . 0.0 112.022 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.43 -167.29 32.56 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.83 1.681 . . . . 0.0 111.815 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.31 67.71 6.13 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.797 2.998 . . . . 0.0 109.644 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 -43.69 0.39 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.215 1.388 . . . . 0.0 110.636 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.64 -0.18 45.98 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.032 1.301 . . . . 0.0 112.369 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -65.84 -175.13 0.27 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.11 1.364 . . . . 0.0 111.576 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -132.3 132.75 43.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.221 1.008 . . . . 0.0 111.019 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.685 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -114.76 165.29 12.97 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.343 2.657 . . . . 0.0 107.304 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 37' ' ' PHE . 26.5 m -148.38 117.64 6.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 155.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 13' ' ' PHE . 1.2 m-90 -83.69 128.02 34.21 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 165.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.92 146.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.86 104.84 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.78 106.4 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.11 47.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -129.25 -54.5 1.19 Allowed 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.319 0.647 . . . . 0.0 109.643 165.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -93.35 140.51 29.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -158.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 -124.54 11.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.23 5.76 35.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.523 1.529 . . . . 0.0 112.116 164.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.01 156.98 9.15 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -171.37 153.53 3.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.916 2.486 . . . . 0.0 107.832 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 17' ' ' GLU . 3.4 t -101.66 114.86 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -173.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.75 117.44 59.78 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -169.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.01 140.12 15.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 -171.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 45.39 29.37 0.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.347 1.859 . . . . 0.0 114.057 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -64.83 141.37 58.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.156 0.889 . . . . 0.0 110.569 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.52 -20.19 60.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.412 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -54.51 126.7 24.63 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -63.16 -176.97 0.15 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.155 0.982 . . . . 0.0 110.034 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.95 159.19 42.74 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.098 1.359 . . . . 0.0 111.113 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -54.37 47.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.133 0.968 . . . . 0.0 109.191 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.0 m -146.41 169.8 18.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.366 2.266 . . . . 0.0 107.387 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 73' ' ' ILE . 10.3 m -114.32 -164.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.581 ' H ' HG22 ' A' ' 72' ' ' THR . 3.9 tt -148.93 178.1 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.495 -1.378 . . . . 0.0 108.13 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.7 m -143.11 138.81 30.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.856 1.662 . . . . 0.0 109.092 167.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -134.99 -12.56 2.2 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.7 143.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.348 2.659 . . . . 0.0 111.588 -146.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.7 -45.61 67.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 126.877 2.071 . . . . 0.0 112.376 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -54.43 -44.99 72.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.858 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.17 -51.24 56.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.717 1.207 . . . . 0.0 110.877 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.71 ' CE2' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -50.48 -50.99 51.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.392 2.277 . . . . 0.0 111.433 178.081 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.7 tp -53.8 -64.64 0.76 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.985 1.714 . . . . 0.0 108.633 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.21 -42.4 51.43 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.872 1.269 . . . . 0.0 111.385 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.72 -68.51 0.18 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.727 1.611 . . . . 0.0 109.912 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.551 ' HE2' HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.51 ' H ' ' HA ' ' A' ' 73' ' ' ILE . 3.1 mp . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.1 t30 . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -92.7 8.36 39.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.66 2.027 . . . . 0.0 110.493 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -153.9 44.69 0.58 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.658 2.783 . . . . 0.0 110.4 -172.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.804 HD21 ' HG3' ' A' ' 15' ' ' GLU . 84.0 mt . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 123.818 1.77 . . . . 0.0 115.44 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.46 16.37 26.76 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 120.4 -1.438 . . . . 0.0 112.533 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.2 173.33 10.48 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.863 1.265 . . . . 0.0 109.905 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 49.1 mttp -74.76 -5.56 44.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.247 169.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.41 -23.04 62.28 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.764 1.225 . . . . 0.0 113.021 167.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -57.01 -52.71 64.17 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.078 0.854 . . . . 0.0 111.232 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -68.8 -32.47 72.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.239 0.616 . . . . 0.0 111.154 178.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.35 -54.59 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.078 0.951 . . . . 0.0 110.755 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -64.53 -27.14 68.76 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.606 0.639 . . . . 0.0 110.646 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.09 -30.51 65.17 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.077 -1.015 . . . . 0.0 112.701 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.498 ' HG3' HD21 ' A' ' 116' ' ' LEU . 29.8 mm-40 -59.8 -31.92 70.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 119.301 0.955 . . . . 0.0 112.081 172.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.0 mt -75.0 -46.56 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -50.86 -50.25 57.34 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.68 1.192 . . . . 0.0 111.306 172.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -58.35 -38.57 77.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.92 0.782 . . . . 0.0 109.942 -166.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -65.06 -47.92 75.63 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 173.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -35.16 65.52 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.048 0.939 . . . . 0.0 112.444 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.2 -53.15 40.81 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.831 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.35 -45.43 91.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.33 0.968 . . . . 0.0 112.686 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -155.72 58.48 0.61 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.746 1.26 . . . . 0.0 110.841 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.79 86.3 Favored Glycine 0 C--O 1.219 -0.79 0 CA-C-O 118.569 -1.129 . . . . 0.0 111.844 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.94 -40.14 42.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.357 1.578 . . . . 0.0 112.581 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -84.37 -18.68 35.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.359 -0.838 . . . . 0.0 111.778 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.94 -38.7 19.02 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.502 1.921 . . . . 0.0 109.246 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 54' ' ' VAL . 9.3 t -54.07 -46.3 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 127.637 2.375 . . . . 0.0 108.755 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.54 -13.02 7.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -92.74 -63.09 1.27 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 120.077 1.308 . . . . 0.0 110.577 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.89 -38.36 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.2 1.0 . . . . 0.0 110.469 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 47.85 59.03 6.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.428 1.489 . . . . 0.0 112.526 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.49 -176.79 39.62 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.272 1.536 . . . . 0.0 110.509 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.6 131.77 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 159.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -121.98 167.26 13.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 111.939 166.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.8 146.02 34.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.832 1.653 . . . . 0.0 108.997 164.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -95.42 100.3 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -77.09 99.56 5.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.049 1.295 . . . . 0.0 109.059 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.12 133.81 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 170.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.48 175.46 5.51 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.607 -1.308 . . . . 0.0 108.706 154.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 55.42 52.52 11.17 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.112 160.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.01 174.74 20.07 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.425 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.8 6.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.455 3.437 . . . . 0.0 115.088 169.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.58 -22.06 1.89 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.403 1.478 . . . . 0.0 114.052 163.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.68 -13.43 17.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 119.515 1.657 . . . . 0.0 111.792 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -66.16 -175.5 0.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.938 1.695 . . . . 0.0 111.177 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.87 167.09 13.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.466 1.506 . . . . 0.0 110.225 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.45 173.37 12.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.547 1.939 . . . . 0.0 107.109 169.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 84.3 m -143.91 143.99 31.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 161.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.41 137.09 49.64 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 161.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.48 144.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.51 107.95 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -75.39 124.5 27.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.586 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -139.67 44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 105.852 -1.906 . . . . 0.0 105.852 172.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -134.5 -46.0 0.75 Allowed 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 125.09 1.356 . . . . 0.0 110.107 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -92.28 103.21 15.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -159.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.34 -113.83 4.51 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.278 -0.889 . . . . 0.0 111.638 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -84.81 -5.72 59.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.073 0.949 . . . . 0.0 112.757 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.75 -97.49 0.72 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 128.722 3.058 . . . . 0.0 110.383 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.7 m 98.89 151.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 1 C-N-CA 135.548 5.539 . . . . 0.0 111.733 -172.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.75 148.64 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 163.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.33 122.5 19.06 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.15 138.52 16.23 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 -177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.64 24.54 3.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.562 1.945 . . . . 0.0 111.958 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 t -74.65 144.76 43.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.264 1.031 . . . . 0.0 111.064 -153.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.4 7.08 23.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 111.882 164.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 tttm -61.99 129.29 40.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 153.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -68.06 -176.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.24 156.45 47.07 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.565 1.546 . . . . 0.0 109.286 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.31 -45.15 41.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.681 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -134.22 177.3 7.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.363 0.665 . . . . 0.0 110.887 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -138.81 -177.78 5.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.475 1.51 . . . . 0.0 107.688 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.27 152.93 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 119.543 -1.973 . . . . 0.0 105.694 166.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.7 m -108.24 122.74 47.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.409 1.459 . . . . 0.0 112.185 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.7 mtm -156.6 119.24 4.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.4 165.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.643 163.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.09 -54.4 45.47 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 121.256 -0.902 . . . . 0.0 109.817 163.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.9 1.69 1.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.839 1.256 . . . . 0.0 112.305 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.0 -63.38 1.13 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.466 2.306 . . . . 0.0 108.613 164.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -60.94 -40.01 91.63 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.327 2.251 . . . . 0.0 113.503 -174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -35.37 71.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.934 1.293 . . . . 0.0 110.038 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.28 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.733 1.213 . . . . 0.0 110.674 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 tt -46.83 -75.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.82 2.448 . . . . 0.0 109.717 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 123.851 0.86 . . . . 0.0 112.992 172.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.498 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.49 -4.87 42.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.383 0.992 . . . . 0.0 111.874 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -163.23 44.26 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.712 1.205 . . . . 0.0 112.172 -165.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 15' ' ' GLU . 50.0 mt . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 125.214 2.435 . . . . 0.0 114.055 -165.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t0 . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.01 77.58 0.39 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 126.725 2.107 . . . . 0.0 108.6 -175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -153.25 151.93 30.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.682 2.393 . . . . 0.0 106.852 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -61.98 -26.55 68.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.838 0.744 . . . . 0.0 110.272 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.89 -14.35 1.42 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.051 0.94 . . . . 0.0 113.443 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 19.0 t-20 -55.9 -52.19 64.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.574 1.079 . . . . 0.0 111.454 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.183 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG13 ' HG3' ' A' ' 84' ' ' MET . 45.6 t -54.69 -54.62 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.454 1.502 . . . . 0.0 110.723 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -71.1 -23.59 62.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.602 0.637 . . . . 0.0 112.199 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -75.29 -26.96 59.15 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.79 -50.0 75.57 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.211 0.46 . . . . 0.0 110.546 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.3 mt -51.39 -47.9 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.92 -50.72 72.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.988 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -55.42 -48.85 73.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.77 0.714 . . . . 0.0 109.213 -170.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.5 -45.57 93.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.181 0.592 . . . . 0.0 109.881 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -34.1 66.04 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.353 1.461 . . . . 0.0 114.355 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.258 7.8 mm-40 -63.67 -52.13 62.07 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.197 -0.939 . . . . 0.0 111.665 171.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.69 -45.54 93.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.071 1.305 . . . . 0.0 113.233 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -157.75 63.55 0.47 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.674 1.59 . . . . 0.0 108.446 -170.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -25.96 74.04 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 121.073 -1.017 . . . . 0.0 112.749 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -52.89 -36.54 59.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 112.195 -171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -77.05 -35.87 56.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.302 1.041 . . . . 0.0 110.005 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.03 -27.76 57.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.08 -55.6 9.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 167.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -63.8 -15.95 60.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.391 0.996 . . . . 0.0 113.472 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 119.634 1.106 . . . . 0.0 110.82 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.65 -50.29 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.279 1.031 . . . . 0.0 109.047 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.52 65.35 3.63 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.652 1.12 . . . . 0.0 112.775 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.06 144.76 4.64 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.31 138.28 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 168.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -138.88 162.66 34.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.046 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HB1' ' CG2' ' A' ' 49' ' ' THR . . . -111.3 144.56 40.29 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.749 1.22 . . . . 0.0 109.253 172.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -92.94 90.06 6.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.951 1.301 . . . . 0.0 108.945 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -74.62 107.56 6.82 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.717 -1.239 . . . . 0.0 109.526 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.771 HG22 ' CE2' ' A' ' 80' ' ' PHE . 40.5 t -128.67 110.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -115.77 -175.29 2.69 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 165.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t0 65.19 38.18 6.14 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.685 1.994 . . . . 0.0 112.578 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.44 -155.13 24.38 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.962 1.268 . . . . 0.0 111.801 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.75 110.06 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.658 2.239 . . . . 0.0 106.448 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.32 -70.5 0.23 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.028 0.823 . . . . 0.0 111.141 -166.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.92 21.44 36.2 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 118.476 1.138 . . . . 0.0 110.843 -162.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -75.52 -176.12 3.09 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 156.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.25 153.33 29.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.553 1.141 . . . . 0.0 108.363 166.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.69 170.85 13.29 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.36 1.864 . . . . 0.0 107.626 163.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.513 ' CG2' ' HB1' ' A' ' 36' ' ' ALA . 16.6 m -152.77 145.78 24.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 163.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -112.61 149.36 32.91 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 102.134 -3.284 . . . . 0.0 102.134 166.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 141.72 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 167.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.17 113.0 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -82.19 114.01 20.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.42 51.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -141.63 -54.22 0.46 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.4 153.02 34.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.729 0.812 . . . . 0.0 109.914 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.96 -134.37 11.65 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.366 0.984 . . . . 0.0 111.144 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.66 3.3 50.34 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.186 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.95 156.19 20.38 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -173.02 157.67 3.57 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 129.505 3.122 . . . . 0.0 107.599 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.15 153.62 3.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.0 mt -140.32 79.29 21.4 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -161.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.9 144.27 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.502 2.135 . . . . 0.0 110.331 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 47.09 24.47 0.4 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.761 2.024 . . . . 0.0 115.138 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -71.77 161.45 30.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.359 1.076 . . . . 0.0 111.479 -161.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.46 -15.73 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.632 1.973 . . . . 0.0 110.71 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -53.83 130.24 36.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.05 -176.03 2.82 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 165.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.54 152.45 45.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.82 0.848 . . . . 0.0 109.447 -174.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.15 -41.02 59.15 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.306 1.042 . . . . 0.0 109.516 -174.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -136.18 174.81 10.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.833 2.053 . . . . 0.0 107.889 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.485 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 23.7 m -155.35 122.71 5.55 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 tt -83.52 152.31 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.8 m -120.71 141.7 50.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.888 -1.133 . . . . 0.0 108.998 159.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.56 -103.41 0.2 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 163.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.21 159.25 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 130.56 3.544 . . . . 0.0 105.473 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.61 -41.2 69.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.834 0.854 . . . . 0.0 111.211 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 t -60.81 -21.23 62.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.632 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.32 -64.06 1.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.788 0.835 . . . . 0.0 109.387 172.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.771 ' CE2' HG22 ' A' ' 39' ' ' VAL . 95.9 m-85 -55.85 -53.32 58.2 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.861 0.865 . . . . 0.0 110.299 -171.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 tp -55.1 -54.72 39.6 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.54 -41.91 77.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.108 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -54.84 -65.02 0.65 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.776 0.716 . . . . 0.0 110.144 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.481 ' HG3' HG13 ' A' ' 12' ' ' VAL 0.275 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.485 ' CG2' ' H ' ' A' ' 72' ' ' THR 0.314 1.2 mp . . . . . 0 N--CA 1.433 -1.279 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 165.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.893 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.7 tp -77.92 -30.71 50.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.725 1.21 . . . . 0.0 110.789 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.405 ' C ' HD23 ' A' ' 116' ' ' LEU . 18.4 mt-30 -134.99 44.48 2.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.508 1.923 . . . . 0.0 108.987 -165.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 116' ' ' LEU 0.307 0.4 OUTLIER . . . . . 0 CA--C 1.547 0.844 0 C-N-CA 129.494 3.118 . . . . 0.0 114.121 -178.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 122.193 0.997 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 3.66 58.23 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.871 1.701 . . . . 0.0 112.031 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CE2' ' HA3' ' A' ' 42' ' ' GLY . 2.3 m-30 -68.0 148.68 50.7 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 108.926 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -60.19 -21.99 62.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.308 0.643 . . . . 0.0 112.663 169.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -2.58 0.11 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 114.505 170.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -54.75 -51.87 64.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.931 1.242 . . . . 0.0 111.352 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.622 HD22 ' C ' ' A' ' 11' ' ' LEU 0.294 0.0 OUTLIER -58.9 -36.34 74.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.325 1.05 . . . . 0.0 112.241 178.274 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 84' ' ' MET . 3.4 t -59.15 -51.76 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.493 1.042 . . . . 0.0 110.848 -175.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.745 ' HA ' HD12 ' A' ' 16' ' ' ILE . 71.8 m-85 -74.94 -14.72 60.67 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.989 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -74.62 -35.84 62.93 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 117.611 -1.185 . . . . 0.0 111.635 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.729 ' HG3' HD21 ' A' ' 116' ' ' LEU . 67.3 mm-40 -57.36 -29.06 63.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.995 1.27 . . . . 0.0 112.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 13' ' ' PHE . 64.8 mt -65.48 -56.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.453 1.901 . . . . 0.0 108.603 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.57 -47.44 63.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 110.609 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.71 -38.98 93.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.088 1.355 . . . . 0.0 109.825 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -69.32 -36.81 77.35 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.435 -0.79 . . . . 0.0 110.445 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -33.17 75.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.706 1.202 . . . . 0.0 112.188 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.83 -53.35 52.13 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.806 -1.184 . . . . 0.0 110.16 167.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.64 -42.55 83.66 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 112.648 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -160.27 40.34 0.18 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.0 -18.77 80.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.979 -172.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.28 -52.83 2.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.941 1.371 . . . . 0.0 111.529 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.16 77.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.456 0.646 . . . . 0.0 109.798 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.16 -29.25 67.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -53.75 -52.51 33.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.398 0.999 . . . . 0.0 108.699 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -62.18 -24.22 67.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.45 1.477 . . . . 0.0 113.641 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.64 -29.92 69.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.039 1.291 . . . . 0.0 112.175 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.34 -61.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.739 1.216 . . . . 0.0 108.533 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.54 64.48 3.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 125.79 1.662 . . . . 0.0 109.794 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.29 45.34 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.955 0.878 . . . . 0.0 113.809 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.37 138.29 24.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 158.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -135.37 164.49 27.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.858 0.299 . . . . 0.0 110.726 163.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.0 167.75 9.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 109.715 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.483 ' H ' HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -132.8 99.23 4.54 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -170.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -87.34 94.02 9.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.215 1.371 . . . . 0.0 110.607 -165.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.82 115.0 38.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.375 0.607 . . . . 0.0 109.787 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -115.29 174.14 6.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.922 1.289 . . . . 0.0 109.464 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.7 t0 44.13 47.23 7.49 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.165 0.916 . . . . 0.0 112.879 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA3' ' CE2' ' A' ' 7' ' ' PHE . . . -69.71 173.27 37.97 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-O 118.564 -1.131 . . . . 0.0 111.834 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.25 94.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.818 3.012 . . . . 0.0 109.894 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.77 -3.48 14.89 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 126.674 2.083 . . . . 0.0 114.116 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.35 13.8 70.07 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.368 2.084 . . . . 0.0 112.284 160.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -85.79 -167.14 1.74 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.09 2.156 . . . . 0.0 108.502 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -134.11 147.76 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.854 1.661 . . . . 0.0 107.679 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.14 174.86 11.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.161 1.784 . . . . 0.0 108.122 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 37' ' ' PHE . 18.4 m -155.54 155.83 34.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.116 1.366 . . . . 0.0 108.655 169.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.31 154.68 36.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 t -122.49 114.61 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.8 t -95.38 112.55 27.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.83 115.37 20.29 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.65 47.31 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 168.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.97 -49.92 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.513 1.525 . . . . 0.0 109.715 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.27 151.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.303 1.041 . . . . 0.0 108.208 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.11 -131.09 44.86 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -111.79 13.14 21.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.429 1.892 . . . . 0.0 109.717 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 156.66 29.45 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -172.62 161.56 4.92 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 128.182 2.593 . . . . 0.0 105.776 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.29 127.7 58.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -107.6 93.37 10.04 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 125.539 1.535 . . . . 0.0 108.061 -162.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.58 137.55 64.9 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.727 1.618 . . . . 0.0 110.297 -165.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.24 44.6 15.96 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.597 3.159 . . . . 0.0 109.06 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.69 147.01 53.9 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.916 0.865 . . . . 0.0 111.205 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.29 -24.68 39.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.547 158.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -60.43 117.12 4.86 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.157 0.979 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -72.21 -177.17 2.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.996 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.15 163.95 30.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.553 1.168 . . . . 0.0 111.542 -163.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -37.19 59.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.115 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.17 -178.85 5.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.273 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -139.03 -176.01 4.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.272 1.429 . . . . 0.0 108.123 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt -142.62 157.37 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 120.911 -1.118 . . . . 0.0 109.285 159.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 m -98.03 124.4 42.51 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 mtt -152.03 124.31 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 163.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 155.74 4.12 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.982 -0.449 . . . . 0.0 110.931 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -52.47 -49.59 64.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 110.871 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 t -65.4 -9.87 28.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.812 1.645 . . . . 0.0 111.603 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.17 -54.67 3.34 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.757 168.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -48.16 -54.34 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.081 0.855 . . . . 0.0 110.061 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.04 -51.08 62.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 125.818 1.647 . . . . 0.0 110.292 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.98 -24.77 66.36 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.052 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -67.91 -82.16 0.03 OUTLIER 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.534 ' CE ' HD11 ' A' ' 16' ' ' ILE . 1.5 ptm . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 126.295 1.838 . . . . 0.0 114.321 -163.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.273 21.8 mm . . . . . 0 C--N 1.316 -0.872 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.7 tp -57.47 -53.97 52.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.44 52.69 0.88 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.681 1.592 . . . . 0.0 110.666 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.729 HD21 ' HG3' ' A' ' 15' ' ' GLU . 9.0 mt . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 122.221 1.01 . . . . 0.0 111.053 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.52 62.67 0.3 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 119.606 -1.933 . . . . 0.0 111.965 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.482 ' CE2' ' HA3' ' A' ' 42' ' ' GLY . 32.5 m-85 -152.32 143.47 23.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.017 1.408 . . . . 0.0 110.938 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -17.7 62.54 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.637 167.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.33 -13.47 0.9 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.857 1.663 . . . . 0.0 113.706 167.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -56.26 -34.09 66.07 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.541 1.064 . . . . 0.0 112.208 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.417 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -83.82 -31.53 25.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.56 -0.733 . . . . 0.0 112.088 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.87 -62.97 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 124.286 1.034 . . . . 0.0 108.907 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' HA ' HD12 ' A' ' 16' ' ' ILE . 39.3 m-85 -67.51 -25.97 66.11 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.346 -174.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -73.03 -34.33 66.26 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.537 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.66 -30.2 70.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 120.406 1.457 . . . . 0.0 112.588 172.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 13' ' ' PHE . 24.3 mt -65.91 -52.99 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -56.38 -45.71 80.4 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.318 1.047 . . . . 0.0 112.303 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -59.81 -46.54 88.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.1 tpmt? -65.33 -39.34 92.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.795 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.35 -37.43 70.0 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 113.63 171.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.1 -53.4 50.24 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.205 1.002 . . . . 0.0 110.542 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -59.43 -46.02 89.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.307 1.412 . . . . 0.0 111.369 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -164.9 65.06 0.13 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.457 1.123 . . . . 0.0 113.341 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.57 79.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.048 1.309 . . . . 0.0 113.272 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.45 -36.93 67.1 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.811 1.305 . . . . 0.0 111.64 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.841 -1.162 . . . . 0.0 111.43 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.06 -25.8 61.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.432 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.24 -51.17 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.449 -0.786 . . . . 0.0 108.997 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.64 -37.34 75.73 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.801 1.182 . . . . 0.0 111.319 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -61.24 -65.76 0.64 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.626 0.77 . . . . 0.0 110.006 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mt -74.84 -66.87 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.51 66.24 2.53 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.819 1.2 . . . . 0.0 111.051 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.79 37.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 171.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.93 134.62 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 158.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -137.18 167.52 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 171.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 141.15 47.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.921 0.782 . . . . 0.0 112.864 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -87.26 103.78 15.77 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.142 0.977 . . . . 0.0 109.832 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -74.09 95.79 2.61 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 119.54 1.064 . . . . 0.0 109.764 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.14 108.9 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.28 179.25 4.21 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.679 1.191 . . . . 0.0 108.322 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 t70 49.51 42.79 23.28 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.631 1.172 . . . . 0.0 110.724 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.482 ' HA3' ' CE2' ' A' ' 7' ' ' PHE . . . -66.86 168.63 36.19 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.148 -1.362 . . . . 0.0 110.413 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 92.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.829 3.019 . . . . 0.0 113.324 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.93 3.34 51.99 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.718 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.02 40.99 1.34 Allowed Glycine 0 C--N 1.339 0.734 0 CA-C-N 120.61 2.205 . . . . 0.0 111.307 164.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.04 -176.98 6.18 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.535 -0.979 . . . . 0.0 111.086 174.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -147.67 140.65 24.96 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.589 2.355 . . . . 0.0 107.381 163.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.25 166.33 30.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.3 m -143.88 147.73 34.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -122.44 132.81 54.53 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.97 151.29 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -126.66 104.84 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.85 105.16 15.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.34 55.18 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.839 0.745 . . . . 0.0 109.391 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -155.12 -43.66 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.674 1.19 . . . . 0.0 111.194 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -95.92 110.26 22.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.41 1.484 . . . . 0.0 107.557 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.49 -153.6 39.15 Favored Glycine 0 N--CA 1.46 0.261 0 O-C-N 119.882 -1.761 . . . . 0.0 111.618 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -5.45 57.02 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.771 0.828 . . . . 0.0 112.614 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.28 157.68 30.12 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-O 122.238 0.91 . . . . 0.0 110.973 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.84 165.41 6.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.125 3.37 . . . . 0.0 107.905 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.89 89.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 120.747 -1.221 . . . . 0.0 107.945 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.66 103.58 0.88 Allowed Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -164.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.94 143.83 41.73 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.678 1.585 . . . . 0.0 110.14 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 47.7 23.77 0.47 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.941 2.496 . . . . 0.0 113.427 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -78.49 149.21 33.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.405 0.621 . . . . 0.0 110.211 -153.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.55 -2.47 58.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.625 1.97 . . . . 0.0 111.183 168.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.09 130.57 46.7 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 155.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -177.28 1.9 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.28 159.34 39.39 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.983 1.713 . . . . 0.0 107.722 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -35.87 73.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.61 -167.19 2.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.519 1.528 . . . . 0.0 110.794 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 m -133.28 -176.62 4.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.766 1.226 . . . . 0.0 109.578 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tt -142.37 143.55 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.065 -1.022 . . . . 0.0 108.774 151.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 m -84.64 138.91 32.42 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.6 tpp -136.17 -57.88 0.75 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.308 1.413 . . . . 0.0 110.466 149.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.69 152.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 130.433 3.493 . . . . 0.0 111.634 -157.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.13 -48.62 75.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 123.717 0.807 . . . . 0.0 110.403 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 p -66.29 -5.34 10.16 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.751 1.22 . . . . 0.0 111.688 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 -47.87 3.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 161.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -55.81 -52.12 65.08 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.813 1.642 . . . . 0.0 110.179 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tp -55.12 -41.9 72.28 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.187 1.795 . . . . 0.0 112.606 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.82 79.92 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.776 0.43 . . . . 0.0 111.578 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -68.59 -76.14 0.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.055 1.742 . . . . 0.0 110.757 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptm . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 125.071 1.349 . . . . 0.0 113.902 -173.574 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -172.711 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.95 -21.53 59.99 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 120.931 -1.105 . . . . 0.0 110.418 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.82 53.1 1.49 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.064 0.945 . . . . 0.0 109.648 -167.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 126.044 1.737 . . . . 0.0 112.568 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 122.111 0.957 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.57 35.48 0.38 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.761 1.172 . . . . 0.0 112.512 -174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.317 1.058 . . . . 0.0 110.349 173.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -54.15 -34.85 61.39 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.718 -0.614 . . . . 0.0 110.525 164.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.21 -10.96 1.42 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.206 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -60.61 -26.67 67.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.984 1.72 . . . . 0.0 110.969 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.536 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -81.56 -38.38 26.24 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.243 1.383 . . . . 0.0 112.039 169.642 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.81 -53.47 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 119.39 0.995 . . . . 0.0 110.591 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.427 ' HB3' ' CD1' ' A' ' 50' ' ' TRP . 84.9 m-85 -67.91 -22.59 65.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.136 -0.625 . . . . 0.0 111.353 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -75.1 -30.33 60.87 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.515 ' HB2' HD22 ' A' ' 116' ' ' LEU . 4.8 mm-40 -57.58 -46.52 83.89 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.375 0.534 . . . . 0.0 109.72 170.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 13' ' ' PHE . 61.9 mt -57.54 -50.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -52.62 -55.68 20.74 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 124.374 1.07 . . . . 0.0 111.5 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -55.19 -48.65 73.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.546 1.138 . . . . 0.0 108.375 -171.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -58.57 -48.96 79.16 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.642 175.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.19 70.22 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.328 59.2 mm-40 -66.2 -51.22 59.83 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 124.434 1.094 . . . . 0.0 110.828 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.37 -46.5 80.03 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.19 -0.944 . . . . 0.0 111.856 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -165.63 61.75 0.11 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.969 1.307 . . . . 0.0 109.456 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -24.01 72.58 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.963 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.43 -28.82 65.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.765 1.783 . . . . 0.0 113.596 -165.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.29 -25.47 16.32 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.488 2.715 . . . . 0.0 110.95 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.1 m-85 -73.77 -28.85 61.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.724 2.01 . . . . 0.0 110.39 172.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -53.23 -44.34 52.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.585 1.154 . . . . 0.0 109.029 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.87 -27.78 69.04 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -71.04 -28.85 64.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.844 1.202 . . . . 0.0 112.277 -167.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.76 -59.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.3 73.96 0.51 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.739 1.161 . . . . 0.0 110.343 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.56 177.09 45.27 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.896 0.848 . . . . 0.0 112.148 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.56 147.36 6.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 144.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -138.27 176.25 8.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 154.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.24 174.53 7.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.551 156.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -116.38 122.69 45.58 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.588 1.555 . . . . 0.0 107.836 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -100.05 104.93 16.54 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 121.12 1.782 . . . . 0.0 106.628 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.58 94.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -162.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -94.53 177.73 5.83 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.869 -1.145 . . . . 0.0 108.414 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.8 t0 60.31 33.3 20.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.344 1.057 . . . . 0.0 111.601 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.46 174.6 38.25 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 118.409 -1.217 . . . . 0.0 111.381 170.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.7 95.66 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.508 2.805 . . . . 0.0 110.528 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.69 -16.57 4.78 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.122 2.296 . . . . 0.0 112.871 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.28 3.72 88.65 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 118.919 1.359 . . . . 0.0 112.086 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -69.5 -174.78 0.73 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.312 2.645 . . . . 0.0 109.444 170.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -126.91 168.74 14.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.079 0.552 . . . . 0.0 110.829 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.39 175.07 10.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.881 1.672 . . . . 0.0 109.338 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.0 m -149.75 149.09 30.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.256 1.022 . . . . 0.0 109.917 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 13' ' ' PHE . 1.2 m-90 -121.7 151.63 40.29 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 t -120.55 133.94 65.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 126.853 2.061 . . . . 0.0 105.985 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.85 114.5 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.15 114.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.97 54.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.34 -45.41 0.05 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.166 1.386 . . . . 0.0 109.106 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -74.91 135.44 41.48 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.37 -133.19 11.0 Favored Glycine 0 C--N 1.333 0.362 0 O-C-N 123.69 0.618 . . . . 0.0 111.885 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.46 4.15 47.57 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.418 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.24 156.89 28.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-O 123.22 1.456 . . . . 0.0 110.212 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -172.31 144.4 1.56 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.005 2.922 . . . . 0.0 109.689 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.97 157.01 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mt -134.71 79.23 53.41 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -166.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.87 132.83 38.82 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.122 2.548 . . . . 0.0 110.81 -166.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.2 23.77 4.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.539 1.936 . . . . 0.0 111.891 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -82.69 145.91 29.35 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.449 -0.782 . . . . 0.0 110.104 -162.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -85.16 -9.45 57.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.748 1.619 . . . . 0.0 111.791 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -53.4 142.36 22.01 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.945 -1.097 . . . . 0.0 110.435 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -71.02 -175.58 1.18 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 111.779 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.58 165.09 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.22 -62.49 1.55 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.562 1.145 . . . . 0.0 112.157 157.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -154.54 166.91 31.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.871 1.669 . . . . 0.0 108.991 -170.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -138.61 126.65 22.58 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 tt -82.53 165.48 2.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 m -102.35 126.37 49.34 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.505 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -157.82 132.07 8.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 158.082 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.21 154.39 39.94 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.456 1.102 . . . . 0.0 110.081 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -49.69 -48.59 49.56 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.535 1.534 . . . . 0.0 112.389 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -59.04 -24.99 63.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 110.948 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.38 -26.44 11.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.465 0.706 . . . . 0.0 110.89 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.505 ' CZ ' ' HG3' ' A' ' 75' ' ' MET . 66.1 m-85 -57.85 -57.97 10.44 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 158.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.47 -35.82 53.51 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.547 -0.72 . . . . 0.0 111.977 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.92 94.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mt -69.94 -67.1 0.51 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 110.107 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.341 0.225 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -167.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt . . . . . 0 N--CA 1.441 -0.895 0 N-CA-C 101.974 -3.343 . . . . 0.0 101.974 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.0 mm . . . . . 0 C--N 1.312 -1.044 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -157.679 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.41 HD12 ' CE2' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -72.07 -5.01 32.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.339 0.972 . . . . 0.0 111.671 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -149.49 44.46 0.94 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 128.639 2.775 . . . . 0.0 109.58 -170.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 15' ' ' GLU 0.379 0.2 OUTLIER . . . . . 0 C--N 1.352 0.681 0 C-N-CA 127.348 2.259 . . . . 0.0 112.756 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.06 68.56 0.42 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 125.225 1.393 . . . . 0.0 111.025 -163.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.807 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 76.5 m-85 -153.42 159.87 42.47 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.727 2.011 . . . . 0.0 107.34 -168.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.71 -34.6 73.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 167.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.21 -10.5 0.37 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.805 2.042 . . . . 0.0 114.607 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -55.16 -52.52 63.05 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 120.347 1.43 . . . . 0.0 111.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.443 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -65.22 -33.63 76.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.434 -179.844 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.66 -54.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.144 0.884 . . . . 0.0 110.248 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 16' ' ' ILE . 72.6 m-85 -68.95 -23.19 64.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.261 0.482 . . . . 0.0 111.646 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -37.57 80.99 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 116.591 -1.671 . . . . 0.0 111.835 173.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -65.45 -38.16 89.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.678 1.581 . . . . 0.0 111.256 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 13' ' ' PHE . 60.0 mt -52.86 -47.91 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 61' ' ' VAL . 19.7 tt0 -64.51 -43.04 95.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.886 0.474 . . . . 0.0 111.826 175.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -63.18 -42.95 99.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -60.16 -35.71 75.94 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.142 -0.974 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.29 -27.26 62.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -63.86 -54.05 41.07 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.19 -0.944 . . . . 0.0 109.079 163.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.06 -43.81 98.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.648 0.779 . . . . 0.0 110.05 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -165.09 64.9 0.12 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.408 1.483 . . . . 0.0 109.064 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.89 -17.28 79.3 Favored Glycine 0 CA--C 1.519 0.334 0 O-C-N 120.959 -1.088 . . . . 0.0 113.166 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.517 ' CB ' ' HE3' ' A' ' 58' ' ' LYS . 5.9 pt-20 -58.21 -33.98 69.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.99 0.895 . . . . 0.0 112.197 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -79.98 -39.35 30.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.775 1.63 . . . . 0.0 109.463 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.39 -29.53 70.82 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.27 -52.25 53.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 119.214 0.916 . . . . 0.0 110.6 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -68.41 -18.04 64.35 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.299 -0.876 . . . . 0.0 112.621 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -72.55 -69.49 0.4 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 120.333 1.424 . . . . 0.0 109.195 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.32 -54.84 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -171.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.29 65.01 3.43 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.06 158.07 21.91 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 167.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.27 137.51 22.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 159.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -132.41 168.81 17.49 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.661 -0.649 . . . . 0.0 109.426 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.06 158.87 26.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' THR . 73.2 m-85 -108.09 113.39 26.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.503 1.521 . . . . 0.0 108.629 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.27 117.3 23.46 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.34 1.882 . . . . 0.0 114.181 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.67 101.28 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -109.45 -169.96 1.57 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 165.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t0 54.12 39.28 30.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.822 2.049 . . . . 0.0 111.917 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -66.22 176.55 17.68 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.721 173.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.88 -8.04 12.77 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.451 2.1 . . . . 0.0 114.119 -174.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.69 4.84 19.1 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.629 1.585 . . . . 0.0 114.617 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.61 77.57 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 120.179 1.989 . . . . 0.0 112.805 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -85.57 -171.77 3.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.062 2.945 . . . . 0.0 110.164 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.45 150.5 39.1 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.807 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -130.87 162.77 28.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 131.528 3.931 . . . . 0.0 107.498 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 37' ' ' PHE . 1.3 m -154.91 140.94 18.36 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 161.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -112.19 154.72 25.11 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 170.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.1 t -118.93 122.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.13 109.97 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 107.681 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -85.4 48.52 1.59 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.077 1.351 . . . . 0.0 112.242 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 m -75.74 53.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 119.998 -1.689 . . . . 0.0 110.977 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.06 -46.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.226 1.81 . . . . 0.0 108.908 174.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.4 143.19 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -168.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.54 -131.57 51.18 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HE3' ' CB ' ' A' ' 25' ' ' GLU . 2.8 mmmt -97.94 5.18 49.2 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.351 1.06 . . . . 0.0 111.346 168.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.77 157.8 20.33 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 119.885 1.22 . . . . 0.0 110.637 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.8 m -171.54 162.49 6.52 Favored 'General case' 0 N--CA 1.442 -0.844 1 C-N-CA 132.386 4.274 . . . . 0.0 105.201 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 17' ' ' GLU . 12.0 t -109.94 157.41 10.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 170.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 mt -129.03 122.55 21.34 Favored Pre-proline 0 N--CA 1.441 -0.897 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -89.74 145.45 4.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.787 2.991 . . . . 0.0 108.849 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 35.49 41.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.088 1.755 . . . . 0.0 114.039 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -68.25 148.9 50.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.722 0.809 . . . . 0.0 109.098 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -86.19 -20.24 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.402 1.081 . . . . 0.0 111.303 163.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -52.3 125.06 14.84 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -62.44 -177.45 0.14 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.165 0.983 . . . . 0.0 109.036 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.36 149.06 33.05 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.609 1.164 . . . . 0.0 109.997 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -43.45 51.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.812 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -127.27 174.23 9.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.511 1.924 . . . . 0.0 109.136 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.9 m -133.75 -169.68 2.35 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.594 ' H ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -155.37 154.67 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 169.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -121.64 128.4 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.6 mtm -136.27 -29.15 1.0 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 117.367 -1.301 . . . . 0.0 111.718 165.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.81 153.6 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.872 1.269 . . . . 0.0 109.517 -166.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 10.1 t70 -54.47 -44.06 72.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.382 1.473 . . . . 0.0 111.216 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.0 t -56.81 -39.31 73.91 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.068 2.547 . . . . 0.0 109.925 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.19 -42.39 10.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.522 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.39 -52.32 62.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.34 1.056 . . . . 0.0 110.489 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.39 -53.45 56.49 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.68 -19.26 15.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.612 0.765 . . . . 0.0 113.054 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -79.81 0.05 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.6 pttp . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.321 33.4 mm . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.722 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p30 . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.47 -56.19 18.98 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.728 0.811 . . . . 0.0 109.294 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.12 44.88 1.21 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.976 0.51 . . . . 0.0 110.49 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 116' ' ' LEU . 10.6 mt . . . . . 0 C--O 1.235 0.324 0 C-N-CA 125.571 1.548 . . . . 0.0 112.933 -170.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.271 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.27 74.87 0.29 Allowed Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.243 -1.535 . . . . 0.0 111.492 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -153.87 158.74 41.22 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.606 1.562 . . . . 0.0 109.955 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -75.05 -13.34 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.841 165.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.86 -30.25 5.59 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.585 1.084 . . . . 0.0 112.575 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 127.135 2.174 . . . . 0.0 110.479 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.83 -31.43 71.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.191 1.396 . . . . 0.0 110.859 -174.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 t -90.63 -45.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.222 2.609 . . . . 0.0 110.989 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -65.14 -37.34 87.1 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.093 0.861 . . . . 0.0 111.797 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -52.25 -37.1 54.4 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 170.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.69 -41.27 96.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.921 0.782 . . . . 0.0 110.906 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.17 -51.68 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.29 -43.71 83.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.807 1.643 . . . . 0.0 112.768 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -65.32 -51.46 60.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -59.58 -38.97 82.59 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.317 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.48 -37.95 71.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.52 -53.38 43.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.29 -0.881 . . . . 0.0 111.938 165.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -55.21 -43.93 74.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.041 1.336 . . . . 0.0 112.136 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -165.42 65.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.621 2.768 . . . . 0.0 108.525 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.89 -25.66 75.36 Favored Glycine 0 CA--C 1.518 0.224 0 O-C-N 120.691 -1.256 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -44.22 62.44 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.952 0.876 . . . . 0.0 111.58 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -77.43 -22.66 51.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 121.426 -0.796 . . . . 0.0 110.815 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.17 -29.04 54.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -55.47 -38.83 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.153 0.888 . . . . 0.0 109.417 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -69.48 -11.17 60.61 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.53 -1.356 . . . . 0.0 114.013 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -78.07 -61.7 1.91 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 121.405 1.911 . . . . 0.0 111.199 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.77 -58.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.02 62.64 4.55 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 126.756 2.122 . . . . 0.0 112.724 -170.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.54 164.38 34.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 125.275 1.417 . . . . 0.0 110.657 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.03 128.36 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 159.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -129.82 159.36 36.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 110.899 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.74 166.67 10.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 109.212 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.485 ' H ' HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -130.09 91.92 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -172.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -78.84 104.41 9.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.307 0.958 . . . . 0.0 109.073 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.59 103.5 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.3 ptmm? -92.83 -171.03 2.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.8 t0 62.22 51.62 3.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 123.23 1.491 . . . . 0.0 111.333 148.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.87 -162.64 11.78 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 126.849 2.166 . . . . 0.0 109.627 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.9 85.84 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 124.053 3.169 . . . . 0.0 110.619 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.13 -20.87 4.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.826 1.679 . . . . 0.0 113.467 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.07 22.67 65.22 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 120.035 1.917 . . . . 0.0 111.285 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -79.06 -169.58 1.88 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.318 1.447 . . . . 0.0 108.409 168.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 34.6 tt0 -130.0 141.67 50.72 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.573 0.749 . . . . 0.0 109.378 170.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.97 160.98 14.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.016 2.527 . . . . 0.0 107.721 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 37' ' ' PHE . 91.5 m -140.05 142.56 36.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 147.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.1 140.83 47.54 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 161.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.13 142.16 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.51 113.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 42.49 1.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.848 1.659 . . . . 0.0 112.197 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 20' ' ' LEU . 1.9 m -74.63 60.37 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.822 1.249 . . . . 0.0 111.117 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -148.99 -46.14 0.14 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.234 1.814 . . . . 0.0 109.584 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -82.08 142.31 32.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.12 -127.71 25.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.953 0.797 . . . . 0.0 113.119 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -92.55 1.44 57.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.606 1.162 . . . . 0.0 111.909 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.12 157.83 15.33 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 120.185 1.357 . . . . 0.0 110.263 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -171.17 165.64 7.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 129.461 3.104 . . . . 0.0 108.509 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -107.96 156.12 8.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.086 1.754 . . . . 0.0 109.039 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -142.23 75.08 20.34 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 -162.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -63.18 140.07 75.83 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.357 2.038 . . . . 0.0 109.531 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 51.43 23.56 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.709 1.603 . . . . 0.0 114.132 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 t -79.22 144.5 34.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.485 0.659 . . . . 0.0 111.406 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.52 8.36 3.59 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 126.021 1.728 . . . . 0.0 111.057 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.91 135.22 57.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.437 -2.039 . . . . 0.0 109.546 162.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -66.95 -173.34 0.24 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.535 1.534 . . . . 0.0 109.482 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 165.85 33.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.293 1.037 . . . . 0.0 109.907 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.08 -50.32 16.78 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.068 160.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.4 m -134.83 -178.65 5.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.891 0.769 . . . . 0.0 111.461 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.645 HG22 ' H ' ' A' ' 73' ' ' ILE . 14.1 m -149.2 -164.66 2.08 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.645 ' H ' HG22 ' A' ' 72' ' ' THR . 5.6 tt -150.75 165.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 125.566 1.546 . . . . 0.0 107.159 161.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.555 ' H ' ' HA ' ' A' ' 100' ' ' LYS . 72.9 m -121.48 136.23 54.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.181 161.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.05 -98.33 0.15 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 152.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 178.0 152.24 0.27 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.755 3.222 . . . . 0.0 106.992 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.17 -40.59 90.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.796 1.638 . . . . 0.0 110.159 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.4 p -58.68 -22.77 57.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.771 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -105.72 -40.79 5.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.661 1.184 . . . . 0.0 109.982 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -53.99 50.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.342 1.457 . . . . 0.0 111.904 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -54.66 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.03 -12.9 58.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.896 -1.526 . . . . 0.0 114.043 -168.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.55 -76.33 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.765 1.626 . . . . 0.0 108.996 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.241 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.555 ' HA ' ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -176.466 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -15.39 25.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.535 0.734 . . . . 0.0 112.283 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -128.17 49.34 2.18 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.495 1.518 . . . . 0.0 109.104 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 C--N 1.344 0.354 0 C-N-CA 125.8 1.64 . . . . 0.0 111.823 -172.611 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.88 4.46 6.95 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.714 1.149 . . . . 0.0 112.483 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -65.51 160.2 22.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.583 1.191 . . . . 0.0 109.092 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -7.18 14.6 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.21 0.45 7.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 113.192 165.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -53.15 -53.62 47.76 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.482 1.492 . . . . 0.0 111.311 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.621 HD22 ' C ' ' A' ' 11' ' ' LEU 0.25 0.0 OUTLIER -57.29 -35.72 70.16 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.346 1.059 . . . . 0.0 113.439 173.395 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.555 HG22 ' SD ' ' A' ' 84' ' ' MET . 0.9 OUTLIER -58.9 -47.81 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.565 1.546 . . . . 0.0 110.463 178.137 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 97.8 m-85 -72.73 -33.62 66.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.332 0.969 . . . . 0.0 111.057 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -71.37 -24.57 62.11 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.421 -0.799 . . . . 0.0 112.777 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.08 -49.24 72.17 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.72 -0.613 . . . . 0.0 112.338 164.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -57.45 -48.85 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -58.15 -54.39 47.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.244 1.417 . . . . 0.0 110.984 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -36.31 81.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.406 1.003 . . . . 0.0 109.547 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -67.38 -39.71 85.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.568 1.147 . . . . 0.0 110.67 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -31.29 72.1 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.26 -51.69 65.11 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.677 173.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.31 -46.47 88.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 118.547 -1.261 . . . . 0.0 111.81 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -160.6 42.49 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.986 1.374 . . . . 0.0 112.306 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -52.57 -20.43 7.59 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.978 1.275 . . . . 0.0 114.856 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -58.0 -23.46 54.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.774 1.787 . . . . 0.0 113.866 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.35 -23.97 16.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.93 0.786 . . . . 0.0 109.145 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.23 -31.27 60.81 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.511 -1.368 . . . . 0.0 108.555 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 54' ' ' VAL . 19.9 t -52.11 -41.33 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.297 1.839 . . . . 0.0 109.6 163.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -70.89 -37.52 73.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.723 1.147 . . . . 0.0 110.985 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -60.2 -61.56 2.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.069 0.85 . . . . 0.0 110.055 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.06 -57.05 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -172.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.31 52.85 36.68 Favored Glycine 0 CA--C 1.525 0.715 0 O-C-N 121.143 -0.973 . . . . 0.0 112.566 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.82 143.33 4.28 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.44 144.22 12.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -140.64 168.57 19.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.967 -0.458 . . . . 0.0 110.507 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.84 131.48 54.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.231 . . . . 0.0 109.787 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -84.91 104.26 14.7 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.808 1.243 . . . . 0.0 108.08 172.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -78.82 100.96 7.39 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 120.815 1.643 . . . . 0.0 110.408 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.409 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 19.3 t -104.48 93.54 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 175.09 6.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.272 -0.892 . . . . 0.0 111.274 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 59.37 24.31 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.695 2.398 . . . . 0.0 113.634 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 177.82 3.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.004 -167.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.52 91.67 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.15 2.566 . . . . 0.0 109.489 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.67 -72.87 0.44 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.052 1.31 . . . . 0.0 112.888 -156.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.04 -7.64 7.21 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.56 1.552 . . . . 0.0 112.894 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -69.47 -174.31 0.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.907 1.283 . . . . 0.0 110.837 170.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.7 147.3 49.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 108.474 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.22 167.62 17.37 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.251 2.62 . . . . 0.0 107.8 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 m -155.57 144.57 20.69 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.307 -0.871 . . . . 0.0 109.136 170.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.64 118.95 30.44 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -78.96 128.52 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.08 107.65 23.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -82.12 110.67 17.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 28' ' ' VAL . 1.3 m -133.36 48.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -133.54 -49.34 0.84 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 165.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -90.41 136.49 33.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.7 -142.26 41.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -80.22 -3.76 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.334 1.453 . . . . 0.0 114.351 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.47 156.58 6.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.654 1.116 . . . . 0.0 111.526 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m -172.62 151.85 2.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 129.123 2.969 . . . . 0.0 107.958 169.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.35 126.07 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt -103.4 99.74 16.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.45 147.87 53.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.852 2.368 . . . . 0.0 108.937 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 47.49 23.48 0.39 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.362 1.865 . . . . 0.0 113.683 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 t -81.88 155.87 25.11 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.408 1.099 . . . . 0.0 111.424 -156.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -25.45 27.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.408 1.083 . . . . 0.0 109.946 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -74.28 129.44 37.81 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.802 0.728 . . . . 0.0 109.153 -166.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -73.11 -177.83 2.62 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.797 1.239 . . . . 0.0 112.41 -163.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.05 174.62 5.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.336 -165.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -57.08 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.002 -1.686 . . . . 0.0 108.353 148.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.41 -177.74 5.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.568 1.947 . . . . 0.0 109.413 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 m -131.15 -173.72 3.18 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.841 -1.162 . . . . 0.0 107.958 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 tt -155.17 146.7 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.3 m -111.19 132.02 54.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 117.122 -1.418 . . . . 0.0 107.68 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.9 mtm -137.08 -48.5 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.854 -1.07 . . . . 0.0 111.993 166.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.54 153.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.362 3.065 . . . . 0.0 110.81 -161.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.93 -39.99 93.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.142 0.901 . . . . 0.0 108.67 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.74 68.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.077 0.465 . . . . 0.0 110.362 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.51 -49.45 6.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.556 -1.212 . . . . 0.0 107.812 -168.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -56.98 -40.53 76.69 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.471 1.108 . . . . 0.0 110.977 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.4 tp -64.28 -60.52 3.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.49 -35.59 65.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.248 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.34 -70.53 0.09 Allowed 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.107 1.763 . . . . 0.0 108.143 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 12' ' ' VAL . 1.4 ptp . . . . . 0 CA--C 1.53 0.198 0 CA-C-N 118.565 0.62 . . . . 0.0 111.906 -172.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -166.789 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 C--O 1.227 -0.127 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tp 48.85 -61.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.728 2.011 . . . . 0.0 111.384 -152.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -135.11 62.88 1.63 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 127.372 2.269 . . . . 0.0 109.895 -163.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.31 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 126.608 1.963 . . . . 0.0 113.175 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 122.34 1.067 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.86 84.4 0.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -164.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -153.8 170.59 20.6 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 128.83 2.852 . . . . 0.0 104.501 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -29.77 70.76 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.299 -0.875 . . . . 0.0 110.078 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.86 -11.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.316 1.846 . . . . 0.0 114.815 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -53.7 -40.55 66.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.675 1.579 . . . . 0.0 110.856 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -65.47 -36.68 84.61 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.757 176.004 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.698 HG13 ' SD ' ' A' ' 84' ' ' MET . 2.6 t -61.77 -59.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.179 0.992 . . . . 0.0 110.839 -173.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.593 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 64.3 m-85 -63.71 -23.99 67.59 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.982 0.81 . . . . 0.0 110.923 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 28.0 tttt -70.34 -25.46 63.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.512 ' HG3' HD21 ' A' ' 116' ' ' LEU . 77.5 mm-40 -67.59 -40.8 84.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.602 0.637 . . . . 0.0 110.939 173.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.68 -48.64 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.384 1.474 . . . . 0.0 107.56 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 14' ' ' LYS . 25.5 tt0 -51.26 -49.93 60.23 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.053 169.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -58.68 -40.65 84.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -65.28 -47.41 76.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.73 1.212 . . . . 0.0 111.707 173.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -33.1 63.83 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.427 0.691 . . . . 0.0 112.009 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.94 -52.59 55.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.828 -1.17 . . . . 0.0 110.22 169.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -53.7 -45.98 70.58 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.949 1.25 . . . . 0.0 111.315 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -162.36 49.76 0.18 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.859 0.838 . . . . 0.0 112.349 -170.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.36 -28.3 61.75 Favored Glycine 0 C--O 1.223 -0.585 0 O-C-N 120.496 -1.378 . . . . 0.0 113.273 -174.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.85 -24.65 64.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -78.31 -41.7 32.96 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.716 -1.24 . . . . 0.0 110.138 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -67.1 -36.05 81.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 108.659 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 54' ' ' VAL . 9.5 t -51.01 -42.11 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 127.834 2.453 . . . . 0.0 111.018 169.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -72.29 -23.77 61.23 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.458 -1.401 . . . . 0.0 111.052 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -89.57 -14.17 35.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -173.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.9 -55.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.484 1.514 . . . . 0.0 107.535 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.39 59.85 7.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 124.85 1.214 . . . . 0.0 111.888 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.04 -177.96 43.6 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.25 138.38 31.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 160.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -129.03 164.72 22.63 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.331 0.586 . . . . 0.0 110.255 165.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.33 166.18 11.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.1 163.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -123.18 98.36 5.84 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.588 1.555 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.52 ' HD2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -73.71 109.21 7.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 120.218 1.372 . . . . 0.0 109.282 172.358 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG22 ' CE2' ' A' ' 80' ' ' PHE . 21.7 t -122.41 93.48 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -96.55 177.89 5.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.959 1.704 . . . . 0.0 109.923 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 65.01 24.52 12.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.081 1.352 . . . . 0.0 112.482 162.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.56 -168.38 33.68 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.835 1.683 . . . . 0.0 112.394 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.71 96.12 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.305 2.67 . . . . 0.0 110.079 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.09 -13.05 10.52 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 127.663 2.554 . . . . 0.0 112.582 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.59 21.08 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 126.108 1.813 . . . . 0.0 112.537 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -51.03 -175.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 129.251 3.02 . . . . 0.0 111.809 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.07 161.46 33.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.834 0.826 . . . . 0.0 110.964 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.37 173.63 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.745 2.418 . . . . 0.0 107.862 161.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.7 m -140.73 156.58 46.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -124.73 149.82 46.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 164.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.96 143.02 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.3 110.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.48 122.26 24.98 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 164.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.536 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -135.78 46.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.01 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -138.83 -46.53 0.49 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.101 0.961 . . . . 0.0 110.639 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.68 103.13 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -156.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.03 -118.29 7.16 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.884 -1.135 . . . . 0.0 111.123 -170.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -74.82 -5.12 41.78 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 171.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.98 -103.4 0.77 Allowed Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 127.774 2.606 . . . . 0.0 108.232 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 m 97.39 157.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 135.444 5.497 . . . . 0.0 110.147 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.5 t -77.09 157.97 5.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.9 mt -143.72 84.88 9.58 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 -169.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.1 152.52 76.34 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 N-CA-C 108.202 -1.499 . . . . 0.0 108.202 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.3 23.52 4.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.196 1.398 . . . . 0.0 112.188 170.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -82.65 146.49 29.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.267 -0.896 . . . . 0.0 110.86 -154.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.45 -0.34 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.634 163.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -59.16 139.75 56.6 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.997 1.272 . . . . 0.0 108.061 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -69.43 -176.43 0.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.23 159.59 43.47 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.401 0.68 . . . . 0.0 111.03 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -36.6 65.34 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.354 1.062 . . . . 0.0 111.494 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.21 -177.05 6.07 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.09 1.756 . . . . 0.0 109.018 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 38' ' ' LYS . 24.3 m -133.35 -172.7 3.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.494 ' H ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.87 146.64 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.7 m -103.76 131.08 51.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 mtp -137.09 -48.88 0.61 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.83 160.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 129.948 3.299 . . . . 0.0 109.57 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.01 -46.89 71.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.389 1.876 . . . . 0.0 109.693 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -62.65 -18.77 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 112.281 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -105.97 -37.15 6.74 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.699 0.8 . . . . 0.0 112.143 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 39' ' ' VAL . 10.0 m-85 -65.79 -54.17 30.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.687 1.195 . . . . 0.0 110.674 173.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.21 -36.09 80.88 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.76 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -48.22 -38.33 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.541 1.136 . . . . 0.0 112.546 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -74.12 0.06 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.698 ' SD ' HG13 ' A' ' 12' ' ' VAL . 16.3 ptp . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.503 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 174.637 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.57 -3.55 57.77 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.26 -0.9 . . . . 0.0 110.872 170.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -164.79 48.27 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.883 1.273 . . . . 0.0 111.76 -164.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 15' ' ' GLU . 6.6 mt . . . . . 0 N--CA 1.474 0.729 0 C-N-CA 127.362 2.265 . . . . 0.0 114.595 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.317 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.48 10.29 33.03 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 119.255 -2.153 . . . . 0.0 114.335 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 28.4 m-85 -77.7 171.37 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.576 1.15 . . . . 0.0 112.856 -160.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.35 -23.77 51.0 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.727 -1.233 . . . . 0.0 111.62 163.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.17 -20.58 42.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.784 1.174 . . . . 0.0 113.496 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -73.23 -19.16 61.14 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.927 1.691 . . . . 0.0 111.146 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.51 -63.45 1.37 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.167 1.787 . . . . 0.0 106.289 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.702 HG13 ' SD ' ' A' ' 84' ' ' MET . 4.6 t -59.58 -56.87 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.085 1.354 . . . . 0.0 112.518 -167.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.49 -21.68 64.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.248 0.931 . . . . 0.0 110.986 -173.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -67.06 -34.01 76.76 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.495 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.643 ' HG3' HD21 ' A' ' 116' ' ' LEU . 15.5 mm-40 -59.02 -33.84 71.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.642 1.11 . . . . 0.0 112.163 174.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -72.18 -46.75 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -55.6 -49.5 72.62 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.323 1.049 . . . . 0.0 111.48 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.082 0.953 . . . . 0.0 109.388 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -70.07 -39.37 75.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.482 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -43.15 79.95 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.645 1.111 . . . . 0.0 113.034 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -63.71 -51.99 62.57 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.278 1.431 . . . . 0.0 110.186 173.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.65 -46.24 87.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.4 -1.438 . . . . 0.0 112.755 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -166.34 62.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.41 1.484 . . . . 0.0 111.976 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.97 -20.19 79.73 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 125.36 1.457 . . . . 0.0 113.528 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -33.79 24.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.681 1.24 . . . . 0.0 112.996 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.457 ' OE1' ' HE2' ' A' ' 30' ' ' LYS . 1.1 tm0? -91.71 -35.25 14.27 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.454 1.502 . . . . 0.0 110.702 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.53 -34.77 71.35 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 108.967 168.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -57.64 -62.35 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 119.824 1.193 . . . . 0.0 108.612 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.79 -20.06 60.75 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HE2' ' OE1' ' A' ' 26' ' ' GLN . 53.1 mttm -67.93 -67.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.905 1.282 . . . . 0.0 111.44 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.6 -60.53 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 109.196 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.05 9.91 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.072 1.796 . . . . 0.0 113.817 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.73 176.51 44.19 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 117.955 0.878 . . . . 0.0 111.493 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 mt -102.14 138.16 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 162.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -135.86 157.84 45.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.79 167.19 10.04 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.293 1.037 . . . . 0.0 109.865 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -129.57 105.78 8.3 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.917 1.687 . . . . 0.0 108.644 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -74.38 121.57 21.6 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 168.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.483 HG22 ' CE2' ' A' ' 80' ' ' PHE . 5.3 t -119.23 110.69 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 171.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -114.03 174.79 5.76 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t0 61.59 24.8 14.84 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.504 1.522 . . . . 0.0 112.478 173.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 77' ' ' ASP . . . -70.87 -176.81 23.15 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.859 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.67 44.3 0.32 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.625 3.55 . . . . 0.0 113.428 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.24 -19.76 0.02 OUTLIER Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.288 2.375 . . . . 0.0 112.698 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.48 -7.71 81.36 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 120.853 2.326 . . . . 0.0 113.351 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -69.19 -173.28 0.51 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.608 157.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.22 158.73 36.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.564 1.945 . . . . 0.0 108.697 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -119.9 174.69 6.3 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.156 2.182 . . . . 0.0 107.51 166.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.6 m -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.145 0.978 . . . . 0.0 108.989 161.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -118.73 152.96 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 170.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.1 t -115.62 135.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 171.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.5 t -116.6 120.79 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.63 116.71 28.73 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.0 52.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -145.31 -49.5 0.24 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.638 1.175 . . . . 0.0 110.371 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -90.61 139.46 30.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -164.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.83 -135.48 46.33 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -89.79 6.62 40.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.053 1.741 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.24 158.14 27.33 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -172.13 145.64 1.8 Allowed 'General case' 0 C--O 1.237 0.447 0 C-N-CA 127.006 2.122 . . . . 0.0 105.588 159.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 157.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mt -136.28 80.57 39.83 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.34 145.17 87.9 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.234 1.956 . . . . 0.0 109.043 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.91 23.95 3.1 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.582 2.353 . . . . 0.0 112.2 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -89.95 140.5 29.57 Favored 'General case' 0 CA--C 1.524 -0.052 0 O-C-N 120.417 -1.427 . . . . 0.0 109.489 -163.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.8 -22.63 65.16 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.374 0.67 . . . . 0.0 111.345 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -58.27 130.3 46.06 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.372 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -60.78 -176.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.235 1.414 . . . . 0.0 111.316 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.26 173.2 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 110.567 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -49.18 19.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 163.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.3 m -146.6 -179.43 6.76 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.641 1.576 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.809 HG22 ' H ' ' A' ' 73' ' ' ILE . 15.0 m -132.51 -165.93 1.67 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.488 1.115 . . . . 0.0 108.194 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.809 ' H ' HG22 ' A' ' 72' ' ' THR . 4.0 tt -150.54 172.75 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.937 -1.102 . . . . 0.0 109.593 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.5 m -122.31 124.07 42.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 163.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.469 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 1.9 mtm -151.73 120.79 6.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 166.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.09 164.07 1.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.426 . . . . 0.0 110.106 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 16.3 t70 -58.9 -54.24 49.34 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.875 0.87 . . . . 0.0 109.405 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -67.59 1.22 2.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.37 1.068 . . . . 0.0 112.691 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -60.85 1.5 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.259 1.824 . . . . 0.0 108.883 168.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.483 ' CE2' HG22 ' A' ' 39' ' ' VAL . 21.4 m-85 -56.18 -41.04 74.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.965 1.306 . . . . 0.0 112.893 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.42 -44.37 62.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.658 0.783 . . . . 0.0 109.417 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -27.77 64.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.739 . . . . 0.0 112.153 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.2 -78.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 C-N-CA 126.365 1.866 . . . . 0.0 109.718 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.702 ' SD ' HG13 ' A' ' 12' ' ' VAL . 6.0 ptp . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.1 mm . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.241 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--O 1.232 0.147 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mp -71.66 -7.07 45.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 117.806 -1.092 . . . . 0.0 110.894 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.3 46.92 2.27 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 120.26 1.391 . . . . 0.0 112.938 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.643 HD21 ' HG3' ' A' ' 15' ' ' GLU . 26.4 mt . . . . . 0 C--N 1.347 0.489 0 CA-C-O 123.603 1.668 . . . . 0.0 110.544 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 120.763 0.316 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.63 39.83 0.64 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.936 1.732 . . . . 0.0 109.874 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -85.54 177.87 7.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -66.42 -22.66 66.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.522 -1.362 . . . . 0.0 111.037 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.24 -5.07 1.38 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.37 -47.33 85.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.081 1.31 . . . . 0.0 112.422 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.544 HD22 ' C ' ' A' ' 11' ' ' LEU 0.266 0.0 OUTLIER -68.97 -33.11 73.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.547 0.739 . . . . 0.0 111.53 176.349 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.25 -53.19 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.969 1.708 . . . . 0.0 110.396 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -67.5 -21.91 65.48 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.728 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -75.46 -26.41 58.23 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.494 -1.241 . . . . 0.0 112.768 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -57.09 -41.09 78.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.46 1.482 . . . . 0.0 110.773 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.496 HD11 ' CE ' ' A' ' 84' ' ' MET . 76.6 mt -61.69 -47.72 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.18 -51.32 70.52 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.378 0.671 . . . . 0.0 110.775 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -53.0 -50.83 63.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.171 2.188 . . . . 0.0 108.639 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -34.38 73.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.198 . . . . 0.0 111.349 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -32.6 61.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 0.0 112.811 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -63.35 -53.81 46.84 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.834 0.854 . . . . 0.0 109.994 170.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -62.74 -45.82 90.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 110.863 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -159.41 58.0 0.4 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.208 1.004 . . . . 0.0 109.217 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.22 -23.06 66.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.315 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -59.38 -43.11 92.94 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.715 1.757 . . . . 0.0 111.6 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.14 -32.4 73.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.627 -0.671 . . . . 0.0 111.465 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -75.62 -34.35 60.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 108.619 -171.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.37 -48.73 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.704 1.202 . . . . 0.0 109.208 164.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -70.99 -10.68 60.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.805 -1.185 . . . . 0.0 113.437 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -86.02 -30.53 22.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.368 1.44 . . . . 0.0 113.603 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.56 -54.11 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.696 1.198 . . . . 0.0 108.772 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.73 57.11 11.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.669 2.08 . . . . 0.0 114.786 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.74 -171.18 37.29 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.348 1.574 . . . . 0.0 111.738 -176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.24 124.55 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 158.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -120.93 173.76 7.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.22 142.82 51.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.087 0.955 . . . . 0.0 109.411 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -88.27 91.53 8.82 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 124.969 1.308 . . . . 0.0 110.259 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -74.88 89.08 2.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.577 -1.327 . . . . 0.0 112.241 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.576 HG22 ' CD2' ' A' ' 80' ' ' PHE . 51.1 t -93.58 123.41 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -115.78 174.89 5.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.384 1.474 . . . . 0.0 110.357 158.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.53 61.17 2.06 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.803 1.641 . . . . 0.0 114.82 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.8 -152.44 8.85 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 126.329 1.919 . . . . 0.0 111.933 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.65 5.9 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.185 3.257 . . . . 0.0 114.605 -169.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.45 -49.13 0.21 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 159.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.94 -24.16 4.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.575 1.188 . . . . 0.0 111.402 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -62.16 -175.65 0.08 Allowed 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.087 1.755 . . . . 0.0 111.279 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -127.42 147.65 50.29 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -172.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.87 170.76 15.4 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.675 1.99 . . . . 0.0 108.087 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -155.9 149.42 24.88 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.62 133.1 55.4 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 166.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.95 142.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.68 113.27 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.54 123.96 30.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 165.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.15 39.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 126.365 1.866 . . . . 0.0 107.76 173.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -124.67 -39.31 2.3 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.574 1.15 . . . . 0.0 109.674 162.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -95.04 115.88 27.99 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -155.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.98 49.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -74.81 -2.68 27.76 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.123 173.412 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.31 157.1 14.11 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -168.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 m -171.46 133.28 0.8 Allowed 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 128.507 2.723 . . . . 0.0 106.137 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.96 147.93 8.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -125.53 93.54 44.52 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.79 150.75 44.98 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.278 1.985 . . . . 0.0 109.381 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.13 22.85 0.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.941 2.497 . . . . 0.0 114.507 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.48 147.79 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.419 -155.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.49 -5.09 46.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.96 0.904 . . . . 0.0 111.279 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -44.9 129.12 7.27 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.868 1.667 . . . . 0.0 108.736 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -69.06 -176.0 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.919 0.866 . . . . 0.0 109.04 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.2 151.77 37.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.205 1.002 . . . . 0.0 108.956 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -75.82 -31.01 59.19 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.932 0.493 . . . . 0.0 112.156 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.1 m -148.37 173.02 13.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.822 2.449 . . . . 0.0 107.689 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -155.48 114.7 3.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.129 -1.607 . . . . 0.0 108.063 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.13 146.18 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.0 m -122.55 131.27 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.122 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 mmm -138.73 -12.56 1.3 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.703 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 67.5 151.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.419 1.888 . . . . 0.0 111.107 -164.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.37 -35.41 79.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.342 -0.837 . . . . 0.0 111.929 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -58.09 2.72 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.73 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.576 ' CD2' HG22 ' A' ' 39' ' ' VAL . 34.6 m-85 -51.21 -55.69 16.76 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.232 1.013 . . . . 0.0 112.139 -173.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -54.14 -58.47 7.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.297 0.953 . . . . 0.0 109.331 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.38 -39.48 73.0 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.878 0.736 . . . . 0.0 112.149 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 tt -55.69 -56.61 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.769 2.428 . . . . 0.0 110.306 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.496 ' CE ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.6 pttm . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.268 2.5 mp . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 115.05 7.5 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 70.06 44.9 0.74 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.221 1.008 . . . . 0.0 110.624 -172.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--N 1.345 0.41 0 C-N-CA 125.497 1.519 . . . . 0.0 111.896 -177.52 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 121.392 0.615 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.39 22.39 0.75 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.352 1.453 . . . . 0.0 113.722 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -82.6 177.69 8.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.875 1.337 . . . . 0.0 109.827 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -66.15 -23.42 66.47 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 118.023 -1.471 . . . . 0.0 111.468 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.84 -18.68 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 114.35 169.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 3.5 t-20 -53.09 -44.64 67.73 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.825 0.85 . . . . 0.0 111.024 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.286 0.0 OUTLIER -85.05 -30.22 24.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.573 0.749 . . . . 0.0 111.769 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.55 -54.23 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.593 1.157 . . . . 0.0 110.656 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.15 -20.9 63.13 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.244 -0.91 . . . . 0.0 111.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 22.2 ttmt -75.9 -28.14 57.94 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 118.016 -0.992 . . . . 0.0 113.535 175.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -58.73 -49.91 75.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 119.742 1.155 . . . . 0.0 110.386 163.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.6 -43.5 78.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -51.7 68.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.229 1.012 . . . . 0.0 111.967 170.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -58.98 -41.02 86.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -169.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -65.1 -31.71 73.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.704 2.002 . . . . 0.0 111.861 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -29.61 59.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.518 1.054 . . . . 0.0 113.787 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.5 -53.29 54.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 119.45 1.023 . . . . 0.0 109.053 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -45.37 93.9 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -161.49 51.55 0.24 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 123.433 1.587 . . . . 0.0 109.862 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.77 -17.49 14.8 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 117.525 -1.708 . . . . 0.0 114.91 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.77 -51.12 58.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.669 2.235 . . . . 0.0 110.852 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -68.08 -28.25 67.19 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.773 -1.205 . . . . 0.0 111.37 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -73.7 -35.75 65.18 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.772 -1.205 . . . . 0.0 108.659 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 54' ' ' VAL . 31.4 t -55.97 -42.03 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.867 1.267 . . . . 0.0 109.459 165.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 4.1 mmpt? -69.31 -29.9 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.55 1.523 . . . . 0.0 113.185 174.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -68.46 -49.33 60.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.591 1.542 . . . . 0.0 111.893 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.06 -48.43 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.003 1.274 . . . . 0.0 109.67 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.08 47.19 84.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.646 -1.641 . . . . 0.0 113.935 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.52 171.0 37.41 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.567 1.684 . . . . 0.0 110.728 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.36 131.1 54.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 162.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -129.4 165.57 21.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.991 0.424 . . . . 0.0 111.279 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.8 137.62 52.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.073 1.749 . . . . 0.0 108.722 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.62 109.15 20.13 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.532 1.133 . . . . 0.0 108.668 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 72' ' ' THR . 15.4 mttm -87.37 103.32 15.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 121.03 1.741 . . . . 0.0 107.626 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 80' ' ' PHE . 5.5 t -112.14 94.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.611 -0.681 . . . . 0.0 109.335 -170.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 174.43 6.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.383 -1.448 . . . . 0.0 110.294 171.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 59.34 43.81 16.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.205 1.802 . . . . 0.0 112.105 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -78.1 -167.96 31.57 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.082 -1.011 . . . . 0.0 113.862 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.28 -11.5 10.85 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.025 3.15 . . . . 0.0 114.05 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.25 -5.19 8.85 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.535 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.04 74.73 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.21 1.505 . . . . 0.0 112.084 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.7 -175.66 0.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.271 1.828 . . . . 0.0 109.768 165.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -135.79 150.71 49.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.145 1.778 . . . . 0.0 109.205 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.87 172.09 13.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.829 2.052 . . . . 0.0 109.065 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.5 m -145.91 147.3 31.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 108.32 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.403 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -117.59 142.84 46.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 163.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.03 143.61 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.31 118.67 50.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.93 110.45 18.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 165.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.461 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -128.44 43.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.308 168.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -132.51 -44.9 0.9 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.377 -0.827 . . . . 0.0 111.611 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -95.84 148.12 22.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.734 0.646 . . . . 0.0 109.451 -172.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.95 -130.55 51.04 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.821 ' H ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.02 4.3 34.32 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.08 1.352 . . . . 0.0 112.383 173.146 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.35 157.73 18.86 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.8 m -172.26 153.01 2.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 128.447 2.699 . . . . 0.0 108.028 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -88.09 156.16 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mt -132.79 96.4 18.31 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 -173.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.98 140.32 41.57 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.04 1.827 . . . . 0.0 109.025 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.9 22.79 4.51 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.047 2.139 . . . . 0.0 112.957 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.47 133.95 35.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.419 0.628 . . . . 0.0 110.177 -157.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.36 -7.16 51.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.633 1.173 . . . . 0.0 110.594 165.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -52.48 132.92 35.57 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -74.64 -177.09 3.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.085 0.945 . . . . 0.0 109.651 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.03 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.968 1.707 . . . . 0.0 108.824 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.56 -25.15 56.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.48 -176.22 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.197 0.999 . . . . 0.0 109.47 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.445 HG21 ' HE2' ' A' ' 38' ' ' LYS . 21.4 m -137.66 -175.77 4.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.932 0.893 . . . . 0.0 108.764 -171.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 tt -145.83 142.5 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 154.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.19 146.2 24.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 157.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.454 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 31.4 mtt -134.19 -51.29 0.82 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 157.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.93 161.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.143 3.377 . . . . 0.0 107.966 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.464 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 6.0 t70 -66.72 -47.04 73.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 122.96 0.504 . . . . 0.0 110.863 -171.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.6 m -55.29 -36.25 65.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.448 0.699 . . . . 0.0 110.326 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.11 -59.43 2.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.307 1.843 . . . . 0.0 109.849 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 75' ' ' MET . 10.7 m-85 -50.83 -58.75 5.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.39 1.876 . . . . 0.0 111.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -42.87 99.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.956 0.902 . . . . 0.0 109.81 -172.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -23.24 65.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.87 -173.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mt -67.77 -51.5 48.26 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.496 1.118 . . . . 0.0 110.882 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.189 0 CA-C-N 119.191 0.905 . . . . 0.0 112.556 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 pttt . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 166.904 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.4 m120 . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.85 -10.98 53.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.359 1.064 . . . . 0.0 112.947 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -137.88 54.72 1.8 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.501 1.521 . . . . 0.0 107.106 166.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER . . . . . 0 C--N 1.348 0.535 0 C-N-CA 128.752 2.821 . . . . 0.0 113.387 -175.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.277 0.561 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.05 42.52 1.27 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.434 1.016 . . . . 0.0 112.535 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -85.1 -176.54 6.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.426 1.613 . . . . 0.0 110.583 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -72.36 -17.15 61.86 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.033 -1.042 . . . . 0.0 111.394 164.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.32 -23.98 4.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.2 1.0 . . . . 0.0 112.903 170.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -45.63 77.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.117 1.367 . . . . 0.0 110.32 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.24 -48.77 76.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.171 1.388 . . . . 0.0 109.67 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 t -58.65 -54.29 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.725 1.21 . . . . 0.0 111.421 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -64.31 -26.22 68.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.911 1.232 . . . . 0.0 111.88 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -75.06 -23.65 58.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.506 -0.746 . . . . 0.0 112.589 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.52 -52.62 53.79 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.434 0.459 . . . . 0.0 109.932 166.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -58.64 -48.28 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.186 1.395 . . . . 0.0 107.83 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -55.78 -51.1 68.59 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.759 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -57.99 -47.56 82.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.948 0.795 . . . . 0.0 109.425 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -38.8 88.83 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.559 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.413 HD21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.55 -38.99 72.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 113.814 172.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.12 -52.94 56.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.29 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.54 -45.74 90.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.828 1.194 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -162.73 56.1 0.21 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.138 0.97 . . . . 0.0 111.893 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.51 -16.01 69.04 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 120.905 -1.122 . . . . 0.0 113.103 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -43.3 68.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.764 1.282 . . . . 0.0 112.165 -171.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.77 -32.02 59.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.566 0.746 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.76 -26.8 60.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -60.31 -28.3 41.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -66.08 -21.91 66.39 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.319 -0.863 . . . . 0.0 111.405 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 9.8 mmpt? -73.0 -70.82 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.266 1.394 . . . . 0.0 111.241 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.65 -59.98 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 56.76 13.05 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.807 1.194 . . . . 0.0 113.146 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.81 42.57 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.38 146.68 7.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 149.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -141.33 177.19 8.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 118.969 -1.093 . . . . 0.0 109.581 158.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 72' ' ' THR . . . -124.73 164.15 20.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.502 1.121 . . . . 0.0 108.897 171.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -121.98 106.99 11.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.174 1.79 . . . . 0.0 108.832 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -73.71 110.49 8.04 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 120.282 1.401 . . . . 0.0 112.107 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.07 98.25 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 174.69 7.04 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 166.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 49.75 53.19 13.19 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.982 2.113 . . . . 0.0 113.737 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.64 176.54 2.23 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.399 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.01 84.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.448 3.432 . . . . 0.0 108.433 158.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.17 -76.46 0.3 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -167.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.54 -12.27 3.21 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.506 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -70.18 -171.58 0.47 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.774 1.787 . . . . 0.0 110.978 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.1 160.64 20.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.222 1.809 . . . . 0.0 108.772 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.41 166.05 30.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.545 2.338 . . . . 0.0 106.296 173.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 m -150.81 128.88 11.83 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.78 0.832 . . . . 0.0 109.996 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -94.3 127.34 40.1 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 167.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.18 149.59 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.2 119.97 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.26 106.78 18.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 172.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 HD21 ' A' ' 20' ' ' LEU . 1.2 m -138.17 56.78 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 121.611 -0.681 . . . . 0.0 110.474 174.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -139.91 -53.63 0.53 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.307 1.043 . . . . 0.0 109.683 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -78.39 140.9 38.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.942 1.697 . . . . 0.0 108.152 -172.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 -137.57 32.85 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -104.88 8.26 34.64 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.015 1.726 . . . . 0.0 111.724 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.44 157.34 29.85 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -173.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.9 m -172.52 161.35 4.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.621 3.968 . . . . 0.0 105.991 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -109.96 154.38 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.9 mt -134.25 70.35 73.37 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -158.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.99 142.65 62.82 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.539 2.159 . . . . 0.0 109.28 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 54.88 23.22 4.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.766 2.427 . . . . 0.0 112.437 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 t -87.61 138.32 31.57 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.042 1.292 . . . . 0.0 110.26 -164.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.65 -4.87 58.4 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.48 1.912 . . . . 0.0 111.223 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -60.56 145.18 49.67 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 118.399 -1.32 . . . . 0.0 108.324 170.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -69.6 -173.6 0.61 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.221 1.808 . . . . 0.0 110.378 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.11 133.88 16.79 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.135 -0.353 . . . . 0.0 111.562 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.29 -52.89 4.35 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.933 2.493 . . . . 0.0 111.053 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.3 m -149.42 168.99 21.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.994 2.518 . . . . 0.0 106.767 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 73' ' ' ILE . 87.9 m -121.83 -171.07 2.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.426 ' N ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -143.05 167.61 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 158.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.77 159.68 16.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.748 1.613 . . . . 0.0 106.756 160.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -150.57 -38.86 0.13 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.817 158.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.57 157.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.545 2.338 . . . . 0.0 110.035 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -59.78 -46.77 88.15 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.802 0.841 . . . . 0.0 111.134 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -44.01 73.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.338 -175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.03 -65.22 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 128.326 2.65 . . . . 0.0 112.06 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 75' ' ' MET . 43.3 m-85 -51.09 -45.36 61.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 110.401 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 tp -60.77 -69.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.616 0.644 . . . . 0.0 109.322 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.37 75.08 Favored 'General case' 0 CA--C 1.524 -0.057 0 C-N-CA 124.244 1.018 . . . . 0.0 113.269 -165.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 tp -52.01 -66.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.677 1.191 . . . . 0.0 109.654 -176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.4 ptm . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.74 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.339 0 CA-C-O 121.942 0.877 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.444 -0.773 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.488 -173.526 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 m120 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tp -85.08 9.73 13.98 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 122.032 2.197 . . . . 0.0 111.827 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.96 48.81 0.85 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.251 2.22 . . . . 0.0 110.466 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 129.738 3.215 . . . . 0.0 114.83 178.264 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 119.971 3.323 . . . . 0.0 119.971 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.75 82.88 0.18 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 126.573 2.035 . . . . 0.0 108.16 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -153.42 160.78 42.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.628 1.571 . . . . 0.0 108.449 -166.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -24.97 50.49 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.3 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.35 -10.69 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.378 1.871 . . . . 0.0 114.624 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 1.5 t-20 -51.35 -44.21 61.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.409 0.684 . . . . 0.0 110.943 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -73.39 -38.35 65.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.351 178.446 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' N ' HD13 ' A' ' 11' ' ' LEU . 48.0 t -58.34 -60.78 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 125.005 1.322 . . . . 0.0 109.969 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 16' ' ' ILE . 39.8 m-85 -66.78 -19.63 65.79 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.746 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -75.56 -28.6 59.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.73 ' HG3' HD21 ' A' ' 116' ' ' LEU . 35.7 mm-40 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.533 172.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.784 HD11 ' HE1' ' A' ' 84' ' ' MET . 48.2 mt -68.56 -52.42 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.37 -54.78 12.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 125.176 1.39 . . . . 0.0 109.895 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -44.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.214 1.005 . . . . 0.0 110.944 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -44.96 79.12 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.168 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -35.15 66.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 112.635 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.48 -52.9 55.55 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.78 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.52 -45.69 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.408 -1.433 . . . . 0.0 114.189 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -153.22 64.94 0.76 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.925 1.69 . . . . 0.0 109.461 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.41 70.52 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-O 118.333 -1.259 . . . . 0.0 111.177 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -52.48 -38.09 58.65 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.721 1.26 . . . . 0.0 111.429 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.22 -42.97 44.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.735 1.214 . . . . 0.0 109.225 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -20.81 63.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.598 -0.689 . . . . 0.0 111.442 -176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 55' ' ' LYS . 48.3 t -57.27 -38.9 64.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 119.131 0.878 . . . . 0.0 110.213 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -74.84 -5.03 41.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.884 -1.135 . . . . 0.0 113.103 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -69.27 0.68 Allowed 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.936 1.244 . . . . 0.0 110.353 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.54 -62.97 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.33 9.39 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.728 1.156 . . . . 0.0 113.28 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.97 -169.24 29.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.77 125.89 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 157.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -121.42 172.65 7.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' A' ' 72' ' ' THR . . . -128.03 131.32 49.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.994 1.717 . . . . 0.0 108.578 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -82.05 93.86 7.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -74.71 101.13 4.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.252 1.842 . . . . 0.0 109.834 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG22 ' CE2' ' A' ' 80' ' ' PHE . 89.2 t -104.22 121.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -115.77 179.7 3.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.363 1.465 . . . . 0.0 109.421 162.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t70 54.69 53.86 10.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.391 1.091 . . . . 0.0 112.273 164.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.43 -154.91 10.65 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.534 1.54 . . . . 0.0 109.784 168.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -48.74 114.91 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.236 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.9 -8.07 17.58 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.265 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.27 16.49 62.48 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 120.547 2.173 . . . . 0.0 112.083 169.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -61.66 -175.12 0.05 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.18 1.392 . . . . 0.0 111.007 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -150.47 111.58 4.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.336 -171.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 174.65 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.77 2.028 . . . . 0.0 110.416 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -147.75 149.43 32.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 109.018 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.434 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -116.7 117.12 28.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 166.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.79 128.59 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.517 HG12 HG22 ' A' ' 54' ' ' VAL . 98.2 t -112.07 110.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.63 129.83 34.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -133.16 30.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.603 ' HA ' HG13 ' A' ' 28' ' ' VAL . 3.6 tmtm? -140.09 -25.9 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 120.981 -1.074 . . . . 0.0 112.775 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -84.71 111.67 19.8 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.63 -117.86 7.96 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -85.99 0.34 53.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.157 0.978 . . . . 0.0 112.566 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.23 156.66 3.81 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -157.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.7 m -172.23 149.59 2.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.418 2.287 . . . . 0.0 106.327 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.72 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mt -127.22 81.61 69.68 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 -170.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.12 144.94 65.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.057 1.838 . . . . 0.0 109.728 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 37.47 44.05 0.46 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.308 2.643 . . . . 0.0 111.292 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -85.8 142.74 28.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.693 1.235 . . . . 0.0 109.615 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.26 -17.9 59.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 111.182 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -57.46 133.05 54.87 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -60.96 -175.75 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.998 1.38 . . . . 0.0 109.778 167.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.45 155.49 48.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.152 166.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.41 -27.74 64.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.535 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.7 p -145.62 -175.92 4.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.551 0.74 . . . . 0.0 112.856 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.4 m -136.14 -171.99 3.02 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.474 ' H ' HG22 ' A' ' 72' ' ' THR . 3.6 tt -142.27 175.6 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 161.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.2 m -141.73 137.44 31.66 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 119.335 -2.103 . . . . 0.0 108.373 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.1 ptp -148.65 -28.83 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.528 -1.669 . . . . 0.0 115.217 161.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.43 147.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.972 3.309 . . . . 0.0 110.618 -162.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.99 -47.95 84.06 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 127.215 2.206 . . . . 0.0 110.443 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.8 m -66.43 -11.46 52.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.3 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.93 -40.24 5.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 168.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.649 ' CE2' HG22 ' A' ' 39' ' ' VAL . 3.3 m-85 -47.42 -54.03 12.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.683 1.193 . . . . 0.0 109.987 171.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.47 -62.26 1.44 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.593 1.957 . . . . 0.0 108.383 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.56 -39.94 77.79 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.693 0.797 . . . . 0.0 112.435 -174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -65.75 0.51 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.479 0.712 . . . . 0.0 110.482 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.784 ' HE1' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.38 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.681 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.51 -5.62 20.54 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -166.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -136.82 55.6 1.83 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.221 1.408 . . . . 0.0 107.324 167.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 15' ' ' GLU . 13.5 mt . . . . . 0 C--N 1.35 0.615 0 C-N-CA 125.071 1.348 . . . . 0.0 114.369 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 11.77 0.06 OUTLIER Glycine 0 N--CA 1.466 0.671 0 O-C-N 120.782 -1.199 . . . . 0.0 115.442 -162.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.412 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 1.2 m-30 -80.21 178.51 8.22 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.823 1.249 . . . . 0.0 108.671 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HA ' HD23 ' A' ' 11' ' ' LEU . 23.7 tttm -69.65 -17.92 63.54 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.735 -1.853 . . . . 0.0 111.378 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.37 17.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.265 1.026 . . . . 0.0 112.815 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.6 -40.05 82.11 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.516 1.527 . . . . 0.0 110.275 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 8' ' ' LYS . 1.4 mm? -61.53 -51.89 66.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.307 1.843 . . . . 0.0 109.79 175.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.55 -43.61 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.493 2.317 . . . . 0.0 111.943 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.18 -26.94 61.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.168 0.894 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -71.48 -24.77 62.05 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 118.977 0.808 . . . . 0.0 112.619 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.13 -46.31 91.09 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 165.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.8 -45.44 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.04 -55.22 33.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.824 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -52.48 -50.51 62.57 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -168.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -65.56 -27.11 68.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.666 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -33.45 66.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.075 0.852 . . . . 0.0 112.006 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.17 -52.3 59.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 170.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.58 -45.2 85.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.534 1.134 . . . . 0.0 111.795 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -165.54 62.79 0.11 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.954 0.902 . . . . 0.0 110.897 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.01 -29.18 71.87 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 116.869 -2.073 . . . . 0.0 114.486 -172.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -36.97 3.59 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.99 2.395 . . . . 0.0 112.918 172.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -81.38 -16.84 51.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -93.49 -34.91 13.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.088 1.355 . . . . 0.0 108.212 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.2 -46.09 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 126.151 1.78 . . . . 0.0 109.036 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -64.39 -23.94 67.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.562 1.528 . . . . 0.0 113.776 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -74.13 -29.21 61.71 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.411 -0.806 . . . . 0.0 111.828 -166.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mp -117.36 -49.76 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.557 2.343 . . . . 0.0 110.321 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.19 49.26 58.69 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.861 1.696 . . . . 0.0 116.245 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.55 27.36 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.758 1.779 . . . . 0.0 108.759 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.95 139.14 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 3.6 p90 -127.15 164.55 21.37 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.978 -1.076 . . . . 0.0 109.961 158.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 156.31 21.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 35' ' ' PHE . 6.6 m-85 -114.72 108.34 16.65 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.464 1.506 . . . . 0.0 108.734 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -87.09 95.9 10.11 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -85.09 116.6 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -107.91 176.63 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 119.07 0.85 . . . . 0.0 109.152 162.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t0 46.42 50.79 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.573 1.549 . . . . 0.0 113.776 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 7' ' ' PHE . . . -63.5 165.55 27.94 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.977 167.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.46 98.43 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.656 3.571 . . . . 0.0 112.648 172.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.81 -41.3 1.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.237 1.875 . . . . 0.0 111.765 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.59 -8.35 3.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.701 -1.61 . . . . 0.0 114.574 163.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -67.61 -175.26 0.5 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.191 1.796 . . . . 0.0 112.782 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -125.15 146.23 49.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.935 1.694 . . . . 0.0 111.221 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.93 162.08 34.25 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.716 3.207 . . . . 0.0 106.832 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 m -139.25 148.13 42.64 Favored 'General case' 0 C--O 1.228 -0.053 0 CA-C-N 119.082 0.856 . . . . 0.0 110.059 166.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -117.65 156.81 27.54 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.42 134.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 57.6 t -123.41 112.75 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -91.98 80.28 5.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.43 53.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -146.62 -54.18 0.24 Allowed 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.18 0.992 . . . . 0.0 110.042 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.36 140.45 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.016 0.823 . . . . 0.0 109.586 -164.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.9 -140.9 43.76 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -84.84 -0.1 52.8 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.506 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 157.07 15.97 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 120.795 1.634 . . . . 0.0 111.873 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m -171.77 166.08 6.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.913 3.285 . . . . 0.0 108.87 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.33 93.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 127.941 2.496 . . . . 0.0 107.254 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.9 101.28 0.48 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 127.231 2.212 . . . . 0.0 107.001 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -70.5 131.22 19.77 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.372 2.714 . . . . 0.0 111.308 -166.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 47.24 24.56 0.44 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.317 2.247 . . . . 0.0 112.591 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.54 143.79 40.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -160.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -73.59 -15.79 61.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.575 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -57.92 145.11 36.76 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.708 -1.597 . . . . 0.0 110.429 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.79 -176.18 0.05 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.861 1.315 . . . . 0.0 109.895 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.95 168.06 20.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.638 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -37.48 55.6 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.395 0.678 . . . . 0.0 111.391 171.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m -150.93 -173.14 4.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.084 2.153 . . . . 0.0 109.307 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -133.95 -172.92 3.11 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.062 -1.024 . . . . 0.0 108.736 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -147.44 165.07 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 155.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -126.48 124.29 39.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 165.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.71 136.62 17.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.15 163.59 1.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 168.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.04 -52.01 62.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.057 1.343 . . . . 0.0 111.005 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.66 -33.77 61.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.3 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.87 -35.26 14.88 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.33 2.252 . . . . 0.0 111.381 -169.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.92 -54.77 33.37 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.482 1.113 . . . . 0.0 108.357 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -31.48 68.59 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.555 0.742 . . . . 0.0 110.361 -175.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.55 -41.76 10.21 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.048 1.339 . . . . 0.0 113.727 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.01 -75.51 0.05 Allowed 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -170.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.242 0.663 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.54 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -13.91 32.76 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 171.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -141.69 62.83 1.44 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.042 0.937 . . . . 0.0 109.514 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.329 0.1 OUTLIER . . . . . 0 C--N 1.353 0.753 0 C-N-CA 124.421 1.089 . . . . 0.0 113.596 170.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 123.039 1.4 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.4 84.41 0.36 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 129.349 3.356 . . . . 0.0 108.414 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 34.6 m-85 -152.83 149.74 28.61 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.675 2.39 . . . . 0.0 107.824 -167.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -6.67 51.13 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.846 -1.159 . . . . 0.0 111.782 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.28 -16.46 53.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.883 0.873 . . . . 0.0 112.975 160.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -59.09 -58.41 8.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.844 1.202 . . . . 0.0 111.019 -168.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 11' ' ' LEU 0.279 0.0 OUTLIER -64.77 -31.37 72.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.346 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.36 -55.92 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.813 2.445 . . . . 0.0 110.618 171.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -65.83 -29.34 69.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.683 1.128 . . . . 0.0 111.119 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -70.09 -24.93 63.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.771 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.585 ' HG2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.05 -44.17 73.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 176.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -52.02 -54.33 14.23 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.33 -48.48 78.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.965 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -56.59 -46.85 80.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -66.11 -42.28 89.43 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.69 177.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -32.54 62.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.307 6.5 mm-40 -70.11 -52.31 24.7 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.877 171.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.06 -40.69 96.64 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -161.04 60.44 0.29 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.833 1.253 . . . . 0.0 109.858 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.12 -29.69 70.32 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-O 118.185 -1.341 . . . . 0.0 111.47 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.44 -29.5 24.86 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.838 1.319 . . . . 0.0 112.694 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -79.93 -34.98 38.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.911 -1.118 . . . . 0.0 111.678 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -80.31 -19.46 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.643 1.111 . . . . 0.0 108.997 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.07 -45.59 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.151 0.887 . . . . 0.0 109.467 169.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.49 -17.67 62.34 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -71.53 -65.17 0.79 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.365 -0.834 . . . . 0.0 109.845 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mm -78.32 -56.07 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.0 1.32 . . . . 0.0 108.713 -166.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 50.61 63.29 4.55 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.253 -167.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 173.0 39.55 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 119.376 1.588 . . . . 0.0 111.941 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.19 121.36 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 102.936 -2.986 . . . . 0.0 102.936 159.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -130.42 166.01 21.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 123.659 0.6 . . . . 0.0 109.724 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB1' ' CG2' ' A' ' 49' ' ' THR . . . -129.12 168.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.889 0.852 . . . . 0.0 112.063 173.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.49 98.5 6.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.932 . . . . 0.0 108.529 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -83.9 89.55 7.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.987 0.812 . . . . 0.0 110.904 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.18 124.03 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -115.11 -175.05 2.61 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.899 -1.126 . . . . 0.0 108.728 158.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t0 47.8 58.23 5.23 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 127.236 2.214 . . . . 0.0 111.881 169.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.89 -177.2 4.58 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.393 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -60.23 7.49 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 1 C-N-CA 125.389 4.059 . . . . 0.0 113.188 159.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.71 -31.79 0.3 Allowed Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.282 -1.511 . . . . 0.0 112.075 155.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -2.68 7.61 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 118.805 1.303 . . . . 0.0 114.018 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -62.04 -175.57 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.958 1.379 . . . . 0.0 110.791 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -120.97 165.38 15.33 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 166.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -150.13 164.94 34.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.498 1.919 . . . . 0.0 107.43 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.436 ' CG2' ' HB1' ' A' ' 36' ' ' ALA . 80.0 m -147.07 144.15 28.86 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -115.67 133.05 56.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 103.595 -2.743 . . . . 0.0 103.595 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -101.35 136.16 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.69 117.29 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.63 117.07 28.24 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 165.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.65 51.55 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -133.4 -53.61 0.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.123 0.969 . . . . 0.0 108.824 160.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.79 111.24 13.39 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.03 -151.93 50.66 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 121.673 0.596 . . . . 0.0 111.648 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.02 9.49 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 127.94 2.496 . . . . 0.0 114.205 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.14 157.76 33.9 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.0 m -172.87 158.12 3.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.49 2.316 . . . . 0.0 106.99 152.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.74 160.37 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -141.51 87.57 10.28 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -160.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.53 147.99 18.02 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.012 2.475 . . . . 0.0 109.963 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.53 25.8 3.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.995 1.718 . . . . 0.0 111.468 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -92.41 146.84 23.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.524 1.154 . . . . 0.0 109.377 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.84 -26.7 25.54 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 111.909 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -50.33 120.98 5.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.512 1.125 . . . . 0.0 108.648 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -178.04 1.52 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 122.798 1.285 . . . . 0.0 108.804 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.21 156.65 46.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.507 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.2 -32.57 71.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.733 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.76 173.83 15.89 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.101 1.36 . . . . 0.0 110.619 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 101' ' ' ILE . 5.0 m -155.23 119.98 4.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -172.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 101' ' ' ILE . 15.8 tt -83.96 155.11 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 118.661 0.664 . . . . 0.0 109.449 -173.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.4 m -100.73 126.32 47.27 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 118.203 -0.904 . . . . 0.0 109.245 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.06 126.74 2.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 157.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.08 166.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 0.0 112.149 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -53.0 63.06 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t -65.32 -4.53 5.56 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.307 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.23 -53.96 2.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.141 1.776 . . . . 0.0 108.998 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.77 -56.72 10.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.205 1.82 . . . . 0.0 111.37 171.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 tp -54.16 -51.66 63.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.46 1.504 . . . . 0.0 107.852 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.62 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -66.02 0.88 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.183 0.993 . . . . 0.0 108.965 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 O-C-N 121.351 -0.843 . . . . 0.0 112.464 -171.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 N--CA 1.47 0.539 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.44 -31.78 73.14 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 166.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -123.43 47.56 1.99 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.421 1.888 . . . . 0.0 111.244 -166.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.585 HD22 ' HG2' ' A' ' 15' ' ' GLU 0.351 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.849 0 C-N-CA 128.219 2.608 . . . . 0.0 112.051 -175.215 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t0 . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 122.304 1.05 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.57 20.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.508 1.051 . . . . 0.0 112.711 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -79.89 171.08 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 120.8 -1.412 . . . . 0.0 108.503 169.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -69.82 -19.36 63.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.879 1.218 . . . . 0.0 110.471 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.72 -22.13 3.27 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.146 0.978 . . . . 0.0 112.798 165.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 27.7 t-20 -55.58 -47.26 76.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.608 0.64 . . . . 0.0 110.725 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.28 -38.97 91.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.57 1.148 . . . . 0.0 112.142 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.638 HG13 ' SD ' ' A' ' 84' ' ' MET . 2.6 t -66.15 -57.81 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.192 1.397 . . . . 0.0 109.412 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.95 -23.29 66.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.928 -0.482 . . . . 0.0 111.495 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.25 -48.99 54.46 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.534 ' CB ' HD22 ' A' ' 116' ' ' LEU . 8.8 mm-40 -51.34 -39.09 56.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 118.845 0.748 . . . . 0.0 112.885 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.47 -51.66 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 10.4 tp10 -57.27 -54.33 48.02 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 123.973 0.909 . . . . 0.0 111.783 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -57.3 -38.29 73.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.888 1.222 . . . . 0.0 110.135 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.59 -43.89 71.88 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.605 1.162 . . . . 0.0 110.39 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -38.51 69.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.525 1.53 . . . . 0.0 114.071 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.59 -50.7 68.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.287 -0.863 . . . . 0.0 108.682 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.0 -46.99 85.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.593 1.542 . . . . 0.0 114.749 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -153.66 55.44 0.74 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 123.513 1.625 . . . . 0.0 111.089 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.51 -16.1 80.18 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.078 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -60.34 -40.47 90.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.161 1.481 . . . . 0.0 111.485 -168.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.75 -27.49 50.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.313 -0.867 . . . . 0.0 110.857 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -70.8 -32.99 70.25 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.0 -42.77 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.142 166.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.63 74.48 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.957 -1.09 . . . . 0.0 111.267 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -71.92 -41.99 67.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 117.554 -1.212 . . . . 0.0 113.462 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.3 mp -95.18 -64.21 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 121.911 2.141 . . . . 0.0 107.176 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 77.03 0.28 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.433 1.016 . . . . 0.0 110.671 -169.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.85 145.78 4.2 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 118.312 -1.271 . . . . 0.0 110.636 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -73.37 137.35 23.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -135.28 168.17 19.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 110.155 170.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.57 137.2 52.36 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.534 1.133 . . . . 0.0 109.83 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -88.22 97.2 10.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -74.56 111.94 10.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.532 1.06 . . . . 0.0 109.475 168.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.79 106.79 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.28 177.44 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 159.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.5 t0 55.96 61.45 2.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.065 1.346 . . . . 0.0 111.903 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.55 -160.98 36.19 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.947 1.737 . . . . 0.0 112.442 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.59 4.95 0.39 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 124.567 3.511 . . . . 0.0 114.869 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.74 2.17 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 120.653 -1.279 . . . . 0.0 113.839 164.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.55 5.59 53.87 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 120.515 2.158 . . . . 0.0 113.244 163.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.41 -175.14 0.76 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.174 1.389 . . . . 0.0 109.802 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -118.87 138.0 53.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.098 1.359 . . . . 0.0 108.818 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.56 166.23 12.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.749 1.62 . . . . 0.0 107.64 164.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.0 m -146.35 148.69 32.63 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 160.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -119.64 133.77 55.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.88 114.07 40.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.402 HG22 HG13 ' A' ' 61' ' ' VAL . 59.2 t -92.91 105.12 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.28 116.58 18.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 163.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.25 52.01 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -144.4 -48.98 0.27 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.609 1.164 . . . . 0.0 109.885 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -80.9 126.01 30.83 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -173.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.17 -142.29 44.72 Favored Glycine 0 N--CA 1.439 -1.112 0 O-C-N 121.391 -0.818 . . . . 0.0 111.632 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -82.74 3.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.686 -1.15 . . . . 0.0 112.286 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.25 158.02 27.14 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 120.782 1.628 . . . . 0.0 109.512 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -171.72 137.27 1.0 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.551 2.74 . . . . 0.0 106.565 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 17' ' ' GLU . 3.5 t -76.53 111.64 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -87.0 122.14 71.31 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.78 130.6 10.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 41.49 45.79 2.85 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.339 1.856 . . . . 0.0 113.465 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.98 137.5 58.03 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -9.07 59.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.404 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -57.72 140.76 50.63 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HE2' ' H ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -71.89 -177.03 1.85 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.276 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.13 157.22 45.86 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 125.085 1.354 . . . . 0.0 108.549 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -33.24 67.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 p -153.24 175.72 12.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.454 2.301 . . . . 0.0 109.034 -170.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 73' ' ' ILE . 99.4 m -140.25 -172.73 3.49 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.442 ' N ' HG22 ' A' ' 72' ' ' THR . 0.7 OUTLIER -147.25 152.0 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 159.02 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.5 m -120.47 133.97 55.34 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.4 -38.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.184 1.356 . . . . 0.0 113.439 170.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 96.88 155.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 131.179 3.792 . . . . 0.0 111.516 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -62.72 -44.35 96.46 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.158 0.583 . . . . 0.0 110.571 -173.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -62.97 -21.41 66.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.123 -0.942 . . . . 0.0 111.595 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.28 -67.0 0.82 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 117.884 -1.055 . . . . 0.0 108.537 166.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -49.69 -45.41 48.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.92 1.688 . . . . 0.0 111.97 -168.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tp -59.89 -65.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.96 -36.43 62.84 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.189 0.996 . . . . 0.0 112.34 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.3 tp -48.6 -71.17 0.07 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.507 2.323 . . . . 0.0 109.123 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.638 ' SD ' HG13 ' A' ' 12' ' ' VAL . 10.1 ptp . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 pttt . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 164.225 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.443 HD13 ' CD1' ' A' ' 27' ' ' PHE . 9.0 tp -83.82 3.98 31.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.715 1.143 . . . . 0.0 110.021 169.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -139.42 45.27 1.95 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.529 2.331 . . . . 0.0 108.249 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 84' ' ' MET 0.379 0.1 OUTLIER . . . . . 0 C--O 1.238 0.462 0 C-N-CA 125.617 1.567 . . . . 0.0 113.389 174.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -65.14 143.09 58.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.454 0.57 . . . . 0.0 109.571 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.8 67.34 1.02 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.124 1.77 . . . . 0.0 110.9 -167.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.4 m -95.2 -82.59 0.37 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.665 1.986 . . . . 0.0 109.885 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.53 23.56 5.93 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.593 0.711 . . . . 0.0 112.099 163.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.55 82.49 0.34 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -169.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 98.0 m-85 -153.22 140.02 19.03 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.815 1.246 . . . . 0.0 107.743 -166.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -59.24 -29.58 67.64 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.899 0.318 . . . . 0.0 110.963 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.61 -11.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.527 1.931 . . . . 0.0 114.74 169.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.432 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 19.8 t-20 -57.69 -36.93 72.63 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 120.279 1.399 . . . . 0.0 111.677 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.637 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -72.79 -38.24 67.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.158 172.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG13 ' HG3' ' A' ' 84' ' ' MET . 2.4 t -56.04 -46.11 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.911 1.284 . . . . 0.0 110.868 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 16' ' ' ILE . 72.1 m-85 -68.65 -24.64 64.56 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.175 -0.328 . . . . 0.0 111.822 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -75.22 -27.15 59.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 121.292 -0.88 . . . . 0.0 111.62 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.88 -46.46 89.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.229 0.468 . . . . 0.0 110.349 169.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 13' ' ' PHE . 64.8 mt -59.46 -48.72 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.499 1.12 . . . . 0.0 108.158 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -55.75 -43.09 76.34 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.466 0.706 . . . . 0.0 111.342 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.45 -47.46 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -57.42 -45.48 84.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.568 172.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -42.45 76.98 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.84 -53.23 53.96 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.083 0.953 . . . . 0.0 110.984 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.14 -45.57 92.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 119.214 0.915 . . . . 0.0 111.947 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -161.97 58.19 0.25 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.431 1.092 . . . . 0.0 111.669 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.57 -12.99 43.12 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 120.015 -1.678 . . . . 0.0 113.213 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.85 -40.47 63.42 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.256 1.528 . . . . 0.0 111.828 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.06 -26.65 43.07 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.913 -1.117 . . . . 0.0 112.294 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.2 m-85 -74.98 -33.68 61.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.037 1.335 . . . . 0.0 108.571 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -54.94 -52.68 41.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -59.53 -14.25 12.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -85.82 -42.06 14.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.98 1.718 . . . . 0.0 111.977 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.23 -59.49 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.72 65.58 2.82 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 124.286 0.946 . . . . 0.0 111.451 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.74 171.51 43.32 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.15 132.33 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 157.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.48 166.93 18.63 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.363 0.602 . . . . 0.0 111.651 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.19 145.3 38.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.584 1.154 . . . . 0.0 108.898 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -94.67 93.49 7.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.737 1.215 . . . . 0.0 108.451 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -77.62 109.39 11.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.652 1.115 . . . . 0.0 109.444 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG22 ' CE2' ' A' ' 80' ' ' PHE . 2.9 t -118.22 104.95 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.63 -179.64 5.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.42 1.088 . . . . 0.0 108.208 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t0 58.76 48.13 11.84 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.58 1.152 . . . . 0.0 113.479 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.8 -173.79 11.85 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.998 1.285 . . . . 0.0 115.373 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.95 78.1 0.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.588 2.859 . . . . 0.0 108.62 161.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.38 -17.63 4.49 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.367 1.937 . . . . 0.0 112.794 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.72 -11.57 68.1 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 126.013 1.768 . . . . 0.0 112.471 170.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.13 -176.46 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.057 1.743 . . . . 0.0 110.675 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.28 152.46 51.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 112.315 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HB2' ' CD2' ' A' ' 7' ' ' PHE . . . -119.11 174.94 6.03 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.345 2.258 . . . . 0.0 107.977 174.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.9 m -147.73 153.89 39.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 147.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.432 ' CH2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -120.74 136.97 54.73 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 162.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.59 144.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.8 113.52 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.23 112.15 18.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 164.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.23 48.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 167.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -137.07 -50.16 0.64 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.034 0.934 . . . . 0.0 110.236 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -79.87 131.11 35.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 -122.7 14.37 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.418 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 8.25 28.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.769 1.628 . . . . 0.0 110.751 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.53 158.7 30.6 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.841 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -171.14 147.63 2.58 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.865 2.466 . . . . 0.0 109.585 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -80.87 153.9 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 mt -136.43 86.19 24.39 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -169.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.45 142.22 48.7 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.609 1.54 . . . . 0.0 109.768 -174.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 45.75 34.95 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 129.278 3.031 . . . . 0.0 111.955 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.8 152.67 25.57 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.622 0.769 . . . . 0.0 110.578 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 -3.92 59.02 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.266 1.026 . . . . 0.0 111.178 161.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.97 128.95 22.68 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -73.92 -176.76 2.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.16 141.58 30.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.362 1.865 . . . . 0.0 108.092 -172.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.75 -29.17 58.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 m -150.41 165.27 33.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.013 1.725 . . . . 0.0 108.348 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.558 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 86.5 m -147.26 119.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.16 -0.962 . . . . 0.0 108.962 -170.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.94 138.46 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.9 m -108.99 131.21 55.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.022 1.283 . . . . 0.0 107.739 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -139.88 -101.22 0.16 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 161.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.08 159.06 0.15 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.503 3.121 . . . . 0.0 106.873 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.3 -48.87 79.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.73 0.812 . . . . 0.0 111.861 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -71.31 1.45 6.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.052 1.341 . . . . 0.0 111.188 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -105.3 -44.55 4.71 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.924 -1.11 . . . . 0.0 112.856 158.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CE2' HG22 ' A' ' 39' ' ' VAL . 3.8 m-85 -60.04 -60.79 3.27 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.223 1.409 . . . . 0.0 111.184 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tp -44.5 -61.22 1.62 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.477 1.111 . . . . 0.0 109.304 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.77 -18.2 29.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.792 -172.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 90' ' ' PRO . 3.1 tt -67.13 -68.69 0.36 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.477 1.111 . . . . 0.0 110.675 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.419 ' HG3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -74.79 -21.94 59.02 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.501 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.2 m -74.57 -19.51 60.3 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.685 -1.259 . . . . 0.0 111.003 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.15 36.76 90.75 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.666 1.121 . . . . 0.0 112.158 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -69.1 -36.17 77.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.421 1.11 . . . . 0.0 111.462 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 18.3 mtt -163.44 160.44 23.39 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.634 2.774 . . . . 0.0 106.233 166.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -36.89 99.4 0.18 Allowed Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 127.147 2.179 . . . . 0.0 111.554 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG3' ' HA ' ' A' ' 83' ' ' LEU . 66.6 Cg_endo -85.43 116.5 1.7 Allowed 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 123.364 2.709 . . . . 0.0 110.74 -162.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -166.64 71.12 0.12 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.48 0.712 . . . . 0.0 111.397 -171.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.4 t -59.2 -33.3 70.8 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.734 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.574 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . . . -51.93 -87.88 0.0 OUTLIER 'General case' 0 C--N 1.353 0.721 0 CA-C-N 120.207 1.367 . . . . 0.0 112.819 162.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.2 t80 33.89 -135.14 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.501 2.32 . . . . 0.0 112.753 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -7.68 59.63 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.467 1.507 . . . . 0.0 113.007 175.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -66.05 -39.8 90.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.936 1.244 . . . . 0.0 108.416 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.12 49.54 21.14 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 123.828 0.728 . . . . 0.0 111.938 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -63.09 -9.0 8.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 117.873 -1.06 . . . . 0.0 113.705 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.1 tp 54.32 45.2 27.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 122.012 0.911 . . . . 0.0 108.751 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -64.74 124.33 21.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.558 ' CG2' ' H ' ' A' ' 72' ' ' THR . 1.2 mp -73.74 166.99 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.288 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -154.83 138.8 16.36 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.922 1.289 . . . . 0.0 107.571 -171.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.37 -15.28 66.79 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.134 -1.37 . . . . 0.0 113.603 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 174.88 -172.34 0.06 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.291 3.036 . . . . 0.0 106.841 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.2 mtp -65.69 -166.79 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.531 1.532 . . . . 0.0 111.214 158.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.88 -63.29 4.09 Favored Glycine 0 C--N 1.338 0.677 0 O-C-N 120.58 -1.325 . . . . 0.0 110.224 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 pp -52.96 -13.34 0.42 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.407 1.883 . . . . 0.0 115.759 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.58 -73.65 0.21 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.978 1.263 . . . . 0.0 110.319 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -159.19 48.21 0.31 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.002 1.273 . . . . 0.0 111.039 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -72.88 -8.11 54.04 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.723 -1.235 . . . . 0.0 113.243 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -165.06 -164.92 0.82 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.451 1.9 . . . . 0.0 108.443 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.9 -30.96 6.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.258 1.023 . . . . 0.0 113.307 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -68.47 -14.1 62.77 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.373 -1.454 . . . . 0.0 113.714 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.476 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -73.11 -3.85 28.97 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 169.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -150.13 44.74 0.89 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.176 1.79 . . . . 0.0 111.393 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.6 mt 50.22 159.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 128.174 2.59 . . . . 0.0 116.018 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.15 130.01 90.06 Favored Pre-proline 0 C--O 1.235 0.338 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.43 164.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.32 174.44 11.97 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.596 2.197 . . . . 0.0 111.123 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.87 83.26 0.15 Allowed Glycine 0 C--N 1.333 0.396 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -168.23 126.94 1.18 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.783 1.233 . . . . 0.0 108.591 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.73 104.19 11.09 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 168.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -80.97 98.82 8.1 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.653 0.781 . . . . 0.0 110.6 -171.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tp . . . . . 0 C--O 1.247 0.951 0 C-N-CA 126.403 1.881 . . . . 0.0 110.252 -168.624 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.0 m -165.89 112.84 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.514 1.126 . . . . 0.0 110.755 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.84 49.38 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.125 1.77 . . . . 0.0 110.328 151.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 t -95.42 -16.38 22.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -169.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.49 24.96 3.27 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 155.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.02 78.06 0.28 Allowed Glycine 0 C--N 1.336 0.544 0 O-C-N 120.67 -1.269 . . . . 0.0 113.088 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -153.68 160.69 42.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.629 1.572 . . . . 0.0 110.263 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm -65.48 -9.56 26.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.81 -6.24 5.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.994 0.815 . . . . 0.0 113.144 166.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.11 -37.93 81.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.681 1.128 . . . . 0.0 112.342 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -69.53 -37.88 77.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.701 1.201 . . . . 0.0 110.734 174.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.648 HG13 ' SD ' ' A' ' 84' ' ' MET . 0.9 OUTLIER -58.84 -52.71 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.627 1.571 . . . . 0.0 111.228 -175.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 67.4 m-85 -70.15 -21.63 63.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.015 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -75.06 -27.5 60.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.774 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.509 ' CB ' HD22 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -55.71 -49.46 72.96 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.353 1.433 . . . . 0.0 110.596 171.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mt -53.56 -47.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.42 1.088 . . . . 0.0 108.204 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -61.21 -53.39 57.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.634 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -51.76 -53.72 36.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.766 1.166 . . . . 0.0 108.42 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -57.12 -46.58 82.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.974 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -35.48 68.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -70.18 -52.24 24.95 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.27 -44.42 95.33 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.347 2.259 . . . . 0.0 112.763 -171.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -154.76 55.16 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.739 1.616 . . . . 0.0 111.072 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.31 -30.93 56.22 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-O 117.741 -1.589 . . . . 0.0 113.529 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.75 -38.91 67.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.898 1.849 . . . . 0.0 111.118 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -81.07 -19.26 44.14 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.279 -0.888 . . . . 0.0 112.429 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.42 -31.5 20.03 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 109.929 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.37 -55.03 6.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 126.682 1.993 . . . . 0.0 108.252 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -61.77 -16.0 45.97 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -79.68 -58.85 2.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.716 0.806 . . . . 0.0 110.52 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.45 -63.46 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.961 1.704 . . . . 0.0 107.155 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.66 72.39 0.69 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.243 1.402 . . . . 0.0 112.32 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.25 153.7 6.46 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.525 -1.153 . . . . 0.0 110.767 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.99 134.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -128.41 162.94 25.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.712 0.768 . . . . 0.0 109.131 162.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.59 157.72 22.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.561 164.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -105.79 96.29 6.39 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.322 1.449 . . . . 0.0 109.469 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.77 108.95 7.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.317 -1.489 . . . . 0.0 109.799 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG22 ' CE1' ' A' ' 80' ' ' PHE . 21.9 t -124.93 94.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 174.45 7.11 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 61.57 40.69 13.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 0.0 111.917 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -61.16 173.08 6.65 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.396 0.998 . . . . 0.0 113.52 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.01 86.61 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.009 2.473 . . . . 0.0 107.085 166.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.81 -57.98 0.41 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -163.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.96 -23.87 7.63 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 125.945 1.736 . . . . 0.0 110.483 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -71.58 -172.48 0.79 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 111.221 168.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.58 149.03 50.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.934 1.694 . . . . 0.0 113.666 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.42 167.14 10.58 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.367 2.267 . . . . 0.0 109.966 166.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.9 m -155.23 114.59 3.64 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.005 0.907 . . . . 0.0 109.854 150.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -88.46 162.35 16.52 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 168.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.88 145.33 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.71 109.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.54 122.57 29.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.5 50.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 126.136 1.775 . . . . 0.0 106.961 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -40.5 0.07 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.401 1.08 . . . . 0.0 110.279 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -95.2 131.54 41.13 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 -145.24 42.72 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -83.16 8.29 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.455 -1.259 . . . . 0.0 113.744 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.78 156.77 8.66 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 120.586 1.539 . . . . 0.0 110.579 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -171.28 144.6 2.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.96 2.104 . . . . 0.0 108.524 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.4 t -74.56 152.05 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 168.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.37 88.6 12.69 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 127.843 2.457 . . . . 0.0 104.501 -164.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.39 138.94 62.76 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.587 1.525 . . . . 0.0 109.479 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 54.49 24.09 5.04 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.301 1.841 . . . . 0.0 112.742 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 t -76.77 145.31 38.64 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.915 0.864 . . . . 0.0 111.424 -159.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.37 -11.12 55.3 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.264 2.226 . . . . 0.0 112.64 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -66.11 164.84 14.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.681 0.673 . . . . 0.0 109.541 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -169.91 0.94 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.51 -0.744 . . . . 0.0 110.106 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.9 178.28 7.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.257 1.423 . . . . 0.0 107.767 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.1 -52.14 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 159.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -149.05 -172.78 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.563 1.545 . . . . 0.0 110.985 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -129.31 178.83 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 tt -125.24 178.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 159.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.6 m -125.29 161.97 25.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 160.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -50.01 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 158.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.08 161.41 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 130.912 3.685 . . . . 0.0 109.961 -166.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 16.6 t70 -62.37 -56.06 22.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.025 -169.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.81 -34.24 62.5 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 125.6 1.812 . . . . 0.0 108.781 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -58.39 5.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 111.626 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.706 ' CE1' HG22 ' A' ' 39' ' ' VAL . 11.9 m-85 -53.97 -50.7 65.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.196 0.598 . . . . 0.0 109.968 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -26.98 66.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.036 1.734 . . . . 0.0 112.519 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.12 -25.93 55.86 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.286 0.948 . . . . 0.0 112.782 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.68 -72.54 0.2 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.654 ' SD ' HD21 ' A' ' 116' ' ' LEU . 11.9 ptp -76.51 53.25 0.85 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.015 1.326 . . . . 0.0 113.581 -171.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.2 p -155.76 -17.45 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 129.177 2.991 . . . . 0.0 110.082 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.14 37.34 91.41 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -164.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -99.4 22.94 9.95 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.509 1.655 . . . . 0.0 110.223 171.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.24 98.77 0.05 OUTLIER 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.521 1.929 . . . . 0.0 111.683 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -139.05 68.4 41.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 O-C-N 121.87 -0.519 . . . . 0.0 112.134 167.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -68.77 77.12 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 125.111 3.874 . . . . 0.0 112.072 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 56.69 37.98 29.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.911 1.285 . . . . 0.0 112.298 170.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.1 t -53.58 -17.69 2.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.757 1.623 . . . . 0.0 112.596 174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 100' ' ' LYS . . . -53.01 -28.72 25.39 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.697 1.599 . . . . 0.0 112.682 169.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.61 -66.59 0.86 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.174 0.99 . . . . 0.0 108.955 166.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -50.02 -51.52 41.42 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.736 1.615 . . . . 0.0 112.049 -163.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -67.48 -8.92 37.35 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.85 30.69 46.71 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 119.575 1.079 . . . . 0.0 111.135 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -93.81 -4.51 50.06 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.229 1.514 . . . . 0.0 113.123 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.5 tp 54.49 84.79 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.364 2.265 . . . . 0.0 113.657 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -65.04 168.15 6.93 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.0 mm -132.3 -172.16 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -97.4 153.94 17.78 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 119.991 -1.693 . . . . 0.0 109.876 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -163.61 -7.75 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.748 -1.029 . . . . 0.0 114.403 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -164.53 -95.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 158.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 40.3 ttm -150.95 -105.48 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.297 0.953 . . . . 0.0 109.618 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.34 48.25 3.76 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 125.847 1.689 . . . . 0.0 110.371 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.33 -10.58 59.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.365 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.4 67.26 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.508 1.049 . . . . 0.0 112.445 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -100.45 -31.74 11.15 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -165.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -76.11 42.54 0.26 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 119.763 -1.836 . . . . 0.0 112.515 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.4 pt? -69.87 -14.17 62.61 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 119.872 -1.767 . . . . 0.0 113.068 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 112' ' ' GLN . 11.6 mm-40 -35.53 -80.77 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.609 2.364 . . . . 0.0 115.272 -171.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -95.85 -48.12 5.87 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.559 1.143 . . . . 0.0 110.533 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.83 -17.36 55.99 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.668 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -127.38 45.68 2.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.091 1.314 . . . . 0.0 109.785 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.654 HD21 ' SD ' ' A' ' 84' ' ' MET 0.308 0.2 OUTLIER 46.68 156.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 1 C-N-CA 132.041 4.136 . . . . 0.0 115.964 170.993 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.78 135.58 59.51 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 120.611 -1.305 . . . . 0.0 110.901 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.45 -176.73 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.271 3.314 . . . . 0.0 113.307 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.91 147.41 22.31 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.993 1.759 . . . . 0.0 109.671 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.08 88.15 0.08 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.128 1.771 . . . . 0.0 109.678 -162.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.27 -60.74 2.99 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.556 1.542 . . . . 0.0 110.85 -172.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -162.3 108.19 1.25 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 103.36 -2.829 . . . . 0.0 103.36 156.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 C--O 1.249 1.057 0 O-C-N 124.473 1.108 . . . . 0.0 109.699 -172.139 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 m -54.44 -60.05 3.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.385 1.074 . . . . 0.0 112.392 -168.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 34.44 57.39 0.68 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.371 2.268 . . . . 0.0 112.687 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.8 m -143.36 -156.65 0.7 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.341 1.456 . . . . 0.0 107.685 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 45.34 22.44 0.09 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.15 65.87 0.24 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 126.578 2.037 . . . . 0.0 109.731 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.685 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 10.2 m-85 -154.07 167.74 28.8 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.694 2.398 . . . . 0.0 107.283 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -62.33 -30.01 70.86 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.079 -0.388 . . . . 0.0 110.515 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.06 -28.13 0.67 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 128.218 2.607 . . . . 0.0 114.885 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.81 -44.1 73.51 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 123.789 0.835 . . . . 0.0 109.859 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.19 -42.7 99.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.683 1.593 . . . . 0.0 110.028 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -81.96 -51.22 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.593 1.557 . . . . 0.0 111.246 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 16' ' ' ILE . 33.8 m-85 -64.36 -23.32 67.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.056 0.844 . . . . 0.0 110.733 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -71.53 -36.4 70.99 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.846 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.804 ' HG3' HD21 ' A' ' 116' ' ' LEU . 34.1 mm-40 -55.43 -39.87 70.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 119.902 1.228 . . . . 0.0 112.32 172.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 13' ' ' PHE . 62.7 mt -62.43 -48.98 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 61' ' ' VAL . 16.9 tt0 -56.23 -53.84 52.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.016 1.326 . . . . 0.0 111.068 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -51.74 28.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.824 1.65 . . . . 0.0 109.092 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -59.26 -48.04 83.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.053 0.541 . . . . 0.0 111.211 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -36.09 68.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.13 -52.13 38.31 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.765 -1.209 . . . . 0.0 108.646 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.35 -47.11 82.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 110.569 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -165.35 64.7 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.411 1.084 . . . . 0.0 111.459 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.75 -15.01 81.78 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.46 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.82 -40.21 60.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.896 1.348 . . . . 0.0 111.994 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -17.99 49.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.654 0.782 . . . . 0.0 112.159 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -14.62 26.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.05 -62.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 126.733 2.013 . . . . 0.0 106.425 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -58.27 -18.71 28.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -66.3 -50.67 62.88 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.53 -53.19 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.45 47.63 76.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.361 0.981 . . . . 0.0 112.674 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.22 171.03 39.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.76 134.01 30.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 159.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -128.34 177.91 6.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.957 0.798 . . . . 0.0 109.211 163.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.42 51.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.412 0.685 . . . . 0.0 109.937 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 39' ' ' VAL . 69.5 m-85 -103.58 101.76 11.64 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.556 1.142 . . . . 0.0 107.997 175.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 106.84 6.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 121.092 1.769 . . . . 0.0 108.533 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.71 HG22 ' CE2' ' A' ' 80' ' ' PHE . 76.3 t -122.43 99.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -166.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -111.05 176.94 4.82 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 121.038 -1.039 . . . . 0.0 108.57 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.9 t0 60.24 60.02 2.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.476 1.91 . . . . 0.0 112.022 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.43 -167.29 32.56 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.83 1.681 . . . . 0.0 111.815 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.31 67.71 6.13 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.797 2.998 . . . . 0.0 109.644 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 -43.69 0.39 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.215 1.388 . . . . 0.0 110.636 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.64 -0.18 45.98 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.032 1.301 . . . . 0.0 112.369 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -65.84 -175.13 0.27 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.11 1.364 . . . . 0.0 111.576 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -132.3 132.75 43.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.221 1.008 . . . . 0.0 111.019 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.685 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -114.76 165.29 12.97 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.343 2.657 . . . . 0.0 107.304 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 37' ' ' PHE . 26.5 m -148.38 117.64 6.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 155.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 13' ' ' PHE . 1.2 m-90 -83.69 128.02 34.21 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 165.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.92 146.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.86 104.84 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.78 106.4 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.11 47.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -129.25 -54.5 1.19 Allowed 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.319 0.647 . . . . 0.0 109.643 165.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -93.35 140.51 29.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -158.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 -124.54 11.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.23 5.76 35.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.523 1.529 . . . . 0.0 112.116 164.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.01 156.98 9.15 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -171.37 153.53 3.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.916 2.486 . . . . 0.0 107.832 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 17' ' ' GLU . 3.4 t -101.66 114.86 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -173.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.75 117.44 59.78 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -169.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.01 140.12 15.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 -171.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 45.39 29.37 0.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.347 1.859 . . . . 0.0 114.057 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -64.83 141.37 58.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.156 0.889 . . . . 0.0 110.569 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.52 -20.19 60.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.412 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -54.51 126.7 24.63 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -63.16 -176.97 0.15 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.155 0.982 . . . . 0.0 110.034 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.95 159.19 42.74 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.098 1.359 . . . . 0.0 111.113 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -54.37 47.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.133 0.968 . . . . 0.0 109.191 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.0 m -146.41 169.8 18.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.366 2.266 . . . . 0.0 107.387 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 73' ' ' ILE . 10.3 m -114.32 -164.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.581 ' H ' HG22 ' A' ' 72' ' ' THR . 3.9 tt -148.93 178.1 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.495 -1.378 . . . . 0.0 108.13 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.7 m -143.11 138.81 30.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.856 1.662 . . . . 0.0 109.092 167.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -134.99 -12.56 2.2 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.7 143.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.348 2.659 . . . . 0.0 111.588 -146.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.7 -45.61 67.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 126.877 2.071 . . . . 0.0 112.376 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -54.43 -44.99 72.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.858 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.17 -51.24 56.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.717 1.207 . . . . 0.0 110.877 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.71 ' CE2' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -50.48 -50.99 51.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.392 2.277 . . . . 0.0 111.433 178.081 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.7 tp -53.8 -64.64 0.76 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.985 1.714 . . . . 0.0 108.633 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 87' ' ' LYS . . . -50.21 -42.4 51.43 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.872 1.269 . . . . 0.0 111.385 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.72 -68.51 0.18 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.727 1.611 . . . . 0.0 109.912 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.551 ' HE2' HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -75.47 -25.15 57.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.9 m -73.64 -11.33 60.38 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.005 0.82 . . . . 0.0 110.238 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.62 33.83 3.01 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.305 0.955 . . . . 0.0 112.033 163.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 7.8 tmtt? -106.4 -29.39 9.75 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.069 -168.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 14.7 ptm -154.35 179.16 9.25 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.817 1.19 . . . . 0.0 111.873 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -46.27 140.87 5.09 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.909 2.084 . . . . 0.0 111.1 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.11 43.12 1.23 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.92 3.08 . . . . 0.0 112.923 -176.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -158.79 78.21 0.77 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.217 1.407 . . . . 0.0 109.384 -171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -25.35 63.65 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.0 -89.76 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.341 166.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.1 t80 48.05 -153.63 0.09 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.004 1.275 . . . . 0.0 112.196 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -63.0 -3.46 1.67 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.038 2.135 . . . . 0.0 113.665 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -78.92 -104.06 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.7 1.591 . . . . 0.0 107.961 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.14 28.27 0.02 OUTLIER Glycine 0 CA--C 1.531 1.048 0 N-CA-C 116.701 1.44 . . . . 0.0 116.701 -170.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -64.91 7.0 0.19 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 121.061 2.43 . . . . 0.0 115.394 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.6 tp 35.03 60.75 0.65 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.703 2.001 . . . . 0.0 109.89 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 160.33 28.58 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.51 ' H ' ' HA ' ' A' ' 73' ' ' ILE . 3.1 mp -100.09 169.82 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.9 p -75.04 -170.82 1.2 Allowed 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.198 -1.564 . . . . 0.0 110.484 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.39 -104.87 0.19 Allowed Glycine 0 C--N 1.337 0.614 0 O-C-N 119.483 -2.011 . . . . 0.0 112.369 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -147.41 -94.04 0.08 Allowed 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.64 1.176 . . . . 0.0 108.041 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.4 ttt -150.19 155.79 40.42 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.499 1.045 . . . . 0.0 110.92 -164.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.02 -83.63 1.61 Allowed Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 mt 49.72 -79.33 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.828 2.851 . . . . 0.0 113.971 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.45 -17.24 62.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.556 1.142 . . . . 0.0 112.063 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.4 ttt -133.48 31.21 3.75 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.176 1.79 . . . . 0.0 109.47 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.439 ' HE2' ' CG ' ' A' ' 115' ' ' GLN . 3.3 pttt -68.94 44.92 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.175 2.59 . . . . 0.0 115.13 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.37 -176.64 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.362 2.665 . . . . 0.0 113.377 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -86.51 -56.96 3.18 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -63.91 -2.94 2.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -170.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -92.7 8.36 39.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.66 2.027 . . . . 0.0 110.493 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.439 ' CG ' ' HE2' ' A' ' 110' ' ' LYS . 30.4 mt-30 -153.9 44.69 0.58 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.658 2.783 . . . . 0.0 110.4 -172.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.804 HD21 ' HG3' ' A' ' 15' ' ' GLU . 84.0 mt 50.48 -177.08 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 123.818 1.77 . . . . 0.0 115.44 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -134.76 169.81 12.88 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 125.87 1.668 . . . . 0.0 107.174 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -78.2 176.35 10.05 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.527 2.151 . . . . 0.0 110.054 167.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.02 70.9 0.78 Allowed Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.867 1.222 . . . . 0.0 111.735 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -144.58 152.31 40.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.935 0.868 . . . . 0.0 108.809 171.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 53.18 90.85 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.479 1.912 . . . . 0.0 111.576 -166.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -141.9 166.51 24.52 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.426 1.091 . . . . 0.0 109.555 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.979 2.112 . . . . 0.0 110.516 -170.818 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.4 m -55.2 155.56 4.78 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.812 1.187 . . . . 0.0 109.759 162.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.99 163.4 14.7 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.84 0.856 . . . . 0.0 109.843 170.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.0 p -144.9 -26.92 0.49 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.29 22.54 2.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.018 1.727 . . . . 0.0 115.41 161.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.46 16.37 26.76 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 120.4 -1.438 . . . . 0.0 112.533 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.2 173.33 10.48 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.863 1.265 . . . . 0.0 109.905 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 49.1 mttp -74.76 -5.56 44.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.247 169.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.41 -23.04 62.28 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.764 1.225 . . . . 0.0 113.021 167.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -57.01 -52.71 64.17 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.078 0.854 . . . . 0.0 111.232 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -68.8 -32.47 72.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.239 0.616 . . . . 0.0 111.154 178.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.35 -54.59 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.078 0.951 . . . . 0.0 110.755 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -64.53 -27.14 68.76 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.606 0.639 . . . . 0.0 110.646 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.09 -30.51 65.17 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.077 -1.015 . . . . 0.0 112.701 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.498 ' HG3' HD21 ' A' ' 116' ' ' LEU . 29.8 mm-40 -59.8 -31.92 70.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 119.301 0.955 . . . . 0.0 112.081 172.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.0 mt -75.0 -46.56 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -50.86 -50.25 57.34 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.68 1.192 . . . . 0.0 111.306 172.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -58.35 -38.57 77.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.92 0.782 . . . . 0.0 109.942 -166.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -65.06 -47.92 75.63 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 173.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -35.16 65.52 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.048 0.939 . . . . 0.0 112.444 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.2 -53.15 40.81 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.831 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.35 -45.43 91.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.33 0.968 . . . . 0.0 112.686 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -155.72 58.48 0.61 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.746 1.26 . . . . 0.0 110.841 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.79 86.3 Favored Glycine 0 C--O 1.219 -0.79 0 CA-C-O 118.569 -1.129 . . . . 0.0 111.844 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.94 -40.14 42.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.357 1.578 . . . . 0.0 112.581 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -84.37 -18.68 35.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.359 -0.838 . . . . 0.0 111.778 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.94 -38.7 19.02 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.502 1.921 . . . . 0.0 109.246 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 54' ' ' VAL . 9.3 t -54.07 -46.3 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 127.637 2.375 . . . . 0.0 108.755 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.54 -13.02 7.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -92.74 -63.09 1.27 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 120.077 1.308 . . . . 0.0 110.577 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.89 -38.36 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.2 1.0 . . . . 0.0 110.469 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 47.85 59.03 6.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.428 1.489 . . . . 0.0 112.526 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.49 -176.79 39.62 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.272 1.536 . . . . 0.0 110.509 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.6 131.77 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 159.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -121.98 167.26 13.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 111.939 166.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.8 146.02 34.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.832 1.653 . . . . 0.0 108.997 164.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -95.42 100.3 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -77.09 99.56 5.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.049 1.295 . . . . 0.0 109.059 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.12 133.81 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 170.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.48 175.46 5.51 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.607 -1.308 . . . . 0.0 108.706 154.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 55.42 52.52 11.17 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.112 160.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.01 174.74 20.07 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.425 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.8 6.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.455 3.437 . . . . 0.0 115.088 169.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.58 -22.06 1.89 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.403 1.478 . . . . 0.0 114.052 163.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.68 -13.43 17.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 119.515 1.657 . . . . 0.0 111.792 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -66.16 -175.5 0.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.938 1.695 . . . . 0.0 111.177 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.87 167.09 13.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.466 1.506 . . . . 0.0 110.225 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.45 173.37 12.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.547 1.939 . . . . 0.0 107.109 169.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 84.3 m -143.91 143.99 31.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 161.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.41 137.09 49.64 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 161.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.48 144.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.51 107.95 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -75.39 124.5 27.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.586 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -139.67 44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 105.852 -1.906 . . . . 0.0 105.852 172.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -134.5 -46.0 0.75 Allowed 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 125.09 1.356 . . . . 0.0 110.107 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -92.28 103.21 15.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -159.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.34 -113.83 4.51 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.278 -0.889 . . . . 0.0 111.638 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -84.81 -5.72 59.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.073 0.949 . . . . 0.0 112.757 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.75 -97.49 0.72 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 128.722 3.058 . . . . 0.0 110.383 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.7 m 98.89 151.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 1 C-N-CA 135.548 5.539 . . . . 0.0 111.733 -172.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.75 148.64 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 163.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.33 122.5 19.06 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.15 138.52 16.23 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 -177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.64 24.54 3.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.562 1.945 . . . . 0.0 111.958 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 t -74.65 144.76 43.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.264 1.031 . . . . 0.0 111.064 -153.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.4 7.08 23.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 111.882 164.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 tttm -61.99 129.29 40.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 153.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -68.06 -176.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.24 156.45 47.07 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.565 1.546 . . . . 0.0 109.286 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.31 -45.15 41.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.681 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -134.22 177.3 7.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.363 0.665 . . . . 0.0 110.887 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -138.81 -177.78 5.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.475 1.51 . . . . 0.0 107.688 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.27 152.93 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 119.543 -1.973 . . . . 0.0 105.694 166.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.7 m -108.24 122.74 47.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.409 1.459 . . . . 0.0 112.185 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.7 mtm -156.6 119.24 4.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.4 165.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.643 163.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.09 -54.4 45.47 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 121.256 -0.902 . . . . 0.0 109.817 163.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.9 1.69 1.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.839 1.256 . . . . 0.0 112.305 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.0 -63.38 1.13 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.466 2.306 . . . . 0.0 108.613 164.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -60.94 -40.01 91.63 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.327 2.251 . . . . 0.0 113.503 -174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -35.37 71.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.934 1.293 . . . . 0.0 110.038 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.28 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.733 1.213 . . . . 0.0 110.674 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 tt -46.83 -75.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.82 2.448 . . . . 0.0 109.717 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.02 54.43 0.85 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.851 0.86 . . . . 0.0 112.992 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 p -137.81 -5.07 1.74 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.488 1.115 . . . . 0.0 112.267 155.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.0 73.45 1.0 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -168.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -140.7 -21.63 0.81 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.021 -0.693 . . . . 0.0 111.952 175.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 ptm -136.36 87.45 2.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -62.25 -55.61 38.67 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.871 -1.062 . . . . 0.0 109.715 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.03 148.19 75.24 Favored 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-N 121.371 1.525 . . . . 0.0 110.252 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -56.2 112.98 1.37 Allowed 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.324 0.65 . . . . 0.0 109.643 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -54.77 -48.26 72.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.175 0.99 . . . . 0.0 111.696 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -65.26 -40.55 94.1 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 121.482 1.947 . . . . 0.0 113.186 -170.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.9 -47.39 80.78 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 173.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -58.33 -58.95 6.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.239 1.816 . . . . 0.0 111.978 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -68.53 -28.09 66.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.7 1.137 . . . . 0.0 111.191 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.43 12.98 53.18 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 116.617 -2.213 . . . . 0.0 114.987 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -64.3 -84.35 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.991 2.396 . . . . 0.0 110.335 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 tp -165.38 69.95 0.14 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.222 1.009 . . . . 0.0 109.456 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -74.58 164.03 27.05 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 175.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.2 mm -136.91 172.97 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 103' ' ' GLY . 2.3 m 64.11 174.75 0.18 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.33 2.252 . . . . 0.0 111.468 -174.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.436 ' H ' HG22 ' A' ' 102' ' ' THR . . . -165.7 16.6 0.09 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 120.444 -1.41 . . . . 0.0 114.225 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -82.86 40.68 0.7 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.58 1.69 . . . . 0.0 113.298 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.4 mpp? 25.73 60.82 0.07 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.482 2.713 . . . . 0.0 113.902 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.71 -18.98 0.04 OUTLIER Glycine 0 C--N 1.337 0.593 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.444 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.5 -14.94 60.0 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.048 1.424 . . . . 0.0 111.671 164.185 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.16 -83.22 0.11 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.663 1.185 . . . . 0.0 108.444 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.0 ttt -142.76 88.77 2.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -76.4 -61.5 1.93 Allowed 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.093 -1.004 . . . . 0.0 112.804 175.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -149.7 -148.2 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.284 0.634 . . . . 0.0 109.504 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -89.76 -60.22 2.0 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.36 1.064 . . . . 0.0 109.734 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -57.02 -21.23 29.27 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.49 -4.87 42.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.383 0.992 . . . . 0.0 111.874 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -163.23 44.26 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.712 1.205 . . . . 0.0 112.172 -165.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 15' ' ' GLU . 50.0 mt 48.74 160.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 125.214 2.435 . . . . 0.0 114.055 -165.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -80.68 171.91 11.13 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.871 172.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.1 178.89 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.675 2.25 . . . . 0.0 111.741 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.45 175.35 47.2 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.754 1.645 . . . . 0.0 109.646 165.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -52.29 3.95 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.561 1.544 . . . . 0.0 111.456 168.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 48.29 77.28 0.1 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.096 2.158 . . . . 0.0 114.278 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 97.36 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 1 C-N-CA 134.292 5.037 . . . . 0.0 107.706 -155.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--O 1.245 0.848 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 160.908 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.45 173.1 0.19 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.838 2.055 . . . . 0.0 113.669 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.26 147.13 37.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.116 1.367 . . . . 0.0 107.944 164.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . 46.2 p -147.36 -153.33 0.48 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 127.426 2.29 . . . . 0.0 107.403 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t0 64.28 24.16 13.25 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 163.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.01 77.58 0.39 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 126.725 2.107 . . . . 0.0 108.6 -175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -153.25 151.93 30.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.682 2.393 . . . . 0.0 106.852 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -61.98 -26.55 68.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.838 0.744 . . . . 0.0 110.272 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.89 -14.35 1.42 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.051 0.94 . . . . 0.0 113.443 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 19.0 t-20 -55.9 -52.19 64.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.574 1.079 . . . . 0.0 111.454 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.183 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG13 ' HG3' ' A' ' 84' ' ' MET . 45.6 t -54.69 -54.62 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.454 1.502 . . . . 0.0 110.723 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -71.1 -23.59 62.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.602 0.637 . . . . 0.0 112.199 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -75.29 -26.96 59.15 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.79 -50.0 75.57 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.211 0.46 . . . . 0.0 110.546 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.3 mt -51.39 -47.9 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.92 -50.72 72.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.988 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -55.42 -48.85 73.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.77 0.714 . . . . 0.0 109.213 -170.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.5 -45.57 93.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.181 0.592 . . . . 0.0 109.881 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -34.1 66.04 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.353 1.461 . . . . 0.0 114.355 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.258 7.8 mm-40 -63.67 -52.13 62.07 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.197 -0.939 . . . . 0.0 111.665 171.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.69 -45.54 93.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.071 1.305 . . . . 0.0 113.233 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -157.75 63.55 0.47 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.674 1.59 . . . . 0.0 108.446 -170.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -25.96 74.04 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 121.073 -1.017 . . . . 0.0 112.749 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -52.89 -36.54 59.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 112.195 -171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -77.05 -35.87 56.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.302 1.041 . . . . 0.0 110.005 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.03 -27.76 57.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.08 -55.6 9.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 167.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -63.8 -15.95 60.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.391 0.996 . . . . 0.0 113.472 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 119.634 1.106 . . . . 0.0 110.82 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.65 -50.29 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.279 1.031 . . . . 0.0 109.047 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.52 65.35 3.63 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.652 1.12 . . . . 0.0 112.775 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.06 144.76 4.64 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.31 138.28 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 168.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -138.88 162.66 34.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.046 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HB1' ' CG2' ' A' ' 49' ' ' THR . . . -111.3 144.56 40.29 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.749 1.22 . . . . 0.0 109.253 172.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -92.94 90.06 6.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.951 1.301 . . . . 0.0 108.945 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -74.62 107.56 6.82 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.717 -1.239 . . . . 0.0 109.526 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.771 HG22 ' CE2' ' A' ' 80' ' ' PHE . 40.5 t -128.67 110.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -115.77 -175.29 2.69 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 165.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t0 65.19 38.18 6.14 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.685 1.994 . . . . 0.0 112.578 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.44 -155.13 24.38 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.962 1.268 . . . . 0.0 111.801 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.75 110.06 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.658 2.239 . . . . 0.0 106.448 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.32 -70.5 0.23 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.028 0.823 . . . . 0.0 111.141 -166.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.92 21.44 36.2 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 118.476 1.138 . . . . 0.0 110.843 -162.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -75.52 -176.12 3.09 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 156.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.25 153.33 29.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.553 1.141 . . . . 0.0 108.363 166.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 4' ' ' SER . . . -129.69 170.85 13.29 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.36 1.864 . . . . 0.0 107.626 163.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.513 ' CG2' ' HB1' ' A' ' 36' ' ' ALA . 16.6 m -152.77 145.78 24.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 163.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -112.61 149.36 32.91 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 102.134 -3.284 . . . . 0.0 102.134 166.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 141.72 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 167.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.17 113.0 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -82.19 114.01 20.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.42 51.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -141.63 -54.22 0.46 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.4 153.02 34.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.729 0.812 . . . . 0.0 109.914 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.96 -134.37 11.65 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.366 0.984 . . . . 0.0 111.144 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.66 3.3 50.34 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.186 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.95 156.19 20.38 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -173.02 157.67 3.57 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 129.505 3.122 . . . . 0.0 107.599 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.15 153.62 3.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.0 mt -140.32 79.29 21.4 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -161.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.9 144.27 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.502 2.135 . . . . 0.0 110.331 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 47.09 24.47 0.4 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.761 2.024 . . . . 0.0 115.138 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -71.77 161.45 30.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.359 1.076 . . . . 0.0 111.479 -161.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.46 -15.73 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.632 1.973 . . . . 0.0 110.71 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -53.83 130.24 36.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.05 -176.03 2.82 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 165.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.54 152.45 45.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.82 0.848 . . . . 0.0 109.447 -174.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.15 -41.02 59.15 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.306 1.042 . . . . 0.0 109.516 -174.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -136.18 174.81 10.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.833 2.053 . . . . 0.0 107.889 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.485 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 23.7 m -155.35 122.71 5.55 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 tt -83.52 152.31 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.8 m -120.71 141.7 50.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.888 -1.133 . . . . 0.0 108.998 159.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.56 -103.41 0.2 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 163.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.21 159.25 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 130.56 3.544 . . . . 0.0 105.473 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.61 -41.2 69.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.834 0.854 . . . . 0.0 111.211 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 t -60.81 -21.23 62.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.632 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.32 -64.06 1.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.788 0.835 . . . . 0.0 109.387 172.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.771 ' CE2' HG22 ' A' ' 39' ' ' VAL . 95.9 m-85 -55.85 -53.32 58.2 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.861 0.865 . . . . 0.0 110.299 -171.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 tp -55.1 -54.72 39.6 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.54 -41.91 77.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.108 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -54.84 -65.02 0.65 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.776 0.716 . . . . 0.0 110.144 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.481 ' HG3' HG13 ' A' ' 12' ' ' VAL 0.275 0.0 OUTLIER -69.34 -28.36 66.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.825 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.7 m -74.47 -12.21 60.43 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.599 1.091 . . . . 0.0 112.102 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.04 19.97 29.47 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 119.589 1.086 . . . . 0.0 113.656 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -106.23 -24.3 12.35 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.428 1.491 . . . . 0.0 112.768 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.1 ttm 48.0 178.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 128.64 2.776 . . . . 0.0 114.86 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.91 154.89 29.68 Favored Pre-proline 0 C--O 1.241 0.625 0 C-N-CA 127.483 2.313 . . . . 0.0 105.732 173.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.64 43.2 1.48 Allowed 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.084 2.522 . . . . 0.0 112.699 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 48.68 78.43 0.09 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 128.547 2.739 . . . . 0.0 112.091 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.53 -43.13 1.24 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.188 2.595 . . . . 0.0 113.22 -172.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -44.91 -48.41 11.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 126.722 2.009 . . . . 0.0 112.955 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.7 t80 37.33 -150.81 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 130.128 3.371 . . . . 0.0 115.141 164.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -68.42 -7.16 29.22 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.396 1.078 . . . . 0.0 112.045 162.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -72.14 -47.07 53.78 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.107 0.867 . . . . 0.0 108.942 -169.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.46 66.47 1.51 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.646 ' O ' HD23 ' A' ' 99' ' ' LEU . 3.6 mtpt -75.11 49.25 0.44 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.255 1.022 . . . . 0.0 108.425 164.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 98' ' ' LYS . 2.3 pt? 36.77 32.74 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.447 2.699 . . . . 0.0 113.447 -167.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.561 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -65.48 138.18 57.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -165.074 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.485 ' CG2' ' H ' ' A' ' 72' ' ' THR 0.314 1.2 mp -106.55 178.15 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 165.27 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.5 p -147.03 160.35 42.48 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 127.527 2.331 . . . . 0.0 105.135 162.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.25 -13.05 12.47 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.905 167.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -146.67 157.62 43.74 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.125 1.462 . . . . 0.0 109.172 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.5 mmm -62.71 134.51 56.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.415 1.886 . . . . 0.0 108.202 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.29 21.41 68.34 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.826 -0.43 . . . . 0.0 113.347 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.74 -21.96 65.26 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.613 1.206 . . . . 0.0 113.052 -172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.09 -38.95 18.51 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.61 0.764 . . . . 0.0 110.425 -172.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.05 63.69 1.35 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' HE2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -76.28 -66.5 0.79 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.052 -1.03 . . . . 0.0 110.442 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.38 161.75 19.12 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.414 1.886 . . . . 0.0 108.989 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -71.6 -42.23 67.95 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -11.8 51.09 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.463 -1.398 . . . . 0.0 113.945 -173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.7 tp -77.92 -30.71 50.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.725 1.21 . . . . 0.0 110.789 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.405 ' C ' HD23 ' A' ' 116' ' ' LEU . 18.4 mt-30 -134.99 44.48 2.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.508 1.923 . . . . 0.0 108.987 -165.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 116' ' ' LEU 0.307 0.4 OUTLIER 37.73 -175.83 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 129.494 3.118 . . . . 0.0 114.121 -178.523 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -134.42 143.43 46.79 Favored Pre-proline 0 N--CA 1.447 -0.619 0 O-C-N 119.012 -2.305 . . . . 0.0 108.823 -158.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.41 174.05 13.2 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.218 1.279 . . . . 0.0 109.767 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.45 -161.92 8.99 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 124.319 0.961 . . . . 0.0 111.019 -168.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -85.72 -29.1 24.18 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.123 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 39.83 -151.22 0.01 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 127.452 2.301 . . . . 0.0 113.159 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -175.46 160.31 2.54 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 130.865 3.666 . . . . 0.0 106.097 145.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . 0.28 1.3 pt? . . . . . 0 C--O 1.26 1.61 0 C-N-CA 127.812 2.445 . . . . 0.0 111.834 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 120.754 0.312 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 m -98.43 -172.2 2.28 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.321 1.448 . . . . 0.0 109.731 -174.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 35.02 69.73 0.16 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.12 2.168 . . . . 0.0 113.259 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 t -81.5 -44.89 16.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.896 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 48.48 23.0 0.54 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.114 2.165 . . . . 0.0 113.109 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 3.66 58.23 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.871 1.701 . . . . 0.0 112.031 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CE2' ' HA3' ' A' ' 42' ' ' GLY . 2.3 m-30 -68.0 148.68 50.7 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 108.926 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -60.19 -21.99 62.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.308 0.643 . . . . 0.0 112.663 169.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -2.58 0.11 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 114.505 170.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -54.75 -51.87 64.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.931 1.242 . . . . 0.0 111.352 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.622 HD22 ' C ' ' A' ' 11' ' ' LEU 0.294 0.0 OUTLIER -58.9 -36.34 74.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.325 1.05 . . . . 0.0 112.241 178.274 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 84' ' ' MET . 3.4 t -59.15 -51.76 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.493 1.042 . . . . 0.0 110.848 -175.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.745 ' HA ' HD12 ' A' ' 16' ' ' ILE . 71.8 m-85 -74.94 -14.72 60.67 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.989 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -74.62 -35.84 62.93 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 117.611 -1.185 . . . . 0.0 111.635 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.729 ' HG3' HD21 ' A' ' 116' ' ' LEU . 67.3 mm-40 -57.36 -29.06 63.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.995 1.27 . . . . 0.0 112.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 13' ' ' PHE . 64.8 mt -65.48 -56.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.453 1.901 . . . . 0.0 108.603 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.57 -47.44 63.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 110.609 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.71 -38.98 93.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.088 1.355 . . . . 0.0 109.825 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -69.32 -36.81 77.35 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.435 -0.79 . . . . 0.0 110.445 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -33.17 75.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.706 1.202 . . . . 0.0 112.188 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.83 -53.35 52.13 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.806 -1.184 . . . . 0.0 110.16 167.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.64 -42.55 83.66 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 112.648 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -160.27 40.34 0.18 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.0 -18.77 80.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.979 -172.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.28 -52.83 2.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.941 1.371 . . . . 0.0 111.529 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.16 77.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.456 0.646 . . . . 0.0 109.798 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.16 -29.25 67.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -53.75 -52.51 33.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.398 0.999 . . . . 0.0 108.699 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -62.18 -24.22 67.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.45 1.477 . . . . 0.0 113.641 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.64 -29.92 69.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.039 1.291 . . . . 0.0 112.175 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.34 -61.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.739 1.216 . . . . 0.0 108.533 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.54 64.48 3.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 125.79 1.662 . . . . 0.0 109.794 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.29 45.34 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.955 0.878 . . . . 0.0 113.809 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.37 138.29 24.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 158.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -135.37 164.49 27.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.858 0.299 . . . . 0.0 110.726 163.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.0 167.75 9.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 109.715 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.483 ' H ' HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -132.8 99.23 4.54 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -170.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -87.34 94.02 9.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.215 1.371 . . . . 0.0 110.607 -165.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.82 115.0 38.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.375 0.607 . . . . 0.0 109.787 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -115.29 174.14 6.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.922 1.289 . . . . 0.0 109.464 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.7 t0 44.13 47.23 7.49 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.165 0.916 . . . . 0.0 112.879 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA3' ' CE2' ' A' ' 7' ' ' PHE . . . -69.71 173.27 37.97 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-O 118.564 -1.131 . . . . 0.0 111.834 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.25 94.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.818 3.012 . . . . 0.0 109.894 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.77 -3.48 14.89 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 126.674 2.083 . . . . 0.0 114.116 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.35 13.8 70.07 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.368 2.084 . . . . 0.0 112.284 160.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -85.79 -167.14 1.74 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.09 2.156 . . . . 0.0 108.502 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -134.11 147.76 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.854 1.661 . . . . 0.0 107.679 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.14 174.86 11.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.161 1.784 . . . . 0.0 108.122 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 37' ' ' PHE . 18.4 m -155.54 155.83 34.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.116 1.366 . . . . 0.0 108.655 169.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.31 154.68 36.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 t -122.49 114.61 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.8 t -95.38 112.55 27.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.83 115.37 20.29 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.65 47.31 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 168.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.97 -49.92 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.513 1.525 . . . . 0.0 109.715 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.27 151.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.303 1.041 . . . . 0.0 108.208 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.11 -131.09 44.86 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -111.79 13.14 21.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.429 1.892 . . . . 0.0 109.717 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 156.66 29.45 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -172.62 161.56 4.92 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 128.182 2.593 . . . . 0.0 105.776 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.29 127.7 58.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -107.6 93.37 10.04 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 125.539 1.535 . . . . 0.0 108.061 -162.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.58 137.55 64.9 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.727 1.618 . . . . 0.0 110.297 -165.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.24 44.6 15.96 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.597 3.159 . . . . 0.0 109.06 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.69 147.01 53.9 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.916 0.865 . . . . 0.0 111.205 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.29 -24.68 39.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.547 158.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -60.43 117.12 4.86 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.157 0.979 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -72.21 -177.17 2.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.996 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.15 163.95 30.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.553 1.168 . . . . 0.0 111.542 -163.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -37.19 59.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.115 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.17 -178.85 5.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.273 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -139.03 -176.01 4.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.272 1.429 . . . . 0.0 108.123 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt -142.62 157.37 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 120.911 -1.118 . . . . 0.0 109.285 159.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 m -98.03 124.4 42.51 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 mtt -152.03 124.31 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 163.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 155.74 4.12 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.982 -0.449 . . . . 0.0 110.931 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -52.47 -49.59 64.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 110.871 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 t -65.4 -9.87 28.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.812 1.645 . . . . 0.0 111.603 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.17 -54.67 3.34 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.757 168.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -48.16 -54.34 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.081 0.855 . . . . 0.0 110.061 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.04 -51.08 62.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 125.818 1.647 . . . . 0.0 110.292 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.98 -24.77 66.36 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.052 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 7.6 mp -67.91 -82.16 0.03 OUTLIER 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 162.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.534 ' CE ' HD11 ' A' ' 16' ' ' ILE . 1.5 ptm -75.89 53.15 0.74 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.295 1.838 . . . . 0.0 114.321 -163.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.8 m -154.53 -19.57 0.12 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.371 2.668 . . . . 0.0 108.799 170.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.15 80.46 1.31 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -125.48 -66.33 0.95 Allowed 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 44.9 mtt -143.05 -6.66 0.84 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 5.2 m-80 38.27 63.61 3.75 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 119.577 1.081 . . . . 0.0 111.911 -165.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -68.82 -175.76 1.03 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.163 2.575 . . . . 0.0 110.884 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -142.52 91.56 2.33 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 168.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.31 -48.26 62.38 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -49.46 -33.43 14.22 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -90.33 -61.29 1.71 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -61.92 -63.55 1.22 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.241 1.417 . . . . 0.0 111.695 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.55 -34.54 78.13 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.74 37.58 61.34 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 11.24 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.191 1.796 . . . . 0.0 115.72 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 tp 49.76 82.35 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.734 2.414 . . . . 0.0 109.994 -166.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -68.18 141.69 55.92 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.859 166.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.273 21.8 mm -78.95 169.74 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.4 p -89.93 -154.31 0.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.759 2.024 . . . . 0.0 107.96 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.92 -51.2 0.82 Allowed Glycine 0 CA--C 1.507 -0.445 0 O-C-N 120.608 -1.307 . . . . 0.0 110.232 162.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -144.52 110.74 5.5 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 101.857 -3.386 . . . . 0.0 101.857 168.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 25.7 ptp -67.05 158.46 31.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.7 -2.09 87.85 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 117.84 -1.533 . . . . 0.0 114.108 172.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . 0.268 1.4 pp -75.08 61.38 1.09 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.664 2.232 . . . . 0.0 110.006 162.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.84 -81.58 0.19 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 162.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -150.46 34.42 0.63 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.164 0.893 . . . . 0.0 110.858 -168.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -75.8 -32.18 59.75 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.892 0.877 . . . . 0.0 113.313 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 163.54 12.47 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.86 0.864 . . . . 0.0 108.899 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . 0.267 0.6 OUTLIER -115.92 -85.37 0.62 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 118.164 -0.922 . . . . 0.0 109.256 -178.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -56.71 -3.77 0.13 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.445 2.298 . . . . 0.0 115.893 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.7 tp -57.47 -53.97 52.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.44 52.69 0.88 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.681 1.592 . . . . 0.0 110.666 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.729 HD21 ' HG3' ' A' ' 15' ' ' GLU . 9.0 mt 57.57 -174.84 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 122.221 1.01 . . . . 0.0 111.053 -170.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -105.8 137.15 19.25 Favored Pre-proline 0 N--CA 1.441 -0.88 0 C-N-CA 125.493 1.517 . . . . 0.0 111.578 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.14 174.53 12.29 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.536 2.157 . . . . 0.0 111.64 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -137.6 134.09 6.78 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-O 118.761 -1.022 . . . . 0.0 110.673 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -168.59 65.26 0.07 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.333 1.053 . . . . 0.0 111.144 171.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.2 97.85 3.07 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 120.669 -1.27 . . . . 0.0 108.804 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.17 78.91 0.39 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.253 1.277 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -149.606 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.239 0.532 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -73.8 60.95 0.74 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.355 1.862 . . . . 0.0 110.8 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.56 175.09 10.21 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.952 1.701 . . . . 0.0 109.003 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.7 p -143.47 -155.98 0.65 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -163.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.4 t0 61.43 27.04 16.7 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.52 62.67 0.3 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 119.606 -1.933 . . . . 0.0 111.965 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.482 ' CE2' ' HA3' ' A' ' 42' ' ' GLY . 32.5 m-85 -152.32 143.47 23.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.017 1.408 . . . . 0.0 110.938 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -17.7 62.54 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.637 167.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.33 -13.47 0.9 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.857 1.663 . . . . 0.0 113.706 167.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -56.26 -34.09 66.07 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.541 1.064 . . . . 0.0 112.208 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.417 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -83.82 -31.53 25.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.56 -0.733 . . . . 0.0 112.088 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.87 -62.97 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 124.286 1.034 . . . . 0.0 108.907 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' HA ' HD12 ' A' ' 16' ' ' ILE . 39.3 m-85 -67.51 -25.97 66.11 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.346 -174.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -73.03 -34.33 66.26 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.537 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.66 -30.2 70.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 120.406 1.457 . . . . 0.0 112.588 172.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 13' ' ' PHE . 24.3 mt -65.91 -52.99 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -56.38 -45.71 80.4 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.318 1.047 . . . . 0.0 112.303 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -59.81 -46.54 88.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.1 tpmt? -65.33 -39.34 92.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.795 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.35 -37.43 70.0 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 113.63 171.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.1 -53.4 50.24 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.205 1.002 . . . . 0.0 110.542 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -59.43 -46.02 89.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.307 1.412 . . . . 0.0 111.369 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -164.9 65.06 0.13 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.457 1.123 . . . . 0.0 113.341 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.57 79.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.048 1.309 . . . . 0.0 113.272 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.45 -36.93 67.1 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.811 1.305 . . . . 0.0 111.64 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.841 -1.162 . . . . 0.0 111.43 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.06 -25.8 61.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.432 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.24 -51.17 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.449 -0.786 . . . . 0.0 108.997 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.64 -37.34 75.73 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.801 1.182 . . . . 0.0 111.319 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -61.24 -65.76 0.64 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.626 0.77 . . . . 0.0 110.006 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mt -74.84 -66.87 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.51 66.24 2.53 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.819 1.2 . . . . 0.0 111.051 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.79 37.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 171.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.93 134.62 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 158.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -137.18 167.52 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 171.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 141.15 47.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.921 0.782 . . . . 0.0 112.864 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -87.26 103.78 15.77 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.142 0.977 . . . . 0.0 109.832 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -74.09 95.79 2.61 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 119.54 1.064 . . . . 0.0 109.764 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.14 108.9 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.28 179.25 4.21 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.679 1.191 . . . . 0.0 108.322 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 t70 49.51 42.79 23.28 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.631 1.172 . . . . 0.0 110.724 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.482 ' HA3' ' CE2' ' A' ' 7' ' ' PHE . . . -66.86 168.63 36.19 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.148 -1.362 . . . . 0.0 110.413 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 92.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.829 3.019 . . . . 0.0 113.324 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.93 3.34 51.99 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.718 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.02 40.99 1.34 Allowed Glycine 0 C--N 1.339 0.734 0 CA-C-N 120.61 2.205 . . . . 0.0 111.307 164.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.04 -176.98 6.18 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.535 -0.979 . . . . 0.0 111.086 174.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -147.67 140.65 24.96 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.589 2.355 . . . . 0.0 107.381 163.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.25 166.33 30.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.3 m -143.88 147.73 34.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -122.44 132.81 54.53 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.97 151.29 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -126.66 104.84 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.85 105.16 15.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.34 55.18 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.839 0.745 . . . . 0.0 109.391 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -155.12 -43.66 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.674 1.19 . . . . 0.0 111.194 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -95.92 110.26 22.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.41 1.484 . . . . 0.0 107.557 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.49 -153.6 39.15 Favored Glycine 0 N--CA 1.46 0.261 0 O-C-N 119.882 -1.761 . . . . 0.0 111.618 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -5.45 57.02 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.771 0.828 . . . . 0.0 112.614 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.28 157.68 30.12 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-O 122.238 0.91 . . . . 0.0 110.973 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.84 165.41 6.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.125 3.37 . . . . 0.0 107.905 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.89 89.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 120.747 -1.221 . . . . 0.0 107.945 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.66 103.58 0.88 Allowed Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -164.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.94 143.83 41.73 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.678 1.585 . . . . 0.0 110.14 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 47.7 23.77 0.47 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.941 2.496 . . . . 0.0 113.427 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -78.49 149.21 33.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.405 0.621 . . . . 0.0 110.211 -153.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.55 -2.47 58.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.625 1.97 . . . . 0.0 111.183 168.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.09 130.57 46.7 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 155.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -177.28 1.9 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.28 159.34 39.39 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.983 1.713 . . . . 0.0 107.722 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -35.87 73.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.61 -167.19 2.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.519 1.528 . . . . 0.0 110.794 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 m -133.28 -176.62 4.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.766 1.226 . . . . 0.0 109.578 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tt -142.37 143.55 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.065 -1.022 . . . . 0.0 108.774 151.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 m -84.64 138.91 32.42 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.6 tpp -136.17 -57.88 0.75 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.308 1.413 . . . . 0.0 110.466 149.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.69 152.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 130.433 3.493 . . . . 0.0 111.634 -157.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.13 -48.62 75.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 123.717 0.807 . . . . 0.0 110.403 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 p -66.29 -5.34 10.16 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.751 1.22 . . . . 0.0 111.688 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 -47.87 3.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 161.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -55.81 -52.12 65.08 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.813 1.642 . . . . 0.0 110.179 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tp -55.12 -41.9 72.28 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.187 1.795 . . . . 0.0 112.606 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.82 79.92 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.776 0.43 . . . . 0.0 111.578 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -68.59 -76.14 0.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.055 1.742 . . . . 0.0 110.757 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptm -76.7 54.53 0.98 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.071 1.349 . . . . 0.0 113.902 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.0 p -155.25 -33.64 0.09 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.469 1.908 . . . . 0.0 110.446 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.85 78.04 1.19 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 125.986 1.755 . . . . 0.0 109.824 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -108.85 -46.01 3.7 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.313 1.445 . . . . 0.0 110.539 156.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -146.92 177.11 9.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.876 1.27 . . . . 0.0 113.603 -153.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -62.74 151.73 83.84 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.085 1.354 . . . . 0.0 112.056 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.17 163.97 22.31 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.385 2.723 . . . . 0.0 114.082 -171.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 59.63 80.84 0.19 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.821 2.048 . . . . 0.0 111.43 -165.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.4 m -41.28 -52.93 3.35 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.252 1.021 . . . . 0.0 113.033 170.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.17 67.76 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.817 -1.177 . . . . 0.0 113.956 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -64.63 -38.62 91.63 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -71.16 -78.22 0.08 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.4 1.88 . . . . 0.0 110.389 168.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -70.78 -18.9 62.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -157.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.97 49.33 72.24 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 120.564 -1.335 . . . . 0.0 112.896 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -105.21 56.03 0.69 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 128.264 2.626 . . . . 0.0 109.597 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.4 tp 33.53 73.06 0.07 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.686 2.394 . . . . 0.0 112.48 167.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 166.6 16.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 171.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.6 mp -129.83 159.56 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -172.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 46.54 -166.34 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.252 1.021 . . . . 0.0 111.775 -161.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 177.98 -24.88 0.05 OUTLIER Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.39 -1.444 . . . . 0.0 112.272 174.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.8 t30 52.41 -174.69 0.03 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.088 2.155 . . . . 0.0 110.624 -170.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -72.5 80.82 1.07 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 164.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.0 73.24 0.38 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 126.452 1.977 . . . . 0.0 111.645 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -64.17 -40.24 95.71 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 118.194 0.997 . . . . 0.0 111.399 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.02 -61.53 2.48 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 118.403 -0.808 . . . . 0.0 108.874 -166.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 68.9 mmm 24.87 -70.37 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 130.081 3.353 . . . . 0.0 117.004 167.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -71.04 -49.58 43.3 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.082 1.31 . . . . 0.0 110.787 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.252 2.2 pp 34.8 4.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.948 1 C-N-CA 134.123 4.969 . . . . 0.0 119.753 177.599 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -88.92 -87.66 0.16 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 121.024 1.738 . . . . 0.0 106.704 -166.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -70.34 -3.89 19.59 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.582 -1.323 . . . . 0.0 112.561 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.95 -21.53 59.99 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 120.931 -1.105 . . . . 0.0 110.418 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.82 53.1 1.49 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.064 0.945 . . . . 0.0 109.648 -167.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER 43.79 -173.46 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.044 1.737 . . . . 0.0 112.568 178.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.404 ' HG2' ' HD2' ' A' ' 118' ' ' PRO . 1.2 mt-30 -142.55 165.62 25.76 Favored Pre-proline 0 C--O 1.24 0.576 0 O-C-N 119.574 -1.954 . . . . 0.0 109.152 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 117' ' ' GLN . 41.1 Cg_endo -75.58 -170.71 0.86 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.795 2.33 . . . . 0.0 109.682 170.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.57 -94.2 1.59 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 105.56 -3.016 . . . . 0.0 105.56 -165.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.3 t30 55.35 76.75 0.25 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.372 1.069 . . . . 0.0 108.206 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.76 101.47 2.1 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -155.97 143.68 19.54 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.246 0.891 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 158.253 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.238 0.474 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.6 168.74 8.89 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 154.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.76 175.16 1.55 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.809 1.244 . . . . 0.0 111.02 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.8 m -154.01 -83.1 0.08 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 76.85 40.55 0.19 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.053 1.741 . . . . 0.0 109.034 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.57 35.48 0.38 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.761 1.172 . . . . 0.0 112.512 -174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.317 1.058 . . . . 0.0 110.349 173.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -54.15 -34.85 61.39 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.718 -0.614 . . . . 0.0 110.525 164.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.21 -10.96 1.42 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.206 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -60.61 -26.67 67.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.984 1.72 . . . . 0.0 110.969 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.536 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -81.56 -38.38 26.24 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.243 1.383 . . . . 0.0 112.039 169.642 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.81 -53.47 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 119.39 0.995 . . . . 0.0 110.591 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.427 ' HB3' ' CD1' ' A' ' 50' ' ' TRP . 84.9 m-85 -67.91 -22.59 65.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.136 -0.625 . . . . 0.0 111.353 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -75.1 -30.33 60.87 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.515 ' HB2' HD22 ' A' ' 116' ' ' LEU . 4.8 mm-40 -57.58 -46.52 83.89 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.375 0.534 . . . . 0.0 109.72 170.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 13' ' ' PHE . 61.9 mt -57.54 -50.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -52.62 -55.68 20.74 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 124.374 1.07 . . . . 0.0 111.5 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -55.19 -48.65 73.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.546 1.138 . . . . 0.0 108.375 -171.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -58.57 -48.96 79.16 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.642 175.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.19 70.22 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.328 59.2 mm-40 -66.2 -51.22 59.83 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 124.434 1.094 . . . . 0.0 110.828 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.37 -46.5 80.03 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.19 -0.944 . . . . 0.0 111.856 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -165.63 61.75 0.11 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.969 1.307 . . . . 0.0 109.456 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -24.01 72.58 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.963 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.43 -28.82 65.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.765 1.783 . . . . 0.0 113.596 -165.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.29 -25.47 16.32 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.488 2.715 . . . . 0.0 110.95 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.1 m-85 -73.77 -28.85 61.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.724 2.01 . . . . 0.0 110.39 172.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -53.23 -44.34 52.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.585 1.154 . . . . 0.0 109.029 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.87 -27.78 69.04 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.622 ' HE3' HD13 ' A' ' 111' ' ' LEU . 57.6 mmtt -71.04 -28.85 64.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.844 1.202 . . . . 0.0 112.277 -167.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.76 -59.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.3 73.96 0.51 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.739 1.161 . . . . 0.0 110.343 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.56 177.09 45.27 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.896 0.848 . . . . 0.0 112.148 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.56 147.36 6.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 144.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -138.27 176.25 8.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 154.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.24 174.53 7.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.551 156.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -116.38 122.69 45.58 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.588 1.555 . . . . 0.0 107.836 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -100.05 104.93 16.54 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 121.12 1.782 . . . . 0.0 106.628 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.58 94.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -162.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -94.53 177.73 5.83 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.869 -1.145 . . . . 0.0 108.414 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.8 t0 60.31 33.3 20.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.344 1.057 . . . . 0.0 111.601 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.46 174.6 38.25 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 118.409 -1.217 . . . . 0.0 111.381 170.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.7 95.66 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.508 2.805 . . . . 0.0 110.528 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.69 -16.57 4.78 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.122 2.296 . . . . 0.0 112.871 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.28 3.72 88.65 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 118.919 1.359 . . . . 0.0 112.086 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -69.5 -174.78 0.73 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.312 2.645 . . . . 0.0 109.444 170.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -126.91 168.74 14.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.079 0.552 . . . . 0.0 110.829 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.39 175.07 10.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.881 1.672 . . . . 0.0 109.338 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.0 m -149.75 149.09 30.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.256 1.022 . . . . 0.0 109.917 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 13' ' ' PHE . 1.2 m-90 -121.7 151.63 40.29 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 t -120.55 133.94 65.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 126.853 2.061 . . . . 0.0 105.985 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.85 114.5 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.15 114.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.97 54.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.34 -45.41 0.05 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.166 1.386 . . . . 0.0 109.106 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -74.91 135.44 41.48 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.37 -133.19 11.0 Favored Glycine 0 C--N 1.333 0.362 0 O-C-N 123.69 0.618 . . . . 0.0 111.885 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.46 4.15 47.57 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.418 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.24 156.89 28.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-O 123.22 1.456 . . . . 0.0 110.212 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -172.31 144.4 1.56 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.005 2.922 . . . . 0.0 109.689 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.97 157.01 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mt -134.71 79.23 53.41 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -166.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.87 132.83 38.82 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.122 2.548 . . . . 0.0 110.81 -166.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.2 23.77 4.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.539 1.936 . . . . 0.0 111.891 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -82.69 145.91 29.35 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.449 -0.782 . . . . 0.0 110.104 -162.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -85.16 -9.45 57.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.748 1.619 . . . . 0.0 111.791 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -53.4 142.36 22.01 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.945 -1.097 . . . . 0.0 110.435 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -71.02 -175.58 1.18 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 111.779 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.58 165.09 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.22 -62.49 1.55 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.562 1.145 . . . . 0.0 112.157 157.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -154.54 166.91 31.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.871 1.669 . . . . 0.0 108.991 -170.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -138.61 126.65 22.58 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.581 HD12 HD11 ' A' ' 107' ' ' LEU . 3.3 tt -82.53 165.48 2.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -172.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 m -102.35 126.37 49.34 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.505 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -157.82 132.07 8.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 158.082 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.21 154.39 39.94 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.456 1.102 . . . . 0.0 110.081 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -49.69 -48.59 49.56 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.535 1.534 . . . . 0.0 112.389 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -59.04 -24.99 63.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 110.948 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.38 -26.44 11.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.465 0.706 . . . . 0.0 110.89 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.505 ' CZ ' ' HG3' ' A' ' 75' ' ' MET . 66.1 m-85 -57.85 -57.97 10.44 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 158.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.47 -35.82 53.51 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.547 -0.72 . . . . 0.0 111.977 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.92 94.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mt -69.94 -67.1 0.51 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 110.107 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -50.7 15.18 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -167.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.1 m -74.43 -26.65 60.2 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.719 -1.238 . . . . 0.0 109.536 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.02 18.41 19.98 Favored Glycine 0 C--O 1.222 -0.595 0 CA-C-O 118.539 -1.145 . . . . 0.0 113.378 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -64.35 -8.09 11.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.216 2.008 . . . . 0.0 114.607 -171.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 32.0 mtp 64.4 112.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.642 2.377 . . . . 0.0 111.877 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -154.71 142.49 14.05 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.92 -178.89 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.863 1.709 . . . . 0.0 110.923 171.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.438 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 1.8 pm0 -57.48 92.76 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.048 1.339 . . . . 0.0 112.4 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -35.17 78.64 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -164.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.0 72.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.603 1.161 . . . . 0.0 111.499 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -76.06 -44.11 40.59 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.785 0.834 . . . . 0.0 110.268 170.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -43.49 67.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.153 0.981 . . . . 0.0 111.667 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -85.21 10.59 11.94 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 118.947 0.794 . . . . 0.0 112.454 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.33 -24.73 1.37 Allowed Glycine 0 C--N 1.339 0.705 0 C-N-CA 126.467 1.984 . . . . 0.0 114.379 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -64.78 -15.7 62.02 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.942 1.297 . . . . 0.0 113.36 -167.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.627 ' HG ' ' H ' ' A' ' 100' ' ' LYS . 13.6 tp 66.62 -172.06 0.19 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.934 1.693 . . . . 0.0 108.657 -166.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.627 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 17.5 ptmt -143.12 129.91 20.42 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 130.631 3.573 . . . . 0.0 101.974 -162.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.511 HG22 ' H ' ' A' ' 102' ' ' THR . 3.0 mm -102.61 -154.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -157.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.511 ' H ' HG22 ' A' ' 101' ' ' ILE . 14.1 p 50.42 -134.41 1.53 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -174.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 168.29 -69.76 0.16 Allowed Glycine 0 C--O 1.225 -0.458 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 166.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 41.11 57.72 2.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.201 1.801 . . . . 0.0 112.295 163.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 51.6 ttm 48.01 63.16 2.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.161 2.184 . . . . 0.0 111.05 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.41 -26.94 1.04 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.628 2.061 . . . . 0.0 114.469 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.581 HD11 HD12 ' A' ' 73' ' ' ILE . 0.3 OUTLIER 40.93 18.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 131.133 3.773 . . . . 0.0 116.575 -176.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.05 -71.63 0.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.554 1.07 . . . . 0.0 110.771 -160.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 ttt -151.73 61.18 0.87 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -70.19 -5.68 29.09 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.136 0.974 . . . . 0.0 112.88 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.622 HD13 ' HE3' ' A' ' 30' ' ' LYS . 1.1 pt? -158.93 135.42 9.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.13 2.172 . . . . 0.0 105.617 166.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -59.94 -35.42 74.9 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -54.91 -28.52 51.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.124 0.97 . . . . 0.0 113.371 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.41 HD12 ' CE2' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -72.07 -5.01 32.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.339 0.972 . . . . 0.0 111.671 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -149.49 44.46 0.94 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 128.639 2.775 . . . . 0.0 109.58 -170.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 15' ' ' GLU 0.379 0.2 OUTLIER 44.45 -173.55 0.01 OUTLIER 'General case' 0 C--N 1.352 0.681 0 C-N-CA 127.348 2.259 . . . . 0.0 112.756 -179.848 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -92.2 115.21 64.28 Favored Pre-proline 0 CA--C 1.538 0.493 0 O-C-N 118.941 -2.349 . . . . 0.0 109.025 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.96 -179.9 5.43 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.262 2.642 . . . . 0.0 111.099 170.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.63 72.38 0.96 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.576 1.56 . . . . 0.0 109.838 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.06 145.94 29.83 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.91 101.13 2.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.453 1.479 . . . . 0.0 111.075 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt 44.65 -151.83 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.235 1.814 . . . . 0.0 111.305 173.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.819 0 CA-C-O 117.002 -1.475 . . . . 0.0 107.051 151.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 120.599 0.238 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 p 78.45 155.97 0.16 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 130.333 3.453 . . . . 0.0 112.583 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.57 95.8 0.01 OUTLIER 'General case' 0 C--N 1.345 0.37 0 C-N-CA 127.963 2.505 . . . . 0.0 111.798 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -135.77 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.112 2.565 . . . . 0.0 111.905 -173.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.55 22.58 13.02 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 119.452 -2.03 . . . . 0.0 113.544 167.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.06 68.56 0.42 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 125.225 1.393 . . . . 0.0 111.025 -163.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.807 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 76.5 m-85 -153.42 159.87 42.47 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.727 2.011 . . . . 0.0 107.34 -168.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.71 -34.6 73.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 167.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.21 -10.5 0.37 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.805 2.042 . . . . 0.0 114.607 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -55.16 -52.52 63.05 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 120.347 1.43 . . . . 0.0 111.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.443 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -65.22 -33.63 76.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.434 -179.844 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.66 -54.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.144 0.884 . . . . 0.0 110.248 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 16' ' ' ILE . 72.6 m-85 -68.95 -23.19 64.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.261 0.482 . . . . 0.0 111.646 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -37.57 80.99 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 116.591 -1.671 . . . . 0.0 111.835 173.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -65.45 -38.16 89.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.678 1.581 . . . . 0.0 111.256 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 13' ' ' PHE . 60.0 mt -52.86 -47.91 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 61' ' ' VAL . 19.7 tt0 -64.51 -43.04 95.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.886 0.474 . . . . 0.0 111.826 175.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -63.18 -42.95 99.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -60.16 -35.71 75.94 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.142 -0.974 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.29 -27.26 62.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -63.86 -54.05 41.07 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.19 -0.944 . . . . 0.0 109.079 163.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.06 -43.81 98.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.648 0.779 . . . . 0.0 110.05 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -165.09 64.9 0.12 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.408 1.483 . . . . 0.0 109.064 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.89 -17.28 79.3 Favored Glycine 0 CA--C 1.519 0.334 0 O-C-N 120.959 -1.088 . . . . 0.0 113.166 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.517 ' CB ' ' HE3' ' A' ' 58' ' ' LYS . 5.9 pt-20 -58.21 -33.98 69.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.99 0.895 . . . . 0.0 112.197 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -79.98 -39.35 30.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.775 1.63 . . . . 0.0 109.463 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.39 -29.53 70.82 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.27 -52.25 53.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 119.214 0.916 . . . . 0.0 110.6 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -68.41 -18.04 64.35 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.299 -0.876 . . . . 0.0 112.621 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -72.55 -69.49 0.4 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 120.333 1.424 . . . . 0.0 109.195 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.32 -54.84 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -171.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.29 65.01 3.43 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.06 158.07 21.91 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 167.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.27 137.51 22.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 159.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -132.41 168.81 17.49 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.661 -0.649 . . . . 0.0 109.426 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.06 158.87 26.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' THR . 73.2 m-85 -108.09 113.39 26.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.503 1.521 . . . . 0.0 108.629 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.27 117.3 23.46 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.34 1.882 . . . . 0.0 114.181 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.67 101.28 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -109.45 -169.96 1.57 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 165.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t0 54.12 39.28 30.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.822 2.049 . . . . 0.0 111.917 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -66.22 176.55 17.68 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.721 173.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.88 -8.04 12.77 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.451 2.1 . . . . 0.0 114.119 -174.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.69 4.84 19.1 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.629 1.585 . . . . 0.0 114.617 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.61 77.57 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 120.179 1.989 . . . . 0.0 112.805 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -85.57 -171.77 3.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.062 2.945 . . . . 0.0 110.164 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.45 150.5 39.1 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.807 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -130.87 162.77 28.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 131.528 3.931 . . . . 0.0 107.498 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 37' ' ' PHE . 1.3 m -154.91 140.94 18.36 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 161.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -112.19 154.72 25.11 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 170.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.1 t -118.93 122.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.13 109.97 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 107.681 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -85.4 48.52 1.59 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.077 1.351 . . . . 0.0 112.242 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 m -75.74 53.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 119.998 -1.689 . . . . 0.0 110.977 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.06 -46.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.226 1.81 . . . . 0.0 108.908 174.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.4 143.19 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -168.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.54 -131.57 51.18 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HE3' ' CB ' ' A' ' 25' ' ' GLU . 2.8 mmmt -97.94 5.18 49.2 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.351 1.06 . . . . 0.0 111.346 168.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.77 157.8 20.33 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 119.885 1.22 . . . . 0.0 110.637 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.8 m -171.54 162.49 6.52 Favored 'General case' 0 N--CA 1.442 -0.844 1 C-N-CA 132.386 4.274 . . . . 0.0 105.201 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 17' ' ' GLU . 12.0 t -109.94 157.41 10.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 170.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 mt -129.03 122.55 21.34 Favored Pre-proline 0 N--CA 1.441 -0.897 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -89.74 145.45 4.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.787 2.991 . . . . 0.0 108.849 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 35.49 41.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.088 1.755 . . . . 0.0 114.039 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -68.25 148.9 50.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.722 0.809 . . . . 0.0 109.098 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -86.19 -20.24 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.402 1.081 . . . . 0.0 111.303 163.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -52.3 125.06 14.84 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -62.44 -177.45 0.14 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.165 0.983 . . . . 0.0 109.036 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.36 149.06 33.05 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.609 1.164 . . . . 0.0 109.997 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -43.45 51.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.812 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -127.27 174.23 9.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.511 1.924 . . . . 0.0 109.136 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.9 m -133.75 -169.68 2.35 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.594 ' H ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -155.37 154.67 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 169.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -121.64 128.4 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.6 mtm -136.27 -29.15 1.0 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 117.367 -1.301 . . . . 0.0 111.718 165.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.81 153.6 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.872 1.269 . . . . 0.0 109.517 -166.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 10.1 t70 -54.47 -44.06 72.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.382 1.473 . . . . 0.0 111.216 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.0 t -56.81 -39.31 73.91 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.068 2.547 . . . . 0.0 109.925 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.19 -42.39 10.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.522 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.39 -52.32 62.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.34 1.056 . . . . 0.0 110.489 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.39 -53.45 56.49 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.68 -19.26 15.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.612 0.765 . . . . 0.0 113.054 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -79.81 0.05 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -30.33 59.85 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -166.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.1 m -74.71 -12.58 60.46 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.188 1.358 . . . . 0.0 110.542 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.06 73.56 1.18 Allowed Glycine 0 C--N 1.34 0.771 0 O-C-N 120.995 -1.066 . . . . 0.0 112.132 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -136.35 -25.37 1.18 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.492 0.717 . . . . 0.0 112.677 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.4 mmt -128.89 161.0 30.88 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.968 1.307 . . . . 0.0 109.327 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.14 128.88 58.26 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 124.621 1.168 . . . . 0.0 108.527 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.49 44.56 1.73 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.349 2.7 . . . . 0.0 112.324 -167.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -149.55 41.09 0.86 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.481 1.113 . . . . 0.0 110.248 -165.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -53.7 34.9 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.906 -1.122 . . . . 0.0 111.21 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.839 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . . . -51.68 -12.62 0.19 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -101.23 -57.14 2.15 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.666 2.387 . . . . 0.0 109.576 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -70.58 -60.43 2.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.075 1.75 . . . . 0.0 110.756 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -40.04 94.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.689 1.595 . . . . 0.0 109.759 170.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.87 17.58 79.99 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 121.336 -0.853 . . . . 0.0 113.621 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -64.01 -6.68 6.67 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.31 1.555 . . . . 0.0 113.657 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.8 tp 44.59 62.33 2.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.863 1.265 . . . . 0.0 109.417 -163.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.839 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 10.6 pttp -64.41 139.9 58.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 168.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.536 ' CG2' ' H ' ' A' ' 102' ' ' THR 0.321 33.4 mm -77.45 -172.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.722 -176.336 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.536 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -153.09 153.09 32.12 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.269 1.828 . . . . 0.0 106.488 -167.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.38 -90.65 1.2 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -159.63 172.89 16.97 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.062 0.945 . . . . 0.0 109.731 169.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 47.84 89.67 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.819 2.447 . . . . 0.0 113.92 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.12 -65.93 2.25 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.755 1.645 . . . . 0.0 113.192 160.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 108' ' ' ALA 0.276 1.2 pp 34.01 -78.41 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.109 1 C-N-CA 132.346 4.258 . . . . 0.0 114.48 174.96 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.616 ' H ' ' HG ' ' A' ' 107' ' ' LEU . . . -58.1 -46.17 85.98 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 128.701 2.8 . . . . 0.0 110.234 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.2 ttm -82.1 -34.32 29.36 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 124.307 1.004 . . . . 0.0 111.133 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.75 46.05 0.35 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.877 1.671 . . . . 0.0 111.397 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.15 79.87 5.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.067 1.347 . . . . 0.0 109.572 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . 0.252 2.6 mt-30 -116.25 -68.06 0.95 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -98.53 -51.4 3.95 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.579 1.552 . . . . 0.0 114.76 166.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.47 -56.19 18.98 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.728 0.811 . . . . 0.0 109.294 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.12 44.88 1.21 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.976 0.51 . . . . 0.0 110.49 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 116' ' ' LEU . 10.6 mt 49.88 -177.32 0.01 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.571 1.548 . . . . 0.0 112.933 -170.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.32 115.48 63.77 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 126.68 1.992 . . . . 0.0 109.265 -170.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.16 174.63 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.034 2.49 . . . . 0.0 112.909 -169.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.39 88.68 0.52 Allowed Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.002 1.287 . . . . 0.0 111.012 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -64.37 151.76 43.16 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 162.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 35.63 82.08 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.23 2.212 . . . . 0.0 113.336 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -143.25 175.97 9.49 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.059 1.344 . . . . 0.0 108.267 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 C--O 1.254 1.299 0 C-N-CA 123.838 0.855 . . . . 0.0 110.277 177.299 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -152.22 -179.76 7.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.507 1.523 . . . . 0.0 109.403 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.06 148.07 26.6 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.025 1.33 . . . . 0.0 107.888 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m -150.61 -16.24 0.23 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.271 0.1 OUTLIER 57.51 23.99 9.79 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.27 74.87 0.29 Allowed Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.243 -1.535 . . . . 0.0 111.492 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -153.87 158.74 41.22 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.606 1.562 . . . . 0.0 109.955 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -75.05 -13.34 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.841 165.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.86 -30.25 5.59 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.585 1.084 . . . . 0.0 112.575 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 127.135 2.174 . . . . 0.0 110.479 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.83 -31.43 71.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.191 1.396 . . . . 0.0 110.859 -174.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 t -90.63 -45.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.222 2.609 . . . . 0.0 110.989 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -65.14 -37.34 87.1 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.093 0.861 . . . . 0.0 111.797 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -52.25 -37.1 54.4 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 170.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.69 -41.27 96.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.921 0.782 . . . . 0.0 110.906 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.17 -51.68 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.29 -43.71 83.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.807 1.643 . . . . 0.0 112.768 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -65.32 -51.46 60.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -59.58 -38.97 82.59 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.317 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.48 -37.95 71.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.52 -53.38 43.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.29 -0.881 . . . . 0.0 111.938 165.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -55.21 -43.93 74.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.041 1.336 . . . . 0.0 112.136 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -165.42 65.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.621 2.768 . . . . 0.0 108.525 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.89 -25.66 75.36 Favored Glycine 0 CA--C 1.518 0.224 0 O-C-N 120.691 -1.256 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -44.22 62.44 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.952 0.876 . . . . 0.0 111.58 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -77.43 -22.66 51.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 121.426 -0.796 . . . . 0.0 110.815 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.17 -29.04 54.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -55.47 -38.83 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.153 0.888 . . . . 0.0 109.417 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -69.48 -11.17 60.61 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.53 -1.356 . . . . 0.0 114.013 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -78.07 -61.7 1.91 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 121.405 1.911 . . . . 0.0 111.199 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.77 -58.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.02 62.64 4.55 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 126.756 2.122 . . . . 0.0 112.724 -170.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.54 164.38 34.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 125.275 1.417 . . . . 0.0 110.657 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.03 128.36 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 159.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -129.82 159.36 36.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 110.899 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.74 166.67 10.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 109.212 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.485 ' H ' HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -130.09 91.92 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -172.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -78.84 104.41 9.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.307 0.958 . . . . 0.0 109.073 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.59 103.5 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.3 ptmm? -92.83 -171.03 2.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.8 t0 62.22 51.62 3.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 123.23 1.491 . . . . 0.0 111.333 148.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.87 -162.64 11.78 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 126.849 2.166 . . . . 0.0 109.627 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.9 85.84 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 124.053 3.169 . . . . 0.0 110.619 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.13 -20.87 4.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.826 1.679 . . . . 0.0 113.467 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.07 22.67 65.22 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 120.035 1.917 . . . . 0.0 111.285 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -79.06 -169.58 1.88 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.318 1.447 . . . . 0.0 108.409 168.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 34.6 tt0 -130.0 141.67 50.72 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.573 0.749 . . . . 0.0 109.378 170.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.97 160.98 14.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.016 2.527 . . . . 0.0 107.721 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 37' ' ' PHE . 91.5 m -140.05 142.56 36.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 147.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.1 140.83 47.54 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 161.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.13 142.16 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.51 113.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 42.49 1.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.848 1.659 . . . . 0.0 112.197 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 20' ' ' LEU . 1.9 m -74.63 60.37 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.822 1.249 . . . . 0.0 111.117 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -148.99 -46.14 0.14 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.234 1.814 . . . . 0.0 109.584 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -82.08 142.31 32.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.12 -127.71 25.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.953 0.797 . . . . 0.0 113.119 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -92.55 1.44 57.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.606 1.162 . . . . 0.0 111.909 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.12 157.83 15.33 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 120.185 1.357 . . . . 0.0 110.263 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -171.17 165.64 7.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 129.461 3.104 . . . . 0.0 108.509 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -107.96 156.12 8.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.086 1.754 . . . . 0.0 109.039 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -142.23 75.08 20.34 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 -162.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -63.18 140.07 75.83 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.357 2.038 . . . . 0.0 109.531 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 51.43 23.56 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.709 1.603 . . . . 0.0 114.132 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 t -79.22 144.5 34.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.485 0.659 . . . . 0.0 111.406 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.52 8.36 3.59 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 126.021 1.728 . . . . 0.0 111.057 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.91 135.22 57.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.437 -2.039 . . . . 0.0 109.546 162.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -66.95 -173.34 0.24 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.535 1.534 . . . . 0.0 109.482 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 165.85 33.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.293 1.037 . . . . 0.0 109.907 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.08 -50.32 16.78 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.068 160.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.4 m -134.83 -178.65 5.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.891 0.769 . . . . 0.0 111.461 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.645 HG22 ' H ' ' A' ' 73' ' ' ILE . 14.1 m -149.2 -164.66 2.08 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.645 ' H ' HG22 ' A' ' 72' ' ' THR . 5.6 tt -150.75 165.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 125.566 1.546 . . . . 0.0 107.159 161.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.555 ' H ' ' HA ' ' A' ' 100' ' ' LYS . 72.9 m -121.48 136.23 54.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.181 161.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.05 -98.33 0.15 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 152.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 178.0 152.24 0.27 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.755 3.222 . . . . 0.0 106.992 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.17 -40.59 90.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.796 1.638 . . . . 0.0 110.159 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.4 p -58.68 -22.77 57.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.771 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -105.72 -40.79 5.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.661 1.184 . . . . 0.0 109.982 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -53.99 50.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.342 1.457 . . . . 0.0 111.904 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -54.66 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.03 -12.9 58.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.896 -1.526 . . . . 0.0 114.043 -168.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.55 -76.33 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.765 1.626 . . . . 0.0 108.996 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -34.97 79.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 m -74.52 -10.76 59.87 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.681 -0.637 . . . . 0.0 109.881 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.8 20.47 61.37 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-O 118.494 -1.17 . . . . 0.0 114.116 154.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -100.29 -64.97 1.0 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.705 1.253 . . . . 0.0 111.246 -169.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 11.4 mtt -155.82 102.37 2.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 108.139 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -134.31 54.66 12.48 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 125.63 1.572 . . . . 0.0 109.709 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -62.67 149.07 92.37 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.798 2.332 . . . . 0.0 109.982 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -34.85 92.73 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.705 2.402 . . . . 0.0 112.064 -172.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.87 -91.76 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 119.595 1.089 . . . . 0.0 110.733 -160.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.573 ' CB ' ' HB3' ' A' ' 100' ' ' LYS . . . -63.64 -21.24 66.27 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.604 1.093 . . . . 0.0 111.169 175.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -64.64 -48.36 75.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.796 1.638 . . . . 0.0 110.775 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -75.6 -53.7 8.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.264 0.938 . . . . 0.0 108.862 171.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -71.4 -25.59 62.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.33 -159.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.66 27.85 70.53 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.899 1.227 . . . . 0.0 114.309 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -67.02 -86.84 0.02 OUTLIER 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.965 1.382 . . . . 0.0 110.262 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.6 tp -165.36 55.28 0.11 Allowed 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.96 -0.462 . . . . 0.0 111.02 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -80.17 169.2 18.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 120.995 -1.065 . . . . 0.0 108.263 174.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -135.85 171.23 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.5 p -150.42 -179.01 6.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.607 1.963 . . . . 0.0 107.977 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 172.6 50.29 0.04 OUTLIER Glycine 0 C--N 1.336 0.544 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 167.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -166.8 -67.86 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.716 0.806 . . . . 0.0 109.135 -166.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.2 ptm 177.46 -106.23 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.851 2.86 . . . . 0.0 107.806 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -138.13 80.87 0.28 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 121.08 1.764 . . . . 0.0 109.636 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.18 20.15 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.815 2.046 . . . . 0.0 115.817 -170.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.91 -94.09 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.668 1.187 . . . . 0.0 112.887 -167.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.0 mtt -105.59 7.39 32.78 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.392 1.477 . . . . 0.0 111.145 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.3 32.32 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.675 2.39 . . . . 0.0 111.833 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.02 164.38 38.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.212 1.805 . . . . 0.0 110.27 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -115.65 -81.59 0.61 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -53.75 -33.97 57.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.164 1.347 . . . . 0.0 113.317 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -15.39 25.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.535 0.734 . . . . 0.0 112.283 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -128.17 49.34 2.18 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.495 1.518 . . . . 0.0 109.104 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.4 mt 47.86 -176.02 0.01 OUTLIER 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.8 1.64 . . . . 0.0 111.823 -172.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.63 166.6 11.05 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 124.134 0.974 . . . . 0.0 111.343 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.73 174.63 5.3 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.15 2.567 . . . . 0.0 111.284 166.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.08 77.07 1.15 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -156.05 -73.2 0.11 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.25 1.02 . . . . 0.0 110.212 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 43.35 44.89 4.98 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.345 1.858 . . . . 0.0 114.512 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -134.37 154.72 51.2 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 120.452 -1.405 . . . . 0.0 108.61 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.249 1.045 0 C-N-CA 125.742 1.617 . . . . 0.0 110.463 -178.853 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 t 154.17 -82.03 0.0 OUTLIER 'General case' 0 C--O 1.237 0.42 1 C-N-CA 132.169 4.187 . . . . 0.0 105.324 169.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.8 179.91 7.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.003 2.121 . . . . 0.0 108.638 175.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.1 m -144.65 -83.26 0.15 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.714 1.205 . . . . 0.0 109.949 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 63.06 32.48 15.32 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 110.378 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.88 4.46 6.95 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.714 1.149 . . . . 0.0 112.483 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -65.51 160.2 22.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.583 1.191 . . . . 0.0 109.092 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -7.18 14.6 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.21 0.45 7.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 113.192 165.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -53.15 -53.62 47.76 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.482 1.492 . . . . 0.0 111.311 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.621 HD22 ' C ' ' A' ' 11' ' ' LEU 0.25 0.0 OUTLIER -57.29 -35.72 70.16 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.346 1.059 . . . . 0.0 113.439 173.395 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.555 HG22 ' SD ' ' A' ' 84' ' ' MET . 0.9 OUTLIER -58.9 -47.81 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.565 1.546 . . . . 0.0 110.463 178.137 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 97.8 m-85 -72.73 -33.62 66.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.332 0.969 . . . . 0.0 111.057 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -71.37 -24.57 62.11 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.421 -0.799 . . . . 0.0 112.777 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.08 -49.24 72.17 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.72 -0.613 . . . . 0.0 112.338 164.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -57.45 -48.85 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -58.15 -54.39 47.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.244 1.417 . . . . 0.0 110.984 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -36.31 81.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.406 1.003 . . . . 0.0 109.547 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -67.38 -39.71 85.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.568 1.147 . . . . 0.0 110.67 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -31.29 72.1 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.26 -51.69 65.11 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.677 173.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.31 -46.47 88.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 118.547 -1.261 . . . . 0.0 111.81 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -160.6 42.49 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.986 1.374 . . . . 0.0 112.306 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -52.57 -20.43 7.59 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.978 1.275 . . . . 0.0 114.856 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -58.0 -23.46 54.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.774 1.787 . . . . 0.0 113.866 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.35 -23.97 16.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.93 0.786 . . . . 0.0 109.145 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.23 -31.27 60.81 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.511 -1.368 . . . . 0.0 108.555 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 54' ' ' VAL . 19.9 t -52.11 -41.33 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.297 1.839 . . . . 0.0 109.6 163.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -70.89 -37.52 73.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.723 1.147 . . . . 0.0 110.985 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -60.2 -61.56 2.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.069 0.85 . . . . 0.0 110.055 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.5 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 84.9 mt -80.06 -57.05 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -172.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.31 52.85 36.68 Favored Glycine 0 CA--C 1.525 0.715 0 O-C-N 121.143 -0.973 . . . . 0.0 112.566 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.82 143.33 4.28 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.44 144.22 12.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -140.64 168.57 19.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.967 -0.458 . . . . 0.0 110.507 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.84 131.48 54.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.231 . . . . 0.0 109.787 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -84.91 104.26 14.7 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.808 1.243 . . . . 0.0 108.08 172.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -78.82 100.96 7.39 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 120.815 1.643 . . . . 0.0 110.408 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.409 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 19.3 t -104.48 93.54 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 175.09 6.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.272 -0.892 . . . . 0.0 111.274 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 59.37 24.31 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.695 2.398 . . . . 0.0 113.634 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 177.82 3.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.004 -167.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.52 91.67 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.15 2.566 . . . . 0.0 109.489 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.67 -72.87 0.44 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.052 1.31 . . . . 0.0 112.888 -156.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.04 -7.64 7.21 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.56 1.552 . . . . 0.0 112.894 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -69.47 -174.31 0.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.907 1.283 . . . . 0.0 110.837 170.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.7 147.3 49.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 108.474 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.22 167.62 17.37 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.251 2.62 . . . . 0.0 107.8 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 m -155.57 144.57 20.69 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.307 -0.871 . . . . 0.0 109.136 170.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.64 118.95 30.44 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -78.96 128.52 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.08 107.65 23.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -82.12 110.67 17.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 28' ' ' VAL . 1.3 m -133.36 48.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -133.54 -49.34 0.84 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 165.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -90.41 136.49 33.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.7 -142.26 41.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -80.22 -3.76 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.334 1.453 . . . . 0.0 114.351 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.47 156.58 6.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.654 1.116 . . . . 0.0 111.526 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m -172.62 151.85 2.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 129.123 2.969 . . . . 0.0 107.958 169.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.35 126.07 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt -103.4 99.74 16.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.45 147.87 53.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.852 2.368 . . . . 0.0 108.937 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 47.49 23.48 0.39 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.362 1.865 . . . . 0.0 113.683 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 t -81.88 155.87 25.11 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.408 1.099 . . . . 0.0 111.424 -156.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -25.45 27.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.408 1.083 . . . . 0.0 109.946 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -74.28 129.44 37.81 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.802 0.728 . . . . 0.0 109.153 -166.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -73.11 -177.83 2.62 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.797 1.239 . . . . 0.0 112.41 -163.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.05 174.62 5.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.336 -165.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -57.08 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.002 -1.686 . . . . 0.0 108.353 148.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.41 -177.74 5.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.568 1.947 . . . . 0.0 109.413 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 m -131.15 -173.72 3.18 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.841 -1.162 . . . . 0.0 107.958 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 tt -155.17 146.7 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.3 m -111.19 132.02 54.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 117.122 -1.418 . . . . 0.0 107.68 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.512 ' HG3' ' HB2' ' A' ' 93' ' ' ALA . 10.9 mtm -137.08 -48.5 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.854 -1.07 . . . . 0.0 111.993 166.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.54 153.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.362 3.065 . . . . 0.0 110.81 -161.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.93 -39.99 93.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.142 0.901 . . . . 0.0 108.67 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.74 68.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.077 0.465 . . . . 0.0 110.362 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.51 -49.45 6.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.556 -1.212 . . . . 0.0 107.812 -168.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -56.98 -40.53 76.69 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.471 1.108 . . . . 0.0 110.977 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.4 tp -64.28 -60.52 3.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.49 -35.59 65.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.248 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.34 -70.53 0.09 Allowed 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.107 1.763 . . . . 0.0 108.143 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 12' ' ' VAL . 1.4 ptp -69.4 -33.88 73.66 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.565 0.62 . . . . 0.0 111.906 -172.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.8 m -74.22 -8.06 54.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.826 1.251 . . . . 0.0 111.502 -171.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.9 72.01 0.73 Allowed Glycine 0 C--N 1.335 0.48 0 O-C-N 120.805 -1.184 . . . . 0.0 110.305 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -144.79 -47.5 0.24 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.38 1.072 . . . . 0.0 108.795 166.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.0 mmt -126.34 103.32 7.58 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.485 1.114 . . . . 0.0 108.7 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -44.92 69.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 117.632 -1.175 . . . . 0.0 113.103 169.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -83.6 -158.68 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.522 2.148 . . . . 0.0 111.627 -170.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -60.47 84.12 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.569 1.548 . . . . 0.0 110.496 173.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 t -57.9 -34.43 69.81 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.873 -1.142 . . . . 0.0 111.234 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -65.31 -15.97 63.08 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.807 -1.183 . . . . 0.0 113.539 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -75.19 -43.11 53.95 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 125.128 1.371 . . . . 0.0 110.227 171.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -61.82 -53.23 58.67 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.62 1.568 . . . . 0.0 110.383 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.7 -18.81 65.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.796 1.18 . . . . 0.0 111.888 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.67 37.49 14.05 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 127.398 2.427 . . . . 0.0 115.019 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -74.32 -101.46 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.985 1.314 . . . . 0.0 109.263 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.65 71.09 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.97 1.308 . . . . 0.0 109.285 -171.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.676 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -83.67 154.28 23.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -104.88 165.23 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -166.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.7 p -87.55 -165.07 1.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.39 116.35 4.05 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 31' ' ' ILE . 19.0 t-20 60.75 115.93 0.02 OUTLIER 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.656 2.382 . . . . 0.0 111.667 -169.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.8 105.12 0.11 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.457 1.503 . . . . 0.0 110.346 174.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.36 63.64 4.21 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.529 2.014 . . . . 0.0 113.481 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -70.69 4.03 2.76 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.49 -79.04 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.425 1.466 . . . . 0.0 111.435 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -83.13 2.41 35.54 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.098 -1.001 . . . . 0.0 113.31 -167.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -7.88 54.2 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.929 -1.107 . . . . 0.0 113.202 -170.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -176.78 2.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.011 1.724 . . . . 0.0 111.436 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -115.05 -67.03 1.02 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 166.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -81.34 -96.64 0.04 OUTLIER 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tp 48.85 -61.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.728 2.011 . . . . 0.0 111.384 -152.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -135.11 62.88 1.63 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 127.372 2.269 . . . . 0.0 109.895 -163.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.31 0.1 OUTLIER 50.78 -175.48 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.608 1.963 . . . . 0.0 113.175 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.09 175.32 3.25 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.459 1.504 . . . . 0.0 109.508 167.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.67 174.94 11.86 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.922 1.748 . . . . 0.0 112.043 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -157.49 -75.34 0.02 OUTLIER Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -144.34 81.52 1.67 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.707 1.203 . . . . 0.0 108.608 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.28 163.1 16.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 158.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.93 104.64 4.72 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 165.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.181 0 C-N-CA 128.255 2.622 . . . . 0.0 111.089 -163.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 p -151.55 -152.37 0.43 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.373 1.869 . . . . 0.0 107.374 -166.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.9 151.68 49.35 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 152.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 m -144.3 -15.25 0.58 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.302 1.041 . . . . 0.0 111.641 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 51.25 32.5 8.25 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.727 1.211 . . . . 0.0 110.622 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.86 84.4 0.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -164.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -153.8 170.59 20.6 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 128.83 2.852 . . . . 0.0 104.501 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -29.77 70.76 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.299 -0.875 . . . . 0.0 110.078 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.86 -11.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.316 1.846 . . . . 0.0 114.815 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -53.7 -40.55 66.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.675 1.579 . . . . 0.0 110.856 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -65.47 -36.68 84.61 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.757 176.004 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.698 HG13 ' SD ' ' A' ' 84' ' ' MET . 2.6 t -61.77 -59.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.179 0.992 . . . . 0.0 110.839 -173.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.593 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 64.3 m-85 -63.71 -23.99 67.59 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.982 0.81 . . . . 0.0 110.923 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 28.0 tttt -70.34 -25.46 63.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.512 ' HG3' HD21 ' A' ' 116' ' ' LEU . 77.5 mm-40 -67.59 -40.8 84.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.602 0.637 . . . . 0.0 110.939 173.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.68 -48.64 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.384 1.474 . . . . 0.0 107.56 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 14' ' ' LYS . 25.5 tt0 -51.26 -49.93 60.23 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.053 169.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -58.68 -40.65 84.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -65.28 -47.41 76.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.73 1.212 . . . . 0.0 111.707 173.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -33.1 63.83 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.427 0.691 . . . . 0.0 112.009 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.94 -52.59 55.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.828 -1.17 . . . . 0.0 110.22 169.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -53.7 -45.98 70.58 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.949 1.25 . . . . 0.0 111.315 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -162.36 49.76 0.18 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.859 0.838 . . . . 0.0 112.349 -170.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.36 -28.3 61.75 Favored Glycine 0 C--O 1.223 -0.585 0 O-C-N 120.496 -1.378 . . . . 0.0 113.273 -174.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.85 -24.65 64.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -78.31 -41.7 32.96 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.716 -1.24 . . . . 0.0 110.138 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -67.1 -36.05 81.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 108.659 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 54' ' ' VAL . 9.5 t -51.01 -42.11 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 127.834 2.453 . . . . 0.0 111.018 169.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -72.29 -23.77 61.23 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.458 -1.401 . . . . 0.0 111.052 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -89.57 -14.17 35.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -173.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.9 -55.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.484 1.514 . . . . 0.0 107.535 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.39 59.85 7.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 124.85 1.214 . . . . 0.0 111.888 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.04 -177.96 43.6 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.25 138.38 31.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 160.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -129.03 164.72 22.63 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.331 0.586 . . . . 0.0 110.255 165.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.33 166.18 11.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.1 163.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -123.18 98.36 5.84 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.588 1.555 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.52 ' HD2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -73.71 109.21 7.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 120.218 1.372 . . . . 0.0 109.282 172.358 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG22 ' CE2' ' A' ' 80' ' ' PHE . 21.7 t -122.41 93.48 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -96.55 177.89 5.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.959 1.704 . . . . 0.0 109.923 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 65.01 24.52 12.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.081 1.352 . . . . 0.0 112.482 162.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.56 -168.38 33.68 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.835 1.683 . . . . 0.0 112.394 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.71 96.12 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.305 2.67 . . . . 0.0 110.079 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.09 -13.05 10.52 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 127.663 2.554 . . . . 0.0 112.582 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.59 21.08 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 126.108 1.813 . . . . 0.0 112.537 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -51.03 -175.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 129.251 3.02 . . . . 0.0 111.809 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.07 161.46 33.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.834 0.826 . . . . 0.0 110.964 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.37 173.63 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.745 2.418 . . . . 0.0 107.862 161.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.7 m -140.73 156.58 46.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -124.73 149.82 46.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 164.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.96 143.02 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.3 110.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.48 122.26 24.98 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 164.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.536 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -135.78 46.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.01 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -138.83 -46.53 0.49 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.101 0.961 . . . . 0.0 110.639 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.68 103.13 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -156.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.03 -118.29 7.16 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.884 -1.135 . . . . 0.0 111.123 -170.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -74.82 -5.12 41.78 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 171.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.98 -103.4 0.77 Allowed Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 127.774 2.606 . . . . 0.0 108.232 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 m 97.39 157.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 135.444 5.497 . . . . 0.0 110.147 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.5 t -77.09 157.97 5.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.9 mt -143.72 84.88 9.58 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 -169.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.1 152.52 76.34 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 N-CA-C 108.202 -1.499 . . . . 0.0 108.202 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.3 23.52 4.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.196 1.398 . . . . 0.0 112.188 170.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -82.65 146.49 29.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.267 -0.896 . . . . 0.0 110.86 -154.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.45 -0.34 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.634 163.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -59.16 139.75 56.6 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.997 1.272 . . . . 0.0 108.061 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -69.43 -176.43 0.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.23 159.59 43.47 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.401 0.68 . . . . 0.0 111.03 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -36.6 65.34 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.354 1.062 . . . . 0.0 111.494 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.21 -177.05 6.07 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.09 1.756 . . . . 0.0 109.018 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 38' ' ' LYS . 24.3 m -133.35 -172.7 3.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.494 ' H ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.87 146.64 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.7 m -103.76 131.08 51.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 mtp -137.09 -48.88 0.61 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.83 160.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 129.948 3.299 . . . . 0.0 109.57 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.01 -46.89 71.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.389 1.876 . . . . 0.0 109.693 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -62.65 -18.77 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 112.281 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -105.97 -37.15 6.74 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.699 0.8 . . . . 0.0 112.143 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 39' ' ' VAL . 10.0 m-85 -65.79 -54.17 30.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.687 1.195 . . . . 0.0 110.674 173.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.21 -36.09 80.88 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.76 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -48.22 -38.33 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.541 1.136 . . . . 0.0 112.546 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 88' ' ' MET . 0.1 OUTLIER -57.05 -74.12 0.06 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.698 ' SD ' HG13 ' A' ' 12' ' ' VAL . 16.3 ptp -76.49 52.47 0.79 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.2 p -142.94 2.29 1.33 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.985 1.714 . . . . 0.0 110.173 156.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.21 86.47 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 118.324 -1.265 . . . . 0.0 113.951 174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -64.73 -59.4 4.28 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.625 1.713 . . . . 0.0 108.15 166.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.418 ' HA ' HD12 ' A' ' 83' ' ' LEU 0.25 8.2 ptt? 44.34 47.23 7.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.873 2.469 . . . . 0.0 115.719 168.139 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -60.54 133.7 91.41 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -72.25 124.71 10.18 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.14 2.56 . . . . 0.0 111.999 -162.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 39.34 57.78 2.01 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.924 2.09 . . . . 0.0 110.9 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -33.83 75.57 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.899 1.28 . . . . 0.0 112.274 -167.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -73.41 -21.62 60.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.06 1.3 . . . . 0.0 111.626 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -74.68 -42.81 57.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.969 0.908 . . . . 0.0 110.388 166.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.08 -66.27 0.56 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.353 1.061 . . . . 0.0 110.093 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.91 -21.7 65.98 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.992 0.917 . . . . 0.0 111.399 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.12 41.06 99.34 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.428 -0.651 . . . . 0.0 113.011 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -64.39 -76.6 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.774 1.287 . . . . 0.0 109.166 -177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.07 52.84 0.09 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.619 1.568 . . . . 0.0 109.931 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.519 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -71.14 162.91 28.64 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.814 -1.179 . . . . 0.0 108.585 -172.061 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.98 167.84 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.1 p -87.99 171.65 10.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.415 1.086 . . . . 0.0 109.62 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -159.03 -20.12 0.03 OUTLIER Glycine 0 C--N 1.336 0.544 0 CA-C-O 117.615 -1.658 . . . . 0.0 115.689 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 174.79 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.506 1.922 . . . . 0.0 108.299 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 16.9 mtt -158.09 -91.94 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.767 2.427 . . . . 0.0 106.507 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -91.2 36.44 3.63 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 119.408 1.004 . . . . 0.0 113.718 -167.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -52.41 -44.51 65.42 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.683 1.193 . . . . 0.0 111.971 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.69 0.87 13.78 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 32.9 ttm -164.9 47.01 0.1 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.309 1.413 . . . . 0.0 111.315 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -68.35 -50.65 51.71 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.996 -1.065 . . . . 0.0 111.631 -171.639 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.13 178.07 7.26 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.187 1.395 . . . . 0.0 108.981 174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -71.72 0.06 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 124.629 1.171 . . . . 0.0 111.051 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -67.11 -3.92 8.73 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -168.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.57 -3.55 57.77 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.26 -0.9 . . . . 0.0 110.872 170.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -164.79 48.27 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.883 1.273 . . . . 0.0 111.76 -164.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 15' ' ' GLU . 6.6 mt 53.85 177.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.362 2.265 . . . . 0.0 114.595 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.36 153.37 85.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -66.65 176.08 4.62 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.46 1.44 . . . . 0.0 110.425 165.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 160.37 58.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -61.95 119.02 8.05 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 35.45 55.39 0.86 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.069 2.148 . . . . 0.0 112.269 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -77.55 70.02 3.88 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.456 -0.777 . . . . 0.0 110.223 -172.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.243 0.748 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 146.731 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.51 168.39 0.58 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.852 1.661 . . . . 0.0 112.102 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 80.81 -10.39 1.24 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.837 2.855 . . . . 0.0 115.033 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.4 m -73.96 -84.88 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 116.994 -1.479 . . . . 0.0 109.203 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.317 0.0 OUTLIER 47.11 24.27 0.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 157.13 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.48 10.29 33.03 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 119.255 -2.153 . . . . 0.0 114.335 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 28.4 m-85 -77.7 171.37 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.576 1.15 . . . . 0.0 112.856 -160.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.35 -23.77 51.0 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.727 -1.233 . . . . 0.0 111.62 163.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.17 -20.58 42.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.784 1.174 . . . . 0.0 113.496 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -73.23 -19.16 61.14 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.927 1.691 . . . . 0.0 111.146 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.51 -63.45 1.37 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.167 1.787 . . . . 0.0 106.289 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.702 HG13 ' SD ' ' A' ' 84' ' ' MET . 4.6 t -59.58 -56.87 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.085 1.354 . . . . 0.0 112.518 -167.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.49 -21.68 64.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.248 0.931 . . . . 0.0 110.986 -173.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -67.06 -34.01 76.76 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.495 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.643 ' HG3' HD21 ' A' ' 116' ' ' LEU . 15.5 mm-40 -59.02 -33.84 71.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.642 1.11 . . . . 0.0 112.163 174.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -72.18 -46.75 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -55.6 -49.5 72.62 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.323 1.049 . . . . 0.0 111.48 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.082 0.953 . . . . 0.0 109.388 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -70.07 -39.37 75.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.482 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -43.15 79.95 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.645 1.111 . . . . 0.0 113.034 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -63.71 -51.99 62.57 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.278 1.431 . . . . 0.0 110.186 173.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.65 -46.24 87.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.4 -1.438 . . . . 0.0 112.755 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -166.34 62.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.41 1.484 . . . . 0.0 111.976 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.97 -20.19 79.73 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 125.36 1.457 . . . . 0.0 113.528 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -33.79 24.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.681 1.24 . . . . 0.0 112.996 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.457 ' OE1' ' HE2' ' A' ' 30' ' ' LYS . 1.1 tm0? -91.71 -35.25 14.27 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.454 1.502 . . . . 0.0 110.702 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.53 -34.77 71.35 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 108.967 168.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -57.64 -62.35 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 119.824 1.193 . . . . 0.0 108.612 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.79 -20.06 60.75 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HE2' ' OE1' ' A' ' 26' ' ' GLN . 53.1 mttm -67.93 -67.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.905 1.282 . . . . 0.0 111.44 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.6 -60.53 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 109.196 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.05 9.91 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.072 1.796 . . . . 0.0 113.817 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.73 176.51 44.19 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 117.955 0.878 . . . . 0.0 111.493 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 mt -102.14 138.16 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 162.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -135.86 157.84 45.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.79 167.19 10.04 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.293 1.037 . . . . 0.0 109.865 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -129.57 105.78 8.3 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.917 1.687 . . . . 0.0 108.644 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -74.38 121.57 21.6 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 168.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.483 HG22 ' CE2' ' A' ' 80' ' ' PHE . 5.3 t -119.23 110.69 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 171.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -114.03 174.79 5.76 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t0 61.59 24.8 14.84 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.504 1.522 . . . . 0.0 112.478 173.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 77' ' ' ASP . . . -70.87 -176.81 23.15 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.859 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.67 44.3 0.32 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.625 3.55 . . . . 0.0 113.428 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.24 -19.76 0.02 OUTLIER Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.288 2.375 . . . . 0.0 112.698 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.48 -7.71 81.36 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 120.853 2.326 . . . . 0.0 113.351 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -69.19 -173.28 0.51 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.608 157.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.22 158.73 36.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.564 1.945 . . . . 0.0 108.697 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -119.9 174.69 6.3 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.156 2.182 . . . . 0.0 107.51 166.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.6 m -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.145 0.978 . . . . 0.0 108.989 161.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -118.73 152.96 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 170.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.1 t -115.62 135.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 171.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.5 t -116.6 120.79 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.63 116.71 28.73 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.0 52.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -145.31 -49.5 0.24 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.638 1.175 . . . . 0.0 110.371 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -90.61 139.46 30.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -164.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.83 -135.48 46.33 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -89.79 6.62 40.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.053 1.741 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.24 158.14 27.33 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -172.13 145.64 1.8 Allowed 'General case' 0 C--O 1.237 0.447 0 C-N-CA 127.006 2.122 . . . . 0.0 105.588 159.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 157.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mt -136.28 80.57 39.83 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.34 145.17 87.9 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.234 1.956 . . . . 0.0 109.043 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.91 23.95 3.1 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.582 2.353 . . . . 0.0 112.2 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -89.95 140.5 29.57 Favored 'General case' 0 CA--C 1.524 -0.052 0 O-C-N 120.417 -1.427 . . . . 0.0 109.489 -163.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.8 -22.63 65.16 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.374 0.67 . . . . 0.0 111.345 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -58.27 130.3 46.06 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.372 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -60.78 -176.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.235 1.414 . . . . 0.0 111.316 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.26 173.2 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 110.567 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -49.18 19.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 163.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.3 m -146.6 -179.43 6.76 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.641 1.576 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.809 HG22 ' H ' ' A' ' 73' ' ' ILE . 15.0 m -132.51 -165.93 1.67 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.488 1.115 . . . . 0.0 108.194 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.809 ' H ' HG22 ' A' ' 72' ' ' THR . 4.0 tt -150.54 172.75 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.937 -1.102 . . . . 0.0 109.593 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.5 m -122.31 124.07 42.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 163.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.469 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 1.9 mtm -151.73 120.79 6.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 166.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.09 164.07 1.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.426 . . . . 0.0 110.106 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 16.3 t70 -58.9 -54.24 49.34 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.875 0.87 . . . . 0.0 109.405 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -67.59 1.22 2.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.37 1.068 . . . . 0.0 112.691 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -60.85 1.5 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.259 1.824 . . . . 0.0 108.883 168.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.483 ' CE2' HG22 ' A' ' 39' ' ' VAL . 21.4 m-85 -56.18 -41.04 74.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.965 1.306 . . . . 0.0 112.893 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.42 -44.37 62.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.658 0.783 . . . . 0.0 109.417 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -27.77 64.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.739 . . . . 0.0 112.153 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.2 -78.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 C-N-CA 126.365 1.866 . . . . 0.0 109.718 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.702 ' SD ' HG13 ' A' ' 12' ' ' VAL . 6.0 ptp -77.24 51.46 0.84 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.1 p -150.04 14.54 0.81 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.465 1.906 . . . . 0.0 109.857 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.31 1.98 17.33 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.575 1.084 . . . . 0.0 113.883 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -81.31 -32.0 33.29 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 119.556 1.678 . . . . 0.0 110.064 -172.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.8 mmt -114.89 178.21 4.37 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.158 1.383 . . . . 0.0 108.394 166.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -98.26 154.4 37.66 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.217 1.407 . . . . 0.0 110.135 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.79 166.17 25.29 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.525 2.15 . . . . 0.0 109.734 171.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.94 63.07 2.33 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.96 1.362 . . . . 0.0 109.4 -158.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -72.13 -48.74 41.38 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.012 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.736 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -50.22 -33.85 20.92 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 121.01 1.732 . . . . 0.0 114.49 172.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -64.31 -53.14 53.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -56.48 -66.89 0.36 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.873 1.669 . . . . 0.0 112.177 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -17.02 63.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.143 1.338 . . . . 0.0 112.635 -173.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.98 4.26 54.6 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 121.026 1.739 . . . . 0.0 114.054 172.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -69.16 24.49 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.538 2.735 . . . . 0.0 114.248 -174.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.7 tp 41.7 75.6 0.08 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 127.845 2.458 . . . . 0.0 111.36 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.736 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -65.06 145.82 55.82 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -177.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.1 mm -74.78 162.38 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 67.2 p -82.74 -170.31 2.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.454 0.701 . . . . 0.0 109.282 -174.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.75 -57.88 0.23 Allowed Glycine 0 N--CA 1.444 -0.807 0 O-C-N 120.687 -1.258 . . . . 0.0 110.592 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -145.37 151.59 38.53 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.923 1.362 . . . . 0.0 111.028 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 11.7 mmt -57.87 -71.59 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.114 1.366 . . . . 0.0 110.948 -165.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.06 25.53 6.06 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.418 1.008 . . . . 0.0 112.187 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -35.72 75.36 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.311 1.556 . . . . 0.0 110.87 177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.04 1.65 23.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.264 1.425 . . . . 0.0 112.42 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.8 ttp -105.86 -37.83 6.56 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.694 1.198 . . . . 0.0 112.556 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -77.4 -58.89 3.02 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.404 -1.435 . . . . 0.0 112.388 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 pt? 38.45 15.88 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.917 1 C-N-CA 131.893 4.077 . . . . 0.0 117.511 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -44.89 -86.01 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 121.725 2.057 . . . . 0.0 112.083 -154.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.58 -6.93 44.48 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 127.334 2.254 . . . . 0.0 113.269 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mp -71.66 -7.07 45.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 117.806 -1.092 . . . . 0.0 110.894 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.3 46.92 2.27 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 120.26 1.391 . . . . 0.0 112.938 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.643 HD21 ' HG3' ' A' ' 15' ' ' GLU . 26.4 mt 56.3 -172.45 0.07 Allowed 'General case' 0 C--N 1.347 0.489 0 CA-C-O 123.603 1.668 . . . . 0.0 110.544 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.9 125.9 19.45 Favored Pre-proline 0 N--CA 1.43 -1.444 0 C-N-CA 127.678 2.391 . . . . 0.0 106.206 178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.19 173.39 11.43 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.487 1.458 . . . . 0.0 109.696 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -125.37 -161.57 11.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 123.991 0.805 . . . . 0.0 111.634 -171.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.03 63.31 4.5 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.741 1.216 . . . . 0.0 109.304 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.53 155.47 25.72 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.262 1.425 . . . . 0.0 112.724 -163.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -158.83 131.6 7.01 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.586 1.555 . . . . 0.0 108.257 173.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.247 0.95 0 C-N-CA 127.571 2.348 . . . . 0.0 112.987 173.594 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 119.471 -0.299 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t 64.59 -59.92 0.22 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 129.819 3.247 . . . . 0.0 114.125 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.19 111.15 0.02 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.917 2.087 . . . . 0.0 110.986 -170.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.5 m -143.4 -45.08 0.28 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.72 1.208 . . . . 0.0 109.242 -170.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.92 33.99 23.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.482 0.489 . . . . 0.0 111.63 150.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.63 39.83 0.64 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.936 1.732 . . . . 0.0 109.874 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -85.54 177.87 7.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -66.42 -22.66 66.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.522 -1.362 . . . . 0.0 111.037 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.24 -5.07 1.38 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.37 -47.33 85.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.081 1.31 . . . . 0.0 112.422 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.544 HD22 ' C ' ' A' ' 11' ' ' LEU 0.266 0.0 OUTLIER -68.97 -33.11 73.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.547 0.739 . . . . 0.0 111.53 176.349 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.25 -53.19 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.969 1.708 . . . . 0.0 110.396 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -67.5 -21.91 65.48 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.728 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -75.46 -26.41 58.23 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.494 -1.241 . . . . 0.0 112.768 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -57.09 -41.09 78.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.46 1.482 . . . . 0.0 110.773 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.496 HD11 ' CE ' ' A' ' 84' ' ' MET . 76.6 mt -61.69 -47.72 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.18 -51.32 70.52 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.378 0.671 . . . . 0.0 110.775 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -53.0 -50.83 63.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.171 2.188 . . . . 0.0 108.639 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -34.38 73.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.198 . . . . 0.0 111.349 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -32.6 61.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 0.0 112.811 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -63.35 -53.81 46.84 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.834 0.854 . . . . 0.0 109.994 170.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -62.74 -45.82 90.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 110.863 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -159.41 58.0 0.4 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.208 1.004 . . . . 0.0 109.217 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.22 -23.06 66.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.315 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -59.38 -43.11 92.94 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.715 1.757 . . . . 0.0 111.6 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.14 -32.4 73.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.627 -0.671 . . . . 0.0 111.465 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -75.62 -34.35 60.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 108.619 -171.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.37 -48.73 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.704 1.202 . . . . 0.0 109.208 164.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -70.99 -10.68 60.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.805 -1.185 . . . . 0.0 113.437 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -86.02 -30.53 22.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.368 1.44 . . . . 0.0 113.603 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.56 -54.11 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.696 1.198 . . . . 0.0 108.772 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.73 57.11 11.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.669 2.08 . . . . 0.0 114.786 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.74 -171.18 37.29 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.348 1.574 . . . . 0.0 111.738 -176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.24 124.55 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 158.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -120.93 173.76 7.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.22 142.82 51.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.087 0.955 . . . . 0.0 109.411 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -88.27 91.53 8.82 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 124.969 1.308 . . . . 0.0 110.259 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -74.88 89.08 2.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.577 -1.327 . . . . 0.0 112.241 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.576 HG22 ' CD2' ' A' ' 80' ' ' PHE . 51.1 t -93.58 123.41 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -115.78 174.89 5.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.384 1.474 . . . . 0.0 110.357 158.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.53 61.17 2.06 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.803 1.641 . . . . 0.0 114.82 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.8 -152.44 8.85 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 126.329 1.919 . . . . 0.0 111.933 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.65 5.9 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.185 3.257 . . . . 0.0 114.605 -169.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.45 -49.13 0.21 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 159.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.94 -24.16 4.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.575 1.188 . . . . 0.0 111.402 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -62.16 -175.65 0.08 Allowed 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.087 1.755 . . . . 0.0 111.279 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -127.42 147.65 50.29 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -172.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.87 170.76 15.4 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.675 1.99 . . . . 0.0 108.087 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -155.9 149.42 24.88 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.62 133.1 55.4 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 166.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.95 142.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.68 113.27 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.54 123.96 30.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 165.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.15 39.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 126.365 1.866 . . . . 0.0 107.76 173.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -124.67 -39.31 2.3 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.574 1.15 . . . . 0.0 109.674 162.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -95.04 115.88 27.99 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -155.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.98 49.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -74.81 -2.68 27.76 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.123 173.412 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.31 157.1 14.11 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -168.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 m -171.46 133.28 0.8 Allowed 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 128.507 2.723 . . . . 0.0 106.137 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.96 147.93 8.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -125.53 93.54 44.52 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.79 150.75 44.98 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.278 1.985 . . . . 0.0 109.381 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.13 22.85 0.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.941 2.497 . . . . 0.0 114.507 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.48 147.79 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.419 -155.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.49 -5.09 46.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.96 0.904 . . . . 0.0 111.279 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -44.9 129.12 7.27 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.868 1.667 . . . . 0.0 108.736 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -69.06 -176.0 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.919 0.866 . . . . 0.0 109.04 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.2 151.77 37.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.205 1.002 . . . . 0.0 108.956 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -75.82 -31.01 59.19 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.932 0.493 . . . . 0.0 112.156 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.1 m -148.37 173.02 13.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.822 2.449 . . . . 0.0 107.689 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -155.48 114.7 3.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.129 -1.607 . . . . 0.0 108.063 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.13 146.18 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.0 m -122.55 131.27 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.122 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 mmm -138.73 -12.56 1.3 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.703 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 67.5 151.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.419 1.888 . . . . 0.0 111.107 -164.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.37 -35.41 79.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.342 -0.837 . . . . 0.0 111.929 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -58.09 2.72 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.73 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.576 ' CD2' HG22 ' A' ' 39' ' ' VAL . 34.6 m-85 -51.21 -55.69 16.76 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.232 1.013 . . . . 0.0 112.139 -173.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -54.14 -58.47 7.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.297 0.953 . . . . 0.0 109.331 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.38 -39.48 73.0 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.878 0.736 . . . . 0.0 112.149 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 tt -55.69 -56.61 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.769 2.428 . . . . 0.0 110.306 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.496 ' CE ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -74.53 -26.92 60.29 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.289 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.4 m -74.53 -15.5 60.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.83 -1.169 . . . . 0.0 113.304 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 57.61 3.37 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -168.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.9 tttt -145.21 -32.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.979 1.712 . . . . 0.0 111.034 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 11.6 mtt 58.14 165.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.165 2.586 . . . . 0.0 112.567 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -142.7 158.18 60.34 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 151.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -59.51 125.91 19.21 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.526 2.15 . . . . 0.0 109.387 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -34.74 101.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.207 0 C-N-CA 129.486 3.114 . . . . 0.0 112.518 -167.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -52.6 46.54 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.073 -172.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 100' ' ' LYS . . . -52.09 -19.17 1.76 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -82.49 -74.42 0.35 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.057 0.943 . . . . 0.0 108.49 166.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -61.19 -40.44 93.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.215 1.406 . . . . 0.0 113.961 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -14.23 60.79 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.48 1.112 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.66 -7.97 0.22 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.898 1.714 . . . . 0.0 115.135 -172.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -64.42 -0.93 1.47 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -163.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.7 tp 54.43 90.71 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.233 1.813 . . . . 0.0 110.496 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 93' ' ' ALA . 16.6 pttm -66.65 171.65 4.95 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.513 ' CG2' ' H ' ' A' ' 102' ' ' THR 0.268 2.5 mp -127.96 -162.65 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -176.599 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.513 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 18.3 p 57.73 -171.21 0.1 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.286 2.234 . . . . 0.0 112.53 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.7 120.11 1.51 Allowed Glycine 0 CA--C 1.527 0.826 0 O-C-N 120.796 -1.19 . . . . 0.0 112.286 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.78 -60.59 1.61 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.086 1.355 . . . . 0.0 111.526 156.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.2 ttm -170.24 74.52 0.07 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.963 2.105 . . . . 0.0 111.072 175.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.39 65.05 1.83 Allowed Glycine 0 CA--C 1.531 1.065 0 O-C-N 120.428 -1.42 . . . . 0.0 113.436 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . 0.274 0.2 OUTLIER -86.92 36.75 0.73 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.73 -80.31 0.21 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.627 1.558 . . . . 0.0 108.787 168.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 68.0 mtm -134.1 27.86 3.83 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.446 1.099 . . . . 0.0 109.857 -169.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -75.17 -43.29 53.08 Favored 'General case' 0 CA--C 1.527 0.061 0 O-C-N 121.187 -0.946 . . . . 0.0 109.726 167.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.27 156.13 29.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.075 2.15 . . . . 0.0 111.917 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -117.73 -47.96 2.59 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -166.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -98.13 -39.3 8.96 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.771 0.829 . . . . 0.0 112.864 168.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 115.05 7.5 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 70.06 44.9 0.74 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.221 1.008 . . . . 0.0 110.624 -172.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.8 mt 48.35 -173.39 0.01 OUTLIER 'General case' 0 C--N 1.345 0.41 0 C-N-CA 125.497 1.519 . . . . 0.0 111.896 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.92 113.76 62.04 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.348 -177.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.52 174.67 11.28 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.154 1.903 . . . . 0.0 111.025 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.4 95.77 1.29 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -54.22 116.43 2.6 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.366 1.467 . . . . 0.0 112.066 -168.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.49 164.82 15.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.477 2.311 . . . . 0.0 112.326 -161.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.16 139.67 35.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 160.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 C--O 1.25 1.105 0 C-N-CA 128.075 2.55 . . . . 0.0 110.606 -170.585 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 t -152.38 114.54 4.45 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.697 -1.252 . . . . 0.0 109.87 168.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.43 63.12 1.42 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 161.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 t -70.19 -82.5 0.04 OUTLIER 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 124.768 1.227 . . . . 0.0 108.546 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.26 50.04 6.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.392 0.615 . . . . 0.0 111.006 167.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.39 22.39 0.75 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.352 1.453 . . . . 0.0 113.722 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -82.6 177.69 8.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.875 1.337 . . . . 0.0 109.827 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -66.15 -23.42 66.47 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 118.023 -1.471 . . . . 0.0 111.468 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.84 -18.68 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 114.35 169.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 3.5 t-20 -53.09 -44.64 67.73 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.825 0.85 . . . . 0.0 111.024 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.286 0.0 OUTLIER -85.05 -30.22 24.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.573 0.749 . . . . 0.0 111.769 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.55 -54.23 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.593 1.157 . . . . 0.0 110.656 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.15 -20.9 63.13 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.244 -0.91 . . . . 0.0 111.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 22.2 ttmt -75.9 -28.14 57.94 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 118.016 -0.992 . . . . 0.0 113.535 175.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -58.73 -49.91 75.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 119.742 1.155 . . . . 0.0 110.386 163.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.6 -43.5 78.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -51.7 68.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.229 1.012 . . . . 0.0 111.967 170.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -58.98 -41.02 86.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -169.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -65.1 -31.71 73.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.704 2.002 . . . . 0.0 111.861 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -29.61 59.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.518 1.054 . . . . 0.0 113.787 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.5 -53.29 54.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 119.45 1.023 . . . . 0.0 109.053 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -45.37 93.9 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -161.49 51.55 0.24 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 123.433 1.587 . . . . 0.0 109.862 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.77 -17.49 14.8 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 117.525 -1.708 . . . . 0.0 114.91 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.77 -51.12 58.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.669 2.235 . . . . 0.0 110.852 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -68.08 -28.25 67.19 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.773 -1.205 . . . . 0.0 111.37 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -73.7 -35.75 65.18 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.772 -1.205 . . . . 0.0 108.659 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 54' ' ' VAL . 31.4 t -55.97 -42.03 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.867 1.267 . . . . 0.0 109.459 165.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 4.1 mmpt? -69.31 -29.9 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.55 1.523 . . . . 0.0 113.185 174.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -68.46 -49.33 60.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.591 1.542 . . . . 0.0 111.893 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.06 -48.43 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.003 1.274 . . . . 0.0 109.67 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.08 47.19 84.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.646 -1.641 . . . . 0.0 113.935 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.52 171.0 37.41 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.567 1.684 . . . . 0.0 110.728 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.36 131.1 54.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 162.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -129.4 165.57 21.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.991 0.424 . . . . 0.0 111.279 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.8 137.62 52.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.073 1.749 . . . . 0.0 108.722 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.62 109.15 20.13 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.532 1.133 . . . . 0.0 108.668 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 72' ' ' THR . 15.4 mttm -87.37 103.32 15.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 121.03 1.741 . . . . 0.0 107.626 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 80' ' ' PHE . 5.5 t -112.14 94.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.611 -0.681 . . . . 0.0 109.335 -170.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 174.43 6.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.383 -1.448 . . . . 0.0 110.294 171.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 59.34 43.81 16.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.205 1.802 . . . . 0.0 112.105 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -78.1 -167.96 31.57 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.082 -1.011 . . . . 0.0 113.862 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.28 -11.5 10.85 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.025 3.15 . . . . 0.0 114.05 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.25 -5.19 8.85 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.535 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.04 74.73 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.21 1.505 . . . . 0.0 112.084 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.7 -175.66 0.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.271 1.828 . . . . 0.0 109.768 165.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -135.79 150.71 49.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.145 1.778 . . . . 0.0 109.205 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.87 172.09 13.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.829 2.052 . . . . 0.0 109.065 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.5 m -145.91 147.3 31.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 108.32 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.403 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -117.59 142.84 46.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 163.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.03 143.61 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.31 118.67 50.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.93 110.45 18.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 165.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.461 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -128.44 43.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.308 168.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -132.51 -44.9 0.9 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.377 -0.827 . . . . 0.0 111.611 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -95.84 148.12 22.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.734 0.646 . . . . 0.0 109.451 -172.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.95 -130.55 51.04 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.821 ' H ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.02 4.3 34.32 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.08 1.352 . . . . 0.0 112.383 173.146 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.35 157.73 18.86 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.8 m -172.26 153.01 2.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 128.447 2.699 . . . . 0.0 108.028 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -88.09 156.16 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mt -132.79 96.4 18.31 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 -173.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.98 140.32 41.57 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.04 1.827 . . . . 0.0 109.025 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.9 22.79 4.51 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.047 2.139 . . . . 0.0 112.957 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.47 133.95 35.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.419 0.628 . . . . 0.0 110.177 -157.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.36 -7.16 51.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.633 1.173 . . . . 0.0 110.594 165.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -52.48 132.92 35.57 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -74.64 -177.09 3.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.085 0.945 . . . . 0.0 109.651 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.03 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.968 1.707 . . . . 0.0 108.824 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.56 -25.15 56.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.48 -176.22 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.197 0.999 . . . . 0.0 109.47 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.445 HG21 ' HE2' ' A' ' 38' ' ' LYS . 21.4 m -137.66 -175.77 4.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.932 0.893 . . . . 0.0 108.764 -171.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 tt -145.83 142.5 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 154.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.19 146.2 24.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 157.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.454 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 31.4 mtt -134.19 -51.29 0.82 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 157.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.93 161.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.143 3.377 . . . . 0.0 107.966 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.464 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 6.0 t70 -66.72 -47.04 73.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 122.96 0.504 . . . . 0.0 110.863 -171.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.6 m -55.29 -36.25 65.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.448 0.699 . . . . 0.0 110.326 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.11 -59.43 2.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.307 1.843 . . . . 0.0 109.849 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 75' ' ' MET . 10.7 m-85 -50.83 -58.75 5.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.39 1.876 . . . . 0.0 111.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -42.87 99.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.956 0.902 . . . . 0.0 109.81 -172.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -23.24 65.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.87 -173.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mt -67.77 -51.5 48.26 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.496 1.118 . . . . 0.0 110.882 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -49.76 18.32 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.191 0.905 . . . . 0.0 112.556 176.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.1 m -74.53 2.13 10.38 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.594 1.157 . . . . 0.0 112.039 -174.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.53 15.78 64.42 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 120.097 -1.627 . . . . 0.0 113.147 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -72.33 -3.53 24.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.457 1.129 . . . . 0.0 111.552 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 8.5 ttm 85.05 91.18 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.22 2.208 . . . . 0.0 110.914 164.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -139.63 123.34 10.79 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 161.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.76 -173.96 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.314 2.676 . . . . 0.0 111.251 158.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -48.51 143.64 4.8 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.576 -0.703 . . . . 0.0 109.271 161.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.2 m -65.78 -29.74 70.28 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.26 0.552 . . . . 0.0 110.294 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.7 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.456 1.902 . . . . 0.0 111.235 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.66 -143.76 0.31 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.709 1.203 . . . . 0.0 111.886 171.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -1.23 56.78 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.602 1.092 . . . . 0.0 112.471 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -71.8 -60.66 2.12 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.985 1.714 . . . . 0.0 109.645 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.87 61.68 2.36 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 125.7 1.619 . . . . 0.0 111.091 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -64.84 -2.32 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 167.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.5 tp 42.28 70.12 0.31 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.384 1.874 . . . . 0.0 111.821 -163.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -68.69 175.97 3.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.791 160.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.09 172.45 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 166.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.3 p 44.72 -161.53 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.134 2.173 . . . . 0.0 113.816 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.05 27.02 0.03 OUTLIER Glycine 0 C--N 1.338 0.688 0 O-C-N 120.828 -1.17 . . . . 0.0 114.25 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -66.46 148.37 51.97 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.207 1.004 . . . . 0.0 112.001 -166.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 39.8 tpp -60.09 101.07 0.11 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.581 1.952 . . . . 0.0 109.116 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.26 -85.62 0.22 Allowed Glycine 0 C--O 1.224 -0.482 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 pp -51.55 -22.27 3.11 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.82 68.31 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.693 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.43 -22.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.976 1.31 . . . . 0.0 113.225 173.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.99 71.13 2.76 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 119.754 -1.841 . . . . 0.0 111.591 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.39 160.68 37.15 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.064 2.145 . . . . 0.0 108.397 169.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -117.28 -79.88 0.6 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 160.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -54.32 -26.74 31.37 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.515 1.126 . . . . 0.0 113.527 -171.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.85 -10.98 53.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.359 1.064 . . . . 0.0 112.947 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -137.88 54.72 1.8 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.501 1.521 . . . . 0.0 107.106 166.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER 38.49 -173.85 0.0 OUTLIER 'General case' 0 C--N 1.348 0.535 0 C-N-CA 128.752 2.821 . . . . 0.0 113.387 -175.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -104.56 129.46 24.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 120.13 -1.606 . . . . 0.0 107.858 -169.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.56 174.09 13.2 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.059 1.839 . . . . 0.0 111.63 -167.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 171.05 141.98 3.5 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -74.68 119.89 19.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 167.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.37 147.98 34.11 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.013 1.725 . . . . 0.0 109.151 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -93.13 141.5 28.34 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.611 0.641 . . . . 0.0 111.081 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.981 0 C-N-CA 128.413 2.685 . . . . 0.0 110.276 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 121.819 0.819 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 p -95.59 -62.27 1.32 Allowed 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.57 -0.706 . . . . 0.0 109.474 163.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.9 152.03 23.8 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.85 1.26 . . . . 0.0 112.488 -175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 m -176.0 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.241 2.616 . . . . 0.0 106.093 -164.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 67.95 44.48 1.51 Allowed 'General case' 0 C--N 1.347 0.479 0 CA-C-O 121.277 0.561 . . . . 0.0 111.978 165.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.05 42.52 1.27 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.434 1.016 . . . . 0.0 112.535 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -85.1 -176.54 6.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.426 1.613 . . . . 0.0 110.583 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -72.36 -17.15 61.86 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.033 -1.042 . . . . 0.0 111.394 164.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.32 -23.98 4.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.2 1.0 . . . . 0.0 112.903 170.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -45.63 77.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.117 1.367 . . . . 0.0 110.32 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.24 -48.77 76.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.171 1.388 . . . . 0.0 109.67 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 t -58.65 -54.29 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.725 1.21 . . . . 0.0 111.421 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -64.31 -26.22 68.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.911 1.232 . . . . 0.0 111.88 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -75.06 -23.65 58.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.506 -0.746 . . . . 0.0 112.589 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.52 -52.62 53.79 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.434 0.459 . . . . 0.0 109.932 166.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -58.64 -48.28 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.186 1.395 . . . . 0.0 107.83 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -55.78 -51.1 68.59 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.759 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -57.99 -47.56 82.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.948 0.795 . . . . 0.0 109.425 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -38.8 88.83 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.559 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.413 HD21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.55 -38.99 72.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 113.814 172.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.12 -52.94 56.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.29 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.54 -45.74 90.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.828 1.194 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -162.73 56.1 0.21 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.138 0.97 . . . . 0.0 111.893 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.51 -16.01 69.04 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 120.905 -1.122 . . . . 0.0 113.103 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -43.3 68.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.764 1.282 . . . . 0.0 112.165 -171.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.77 -32.02 59.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.566 0.746 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.76 -26.8 60.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -60.31 -28.3 41.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -66.08 -21.91 66.39 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.319 -0.863 . . . . 0.0 111.405 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 9.8 mmpt? -73.0 -70.82 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.266 1.394 . . . . 0.0 111.241 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.65 -59.98 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 56.76 13.05 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.807 1.194 . . . . 0.0 113.146 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.81 42.57 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.38 146.68 7.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 149.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -141.33 177.19 8.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 118.969 -1.093 . . . . 0.0 109.581 158.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 72' ' ' THR . . . -124.73 164.15 20.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.502 1.121 . . . . 0.0 108.897 171.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -121.98 106.99 11.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.174 1.79 . . . . 0.0 108.832 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -73.71 110.49 8.04 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 120.282 1.401 . . . . 0.0 112.107 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.07 98.25 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 174.69 7.04 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 166.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 49.75 53.19 13.19 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.982 2.113 . . . . 0.0 113.737 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.64 176.54 2.23 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.399 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.01 84.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.448 3.432 . . . . 0.0 108.433 158.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.17 -76.46 0.3 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -167.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.54 -12.27 3.21 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.506 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -70.18 -171.58 0.47 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.774 1.787 . . . . 0.0 110.978 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.1 160.64 20.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.222 1.809 . . . . 0.0 108.772 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.41 166.05 30.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.545 2.338 . . . . 0.0 106.296 173.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 m -150.81 128.88 11.83 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.78 0.832 . . . . 0.0 109.996 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -94.3 127.34 40.1 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 167.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.18 149.59 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.2 119.97 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.26 106.78 18.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 172.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 HD21 ' A' ' 20' ' ' LEU . 1.2 m -138.17 56.78 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 121.611 -0.681 . . . . 0.0 110.474 174.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -139.91 -53.63 0.53 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.307 1.043 . . . . 0.0 109.683 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -78.39 140.9 38.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.942 1.697 . . . . 0.0 108.152 -172.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 -137.57 32.85 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -104.88 8.26 34.64 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.015 1.726 . . . . 0.0 111.724 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.44 157.34 29.85 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -173.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.9 m -172.52 161.35 4.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.621 3.968 . . . . 0.0 105.991 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -109.96 154.38 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.9 mt -134.25 70.35 73.37 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -158.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.99 142.65 62.82 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.539 2.159 . . . . 0.0 109.28 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 54.88 23.22 4.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.766 2.427 . . . . 0.0 112.437 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 t -87.61 138.32 31.57 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.042 1.292 . . . . 0.0 110.26 -164.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.65 -4.87 58.4 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.48 1.912 . . . . 0.0 111.223 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -60.56 145.18 49.67 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 118.399 -1.32 . . . . 0.0 108.324 170.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -69.6 -173.6 0.61 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.221 1.808 . . . . 0.0 110.378 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.11 133.88 16.79 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.135 -0.353 . . . . 0.0 111.562 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.29 -52.89 4.35 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.933 2.493 . . . . 0.0 111.053 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.3 m -149.42 168.99 21.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.994 2.518 . . . . 0.0 106.767 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 73' ' ' ILE . 87.9 m -121.83 -171.07 2.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.426 ' N ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -143.05 167.61 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 158.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.77 159.68 16.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.748 1.613 . . . . 0.0 106.756 160.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -150.57 -38.86 0.13 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.817 158.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.57 157.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.545 2.338 . . . . 0.0 110.035 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -59.78 -46.77 88.15 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.802 0.841 . . . . 0.0 111.134 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -44.01 73.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.338 -175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.03 -65.22 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 128.326 2.65 . . . . 0.0 112.06 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 75' ' ' MET . 43.3 m-85 -51.09 -45.36 61.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 110.401 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 tp -60.77 -69.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.616 0.644 . . . . 0.0 109.322 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.37 75.08 Favored 'General case' 0 CA--C 1.524 -0.057 0 C-N-CA 124.244 1.018 . . . . 0.0 113.269 -165.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 tp -52.01 -66.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.677 1.191 . . . . 0.0 109.654 -176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.4 ptm -76.36 -19.48 58.14 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.8 m -77.25 12.35 1.53 Allowed 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.385 -1.447 . . . . 0.0 111.883 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.46 48.1 86.07 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.102 -1.624 . . . . 0.0 110.477 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -134.28 25.75 3.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.844 1.657 . . . . 0.0 110.153 -177.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 89.0 mtp 71.99 -74.56 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 129.225 3.01 . . . . 0.0 112.223 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.294 0.2 OUTLIER 33.78 89.11 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 127.254 2.222 . . . . 0.0 112.643 -136.37 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.68 100.86 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.671 2.247 . . . . 0.0 109.893 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 71.26 123.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.532 2.333 . . . . 0.0 110.191 -167.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.9 m -74.36 -103.17 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.58 ' HA ' HE21 ' A' ' 96' ' ' GLN . . . -73.99 -17.77 60.95 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 118.479 -2.638 . . . . 0.0 112.688 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -38.65 91.69 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 117.759 -1.115 . . . . 0.0 109.385 175.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -55.23 -60.54 3.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.969 1.259 . . . . 0.0 110.034 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.58 HE21 ' HA ' ' A' ' 93' ' ' ALA . 6.9 pt20 -69.72 -27.41 64.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.62 24.71 76.11 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 118.852 0.751 . . . . 0.0 113.441 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -76.62 41.22 0.25 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.084 1.442 . . . . 0.0 110.859 175.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 35.2 73.48 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.772 2.429 . . . . 0.0 113.239 168.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.414 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -64.05 138.74 58.6 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.109 -0.995 . . . . 0.0 109.07 -172.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.46 159.23 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.488 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 p -139.7 172.53 12.66 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.287 1.435 . . . . 0.0 109.682 -167.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.15 -56.27 0.71 Allowed Glycine 0 N--CA 1.466 0.685 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -60.93 -17.33 50.55 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.806 0.842 . . . . 0.0 112.37 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 58.2 mtm 47.87 -168.98 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.175 2.19 . . . . 0.0 111.198 -166.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.57 -111.62 2.23 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 124.979 1.276 . . . . 0.0 111.06 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.745 HD23 ' HE3' ' A' ' 110' ' ' LYS . 11.1 mt 63.69 -36.48 0.16 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 129.252 3.021 . . . . 0.0 114.217 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.49 -70.96 0.17 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.923 1.689 . . . . 0.0 110.158 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.7 mtt -76.3 65.8 2.28 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.353 0.978 . . . . 0.0 111.7 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.745 ' HE3' HD23 ' A' ' 107' ' ' LEU . 27.4 mttt -75.72 36.99 0.14 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.004 1.722 . . . . 0.0 112.728 167.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 46.34 -155.19 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.016 1.726 . . . . 0.0 110.683 -175.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.49 -50.48 4.72 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.55 1.068 . . . . 0.0 110.493 164.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -54.82 -28.04 46.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tp -85.08 9.73 13.98 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 122.032 2.197 . . . . 0.0 111.827 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.96 48.81 0.85 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.251 2.22 . . . . 0.0 110.466 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.3 mt 56.41 163.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 129.738 3.215 . . . . 0.0 114.83 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 134.48 88.07 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.788 163.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.78 173.55 10.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.204 1.269 . . . . 0.0 109.317 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.22 81.99 1.63 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -144.35 -179.39 6.5 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.169 2.187 . . . . 0.0 105.522 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.92 -52.4 0.29 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.219 1.008 . . . . 0.0 109.655 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? 71.16 103.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 128.788 2.835 . . . . 0.0 112.053 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 C--O 1.251 1.135 0 C-N-CA 129.803 3.241 . . . . 0.0 111.948 168.854 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t -153.82 -155.44 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.061 -2.199 . . . . 0.0 105.061 165.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.99 168.99 5.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.23 1.014 . . . . 0.0 110.98 163.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -96.63 -134.13 0.22 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 127.451 2.3 . . . . 0.0 108.755 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 44.29 23.53 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 119.971 3.323 . . . . 0.0 119.971 129.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.75 82.88 0.18 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 126.573 2.035 . . . . 0.0 108.16 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -153.42 160.78 42.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.628 1.571 . . . . 0.0 108.449 -166.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -24.97 50.49 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.3 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.35 -10.69 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.378 1.871 . . . . 0.0 114.624 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 1.5 t-20 -51.35 -44.21 61.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.409 0.684 . . . . 0.0 110.943 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -73.39 -38.35 65.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.351 178.446 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' N ' HD13 ' A' ' 11' ' ' LEU . 48.0 t -58.34 -60.78 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 125.005 1.322 . . . . 0.0 109.969 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 16' ' ' ILE . 39.8 m-85 -66.78 -19.63 65.79 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.746 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -75.56 -28.6 59.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.73 ' HG3' HD21 ' A' ' 116' ' ' LEU . 35.7 mm-40 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.533 172.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.784 HD11 ' HE1' ' A' ' 84' ' ' MET . 48.2 mt -68.56 -52.42 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.37 -54.78 12.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 125.176 1.39 . . . . 0.0 109.895 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -44.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.214 1.005 . . . . 0.0 110.944 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -44.96 79.12 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.168 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -35.15 66.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 112.635 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.48 -52.9 55.55 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.78 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.52 -45.69 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.408 -1.433 . . . . 0.0 114.189 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -153.22 64.94 0.76 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.925 1.69 . . . . 0.0 109.461 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.41 70.52 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-O 118.333 -1.259 . . . . 0.0 111.177 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -52.48 -38.09 58.65 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.721 1.26 . . . . 0.0 111.429 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.22 -42.97 44.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.735 1.214 . . . . 0.0 109.225 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -20.81 63.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.598 -0.689 . . . . 0.0 111.442 -176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 55' ' ' LYS . 48.3 t -57.27 -38.9 64.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 119.131 0.878 . . . . 0.0 110.213 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -74.84 -5.03 41.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.884 -1.135 . . . . 0.0 113.103 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -69.27 0.68 Allowed 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.936 1.244 . . . . 0.0 110.353 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.54 -62.97 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.33 9.39 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.728 1.156 . . . . 0.0 113.28 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.97 -169.24 29.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.77 125.89 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 157.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -121.42 172.65 7.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' A' ' 72' ' ' THR . . . -128.03 131.32 49.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.994 1.717 . . . . 0.0 108.578 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -82.05 93.86 7.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -74.71 101.13 4.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.252 1.842 . . . . 0.0 109.834 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG22 ' CE2' ' A' ' 80' ' ' PHE . 89.2 t -104.22 121.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -115.77 179.7 3.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.363 1.465 . . . . 0.0 109.421 162.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t70 54.69 53.86 10.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.391 1.091 . . . . 0.0 112.273 164.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.43 -154.91 10.65 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.534 1.54 . . . . 0.0 109.784 168.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -48.74 114.91 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.236 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.9 -8.07 17.58 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.265 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.27 16.49 62.48 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 120.547 2.173 . . . . 0.0 112.083 169.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -61.66 -175.12 0.05 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.18 1.392 . . . . 0.0 111.007 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -150.47 111.58 4.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.336 -171.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 174.65 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.77 2.028 . . . . 0.0 110.416 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -147.75 149.43 32.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 109.018 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.434 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -116.7 117.12 28.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 166.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.79 128.59 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.517 HG12 HG22 ' A' ' 54' ' ' VAL . 98.2 t -112.07 110.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.63 129.83 34.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -133.16 30.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.603 ' HA ' HG13 ' A' ' 28' ' ' VAL . 3.6 tmtm? -140.09 -25.9 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 120.981 -1.074 . . . . 0.0 112.775 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -84.71 111.67 19.8 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.63 -117.86 7.96 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -85.99 0.34 53.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.157 0.978 . . . . 0.0 112.566 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.23 156.66 3.81 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -157.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.7 m -172.23 149.59 2.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.418 2.287 . . . . 0.0 106.327 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.72 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mt -127.22 81.61 69.68 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 -170.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.12 144.94 65.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.057 1.838 . . . . 0.0 109.728 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 37.47 44.05 0.46 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.308 2.643 . . . . 0.0 111.292 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -85.8 142.74 28.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.693 1.235 . . . . 0.0 109.615 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.26 -17.9 59.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 111.182 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -57.46 133.05 54.87 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -60.96 -175.75 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.998 1.38 . . . . 0.0 109.778 167.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.45 155.49 48.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.152 166.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.41 -27.74 64.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.535 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.7 p -145.62 -175.92 4.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.551 0.74 . . . . 0.0 112.856 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.4 m -136.14 -171.99 3.02 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.474 ' H ' HG22 ' A' ' 72' ' ' THR . 3.6 tt -142.27 175.6 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 161.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.2 m -141.73 137.44 31.66 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 119.335 -2.103 . . . . 0.0 108.373 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.1 ptp -148.65 -28.83 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.528 -1.669 . . . . 0.0 115.217 161.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.43 147.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.972 3.309 . . . . 0.0 110.618 -162.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.99 -47.95 84.06 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 127.215 2.206 . . . . 0.0 110.443 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.8 m -66.43 -11.46 52.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.3 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.93 -40.24 5.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 168.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.649 ' CE2' HG22 ' A' ' 39' ' ' VAL . 3.3 m-85 -47.42 -54.03 12.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.683 1.193 . . . . 0.0 109.987 171.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.47 -62.26 1.44 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.593 1.957 . . . . 0.0 108.383 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.56 -39.94 77.79 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.693 0.797 . . . . 0.0 112.435 -174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -65.75 0.51 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.479 0.712 . . . . 0.0 110.482 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.784 ' HE1' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -76.68 -26.62 54.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -175.019 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.3 m -73.95 -3.65 30.33 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 120.507 -1.371 . . . . 0.0 110.838 -175.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.89 62.85 1.8 Allowed Glycine 0 C--N 1.338 0.67 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -145.76 -9.35 0.54 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.121 1.368 . . . . 0.0 112.195 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 6.2 mtt -151.33 149.94 29.93 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.708 1.14 . . . . 0.0 112.846 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -75.61 160.88 78.27 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.454 0.701 . . . . 0.0 110.087 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.5 165.5 31.55 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.67 1.58 . . . . 0.0 113.014 -165.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.39 97.86 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.182 2.193 . . . . 0.0 110.362 -161.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.3 t -54.55 -61.72 2.13 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 123.887 0.875 . . . . 0.0 109.81 172.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.69 -63.33 1.21 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 116.922 -1.513 . . . . 0.0 111.891 -162.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.2 t80 22.87 -89.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 127.853 2.461 . . . . 0.0 113.91 161.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -62.12 1.51 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.917 1.687 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -64.24 -10.93 26.63 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.67 28.05 62.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.524 1.059 . . . . 0.0 114.667 165.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -65.98 17.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.522 2.329 . . . . 0.0 115.493 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 tp 47.09 61.84 2.67 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.053 1.741 . . . . 0.0 109.063 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.47 142.44 57.55 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 173.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.76 164.62 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.87 131.28 40.61 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.995 -1.065 . . . . 0.0 108.533 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.91 60.87 0.59 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.38 -150.71 0.43 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.194 0.998 . . . . 0.0 108.556 -161.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.9 ttp -138.38 148.17 44.22 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.251 1.42 . . . . 0.0 107.563 -168.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.64 8.91 49.46 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.398 0.999 . . . . 0.0 113.699 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.6 -36.18 75.78 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.847 1.259 . . . . 0.0 113.658 -164.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.94 -88.5 0.08 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -170.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.6 mmt 29.1 -83.0 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.26 2.624 . . . . 0.0 114.02 169.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -76.27 33.48 0.13 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.031 1.332 . . . . 0.0 113.225 -175.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.76 102.33 3.97 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.79 -55.54 2.42 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -97.6 -23.82 15.81 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 161.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.51 -5.62 20.54 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -166.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -136.82 55.6 1.83 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.221 1.408 . . . . 0.0 107.324 167.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 15' ' ' GLU . 13.5 mt 51.05 -174.01 0.02 OUTLIER 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.071 1.348 . . . . 0.0 114.369 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -146.05 129.22 8.21 Favored Pre-proline 0 N--CA 1.452 -0.343 0 O-C-N 121.527 -0.733 . . . . 0.0 111.599 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -69.2 173.9 9.8 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.743 1.628 . . . . 0.0 110.291 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.81 62.13 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 107.884 -2.087 . . . . 0.0 107.884 -170.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.63 167.84 22.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.336 1.054 . . . . 0.0 109.446 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.96 15.18 0.41 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -169.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -134.28 151.32 51.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.9 1.227 . . . . 0.0 110.82 -168.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.989 0 C-N-CA 129.536 3.134 . . . . 0.0 111.852 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t -53.58 93.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.487 1.915 . . . . 0.0 112.874 -158.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.43 -22.59 0.33 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.79 1.236 . . . . 0.0 113.164 -171.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 m -157.76 -155.48 0.51 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.794 1.238 . . . . 0.0 108.581 -156.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.67 22.91 13.63 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 149.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 11.77 0.06 OUTLIER Glycine 0 N--CA 1.466 0.671 0 O-C-N 120.782 -1.199 . . . . 0.0 115.442 -162.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.412 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 1.2 m-30 -80.21 178.51 8.22 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.823 1.249 . . . . 0.0 108.671 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HA ' HD23 ' A' ' 11' ' ' LEU . 23.7 tttm -69.65 -17.92 63.54 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.735 -1.853 . . . . 0.0 111.378 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.37 17.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.265 1.026 . . . . 0.0 112.815 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.6 -40.05 82.11 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.516 1.527 . . . . 0.0 110.275 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 8' ' ' LYS . 1.4 mm? -61.53 -51.89 66.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.307 1.843 . . . . 0.0 109.79 175.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.55 -43.61 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.493 2.317 . . . . 0.0 111.943 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.18 -26.94 61.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.168 0.894 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -71.48 -24.77 62.05 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 118.977 0.808 . . . . 0.0 112.619 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.13 -46.31 91.09 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 165.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.8 -45.44 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.04 -55.22 33.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.824 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -52.48 -50.51 62.57 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -168.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -65.56 -27.11 68.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.666 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -33.45 66.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.075 0.852 . . . . 0.0 112.006 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.17 -52.3 59.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 170.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.58 -45.2 85.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.534 1.134 . . . . 0.0 111.795 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -165.54 62.79 0.11 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.954 0.902 . . . . 0.0 110.897 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.01 -29.18 71.87 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 116.869 -2.073 . . . . 0.0 114.486 -172.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -36.97 3.59 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.99 2.395 . . . . 0.0 112.918 172.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -81.38 -16.84 51.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -93.49 -34.91 13.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.088 1.355 . . . . 0.0 108.212 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.2 -46.09 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 126.151 1.78 . . . . 0.0 109.036 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -64.39 -23.94 67.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.562 1.528 . . . . 0.0 113.776 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -74.13 -29.21 61.71 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.411 -0.806 . . . . 0.0 111.828 -166.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mp -117.36 -49.76 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.557 2.343 . . . . 0.0 110.321 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.19 49.26 58.69 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.861 1.696 . . . . 0.0 116.245 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.55 27.36 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.758 1.779 . . . . 0.0 108.759 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.95 139.14 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 3.6 p90 -127.15 164.55 21.37 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.978 -1.076 . . . . 0.0 109.961 158.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 156.31 21.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 35' ' ' PHE . 6.6 m-85 -114.72 108.34 16.65 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.464 1.506 . . . . 0.0 108.734 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -87.09 95.9 10.11 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -85.09 116.6 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -107.91 176.63 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 119.07 0.85 . . . . 0.0 109.152 162.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t0 46.42 50.79 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.573 1.549 . . . . 0.0 113.776 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 7' ' ' PHE . . . -63.5 165.55 27.94 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.977 167.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.46 98.43 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.656 3.571 . . . . 0.0 112.648 172.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.81 -41.3 1.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.237 1.875 . . . . 0.0 111.765 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.59 -8.35 3.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.701 -1.61 . . . . 0.0 114.574 163.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -67.61 -175.26 0.5 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.191 1.796 . . . . 0.0 112.782 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -125.15 146.23 49.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.935 1.694 . . . . 0.0 111.221 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.93 162.08 34.25 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.716 3.207 . . . . 0.0 106.832 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 m -139.25 148.13 42.64 Favored 'General case' 0 C--O 1.228 -0.053 0 CA-C-N 119.082 0.856 . . . . 0.0 110.059 166.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -117.65 156.81 27.54 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.42 134.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 57.6 t -123.41 112.75 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -91.98 80.28 5.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.43 53.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -146.62 -54.18 0.24 Allowed 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.18 0.992 . . . . 0.0 110.042 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.36 140.45 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.016 0.823 . . . . 0.0 109.586 -164.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.9 -140.9 43.76 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -84.84 -0.1 52.8 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.506 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 157.07 15.97 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 120.795 1.634 . . . . 0.0 111.873 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m -171.77 166.08 6.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.913 3.285 . . . . 0.0 108.87 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.33 93.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 127.941 2.496 . . . . 0.0 107.254 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.9 101.28 0.48 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 127.231 2.212 . . . . 0.0 107.001 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -70.5 131.22 19.77 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.372 2.714 . . . . 0.0 111.308 -166.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 47.24 24.56 0.44 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.317 2.247 . . . . 0.0 112.591 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.54 143.79 40.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -160.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -73.59 -15.79 61.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.575 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -57.92 145.11 36.76 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.708 -1.597 . . . . 0.0 110.429 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.79 -176.18 0.05 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.861 1.315 . . . . 0.0 109.895 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.95 168.06 20.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.638 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -37.48 55.6 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.395 0.678 . . . . 0.0 111.391 171.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m -150.93 -173.14 4.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.084 2.153 . . . . 0.0 109.307 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -133.95 -172.92 3.11 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.062 -1.024 . . . . 0.0 108.736 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -147.44 165.07 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 155.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -126.48 124.29 39.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 165.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.71 136.62 17.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.15 163.59 1.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 168.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.04 -52.01 62.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.057 1.343 . . . . 0.0 111.005 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.66 -33.77 61.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.3 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.87 -35.26 14.88 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.33 2.252 . . . . 0.0 111.381 -169.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.92 -54.77 33.37 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.482 1.113 . . . . 0.0 108.357 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -31.48 68.59 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.555 0.742 . . . . 0.0 110.361 -175.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.55 -41.76 10.21 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.048 1.339 . . . . 0.0 113.727 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.01 -75.51 0.05 Allowed 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -170.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.56 52.22 0.79 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.2 p -152.78 -35.91 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.144 -0.973 . . . . 0.0 110.833 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 132.83 -6.64 5.17 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 118.8 -1.0 . . . . 0.0 115.144 167.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -69.19 -52.81 24.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.124 1.962 . . . . 0.0 109.153 161.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 3.3 mtm 54.55 169.71 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.264 1.825 . . . . 0.0 112.574 -162.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -177.42 53.99 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 127.559 2.344 . . . . 0.0 107.695 160.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -67.48 147.3 76.84 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.89 1.726 . . . . 0.0 109.007 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.48 -25.87 0.06 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.301 1.841 . . . . 0.0 114.907 -173.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 t -50.61 -24.26 3.15 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.029 2.132 . . . . 0.0 112.226 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 100' ' ' LYS . . . -62.09 -26.12 68.1 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.14 -0.975 . . . . 0.0 111.713 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -83.02 -51.99 7.06 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.877 1.217 . . . . 0.0 109.615 164.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -58.09 -51.5 69.44 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.192 1.397 . . . . 0.0 110.863 -161.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -71.28 -70.38 0.32 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.561 1.544 . . . . 0.0 107.652 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 150.06 61.25 0.01 OUTLIER Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -99.79 -6.65 26.6 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.796 163.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.4 tp 49.31 80.56 0.06 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 126.722 2.009 . . . . 0.0 110.565 -168.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -71.19 174.83 5.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.38 168.84 17.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -152.7 -139.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 130.198 3.399 . . . . 0.0 105.783 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.34 -53.64 0.58 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 120.618 1.554 . . . . 0.0 110.836 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -65.82 -29.28 69.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.901 0.85 . . . . 0.0 111.909 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 57.44 -165.36 0.16 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -160.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.57 -50.49 4.07 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.752 -1.218 . . . . 0.0 113.264 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -48.09 -61.75 1.82 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.001 1.72 . . . . 0.0 111.766 -171.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.0 -0.62 40.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.851 0.861 . . . . 0.0 112.929 -170.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.27 -48.42 8.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -75.82 -72.97 0.29 Allowed 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.399 -0.813 . . . . 0.0 112.155 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 34.63 38.84 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 130.799 3.64 . . . . 0.0 115.542 -166.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -106.7 -96.19 0.36 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.121 1.328 . . . . 0.0 108.774 -167.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -19.33 64.34 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.904 1.684 . . . . 0.0 110.223 174.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -13.91 32.76 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 171.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -141.69 62.83 1.44 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.042 0.937 . . . . 0.0 109.514 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.329 0.1 OUTLIER 49.77 -173.48 0.02 OUTLIER 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.421 1.089 . . . . 0.0 113.596 170.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.95 121.84 4.14 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 119.876 -1.765 . . . . 0.0 112.156 170.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.69 173.54 13.75 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.288 1.992 . . . . 0.0 110.289 172.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.33 -175.93 30.12 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 123.71 0.671 . . . . 0.0 111.455 -173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -158.22 123.69 4.47 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.409 1.484 . . . . 0.0 107.776 168.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 50.37 97.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.997 2.919 . . . . 0.0 113.432 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.48 155.03 0.14 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.303 2.241 . . . . 0.0 108.633 -174.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 123' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.397 1.079 . . . . 0.0 109.264 174.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t -143.34 89.57 2.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 171.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.61 179.34 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.469 2.308 . . . . 0.0 112.881 -165.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -177.17 -36.22 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.416 1.087 . . . . 0.0 111.046 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.39 25.95 6.82 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.039 1.4 . . . . 0.0 112.022 154.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.4 84.41 0.36 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 129.349 3.356 . . . . 0.0 108.414 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 34.6 m-85 -152.83 149.74 28.61 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.675 2.39 . . . . 0.0 107.824 -167.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -6.67 51.13 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.846 -1.159 . . . . 0.0 111.782 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.28 -16.46 53.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.883 0.873 . . . . 0.0 112.975 160.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -59.09 -58.41 8.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.844 1.202 . . . . 0.0 111.019 -168.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 11' ' ' LEU 0.279 0.0 OUTLIER -64.77 -31.37 72.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.346 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.36 -55.92 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.813 2.445 . . . . 0.0 110.618 171.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -65.83 -29.34 69.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.683 1.128 . . . . 0.0 111.119 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -70.09 -24.93 63.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.771 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.585 ' HG2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.05 -44.17 73.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 176.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -52.02 -54.33 14.23 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.33 -48.48 78.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.965 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -56.59 -46.85 80.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -66.11 -42.28 89.43 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.69 177.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -32.54 62.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.307 6.5 mm-40 -70.11 -52.31 24.7 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.877 171.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.06 -40.69 96.64 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -161.04 60.44 0.29 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.833 1.253 . . . . 0.0 109.858 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.12 -29.69 70.32 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-O 118.185 -1.341 . . . . 0.0 111.47 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.44 -29.5 24.86 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.838 1.319 . . . . 0.0 112.694 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -79.93 -34.98 38.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.911 -1.118 . . . . 0.0 111.678 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -80.31 -19.46 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.643 1.111 . . . . 0.0 108.997 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.07 -45.59 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.151 0.887 . . . . 0.0 109.467 169.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.49 -17.67 62.34 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -71.53 -65.17 0.79 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.365 -0.834 . . . . 0.0 109.845 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mm -78.32 -56.07 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.0 1.32 . . . . 0.0 108.713 -166.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 50.61 63.29 4.55 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.253 -167.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 173.0 39.55 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 119.376 1.588 . . . . 0.0 111.941 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.19 121.36 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 102.936 -2.986 . . . . 0.0 102.936 159.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -130.42 166.01 21.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 123.659 0.6 . . . . 0.0 109.724 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB1' ' CG2' ' A' ' 49' ' ' THR . . . -129.12 168.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.889 0.852 . . . . 0.0 112.063 173.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.49 98.5 6.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.932 . . . . 0.0 108.529 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -83.9 89.55 7.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.987 0.812 . . . . 0.0 110.904 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.18 124.03 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -115.11 -175.05 2.61 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.899 -1.126 . . . . 0.0 108.728 158.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t0 47.8 58.23 5.23 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 127.236 2.214 . . . . 0.0 111.881 169.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.89 -177.2 4.58 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.393 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -60.23 7.49 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 1 C-N-CA 125.389 4.059 . . . . 0.0 113.188 159.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.71 -31.79 0.3 Allowed Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.282 -1.511 . . . . 0.0 112.075 155.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -2.68 7.61 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 118.805 1.303 . . . . 0.0 114.018 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -62.04 -175.57 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.958 1.379 . . . . 0.0 110.791 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -120.97 165.38 15.33 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 166.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -150.13 164.94 34.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.498 1.919 . . . . 0.0 107.43 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.436 ' CG2' ' HB1' ' A' ' 36' ' ' ALA . 80.0 m -147.07 144.15 28.86 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -115.67 133.05 56.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 103.595 -2.743 . . . . 0.0 103.595 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -101.35 136.16 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.69 117.29 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.63 117.07 28.24 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 165.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.65 51.55 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -133.4 -53.61 0.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.123 0.969 . . . . 0.0 108.824 160.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.79 111.24 13.39 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.03 -151.93 50.66 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 121.673 0.596 . . . . 0.0 111.648 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.02 9.49 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 127.94 2.496 . . . . 0.0 114.205 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.14 157.76 33.9 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.0 m -172.87 158.12 3.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.49 2.316 . . . . 0.0 106.99 152.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.74 160.37 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -141.51 87.57 10.28 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -160.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.53 147.99 18.02 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.012 2.475 . . . . 0.0 109.963 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.53 25.8 3.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.995 1.718 . . . . 0.0 111.468 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -92.41 146.84 23.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.524 1.154 . . . . 0.0 109.377 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.84 -26.7 25.54 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 111.909 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -50.33 120.98 5.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.512 1.125 . . . . 0.0 108.648 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -178.04 1.52 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 122.798 1.285 . . . . 0.0 108.804 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.21 156.65 46.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.507 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.2 -32.57 71.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.733 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.76 173.83 15.89 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.101 1.36 . . . . 0.0 110.619 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 101' ' ' ILE . 5.0 m -155.23 119.98 4.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -172.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 101' ' ' ILE . 15.8 tt -83.96 155.11 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 118.661 0.664 . . . . 0.0 109.449 -173.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.4 m -100.73 126.32 47.27 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 118.203 -0.904 . . . . 0.0 109.245 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.06 126.74 2.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 157.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.08 166.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 0.0 112.149 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -53.0 63.06 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t -65.32 -4.53 5.56 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.307 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.23 -53.96 2.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.141 1.776 . . . . 0.0 108.998 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.77 -56.72 10.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.205 1.82 . . . . 0.0 111.37 171.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 tp -54.16 -51.66 63.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.46 1.504 . . . . 0.0 107.852 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -61.4 -23.62 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -66.02 0.88 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.183 0.993 . . . . 0.0 108.965 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -32.52 61.64 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.351 -0.843 . . . . 0.0 112.464 -171.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.81 1.75 11.8 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.946 -1.096 . . . . 0.0 110.971 169.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.32 45.0 94.64 Favored Glycine 0 C--N 1.341 0.832 0 O-C-N 120.705 -1.247 . . . . 0.0 112.53 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HE2' ' HB1' ' A' ' 82' ' ' ALA . 33.8 ttpt -80.63 -36.46 32.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.702 1.251 . . . . 0.0 110.457 174.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.6 ptp -142.77 -173.73 3.97 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.507 0.594 . . . . 0.0 112.534 -162.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -53.55 116.0 8.96 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.974 1.709 . . . . 0.0 109.978 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -81.46 44.19 1.69 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.828 3.019 . . . . 0.0 112.822 -163.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -156.61 33.67 0.31 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.084 1.353 . . . . 0.0 109.459 170.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.7 t -52.77 -34.03 51.24 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.777 0.717 . . . . 0.0 112.81 -166.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -55.95 -37.14 68.61 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.58 1.082 . . . . 0.0 111.905 178.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.436 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 34.9 t80 -86.59 -44.66 11.72 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.718 1.607 . . . . 0.0 112.362 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -59.33 -43.58 92.7 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.356 0.662 . . . . 0.0 110.349 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.62 -16.41 58.58 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.607 -0.683 . . . . 0.0 111.371 172.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.79 45.54 95.59 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.583 1.087 . . . . 0.0 111.693 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -84.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.757 0.778 . . . . 0.0 110.64 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -165.78 57.32 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 127.481 2.312 . . . . 0.0 106.949 167.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -72.85 148.8 44.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.746 -1.221 . . . . 0.0 107.954 -177.391 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -130.27 173.04 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 p -154.91 145.14 21.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.426 1.891 . . . . 0.0 107.24 -169.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.91 -23.96 50.68 Favored Glycine 0 N--CA 1.467 0.709 0 CA-C-N 120.173 1.351 . . . . 0.0 111.452 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -156.46 147.89 22.49 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.572 2.349 . . . . 0.0 105.761 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.6 mtm -62.98 130.16 43.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.959 1.254 . . . . 0.0 109.407 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.85 -144.46 15.63 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -168.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 46.32 17.59 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 129.795 3.238 . . . . 0.0 117.25 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.94 -67.95 0.45 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.802 0.728 . . . . 0.0 110.139 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 34.1 ttm -133.65 -3.43 2.95 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.371 -0.83 . . . . 0.0 111.848 -168.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -68.62 -35.24 77.04 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.052 -1.655 . . . . 0.0 112.658 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.74 119.84 25.29 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -110.82 -78.45 0.59 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 123.829 0.851 . . . . 0.0 108.785 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -62.41 -8.74 6.56 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.44 -31.78 73.14 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 166.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -123.43 47.56 1.99 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.421 1.888 . . . . 0.0 111.244 -166.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.585 HD22 ' HG2' ' A' ' 15' ' ' GLU 0.351 0.2 OUTLIER 49.27 172.17 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.219 2.608 . . . . 0.0 112.051 -175.215 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -105.52 141.96 23.73 Favored Pre-proline 0 CA--C 1.533 0.311 0 O-C-N 119.098 -2.251 . . . . 0.0 111.788 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -79.62 179.54 6.24 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.139 2.559 . . . . 0.0 110.387 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.63 74.57 1.25 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 -171.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -144.29 145.58 32.1 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.19 0.996 . . . . 0.0 109.211 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.67 -63.47 0.18 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 43.05 74.98 0.1 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.89 2.076 . . . . 0.0 110.396 -169.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--O 1.244 0.797 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -156.697 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.56 175.09 13.66 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.08 1.352 . . . . 0.0 107.842 155.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.88 145.71 29.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 155.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 t -144.63 -81.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t0 63.49 62.17 0.97 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.304 1.05 . . . . 0.0 111.938 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.57 20.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.508 1.051 . . . . 0.0 112.711 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -79.89 171.08 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 120.8 -1.412 . . . . 0.0 108.503 169.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -69.82 -19.36 63.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.879 1.218 . . . . 0.0 110.471 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.72 -22.13 3.27 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.146 0.978 . . . . 0.0 112.798 165.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 27.7 t-20 -55.58 -47.26 76.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.608 0.64 . . . . 0.0 110.725 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.28 -38.97 91.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.57 1.148 . . . . 0.0 112.142 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.638 HG13 ' SD ' ' A' ' 84' ' ' MET . 2.6 t -66.15 -57.81 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.192 1.397 . . . . 0.0 109.412 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.95 -23.29 66.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.928 -0.482 . . . . 0.0 111.495 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.25 -48.99 54.46 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.534 ' CB ' HD22 ' A' ' 116' ' ' LEU . 8.8 mm-40 -51.34 -39.09 56.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 118.845 0.748 . . . . 0.0 112.885 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.47 -51.66 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 10.4 tp10 -57.27 -54.33 48.02 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 123.973 0.909 . . . . 0.0 111.783 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -57.3 -38.29 73.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.888 1.222 . . . . 0.0 110.135 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.59 -43.89 71.88 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.605 1.162 . . . . 0.0 110.39 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -38.51 69.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.525 1.53 . . . . 0.0 114.071 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.59 -50.7 68.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.287 -0.863 . . . . 0.0 108.682 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.0 -46.99 85.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.593 1.542 . . . . 0.0 114.749 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -153.66 55.44 0.74 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 123.513 1.625 . . . . 0.0 111.089 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.51 -16.1 80.18 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.078 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -60.34 -40.47 90.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.161 1.481 . . . . 0.0 111.485 -168.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.75 -27.49 50.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.313 -0.867 . . . . 0.0 110.857 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -70.8 -32.99 70.25 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.0 -42.77 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.142 166.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.63 74.48 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.957 -1.09 . . . . 0.0 111.267 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -71.92 -41.99 67.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 117.554 -1.212 . . . . 0.0 113.462 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.46 ' CD1' ' HE2' ' A' ' 110' ' ' LYS . 1.3 mp -95.18 -64.21 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 121.911 2.141 . . . . 0.0 107.176 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 77.03 0.28 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.433 1.016 . . . . 0.0 110.671 -169.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.85 145.78 4.2 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 118.312 -1.271 . . . . 0.0 110.636 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -73.37 137.35 23.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -135.28 168.17 19.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 110.155 170.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.57 137.2 52.36 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.534 1.133 . . . . 0.0 109.83 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -88.22 97.2 10.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -74.56 111.94 10.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.532 1.06 . . . . 0.0 109.475 168.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.79 106.79 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.28 177.44 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 159.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.5 t0 55.96 61.45 2.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.065 1.346 . . . . 0.0 111.903 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.55 -160.98 36.19 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.947 1.737 . . . . 0.0 112.442 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.59 4.95 0.39 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 124.567 3.511 . . . . 0.0 114.869 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.74 2.17 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 120.653 -1.279 . . . . 0.0 113.839 164.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.55 5.59 53.87 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 120.515 2.158 . . . . 0.0 113.244 163.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.41 -175.14 0.76 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.174 1.389 . . . . 0.0 109.802 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -118.87 138.0 53.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.098 1.359 . . . . 0.0 108.818 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.56 166.23 12.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.749 1.62 . . . . 0.0 107.64 164.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.0 m -146.35 148.69 32.63 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 160.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -119.64 133.77 55.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.88 114.07 40.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.402 HG22 HG13 ' A' ' 61' ' ' VAL . 59.2 t -92.91 105.12 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.28 116.58 18.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 163.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.25 52.01 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -144.4 -48.98 0.27 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.609 1.164 . . . . 0.0 109.885 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -80.9 126.01 30.83 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -173.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.17 -142.29 44.72 Favored Glycine 0 N--CA 1.439 -1.112 0 O-C-N 121.391 -0.818 . . . . 0.0 111.632 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -82.74 3.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.686 -1.15 . . . . 0.0 112.286 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.25 158.02 27.14 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 120.782 1.628 . . . . 0.0 109.512 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -171.72 137.27 1.0 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.551 2.74 . . . . 0.0 106.565 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 17' ' ' GLU . 3.5 t -76.53 111.64 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -87.0 122.14 71.31 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.78 130.6 10.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 41.49 45.79 2.85 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.339 1.856 . . . . 0.0 113.465 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.98 137.5 58.03 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -9.07 59.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.404 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -57.72 140.76 50.63 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HE2' ' H ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -71.89 -177.03 1.85 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.13 157.22 45.86 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 125.085 1.354 . . . . 0.0 108.549 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -33.24 67.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 p -153.24 175.72 12.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.454 2.301 . . . . 0.0 109.034 -170.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 73' ' ' ILE . 99.4 m -140.25 -172.73 3.49 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' N ' HG22 ' A' ' 72' ' ' THR . 0.7 OUTLIER -147.25 152.0 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 159.02 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.5 m -120.47 133.97 55.34 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.4 -38.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.184 1.356 . . . . 0.0 113.439 170.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 96.88 155.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 131.179 3.792 . . . . 0.0 111.516 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -62.72 -44.35 96.46 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.158 0.583 . . . . 0.0 110.571 -173.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -62.97 -21.41 66.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.123 -0.942 . . . . 0.0 111.595 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.28 -67.0 0.82 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 117.884 -1.055 . . . . 0.0 108.537 166.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -49.69 -45.41 48.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.92 1.688 . . . . 0.0 111.97 -168.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tp -59.89 -65.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.96 -36.43 62.84 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.189 0.996 . . . . 0.0 112.34 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.3 tp -48.6 -71.17 0.07 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.507 2.323 . . . . 0.0 109.123 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.638 ' SD ' HG13 ' A' ' 12' ' ' VAL . 10.1 ptp -75.78 -37.16 59.48 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.0 m -75.75 22.78 0.13 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.224 1.374 . . . . 0.0 111.832 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.99 18.1 59.56 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 124.748 1.166 . . . . 0.0 113.614 167.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -100.25 12.86 36.08 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.932 1.366 . . . . 0.0 111.855 -171.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.0 ttt 76.2 79.51 0.09 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 127.188 2.195 . . . . 0.0 112.882 162.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.77 123.86 21.36 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 169.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.11 169.4 4.92 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.142 1.895 . . . . 0.0 110.132 162.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -63.84 104.79 0.73 Allowed 'General case' 0 C--O 1.238 0.475 0 O-C-N 120.663 -1.273 . . . . 0.0 109.329 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.3 m -51.23 -38.74 54.21 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 118.423 -0.798 . . . . 0.0 112.739 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 100' ' ' LYS . . . -48.25 -39.29 20.92 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -85.9 -64.99 1.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.417 1.087 . . . . 0.0 109.647 172.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -54.92 -50.74 68.05 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.12 1.368 . . . . 0.0 113.025 -168.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -76.48 -42.88 42.06 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.29 22.78 46.7 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -9.96 22.6 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.247 -1.359 . . . . 0.0 113.615 177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.4 tp 55.83 95.47 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.282 1.833 . . . . 0.0 110.506 -173.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 93' ' ' ALA . 24.3 pttt -66.69 175.56 2.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.998 0.919 . . . . 0.0 108.844 169.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.79 159.66 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 164.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 m 61.24 166.48 0.09 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.332 2.653 . . . . 0.0 114.342 -176.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -133.87 -64.74 0.07 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.765 1.65 . . . . 0.0 109.49 172.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.6 m120 57.61 -173.18 0.08 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.372 1.869 . . . . 0.0 111.004 -172.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -64.1 6.23 0.19 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.692 1.597 . . . . 0.0 113.813 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.14 89.61 0.86 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 125.358 1.456 . . . . 0.0 109.687 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.39 -29.81 65.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.929 -175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.67 -64.03 1.23 Allowed 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 124.002 0.814 . . . . 0.0 109.452 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.04 29.3 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.158 2.583 . . . . 0.0 114.114 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HE2' ' CD1' ' A' ' 31' ' ' ILE . 41.0 tptt -61.67 -72.13 0.13 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.633 2.773 . . . . 0.0 110.715 -169.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -164.23 165.31 22.07 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.111 2.165 . . . . 0.0 106.974 168.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.25 -47.37 86.36 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -72.34 -14.91 61.85 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -165.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.443 HD13 ' CD1' ' A' ' 27' ' ' PHE . 9.0 tp -83.82 3.98 31.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.715 1.143 . . . . 0.0 110.021 169.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -139.42 45.27 1.95 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.529 2.331 . . . . 0.0 108.249 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 84' ' ' MET 0.379 0.1 OUTLIER 57.06 -176.13 0.06 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.617 1.567 . . . . 0.0 113.389 174.153 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.91 135.31 19.44 Favored Pre-proline 0 CA--C 1.538 0.513 0 O-C-N 120.566 -1.334 . . . . 0.0 109.376 170.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.19 -175.68 2.84 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.296 2.664 . . . . 0.0 111.737 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.78 83.67 0.52 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.141 1.353 . . . . 0.0 109.75 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 53.95 157.15 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 130.148 3.379 . . . . 0.0 114.416 -173.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.84 -105.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -145.28 124.12 12.67 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.634 1.106 . . . . 0.0 109.328 174.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.504 -0.794 0 C-N-CA 129.519 3.127 . . . . 0.0 105.771 -162.793 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.593 0.711 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.55 82.49 0.34 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -169.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.53 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 98.0 m-85 -153.22 140.02 19.03 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.815 1.246 . . . . 0.0 107.743 -166.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -59.24 -29.58 67.64 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.899 0.318 . . . . 0.0 110.963 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.61 -11.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.527 1.931 . . . . 0.0 114.74 169.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.432 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 19.8 t-20 -57.69 -36.93 72.63 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 120.279 1.399 . . . . 0.0 111.677 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.637 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -72.79 -38.24 67.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.158 172.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG13 ' HG3' ' A' ' 84' ' ' MET . 2.4 t -56.04 -46.11 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.911 1.284 . . . . 0.0 110.868 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 16' ' ' ILE . 72.1 m-85 -68.65 -24.64 64.56 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.175 -0.328 . . . . 0.0 111.822 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -75.22 -27.15 59.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 121.292 -0.88 . . . . 0.0 111.62 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.88 -46.46 89.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.229 0.468 . . . . 0.0 110.349 169.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 13' ' ' PHE . 64.8 mt -59.46 -48.72 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.499 1.12 . . . . 0.0 108.158 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -55.75 -43.09 76.34 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.466 0.706 . . . . 0.0 111.342 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.45 -47.46 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -57.42 -45.48 84.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.568 172.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -42.45 76.98 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.84 -53.23 53.96 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.083 0.953 . . . . 0.0 110.984 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.14 -45.57 92.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 119.214 0.915 . . . . 0.0 111.947 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -161.97 58.19 0.25 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.431 1.092 . . . . 0.0 111.669 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.57 -12.99 43.12 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 120.015 -1.678 . . . . 0.0 113.213 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.85 -40.47 63.42 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.256 1.528 . . . . 0.0 111.828 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.06 -26.65 43.07 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.913 -1.117 . . . . 0.0 112.294 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.2 m-85 -74.98 -33.68 61.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.037 1.335 . . . . 0.0 108.571 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -54.94 -52.68 41.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -59.53 -14.25 12.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -85.82 -42.06 14.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.98 1.718 . . . . 0.0 111.977 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.23 -59.49 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.72 65.58 2.82 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 124.286 0.946 . . . . 0.0 111.451 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.74 171.51 43.32 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.15 132.33 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 157.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.48 166.93 18.63 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.363 0.602 . . . . 0.0 111.651 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.19 145.3 38.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.584 1.154 . . . . 0.0 108.898 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -94.67 93.49 7.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.737 1.215 . . . . 0.0 108.451 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -77.62 109.39 11.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.652 1.115 . . . . 0.0 109.444 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.526 HG22 ' CE2' ' A' ' 80' ' ' PHE . 2.9 t -118.22 104.95 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.63 -179.64 5.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.42 1.088 . . . . 0.0 108.208 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t0 58.76 48.13 11.84 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.58 1.152 . . . . 0.0 113.479 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.8 -173.79 11.85 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.998 1.285 . . . . 0.0 115.373 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.95 78.1 0.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.588 2.859 . . . . 0.0 108.62 161.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.38 -17.63 4.49 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.367 1.937 . . . . 0.0 112.794 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.72 -11.57 68.1 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 126.013 1.768 . . . . 0.0 112.471 170.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.13 -176.46 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.057 1.743 . . . . 0.0 110.675 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.28 152.46 51.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 112.315 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HB2' ' CD2' ' A' ' 7' ' ' PHE . . . -119.11 174.94 6.03 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.345 2.258 . . . . 0.0 107.977 174.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.9 m -147.73 153.89 39.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 147.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.432 ' CH2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -120.74 136.97 54.73 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 162.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.59 144.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.8 113.52 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.23 112.15 18.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 164.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.23 48.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 167.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -137.07 -50.16 0.64 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.034 0.934 . . . . 0.0 110.236 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -79.87 131.11 35.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 -122.7 14.37 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.418 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 8.25 28.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.769 1.628 . . . . 0.0 110.751 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.53 158.7 30.6 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.841 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -171.14 147.63 2.58 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.865 2.466 . . . . 0.0 109.585 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -80.87 153.9 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 mt -136.43 86.19 24.39 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -169.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.45 142.22 48.7 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.609 1.54 . . . . 0.0 109.768 -174.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 45.75 34.95 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 129.278 3.031 . . . . 0.0 111.955 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.8 152.67 25.57 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.622 0.769 . . . . 0.0 110.578 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 -3.92 59.02 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.266 1.026 . . . . 0.0 111.178 161.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.97 128.95 22.68 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -73.92 -176.76 2.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.16 141.58 30.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.362 1.865 . . . . 0.0 108.092 -172.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.75 -29.17 58.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 m -150.41 165.27 33.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.013 1.725 . . . . 0.0 108.348 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.558 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 86.5 m -147.26 119.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.16 -0.962 . . . . 0.0 108.962 -170.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.94 138.46 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.9 m -108.99 131.21 55.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.022 1.283 . . . . 0.0 107.739 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -139.88 -101.22 0.16 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 161.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.08 159.06 0.15 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.503 3.121 . . . . 0.0 106.873 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.3 -48.87 79.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.73 0.812 . . . . 0.0 111.861 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -71.31 1.45 6.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.052 1.341 . . . . 0.0 111.188 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -105.3 -44.55 4.71 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.924 -1.11 . . . . 0.0 112.856 158.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CE2' HG22 ' A' ' 39' ' ' VAL . 3.8 m-85 -60.04 -60.79 3.27 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.223 1.409 . . . . 0.0 111.184 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tp -44.5 -61.22 1.62 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.477 1.111 . . . . 0.0 109.304 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.77 -18.2 29.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.792 -172.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.1 tt -67.13 -68.69 0.36 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.477 1.111 . . . . 0.0 110.675 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.419 ' HG3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.333 -0.146 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.558 ' CG2' ' H ' ' A' ' 72' ' ' THR . 1.2 mp . . . . . 0 C--N 1.312 -1.048 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.288 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.476 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -73.11 -3.85 28.97 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 169.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -150.13 44.74 0.89 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.176 1.79 . . . . 0.0 111.393 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.6 mt . . . . . 0 N--CA 1.467 0.42 0 C-N-CA 128.174 2.59 . . . . 0.0 116.018 -169.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.02 78.06 0.28 Allowed Glycine 0 C--N 1.336 0.544 0 O-C-N 120.67 -1.269 . . . . 0.0 113.088 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -153.68 160.69 42.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.629 1.572 . . . . 0.0 110.263 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm -65.48 -9.56 26.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.81 -6.24 5.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.994 0.815 . . . . 0.0 113.144 166.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.11 -37.93 81.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.681 1.128 . . . . 0.0 112.342 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -69.53 -37.88 77.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.701 1.201 . . . . 0.0 110.734 174.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.648 HG13 ' SD ' ' A' ' 84' ' ' MET . 0.9 OUTLIER -58.84 -52.71 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.627 1.571 . . . . 0.0 111.228 -175.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 67.4 m-85 -70.15 -21.63 63.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.015 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -75.06 -27.5 60.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.774 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.509 ' CB ' HD22 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -55.71 -49.46 72.96 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.353 1.433 . . . . 0.0 110.596 171.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mt -53.56 -47.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.42 1.088 . . . . 0.0 108.204 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -61.21 -53.39 57.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.634 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -51.76 -53.72 36.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.766 1.166 . . . . 0.0 108.42 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -57.12 -46.58 82.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.974 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -35.48 68.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -70.18 -52.24 24.95 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.27 -44.42 95.33 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.347 2.259 . . . . 0.0 112.763 -171.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -154.76 55.16 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.739 1.616 . . . . 0.0 111.072 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.31 -30.93 56.22 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-O 117.741 -1.589 . . . . 0.0 113.529 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.75 -38.91 67.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.898 1.849 . . . . 0.0 111.118 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -81.07 -19.26 44.14 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.279 -0.888 . . . . 0.0 112.429 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.42 -31.5 20.03 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 109.929 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.37 -55.03 6.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 126.682 1.993 . . . . 0.0 108.252 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -61.77 -16.0 45.97 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -79.68 -58.85 2.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.716 0.806 . . . . 0.0 110.52 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.45 -63.46 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.961 1.704 . . . . 0.0 107.155 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.66 72.39 0.69 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.243 1.402 . . . . 0.0 112.32 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.25 153.7 6.46 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.525 -1.153 . . . . 0.0 110.767 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.99 134.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -128.41 162.94 25.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.712 0.768 . . . . 0.0 109.131 162.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.59 157.72 22.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.561 164.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -105.79 96.29 6.39 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.322 1.449 . . . . 0.0 109.469 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.77 108.95 7.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.317 -1.489 . . . . 0.0 109.799 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG22 ' CE1' ' A' ' 80' ' ' PHE . 21.9 t -124.93 94.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 174.45 7.11 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 61.57 40.69 13.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 0.0 111.917 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -61.16 173.08 6.65 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.396 0.998 . . . . 0.0 113.52 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.01 86.61 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.009 2.473 . . . . 0.0 107.085 166.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.81 -57.98 0.41 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -163.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.96 -23.87 7.63 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 125.945 1.736 . . . . 0.0 110.483 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -71.58 -172.48 0.79 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 111.221 168.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.58 149.03 50.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.934 1.694 . . . . 0.0 113.666 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.42 167.14 10.58 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.367 2.267 . . . . 0.0 109.966 166.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.9 m -155.23 114.59 3.64 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.005 0.907 . . . . 0.0 109.854 150.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -88.46 162.35 16.52 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 168.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.88 145.33 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.71 109.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.54 122.57 29.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.5 50.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 126.136 1.775 . . . . 0.0 106.961 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -40.5 0.07 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.401 1.08 . . . . 0.0 110.279 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -95.2 131.54 41.13 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 -145.24 42.72 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -83.16 8.29 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.455 -1.259 . . . . 0.0 113.744 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.78 156.77 8.66 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 120.586 1.539 . . . . 0.0 110.579 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -171.28 144.6 2.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.96 2.104 . . . . 0.0 108.524 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.4 t -74.56 152.05 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 168.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.37 88.6 12.69 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 127.843 2.457 . . . . 0.0 104.501 -164.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.39 138.94 62.76 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.587 1.525 . . . . 0.0 109.479 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 54.49 24.09 5.04 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.301 1.841 . . . . 0.0 112.742 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 t -76.77 145.31 38.64 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.915 0.864 . . . . 0.0 111.424 -159.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.37 -11.12 55.3 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.264 2.226 . . . . 0.0 112.64 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -66.11 164.84 14.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.681 0.673 . . . . 0.0 109.541 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -169.91 0.94 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.51 -0.744 . . . . 0.0 110.106 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.9 178.28 7.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.257 1.423 . . . . 0.0 107.767 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.1 -52.14 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 159.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -149.05 -172.78 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.563 1.545 . . . . 0.0 110.985 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -129.31 178.83 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 tt -125.24 178.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 159.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.6 m -125.29 161.97 25.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 160.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -50.01 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 158.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.08 161.41 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 130.912 3.685 . . . . 0.0 109.961 -166.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 16.6 t70 -62.37 -56.06 22.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.025 -169.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.81 -34.24 62.5 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 125.6 1.812 . . . . 0.0 108.781 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -58.39 5.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 111.626 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.706 ' CE1' HG22 ' A' ' 39' ' ' VAL . 11.9 m-85 -53.97 -50.7 65.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.196 0.598 . . . . 0.0 109.968 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -26.98 66.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.036 1.734 . . . . 0.0 112.519 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.12 -25.93 55.86 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.286 0.948 . . . . 0.0 112.782 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.68 -72.54 0.2 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.654 ' SD ' HD21 ' A' ' 116' ' ' LEU . 11.9 ptp . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 125.015 1.326 . . . . 0.0 113.581 -171.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.0 mm . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 177.597 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.1 m120 . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.83 -17.36 55.99 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.668 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -127.38 45.68 2.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.091 1.314 . . . . 0.0 109.785 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.654 HD21 ' SD ' ' A' ' 84' ' ' MET 0.308 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.526 1 C-N-CA 132.041 4.136 . . . . 0.0 115.964 170.993 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.15 65.87 0.24 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 126.578 2.037 . . . . 0.0 109.731 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.685 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 10.2 m-85 -154.07 167.74 28.8 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.694 2.398 . . . . 0.0 107.283 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -62.33 -30.01 70.86 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.079 -0.388 . . . . 0.0 110.515 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.06 -28.13 0.67 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 128.218 2.607 . . . . 0.0 114.885 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.81 -44.1 73.51 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 123.789 0.835 . . . . 0.0 109.859 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.19 -42.7 99.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.683 1.593 . . . . 0.0 110.028 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -81.96 -51.22 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.593 1.557 . . . . 0.0 111.246 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 16' ' ' ILE . 33.8 m-85 -64.36 -23.32 67.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.056 0.844 . . . . 0.0 110.733 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -71.53 -36.4 70.99 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.846 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.804 ' HG3' HD21 ' A' ' 116' ' ' LEU . 34.1 mm-40 -55.43 -39.87 70.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 119.902 1.228 . . . . 0.0 112.32 172.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 13' ' ' PHE . 62.7 mt -62.43 -48.98 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 61' ' ' VAL . 16.9 tt0 -56.23 -53.84 52.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.016 1.326 . . . . 0.0 111.068 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -51.74 28.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.824 1.65 . . . . 0.0 109.092 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -59.26 -48.04 83.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.053 0.541 . . . . 0.0 111.211 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -36.09 68.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.13 -52.13 38.31 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.765 -1.209 . . . . 0.0 108.646 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.35 -47.11 82.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 110.569 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -165.35 64.7 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.411 1.084 . . . . 0.0 111.459 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.75 -15.01 81.78 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.46 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.82 -40.21 60.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.896 1.348 . . . . 0.0 111.994 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -17.99 49.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.654 0.782 . . . . 0.0 112.159 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -14.62 26.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.05 -62.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 126.733 2.013 . . . . 0.0 106.425 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -58.27 -18.71 28.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -66.3 -50.67 62.88 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.53 -53.19 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.45 47.63 76.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.361 0.981 . . . . 0.0 112.674 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.22 171.03 39.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.76 134.01 30.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 159.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -128.34 177.91 6.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.957 0.798 . . . . 0.0 109.211 163.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.42 51.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.412 0.685 . . . . 0.0 109.937 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 39' ' ' VAL . 69.5 m-85 -103.58 101.76 11.64 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.556 1.142 . . . . 0.0 107.997 175.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 106.84 6.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 121.092 1.769 . . . . 0.0 108.533 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.71 HG22 ' CE2' ' A' ' 80' ' ' PHE . 76.3 t -122.43 99.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -166.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -111.05 176.94 4.82 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 121.038 -1.039 . . . . 0.0 108.57 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.9 t0 60.24 60.02 2.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.476 1.91 . . . . 0.0 112.022 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.43 -167.29 32.56 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.83 1.681 . . . . 0.0 111.815 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.31 67.71 6.13 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.797 2.998 . . . . 0.0 109.644 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 -43.69 0.39 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.215 1.388 . . . . 0.0 110.636 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.64 -0.18 45.98 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.032 1.301 . . . . 0.0 112.369 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -65.84 -175.13 0.27 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.11 1.364 . . . . 0.0 111.576 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -132.3 132.75 43.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.221 1.008 . . . . 0.0 111.019 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.685 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -114.76 165.29 12.97 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.343 2.657 . . . . 0.0 107.304 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 37' ' ' PHE . 26.5 m -148.38 117.64 6.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 155.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 13' ' ' PHE . 1.2 m-90 -83.69 128.02 34.21 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 165.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.92 146.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.86 104.84 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.78 106.4 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.11 47.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -129.25 -54.5 1.19 Allowed 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.319 0.647 . . . . 0.0 109.643 165.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -93.35 140.51 29.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -158.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 -124.54 11.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.23 5.76 35.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.523 1.529 . . . . 0.0 112.116 164.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.01 156.98 9.15 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -171.37 153.53 3.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.916 2.486 . . . . 0.0 107.832 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 17' ' ' GLU . 3.4 t -101.66 114.86 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -173.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.75 117.44 59.78 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -169.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.01 140.12 15.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 -171.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 45.39 29.37 0.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.347 1.859 . . . . 0.0 114.057 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -64.83 141.37 58.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.156 0.889 . . . . 0.0 110.569 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.52 -20.19 60.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.412 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -54.51 126.7 24.63 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -63.16 -176.97 0.15 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.155 0.982 . . . . 0.0 110.034 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.95 159.19 42.74 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.098 1.359 . . . . 0.0 111.113 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -54.37 47.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.133 0.968 . . . . 0.0 109.191 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.0 m -146.41 169.8 18.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.366 2.266 . . . . 0.0 107.387 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 73' ' ' ILE . 10.3 m -114.32 -164.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.581 ' H ' HG22 ' A' ' 72' ' ' THR . 3.9 tt -148.93 178.1 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.495 -1.378 . . . . 0.0 108.13 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.7 m -143.11 138.81 30.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.856 1.662 . . . . 0.0 109.092 167.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -134.99 -12.56 2.2 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.7 143.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.348 2.659 . . . . 0.0 111.588 -146.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.7 -45.61 67.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 126.877 2.071 . . . . 0.0 112.376 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -54.43 -44.99 72.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.858 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.17 -51.24 56.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.717 1.207 . . . . 0.0 110.877 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.71 ' CE2' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -50.48 -50.99 51.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.392 2.277 . . . . 0.0 111.433 178.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.7 tp -53.8 -64.64 0.76 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.985 1.714 . . . . 0.0 108.633 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.21 -42.4 51.43 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.872 1.269 . . . . 0.0 111.385 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.72 -68.51 0.18 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.727 1.611 . . . . 0.0 109.912 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.551 ' HE2' HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.51 ' H ' ' HA ' ' A' ' 73' ' ' ILE . 3.1 mp . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.1 t30 . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -92.7 8.36 39.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.66 2.027 . . . . 0.0 110.493 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -153.9 44.69 0.58 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.658 2.783 . . . . 0.0 110.4 -172.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.804 HD21 ' HG3' ' A' ' 15' ' ' GLU . 84.0 mt . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 123.818 1.77 . . . . 0.0 115.44 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.46 16.37 26.76 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 120.4 -1.438 . . . . 0.0 112.533 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.2 173.33 10.48 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.863 1.265 . . . . 0.0 109.905 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 49.1 mttp -74.76 -5.56 44.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.247 169.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.41 -23.04 62.28 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.764 1.225 . . . . 0.0 113.021 167.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -57.01 -52.71 64.17 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.078 0.854 . . . . 0.0 111.232 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -68.8 -32.47 72.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.239 0.616 . . . . 0.0 111.154 178.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.35 -54.59 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.078 0.951 . . . . 0.0 110.755 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -64.53 -27.14 68.76 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.606 0.639 . . . . 0.0 110.646 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.09 -30.51 65.17 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.077 -1.015 . . . . 0.0 112.701 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.498 ' HG3' HD21 ' A' ' 116' ' ' LEU . 29.8 mm-40 -59.8 -31.92 70.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 119.301 0.955 . . . . 0.0 112.081 172.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.0 mt -75.0 -46.56 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -50.86 -50.25 57.34 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.68 1.192 . . . . 0.0 111.306 172.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -58.35 -38.57 77.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.92 0.782 . . . . 0.0 109.942 -166.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -65.06 -47.92 75.63 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 173.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -35.16 65.52 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.048 0.939 . . . . 0.0 112.444 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.2 -53.15 40.81 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.831 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.35 -45.43 91.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.33 0.968 . . . . 0.0 112.686 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -155.72 58.48 0.61 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.746 1.26 . . . . 0.0 110.841 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.79 86.3 Favored Glycine 0 C--O 1.219 -0.79 0 CA-C-O 118.569 -1.129 . . . . 0.0 111.844 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.94 -40.14 42.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.357 1.578 . . . . 0.0 112.581 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -84.37 -18.68 35.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.359 -0.838 . . . . 0.0 111.778 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.94 -38.7 19.02 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.502 1.921 . . . . 0.0 109.246 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 54' ' ' VAL . 9.3 t -54.07 -46.3 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 127.637 2.375 . . . . 0.0 108.755 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.54 -13.02 7.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -92.74 -63.09 1.27 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 120.077 1.308 . . . . 0.0 110.577 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.89 -38.36 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.2 1.0 . . . . 0.0 110.469 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 47.85 59.03 6.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.428 1.489 . . . . 0.0 112.526 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.49 -176.79 39.62 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.272 1.536 . . . . 0.0 110.509 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.6 131.77 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 159.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -121.98 167.26 13.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 111.939 166.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.8 146.02 34.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.832 1.653 . . . . 0.0 108.997 164.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -95.42 100.3 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -77.09 99.56 5.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.049 1.295 . . . . 0.0 109.059 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.12 133.81 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 170.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.48 175.46 5.51 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.607 -1.308 . . . . 0.0 108.706 154.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 55.42 52.52 11.17 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.112 160.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.01 174.74 20.07 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.425 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.8 6.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.455 3.437 . . . . 0.0 115.088 169.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.58 -22.06 1.89 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.403 1.478 . . . . 0.0 114.052 163.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.68 -13.43 17.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 119.515 1.657 . . . . 0.0 111.792 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -66.16 -175.5 0.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.938 1.695 . . . . 0.0 111.177 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.87 167.09 13.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.466 1.506 . . . . 0.0 110.225 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.45 173.37 12.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.547 1.939 . . . . 0.0 107.109 169.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 84.3 m -143.91 143.99 31.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 161.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.41 137.09 49.64 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 161.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.48 144.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.51 107.95 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -75.39 124.5 27.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.586 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -139.67 44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 105.852 -1.906 . . . . 0.0 105.852 172.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -134.5 -46.0 0.75 Allowed 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 125.09 1.356 . . . . 0.0 110.107 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -92.28 103.21 15.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -159.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.34 -113.83 4.51 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.278 -0.889 . . . . 0.0 111.638 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -84.81 -5.72 59.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.073 0.949 . . . . 0.0 112.757 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.75 -97.49 0.72 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 128.722 3.058 . . . . 0.0 110.383 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.7 m 98.89 151.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 1 C-N-CA 135.548 5.539 . . . . 0.0 111.733 -172.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.75 148.64 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 163.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.33 122.5 19.06 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.15 138.52 16.23 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 -177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.64 24.54 3.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.562 1.945 . . . . 0.0 111.958 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 t -74.65 144.76 43.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.264 1.031 . . . . 0.0 111.064 -153.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.4 7.08 23.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 111.882 164.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 tttm -61.99 129.29 40.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 153.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -68.06 -176.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.24 156.45 47.07 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.565 1.546 . . . . 0.0 109.286 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.31 -45.15 41.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.681 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -134.22 177.3 7.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.363 0.665 . . . . 0.0 110.887 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -138.81 -177.78 5.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.475 1.51 . . . . 0.0 107.688 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.27 152.93 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 119.543 -1.973 . . . . 0.0 105.694 166.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.7 m -108.24 122.74 47.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.409 1.459 . . . . 0.0 112.185 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.7 mtm -156.6 119.24 4.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.4 165.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.643 163.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.09 -54.4 45.47 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 121.256 -0.902 . . . . 0.0 109.817 163.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.9 1.69 1.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.839 1.256 . . . . 0.0 112.305 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.0 -63.38 1.13 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.466 2.306 . . . . 0.0 108.613 164.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -60.94 -40.01 91.63 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.327 2.251 . . . . 0.0 113.503 -174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -35.37 71.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.934 1.293 . . . . 0.0 110.038 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.28 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.733 1.213 . . . . 0.0 110.674 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 tt -46.83 -75.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.82 2.448 . . . . 0.0 109.717 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 123.851 0.86 . . . . 0.0 112.992 172.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.498 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.49 -4.87 42.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.383 0.992 . . . . 0.0 111.874 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -163.23 44.26 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.712 1.205 . . . . 0.0 112.172 -165.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 15' ' ' GLU . 50.0 mt . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 125.214 2.435 . . . . 0.0 114.055 -165.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t0 . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.01 77.58 0.39 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 126.725 2.107 . . . . 0.0 108.6 -175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -153.25 151.93 30.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.682 2.393 . . . . 0.0 106.852 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -61.98 -26.55 68.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.838 0.744 . . . . 0.0 110.272 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.89 -14.35 1.42 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.051 0.94 . . . . 0.0 113.443 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 19.0 t-20 -55.9 -52.19 64.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.574 1.079 . . . . 0.0 111.454 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.183 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG13 ' HG3' ' A' ' 84' ' ' MET . 45.6 t -54.69 -54.62 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.454 1.502 . . . . 0.0 110.723 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -71.1 -23.59 62.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.602 0.637 . . . . 0.0 112.199 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -75.29 -26.96 59.15 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.79 -50.0 75.57 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.211 0.46 . . . . 0.0 110.546 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.3 mt -51.39 -47.9 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.92 -50.72 72.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.988 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -55.42 -48.85 73.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.77 0.714 . . . . 0.0 109.213 -170.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.5 -45.57 93.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.181 0.592 . . . . 0.0 109.881 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -34.1 66.04 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.353 1.461 . . . . 0.0 114.355 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.258 7.8 mm-40 -63.67 -52.13 62.07 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.197 -0.939 . . . . 0.0 111.665 171.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.69 -45.54 93.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.071 1.305 . . . . 0.0 113.233 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -157.75 63.55 0.47 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.674 1.59 . . . . 0.0 108.446 -170.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -25.96 74.04 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 121.073 -1.017 . . . . 0.0 112.749 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -52.89 -36.54 59.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 112.195 -171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -77.05 -35.87 56.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.302 1.041 . . . . 0.0 110.005 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.03 -27.76 57.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.08 -55.6 9.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 167.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -63.8 -15.95 60.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.391 0.996 . . . . 0.0 113.472 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 119.634 1.106 . . . . 0.0 110.82 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.65 -50.29 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.279 1.031 . . . . 0.0 109.047 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.52 65.35 3.63 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.652 1.12 . . . . 0.0 112.775 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.06 144.76 4.64 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.31 138.28 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 168.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -138.88 162.66 34.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.046 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HB1' ' CG2' ' A' ' 49' ' ' THR . . . -111.3 144.56 40.29 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.749 1.22 . . . . 0.0 109.253 172.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -92.94 90.06 6.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.951 1.301 . . . . 0.0 108.945 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -74.62 107.56 6.82 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.717 -1.239 . . . . 0.0 109.526 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.771 HG22 ' CE2' ' A' ' 80' ' ' PHE . 40.5 t -128.67 110.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -115.77 -175.29 2.69 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 165.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t0 65.19 38.18 6.14 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.685 1.994 . . . . 0.0 112.578 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.44 -155.13 24.38 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.962 1.268 . . . . 0.0 111.801 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.75 110.06 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.658 2.239 . . . . 0.0 106.448 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.32 -70.5 0.23 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.028 0.823 . . . . 0.0 111.141 -166.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.92 21.44 36.2 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 118.476 1.138 . . . . 0.0 110.843 -162.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -75.52 -176.12 3.09 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 156.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.25 153.33 29.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.553 1.141 . . . . 0.0 108.363 166.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.69 170.85 13.29 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.36 1.864 . . . . 0.0 107.626 163.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.513 ' CG2' ' HB1' ' A' ' 36' ' ' ALA . 16.6 m -152.77 145.78 24.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 163.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -112.61 149.36 32.91 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 102.134 -3.284 . . . . 0.0 102.134 166.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 141.72 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 167.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.17 113.0 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -82.19 114.01 20.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.42 51.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -141.63 -54.22 0.46 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.4 153.02 34.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.729 0.812 . . . . 0.0 109.914 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.96 -134.37 11.65 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.366 0.984 . . . . 0.0 111.144 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.66 3.3 50.34 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.186 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.95 156.19 20.38 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -173.02 157.67 3.57 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 129.505 3.122 . . . . 0.0 107.599 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.15 153.62 3.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.0 mt -140.32 79.29 21.4 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -161.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.9 144.27 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.502 2.135 . . . . 0.0 110.331 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 47.09 24.47 0.4 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.761 2.024 . . . . 0.0 115.138 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -71.77 161.45 30.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.359 1.076 . . . . 0.0 111.479 -161.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.46 -15.73 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.632 1.973 . . . . 0.0 110.71 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -53.83 130.24 36.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.05 -176.03 2.82 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 165.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.54 152.45 45.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.82 0.848 . . . . 0.0 109.447 -174.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.15 -41.02 59.15 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.306 1.042 . . . . 0.0 109.516 -174.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -136.18 174.81 10.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.833 2.053 . . . . 0.0 107.889 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.485 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 23.7 m -155.35 122.71 5.55 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 tt -83.52 152.31 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.8 m -120.71 141.7 50.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.888 -1.133 . . . . 0.0 108.998 159.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.56 -103.41 0.2 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 163.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.21 159.25 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 130.56 3.544 . . . . 0.0 105.473 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.61 -41.2 69.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.834 0.854 . . . . 0.0 111.211 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 t -60.81 -21.23 62.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.632 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.32 -64.06 1.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.788 0.835 . . . . 0.0 109.387 172.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.771 ' CE2' HG22 ' A' ' 39' ' ' VAL . 95.9 m-85 -55.85 -53.32 58.2 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.861 0.865 . . . . 0.0 110.299 -171.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 tp -55.1 -54.72 39.6 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.54 -41.91 77.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.108 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -54.84 -65.02 0.65 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.776 0.716 . . . . 0.0 110.144 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.481 ' HG3' HG13 ' A' ' 12' ' ' VAL 0.275 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.485 ' CG2' ' H ' ' A' ' 72' ' ' THR 0.314 1.2 mp . . . . . 0 N--CA 1.433 -1.279 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 165.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.893 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.7 tp -77.92 -30.71 50.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.725 1.21 . . . . 0.0 110.789 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.405 ' C ' HD23 ' A' ' 116' ' ' LEU . 18.4 mt-30 -134.99 44.48 2.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.508 1.923 . . . . 0.0 108.987 -165.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 116' ' ' LEU 0.307 0.4 OUTLIER . . . . . 0 CA--C 1.547 0.844 0 C-N-CA 129.494 3.118 . . . . 0.0 114.121 -178.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 122.193 0.997 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 3.66 58.23 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.871 1.701 . . . . 0.0 112.031 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CE2' ' HA3' ' A' ' 42' ' ' GLY . 2.3 m-30 -68.0 148.68 50.7 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 108.926 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -60.19 -21.99 62.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.308 0.643 . . . . 0.0 112.663 169.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -2.58 0.11 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 114.505 170.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -54.75 -51.87 64.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.931 1.242 . . . . 0.0 111.352 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.622 HD22 ' C ' ' A' ' 11' ' ' LEU 0.294 0.0 OUTLIER -58.9 -36.34 74.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.325 1.05 . . . . 0.0 112.241 178.274 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 84' ' ' MET . 3.4 t -59.15 -51.76 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.493 1.042 . . . . 0.0 110.848 -175.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.745 ' HA ' HD12 ' A' ' 16' ' ' ILE . 71.8 m-85 -74.94 -14.72 60.67 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.989 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -74.62 -35.84 62.93 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 117.611 -1.185 . . . . 0.0 111.635 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.729 ' HG3' HD21 ' A' ' 116' ' ' LEU . 67.3 mm-40 -57.36 -29.06 63.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.995 1.27 . . . . 0.0 112.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 13' ' ' PHE . 64.8 mt -65.48 -56.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.453 1.901 . . . . 0.0 108.603 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.57 -47.44 63.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 110.609 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.71 -38.98 93.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.088 1.355 . . . . 0.0 109.825 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -69.32 -36.81 77.35 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.435 -0.79 . . . . 0.0 110.445 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -33.17 75.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.706 1.202 . . . . 0.0 112.188 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.83 -53.35 52.13 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.806 -1.184 . . . . 0.0 110.16 167.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.64 -42.55 83.66 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 112.648 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -160.27 40.34 0.18 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.0 -18.77 80.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.979 -172.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.28 -52.83 2.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.941 1.371 . . . . 0.0 111.529 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.16 77.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.456 0.646 . . . . 0.0 109.798 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.16 -29.25 67.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -53.75 -52.51 33.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.398 0.999 . . . . 0.0 108.699 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -62.18 -24.22 67.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.45 1.477 . . . . 0.0 113.641 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.64 -29.92 69.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.039 1.291 . . . . 0.0 112.175 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.34 -61.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.739 1.216 . . . . 0.0 108.533 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.54 64.48 3.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 125.79 1.662 . . . . 0.0 109.794 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.29 45.34 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.955 0.878 . . . . 0.0 113.809 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.37 138.29 24.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 158.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -135.37 164.49 27.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.858 0.299 . . . . 0.0 110.726 163.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.0 167.75 9.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 109.715 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.483 ' H ' HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -132.8 99.23 4.54 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -170.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -87.34 94.02 9.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.215 1.371 . . . . 0.0 110.607 -165.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.82 115.0 38.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.375 0.607 . . . . 0.0 109.787 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -115.29 174.14 6.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.922 1.289 . . . . 0.0 109.464 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.7 t0 44.13 47.23 7.49 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.165 0.916 . . . . 0.0 112.879 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA3' ' CE2' ' A' ' 7' ' ' PHE . . . -69.71 173.27 37.97 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-O 118.564 -1.131 . . . . 0.0 111.834 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.25 94.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.818 3.012 . . . . 0.0 109.894 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.77 -3.48 14.89 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 126.674 2.083 . . . . 0.0 114.116 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.35 13.8 70.07 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.368 2.084 . . . . 0.0 112.284 160.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -85.79 -167.14 1.74 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.09 2.156 . . . . 0.0 108.502 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -134.11 147.76 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.854 1.661 . . . . 0.0 107.679 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.14 174.86 11.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.161 1.784 . . . . 0.0 108.122 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 37' ' ' PHE . 18.4 m -155.54 155.83 34.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.116 1.366 . . . . 0.0 108.655 169.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.31 154.68 36.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 t -122.49 114.61 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.8 t -95.38 112.55 27.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.83 115.37 20.29 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.65 47.31 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 168.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.97 -49.92 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.513 1.525 . . . . 0.0 109.715 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.27 151.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.303 1.041 . . . . 0.0 108.208 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.11 -131.09 44.86 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -111.79 13.14 21.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.429 1.892 . . . . 0.0 109.717 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 156.66 29.45 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -172.62 161.56 4.92 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 128.182 2.593 . . . . 0.0 105.776 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.29 127.7 58.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -107.6 93.37 10.04 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 125.539 1.535 . . . . 0.0 108.061 -162.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.58 137.55 64.9 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.727 1.618 . . . . 0.0 110.297 -165.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.24 44.6 15.96 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.597 3.159 . . . . 0.0 109.06 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.69 147.01 53.9 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.916 0.865 . . . . 0.0 111.205 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.29 -24.68 39.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.547 158.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -60.43 117.12 4.86 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.157 0.979 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -72.21 -177.17 2.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.996 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.15 163.95 30.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.553 1.168 . . . . 0.0 111.542 -163.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -37.19 59.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.115 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.17 -178.85 5.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.273 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -139.03 -176.01 4.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.272 1.429 . . . . 0.0 108.123 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt -142.62 157.37 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 120.911 -1.118 . . . . 0.0 109.285 159.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 m -98.03 124.4 42.51 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 mtt -152.03 124.31 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 163.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 155.74 4.12 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.982 -0.449 . . . . 0.0 110.931 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -52.47 -49.59 64.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 110.871 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 t -65.4 -9.87 28.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.812 1.645 . . . . 0.0 111.603 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.17 -54.67 3.34 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.757 168.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -48.16 -54.34 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.081 0.855 . . . . 0.0 110.061 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.04 -51.08 62.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 125.818 1.647 . . . . 0.0 110.292 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.98 -24.77 66.36 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.052 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -67.91 -82.16 0.03 OUTLIER 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.534 ' CE ' HD11 ' A' ' 16' ' ' ILE . 1.5 ptm . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 126.295 1.838 . . . . 0.0 114.321 -163.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.273 21.8 mm . . . . . 0 C--N 1.316 -0.872 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.7 tp -57.47 -53.97 52.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.44 52.69 0.88 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.681 1.592 . . . . 0.0 110.666 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.729 HD21 ' HG3' ' A' ' 15' ' ' GLU . 9.0 mt . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 122.221 1.01 . . . . 0.0 111.053 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.52 62.67 0.3 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 119.606 -1.933 . . . . 0.0 111.965 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.482 ' CE2' ' HA3' ' A' ' 42' ' ' GLY . 32.5 m-85 -152.32 143.47 23.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.017 1.408 . . . . 0.0 110.938 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -17.7 62.54 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.637 167.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.33 -13.47 0.9 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.857 1.663 . . . . 0.0 113.706 167.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -56.26 -34.09 66.07 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.541 1.064 . . . . 0.0 112.208 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.417 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -83.82 -31.53 25.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.56 -0.733 . . . . 0.0 112.088 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.87 -62.97 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 124.286 1.034 . . . . 0.0 108.907 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' HA ' HD12 ' A' ' 16' ' ' ILE . 39.3 m-85 -67.51 -25.97 66.11 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.346 -174.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -73.03 -34.33 66.26 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.537 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.66 -30.2 70.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 120.406 1.457 . . . . 0.0 112.588 172.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 13' ' ' PHE . 24.3 mt -65.91 -52.99 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -56.38 -45.71 80.4 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.318 1.047 . . . . 0.0 112.303 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -59.81 -46.54 88.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.1 tpmt? -65.33 -39.34 92.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.795 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.35 -37.43 70.0 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 113.63 171.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.1 -53.4 50.24 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.205 1.002 . . . . 0.0 110.542 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -59.43 -46.02 89.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.307 1.412 . . . . 0.0 111.369 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -164.9 65.06 0.13 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.457 1.123 . . . . 0.0 113.341 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.57 79.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.048 1.309 . . . . 0.0 113.272 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.45 -36.93 67.1 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.811 1.305 . . . . 0.0 111.64 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.841 -1.162 . . . . 0.0 111.43 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.06 -25.8 61.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.432 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.24 -51.17 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.449 -0.786 . . . . 0.0 108.997 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.64 -37.34 75.73 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.801 1.182 . . . . 0.0 111.319 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -61.24 -65.76 0.64 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.626 0.77 . . . . 0.0 110.006 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mt -74.84 -66.87 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.51 66.24 2.53 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.819 1.2 . . . . 0.0 111.051 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.79 37.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 171.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.93 134.62 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 158.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -137.18 167.52 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 171.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 141.15 47.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.921 0.782 . . . . 0.0 112.864 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -87.26 103.78 15.77 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.142 0.977 . . . . 0.0 109.832 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -74.09 95.79 2.61 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 119.54 1.064 . . . . 0.0 109.764 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.14 108.9 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.28 179.25 4.21 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.679 1.191 . . . . 0.0 108.322 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 t70 49.51 42.79 23.28 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.631 1.172 . . . . 0.0 110.724 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.482 ' HA3' ' CE2' ' A' ' 7' ' ' PHE . . . -66.86 168.63 36.19 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.148 -1.362 . . . . 0.0 110.413 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 92.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.829 3.019 . . . . 0.0 113.324 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.93 3.34 51.99 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.718 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.02 40.99 1.34 Allowed Glycine 0 C--N 1.339 0.734 0 CA-C-N 120.61 2.205 . . . . 0.0 111.307 164.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.04 -176.98 6.18 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.535 -0.979 . . . . 0.0 111.086 174.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -147.67 140.65 24.96 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.589 2.355 . . . . 0.0 107.381 163.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.25 166.33 30.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.3 m -143.88 147.73 34.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -122.44 132.81 54.53 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.97 151.29 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -126.66 104.84 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.85 105.16 15.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.34 55.18 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.839 0.745 . . . . 0.0 109.391 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -155.12 -43.66 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.674 1.19 . . . . 0.0 111.194 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -95.92 110.26 22.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.41 1.484 . . . . 0.0 107.557 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.49 -153.6 39.15 Favored Glycine 0 N--CA 1.46 0.261 0 O-C-N 119.882 -1.761 . . . . 0.0 111.618 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -5.45 57.02 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.771 0.828 . . . . 0.0 112.614 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.28 157.68 30.12 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-O 122.238 0.91 . . . . 0.0 110.973 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.84 165.41 6.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.125 3.37 . . . . 0.0 107.905 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.89 89.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 120.747 -1.221 . . . . 0.0 107.945 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.66 103.58 0.88 Allowed Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -164.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.94 143.83 41.73 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.678 1.585 . . . . 0.0 110.14 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 47.7 23.77 0.47 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.941 2.496 . . . . 0.0 113.427 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -78.49 149.21 33.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.405 0.621 . . . . 0.0 110.211 -153.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.55 -2.47 58.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.625 1.97 . . . . 0.0 111.183 168.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.09 130.57 46.7 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 155.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -177.28 1.9 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.28 159.34 39.39 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.983 1.713 . . . . 0.0 107.722 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -35.87 73.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.61 -167.19 2.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.519 1.528 . . . . 0.0 110.794 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 m -133.28 -176.62 4.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.766 1.226 . . . . 0.0 109.578 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tt -142.37 143.55 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.065 -1.022 . . . . 0.0 108.774 151.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 m -84.64 138.91 32.42 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.6 tpp -136.17 -57.88 0.75 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.308 1.413 . . . . 0.0 110.466 149.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.69 152.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 130.433 3.493 . . . . 0.0 111.634 -157.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.13 -48.62 75.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 123.717 0.807 . . . . 0.0 110.403 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 p -66.29 -5.34 10.16 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.751 1.22 . . . . 0.0 111.688 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 -47.87 3.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 161.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -55.81 -52.12 65.08 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.813 1.642 . . . . 0.0 110.179 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tp -55.12 -41.9 72.28 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.187 1.795 . . . . 0.0 112.606 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.82 79.92 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.776 0.43 . . . . 0.0 111.578 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -68.59 -76.14 0.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.055 1.742 . . . . 0.0 110.757 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptm . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 125.071 1.349 . . . . 0.0 113.902 -173.574 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -172.711 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.95 -21.53 59.99 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 120.931 -1.105 . . . . 0.0 110.418 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.82 53.1 1.49 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.064 0.945 . . . . 0.0 109.648 -167.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 126.044 1.737 . . . . 0.0 112.568 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 122.111 0.957 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.57 35.48 0.38 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.761 1.172 . . . . 0.0 112.512 -174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.317 1.058 . . . . 0.0 110.349 173.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -54.15 -34.85 61.39 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.718 -0.614 . . . . 0.0 110.525 164.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.21 -10.96 1.42 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.206 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -60.61 -26.67 67.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.984 1.72 . . . . 0.0 110.969 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.536 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -81.56 -38.38 26.24 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.243 1.383 . . . . 0.0 112.039 169.642 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.81 -53.47 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 119.39 0.995 . . . . 0.0 110.591 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.427 ' HB3' ' CD1' ' A' ' 50' ' ' TRP . 84.9 m-85 -67.91 -22.59 65.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.136 -0.625 . . . . 0.0 111.353 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -75.1 -30.33 60.87 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.515 ' HB2' HD22 ' A' ' 116' ' ' LEU . 4.8 mm-40 -57.58 -46.52 83.89 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.375 0.534 . . . . 0.0 109.72 170.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 13' ' ' PHE . 61.9 mt -57.54 -50.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -52.62 -55.68 20.74 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 124.374 1.07 . . . . 0.0 111.5 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -55.19 -48.65 73.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.546 1.138 . . . . 0.0 108.375 -171.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -58.57 -48.96 79.16 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.642 175.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.19 70.22 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.328 59.2 mm-40 -66.2 -51.22 59.83 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 124.434 1.094 . . . . 0.0 110.828 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.37 -46.5 80.03 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.19 -0.944 . . . . 0.0 111.856 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -165.63 61.75 0.11 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.969 1.307 . . . . 0.0 109.456 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -24.01 72.58 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.963 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.43 -28.82 65.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.765 1.783 . . . . 0.0 113.596 -165.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.29 -25.47 16.32 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.488 2.715 . . . . 0.0 110.95 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.1 m-85 -73.77 -28.85 61.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.724 2.01 . . . . 0.0 110.39 172.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -53.23 -44.34 52.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.585 1.154 . . . . 0.0 109.029 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.87 -27.78 69.04 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -71.04 -28.85 64.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.844 1.202 . . . . 0.0 112.277 -167.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.76 -59.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.3 73.96 0.51 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.739 1.161 . . . . 0.0 110.343 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.56 177.09 45.27 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.896 0.848 . . . . 0.0 112.148 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.56 147.36 6.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 144.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -138.27 176.25 8.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 154.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.24 174.53 7.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.551 156.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -116.38 122.69 45.58 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.588 1.555 . . . . 0.0 107.836 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -100.05 104.93 16.54 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 121.12 1.782 . . . . 0.0 106.628 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.58 94.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -162.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -94.53 177.73 5.83 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.869 -1.145 . . . . 0.0 108.414 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.8 t0 60.31 33.3 20.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.344 1.057 . . . . 0.0 111.601 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.46 174.6 38.25 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 118.409 -1.217 . . . . 0.0 111.381 170.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.7 95.66 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.508 2.805 . . . . 0.0 110.528 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.69 -16.57 4.78 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.122 2.296 . . . . 0.0 112.871 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.28 3.72 88.65 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 118.919 1.359 . . . . 0.0 112.086 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -69.5 -174.78 0.73 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.312 2.645 . . . . 0.0 109.444 170.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -126.91 168.74 14.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.079 0.552 . . . . 0.0 110.829 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.39 175.07 10.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.881 1.672 . . . . 0.0 109.338 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.0 m -149.75 149.09 30.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.256 1.022 . . . . 0.0 109.917 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 13' ' ' PHE . 1.2 m-90 -121.7 151.63 40.29 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 t -120.55 133.94 65.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 126.853 2.061 . . . . 0.0 105.985 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.85 114.5 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.15 114.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.97 54.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.34 -45.41 0.05 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.166 1.386 . . . . 0.0 109.106 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -74.91 135.44 41.48 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.37 -133.19 11.0 Favored Glycine 0 C--N 1.333 0.362 0 O-C-N 123.69 0.618 . . . . 0.0 111.885 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.46 4.15 47.57 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.418 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.24 156.89 28.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-O 123.22 1.456 . . . . 0.0 110.212 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -172.31 144.4 1.56 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.005 2.922 . . . . 0.0 109.689 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.97 157.01 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mt -134.71 79.23 53.41 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -166.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.87 132.83 38.82 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.122 2.548 . . . . 0.0 110.81 -166.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.2 23.77 4.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.539 1.936 . . . . 0.0 111.891 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -82.69 145.91 29.35 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.449 -0.782 . . . . 0.0 110.104 -162.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -85.16 -9.45 57.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.748 1.619 . . . . 0.0 111.791 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -53.4 142.36 22.01 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.945 -1.097 . . . . 0.0 110.435 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -71.02 -175.58 1.18 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 111.779 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.58 165.09 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.22 -62.49 1.55 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.562 1.145 . . . . 0.0 112.157 157.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -154.54 166.91 31.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.871 1.669 . . . . 0.0 108.991 -170.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -138.61 126.65 22.58 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 tt -82.53 165.48 2.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 m -102.35 126.37 49.34 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.505 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -157.82 132.07 8.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 158.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.21 154.39 39.94 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.456 1.102 . . . . 0.0 110.081 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -49.69 -48.59 49.56 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.535 1.534 . . . . 0.0 112.389 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -59.04 -24.99 63.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 110.948 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.38 -26.44 11.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.465 0.706 . . . . 0.0 110.89 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.505 ' CZ ' ' HG3' ' A' ' 75' ' ' MET . 66.1 m-85 -57.85 -57.97 10.44 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 158.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.47 -35.82 53.51 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.547 -0.72 . . . . 0.0 111.977 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.92 94.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mt -69.94 -67.1 0.51 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 110.107 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.341 0.225 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -167.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt . . . . . 0 N--CA 1.441 -0.895 0 N-CA-C 101.974 -3.343 . . . . 0.0 101.974 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.0 mm . . . . . 0 C--N 1.312 -1.044 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -157.679 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.41 HD12 ' CE2' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -72.07 -5.01 32.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.339 0.972 . . . . 0.0 111.671 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -149.49 44.46 0.94 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 128.639 2.775 . . . . 0.0 109.58 -170.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 15' ' ' GLU 0.379 0.2 OUTLIER . . . . . 0 C--N 1.352 0.681 0 C-N-CA 127.348 2.259 . . . . 0.0 112.756 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.06 68.56 0.42 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 125.225 1.393 . . . . 0.0 111.025 -163.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.807 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 76.5 m-85 -153.42 159.87 42.47 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.727 2.011 . . . . 0.0 107.34 -168.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.71 -34.6 73.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 167.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.21 -10.5 0.37 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.805 2.042 . . . . 0.0 114.607 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -55.16 -52.52 63.05 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 120.347 1.43 . . . . 0.0 111.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.443 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -65.22 -33.63 76.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.434 -179.844 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.66 -54.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.144 0.884 . . . . 0.0 110.248 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 16' ' ' ILE . 72.6 m-85 -68.95 -23.19 64.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.261 0.482 . . . . 0.0 111.646 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -37.57 80.99 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 116.591 -1.671 . . . . 0.0 111.835 173.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -65.45 -38.16 89.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.678 1.581 . . . . 0.0 111.256 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 13' ' ' PHE . 60.0 mt -52.86 -47.91 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 61' ' ' VAL . 19.7 tt0 -64.51 -43.04 95.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.886 0.474 . . . . 0.0 111.826 175.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -63.18 -42.95 99.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -60.16 -35.71 75.94 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.142 -0.974 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.29 -27.26 62.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -63.86 -54.05 41.07 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.19 -0.944 . . . . 0.0 109.079 163.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.06 -43.81 98.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.648 0.779 . . . . 0.0 110.05 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -165.09 64.9 0.12 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.408 1.483 . . . . 0.0 109.064 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.89 -17.28 79.3 Favored Glycine 0 CA--C 1.519 0.334 0 O-C-N 120.959 -1.088 . . . . 0.0 113.166 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.517 ' CB ' ' HE3' ' A' ' 58' ' ' LYS . 5.9 pt-20 -58.21 -33.98 69.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.99 0.895 . . . . 0.0 112.197 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -79.98 -39.35 30.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.775 1.63 . . . . 0.0 109.463 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.39 -29.53 70.82 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.27 -52.25 53.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 119.214 0.916 . . . . 0.0 110.6 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -68.41 -18.04 64.35 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.299 -0.876 . . . . 0.0 112.621 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -72.55 -69.49 0.4 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 120.333 1.424 . . . . 0.0 109.195 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.32 -54.84 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -171.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.29 65.01 3.43 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.06 158.07 21.91 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 167.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.27 137.51 22.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 159.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -132.41 168.81 17.49 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.661 -0.649 . . . . 0.0 109.426 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.06 158.87 26.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' THR . 73.2 m-85 -108.09 113.39 26.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.503 1.521 . . . . 0.0 108.629 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.27 117.3 23.46 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.34 1.882 . . . . 0.0 114.181 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.67 101.28 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -109.45 -169.96 1.57 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 165.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t0 54.12 39.28 30.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.822 2.049 . . . . 0.0 111.917 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -66.22 176.55 17.68 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.721 173.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.88 -8.04 12.77 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.451 2.1 . . . . 0.0 114.119 -174.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.69 4.84 19.1 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.629 1.585 . . . . 0.0 114.617 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.61 77.57 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 120.179 1.989 . . . . 0.0 112.805 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -85.57 -171.77 3.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.062 2.945 . . . . 0.0 110.164 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.45 150.5 39.1 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.807 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -130.87 162.77 28.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 131.528 3.931 . . . . 0.0 107.498 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 37' ' ' PHE . 1.3 m -154.91 140.94 18.36 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 161.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -112.19 154.72 25.11 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 170.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.1 t -118.93 122.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.13 109.97 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 107.681 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -85.4 48.52 1.59 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.077 1.351 . . . . 0.0 112.242 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 m -75.74 53.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 119.998 -1.689 . . . . 0.0 110.977 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.06 -46.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.226 1.81 . . . . 0.0 108.908 174.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.4 143.19 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -168.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.54 -131.57 51.18 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HE3' ' CB ' ' A' ' 25' ' ' GLU . 2.8 mmmt -97.94 5.18 49.2 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.351 1.06 . . . . 0.0 111.346 168.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.77 157.8 20.33 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 119.885 1.22 . . . . 0.0 110.637 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.8 m -171.54 162.49 6.52 Favored 'General case' 0 N--CA 1.442 -0.844 1 C-N-CA 132.386 4.274 . . . . 0.0 105.201 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 17' ' ' GLU . 12.0 t -109.94 157.41 10.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 170.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 mt -129.03 122.55 21.34 Favored Pre-proline 0 N--CA 1.441 -0.897 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -89.74 145.45 4.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.787 2.991 . . . . 0.0 108.849 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 35.49 41.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.088 1.755 . . . . 0.0 114.039 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -68.25 148.9 50.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.722 0.809 . . . . 0.0 109.098 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -86.19 -20.24 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.402 1.081 . . . . 0.0 111.303 163.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -52.3 125.06 14.84 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -62.44 -177.45 0.14 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.165 0.983 . . . . 0.0 109.036 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.36 149.06 33.05 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.609 1.164 . . . . 0.0 109.997 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -43.45 51.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.812 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -127.27 174.23 9.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.511 1.924 . . . . 0.0 109.136 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.9 m -133.75 -169.68 2.35 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.594 ' H ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -155.37 154.67 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 169.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -121.64 128.4 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.6 mtm -136.27 -29.15 1.0 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 117.367 -1.301 . . . . 0.0 111.718 165.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.81 153.6 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.872 1.269 . . . . 0.0 109.517 -166.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 10.1 t70 -54.47 -44.06 72.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.382 1.473 . . . . 0.0 111.216 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.0 t -56.81 -39.31 73.91 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.068 2.547 . . . . 0.0 109.925 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.19 -42.39 10.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.522 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.39 -52.32 62.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.34 1.056 . . . . 0.0 110.489 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.39 -53.45 56.49 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.68 -19.26 15.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.612 0.765 . . . . 0.0 113.054 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -79.81 0.05 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.6 pttp . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.321 33.4 mm . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.722 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p30 . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.47 -56.19 18.98 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.728 0.811 . . . . 0.0 109.294 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.12 44.88 1.21 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.976 0.51 . . . . 0.0 110.49 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 116' ' ' LEU . 10.6 mt . . . . . 0 C--O 1.235 0.324 0 C-N-CA 125.571 1.548 . . . . 0.0 112.933 -170.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.271 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.27 74.87 0.29 Allowed Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.243 -1.535 . . . . 0.0 111.492 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -153.87 158.74 41.22 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.606 1.562 . . . . 0.0 109.955 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -75.05 -13.34 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.841 165.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.86 -30.25 5.59 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.585 1.084 . . . . 0.0 112.575 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 127.135 2.174 . . . . 0.0 110.479 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.83 -31.43 71.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.191 1.396 . . . . 0.0 110.859 -174.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 t -90.63 -45.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.222 2.609 . . . . 0.0 110.989 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -65.14 -37.34 87.1 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.093 0.861 . . . . 0.0 111.797 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -52.25 -37.1 54.4 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 170.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.69 -41.27 96.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.921 0.782 . . . . 0.0 110.906 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.17 -51.68 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.29 -43.71 83.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.807 1.643 . . . . 0.0 112.768 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -65.32 -51.46 60.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -59.58 -38.97 82.59 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.317 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.48 -37.95 71.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.52 -53.38 43.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.29 -0.881 . . . . 0.0 111.938 165.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -55.21 -43.93 74.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.041 1.336 . . . . 0.0 112.136 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -165.42 65.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.621 2.768 . . . . 0.0 108.525 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.89 -25.66 75.36 Favored Glycine 0 CA--C 1.518 0.224 0 O-C-N 120.691 -1.256 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -44.22 62.44 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.952 0.876 . . . . 0.0 111.58 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -77.43 -22.66 51.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 121.426 -0.796 . . . . 0.0 110.815 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.17 -29.04 54.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -55.47 -38.83 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.153 0.888 . . . . 0.0 109.417 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -69.48 -11.17 60.61 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.53 -1.356 . . . . 0.0 114.013 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -78.07 -61.7 1.91 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 121.405 1.911 . . . . 0.0 111.199 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.77 -58.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.02 62.64 4.55 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 126.756 2.122 . . . . 0.0 112.724 -170.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.54 164.38 34.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 125.275 1.417 . . . . 0.0 110.657 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.03 128.36 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 159.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -129.82 159.36 36.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 110.899 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.74 166.67 10.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 109.212 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.485 ' H ' HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -130.09 91.92 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -172.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -78.84 104.41 9.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.307 0.958 . . . . 0.0 109.073 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.59 103.5 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.3 ptmm? -92.83 -171.03 2.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.8 t0 62.22 51.62 3.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 123.23 1.491 . . . . 0.0 111.333 148.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.87 -162.64 11.78 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 126.849 2.166 . . . . 0.0 109.627 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.9 85.84 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 124.053 3.169 . . . . 0.0 110.619 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.13 -20.87 4.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.826 1.679 . . . . 0.0 113.467 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.07 22.67 65.22 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 120.035 1.917 . . . . 0.0 111.285 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -79.06 -169.58 1.88 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.318 1.447 . . . . 0.0 108.409 168.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 34.6 tt0 -130.0 141.67 50.72 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.573 0.749 . . . . 0.0 109.378 170.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.97 160.98 14.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.016 2.527 . . . . 0.0 107.721 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 37' ' ' PHE . 91.5 m -140.05 142.56 36.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 147.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.1 140.83 47.54 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 161.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.13 142.16 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.51 113.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 42.49 1.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.848 1.659 . . . . 0.0 112.197 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 20' ' ' LEU . 1.9 m -74.63 60.37 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.822 1.249 . . . . 0.0 111.117 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -148.99 -46.14 0.14 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.234 1.814 . . . . 0.0 109.584 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -82.08 142.31 32.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.12 -127.71 25.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.953 0.797 . . . . 0.0 113.119 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -92.55 1.44 57.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.606 1.162 . . . . 0.0 111.909 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.12 157.83 15.33 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 120.185 1.357 . . . . 0.0 110.263 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -171.17 165.64 7.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 129.461 3.104 . . . . 0.0 108.509 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -107.96 156.12 8.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.086 1.754 . . . . 0.0 109.039 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -142.23 75.08 20.34 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 -162.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -63.18 140.07 75.83 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.357 2.038 . . . . 0.0 109.531 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 51.43 23.56 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.709 1.603 . . . . 0.0 114.132 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 t -79.22 144.5 34.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.485 0.659 . . . . 0.0 111.406 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.52 8.36 3.59 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 126.021 1.728 . . . . 0.0 111.057 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.91 135.22 57.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.437 -2.039 . . . . 0.0 109.546 162.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -66.95 -173.34 0.24 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.535 1.534 . . . . 0.0 109.482 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 165.85 33.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.293 1.037 . . . . 0.0 109.907 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.08 -50.32 16.78 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.068 160.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.4 m -134.83 -178.65 5.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.891 0.769 . . . . 0.0 111.461 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.645 HG22 ' H ' ' A' ' 73' ' ' ILE . 14.1 m -149.2 -164.66 2.08 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.645 ' H ' HG22 ' A' ' 72' ' ' THR . 5.6 tt -150.75 165.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 125.566 1.546 . . . . 0.0 107.159 161.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.555 ' H ' ' HA ' ' A' ' 100' ' ' LYS . 72.9 m -121.48 136.23 54.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.181 161.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.05 -98.33 0.15 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 152.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 178.0 152.24 0.27 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.755 3.222 . . . . 0.0 106.992 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.17 -40.59 90.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.796 1.638 . . . . 0.0 110.159 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.4 p -58.68 -22.77 57.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.771 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -105.72 -40.79 5.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.661 1.184 . . . . 0.0 109.982 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -53.99 50.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.342 1.457 . . . . 0.0 111.904 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -54.66 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.03 -12.9 58.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.896 -1.526 . . . . 0.0 114.043 -168.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.55 -76.33 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.765 1.626 . . . . 0.0 108.996 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.241 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.555 ' HA ' ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -176.466 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -15.39 25.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.535 0.734 . . . . 0.0 112.283 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -128.17 49.34 2.18 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.495 1.518 . . . . 0.0 109.104 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 C--N 1.344 0.354 0 C-N-CA 125.8 1.64 . . . . 0.0 111.823 -172.611 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.88 4.46 6.95 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.714 1.149 . . . . 0.0 112.483 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -65.51 160.2 22.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.583 1.191 . . . . 0.0 109.092 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -7.18 14.6 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.21 0.45 7.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 113.192 165.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -53.15 -53.62 47.76 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.482 1.492 . . . . 0.0 111.311 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.621 HD22 ' C ' ' A' ' 11' ' ' LEU 0.25 0.0 OUTLIER -57.29 -35.72 70.16 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.346 1.059 . . . . 0.0 113.439 173.395 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.555 HG22 ' SD ' ' A' ' 84' ' ' MET . 0.9 OUTLIER -58.9 -47.81 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.565 1.546 . . . . 0.0 110.463 178.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 97.8 m-85 -72.73 -33.62 66.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.332 0.969 . . . . 0.0 111.057 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -71.37 -24.57 62.11 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.421 -0.799 . . . . 0.0 112.777 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.08 -49.24 72.17 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.72 -0.613 . . . . 0.0 112.338 164.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -57.45 -48.85 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -58.15 -54.39 47.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.244 1.417 . . . . 0.0 110.984 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -36.31 81.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.406 1.003 . . . . 0.0 109.547 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -67.38 -39.71 85.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.568 1.147 . . . . 0.0 110.67 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -31.29 72.1 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.26 -51.69 65.11 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.677 173.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.31 -46.47 88.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 118.547 -1.261 . . . . 0.0 111.81 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -160.6 42.49 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.986 1.374 . . . . 0.0 112.306 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -52.57 -20.43 7.59 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.978 1.275 . . . . 0.0 114.856 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -58.0 -23.46 54.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.774 1.787 . . . . 0.0 113.866 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.35 -23.97 16.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.93 0.786 . . . . 0.0 109.145 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.23 -31.27 60.81 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.511 -1.368 . . . . 0.0 108.555 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 54' ' ' VAL . 19.9 t -52.11 -41.33 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.297 1.839 . . . . 0.0 109.6 163.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -70.89 -37.52 73.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.723 1.147 . . . . 0.0 110.985 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -60.2 -61.56 2.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.069 0.85 . . . . 0.0 110.055 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.06 -57.05 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -172.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.31 52.85 36.68 Favored Glycine 0 CA--C 1.525 0.715 0 O-C-N 121.143 -0.973 . . . . 0.0 112.566 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.82 143.33 4.28 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.44 144.22 12.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -140.64 168.57 19.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.967 -0.458 . . . . 0.0 110.507 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.84 131.48 54.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.231 . . . . 0.0 109.787 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -84.91 104.26 14.7 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.808 1.243 . . . . 0.0 108.08 172.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -78.82 100.96 7.39 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 120.815 1.643 . . . . 0.0 110.408 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.409 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 19.3 t -104.48 93.54 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 175.09 6.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.272 -0.892 . . . . 0.0 111.274 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 59.37 24.31 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.695 2.398 . . . . 0.0 113.634 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 177.82 3.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.004 -167.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.52 91.67 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.15 2.566 . . . . 0.0 109.489 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.67 -72.87 0.44 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.052 1.31 . . . . 0.0 112.888 -156.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.04 -7.64 7.21 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.56 1.552 . . . . 0.0 112.894 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -69.47 -174.31 0.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.907 1.283 . . . . 0.0 110.837 170.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.7 147.3 49.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 108.474 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.22 167.62 17.37 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.251 2.62 . . . . 0.0 107.8 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 m -155.57 144.57 20.69 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.307 -0.871 . . . . 0.0 109.136 170.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.64 118.95 30.44 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -78.96 128.52 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.08 107.65 23.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -82.12 110.67 17.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 28' ' ' VAL . 1.3 m -133.36 48.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -133.54 -49.34 0.84 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 165.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -90.41 136.49 33.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.7 -142.26 41.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -80.22 -3.76 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.334 1.453 . . . . 0.0 114.351 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.47 156.58 6.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.654 1.116 . . . . 0.0 111.526 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m -172.62 151.85 2.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 129.123 2.969 . . . . 0.0 107.958 169.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.35 126.07 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt -103.4 99.74 16.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.45 147.87 53.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.852 2.368 . . . . 0.0 108.937 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 47.49 23.48 0.39 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.362 1.865 . . . . 0.0 113.683 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 t -81.88 155.87 25.11 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.408 1.099 . . . . 0.0 111.424 -156.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -25.45 27.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.408 1.083 . . . . 0.0 109.946 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -74.28 129.44 37.81 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.802 0.728 . . . . 0.0 109.153 -166.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -73.11 -177.83 2.62 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.797 1.239 . . . . 0.0 112.41 -163.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.05 174.62 5.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.336 -165.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -57.08 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.002 -1.686 . . . . 0.0 108.353 148.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.41 -177.74 5.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.568 1.947 . . . . 0.0 109.413 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 m -131.15 -173.72 3.18 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.841 -1.162 . . . . 0.0 107.958 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 tt -155.17 146.7 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.3 m -111.19 132.02 54.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 117.122 -1.418 . . . . 0.0 107.68 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.9 mtm -137.08 -48.5 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.854 -1.07 . . . . 0.0 111.993 166.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.54 153.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.362 3.065 . . . . 0.0 110.81 -161.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.93 -39.99 93.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.142 0.901 . . . . 0.0 108.67 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.74 68.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.077 0.465 . . . . 0.0 110.362 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.51 -49.45 6.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.556 -1.212 . . . . 0.0 107.812 -168.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -56.98 -40.53 76.69 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.471 1.108 . . . . 0.0 110.977 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.4 tp -64.28 -60.52 3.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.49 -35.59 65.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.248 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.34 -70.53 0.09 Allowed 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.107 1.763 . . . . 0.0 108.143 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 12' ' ' VAL . 1.4 ptp . . . . . 0 CA--C 1.53 0.198 0 CA-C-N 118.565 0.62 . . . . 0.0 111.906 -172.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -166.789 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 C--O 1.227 -0.127 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tp 48.85 -61.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.728 2.011 . . . . 0.0 111.384 -152.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -135.11 62.88 1.63 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 127.372 2.269 . . . . 0.0 109.895 -163.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.31 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 126.608 1.963 . . . . 0.0 113.175 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 122.34 1.067 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.86 84.4 0.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -164.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -153.8 170.59 20.6 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 128.83 2.852 . . . . 0.0 104.501 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -29.77 70.76 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.299 -0.875 . . . . 0.0 110.078 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.86 -11.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.316 1.846 . . . . 0.0 114.815 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -53.7 -40.55 66.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.675 1.579 . . . . 0.0 110.856 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -65.47 -36.68 84.61 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.757 176.004 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.698 HG13 ' SD ' ' A' ' 84' ' ' MET . 2.6 t -61.77 -59.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.179 0.992 . . . . 0.0 110.839 -173.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.593 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 64.3 m-85 -63.71 -23.99 67.59 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.982 0.81 . . . . 0.0 110.923 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 28.0 tttt -70.34 -25.46 63.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.512 ' HG3' HD21 ' A' ' 116' ' ' LEU . 77.5 mm-40 -67.59 -40.8 84.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.602 0.637 . . . . 0.0 110.939 173.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.68 -48.64 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.384 1.474 . . . . 0.0 107.56 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 14' ' ' LYS . 25.5 tt0 -51.26 -49.93 60.23 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.053 169.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -58.68 -40.65 84.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -65.28 -47.41 76.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.73 1.212 . . . . 0.0 111.707 173.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -33.1 63.83 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.427 0.691 . . . . 0.0 112.009 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.94 -52.59 55.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.828 -1.17 . . . . 0.0 110.22 169.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -53.7 -45.98 70.58 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.949 1.25 . . . . 0.0 111.315 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -162.36 49.76 0.18 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.859 0.838 . . . . 0.0 112.349 -170.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.36 -28.3 61.75 Favored Glycine 0 C--O 1.223 -0.585 0 O-C-N 120.496 -1.378 . . . . 0.0 113.273 -174.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.85 -24.65 64.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -78.31 -41.7 32.96 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.716 -1.24 . . . . 0.0 110.138 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -67.1 -36.05 81.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 108.659 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 54' ' ' VAL . 9.5 t -51.01 -42.11 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 127.834 2.453 . . . . 0.0 111.018 169.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -72.29 -23.77 61.23 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.458 -1.401 . . . . 0.0 111.052 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -89.57 -14.17 35.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -173.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.9 -55.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.484 1.514 . . . . 0.0 107.535 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.39 59.85 7.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 124.85 1.214 . . . . 0.0 111.888 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.04 -177.96 43.6 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.25 138.38 31.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 160.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -129.03 164.72 22.63 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.331 0.586 . . . . 0.0 110.255 165.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.33 166.18 11.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.1 163.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -123.18 98.36 5.84 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.588 1.555 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.52 ' HD2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -73.71 109.21 7.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 120.218 1.372 . . . . 0.0 109.282 172.358 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG22 ' CE2' ' A' ' 80' ' ' PHE . 21.7 t -122.41 93.48 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -96.55 177.89 5.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.959 1.704 . . . . 0.0 109.923 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 65.01 24.52 12.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.081 1.352 . . . . 0.0 112.482 162.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.56 -168.38 33.68 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.835 1.683 . . . . 0.0 112.394 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.71 96.12 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.305 2.67 . . . . 0.0 110.079 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.09 -13.05 10.52 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 127.663 2.554 . . . . 0.0 112.582 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.59 21.08 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 126.108 1.813 . . . . 0.0 112.537 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -51.03 -175.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 129.251 3.02 . . . . 0.0 111.809 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.07 161.46 33.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.834 0.826 . . . . 0.0 110.964 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.37 173.63 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.745 2.418 . . . . 0.0 107.862 161.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.7 m -140.73 156.58 46.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -124.73 149.82 46.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 164.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.96 143.02 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.3 110.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.48 122.26 24.98 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 164.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.536 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -135.78 46.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -138.83 -46.53 0.49 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.101 0.961 . . . . 0.0 110.639 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.68 103.13 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -156.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.03 -118.29 7.16 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.884 -1.135 . . . . 0.0 111.123 -170.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -74.82 -5.12 41.78 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 171.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.98 -103.4 0.77 Allowed Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 127.774 2.606 . . . . 0.0 108.232 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 m 97.39 157.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 135.444 5.497 . . . . 0.0 110.147 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.5 t -77.09 157.97 5.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.9 mt -143.72 84.88 9.58 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 -169.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.1 152.52 76.34 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 N-CA-C 108.202 -1.499 . . . . 0.0 108.202 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.3 23.52 4.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.196 1.398 . . . . 0.0 112.188 170.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -82.65 146.49 29.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.267 -0.896 . . . . 0.0 110.86 -154.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.45 -0.34 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.634 163.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -59.16 139.75 56.6 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.997 1.272 . . . . 0.0 108.061 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -69.43 -176.43 0.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.23 159.59 43.47 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.401 0.68 . . . . 0.0 111.03 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -36.6 65.34 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.354 1.062 . . . . 0.0 111.494 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.21 -177.05 6.07 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.09 1.756 . . . . 0.0 109.018 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 38' ' ' LYS . 24.3 m -133.35 -172.7 3.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.494 ' H ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.87 146.64 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.7 m -103.76 131.08 51.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 mtp -137.09 -48.88 0.61 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.83 160.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 129.948 3.299 . . . . 0.0 109.57 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.01 -46.89 71.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.389 1.876 . . . . 0.0 109.693 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -62.65 -18.77 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 112.281 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -105.97 -37.15 6.74 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.699 0.8 . . . . 0.0 112.143 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 39' ' ' VAL . 10.0 m-85 -65.79 -54.17 30.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.687 1.195 . . . . 0.0 110.674 173.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.21 -36.09 80.88 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.76 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -48.22 -38.33 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.541 1.136 . . . . 0.0 112.546 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -74.12 0.06 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.698 ' SD ' HG13 ' A' ' 12' ' ' VAL . 16.3 ptp . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.503 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 174.637 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.57 -3.55 57.77 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.26 -0.9 . . . . 0.0 110.872 170.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -164.79 48.27 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.883 1.273 . . . . 0.0 111.76 -164.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 15' ' ' GLU . 6.6 mt . . . . . 0 N--CA 1.474 0.729 0 C-N-CA 127.362 2.265 . . . . 0.0 114.595 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.317 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.48 10.29 33.03 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 119.255 -2.153 . . . . 0.0 114.335 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 28.4 m-85 -77.7 171.37 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.576 1.15 . . . . 0.0 112.856 -160.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.35 -23.77 51.0 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.727 -1.233 . . . . 0.0 111.62 163.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.17 -20.58 42.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.784 1.174 . . . . 0.0 113.496 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -73.23 -19.16 61.14 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.927 1.691 . . . . 0.0 111.146 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.51 -63.45 1.37 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.167 1.787 . . . . 0.0 106.289 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.702 HG13 ' SD ' ' A' ' 84' ' ' MET . 4.6 t -59.58 -56.87 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.085 1.354 . . . . 0.0 112.518 -167.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.49 -21.68 64.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.248 0.931 . . . . 0.0 110.986 -173.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -67.06 -34.01 76.76 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.495 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.643 ' HG3' HD21 ' A' ' 116' ' ' LEU . 15.5 mm-40 -59.02 -33.84 71.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.642 1.11 . . . . 0.0 112.163 174.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -72.18 -46.75 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -55.6 -49.5 72.62 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.323 1.049 . . . . 0.0 111.48 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.082 0.953 . . . . 0.0 109.388 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -70.07 -39.37 75.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.482 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -43.15 79.95 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.645 1.111 . . . . 0.0 113.034 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -63.71 -51.99 62.57 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.278 1.431 . . . . 0.0 110.186 173.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.65 -46.24 87.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.4 -1.438 . . . . 0.0 112.755 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -166.34 62.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.41 1.484 . . . . 0.0 111.976 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.97 -20.19 79.73 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 125.36 1.457 . . . . 0.0 113.528 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -33.79 24.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.681 1.24 . . . . 0.0 112.996 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.457 ' OE1' ' HE2' ' A' ' 30' ' ' LYS . 1.1 tm0? -91.71 -35.25 14.27 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.454 1.502 . . . . 0.0 110.702 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.53 -34.77 71.35 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 108.967 168.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -57.64 -62.35 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 119.824 1.193 . . . . 0.0 108.612 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.79 -20.06 60.75 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HE2' ' OE1' ' A' ' 26' ' ' GLN . 53.1 mttm -67.93 -67.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.905 1.282 . . . . 0.0 111.44 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.6 -60.53 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 109.196 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.05 9.91 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.072 1.796 . . . . 0.0 113.817 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.73 176.51 44.19 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 117.955 0.878 . . . . 0.0 111.493 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 mt -102.14 138.16 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 162.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -135.86 157.84 45.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.79 167.19 10.04 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.293 1.037 . . . . 0.0 109.865 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -129.57 105.78 8.3 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.917 1.687 . . . . 0.0 108.644 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -74.38 121.57 21.6 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 168.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.483 HG22 ' CE2' ' A' ' 80' ' ' PHE . 5.3 t -119.23 110.69 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 171.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -114.03 174.79 5.76 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t0 61.59 24.8 14.84 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.504 1.522 . . . . 0.0 112.478 173.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 77' ' ' ASP . . . -70.87 -176.81 23.15 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.859 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.67 44.3 0.32 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.625 3.55 . . . . 0.0 113.428 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.24 -19.76 0.02 OUTLIER Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.288 2.375 . . . . 0.0 112.698 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.48 -7.71 81.36 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 120.853 2.326 . . . . 0.0 113.351 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -69.19 -173.28 0.51 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.608 157.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.22 158.73 36.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.564 1.945 . . . . 0.0 108.697 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -119.9 174.69 6.3 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.156 2.182 . . . . 0.0 107.51 166.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.6 m -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.145 0.978 . . . . 0.0 108.989 161.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -118.73 152.96 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 170.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.1 t -115.62 135.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 171.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.5 t -116.6 120.79 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.63 116.71 28.73 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.0 52.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -145.31 -49.5 0.24 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.638 1.175 . . . . 0.0 110.371 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -90.61 139.46 30.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -164.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.83 -135.48 46.33 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -89.79 6.62 40.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.053 1.741 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.24 158.14 27.33 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -172.13 145.64 1.8 Allowed 'General case' 0 C--O 1.237 0.447 0 C-N-CA 127.006 2.122 . . . . 0.0 105.588 159.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 157.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mt -136.28 80.57 39.83 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.34 145.17 87.9 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.234 1.956 . . . . 0.0 109.043 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.91 23.95 3.1 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.582 2.353 . . . . 0.0 112.2 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -89.95 140.5 29.57 Favored 'General case' 0 CA--C 1.524 -0.052 0 O-C-N 120.417 -1.427 . . . . 0.0 109.489 -163.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.8 -22.63 65.16 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.374 0.67 . . . . 0.0 111.345 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -58.27 130.3 46.06 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.372 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -60.78 -176.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.235 1.414 . . . . 0.0 111.316 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.26 173.2 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 110.567 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -49.18 19.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 163.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.3 m -146.6 -179.43 6.76 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.641 1.576 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.809 HG22 ' H ' ' A' ' 73' ' ' ILE . 15.0 m -132.51 -165.93 1.67 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.488 1.115 . . . . 0.0 108.194 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.809 ' H ' HG22 ' A' ' 72' ' ' THR . 4.0 tt -150.54 172.75 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.937 -1.102 . . . . 0.0 109.593 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.5 m -122.31 124.07 42.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 163.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.469 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 1.9 mtm -151.73 120.79 6.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 166.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.09 164.07 1.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.426 . . . . 0.0 110.106 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 16.3 t70 -58.9 -54.24 49.34 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.875 0.87 . . . . 0.0 109.405 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -67.59 1.22 2.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.37 1.068 . . . . 0.0 112.691 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -60.85 1.5 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.259 1.824 . . . . 0.0 108.883 168.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.483 ' CE2' HG22 ' A' ' 39' ' ' VAL . 21.4 m-85 -56.18 -41.04 74.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.965 1.306 . . . . 0.0 112.893 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.42 -44.37 62.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.658 0.783 . . . . 0.0 109.417 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -27.77 64.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.739 . . . . 0.0 112.153 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.2 -78.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 C-N-CA 126.365 1.866 . . . . 0.0 109.718 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.702 ' SD ' HG13 ' A' ' 12' ' ' VAL . 6.0 ptp . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.1 mm . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.241 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--O 1.232 0.147 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mp -71.66 -7.07 45.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 117.806 -1.092 . . . . 0.0 110.894 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.3 46.92 2.27 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 120.26 1.391 . . . . 0.0 112.938 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.643 HD21 ' HG3' ' A' ' 15' ' ' GLU . 26.4 mt . . . . . 0 C--N 1.347 0.489 0 CA-C-O 123.603 1.668 . . . . 0.0 110.544 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 120.763 0.316 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.63 39.83 0.64 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.936 1.732 . . . . 0.0 109.874 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -85.54 177.87 7.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -66.42 -22.66 66.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.522 -1.362 . . . . 0.0 111.037 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.24 -5.07 1.38 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.37 -47.33 85.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.081 1.31 . . . . 0.0 112.422 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.544 HD22 ' C ' ' A' ' 11' ' ' LEU 0.266 0.0 OUTLIER -68.97 -33.11 73.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.547 0.739 . . . . 0.0 111.53 176.349 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.25 -53.19 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.969 1.708 . . . . 0.0 110.396 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -67.5 -21.91 65.48 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.728 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -75.46 -26.41 58.23 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.494 -1.241 . . . . 0.0 112.768 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -57.09 -41.09 78.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.46 1.482 . . . . 0.0 110.773 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.496 HD11 ' CE ' ' A' ' 84' ' ' MET . 76.6 mt -61.69 -47.72 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.18 -51.32 70.52 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.378 0.671 . . . . 0.0 110.775 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -53.0 -50.83 63.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.171 2.188 . . . . 0.0 108.639 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -34.38 73.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.198 . . . . 0.0 111.349 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -32.6 61.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 0.0 112.811 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -63.35 -53.81 46.84 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.834 0.854 . . . . 0.0 109.994 170.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -62.74 -45.82 90.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 110.863 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -159.41 58.0 0.4 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.208 1.004 . . . . 0.0 109.217 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.22 -23.06 66.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.315 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -59.38 -43.11 92.94 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.715 1.757 . . . . 0.0 111.6 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.14 -32.4 73.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.627 -0.671 . . . . 0.0 111.465 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -75.62 -34.35 60.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 108.619 -171.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.37 -48.73 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.704 1.202 . . . . 0.0 109.208 164.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -70.99 -10.68 60.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.805 -1.185 . . . . 0.0 113.437 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -86.02 -30.53 22.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.368 1.44 . . . . 0.0 113.603 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.56 -54.11 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.696 1.198 . . . . 0.0 108.772 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.73 57.11 11.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.669 2.08 . . . . 0.0 114.786 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.74 -171.18 37.29 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.348 1.574 . . . . 0.0 111.738 -176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.24 124.55 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 158.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -120.93 173.76 7.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.22 142.82 51.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.087 0.955 . . . . 0.0 109.411 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -88.27 91.53 8.82 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 124.969 1.308 . . . . 0.0 110.259 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -74.88 89.08 2.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.577 -1.327 . . . . 0.0 112.241 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.576 HG22 ' CD2' ' A' ' 80' ' ' PHE . 51.1 t -93.58 123.41 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -115.78 174.89 5.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.384 1.474 . . . . 0.0 110.357 158.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.53 61.17 2.06 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.803 1.641 . . . . 0.0 114.82 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.8 -152.44 8.85 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 126.329 1.919 . . . . 0.0 111.933 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.65 5.9 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.185 3.257 . . . . 0.0 114.605 -169.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.45 -49.13 0.21 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 159.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.94 -24.16 4.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.575 1.188 . . . . 0.0 111.402 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -62.16 -175.65 0.08 Allowed 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.087 1.755 . . . . 0.0 111.279 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -127.42 147.65 50.29 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -172.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.87 170.76 15.4 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.675 1.99 . . . . 0.0 108.087 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -155.9 149.42 24.88 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.62 133.1 55.4 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 166.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.95 142.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.68 113.27 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.54 123.96 30.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 165.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.15 39.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 126.365 1.866 . . . . 0.0 107.76 173.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -124.67 -39.31 2.3 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.574 1.15 . . . . 0.0 109.674 162.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -95.04 115.88 27.99 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -155.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.98 49.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -74.81 -2.68 27.76 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.123 173.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.31 157.1 14.11 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -168.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 m -171.46 133.28 0.8 Allowed 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 128.507 2.723 . . . . 0.0 106.137 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.96 147.93 8.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -125.53 93.54 44.52 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.79 150.75 44.98 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.278 1.985 . . . . 0.0 109.381 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.13 22.85 0.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.941 2.497 . . . . 0.0 114.507 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.48 147.79 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.419 -155.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.49 -5.09 46.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.96 0.904 . . . . 0.0 111.279 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -44.9 129.12 7.27 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.868 1.667 . . . . 0.0 108.736 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -69.06 -176.0 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.919 0.866 . . . . 0.0 109.04 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.2 151.77 37.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.205 1.002 . . . . 0.0 108.956 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -75.82 -31.01 59.19 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.932 0.493 . . . . 0.0 112.156 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.1 m -148.37 173.02 13.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.822 2.449 . . . . 0.0 107.689 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -155.48 114.7 3.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.129 -1.607 . . . . 0.0 108.063 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.13 146.18 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.0 m -122.55 131.27 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.122 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 mmm -138.73 -12.56 1.3 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.703 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 67.5 151.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.419 1.888 . . . . 0.0 111.107 -164.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.37 -35.41 79.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.342 -0.837 . . . . 0.0 111.929 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -58.09 2.72 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.73 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.576 ' CD2' HG22 ' A' ' 39' ' ' VAL . 34.6 m-85 -51.21 -55.69 16.76 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.232 1.013 . . . . 0.0 112.139 -173.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -54.14 -58.47 7.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.297 0.953 . . . . 0.0 109.331 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.38 -39.48 73.0 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.878 0.736 . . . . 0.0 112.149 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 tt -55.69 -56.61 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.769 2.428 . . . . 0.0 110.306 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.496 ' CE ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.6 pttm . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.268 2.5 mp . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 115.05 7.5 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 70.06 44.9 0.74 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.221 1.008 . . . . 0.0 110.624 -172.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--N 1.345 0.41 0 C-N-CA 125.497 1.519 . . . . 0.0 111.896 -177.52 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 121.392 0.615 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.39 22.39 0.75 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.352 1.453 . . . . 0.0 113.722 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -82.6 177.69 8.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.875 1.337 . . . . 0.0 109.827 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -66.15 -23.42 66.47 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 118.023 -1.471 . . . . 0.0 111.468 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.84 -18.68 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 114.35 169.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 3.5 t-20 -53.09 -44.64 67.73 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.825 0.85 . . . . 0.0 111.024 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.286 0.0 OUTLIER -85.05 -30.22 24.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.573 0.749 . . . . 0.0 111.769 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.55 -54.23 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.593 1.157 . . . . 0.0 110.656 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.15 -20.9 63.13 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.244 -0.91 . . . . 0.0 111.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 22.2 ttmt -75.9 -28.14 57.94 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 118.016 -0.992 . . . . 0.0 113.535 175.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -58.73 -49.91 75.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 119.742 1.155 . . . . 0.0 110.386 163.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.6 -43.5 78.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -51.7 68.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.229 1.012 . . . . 0.0 111.967 170.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -58.98 -41.02 86.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -169.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -65.1 -31.71 73.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.704 2.002 . . . . 0.0 111.861 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -29.61 59.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.518 1.054 . . . . 0.0 113.787 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.5 -53.29 54.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 119.45 1.023 . . . . 0.0 109.053 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -45.37 93.9 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -161.49 51.55 0.24 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 123.433 1.587 . . . . 0.0 109.862 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.77 -17.49 14.8 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 117.525 -1.708 . . . . 0.0 114.91 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.77 -51.12 58.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.669 2.235 . . . . 0.0 110.852 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -68.08 -28.25 67.19 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.773 -1.205 . . . . 0.0 111.37 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -73.7 -35.75 65.18 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.772 -1.205 . . . . 0.0 108.659 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 54' ' ' VAL . 31.4 t -55.97 -42.03 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.867 1.267 . . . . 0.0 109.459 165.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 4.1 mmpt? -69.31 -29.9 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.55 1.523 . . . . 0.0 113.185 174.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -68.46 -49.33 60.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.591 1.542 . . . . 0.0 111.893 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.06 -48.43 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.003 1.274 . . . . 0.0 109.67 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.08 47.19 84.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.646 -1.641 . . . . 0.0 113.935 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.52 171.0 37.41 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.567 1.684 . . . . 0.0 110.728 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.36 131.1 54.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 162.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -129.4 165.57 21.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.991 0.424 . . . . 0.0 111.279 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.8 137.62 52.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.073 1.749 . . . . 0.0 108.722 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.62 109.15 20.13 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.532 1.133 . . . . 0.0 108.668 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 72' ' ' THR . 15.4 mttm -87.37 103.32 15.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 121.03 1.741 . . . . 0.0 107.626 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 80' ' ' PHE . 5.5 t -112.14 94.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.611 -0.681 . . . . 0.0 109.335 -170.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 174.43 6.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.383 -1.448 . . . . 0.0 110.294 171.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 59.34 43.81 16.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.205 1.802 . . . . 0.0 112.105 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -78.1 -167.96 31.57 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.082 -1.011 . . . . 0.0 113.862 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.28 -11.5 10.85 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.025 3.15 . . . . 0.0 114.05 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.25 -5.19 8.85 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.535 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.04 74.73 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.21 1.505 . . . . 0.0 112.084 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.7 -175.66 0.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.271 1.828 . . . . 0.0 109.768 165.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -135.79 150.71 49.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.145 1.778 . . . . 0.0 109.205 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.87 172.09 13.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.829 2.052 . . . . 0.0 109.065 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.5 m -145.91 147.3 31.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 108.32 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.403 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -117.59 142.84 46.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 163.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.03 143.61 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.31 118.67 50.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.93 110.45 18.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 165.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.461 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -128.44 43.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.308 168.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -132.51 -44.9 0.9 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.377 -0.827 . . . . 0.0 111.611 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -95.84 148.12 22.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.734 0.646 . . . . 0.0 109.451 -172.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.95 -130.55 51.04 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.821 ' H ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.02 4.3 34.32 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.08 1.352 . . . . 0.0 112.383 173.146 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.35 157.73 18.86 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.8 m -172.26 153.01 2.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 128.447 2.699 . . . . 0.0 108.028 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -88.09 156.16 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mt -132.79 96.4 18.31 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 -173.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.98 140.32 41.57 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.04 1.827 . . . . 0.0 109.025 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.9 22.79 4.51 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.047 2.139 . . . . 0.0 112.957 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.47 133.95 35.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.419 0.628 . . . . 0.0 110.177 -157.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.36 -7.16 51.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.633 1.173 . . . . 0.0 110.594 165.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -52.48 132.92 35.57 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -74.64 -177.09 3.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.085 0.945 . . . . 0.0 109.651 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.03 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.968 1.707 . . . . 0.0 108.824 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.56 -25.15 56.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.48 -176.22 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.197 0.999 . . . . 0.0 109.47 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.445 HG21 ' HE2' ' A' ' 38' ' ' LYS . 21.4 m -137.66 -175.77 4.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.932 0.893 . . . . 0.0 108.764 -171.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 tt -145.83 142.5 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 154.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.19 146.2 24.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 157.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.454 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 31.4 mtt -134.19 -51.29 0.82 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 157.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.93 161.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.143 3.377 . . . . 0.0 107.966 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.464 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 6.0 t70 -66.72 -47.04 73.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 122.96 0.504 . . . . 0.0 110.863 -171.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.6 m -55.29 -36.25 65.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.448 0.699 . . . . 0.0 110.326 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.11 -59.43 2.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.307 1.843 . . . . 0.0 109.849 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 75' ' ' MET . 10.7 m-85 -50.83 -58.75 5.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.39 1.876 . . . . 0.0 111.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -42.87 99.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.956 0.902 . . . . 0.0 109.81 -172.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -23.24 65.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.87 -173.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mt -67.77 -51.5 48.26 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.496 1.118 . . . . 0.0 110.882 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.189 0 CA-C-N 119.191 0.905 . . . . 0.0 112.556 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 pttt . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 166.904 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.4 m120 . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.85 -10.98 53.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.359 1.064 . . . . 0.0 112.947 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -137.88 54.72 1.8 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.501 1.521 . . . . 0.0 107.106 166.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER . . . . . 0 C--N 1.348 0.535 0 C-N-CA 128.752 2.821 . . . . 0.0 113.387 -175.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.277 0.561 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.05 42.52 1.27 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.434 1.016 . . . . 0.0 112.535 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -85.1 -176.54 6.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.426 1.613 . . . . 0.0 110.583 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -72.36 -17.15 61.86 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.033 -1.042 . . . . 0.0 111.394 164.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.32 -23.98 4.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.2 1.0 . . . . 0.0 112.903 170.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -45.63 77.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.117 1.367 . . . . 0.0 110.32 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.24 -48.77 76.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.171 1.388 . . . . 0.0 109.67 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 t -58.65 -54.29 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.725 1.21 . . . . 0.0 111.421 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -64.31 -26.22 68.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.911 1.232 . . . . 0.0 111.88 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -75.06 -23.65 58.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.506 -0.746 . . . . 0.0 112.589 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.52 -52.62 53.79 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.434 0.459 . . . . 0.0 109.932 166.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -58.64 -48.28 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.186 1.395 . . . . 0.0 107.83 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -55.78 -51.1 68.59 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.759 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -57.99 -47.56 82.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.948 0.795 . . . . 0.0 109.425 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -38.8 88.83 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.559 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.413 HD21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.55 -38.99 72.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 113.814 172.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.12 -52.94 56.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.29 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.54 -45.74 90.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.828 1.194 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -162.73 56.1 0.21 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.138 0.97 . . . . 0.0 111.893 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.51 -16.01 69.04 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 120.905 -1.122 . . . . 0.0 113.103 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -43.3 68.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.764 1.282 . . . . 0.0 112.165 -171.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.77 -32.02 59.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.566 0.746 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.76 -26.8 60.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -60.31 -28.3 41.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -66.08 -21.91 66.39 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.319 -0.863 . . . . 0.0 111.405 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 9.8 mmpt? -73.0 -70.82 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.266 1.394 . . . . 0.0 111.241 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.65 -59.98 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 56.76 13.05 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.807 1.194 . . . . 0.0 113.146 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.81 42.57 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.38 146.68 7.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 149.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -141.33 177.19 8.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 118.969 -1.093 . . . . 0.0 109.581 158.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 72' ' ' THR . . . -124.73 164.15 20.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.502 1.121 . . . . 0.0 108.897 171.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -121.98 106.99 11.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.174 1.79 . . . . 0.0 108.832 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -73.71 110.49 8.04 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 120.282 1.401 . . . . 0.0 112.107 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.07 98.25 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 174.69 7.04 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 166.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 49.75 53.19 13.19 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.982 2.113 . . . . 0.0 113.737 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.64 176.54 2.23 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.399 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.01 84.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.448 3.432 . . . . 0.0 108.433 158.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.17 -76.46 0.3 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -167.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.54 -12.27 3.21 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.506 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -70.18 -171.58 0.47 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.774 1.787 . . . . 0.0 110.978 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.1 160.64 20.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.222 1.809 . . . . 0.0 108.772 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.41 166.05 30.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.545 2.338 . . . . 0.0 106.296 173.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 m -150.81 128.88 11.83 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.78 0.832 . . . . 0.0 109.996 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -94.3 127.34 40.1 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 167.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.18 149.59 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.2 119.97 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.26 106.78 18.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 172.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 HD21 ' A' ' 20' ' ' LEU . 1.2 m -138.17 56.78 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 121.611 -0.681 . . . . 0.0 110.474 174.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -139.91 -53.63 0.53 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.307 1.043 . . . . 0.0 109.683 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -78.39 140.9 38.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.942 1.697 . . . . 0.0 108.152 -172.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 -137.57 32.85 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -104.88 8.26 34.64 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.015 1.726 . . . . 0.0 111.724 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.44 157.34 29.85 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -173.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.9 m -172.52 161.35 4.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.621 3.968 . . . . 0.0 105.991 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -109.96 154.38 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.9 mt -134.25 70.35 73.37 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -158.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.99 142.65 62.82 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.539 2.159 . . . . 0.0 109.28 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 54.88 23.22 4.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.766 2.427 . . . . 0.0 112.437 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 t -87.61 138.32 31.57 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.042 1.292 . . . . 0.0 110.26 -164.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.65 -4.87 58.4 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.48 1.912 . . . . 0.0 111.223 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -60.56 145.18 49.67 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 118.399 -1.32 . . . . 0.0 108.324 170.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -69.6 -173.6 0.61 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.221 1.808 . . . . 0.0 110.378 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.11 133.88 16.79 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.135 -0.353 . . . . 0.0 111.562 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.29 -52.89 4.35 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.933 2.493 . . . . 0.0 111.053 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.3 m -149.42 168.99 21.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.994 2.518 . . . . 0.0 106.767 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 73' ' ' ILE . 87.9 m -121.83 -171.07 2.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.426 ' N ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -143.05 167.61 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 158.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.77 159.68 16.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.748 1.613 . . . . 0.0 106.756 160.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -150.57 -38.86 0.13 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.817 158.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.57 157.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.545 2.338 . . . . 0.0 110.035 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -59.78 -46.77 88.15 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.802 0.841 . . . . 0.0 111.134 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -44.01 73.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.338 -175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.03 -65.22 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 128.326 2.65 . . . . 0.0 112.06 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 75' ' ' MET . 43.3 m-85 -51.09 -45.36 61.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 110.401 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 tp -60.77 -69.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.616 0.644 . . . . 0.0 109.322 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.37 75.08 Favored 'General case' 0 CA--C 1.524 -0.057 0 C-N-CA 124.244 1.018 . . . . 0.0 113.269 -165.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 tp -52.01 -66.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.677 1.191 . . . . 0.0 109.654 -176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.4 ptm . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.74 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.339 0 CA-C-O 121.942 0.877 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.444 -0.773 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.488 -173.526 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 m120 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tp -85.08 9.73 13.98 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 122.032 2.197 . . . . 0.0 111.827 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.96 48.81 0.85 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.251 2.22 . . . . 0.0 110.466 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 129.738 3.215 . . . . 0.0 114.83 178.264 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 119.971 3.323 . . . . 0.0 119.971 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.75 82.88 0.18 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 126.573 2.035 . . . . 0.0 108.16 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -153.42 160.78 42.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.628 1.571 . . . . 0.0 108.449 -166.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -24.97 50.49 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.3 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.35 -10.69 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.378 1.871 . . . . 0.0 114.624 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 1.5 t-20 -51.35 -44.21 61.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.409 0.684 . . . . 0.0 110.943 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -73.39 -38.35 65.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.351 178.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' N ' HD13 ' A' ' 11' ' ' LEU . 48.0 t -58.34 -60.78 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 125.005 1.322 . . . . 0.0 109.969 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 16' ' ' ILE . 39.8 m-85 -66.78 -19.63 65.79 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.746 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -75.56 -28.6 59.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.73 ' HG3' HD21 ' A' ' 116' ' ' LEU . 35.7 mm-40 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.533 172.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.784 HD11 ' HE1' ' A' ' 84' ' ' MET . 48.2 mt -68.56 -52.42 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.37 -54.78 12.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 125.176 1.39 . . . . 0.0 109.895 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -44.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.214 1.005 . . . . 0.0 110.944 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -44.96 79.12 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.168 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -35.15 66.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 112.635 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.48 -52.9 55.55 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.78 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.52 -45.69 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.408 -1.433 . . . . 0.0 114.189 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -153.22 64.94 0.76 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.925 1.69 . . . . 0.0 109.461 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.41 70.52 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-O 118.333 -1.259 . . . . 0.0 111.177 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -52.48 -38.09 58.65 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.721 1.26 . . . . 0.0 111.429 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.22 -42.97 44.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.735 1.214 . . . . 0.0 109.225 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -20.81 63.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.598 -0.689 . . . . 0.0 111.442 -176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 55' ' ' LYS . 48.3 t -57.27 -38.9 64.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 119.131 0.878 . . . . 0.0 110.213 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -74.84 -5.03 41.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.884 -1.135 . . . . 0.0 113.103 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -69.27 0.68 Allowed 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.936 1.244 . . . . 0.0 110.353 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.54 -62.97 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.33 9.39 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.728 1.156 . . . . 0.0 113.28 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.97 -169.24 29.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.77 125.89 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 157.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -121.42 172.65 7.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' A' ' 72' ' ' THR . . . -128.03 131.32 49.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.994 1.717 . . . . 0.0 108.578 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -82.05 93.86 7.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -74.71 101.13 4.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.252 1.842 . . . . 0.0 109.834 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG22 ' CE2' ' A' ' 80' ' ' PHE . 89.2 t -104.22 121.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -115.77 179.7 3.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.363 1.465 . . . . 0.0 109.421 162.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t70 54.69 53.86 10.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.391 1.091 . . . . 0.0 112.273 164.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.43 -154.91 10.65 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.534 1.54 . . . . 0.0 109.784 168.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -48.74 114.91 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.236 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.9 -8.07 17.58 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.265 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.27 16.49 62.48 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 120.547 2.173 . . . . 0.0 112.083 169.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -61.66 -175.12 0.05 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.18 1.392 . . . . 0.0 111.007 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -150.47 111.58 4.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.336 -171.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 174.65 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.77 2.028 . . . . 0.0 110.416 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -147.75 149.43 32.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 109.018 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.434 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -116.7 117.12 28.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 166.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.79 128.59 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.517 HG12 HG22 ' A' ' 54' ' ' VAL . 98.2 t -112.07 110.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.63 129.83 34.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -133.16 30.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.603 ' HA ' HG13 ' A' ' 28' ' ' VAL . 3.6 tmtm? -140.09 -25.9 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 120.981 -1.074 . . . . 0.0 112.775 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -84.71 111.67 19.8 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.63 -117.86 7.96 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -85.99 0.34 53.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.157 0.978 . . . . 0.0 112.566 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.23 156.66 3.81 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -157.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.7 m -172.23 149.59 2.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.418 2.287 . . . . 0.0 106.327 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.72 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mt -127.22 81.61 69.68 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 -170.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.12 144.94 65.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.057 1.838 . . . . 0.0 109.728 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 37.47 44.05 0.46 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.308 2.643 . . . . 0.0 111.292 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -85.8 142.74 28.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.693 1.235 . . . . 0.0 109.615 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.26 -17.9 59.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 111.182 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -57.46 133.05 54.87 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -60.96 -175.75 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.998 1.38 . . . . 0.0 109.778 167.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.45 155.49 48.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.152 166.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.41 -27.74 64.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.535 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.7 p -145.62 -175.92 4.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.551 0.74 . . . . 0.0 112.856 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.4 m -136.14 -171.99 3.02 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.474 ' H ' HG22 ' A' ' 72' ' ' THR . 3.6 tt -142.27 175.6 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 161.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.2 m -141.73 137.44 31.66 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 119.335 -2.103 . . . . 0.0 108.373 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.1 ptp -148.65 -28.83 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.528 -1.669 . . . . 0.0 115.217 161.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.43 147.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.972 3.309 . . . . 0.0 110.618 -162.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.99 -47.95 84.06 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 127.215 2.206 . . . . 0.0 110.443 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.8 m -66.43 -11.46 52.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.3 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.93 -40.24 5.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 168.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.649 ' CE2' HG22 ' A' ' 39' ' ' VAL . 3.3 m-85 -47.42 -54.03 12.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.683 1.193 . . . . 0.0 109.987 171.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.47 -62.26 1.44 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.593 1.957 . . . . 0.0 108.383 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.56 -39.94 77.79 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.693 0.797 . . . . 0.0 112.435 -174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -65.75 0.51 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.479 0.712 . . . . 0.0 110.482 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.784 ' HE1' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.38 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.681 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.51 -5.62 20.54 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -166.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -136.82 55.6 1.83 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.221 1.408 . . . . 0.0 107.324 167.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 15' ' ' GLU . 13.5 mt . . . . . 0 C--N 1.35 0.615 0 C-N-CA 125.071 1.348 . . . . 0.0 114.369 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 11.77 0.06 OUTLIER Glycine 0 N--CA 1.466 0.671 0 O-C-N 120.782 -1.199 . . . . 0.0 115.442 -162.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.412 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 1.2 m-30 -80.21 178.51 8.22 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.823 1.249 . . . . 0.0 108.671 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HA ' HD23 ' A' ' 11' ' ' LEU . 23.7 tttm -69.65 -17.92 63.54 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.735 -1.853 . . . . 0.0 111.378 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.37 17.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.265 1.026 . . . . 0.0 112.815 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -58.6 -40.05 82.11 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.516 1.527 . . . . 0.0 110.275 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 8' ' ' LYS . 1.4 mm? -61.53 -51.89 66.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.307 1.843 . . . . 0.0 109.79 175.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.55 -43.61 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.493 2.317 . . . . 0.0 111.943 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.18 -26.94 61.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.168 0.894 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -71.48 -24.77 62.05 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 118.977 0.808 . . . . 0.0 112.619 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.13 -46.31 91.09 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 165.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.8 -45.44 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.04 -55.22 33.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.824 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -52.48 -50.51 62.57 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -168.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -65.56 -27.11 68.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.666 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -33.45 66.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.075 0.852 . . . . 0.0 112.006 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.17 -52.3 59.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 170.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.58 -45.2 85.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.534 1.134 . . . . 0.0 111.795 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -165.54 62.79 0.11 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.954 0.902 . . . . 0.0 110.897 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.01 -29.18 71.87 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 116.869 -2.073 . . . . 0.0 114.486 -172.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -36.97 3.59 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.99 2.395 . . . . 0.0 112.918 172.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -81.38 -16.84 51.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -93.49 -34.91 13.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.088 1.355 . . . . 0.0 108.212 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.2 -46.09 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 126.151 1.78 . . . . 0.0 109.036 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -64.39 -23.94 67.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.562 1.528 . . . . 0.0 113.776 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -74.13 -29.21 61.71 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.411 -0.806 . . . . 0.0 111.828 -166.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mp -117.36 -49.76 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.557 2.343 . . . . 0.0 110.321 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.19 49.26 58.69 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.861 1.696 . . . . 0.0 116.245 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.55 27.36 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.758 1.779 . . . . 0.0 108.759 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.95 139.14 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 3.6 p90 -127.15 164.55 21.37 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.978 -1.076 . . . . 0.0 109.961 158.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 156.31 21.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 35' ' ' PHE . 6.6 m-85 -114.72 108.34 16.65 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.464 1.506 . . . . 0.0 108.734 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -87.09 95.9 10.11 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -85.09 116.6 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -107.91 176.63 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 119.07 0.85 . . . . 0.0 109.152 162.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t0 46.42 50.79 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.573 1.549 . . . . 0.0 113.776 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 7' ' ' PHE . . . -63.5 165.55 27.94 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.977 167.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.46 98.43 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.656 3.571 . . . . 0.0 112.648 172.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.81 -41.3 1.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.237 1.875 . . . . 0.0 111.765 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.59 -8.35 3.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.701 -1.61 . . . . 0.0 114.574 163.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -67.61 -175.26 0.5 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.191 1.796 . . . . 0.0 112.782 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -125.15 146.23 49.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.935 1.694 . . . . 0.0 111.221 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.93 162.08 34.25 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.716 3.207 . . . . 0.0 106.832 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 m -139.25 148.13 42.64 Favored 'General case' 0 C--O 1.228 -0.053 0 CA-C-N 119.082 0.856 . . . . 0.0 110.059 166.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -117.65 156.81 27.54 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.42 134.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 57.6 t -123.41 112.75 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -91.98 80.28 5.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.43 53.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -146.62 -54.18 0.24 Allowed 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.18 0.992 . . . . 0.0 110.042 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -95.36 140.45 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.016 0.823 . . . . 0.0 109.586 -164.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.9 -140.9 43.76 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -84.84 -0.1 52.8 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.506 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 157.07 15.97 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 120.795 1.634 . . . . 0.0 111.873 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m -171.77 166.08 6.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.913 3.285 . . . . 0.0 108.87 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.33 93.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 127.941 2.496 . . . . 0.0 107.254 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.9 101.28 0.48 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 127.231 2.212 . . . . 0.0 107.001 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -70.5 131.22 19.77 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.372 2.714 . . . . 0.0 111.308 -166.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 47.24 24.56 0.44 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.317 2.247 . . . . 0.0 112.591 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.54 143.79 40.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -160.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -73.59 -15.79 61.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.575 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -57.92 145.11 36.76 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.708 -1.597 . . . . 0.0 110.429 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.79 -176.18 0.05 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.861 1.315 . . . . 0.0 109.895 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.95 168.06 20.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.638 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -37.48 55.6 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.395 0.678 . . . . 0.0 111.391 171.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m -150.93 -173.14 4.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.084 2.153 . . . . 0.0 109.307 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -133.95 -172.92 3.11 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.062 -1.024 . . . . 0.0 108.736 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -147.44 165.07 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 155.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -126.48 124.29 39.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 165.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.71 136.62 17.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.15 163.59 1.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 168.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.04 -52.01 62.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.057 1.343 . . . . 0.0 111.005 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.66 -33.77 61.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.3 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.87 -35.26 14.88 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.33 2.252 . . . . 0.0 111.381 -169.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.92 -54.77 33.37 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.482 1.113 . . . . 0.0 108.357 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -31.48 68.59 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.555 0.742 . . . . 0.0 110.361 -175.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.55 -41.76 10.21 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.048 1.339 . . . . 0.0 113.727 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.01 -75.51 0.05 Allowed 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -170.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.242 0.663 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.54 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -13.91 32.76 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 171.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -141.69 62.83 1.44 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.042 0.937 . . . . 0.0 109.514 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.329 0.1 OUTLIER . . . . . 0 C--N 1.353 0.753 0 C-N-CA 124.421 1.089 . . . . 0.0 113.596 170.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 123.039 1.4 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.4 84.41 0.36 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 129.349 3.356 . . . . 0.0 108.414 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 34.6 m-85 -152.83 149.74 28.61 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.675 2.39 . . . . 0.0 107.824 -167.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -6.67 51.13 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.846 -1.159 . . . . 0.0 111.782 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.28 -16.46 53.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.883 0.873 . . . . 0.0 112.975 160.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -59.09 -58.41 8.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.844 1.202 . . . . 0.0 111.019 -168.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 11' ' ' LEU 0.279 0.0 OUTLIER -64.77 -31.37 72.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.346 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.36 -55.92 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.813 2.445 . . . . 0.0 110.618 171.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -65.83 -29.34 69.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.683 1.128 . . . . 0.0 111.119 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -70.09 -24.93 63.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.771 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.585 ' HG2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.05 -44.17 73.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 176.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -52.02 -54.33 14.23 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.33 -48.48 78.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.965 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -56.59 -46.85 80.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -66.11 -42.28 89.43 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.69 177.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -32.54 62.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.307 6.5 mm-40 -70.11 -52.31 24.7 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.877 171.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.06 -40.69 96.64 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -161.04 60.44 0.29 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.833 1.253 . . . . 0.0 109.858 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.12 -29.69 70.32 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-O 118.185 -1.341 . . . . 0.0 111.47 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.44 -29.5 24.86 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.838 1.319 . . . . 0.0 112.694 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -79.93 -34.98 38.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.911 -1.118 . . . . 0.0 111.678 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -80.31 -19.46 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.643 1.111 . . . . 0.0 108.997 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.07 -45.59 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.151 0.887 . . . . 0.0 109.467 169.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.49 -17.67 62.34 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -71.53 -65.17 0.79 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.365 -0.834 . . . . 0.0 109.845 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mm -78.32 -56.07 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.0 1.32 . . . . 0.0 108.713 -166.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 50.61 63.29 4.55 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.253 -167.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 173.0 39.55 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 119.376 1.588 . . . . 0.0 111.941 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.19 121.36 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 102.936 -2.986 . . . . 0.0 102.936 159.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -130.42 166.01 21.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 123.659 0.6 . . . . 0.0 109.724 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB1' ' CG2' ' A' ' 49' ' ' THR . . . -129.12 168.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.889 0.852 . . . . 0.0 112.063 173.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.49 98.5 6.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.932 . . . . 0.0 108.529 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -83.9 89.55 7.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.987 0.812 . . . . 0.0 110.904 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.18 124.03 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -115.11 -175.05 2.61 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.899 -1.126 . . . . 0.0 108.728 158.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t0 47.8 58.23 5.23 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 127.236 2.214 . . . . 0.0 111.881 169.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.89 -177.2 4.58 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.393 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -60.23 7.49 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 1 C-N-CA 125.389 4.059 . . . . 0.0 113.188 159.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.71 -31.79 0.3 Allowed Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.282 -1.511 . . . . 0.0 112.075 155.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -2.68 7.61 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 118.805 1.303 . . . . 0.0 114.018 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -62.04 -175.57 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.958 1.379 . . . . 0.0 110.791 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -120.97 165.38 15.33 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 166.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -150.13 164.94 34.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.498 1.919 . . . . 0.0 107.43 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.436 ' CG2' ' HB1' ' A' ' 36' ' ' ALA . 80.0 m -147.07 144.15 28.86 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -115.67 133.05 56.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 103.595 -2.743 . . . . 0.0 103.595 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -101.35 136.16 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.69 117.29 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.63 117.07 28.24 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 165.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.65 51.55 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -133.4 -53.61 0.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.123 0.969 . . . . 0.0 108.824 160.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.79 111.24 13.39 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.03 -151.93 50.66 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 121.673 0.596 . . . . 0.0 111.648 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.02 9.49 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 127.94 2.496 . . . . 0.0 114.205 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.14 157.76 33.9 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.0 m -172.87 158.12 3.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.49 2.316 . . . . 0.0 106.99 152.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.74 160.37 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -141.51 87.57 10.28 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -160.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.53 147.99 18.02 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.012 2.475 . . . . 0.0 109.963 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.53 25.8 3.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.995 1.718 . . . . 0.0 111.468 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -92.41 146.84 23.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.524 1.154 . . . . 0.0 109.377 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.84 -26.7 25.54 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 111.909 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -50.33 120.98 5.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.512 1.125 . . . . 0.0 108.648 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -178.04 1.52 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 122.798 1.285 . . . . 0.0 108.804 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.21 156.65 46.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.507 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.2 -32.57 71.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.733 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.76 173.83 15.89 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.101 1.36 . . . . 0.0 110.619 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 101' ' ' ILE . 5.0 m -155.23 119.98 4.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -172.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 101' ' ' ILE . 15.8 tt -83.96 155.11 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 118.661 0.664 . . . . 0.0 109.449 -173.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.4 m -100.73 126.32 47.27 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 118.203 -0.904 . . . . 0.0 109.245 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.06 126.74 2.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 157.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.08 166.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 0.0 112.149 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -53.0 63.06 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t -65.32 -4.53 5.56 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.307 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.23 -53.96 2.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.141 1.776 . . . . 0.0 108.998 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.77 -56.72 10.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.205 1.82 . . . . 0.0 111.37 171.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 tp -54.16 -51.66 63.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.46 1.504 . . . . 0.0 107.852 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.62 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -66.02 0.88 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.183 0.993 . . . . 0.0 108.965 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 O-C-N 121.351 -0.843 . . . . 0.0 112.464 -171.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 N--CA 1.47 0.539 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.44 -31.78 73.14 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 166.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -123.43 47.56 1.99 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.421 1.888 . . . . 0.0 111.244 -166.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.585 HD22 ' HG2' ' A' ' 15' ' ' GLU 0.351 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.849 0 C-N-CA 128.219 2.608 . . . . 0.0 112.051 -175.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t0 . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 122.304 1.05 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.57 20.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.508 1.051 . . . . 0.0 112.711 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -79.89 171.08 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 120.8 -1.412 . . . . 0.0 108.503 169.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -69.82 -19.36 63.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.879 1.218 . . . . 0.0 110.471 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.72 -22.13 3.27 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.146 0.978 . . . . 0.0 112.798 165.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 27.7 t-20 -55.58 -47.26 76.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.608 0.64 . . . . 0.0 110.725 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.28 -38.97 91.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.57 1.148 . . . . 0.0 112.142 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.638 HG13 ' SD ' ' A' ' 84' ' ' MET . 2.6 t -66.15 -57.81 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.192 1.397 . . . . 0.0 109.412 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.95 -23.29 66.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.928 -0.482 . . . . 0.0 111.495 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.25 -48.99 54.46 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.534 ' CB ' HD22 ' A' ' 116' ' ' LEU . 8.8 mm-40 -51.34 -39.09 56.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 118.845 0.748 . . . . 0.0 112.885 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.47 -51.66 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 10.4 tp10 -57.27 -54.33 48.02 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 123.973 0.909 . . . . 0.0 111.783 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -57.3 -38.29 73.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.888 1.222 . . . . 0.0 110.135 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.59 -43.89 71.88 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.605 1.162 . . . . 0.0 110.39 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -38.51 69.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.525 1.53 . . . . 0.0 114.071 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.59 -50.7 68.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.287 -0.863 . . . . 0.0 108.682 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.0 -46.99 85.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.593 1.542 . . . . 0.0 114.749 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -153.66 55.44 0.74 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 123.513 1.625 . . . . 0.0 111.089 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.51 -16.1 80.18 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.078 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -60.34 -40.47 90.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.161 1.481 . . . . 0.0 111.485 -168.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -27.49 50.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.313 -0.867 . . . . 0.0 110.857 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -70.8 -32.99 70.25 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.0 -42.77 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.142 166.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.63 74.48 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.957 -1.09 . . . . 0.0 111.267 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -71.92 -41.99 67.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 117.554 -1.212 . . . . 0.0 113.462 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.3 mp -95.18 -64.21 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 121.911 2.141 . . . . 0.0 107.176 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 77.03 0.28 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.433 1.016 . . . . 0.0 110.671 -169.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.85 145.78 4.2 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 118.312 -1.271 . . . . 0.0 110.636 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -73.37 137.35 23.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -135.28 168.17 19.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 110.155 170.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.57 137.2 52.36 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.534 1.133 . . . . 0.0 109.83 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -88.22 97.2 10.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -74.56 111.94 10.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.532 1.06 . . . . 0.0 109.475 168.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.79 106.79 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.28 177.44 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 159.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.5 t0 55.96 61.45 2.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.065 1.346 . . . . 0.0 111.903 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.55 -160.98 36.19 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.947 1.737 . . . . 0.0 112.442 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.59 4.95 0.39 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 124.567 3.511 . . . . 0.0 114.869 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.74 2.17 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 120.653 -1.279 . . . . 0.0 113.839 164.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.55 5.59 53.87 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 120.515 2.158 . . . . 0.0 113.244 163.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.41 -175.14 0.76 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.174 1.389 . . . . 0.0 109.802 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -118.87 138.0 53.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.098 1.359 . . . . 0.0 108.818 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.56 166.23 12.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.749 1.62 . . . . 0.0 107.64 164.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.0 m -146.35 148.69 32.63 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 160.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -119.64 133.77 55.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.88 114.07 40.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.402 HG22 HG13 ' A' ' 61' ' ' VAL . 59.2 t -92.91 105.12 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.28 116.58 18.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 163.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.25 52.01 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -144.4 -48.98 0.27 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.609 1.164 . . . . 0.0 109.885 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -80.9 126.01 30.83 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -173.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.17 -142.29 44.72 Favored Glycine 0 N--CA 1.439 -1.112 0 O-C-N 121.391 -0.818 . . . . 0.0 111.632 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -82.74 3.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.686 -1.15 . . . . 0.0 112.286 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.25 158.02 27.14 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 120.782 1.628 . . . . 0.0 109.512 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -171.72 137.27 1.0 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.551 2.74 . . . . 0.0 106.565 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 17' ' ' GLU . 3.5 t -76.53 111.64 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -87.0 122.14 71.31 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.78 130.6 10.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 41.49 45.79 2.85 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.339 1.856 . . . . 0.0 113.465 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.98 137.5 58.03 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -9.07 59.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.404 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -57.72 140.76 50.63 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HE2' ' H ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -71.89 -177.03 1.85 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.13 157.22 45.86 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 125.085 1.354 . . . . 0.0 108.549 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -33.24 67.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 p -153.24 175.72 12.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.454 2.301 . . . . 0.0 109.034 -170.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 73' ' ' ILE . 99.4 m -140.25 -172.73 3.49 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.442 ' N ' HG22 ' A' ' 72' ' ' THR . 0.7 OUTLIER -147.25 152.0 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 159.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.5 m -120.47 133.97 55.34 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.4 -38.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.184 1.356 . . . . 0.0 113.439 170.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 96.88 155.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 131.179 3.792 . . . . 0.0 111.516 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -62.72 -44.35 96.46 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.158 0.583 . . . . 0.0 110.571 -173.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -62.97 -21.41 66.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.123 -0.942 . . . . 0.0 111.595 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.28 -67.0 0.82 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 117.884 -1.055 . . . . 0.0 108.537 166.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -49.69 -45.41 48.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.92 1.688 . . . . 0.0 111.97 -168.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tp -59.89 -65.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.96 -36.43 62.84 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.189 0.996 . . . . 0.0 112.34 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.3 tp -48.6 -71.17 0.07 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.507 2.323 . . . . 0.0 109.123 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.638 ' SD ' HG13 ' A' ' 12' ' ' VAL . 10.1 ptp . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 pttt . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 164.225 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.443 HD13 ' CD1' ' A' ' 27' ' ' PHE . 9.0 tp -83.82 3.98 31.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.715 1.143 . . . . 0.0 110.021 169.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -139.42 45.27 1.95 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.529 2.331 . . . . 0.0 108.249 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 84' ' ' MET 0.379 0.1 OUTLIER . . . . . 0 C--O 1.238 0.462 0 C-N-CA 125.617 1.567 . . . . 0.0 113.389 174.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -65.14 143.09 58.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.454 0.57 . . . . 0.0 109.571 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.8 67.34 1.02 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.124 1.77 . . . . 0.0 110.9 -167.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.4 m -95.2 -82.59 0.37 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.665 1.986 . . . . 0.0 109.885 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.53 23.56 5.93 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.593 0.711 . . . . 0.0 112.099 163.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.55 82.49 0.34 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -169.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 98.0 m-85 -153.22 140.02 19.03 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.815 1.246 . . . . 0.0 107.743 -166.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -59.24 -29.58 67.64 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.899 0.318 . . . . 0.0 110.963 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.61 -11.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.527 1.931 . . . . 0.0 114.74 169.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.432 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 19.8 t-20 -57.69 -36.93 72.63 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 120.279 1.399 . . . . 0.0 111.677 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.637 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -72.79 -38.24 67.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.158 172.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG13 ' HG3' ' A' ' 84' ' ' MET . 2.4 t -56.04 -46.11 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.911 1.284 . . . . 0.0 110.868 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 16' ' ' ILE . 72.1 m-85 -68.65 -24.64 64.56 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.175 -0.328 . . . . 0.0 111.822 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -75.22 -27.15 59.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 121.292 -0.88 . . . . 0.0 111.62 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.88 -46.46 89.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.229 0.468 . . . . 0.0 110.349 169.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 13' ' ' PHE . 64.8 mt -59.46 -48.72 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.499 1.12 . . . . 0.0 108.158 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -55.75 -43.09 76.34 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.466 0.706 . . . . 0.0 111.342 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -60.45 -47.46 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -57.42 -45.48 84.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.568 172.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -42.45 76.98 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.84 -53.23 53.96 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.083 0.953 . . . . 0.0 110.984 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.14 -45.57 92.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 119.214 0.915 . . . . 0.0 111.947 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -161.97 58.19 0.25 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.431 1.092 . . . . 0.0 111.669 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.57 -12.99 43.12 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 120.015 -1.678 . . . . 0.0 113.213 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -52.85 -40.47 63.42 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.256 1.528 . . . . 0.0 111.828 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.06 -26.65 43.07 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.913 -1.117 . . . . 0.0 112.294 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.2 m-85 -74.98 -33.68 61.91 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.037 1.335 . . . . 0.0 108.571 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -54.94 -52.68 41.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -59.53 -14.25 12.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -85.82 -42.06 14.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.98 1.718 . . . . 0.0 111.977 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.23 -59.49 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.72 65.58 2.82 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 124.286 0.946 . . . . 0.0 111.451 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.74 171.51 43.32 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.15 132.33 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 157.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.48 166.93 18.63 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.363 0.602 . . . . 0.0 111.651 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.19 145.3 38.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.584 1.154 . . . . 0.0 108.898 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -94.67 93.49 7.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.737 1.215 . . . . 0.0 108.451 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -77.62 109.39 11.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.652 1.115 . . . . 0.0 109.444 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG22 ' CE2' ' A' ' 80' ' ' PHE . 2.9 t -118.22 104.95 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.63 -179.64 5.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.42 1.088 . . . . 0.0 108.208 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t0 58.76 48.13 11.84 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.58 1.152 . . . . 0.0 113.479 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.8 -173.79 11.85 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.998 1.285 . . . . 0.0 115.373 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.95 78.1 0.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.588 2.859 . . . . 0.0 108.62 161.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.38 -17.63 4.49 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.367 1.937 . . . . 0.0 112.794 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.72 -11.57 68.1 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 126.013 1.768 . . . . 0.0 112.471 170.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.13 -176.46 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.057 1.743 . . . . 0.0 110.675 170.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.28 152.46 51.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.9 1.28 . . . . 0.0 112.315 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HB2' ' CD2' ' A' ' 7' ' ' PHE . . . -119.11 174.94 6.03 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.345 2.258 . . . . 0.0 107.977 174.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.9 m -147.73 153.89 39.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 147.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.432 ' CH2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -120.74 136.97 54.73 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 162.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.59 144.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 170.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.8 113.52 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -81.23 112.15 18.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 164.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.23 48.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 167.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -137.07 -50.16 0.64 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.034 0.934 . . . . 0.0 110.236 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -79.87 131.11 35.79 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -170.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 -122.7 14.37 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.418 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 8.25 28.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.769 1.628 . . . . 0.0 110.751 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.53 158.7 30.6 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.841 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -171.14 147.63 2.58 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.865 2.466 . . . . 0.0 109.585 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -80.87 153.9 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 mt -136.43 86.19 24.39 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -169.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.45 142.22 48.7 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.609 1.54 . . . . 0.0 109.768 -174.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 45.75 34.95 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 129.278 3.031 . . . . 0.0 111.955 174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.8 152.67 25.57 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.622 0.769 . . . . 0.0 110.578 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 -3.92 59.02 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.266 1.026 . . . . 0.0 111.178 161.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.97 128.95 22.68 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -73.92 -176.76 2.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.16 141.58 30.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 126.362 1.865 . . . . 0.0 108.092 -172.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.75 -29.17 58.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 m -150.41 165.27 33.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.013 1.725 . . . . 0.0 108.348 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.558 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 86.5 m -147.26 119.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.16 -0.962 . . . . 0.0 108.962 -170.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.94 138.46 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.9 m -108.99 131.21 55.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.022 1.283 . . . . 0.0 107.739 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -139.88 -101.22 0.16 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 161.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 174.08 159.06 0.15 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 129.503 3.121 . . . . 0.0 106.873 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.3 -48.87 79.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.73 0.812 . . . . 0.0 111.861 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -71.31 1.45 6.16 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.052 1.341 . . . . 0.0 111.188 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -105.3 -44.55 4.71 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.924 -1.11 . . . . 0.0 112.856 158.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CE2' HG22 ' A' ' 39' ' ' VAL . 3.8 m-85 -60.04 -60.79 3.27 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.223 1.409 . . . . 0.0 111.184 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.6 tp -44.5 -61.22 1.62 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.477 1.111 . . . . 0.0 109.304 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.77 -18.2 29.84 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.792 -172.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 90' ' ' PRO . 3.1 tt -67.13 -68.69 0.36 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.477 1.111 . . . . 0.0 110.675 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.419 ' HG3' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -74.79 -21.94 59.02 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.2 m -74.57 -19.51 60.3 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.685 -1.259 . . . . 0.0 111.003 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.15 36.76 90.75 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.666 1.121 . . . . 0.0 112.158 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -69.1 -36.17 77.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.421 1.11 . . . . 0.0 111.462 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 18.3 mtt -163.44 160.44 23.39 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 128.634 2.774 . . . . 0.0 106.233 166.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -36.89 99.4 0.18 Allowed Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 127.147 2.179 . . . . 0.0 111.554 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG3' ' HA ' ' A' ' 83' ' ' LEU . 66.6 Cg_endo -85.43 116.5 1.7 Allowed 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 123.364 2.709 . . . . 0.0 110.74 -162.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -166.64 71.12 0.12 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.48 0.712 . . . . 0.0 111.397 -171.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.4 t -59.2 -33.3 70.8 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.734 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.574 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . . . -51.93 -87.88 0.0 OUTLIER 'General case' 0 C--N 1.353 0.721 0 CA-C-N 120.207 1.367 . . . . 0.0 112.819 162.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.2 t80 33.89 -135.14 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.501 2.32 . . . . 0.0 112.753 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.22 -7.68 59.63 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.467 1.507 . . . . 0.0 113.007 175.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -66.05 -39.8 90.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.936 1.244 . . . . 0.0 108.416 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.12 49.54 21.14 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 123.828 0.728 . . . . 0.0 111.938 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -63.09 -9.0 8.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 117.873 -1.06 . . . . 0.0 113.705 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.1 tp 54.32 45.2 27.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 122.012 0.911 . . . . 0.0 108.751 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -64.74 124.33 21.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 171.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.558 ' CG2' ' H ' ' A' ' 72' ' ' THR . 1.2 mp -73.74 166.99 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 113.917 -1.492 . . . . 0.0 107.288 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -154.83 138.8 16.36 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.922 1.289 . . . . 0.0 107.571 -171.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.37 -15.28 66.79 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.134 -1.37 . . . . 0.0 113.603 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 174.88 -172.34 0.06 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.291 3.036 . . . . 0.0 106.841 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.2 mtp -65.69 -166.79 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.531 1.532 . . . . 0.0 111.214 158.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.88 -63.29 4.09 Favored Glycine 0 C--N 1.338 0.677 0 O-C-N 120.58 -1.325 . . . . 0.0 110.224 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 pp -52.96 -13.34 0.42 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.407 1.883 . . . . 0.0 115.759 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.58 -73.65 0.21 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.978 1.263 . . . . 0.0 110.319 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -159.19 48.21 0.31 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.002 1.273 . . . . 0.0 111.039 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -72.88 -8.11 54.04 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.723 -1.235 . . . . 0.0 113.243 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -165.06 -164.92 0.82 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.451 1.9 . . . . 0.0 108.443 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -114.9 -30.96 6.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.258 1.023 . . . . 0.0 113.307 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -68.47 -14.1 62.77 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.373 -1.454 . . . . 0.0 113.714 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.476 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -73.11 -3.85 28.97 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 169.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -150.13 44.74 0.89 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.176 1.79 . . . . 0.0 111.393 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 32.6 mt 50.22 159.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 128.174 2.59 . . . . 0.0 116.018 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.15 130.01 90.06 Favored Pre-proline 0 C--O 1.235 0.338 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.43 164.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.32 174.44 11.97 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.596 2.197 . . . . 0.0 111.123 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.87 83.26 0.15 Allowed Glycine 0 C--N 1.333 0.396 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -168.23 126.94 1.18 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.783 1.233 . . . . 0.0 108.591 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.73 104.19 11.09 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 168.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -80.97 98.82 8.1 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.653 0.781 . . . . 0.0 110.6 -171.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tp . . . . . 0 C--O 1.247 0.951 0 C-N-CA 126.403 1.881 . . . . 0.0 110.252 -168.624 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.0 m -165.89 112.84 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.514 1.126 . . . . 0.0 110.755 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.84 49.38 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.125 1.77 . . . . 0.0 110.328 151.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 t -95.42 -16.38 22.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -169.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.49 24.96 3.27 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 155.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.02 78.06 0.28 Allowed Glycine 0 C--N 1.336 0.544 0 O-C-N 120.67 -1.269 . . . . 0.0 113.088 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -153.68 160.69 42.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.629 1.572 . . . . 0.0 110.263 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm -65.48 -9.56 26.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 168.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.81 -6.24 5.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.994 0.815 . . . . 0.0 113.144 166.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.11 -37.93 81.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.681 1.128 . . . . 0.0 112.342 -176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -69.53 -37.88 77.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.701 1.201 . . . . 0.0 110.734 174.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.648 HG13 ' SD ' ' A' ' 84' ' ' MET . 0.9 OUTLIER -58.84 -52.71 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 125.627 1.571 . . . . 0.0 111.228 -175.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 67.4 m-85 -70.15 -21.63 63.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.015 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -75.06 -27.5 60.01 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.774 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.509 ' CB ' HD22 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -55.71 -49.46 72.96 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.353 1.433 . . . . 0.0 110.596 171.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mt -53.56 -47.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.42 1.088 . . . . 0.0 108.204 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -61.21 -53.39 57.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.33 -1.319 . . . . 0.0 111.634 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -51.76 -53.72 36.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.766 1.166 . . . . 0.0 108.42 -174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -57.12 -46.58 82.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.974 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.75 -35.48 68.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -70.18 -52.24 24.95 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.27 -44.42 95.33 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.347 2.259 . . . . 0.0 112.763 -171.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -154.76 55.16 0.67 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.739 1.616 . . . . 0.0 111.072 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.31 -30.93 56.22 Favored Glycine 0 C--O 1.227 -0.296 0 CA-C-O 117.741 -1.589 . . . . 0.0 113.529 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.75 -38.91 67.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.898 1.849 . . . . 0.0 111.118 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -81.07 -19.26 44.14 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.279 -0.888 . . . . 0.0 112.429 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.42 -31.5 20.03 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.053 -1.03 . . . . 0.0 109.929 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.4 t -50.37 -55.03 6.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 126.682 1.993 . . . . 0.0 108.252 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -61.77 -16.0 45.97 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -79.68 -58.85 2.98 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.716 0.806 . . . . 0.0 110.52 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.45 -63.46 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 125.961 1.704 . . . . 0.0 107.155 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.66 72.39 0.69 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.243 1.402 . . . . 0.0 112.32 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.25 153.7 6.46 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.525 -1.153 . . . . 0.0 110.767 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.99 134.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -128.41 162.94 25.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.712 0.768 . . . . 0.0 109.131 162.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.59 157.72 22.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.561 164.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -105.79 96.29 6.39 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.322 1.449 . . . . 0.0 109.469 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -74.77 108.95 7.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 120.317 -1.489 . . . . 0.0 109.799 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG22 ' CE1' ' A' ' 80' ' ' PHE . 21.9 t -124.93 94.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 174.45 7.11 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 61.57 40.69 13.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 0.0 111.917 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -61.16 173.08 6.65 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.396 0.998 . . . . 0.0 113.52 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.01 86.61 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.009 2.473 . . . . 0.0 107.085 166.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.81 -57.98 0.41 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -163.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.96 -23.87 7.63 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 125.945 1.736 . . . . 0.0 110.483 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -71.58 -172.48 0.79 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.382 1.473 . . . . 0.0 111.221 168.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.58 149.03 50.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.934 1.694 . . . . 0.0 113.666 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.42 167.14 10.58 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 127.367 2.267 . . . . 0.0 109.966 166.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.9 m -155.23 114.59 3.64 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.005 0.907 . . . . 0.0 109.854 150.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -88.46 162.35 16.52 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 168.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.88 145.33 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.71 109.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.54 122.57 29.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.5 50.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 126.136 1.775 . . . . 0.0 106.961 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -40.5 0.07 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.401 1.08 . . . . 0.0 110.279 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -95.2 131.54 41.13 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 -145.24 42.72 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -83.16 8.29 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.455 -1.259 . . . . 0.0 113.744 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.78 156.77 8.66 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 120.586 1.539 . . . . 0.0 110.579 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -171.28 144.6 2.04 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.96 2.104 . . . . 0.0 108.524 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.4 t -74.56 152.05 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 168.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.37 88.6 12.69 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 127.843 2.457 . . . . 0.0 104.501 -164.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.39 138.94 62.76 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.587 1.525 . . . . 0.0 109.479 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 54.49 24.09 5.04 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.301 1.841 . . . . 0.0 112.742 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 t -76.77 145.31 38.64 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.915 0.864 . . . . 0.0 111.424 -159.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.37 -11.12 55.3 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.264 2.226 . . . . 0.0 112.64 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -66.11 164.84 14.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.681 0.673 . . . . 0.0 109.541 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -169.91 0.94 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.51 -0.744 . . . . 0.0 110.106 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.9 178.28 7.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.257 1.423 . . . . 0.0 107.767 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.1 -52.14 13.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 159.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 m -149.05 -172.78 4.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.563 1.545 . . . . 0.0 110.985 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -129.31 178.83 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 tt -125.24 178.81 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 159.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.6 m -125.29 161.97 25.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 160.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.59 -50.01 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 158.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.08 161.41 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 130.912 3.685 . . . . 0.0 109.961 -166.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 16.6 t70 -62.37 -56.06 22.0 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.025 -169.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.81 -34.24 62.5 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 125.6 1.812 . . . . 0.0 108.781 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -58.39 5.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 111.626 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.706 ' CE1' HG22 ' A' ' 39' ' ' VAL . 11.9 m-85 -53.97 -50.7 65.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.196 0.598 . . . . 0.0 109.968 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.37 -26.98 66.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.036 1.734 . . . . 0.0 112.519 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.12 -25.93 55.86 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.286 0.948 . . . . 0.0 112.782 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 tt -70.68 -72.54 0.2 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.654 ' SD ' HD21 ' A' ' 116' ' ' LEU . 11.9 ptp -76.51 53.25 0.85 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.015 1.326 . . . . 0.0 113.581 -171.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.2 p -155.76 -17.45 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 129.177 2.991 . . . . 0.0 110.082 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.14 37.34 91.41 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -164.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -99.4 22.94 9.95 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.509 1.655 . . . . 0.0 110.223 171.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.24 98.77 0.05 OUTLIER 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.521 1.929 . . . . 0.0 111.683 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -139.05 68.4 41.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 O-C-N 121.87 -0.519 . . . . 0.0 112.134 167.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -68.77 77.12 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 125.111 3.874 . . . . 0.0 112.072 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 56.69 37.98 29.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.911 1.285 . . . . 0.0 112.298 170.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.1 t -53.58 -17.69 2.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.757 1.623 . . . . 0.0 112.596 174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 100' ' ' LYS . . . -53.01 -28.72 25.39 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.697 1.599 . . . . 0.0 112.682 169.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.61 -66.59 0.86 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.174 0.99 . . . . 0.0 108.955 166.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -50.02 -51.52 41.42 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.736 1.615 . . . . 0.0 112.049 -163.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -67.48 -8.92 37.35 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.85 30.69 46.71 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 119.575 1.079 . . . . 0.0 111.135 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -93.81 -4.51 50.06 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.229 1.514 . . . . 0.0 113.123 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.5 tp 54.49 84.79 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.364 2.265 . . . . 0.0 113.657 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -65.04 168.15 6.93 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.0 mm -132.3 -172.16 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -97.4 153.94 17.78 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 119.991 -1.693 . . . . 0.0 109.876 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -163.61 -7.75 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.748 -1.029 . . . . 0.0 114.403 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -164.53 -95.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 158.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 40.3 ttm -150.95 -105.48 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.297 0.953 . . . . 0.0 109.618 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.34 48.25 3.76 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 125.847 1.689 . . . . 0.0 110.371 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.33 -10.58 59.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.365 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.4 67.26 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.508 1.049 . . . . 0.0 112.445 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -100.45 -31.74 11.15 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -165.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -76.11 42.54 0.26 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 119.763 -1.836 . . . . 0.0 112.515 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.4 pt? -69.87 -14.17 62.61 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 119.872 -1.767 . . . . 0.0 113.068 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 112' ' ' GLN . 11.6 mm-40 -35.53 -80.77 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.609 2.364 . . . . 0.0 115.272 -171.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -95.85 -48.12 5.87 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.559 1.143 . . . . 0.0 110.533 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.83 -17.36 55.99 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.668 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -127.38 45.68 2.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.091 1.314 . . . . 0.0 109.785 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.654 HD21 ' SD ' ' A' ' 84' ' ' MET 0.308 0.2 OUTLIER 46.68 156.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 1 C-N-CA 132.041 4.136 . . . . 0.0 115.964 170.993 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.78 135.58 59.51 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 120.611 -1.305 . . . . 0.0 110.901 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.45 -176.73 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.271 3.314 . . . . 0.0 113.307 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.91 147.41 22.31 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.993 1.759 . . . . 0.0 109.671 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.08 88.15 0.08 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.128 1.771 . . . . 0.0 109.678 -162.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.27 -60.74 2.99 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.556 1.542 . . . . 0.0 110.85 -172.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -162.3 108.19 1.25 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 103.36 -2.829 . . . . 0.0 103.36 156.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 C--O 1.249 1.057 0 O-C-N 124.473 1.108 . . . . 0.0 109.699 -172.139 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 m -54.44 -60.05 3.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.385 1.074 . . . . 0.0 112.392 -168.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 34.44 57.39 0.68 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.371 2.268 . . . . 0.0 112.687 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.8 m -143.36 -156.65 0.7 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.341 1.456 . . . . 0.0 107.685 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 p30 45.34 22.44 0.09 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.15 65.87 0.24 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 126.578 2.037 . . . . 0.0 109.731 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.685 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 10.2 m-85 -154.07 167.74 28.8 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 127.694 2.398 . . . . 0.0 107.283 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -62.33 -30.01 70.86 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.079 -0.388 . . . . 0.0 110.515 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.06 -28.13 0.67 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 128.218 2.607 . . . . 0.0 114.885 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.81 -44.1 73.51 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 123.789 0.835 . . . . 0.0 109.859 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.19 -42.7 99.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.683 1.593 . . . . 0.0 110.028 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -81.96 -51.22 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.593 1.557 . . . . 0.0 111.246 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 16' ' ' ILE . 33.8 m-85 -64.36 -23.32 67.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.056 0.844 . . . . 0.0 110.733 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -71.53 -36.4 70.99 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.846 172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.804 ' HG3' HD21 ' A' ' 116' ' ' LEU . 34.1 mm-40 -55.43 -39.87 70.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 119.902 1.228 . . . . 0.0 112.32 172.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 13' ' ' PHE . 62.7 mt -62.43 -48.98 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 61' ' ' VAL . 16.9 tt0 -56.23 -53.84 52.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.016 1.326 . . . . 0.0 111.068 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -51.74 28.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.824 1.65 . . . . 0.0 109.092 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -59.26 -48.04 83.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.053 0.541 . . . . 0.0 111.211 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -36.09 68.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.13 -52.13 38.31 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.765 -1.209 . . . . 0.0 108.646 172.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.35 -47.11 82.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 110.569 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -165.35 64.7 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.411 1.084 . . . . 0.0 111.459 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.75 -15.01 81.78 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 118.271 -1.294 . . . . 0.0 114.46 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.82 -40.21 60.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.896 1.348 . . . . 0.0 111.994 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.7 -17.99 49.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.654 0.782 . . . . 0.0 112.159 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -14.62 26.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.05 -62.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 126.733 2.013 . . . . 0.0 106.425 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -58.27 -18.71 28.73 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -66.3 -50.67 62.88 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.53 -53.19 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.45 47.63 76.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.361 0.981 . . . . 0.0 112.674 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.22 171.03 39.65 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.76 134.01 30.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 159.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -128.34 177.91 6.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.957 0.798 . . . . 0.0 109.211 163.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.42 51.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.412 0.685 . . . . 0.0 109.937 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 39' ' ' VAL . 69.5 m-85 -103.58 101.76 11.64 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.556 1.142 . . . . 0.0 107.997 175.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.71 106.84 6.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 121.092 1.769 . . . . 0.0 108.533 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.71 HG22 ' CE2' ' A' ' 80' ' ' PHE . 76.3 t -122.43 99.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -166.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -111.05 176.94 4.82 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 121.038 -1.039 . . . . 0.0 108.57 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.9 t0 60.24 60.02 2.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.476 1.91 . . . . 0.0 112.022 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.43 -167.29 32.56 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.83 1.681 . . . . 0.0 111.815 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.31 67.71 6.13 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.797 2.998 . . . . 0.0 109.644 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 -43.69 0.39 Allowed Glycine 0 CA--C 1.526 0.727 0 C-N-CA 125.215 1.388 . . . . 0.0 110.636 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.64 -0.18 45.98 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.032 1.301 . . . . 0.0 112.369 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -65.84 -175.13 0.27 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.11 1.364 . . . . 0.0 111.576 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -132.3 132.75 43.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.221 1.008 . . . . 0.0 111.019 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.685 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -114.76 165.29 12.97 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 128.343 2.657 . . . . 0.0 107.304 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 37' ' ' PHE . 26.5 m -148.38 117.64 6.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 155.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 13' ' ' PHE . 1.2 m-90 -83.69 128.02 34.21 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 165.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.92 146.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.86 104.84 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.78 106.4 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.11 47.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -129.25 -54.5 1.19 Allowed 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.319 0.647 . . . . 0.0 109.643 165.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -93.35 140.51 29.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -158.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 -124.54 11.24 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.23 5.76 35.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.523 1.529 . . . . 0.0 112.116 164.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.01 156.98 9.15 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -171.37 153.53 3.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.916 2.486 . . . . 0.0 107.832 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 17' ' ' GLU . 3.4 t -101.66 114.86 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -173.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.75 117.44 59.78 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -169.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -79.01 140.12 15.69 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 -171.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 45.39 29.37 0.57 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.347 1.859 . . . . 0.0 114.057 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -64.83 141.37 58.8 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.156 0.889 . . . . 0.0 110.569 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.52 -20.19 60.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.412 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -54.51 126.7 24.63 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -63.16 -176.97 0.15 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.155 0.982 . . . . 0.0 110.034 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.95 159.19 42.74 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.098 1.359 . . . . 0.0 111.113 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -54.37 47.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.133 0.968 . . . . 0.0 109.191 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.0 m -146.41 169.8 18.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.366 2.266 . . . . 0.0 107.387 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 73' ' ' ILE . 10.3 m -114.32 -164.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.581 ' H ' HG22 ' A' ' 72' ' ' THR . 3.9 tt -148.93 178.1 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.495 -1.378 . . . . 0.0 108.13 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.7 m -143.11 138.81 30.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.856 1.662 . . . . 0.0 109.092 167.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -134.99 -12.56 2.2 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.7 143.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 128.348 2.659 . . . . 0.0 111.588 -146.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.7 -45.61 67.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 126.877 2.071 . . . . 0.0 112.376 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -54.43 -44.99 72.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.858 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.17 -51.24 56.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.717 1.207 . . . . 0.0 110.877 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.71 ' CE2' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -50.48 -50.99 51.1 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.392 2.277 . . . . 0.0 111.433 178.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.7 tp -53.8 -64.64 0.76 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.985 1.714 . . . . 0.0 108.633 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 87' ' ' LYS . . . -50.21 -42.4 51.43 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.872 1.269 . . . . 0.0 111.385 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.72 -68.51 0.18 Allowed 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.727 1.611 . . . . 0.0 109.912 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.551 ' HE2' HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -75.47 -25.15 57.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.9 m -73.64 -11.33 60.38 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.005 0.82 . . . . 0.0 110.238 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.62 33.83 3.01 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.305 0.955 . . . . 0.0 112.033 163.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 7.8 tmtt? -106.4 -29.39 9.75 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.069 -168.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 14.7 ptm -154.35 179.16 9.25 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.817 1.19 . . . . 0.0 111.873 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -46.27 140.87 5.09 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.909 2.084 . . . . 0.0 111.1 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.11 43.12 1.23 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.92 3.08 . . . . 0.0 112.923 -176.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -158.79 78.21 0.77 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.217 1.407 . . . . 0.0 109.384 -171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -25.35 63.65 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.0 -89.76 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.341 166.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.1 t80 48.05 -153.63 0.09 Allowed 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.004 1.275 . . . . 0.0 112.196 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -63.0 -3.46 1.67 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.038 2.135 . . . . 0.0 113.665 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -78.92 -104.06 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.7 1.591 . . . . 0.0 107.961 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.14 28.27 0.02 OUTLIER Glycine 0 CA--C 1.531 1.048 0 N-CA-C 116.701 1.44 . . . . 0.0 116.701 -170.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -64.91 7.0 0.19 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 121.061 2.43 . . . . 0.0 115.394 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.6 tp 35.03 60.75 0.65 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.703 2.001 . . . . 0.0 109.89 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 160.33 28.58 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.51 ' H ' ' HA ' ' A' ' 73' ' ' ILE . 3.1 mp -100.09 169.82 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -175.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.9 p -75.04 -170.82 1.2 Allowed 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.198 -1.564 . . . . 0.0 110.484 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.39 -104.87 0.19 Allowed Glycine 0 C--N 1.337 0.614 0 O-C-N 119.483 -2.011 . . . . 0.0 112.369 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -147.41 -94.04 0.08 Allowed 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.64 1.176 . . . . 0.0 108.041 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.4 ttt -150.19 155.79 40.42 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.499 1.045 . . . . 0.0 110.92 -164.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.02 -83.63 1.61 Allowed Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 mt 49.72 -79.33 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.828 2.851 . . . . 0.0 113.971 168.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.45 -17.24 62.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.556 1.142 . . . . 0.0 112.063 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.4 ttt -133.48 31.21 3.75 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.176 1.79 . . . . 0.0 109.47 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.439 ' HE2' ' CG ' ' A' ' 115' ' ' GLN . 3.3 pttt -68.94 44.92 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.175 2.59 . . . . 0.0 115.13 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 52.37 -176.64 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.362 2.665 . . . . 0.0 113.377 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -86.51 -56.96 3.18 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -63.91 -2.94 2.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -170.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -92.7 8.36 39.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 121.66 2.027 . . . . 0.0 110.493 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.439 ' CG ' ' HE2' ' A' ' 110' ' ' LYS . 30.4 mt-30 -153.9 44.69 0.58 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.658 2.783 . . . . 0.0 110.4 -172.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.804 HD21 ' HG3' ' A' ' 15' ' ' GLU . 84.0 mt 50.48 -177.08 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 123.818 1.77 . . . . 0.0 115.44 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -134.76 169.81 12.88 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 125.87 1.668 . . . . 0.0 107.174 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -78.2 176.35 10.05 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.527 2.151 . . . . 0.0 110.054 167.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.02 70.9 0.78 Allowed Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.867 1.222 . . . . 0.0 111.735 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -144.58 152.31 40.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.935 0.868 . . . . 0.0 108.809 171.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 53.18 90.85 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.479 1.912 . . . . 0.0 111.576 -166.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -141.9 166.51 24.52 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.426 1.091 . . . . 0.0 109.555 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.979 2.112 . . . . 0.0 110.516 -170.818 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.4 m -55.2 155.56 4.78 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.812 1.187 . . . . 0.0 109.759 162.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.99 163.4 14.7 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.84 0.856 . . . . 0.0 109.843 170.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.0 p -144.9 -26.92 0.49 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 53.29 22.54 2.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.018 1.727 . . . . 0.0 115.41 161.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.46 16.37 26.76 Favored Glycine 0 N--CA 1.466 0.689 0 O-C-N 120.4 -1.438 . . . . 0.0 112.533 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.2 173.33 10.48 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.863 1.265 . . . . 0.0 109.905 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.267 49.1 mttp -74.76 -5.56 44.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.247 169.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.41 -23.04 62.28 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.764 1.225 . . . . 0.0 113.021 167.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -57.01 -52.71 64.17 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.078 0.854 . . . . 0.0 111.232 -173.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -68.8 -32.47 72.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.239 0.616 . . . . 0.0 111.154 178.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.35 -54.59 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.078 0.951 . . . . 0.0 110.755 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -64.53 -27.14 68.76 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.606 0.639 . . . . 0.0 110.646 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.09 -30.51 65.17 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.077 -1.015 . . . . 0.0 112.701 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.498 ' HG3' HD21 ' A' ' 116' ' ' LEU . 29.8 mm-40 -59.8 -31.92 70.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 119.301 0.955 . . . . 0.0 112.081 172.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.0 mt -75.0 -46.56 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -50.86 -50.25 57.34 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.68 1.192 . . . . 0.0 111.306 172.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -58.35 -38.57 77.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.92 0.782 . . . . 0.0 109.942 -166.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -65.06 -47.92 75.63 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 173.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -35.16 65.52 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.048 0.939 . . . . 0.0 112.444 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.2 -53.15 40.81 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.831 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.35 -45.43 91.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.33 0.968 . . . . 0.0 112.686 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -155.72 58.48 0.61 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.746 1.26 . . . . 0.0 110.841 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.79 86.3 Favored Glycine 0 C--O 1.219 -0.79 0 CA-C-O 118.569 -1.129 . . . . 0.0 111.844 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.94 -40.14 42.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.357 1.578 . . . . 0.0 112.581 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -84.37 -18.68 35.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.359 -0.838 . . . . 0.0 111.778 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.94 -38.7 19.02 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.502 1.921 . . . . 0.0 109.246 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 54' ' ' VAL . 9.3 t -54.07 -46.3 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 127.637 2.375 . . . . 0.0 108.755 175.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -59.54 -13.02 7.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -92.74 -63.09 1.27 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 120.077 1.308 . . . . 0.0 110.577 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.89 -38.36 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.2 1.0 . . . . 0.0 110.469 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 47.85 59.03 6.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.428 1.489 . . . . 0.0 112.526 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.49 -176.79 39.62 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.272 1.536 . . . . 0.0 110.509 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.6 131.77 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 159.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -121.98 167.26 13.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 111.939 166.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.8 146.02 34.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.832 1.653 . . . . 0.0 108.997 164.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -95.42 100.3 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -77.09 99.56 5.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.049 1.295 . . . . 0.0 109.059 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.12 133.81 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 170.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.48 175.46 5.51 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.607 -1.308 . . . . 0.0 108.706 154.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 55.42 52.52 11.17 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.112 160.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.01 174.74 20.07 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.425 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.8 6.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.455 3.437 . . . . 0.0 115.088 169.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.58 -22.06 1.89 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.403 1.478 . . . . 0.0 114.052 163.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.68 -13.43 17.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 119.515 1.657 . . . . 0.0 111.792 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -66.16 -175.5 0.34 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.938 1.695 . . . . 0.0 111.177 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.87 167.09 13.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.466 1.506 . . . . 0.0 110.225 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.45 173.37 12.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.547 1.939 . . . . 0.0 107.109 169.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 84.3 m -143.91 143.99 31.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 161.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.41 137.09 49.64 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 161.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.48 144.34 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.51 107.95 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -75.39 124.5 27.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.586 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -139.67 44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 105.852 -1.906 . . . . 0.0 105.852 172.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -134.5 -46.0 0.75 Allowed 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 125.09 1.356 . . . . 0.0 110.107 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -92.28 103.21 15.7 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -159.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.34 -113.83 4.51 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.278 -0.889 . . . . 0.0 111.638 -174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -84.81 -5.72 59.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.073 0.949 . . . . 0.0 112.757 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.75 -97.49 0.72 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 128.722 3.058 . . . . 0.0 110.383 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.7 m 98.89 151.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 1 C-N-CA 135.548 5.539 . . . . 0.0 111.733 -172.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.75 148.64 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 163.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.33 122.5 19.06 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.15 138.52 16.23 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 -177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.64 24.54 3.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.562 1.945 . . . . 0.0 111.958 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 t -74.65 144.76 43.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.264 1.031 . . . . 0.0 111.064 -153.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.4 7.08 23.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 111.882 164.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.3 tttm -61.99 129.29 40.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 153.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -68.06 -176.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.24 156.45 47.07 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.565 1.546 . . . . 0.0 109.286 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.31 -45.15 41.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.681 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.9 m -134.22 177.3 7.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.363 0.665 . . . . 0.0 110.887 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -138.81 -177.78 5.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.475 1.51 . . . . 0.0 107.688 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.27 152.93 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 119.543 -1.973 . . . . 0.0 105.694 166.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.7 m -108.24 122.74 47.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.409 1.459 . . . . 0.0 112.185 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.7 mtm -156.6 119.24 4.04 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.4 165.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.643 163.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.09 -54.4 45.47 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 121.256 -0.902 . . . . 0.0 109.817 163.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.9 1.69 1.31 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.839 1.256 . . . . 0.0 112.305 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.0 -63.38 1.13 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.466 2.306 . . . . 0.0 108.613 164.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -60.94 -40.01 91.63 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.327 2.251 . . . . 0.0 113.503 -174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.35 -35.37 71.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.934 1.293 . . . . 0.0 110.038 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.28 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.733 1.213 . . . . 0.0 110.674 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 tt -46.83 -75.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 127.82 2.448 . . . . 0.0 109.717 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.02 54.43 0.85 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.851 0.86 . . . . 0.0 112.992 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 p -137.81 -5.07 1.74 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.488 1.115 . . . . 0.0 112.267 155.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.0 73.45 1.0 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -168.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -140.7 -21.63 0.81 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.021 -0.693 . . . . 0.0 111.952 175.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 ptm -136.36 87.45 2.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -62.25 -55.61 38.67 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.871 -1.062 . . . . 0.0 109.715 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.03 148.19 75.24 Favored 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-N 121.371 1.525 . . . . 0.0 110.252 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -56.2 112.98 1.37 Allowed 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.324 0.65 . . . . 0.0 109.643 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -54.77 -48.26 72.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.175 0.99 . . . . 0.0 111.696 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.602 ' HA ' HE21 ' A' ' 96' ' ' GLN . . . -65.26 -40.55 94.1 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 121.482 1.947 . . . . 0.0 113.186 -170.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.9 -47.39 80.78 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 173.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -58.33 -58.95 6.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.239 1.816 . . . . 0.0 111.978 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.602 HE21 ' HA ' ' A' ' 93' ' ' ALA . 6.3 pt20 -68.53 -28.09 66.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.7 1.137 . . . . 0.0 111.191 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.43 12.98 53.18 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 116.617 -2.213 . . . . 0.0 114.987 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -64.3 -84.35 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.991 2.396 . . . . 0.0 110.335 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 tp -165.38 69.95 0.14 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.222 1.009 . . . . 0.0 109.456 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -74.58 164.03 27.05 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 175.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.2 mm -136.91 172.97 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 103' ' ' GLY . 2.3 m 64.11 174.75 0.18 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.33 2.252 . . . . 0.0 111.468 -174.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.436 ' H ' HG22 ' A' ' 102' ' ' THR . . . -165.7 16.6 0.09 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 120.444 -1.41 . . . . 0.0 114.225 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -82.86 40.68 0.7 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.58 1.69 . . . . 0.0 113.298 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.4 mpp? 25.73 60.82 0.07 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.482 2.713 . . . . 0.0 113.902 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.71 -18.98 0.04 OUTLIER Glycine 0 C--N 1.337 0.593 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.444 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.5 -14.94 60.0 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.048 1.424 . . . . 0.0 111.671 164.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.16 -83.22 0.11 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.663 1.185 . . . . 0.0 108.444 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.0 ttt -142.76 88.77 2.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -76.4 -61.5 1.93 Allowed 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.093 -1.004 . . . . 0.0 112.804 175.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -149.7 -148.2 0.25 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.284 0.634 . . . . 0.0 109.504 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -89.76 -60.22 2.0 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.36 1.064 . . . . 0.0 109.734 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -57.02 -21.23 29.27 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.49 -4.87 42.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.383 0.992 . . . . 0.0 111.874 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -163.23 44.26 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.712 1.205 . . . . 0.0 112.172 -165.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.498 HD21 ' HG3' ' A' ' 15' ' ' GLU . 50.0 mt 48.74 160.53 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 125.214 2.435 . . . . 0.0 114.055 -165.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -80.68 171.91 11.13 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.871 172.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.1 178.89 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.675 2.25 . . . . 0.0 111.741 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.45 175.35 47.2 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.754 1.645 . . . . 0.0 109.646 165.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -52.29 3.95 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.561 1.544 . . . . 0.0 111.456 168.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 48.29 77.28 0.1 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.096 2.158 . . . . 0.0 114.278 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 97.36 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 1 C-N-CA 134.292 5.037 . . . . 0.0 107.706 -155.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--O 1.245 0.848 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 160.908 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.45 173.1 0.19 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.838 2.055 . . . . 0.0 113.669 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.26 147.13 37.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.116 1.367 . . . . 0.0 107.944 164.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . 46.2 p -147.36 -153.33 0.48 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 127.426 2.29 . . . . 0.0 107.403 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t0 64.28 24.16 13.25 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 163.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.01 77.58 0.39 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 126.725 2.107 . . . . 0.0 108.6 -175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -153.25 151.93 30.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.682 2.393 . . . . 0.0 106.852 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -61.98 -26.55 68.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.838 0.744 . . . . 0.0 110.272 167.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.89 -14.35 1.42 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.051 0.94 . . . . 0.0 113.443 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 19.0 t-20 -55.9 -52.19 64.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.574 1.079 . . . . 0.0 111.454 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.361 -0.837 . . . . 0.0 111.183 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG13 ' HG3' ' A' ' 84' ' ' MET . 45.6 t -54.69 -54.62 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.454 1.502 . . . . 0.0 110.723 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -71.1 -23.59 62.14 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.602 0.637 . . . . 0.0 112.199 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -75.29 -26.96 59.15 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.79 -50.0 75.57 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.211 0.46 . . . . 0.0 110.546 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.3 mt -51.39 -47.9 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.92 -50.72 72.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.988 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -55.42 -48.85 73.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.77 0.714 . . . . 0.0 109.213 -170.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.5 -45.57 93.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.181 0.592 . . . . 0.0 109.881 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -34.1 66.04 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.353 1.461 . . . . 0.0 114.355 173.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.258 7.8 mm-40 -63.67 -52.13 62.07 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.197 -0.939 . . . . 0.0 111.665 171.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.69 -45.54 93.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.071 1.305 . . . . 0.0 113.233 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -157.75 63.55 0.47 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.674 1.59 . . . . 0.0 108.446 -170.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.63 -25.96 74.04 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 121.073 -1.017 . . . . 0.0 112.749 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -52.89 -36.54 59.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 112.195 -171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -77.05 -35.87 56.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.302 1.041 . . . . 0.0 110.005 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.03 -27.76 57.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.08 -55.6 9.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 167.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -63.8 -15.95 60.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.391 0.996 . . . . 0.0 113.472 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 119.634 1.106 . . . . 0.0 110.82 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.65 -50.29 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.279 1.031 . . . . 0.0 109.047 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.52 65.35 3.63 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.652 1.12 . . . . 0.0 112.775 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.06 144.76 4.64 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.31 138.28 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 168.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -138.88 162.66 34.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.046 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HB1' ' CG2' ' A' ' 49' ' ' THR . . . -111.3 144.56 40.29 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.749 1.22 . . . . 0.0 109.253 172.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -92.94 90.06 6.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.951 1.301 . . . . 0.0 108.945 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -74.62 107.56 6.82 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.717 -1.239 . . . . 0.0 109.526 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.771 HG22 ' CE2' ' A' ' 80' ' ' PHE . 40.5 t -128.67 110.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -115.77 -175.29 2.69 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 165.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 t0 65.19 38.18 6.14 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.685 1.994 . . . . 0.0 112.578 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.44 -155.13 24.38 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.962 1.268 . . . . 0.0 111.801 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.75 110.06 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.658 2.239 . . . . 0.0 106.448 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.32 -70.5 0.23 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.028 0.823 . . . . 0.0 111.141 -166.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.92 21.44 36.2 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 118.476 1.138 . . . . 0.0 110.843 -162.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -75.52 -176.12 3.09 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 156.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.25 153.33 29.86 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.553 1.141 . . . . 0.0 108.363 166.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 4' ' ' SER . . . -129.69 170.85 13.29 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.36 1.864 . . . . 0.0 107.626 163.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.513 ' CG2' ' HB1' ' A' ' 36' ' ' ALA . 16.6 m -152.77 145.78 24.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 163.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -112.61 149.36 32.91 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 102.134 -3.284 . . . . 0.0 102.134 166.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 141.72 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 167.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.17 113.0 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -82.19 114.01 20.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 167.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.42 51.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -141.63 -54.22 0.46 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.4 153.02 34.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.729 0.812 . . . . 0.0 109.914 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.96 -134.37 11.65 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.366 0.984 . . . . 0.0 111.144 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.66 3.3 50.34 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.186 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.95 156.19 20.38 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -173.02 157.67 3.57 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 129.505 3.122 . . . . 0.0 107.599 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.15 153.62 3.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.0 mt -140.32 79.29 21.4 Favored Pre-proline 0 N--CA 1.445 -0.699 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -161.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.9 144.27 76.2 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.502 2.135 . . . . 0.0 110.331 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 47.09 24.47 0.4 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.761 2.024 . . . . 0.0 115.138 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -71.77 161.45 30.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.359 1.076 . . . . 0.0 111.479 -161.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.46 -15.73 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.632 1.973 . . . . 0.0 110.71 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -53.83 130.24 36.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.05 -176.03 2.82 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 165.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.54 152.45 45.54 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.82 0.848 . . . . 0.0 109.447 -174.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.15 -41.02 59.15 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.306 1.042 . . . . 0.0 109.516 -174.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -136.18 174.81 10.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.833 2.053 . . . . 0.0 107.889 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.485 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 23.7 m -155.35 122.71 5.55 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 tt -83.52 152.31 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.8 m -120.71 141.7 50.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.888 -1.133 . . . . 0.0 108.998 159.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.56 -103.41 0.2 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 163.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.21 159.25 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 130.56 3.544 . . . . 0.0 105.473 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -54.61 -41.2 69.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.834 0.854 . . . . 0.0 111.211 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 t -60.81 -21.23 62.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.632 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.32 -64.06 1.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.788 0.835 . . . . 0.0 109.387 172.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.771 ' CE2' HG22 ' A' ' 39' ' ' VAL . 95.9 m-85 -55.85 -53.32 58.2 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.861 0.865 . . . . 0.0 110.299 -171.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 tp -55.1 -54.72 39.6 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.54 -41.91 77.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.108 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -54.84 -65.02 0.65 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.776 0.716 . . . . 0.0 110.144 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.481 ' HG3' HG13 ' A' ' 12' ' ' VAL 0.275 0.0 OUTLIER -69.34 -28.36 66.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.825 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.7 m -74.47 -12.21 60.43 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.599 1.091 . . . . 0.0 112.102 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.04 19.97 29.47 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 119.589 1.086 . . . . 0.0 113.656 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -106.23 -24.3 12.35 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.428 1.491 . . . . 0.0 112.768 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.1 ttm 48.0 178.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 128.64 2.776 . . . . 0.0 114.86 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.91 154.89 29.68 Favored Pre-proline 0 C--O 1.241 0.625 0 C-N-CA 127.483 2.313 . . . . 0.0 105.732 173.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.64 43.2 1.48 Allowed 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.084 2.522 . . . . 0.0 112.699 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 48.68 78.43 0.09 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 128.547 2.739 . . . . 0.0 112.091 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.53 -43.13 1.24 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.188 2.595 . . . . 0.0 113.22 -172.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -44.91 -48.41 11.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 126.722 2.009 . . . . 0.0 112.955 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.7 t80 37.33 -150.81 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 130.128 3.371 . . . . 0.0 115.141 164.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -68.42 -7.16 29.22 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.396 1.078 . . . . 0.0 112.045 162.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -72.14 -47.07 53.78 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.107 0.867 . . . . 0.0 108.942 -169.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.46 66.47 1.51 Allowed Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.646 ' O ' HD23 ' A' ' 99' ' ' LEU . 3.6 mtpt -75.11 49.25 0.44 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.255 1.022 . . . . 0.0 108.425 164.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 98' ' ' LYS . 2.3 pt? 36.77 32.74 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.447 2.699 . . . . 0.0 113.447 -167.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.561 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -65.48 138.18 57.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -165.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.485 ' CG2' ' H ' ' A' ' 72' ' ' THR 0.314 1.2 mp -106.55 178.15 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 165.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.5 p -147.03 160.35 42.48 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 127.527 2.331 . . . . 0.0 105.135 162.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.25 -13.05 12.47 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.971 -0.905 . . . . 0.0 112.905 167.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -146.67 157.62 43.74 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.125 1.462 . . . . 0.0 109.172 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.5 mmm -62.71 134.51 56.42 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.415 1.886 . . . . 0.0 108.202 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.29 21.41 68.34 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.826 -0.43 . . . . 0.0 113.347 170.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.74 -21.96 65.26 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.613 1.206 . . . . 0.0 113.052 -172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.09 -38.95 18.51 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.61 0.764 . . . . 0.0 110.425 -172.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.05 63.69 1.35 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' HE2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -76.28 -66.5 0.79 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.052 -1.03 . . . . 0.0 110.442 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.38 161.75 19.12 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.414 1.886 . . . . 0.0 108.989 175.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -71.6 -42.23 67.95 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -11.8 51.09 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.463 -1.398 . . . . 0.0 113.945 -173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.7 tp -77.92 -30.71 50.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.725 1.21 . . . . 0.0 110.789 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.405 ' C ' HD23 ' A' ' 116' ' ' LEU . 18.4 mt-30 -134.99 44.48 2.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.508 1.923 . . . . 0.0 108.987 -165.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 116' ' ' LEU 0.307 0.4 OUTLIER 37.73 -175.83 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 129.494 3.118 . . . . 0.0 114.121 -178.523 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -134.42 143.43 46.79 Favored Pre-proline 0 N--CA 1.447 -0.619 0 O-C-N 119.012 -2.305 . . . . 0.0 108.823 -158.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.41 174.05 13.2 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.218 1.279 . . . . 0.0 109.767 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.45 -161.92 8.99 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 124.319 0.961 . . . . 0.0 111.019 -168.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -85.72 -29.1 24.18 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.123 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 39.83 -151.22 0.01 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 127.452 2.301 . . . . 0.0 113.159 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -175.46 160.31 2.54 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 130.865 3.666 . . . . 0.0 106.097 145.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . 0.28 1.3 pt? . . . . . 0 C--O 1.26 1.61 0 C-N-CA 127.812 2.445 . . . . 0.0 111.834 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 120.754 0.312 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 m -98.43 -172.2 2.28 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.321 1.448 . . . . 0.0 109.731 -174.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 35.02 69.73 0.16 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.12 2.168 . . . . 0.0 113.259 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.1 t -81.5 -44.89 16.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.896 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 48.48 23.0 0.54 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.114 2.165 . . . . 0.0 113.109 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.28 3.66 58.23 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.871 1.701 . . . . 0.0 112.031 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CE2' ' HA3' ' A' ' 42' ' ' GLY . 2.3 m-30 -68.0 148.68 50.7 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 108.926 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -60.19 -21.99 62.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.308 0.643 . . . . 0.0 112.663 169.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.22 -2.58 0.11 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.88 2.072 . . . . 0.0 114.505 170.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -54.75 -51.87 64.32 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.931 1.242 . . . . 0.0 111.352 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.622 HD22 ' C ' ' A' ' 11' ' ' LEU 0.294 0.0 OUTLIER -58.9 -36.34 74.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.325 1.05 . . . . 0.0 112.241 178.274 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG13 ' HG3' ' A' ' 84' ' ' MET . 3.4 t -59.15 -51.76 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.493 1.042 . . . . 0.0 110.848 -175.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.745 ' HA ' HD12 ' A' ' 16' ' ' ILE . 71.8 m-85 -74.94 -14.72 60.67 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.989 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -74.62 -35.84 62.93 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 117.611 -1.185 . . . . 0.0 111.635 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.729 ' HG3' HD21 ' A' ' 116' ' ' LEU . 67.3 mm-40 -57.36 -29.06 63.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.995 1.27 . . . . 0.0 112.795 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 13' ' ' PHE . 64.8 mt -65.48 -56.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.453 1.901 . . . . 0.0 108.603 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.57 -47.44 63.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 110.609 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.71 -38.98 93.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.088 1.355 . . . . 0.0 109.825 -171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -69.32 -36.81 77.35 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.435 -0.79 . . . . 0.0 110.445 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -33.17 75.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.706 1.202 . . . . 0.0 112.188 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.83 -53.35 52.13 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.806 -1.184 . . . . 0.0 110.16 167.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.64 -42.55 83.66 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.289 0.949 . . . . 0.0 112.648 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -160.27 40.34 0.18 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.0 -18.77 80.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.979 -172.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.28 -52.83 2.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.941 1.371 . . . . 0.0 111.529 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.16 77.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.456 0.646 . . . . 0.0 109.798 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -69.16 -29.25 67.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -53.75 -52.51 33.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.398 0.999 . . . . 0.0 108.699 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -62.18 -24.22 67.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.45 1.477 . . . . 0.0 113.641 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -67.64 -29.92 69.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 120.039 1.291 . . . . 0.0 112.175 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.34 -61.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.739 1.216 . . . . 0.0 108.533 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.54 64.48 3.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 125.79 1.662 . . . . 0.0 109.794 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.29 45.34 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 117.955 0.878 . . . . 0.0 113.809 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.37 138.29 24.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 158.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -135.37 164.49 27.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 117.858 0.299 . . . . 0.0 110.726 163.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.0 167.75 9.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.915 1.286 . . . . 0.0 109.715 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.483 ' H ' HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -132.8 99.23 4.54 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -170.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -87.34 94.02 9.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.215 1.371 . . . . 0.0 110.607 -165.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.82 115.0 38.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.375 0.607 . . . . 0.0 109.787 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -115.29 174.14 6.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.922 1.289 . . . . 0.0 109.464 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.7 t0 44.13 47.23 7.49 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.165 0.916 . . . . 0.0 112.879 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA3' ' CE2' ' A' ' 7' ' ' PHE . . . -69.71 173.27 37.97 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-O 118.564 -1.131 . . . . 0.0 111.834 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.25 94.16 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.818 3.012 . . . . 0.0 109.894 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.77 -3.48 14.89 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 126.674 2.083 . . . . 0.0 114.116 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.35 13.8 70.07 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 120.368 2.084 . . . . 0.0 112.284 160.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -85.79 -167.14 1.74 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.09 2.156 . . . . 0.0 108.502 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -134.11 147.76 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.854 1.661 . . . . 0.0 107.679 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.14 174.86 11.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.161 1.784 . . . . 0.0 108.122 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 37' ' ' PHE . 18.4 m -155.54 155.83 34.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.116 1.366 . . . . 0.0 108.655 169.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.31 154.68 36.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 t -122.49 114.61 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.8 t -95.38 112.55 27.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.83 115.37 20.29 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.65 47.31 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 168.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.97 -49.92 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.513 1.525 . . . . 0.0 109.715 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -95.27 151.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.303 1.041 . . . . 0.0 108.208 -172.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.11 -131.09 44.86 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -111.79 13.14 21.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.429 1.892 . . . . 0.0 109.717 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 156.66 29.45 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.7 m -172.62 161.56 4.92 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 128.182 2.593 . . . . 0.0 105.776 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -104.29 127.7 58.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -107.6 93.37 10.04 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 125.539 1.535 . . . . 0.0 108.061 -162.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.58 137.55 64.9 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.727 1.618 . . . . 0.0 110.297 -165.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.24 44.6 15.96 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.597 3.159 . . . . 0.0 109.06 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.69 147.01 53.9 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.916 0.865 . . . . 0.0 111.205 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.29 -24.68 39.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.547 158.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -60.43 117.12 4.86 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.157 0.979 . . . . 0.0 108.603 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -72.21 -177.17 2.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.996 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.15 163.95 30.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.553 1.168 . . . . 0.0 111.542 -163.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -37.19 59.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.115 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.17 -178.85 5.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.273 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -139.03 -176.01 4.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.272 1.429 . . . . 0.0 108.123 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt -142.62 157.37 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 120.911 -1.118 . . . . 0.0 109.285 159.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 m -98.03 124.4 42.51 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 168.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.1 mtt -152.03 124.31 8.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 163.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.81 155.74 4.12 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.982 -0.449 . . . . 0.0 110.931 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -52.47 -49.59 64.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 110.871 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 t -65.4 -9.87 28.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.812 1.645 . . . . 0.0 111.603 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.17 -54.67 3.34 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.757 168.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -48.16 -54.34 13.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.081 0.855 . . . . 0.0 110.061 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.04 -51.08 62.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 125.818 1.647 . . . . 0.0 110.292 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.98 -24.77 66.36 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.052 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 7.6 mp -67.91 -82.16 0.03 OUTLIER 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 162.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.534 ' CE ' HD11 ' A' ' 16' ' ' ILE . 1.5 ptm -75.89 53.15 0.74 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.295 1.838 . . . . 0.0 114.321 -163.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.8 m -154.53 -19.57 0.12 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.371 2.668 . . . . 0.0 108.799 170.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.15 80.46 1.31 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -125.48 -66.33 0.95 Allowed 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 44.9 mtt -143.05 -6.66 0.84 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 5.2 m-80 38.27 63.61 3.75 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 119.577 1.081 . . . . 0.0 111.911 -165.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -68.82 -175.76 1.03 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.163 2.575 . . . . 0.0 110.884 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -142.52 91.56 2.33 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 168.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.31 -48.26 62.38 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -49.46 -33.43 14.22 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -90.33 -61.29 1.71 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -61.92 -63.55 1.22 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.241 1.417 . . . . 0.0 111.695 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.55 -34.54 78.13 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.74 37.58 61.34 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 11.24 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.191 1.796 . . . . 0.0 115.72 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 tp 49.76 82.35 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.734 2.414 . . . . 0.0 109.994 -166.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -68.18 141.69 55.92 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.859 166.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.273 21.8 mm -78.95 169.74 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.4 p -89.93 -154.31 0.32 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.759 2.024 . . . . 0.0 107.96 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.92 -51.2 0.82 Allowed Glycine 0 CA--C 1.507 -0.445 0 O-C-N 120.608 -1.307 . . . . 0.0 110.232 162.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -144.52 110.74 5.5 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 101.857 -3.386 . . . . 0.0 101.857 168.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 25.7 ptp -67.05 158.46 31.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.7 -2.09 87.85 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 117.84 -1.533 . . . . 0.0 114.108 172.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . 0.268 1.4 pp -75.08 61.38 1.09 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.664 2.232 . . . . 0.0 110.006 162.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.84 -81.58 0.19 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 162.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -150.46 34.42 0.63 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.164 0.893 . . . . 0.0 110.858 -168.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -75.8 -32.18 59.75 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.892 0.877 . . . . 0.0 113.313 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 163.54 12.47 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.86 0.864 . . . . 0.0 108.899 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . 0.267 0.6 OUTLIER -115.92 -85.37 0.62 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 118.164 -0.922 . . . . 0.0 109.256 -178.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -56.71 -3.77 0.13 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.445 2.298 . . . . 0.0 115.893 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.7 tp -57.47 -53.97 52.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 163.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.44 52.69 0.88 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.681 1.592 . . . . 0.0 110.666 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.729 HD21 ' HG3' ' A' ' 15' ' ' GLU . 9.0 mt 57.57 -174.84 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 122.221 1.01 . . . . 0.0 111.053 -170.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -105.8 137.15 19.25 Favored Pre-proline 0 N--CA 1.441 -0.88 0 C-N-CA 125.493 1.517 . . . . 0.0 111.578 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.14 174.53 12.29 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.536 2.157 . . . . 0.0 111.64 176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -137.6 134.09 6.78 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-O 118.761 -1.022 . . . . 0.0 110.673 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -168.59 65.26 0.07 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.333 1.053 . . . . 0.0 111.144 171.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.2 97.85 3.07 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 120.669 -1.27 . . . . 0.0 108.804 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.17 78.91 0.39 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.253 1.277 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -149.606 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.239 0.532 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -73.8 60.95 0.74 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.355 1.862 . . . . 0.0 110.8 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.56 175.09 10.21 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.952 1.701 . . . . 0.0 109.003 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.7 p -143.47 -155.98 0.65 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -163.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.4 t0 61.43 27.04 16.7 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.52 62.67 0.3 Allowed Glycine 0 CA--C 1.521 0.45 0 O-C-N 119.606 -1.933 . . . . 0.0 111.965 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.482 ' CE2' ' HA3' ' A' ' 42' ' ' GLY . 32.5 m-85 -152.32 143.47 23.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.017 1.408 . . . . 0.0 110.938 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -17.7 62.54 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.637 167.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.33 -13.47 0.9 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.857 1.663 . . . . 0.0 113.706 167.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -56.26 -34.09 66.07 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.541 1.064 . . . . 0.0 112.208 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.417 HD22 ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -83.82 -31.53 25.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 118.56 -0.733 . . . . 0.0 112.088 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.87 -62.97 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 124.286 1.034 . . . . 0.0 108.907 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' HA ' HD12 ' A' ' 16' ' ' ILE . 39.3 m-85 -67.51 -25.97 66.11 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.346 -174.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -73.03 -34.33 66.26 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.537 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.66 -30.2 70.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 120.406 1.457 . . . . 0.0 112.588 172.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 13' ' ' PHE . 24.3 mt -65.91 -52.99 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -56.38 -45.71 80.4 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.318 1.047 . . . . 0.0 112.303 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -59.81 -46.54 88.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.1 tpmt? -65.33 -39.34 92.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.795 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.35 -37.43 70.0 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.726 1.148 . . . . 0.0 113.63 171.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.1 -53.4 50.24 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.205 1.002 . . . . 0.0 110.542 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -59.43 -46.02 89.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.307 1.412 . . . . 0.0 111.369 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -164.9 65.06 0.13 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.457 1.123 . . . . 0.0 113.341 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.58 -20.57 79.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.048 1.309 . . . . 0.0 113.272 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.45 -36.93 67.1 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.811 1.305 . . . . 0.0 111.64 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.841 -1.162 . . . . 0.0 111.43 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -73.06 -25.8 61.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.432 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.24 -51.17 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.449 -0.786 . . . . 0.0 108.997 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.64 -37.34 75.73 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.801 1.182 . . . . 0.0 111.319 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -61.24 -65.76 0.64 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.626 0.77 . . . . 0.0 110.006 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mt -74.84 -66.87 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.51 66.24 2.53 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.819 1.2 . . . . 0.0 111.051 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.39 -175.79 37.64 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 171.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.93 134.62 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 158.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -137.18 167.52 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.127 -0.983 . . . . 0.0 109.284 171.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 141.15 47.19 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.921 0.782 . . . . 0.0 112.864 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -87.26 103.78 15.77 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.142 0.977 . . . . 0.0 109.832 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -74.09 95.79 2.61 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 119.54 1.064 . . . . 0.0 109.764 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.14 108.9 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.28 179.25 4.21 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.679 1.191 . . . . 0.0 108.322 164.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.2 t70 49.51 42.79 23.28 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.631 1.172 . . . . 0.0 110.724 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.482 ' HA3' ' CE2' ' A' ' 7' ' ' PHE . . . -66.86 168.63 36.19 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.148 -1.362 . . . . 0.0 110.413 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.18 92.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.829 3.019 . . . . 0.0 113.324 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.93 3.34 51.99 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.718 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.02 40.99 1.34 Allowed Glycine 0 C--N 1.339 0.734 0 CA-C-N 120.61 2.205 . . . . 0.0 111.307 164.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.04 -176.98 6.18 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.535 -0.979 . . . . 0.0 111.086 174.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -147.67 140.65 24.96 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.589 2.355 . . . . 0.0 107.381 163.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.25 166.33 30.24 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.3 m -143.88 147.73 34.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -122.44 132.81 54.53 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.97 151.29 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -126.66 104.84 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -84.85 105.16 15.42 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.34 55.18 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.839 0.745 . . . . 0.0 109.391 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -155.12 -43.66 0.08 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.674 1.19 . . . . 0.0 111.194 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -95.92 110.26 22.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.41 1.484 . . . . 0.0 107.557 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.49 -153.6 39.15 Favored Glycine 0 N--CA 1.46 0.261 0 O-C-N 119.882 -1.761 . . . . 0.0 111.618 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -5.45 57.02 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.771 0.828 . . . . 0.0 112.614 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.28 157.68 30.12 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-O 122.238 0.91 . . . . 0.0 110.973 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.84 165.41 6.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 130.125 3.37 . . . . 0.0 107.905 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.89 89.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 120.747 -1.221 . . . . 0.0 107.945 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mt -73.66 103.58 0.88 Allowed Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -164.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.94 143.83 41.73 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.678 1.585 . . . . 0.0 110.14 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 47.7 23.77 0.47 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.941 2.496 . . . . 0.0 113.427 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.8 t -78.49 149.21 33.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.405 0.621 . . . . 0.0 110.211 -153.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.55 -2.47 58.18 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.625 1.97 . . . . 0.0 111.183 168.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.09 130.57 46.7 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 155.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.8 -177.28 1.9 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.28 159.34 39.39 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.983 1.713 . . . . 0.0 107.722 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -35.87 73.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.61 -167.19 2.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.519 1.528 . . . . 0.0 110.794 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 m -133.28 -176.62 4.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.766 1.226 . . . . 0.0 109.578 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tt -142.37 143.55 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.065 -1.022 . . . . 0.0 108.774 151.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 m -84.64 138.91 32.42 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.6 tpp -136.17 -57.88 0.75 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.308 1.413 . . . . 0.0 110.466 149.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.69 152.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 130.433 3.493 . . . . 0.0 111.634 -157.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.13 -48.62 75.37 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 123.717 0.807 . . . . 0.0 110.403 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 p -66.29 -5.34 10.16 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.751 1.22 . . . . 0.0 111.688 -175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 -47.87 3.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 161.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -55.81 -52.12 65.08 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.813 1.642 . . . . 0.0 110.179 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tp -55.12 -41.9 72.28 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.187 1.795 . . . . 0.0 112.606 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.82 79.92 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.776 0.43 . . . . 0.0 111.578 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -68.59 -76.14 0.1 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.055 1.742 . . . . 0.0 110.757 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.1 ptm -76.7 54.53 0.98 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.071 1.349 . . . . 0.0 113.902 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.0 p -155.25 -33.64 0.09 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.469 1.908 . . . . 0.0 110.446 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.85 78.04 1.19 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 125.986 1.755 . . . . 0.0 109.824 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -108.85 -46.01 3.7 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.313 1.445 . . . . 0.0 110.539 156.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -146.92 177.11 9.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.876 1.27 . . . . 0.0 113.603 -153.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -62.74 151.73 83.84 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.085 1.354 . . . . 0.0 112.056 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.17 163.97 22.31 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.385 2.723 . . . . 0.0 114.082 -171.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 59.63 80.84 0.19 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.821 2.048 . . . . 0.0 111.43 -165.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.4 m -41.28 -52.93 3.35 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.252 1.021 . . . . 0.0 113.033 170.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.17 67.76 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.817 -1.177 . . . . 0.0 113.956 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -64.63 -38.62 91.63 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -71.16 -78.22 0.08 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.4 1.88 . . . . 0.0 110.389 168.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -70.78 -18.9 62.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -157.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.97 49.33 72.24 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 120.564 -1.335 . . . . 0.0 112.896 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -105.21 56.03 0.69 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 128.264 2.626 . . . . 0.0 109.597 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.4 tp 33.53 73.06 0.07 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.686 2.394 . . . . 0.0 112.48 167.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 166.6 16.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 171.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.6 mp -129.83 159.56 41.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -172.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 46.54 -166.34 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.252 1.021 . . . . 0.0 111.775 -161.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 177.98 -24.88 0.05 OUTLIER Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.39 -1.444 . . . . 0.0 112.272 174.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.8 t30 52.41 -174.69 0.03 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.088 2.155 . . . . 0.0 110.624 -170.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -72.5 80.82 1.07 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 164.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.0 73.24 0.38 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 126.452 1.977 . . . . 0.0 111.645 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -64.17 -40.24 95.71 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 118.194 0.997 . . . . 0.0 111.399 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.02 -61.53 2.48 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 118.403 -0.808 . . . . 0.0 108.874 -166.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 68.9 mmm 24.87 -70.37 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 130.081 3.353 . . . . 0.0 117.004 167.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -71.04 -49.58 43.3 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.082 1.31 . . . . 0.0 110.787 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.252 2.2 pp 34.8 4.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.948 1 C-N-CA 134.123 4.969 . . . . 0.0 119.753 177.599 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -88.92 -87.66 0.16 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 121.024 1.738 . . . . 0.0 106.704 -166.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -70.34 -3.89 19.59 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.582 -1.323 . . . . 0.0 112.561 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.95 -21.53 59.99 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 120.931 -1.105 . . . . 0.0 110.418 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.82 53.1 1.49 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.064 0.945 . . . . 0.0 109.648 -167.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER 43.79 -173.46 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.044 1.737 . . . . 0.0 112.568 178.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.404 ' HG2' ' HD2' ' A' ' 118' ' ' PRO . 1.2 mt-30 -142.55 165.62 25.76 Favored Pre-proline 0 C--O 1.24 0.576 0 O-C-N 119.574 -1.954 . . . . 0.0 109.152 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 117' ' ' GLN . 41.1 Cg_endo -75.58 -170.71 0.86 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.795 2.33 . . . . 0.0 109.682 170.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.57 -94.2 1.59 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 105.56 -3.016 . . . . 0.0 105.56 -165.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.3 t30 55.35 76.75 0.25 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.372 1.069 . . . . 0.0 108.206 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.76 101.47 2.1 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -155.97 143.68 19.54 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 171.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.246 0.891 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 158.253 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.238 0.474 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.6 168.74 8.89 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 154.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.76 175.16 1.55 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.809 1.244 . . . . 0.0 111.02 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.8 m -154.01 -83.1 0.08 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 76.85 40.55 0.19 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.053 1.741 . . . . 0.0 109.034 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.57 35.48 0.38 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.761 1.172 . . . . 0.0 112.512 -174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.317 1.058 . . . . 0.0 110.349 173.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -54.15 -34.85 61.39 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.718 -0.614 . . . . 0.0 110.525 164.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.21 -10.96 1.42 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.584 -1.198 . . . . 0.0 114.206 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -60.61 -26.67 67.18 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.984 1.72 . . . . 0.0 110.969 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.536 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -81.56 -38.38 26.24 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.243 1.383 . . . . 0.0 112.039 169.642 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.81 -53.47 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 119.39 0.995 . . . . 0.0 110.591 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.427 ' HB3' ' CD1' ' A' ' 50' ' ' TRP . 84.9 m-85 -67.91 -22.59 65.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.136 -0.625 . . . . 0.0 111.353 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -75.1 -30.33 60.87 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.515 ' HB2' HD22 ' A' ' 116' ' ' LEU . 4.8 mm-40 -57.58 -46.52 83.89 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 118.375 0.534 . . . . 0.0 109.72 170.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 13' ' ' PHE . 61.9 mt -57.54 -50.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -52.62 -55.68 20.74 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 124.374 1.07 . . . . 0.0 111.5 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -55.19 -48.65 73.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.546 1.138 . . . . 0.0 108.375 -171.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -58.57 -48.96 79.16 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.642 175.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.19 70.22 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 175.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.328 59.2 mm-40 -66.2 -51.22 59.83 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 124.434 1.094 . . . . 0.0 110.828 171.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.37 -46.5 80.03 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.19 -0.944 . . . . 0.0 111.856 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -165.63 61.75 0.11 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.969 1.307 . . . . 0.0 109.456 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -24.01 72.58 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 118.609 -1.106 . . . . 0.0 111.963 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.43 -28.82 65.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.765 1.783 . . . . 0.0 113.596 -165.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.29 -25.47 16.32 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.488 2.715 . . . . 0.0 110.95 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.1 m-85 -73.77 -28.85 61.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.724 2.01 . . . . 0.0 110.39 172.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -53.23 -44.34 52.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.585 1.154 . . . . 0.0 109.029 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -61.87 -27.78 69.04 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.622 ' HE3' HD13 ' A' ' 111' ' ' LEU . 57.6 mmtt -71.04 -28.85 64.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.844 1.202 . . . . 0.0 112.277 -167.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.76 -59.01 3.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.3 73.96 0.51 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.739 1.161 . . . . 0.0 110.343 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.56 177.09 45.27 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.896 0.848 . . . . 0.0 112.148 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.56 147.36 6.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 144.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -138.27 176.25 8.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 154.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.24 174.53 7.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.551 156.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -116.38 122.69 45.58 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.588 1.555 . . . . 0.0 107.836 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -100.05 104.93 16.54 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 121.12 1.782 . . . . 0.0 106.628 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.58 94.52 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -162.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -94.53 177.73 5.83 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.869 -1.145 . . . . 0.0 108.414 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 40.8 t0 60.31 33.3 20.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.344 1.057 . . . . 0.0 111.601 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.46 174.6 38.25 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-O 118.409 -1.217 . . . . 0.0 111.381 170.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.7 95.66 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.508 2.805 . . . . 0.0 110.528 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.69 -16.57 4.78 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 127.122 2.296 . . . . 0.0 112.871 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.28 3.72 88.65 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 118.919 1.359 . . . . 0.0 112.086 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -69.5 -174.78 0.73 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.312 2.645 . . . . 0.0 109.444 170.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -126.91 168.74 14.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.079 0.552 . . . . 0.0 110.829 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.39 175.07 10.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.881 1.672 . . . . 0.0 109.338 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.0 m -149.75 149.09 30.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.256 1.022 . . . . 0.0 109.917 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 13' ' ' PHE . 1.2 m-90 -121.7 151.63 40.29 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 t -120.55 133.94 65.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 126.853 2.061 . . . . 0.0 105.985 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.85 114.5 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.15 114.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.97 54.97 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.34 -45.41 0.05 Allowed 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.166 1.386 . . . . 0.0 109.106 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -74.91 135.44 41.48 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 46.37 -133.19 11.0 Favored Glycine 0 C--N 1.333 0.362 0 O-C-N 123.69 0.618 . . . . 0.0 111.885 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.46 4.15 47.57 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.418 173.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.24 156.89 28.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-O 123.22 1.456 . . . . 0.0 110.212 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -172.31 144.4 1.56 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.005 2.922 . . . . 0.0 109.689 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.1 t -90.97 157.01 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mt -134.71 79.23 53.41 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -166.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.87 132.83 38.82 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.122 2.548 . . . . 0.0 110.81 -166.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.2 23.77 4.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.539 1.936 . . . . 0.0 111.891 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -82.69 145.91 29.35 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.449 -0.782 . . . . 0.0 110.104 -162.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -85.16 -9.45 57.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.748 1.619 . . . . 0.0 111.791 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -53.4 142.36 22.01 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.945 -1.097 . . . . 0.0 110.435 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -71.02 -175.58 1.18 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.587 0.708 . . . . 0.0 111.779 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.58 165.09 31.41 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.22 -62.49 1.55 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.562 1.145 . . . . 0.0 112.157 157.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -154.54 166.91 31.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.871 1.669 . . . . 0.0 108.991 -170.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -138.61 126.65 22.58 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.581 HD12 HD11 ' A' ' 107' ' ' LEU . 3.3 tt -82.53 165.48 2.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -172.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 m -102.35 126.37 49.34 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 164.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.505 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -157.82 132.07 8.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 158.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.21 154.39 39.94 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.456 1.102 . . . . 0.0 110.081 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -49.69 -48.59 49.56 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.535 1.534 . . . . 0.0 112.389 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -59.04 -24.99 63.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 110.948 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.38 -26.44 11.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.465 0.706 . . . . 0.0 110.89 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.505 ' CZ ' ' HG3' ' A' ' 75' ' ' MET . 66.1 m-85 -57.85 -57.97 10.44 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 158.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.47 -35.82 53.51 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.547 -0.72 . . . . 0.0 111.977 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.92 94.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mt -69.94 -67.1 0.51 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 110.107 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -50.7 15.18 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -167.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.1 m -74.43 -26.65 60.2 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.719 -1.238 . . . . 0.0 109.536 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.02 18.41 19.98 Favored Glycine 0 C--O 1.222 -0.595 0 CA-C-O 118.539 -1.145 . . . . 0.0 113.378 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -64.35 -8.09 11.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.216 2.008 . . . . 0.0 114.607 -171.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 32.0 mtp 64.4 112.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.642 2.377 . . . . 0.0 111.877 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -154.71 142.49 14.05 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.92 -178.89 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.863 1.709 . . . . 0.0 110.923 171.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.438 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 1.8 pm0 -57.48 92.76 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.048 1.339 . . . . 0.0 112.4 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.48 -35.17 78.64 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -164.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.0 72.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.603 1.161 . . . . 0.0 111.499 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -76.06 -44.11 40.59 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.785 0.834 . . . . 0.0 110.268 170.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -43.49 67.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.153 0.981 . . . . 0.0 111.667 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -85.21 10.59 11.94 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 118.947 0.794 . . . . 0.0 112.454 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.33 -24.73 1.37 Allowed Glycine 0 C--N 1.339 0.705 0 C-N-CA 126.467 1.984 . . . . 0.0 114.379 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -64.78 -15.7 62.02 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.942 1.297 . . . . 0.0 113.36 -167.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.627 ' HG ' ' H ' ' A' ' 100' ' ' LYS . 13.6 tp 66.62 -172.06 0.19 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.934 1.693 . . . . 0.0 108.657 -166.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.627 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 17.5 ptmt -143.12 129.91 20.42 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 130.631 3.573 . . . . 0.0 101.974 -162.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.511 HG22 ' H ' ' A' ' 102' ' ' THR . 3.0 mm -102.61 -154.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -157.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.511 ' H ' HG22 ' A' ' 101' ' ' ILE . 14.1 p 50.42 -134.41 1.53 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -174.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 168.29 -69.76 0.16 Allowed Glycine 0 C--O 1.225 -0.458 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 166.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 41.11 57.72 2.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.201 1.801 . . . . 0.0 112.295 163.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 51.6 ttm 48.01 63.16 2.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.161 2.184 . . . . 0.0 111.05 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.41 -26.94 1.04 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.628 2.061 . . . . 0.0 114.469 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.581 HD11 HD12 ' A' ' 73' ' ' ILE . 0.3 OUTLIER 40.93 18.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 131.133 3.773 . . . . 0.0 116.575 -176.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.05 -71.63 0.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.554 1.07 . . . . 0.0 110.771 -160.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 ttt -151.73 61.18 0.87 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -70.19 -5.68 29.09 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.136 0.974 . . . . 0.0 112.88 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.622 HD13 ' HE3' ' A' ' 30' ' ' LYS . 1.1 pt? -158.93 135.42 9.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.13 2.172 . . . . 0.0 105.617 166.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -59.94 -35.42 74.9 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -54.91 -28.52 51.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.124 0.97 . . . . 0.0 113.371 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.41 HD12 ' CE2' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -72.07 -5.01 32.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.339 0.972 . . . . 0.0 111.671 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -149.49 44.46 0.94 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 128.639 2.775 . . . . 0.0 109.58 -170.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 15' ' ' GLU 0.379 0.2 OUTLIER 44.45 -173.55 0.01 OUTLIER 'General case' 0 C--N 1.352 0.681 0 C-N-CA 127.348 2.259 . . . . 0.0 112.756 -179.848 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -92.2 115.21 64.28 Favored Pre-proline 0 CA--C 1.538 0.493 0 O-C-N 118.941 -2.349 . . . . 0.0 109.025 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.96 -179.9 5.43 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.262 2.642 . . . . 0.0 111.099 170.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.63 72.38 0.96 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.576 1.56 . . . . 0.0 109.838 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.06 145.94 29.83 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.91 101.13 2.57 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.453 1.479 . . . . 0.0 111.075 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt 44.65 -151.83 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.235 1.814 . . . . 0.0 111.305 173.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.819 0 CA-C-O 117.002 -1.475 . . . . 0.0 107.051 151.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 120.599 0.238 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 p 78.45 155.97 0.16 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 130.333 3.453 . . . . 0.0 112.583 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.57 95.8 0.01 OUTLIER 'General case' 0 C--N 1.345 0.37 0 C-N-CA 127.963 2.505 . . . . 0.0 111.798 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -135.77 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.112 2.565 . . . . 0.0 111.905 -173.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.55 22.58 13.02 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 119.452 -2.03 . . . . 0.0 113.544 167.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.06 68.56 0.42 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 125.225 1.393 . . . . 0.0 111.025 -163.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.807 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 76.5 m-85 -153.42 159.87 42.47 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.727 2.011 . . . . 0.0 107.34 -168.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.71 -34.6 73.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 167.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.21 -10.5 0.37 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.805 2.042 . . . . 0.0 114.607 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -55.16 -52.52 63.05 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 120.347 1.43 . . . . 0.0 111.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.443 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -65.22 -33.63 76.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.434 -179.844 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.66 -54.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.144 0.884 . . . . 0.0 110.248 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 16' ' ' ILE . 72.6 m-85 -68.95 -23.19 64.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.261 0.482 . . . . 0.0 111.646 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -37.57 80.99 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 116.591 -1.671 . . . . 0.0 111.835 173.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -65.45 -38.16 89.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.678 1.581 . . . . 0.0 111.256 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 13' ' ' PHE . 60.0 mt -52.86 -47.91 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 61' ' ' VAL . 19.7 tt0 -64.51 -43.04 95.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.886 0.474 . . . . 0.0 111.826 175.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -63.18 -42.95 99.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -60.16 -35.71 75.94 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.142 -0.974 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.29 -27.26 62.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -63.86 -54.05 41.07 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.19 -0.944 . . . . 0.0 109.079 163.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.06 -43.81 98.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.648 0.779 . . . . 0.0 110.05 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -165.09 64.9 0.12 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.408 1.483 . . . . 0.0 109.064 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.89 -17.28 79.3 Favored Glycine 0 CA--C 1.519 0.334 0 O-C-N 120.959 -1.088 . . . . 0.0 113.166 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.517 ' CB ' ' HE3' ' A' ' 58' ' ' LYS . 5.9 pt-20 -58.21 -33.98 69.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.99 0.895 . . . . 0.0 112.197 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -79.98 -39.35 30.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.775 1.63 . . . . 0.0 109.463 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.39 -29.53 70.82 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.27 -52.25 53.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 CA-C-N 119.214 0.916 . . . . 0.0 110.6 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -68.41 -18.04 64.35 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.299 -0.876 . . . . 0.0 112.621 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -72.55 -69.49 0.4 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 120.333 1.424 . . . . 0.0 109.195 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.32 -54.84 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -171.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.29 65.01 3.43 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.06 158.07 21.91 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 167.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.27 137.51 22.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 159.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -132.41 168.81 17.49 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.661 -0.649 . . . . 0.0 109.426 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.06 158.87 26.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.33 1.052 . . . . 0.0 109.686 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' THR . 73.2 m-85 -108.09 113.39 26.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 125.503 1.521 . . . . 0.0 108.629 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.27 117.3 23.46 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.34 1.882 . . . . 0.0 114.181 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.67 101.28 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -109.45 -169.96 1.57 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 165.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t0 54.12 39.28 30.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.822 2.049 . . . . 0.0 111.917 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -66.22 176.55 17.68 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.721 173.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.88 -8.04 12.77 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.451 2.1 . . . . 0.0 114.119 -174.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.69 4.84 19.1 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.629 1.585 . . . . 0.0 114.617 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.04 2.61 77.57 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 120.179 1.989 . . . . 0.0 112.805 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -85.57 -171.77 3.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.062 2.945 . . . . 0.0 110.164 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.45 150.5 39.1 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.807 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -130.87 162.77 28.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 131.528 3.931 . . . . 0.0 107.498 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 37' ' ' PHE . 1.3 m -154.91 140.94 18.36 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 161.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -112.19 154.72 25.11 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 170.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.1 t -118.93 122.49 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.13 109.97 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 107.681 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -85.4 48.52 1.59 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.077 1.351 . . . . 0.0 112.242 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 m -75.74 53.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 119.998 -1.689 . . . . 0.0 110.977 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.06 -46.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.226 1.81 . . . . 0.0 108.908 174.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.4 143.19 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -168.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.54 -131.57 51.18 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HE3' ' CB ' ' A' ' 25' ' ' GLU . 2.8 mmmt -97.94 5.18 49.2 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.351 1.06 . . . . 0.0 111.346 168.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.77 157.8 20.33 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 119.885 1.22 . . . . 0.0 110.637 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.8 m -171.54 162.49 6.52 Favored 'General case' 0 N--CA 1.442 -0.844 1 C-N-CA 132.386 4.274 . . . . 0.0 105.201 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 17' ' ' GLU . 12.0 t -109.94 157.41 10.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 170.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 mt -129.03 122.55 21.34 Favored Pre-proline 0 N--CA 1.441 -0.897 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -89.74 145.45 4.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.787 2.991 . . . . 0.0 108.849 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 35.49 41.23 0.09 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.088 1.755 . . . . 0.0 114.039 -171.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -68.25 148.9 50.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.722 0.809 . . . . 0.0 109.098 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -86.19 -20.24 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.402 1.081 . . . . 0.0 111.303 163.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -52.3 125.06 14.84 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -62.44 -177.45 0.14 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.165 0.983 . . . . 0.0 109.036 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.36 149.06 33.05 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.609 1.164 . . . . 0.0 109.997 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -43.45 51.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.812 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.3 m -127.27 174.23 9.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.511 1.924 . . . . 0.0 109.136 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.9 m -133.75 -169.68 2.35 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.594 ' H ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -155.37 154.67 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 169.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 m -121.64 128.4 51.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.6 mtm -136.27 -29.15 1.0 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 117.367 -1.301 . . . . 0.0 111.718 165.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.81 153.6 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.872 1.269 . . . . 0.0 109.517 -166.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 10.1 t70 -54.47 -44.06 72.24 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.382 1.473 . . . . 0.0 111.216 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.0 t -56.81 -39.31 73.91 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.068 2.547 . . . . 0.0 109.925 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.19 -42.39 10.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.079 -0.486 . . . . 0.0 110.522 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.39 -52.32 62.05 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.34 1.056 . . . . 0.0 110.489 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.39 -53.45 56.49 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.68 -19.26 15.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.612 0.765 . . . . 0.0 113.054 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -79.81 0.05 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 171.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -30.33 59.85 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -166.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.1 m -74.71 -12.58 60.46 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.188 1.358 . . . . 0.0 110.542 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.06 73.56 1.18 Allowed Glycine 0 C--N 1.34 0.771 0 O-C-N 120.995 -1.066 . . . . 0.0 112.132 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -136.35 -25.37 1.18 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.492 0.717 . . . . 0.0 112.677 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.4 mmt -128.89 161.0 30.88 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.968 1.307 . . . . 0.0 109.327 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.14 128.88 58.26 Favored Pre-proline 0 C--O 1.236 0.381 0 C-N-CA 124.621 1.168 . . . . 0.0 108.527 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.49 44.56 1.73 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.349 2.7 . . . . 0.0 112.324 -167.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -149.55 41.09 0.86 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.481 1.113 . . . . 0.0 110.248 -165.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -53.7 34.9 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.906 -1.122 . . . . 0.0 111.21 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.839 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . . . -51.68 -12.62 0.19 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -101.23 -57.14 2.15 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.666 2.387 . . . . 0.0 109.576 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -70.58 -60.43 2.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.075 1.75 . . . . 0.0 110.756 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -40.04 94.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.689 1.595 . . . . 0.0 109.759 170.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.87 17.58 79.99 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 121.336 -0.853 . . . . 0.0 113.621 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -64.01 -6.68 6.67 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.31 1.555 . . . . 0.0 113.657 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.8 tp 44.59 62.33 2.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.863 1.265 . . . . 0.0 109.417 -163.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.839 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 10.6 pttp -64.41 139.9 58.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 168.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.536 ' CG2' ' H ' ' A' ' 102' ' ' THR 0.321 33.4 mm -77.45 -172.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.722 -176.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.536 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -153.09 153.09 32.12 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.269 1.828 . . . . 0.0 106.488 -167.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.38 -90.65 1.2 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -159.63 172.89 16.97 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.062 0.945 . . . . 0.0 109.731 169.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 47.84 89.67 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.819 2.447 . . . . 0.0 113.92 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.12 -65.93 2.25 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.755 1.645 . . . . 0.0 113.192 160.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 108' ' ' ALA 0.276 1.2 pp 34.01 -78.41 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.109 1 C-N-CA 132.346 4.258 . . . . 0.0 114.48 174.96 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.616 ' H ' ' HG ' ' A' ' 107' ' ' LEU . . . -58.1 -46.17 85.98 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 128.701 2.8 . . . . 0.0 110.234 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 33.2 ttm -82.1 -34.32 29.36 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 124.307 1.004 . . . . 0.0 111.133 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.75 46.05 0.35 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.877 1.671 . . . . 0.0 111.397 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.15 79.87 5.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.067 1.347 . . . . 0.0 109.572 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . 0.252 2.6 mt-30 -116.25 -68.06 0.95 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -98.53 -51.4 3.95 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.579 1.552 . . . . 0.0 114.76 166.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.47 -56.19 18.98 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.728 0.811 . . . . 0.0 109.294 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -91.12 44.88 1.21 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.976 0.51 . . . . 0.0 110.49 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 116' ' ' LEU . 10.6 mt 49.88 -177.32 0.01 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.571 1.548 . . . . 0.0 112.933 -170.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.32 115.48 63.77 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 126.68 1.992 . . . . 0.0 109.265 -170.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.16 174.63 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.034 2.49 . . . . 0.0 112.909 -169.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.39 88.68 0.52 Allowed Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.002 1.287 . . . . 0.0 111.012 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -64.37 151.76 43.16 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 162.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 35.63 82.08 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.23 2.212 . . . . 0.0 113.336 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -143.25 175.97 9.49 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.059 1.344 . . . . 0.0 108.267 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 C--O 1.254 1.299 0 C-N-CA 123.838 0.855 . . . . 0.0 110.277 177.299 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -152.22 -179.76 7.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.507 1.523 . . . . 0.0 109.403 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.06 148.07 26.6 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.025 1.33 . . . . 0.0 107.888 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m -150.61 -16.24 0.23 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.271 0.1 OUTLIER 57.51 23.99 9.79 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.27 74.87 0.29 Allowed Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.243 -1.535 . . . . 0.0 111.492 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -153.87 158.74 41.22 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.606 1.562 . . . . 0.0 109.955 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -75.05 -13.34 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.841 165.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.86 -30.25 5.59 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.585 1.084 . . . . 0.0 112.575 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -51.27 -48.48 62.19 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 127.135 2.174 . . . . 0.0 110.479 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.83 -31.43 71.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.191 1.396 . . . . 0.0 110.859 -174.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 t -90.63 -45.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.222 2.609 . . . . 0.0 110.989 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -65.14 -37.34 87.1 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.093 0.861 . . . . 0.0 111.797 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -52.25 -37.1 54.4 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 170.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.69 -41.27 96.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 118.921 0.782 . . . . 0.0 110.906 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.17 -51.68 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.29 -43.71 83.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.807 1.643 . . . . 0.0 112.768 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -65.32 -51.46 60.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -59.58 -38.97 82.59 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.317 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.48 -37.95 71.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.52 -53.38 43.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.29 -0.881 . . . . 0.0 111.938 165.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -55.21 -43.93 74.93 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.041 1.336 . . . . 0.0 112.136 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -165.42 65.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.621 2.768 . . . . 0.0 108.525 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.89 -25.66 75.36 Favored Glycine 0 CA--C 1.518 0.224 0 O-C-N 120.691 -1.256 . . . . 0.0 112.319 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -44.22 62.44 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.952 0.876 . . . . 0.0 111.58 -176.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -77.43 -22.66 51.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 121.426 -0.796 . . . . 0.0 110.815 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -77.17 -29.04 54.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.9 t -55.47 -38.83 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.153 0.888 . . . . 0.0 109.417 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -69.48 -11.17 60.61 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.53 -1.356 . . . . 0.0 114.013 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -78.07 -61.7 1.91 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 121.405 1.911 . . . . 0.0 111.199 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.77 -58.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.02 62.64 4.55 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 126.756 2.122 . . . . 0.0 112.724 -170.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.54 164.38 34.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 125.275 1.417 . . . . 0.0 110.657 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.03 128.36 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 159.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -129.82 159.36 36.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 110.899 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.74 166.67 10.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.135 1.374 . . . . 0.0 109.212 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.485 ' H ' HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -130.09 91.92 3.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -172.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -78.84 104.41 9.45 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.307 0.958 . . . . 0.0 109.073 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.59 103.5 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.3 ptmm? -92.83 -171.03 2.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.8 t0 62.22 51.62 3.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 123.23 1.491 . . . . 0.0 111.333 148.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.87 -162.64 11.78 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 126.849 2.166 . . . . 0.0 109.627 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.9 85.84 0.62 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 124.053 3.169 . . . . 0.0 110.619 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.13 -20.87 4.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.826 1.679 . . . . 0.0 113.467 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.07 22.67 65.22 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 120.035 1.917 . . . . 0.0 111.285 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -79.06 -169.58 1.88 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.318 1.447 . . . . 0.0 108.409 168.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 34.6 tt0 -130.0 141.67 50.72 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.573 0.749 . . . . 0.0 109.378 170.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.97 160.98 14.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.016 2.527 . . . . 0.0 107.721 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 37' ' ' PHE . 91.5 m -140.05 142.56 36.17 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 147.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.1 140.83 47.54 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 161.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.13 142.16 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.51 113.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 42.49 1.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.848 1.659 . . . . 0.0 112.197 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 20' ' ' LEU . 1.9 m -74.63 60.37 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.822 1.249 . . . . 0.0 111.117 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -148.99 -46.14 0.14 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.234 1.814 . . . . 0.0 109.584 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -82.08 142.31 32.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.12 -127.71 25.36 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.953 0.797 . . . . 0.0 113.119 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -92.55 1.44 57.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.606 1.162 . . . . 0.0 111.909 170.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.12 157.83 15.33 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 120.185 1.357 . . . . 0.0 110.263 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.2 m -171.17 165.64 7.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 129.461 3.104 . . . . 0.0 108.509 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -107.96 156.12 8.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.086 1.754 . . . . 0.0 109.039 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -142.23 75.08 20.34 Favored Pre-proline 0 N--CA 1.441 -0.904 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 -162.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -63.18 140.07 75.83 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.357 2.038 . . . . 0.0 109.531 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 51.43 23.56 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.709 1.603 . . . . 0.0 114.132 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 t -79.22 144.5 34.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.485 0.659 . . . . 0.0 111.406 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.52 8.36 3.59 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 126.021 1.728 . . . . 0.0 111.057 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.91 135.22 57.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.437 -2.039 . . . . 0.0 109.546 162.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -66.95 -173.34 0.24 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.535 1.534 . . . . 0.0 109.482 168.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 165.85 33.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.293 1.037 . . . . 0.0 109.907 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.08 -50.32 16.78 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.068 160.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 84.4 m -134.83 -178.65 5.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.891 0.769 . . . . 0.0 111.461 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.645 HG22 ' H ' ' A' ' 73' ' ' ILE . 14.1 m -149.2 -164.66 2.08 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.645 ' H ' HG22 ' A' ' 72' ' ' THR . 5.6 tt -150.75 165.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 125.566 1.546 . . . . 0.0 107.159 161.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.555 ' H ' ' HA ' ' A' ' 100' ' ' LYS . 72.9 m -121.48 136.23 54.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.181 161.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.05 -98.33 0.15 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 152.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 178.0 152.24 0.27 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.755 3.222 . . . . 0.0 106.992 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.17 -40.59 90.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.796 1.638 . . . . 0.0 110.159 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.4 p -58.68 -22.77 57.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.771 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -105.72 -40.79 5.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.661 1.184 . . . . 0.0 109.982 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -53.99 50.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.342 1.457 . . . . 0.0 111.904 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -54.66 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.03 -12.9 58.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.896 -1.526 . . . . 0.0 114.043 -168.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.55 -76.33 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.765 1.626 . . . . 0.0 108.996 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -34.97 79.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 m -74.52 -10.76 59.87 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.681 -0.637 . . . . 0.0 109.881 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.8 20.47 61.37 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-O 118.494 -1.17 . . . . 0.0 114.116 154.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -100.29 -64.97 1.0 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.705 1.253 . . . . 0.0 111.246 -169.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 11.4 mtt -155.82 102.37 2.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.358 1.063 . . . . 0.0 108.139 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -134.31 54.66 12.48 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 125.63 1.572 . . . . 0.0 109.709 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -62.67 149.07 92.37 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.798 2.332 . . . . 0.0 109.982 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -34.85 92.73 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.705 2.402 . . . . 0.0 112.064 -172.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.87 -91.76 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 119.595 1.089 . . . . 0.0 110.733 -160.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.573 ' CB ' ' HB3' ' A' ' 100' ' ' LYS . . . -63.64 -21.24 66.27 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.604 1.093 . . . . 0.0 111.169 175.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -64.64 -48.36 75.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.796 1.638 . . . . 0.0 110.775 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -75.6 -53.7 8.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.264 0.938 . . . . 0.0 108.862 171.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -71.4 -25.59 62.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.33 -159.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.66 27.85 70.53 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.899 1.227 . . . . 0.0 114.309 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -67.02 -86.84 0.02 OUTLIER 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.965 1.382 . . . . 0.0 110.262 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.6 tp -165.36 55.28 0.11 Allowed 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.96 -0.462 . . . . 0.0 111.02 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -80.17 169.2 18.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 120.995 -1.065 . . . . 0.0 108.263 174.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -135.85 171.23 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.5 p -150.42 -179.01 6.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.607 1.963 . . . . 0.0 107.977 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 172.6 50.29 0.04 OUTLIER Glycine 0 C--N 1.336 0.544 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 167.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -166.8 -67.86 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.716 0.806 . . . . 0.0 109.135 -166.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.2 ptm 177.46 -106.23 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.851 2.86 . . . . 0.0 107.806 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -138.13 80.87 0.28 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 121.08 1.764 . . . . 0.0 109.636 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.18 20.15 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.815 2.046 . . . . 0.0 115.817 -170.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.91 -94.09 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.668 1.187 . . . . 0.0 112.887 -167.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 15.0 mtt -105.59 7.39 32.78 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.392 1.477 . . . . 0.0 111.145 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.3 32.32 0.1 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.675 2.39 . . . . 0.0 111.833 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.02 164.38 38.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.212 1.805 . . . . 0.0 110.27 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.65 -81.59 0.61 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -53.75 -33.97 57.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.164 1.347 . . . . 0.0 113.317 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -15.39 25.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.535 0.734 . . . . 0.0 112.283 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -128.17 49.34 2.18 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.495 1.518 . . . . 0.0 109.104 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.4 mt 47.86 -176.02 0.01 OUTLIER 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.8 1.64 . . . . 0.0 111.823 -172.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.63 166.6 11.05 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 124.134 0.974 . . . . 0.0 111.343 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.73 174.63 5.3 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.15 2.567 . . . . 0.0 111.284 166.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.08 77.07 1.15 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -156.05 -73.2 0.11 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.25 1.02 . . . . 0.0 110.212 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 43.35 44.89 4.98 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.345 1.858 . . . . 0.0 114.512 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -134.37 154.72 51.2 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 120.452 -1.405 . . . . 0.0 108.61 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.249 1.045 0 C-N-CA 125.742 1.617 . . . . 0.0 110.463 -178.853 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 t 154.17 -82.03 0.0 OUTLIER 'General case' 0 C--O 1.237 0.42 1 C-N-CA 132.169 4.187 . . . . 0.0 105.324 169.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.8 179.91 7.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.003 2.121 . . . . 0.0 108.638 175.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.1 m -144.65 -83.26 0.15 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.714 1.205 . . . . 0.0 109.949 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 63.06 32.48 15.32 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 110.378 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.88 4.46 6.95 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.714 1.149 . . . . 0.0 112.483 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -65.51 160.2 22.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.583 1.191 . . . . 0.0 109.092 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.8 -7.18 14.6 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.21 0.45 7.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 113.192 165.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -53.15 -53.62 47.76 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 120.482 1.492 . . . . 0.0 111.311 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.621 HD22 ' C ' ' A' ' 11' ' ' LEU 0.25 0.0 OUTLIER -57.29 -35.72 70.16 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.346 1.059 . . . . 0.0 113.439 173.395 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.555 HG22 ' SD ' ' A' ' 84' ' ' MET . 0.9 OUTLIER -58.9 -47.81 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.565 1.546 . . . . 0.0 110.463 178.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 97.8 m-85 -72.73 -33.62 66.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 119.332 0.969 . . . . 0.0 111.057 176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -71.37 -24.57 62.11 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.421 -0.799 . . . . 0.0 112.777 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.08 -49.24 72.17 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.72 -0.613 . . . . 0.0 112.338 164.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.5 mt -57.45 -48.85 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -58.15 -54.39 47.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.244 1.417 . . . . 0.0 110.984 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -36.31 81.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.406 1.003 . . . . 0.0 109.547 -169.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -67.38 -39.71 85.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.568 1.147 . . . . 0.0 110.67 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -31.29 72.1 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 174.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.26 -51.69 65.11 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.677 173.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.31 -46.47 88.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 118.547 -1.261 . . . . 0.0 111.81 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -160.6 42.49 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.986 1.374 . . . . 0.0 112.306 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -52.57 -20.43 7.59 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.978 1.275 . . . . 0.0 114.856 170.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -58.0 -23.46 54.13 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.774 1.787 . . . . 0.0 113.866 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.35 -23.97 16.94 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.93 0.786 . . . . 0.0 109.145 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.23 -31.27 60.81 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.511 -1.368 . . . . 0.0 108.555 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 54' ' ' VAL . 19.9 t -52.11 -41.33 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.297 1.839 . . . . 0.0 109.6 163.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -70.89 -37.52 73.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.723 1.147 . . . . 0.0 110.985 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -60.2 -61.56 2.51 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.069 0.85 . . . . 0.0 110.055 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.06 -57.05 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -172.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.31 52.85 36.68 Favored Glycine 0 CA--C 1.525 0.715 0 O-C-N 121.143 -0.973 . . . . 0.0 112.566 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.82 143.33 4.28 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.44 144.22 12.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -140.64 168.57 19.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.967 -0.458 . . . . 0.0 110.507 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.84 131.48 54.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.231 . . . . 0.0 109.787 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -84.91 104.26 14.7 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.808 1.243 . . . . 0.0 108.08 172.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -78.82 100.96 7.39 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 120.815 1.643 . . . . 0.0 110.408 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.409 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 19.3 t -104.48 93.54 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 175.09 6.71 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.272 -0.892 . . . . 0.0 111.274 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 59.37 24.31 12.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.695 2.398 . . . . 0.0 113.634 170.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 177.82 3.86 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.735 -1.036 . . . . 0.0 113.004 -167.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.52 91.67 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.15 2.566 . . . . 0.0 109.489 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.67 -72.87 0.44 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.052 1.31 . . . . 0.0 112.888 -156.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.04 -7.64 7.21 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.56 1.552 . . . . 0.0 112.894 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -69.47 -174.31 0.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.907 1.283 . . . . 0.0 110.837 170.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.7 147.3 49.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 108.474 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.22 167.62 17.37 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.251 2.62 . . . . 0.0 107.8 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 m -155.57 144.57 20.69 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.307 -0.871 . . . . 0.0 109.136 170.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -121.64 118.95 30.44 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -78.96 128.52 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.5 t -107.08 107.65 23.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -82.12 110.67 17.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 28' ' ' VAL . 1.3 m -133.36 48.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -133.54 -49.34 0.84 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 165.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -90.41 136.49 33.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -167.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.7 -142.26 41.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -80.22 -3.76 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.334 1.453 . . . . 0.0 114.351 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.47 156.58 6.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 119.654 1.116 . . . . 0.0 111.526 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.1 m -172.62 151.85 2.45 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 129.123 2.969 . . . . 0.0 107.958 169.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.35 126.07 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt -103.4 99.74 16.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.45 147.87 53.19 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.852 2.368 . . . . 0.0 108.937 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 47.49 23.48 0.39 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.362 1.865 . . . . 0.0 113.683 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 t -81.88 155.87 25.11 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.408 1.099 . . . . 0.0 111.424 -156.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -25.45 27.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.408 1.083 . . . . 0.0 109.946 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -74.28 129.44 37.81 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.802 0.728 . . . . 0.0 109.153 -166.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -73.11 -177.83 2.62 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.797 1.239 . . . . 0.0 112.41 -163.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.05 174.62 5.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.336 -165.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -57.08 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.002 -1.686 . . . . 0.0 108.353 148.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.41 -177.74 5.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.568 1.947 . . . . 0.0 109.413 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.6 m -131.15 -173.72 3.18 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.841 -1.162 . . . . 0.0 107.958 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 tt -155.17 146.7 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 166.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.3 m -111.19 132.02 54.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 117.122 -1.418 . . . . 0.0 107.68 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.512 ' HG3' ' HB2' ' A' ' 93' ' ' ALA . 10.9 mtm -137.08 -48.5 0.6 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.854 -1.07 . . . . 0.0 111.993 166.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.54 153.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.362 3.065 . . . . 0.0 110.81 -161.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.93 -39.99 93.98 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 124.142 0.901 . . . . 0.0 108.67 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.74 68.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.077 0.465 . . . . 0.0 110.362 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.51 -49.45 6.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.556 -1.212 . . . . 0.0 107.812 -168.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -56.98 -40.53 76.69 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.471 1.108 . . . . 0.0 110.977 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.4 tp -64.28 -60.52 3.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.49 -35.59 65.73 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.248 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 tt -53.34 -70.53 0.09 Allowed 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.107 1.763 . . . . 0.0 108.143 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 12' ' ' VAL . 1.4 ptp -69.4 -33.88 73.66 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.565 0.62 . . . . 0.0 111.906 -172.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.8 m -74.22 -8.06 54.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.826 1.251 . . . . 0.0 111.502 -171.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.9 72.01 0.73 Allowed Glycine 0 C--N 1.335 0.48 0 O-C-N 120.805 -1.184 . . . . 0.0 110.305 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -144.79 -47.5 0.24 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.38 1.072 . . . . 0.0 108.795 166.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.0 mmt -126.34 103.32 7.58 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.485 1.114 . . . . 0.0 108.7 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -44.92 69.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 117.632 -1.175 . . . . 0.0 113.103 169.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -83.6 -158.68 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.522 2.148 . . . . 0.0 111.627 -170.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -60.47 84.12 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.569 1.548 . . . . 0.0 110.496 173.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 t -57.9 -34.43 69.81 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.873 -1.142 . . . . 0.0 111.234 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -65.31 -15.97 63.08 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.807 -1.183 . . . . 0.0 113.539 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -75.19 -43.11 53.95 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 125.128 1.371 . . . . 0.0 110.227 171.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -61.82 -53.23 58.67 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.62 1.568 . . . . 0.0 110.383 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -67.7 -18.81 65.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.796 1.18 . . . . 0.0 111.888 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.67 37.49 14.05 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 127.398 2.427 . . . . 0.0 115.019 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -74.32 -101.46 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.985 1.314 . . . . 0.0 109.263 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.65 71.09 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.97 1.308 . . . . 0.0 109.285 -171.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.676 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -83.67 154.28 23.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -104.88 165.23 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -166.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.7 p -87.55 -165.07 1.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.39 116.35 4.05 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.75 115.93 0.02 OUTLIER 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.656 2.382 . . . . 0.0 111.667 -169.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.8 105.12 0.11 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.457 1.503 . . . . 0.0 110.346 174.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.36 63.64 4.21 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.529 2.014 . . . . 0.0 113.481 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -70.69 4.03 2.76 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.49 -79.04 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.425 1.466 . . . . 0.0 111.435 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -83.13 2.41 35.54 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.098 -1.001 . . . . 0.0 113.31 -167.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -7.88 54.2 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.929 -1.107 . . . . 0.0 113.202 -170.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -176.78 2.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.011 1.724 . . . . 0.0 111.436 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -115.05 -67.03 1.02 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 166.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -81.34 -96.64 0.04 OUTLIER 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tp 48.85 -61.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.728 2.011 . . . . 0.0 111.384 -152.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -135.11 62.88 1.63 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 127.372 2.269 . . . . 0.0 109.895 -163.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.31 0.1 OUTLIER 50.78 -175.48 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.608 1.963 . . . . 0.0 113.175 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.09 175.32 3.25 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.459 1.504 . . . . 0.0 109.508 167.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.67 174.94 11.86 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.922 1.748 . . . . 0.0 112.043 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -157.49 -75.34 0.02 OUTLIER Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -144.34 81.52 1.67 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.707 1.203 . . . . 0.0 108.608 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.28 163.1 16.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 158.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.93 104.64 4.72 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 165.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.181 0 C-N-CA 128.255 2.622 . . . . 0.0 111.089 -163.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 p -151.55 -152.37 0.43 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.373 1.869 . . . . 0.0 107.374 -166.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.9 151.68 49.35 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 152.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 m -144.3 -15.25 0.58 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.302 1.041 . . . . 0.0 111.641 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 51.25 32.5 8.25 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.727 1.211 . . . . 0.0 110.622 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.86 84.4 0.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -164.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -153.8 170.59 20.6 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 128.83 2.852 . . . . 0.0 104.501 174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -29.77 70.76 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.299 -0.875 . . . . 0.0 110.078 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.86 -11.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.316 1.846 . . . . 0.0 114.815 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -53.7 -40.55 66.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.675 1.579 . . . . 0.0 110.856 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 11' ' ' LEU 0.254 0.0 OUTLIER -65.47 -36.68 84.61 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.757 176.004 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.698 HG13 ' SD ' ' A' ' 84' ' ' MET . 2.6 t -61.77 -59.59 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 124.179 0.992 . . . . 0.0 110.839 -173.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.593 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 64.3 m-85 -63.71 -23.99 67.59 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.982 0.81 . . . . 0.0 110.923 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 28.0 tttt -70.34 -25.46 63.3 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.512 ' HG3' HD21 ' A' ' 116' ' ' LEU . 77.5 mm-40 -67.59 -40.8 84.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.602 0.637 . . . . 0.0 110.939 173.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.68 -48.64 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.384 1.474 . . . . 0.0 107.56 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 14' ' ' LYS . 25.5 tt0 -51.26 -49.93 60.23 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.053 169.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -58.68 -40.65 84.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HG2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -65.28 -47.41 76.76 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.73 1.212 . . . . 0.0 111.707 173.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -33.1 63.83 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.427 0.691 . . . . 0.0 112.009 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.94 -52.59 55.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.828 -1.17 . . . . 0.0 110.22 169.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -53.7 -45.98 70.58 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.949 1.25 . . . . 0.0 111.315 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -162.36 49.76 0.18 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.859 0.838 . . . . 0.0 112.349 -170.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.36 -28.3 61.75 Favored Glycine 0 C--O 1.223 -0.585 0 O-C-N 120.496 -1.378 . . . . 0.0 113.273 -174.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -59.85 -24.65 64.38 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -78.31 -41.7 32.96 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.716 -1.24 . . . . 0.0 110.138 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CZ ' ' HG2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -67.1 -36.05 81.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.669 1.588 . . . . 0.0 108.659 -177.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 54' ' ' VAL . 9.5 t -51.01 -42.11 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 127.834 2.453 . . . . 0.0 111.018 169.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -72.29 -23.77 61.23 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.458 -1.401 . . . . 0.0 111.052 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -89.57 -14.17 35.64 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -173.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.9 -55.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.484 1.514 . . . . 0.0 107.535 169.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.39 59.85 7.34 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 124.85 1.214 . . . . 0.0 111.888 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.04 -177.96 43.6 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.25 138.38 31.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 160.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -129.03 164.72 22.63 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.331 0.586 . . . . 0.0 110.255 165.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.33 166.18 11.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.1 163.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -123.18 98.36 5.84 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 125.588 1.555 . . . . 0.0 109.396 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.52 ' HD2' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -73.71 109.21 7.04 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 120.218 1.372 . . . . 0.0 109.282 172.358 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG22 ' CE2' ' A' ' 80' ' ' PHE . 21.7 t -122.41 93.48 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -96.55 177.89 5.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.959 1.704 . . . . 0.0 109.923 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 65.01 24.52 12.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.081 1.352 . . . . 0.0 112.482 162.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.56 -168.38 33.68 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.835 1.683 . . . . 0.0 112.394 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.71 96.12 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.305 2.67 . . . . 0.0 110.079 174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.09 -13.05 10.52 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 127.663 2.554 . . . . 0.0 112.582 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.59 21.08 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 126.108 1.813 . . . . 0.0 112.537 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -51.03 -175.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 129.251 3.02 . . . . 0.0 111.809 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.07 161.46 33.19 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.834 0.826 . . . . 0.0 110.964 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.37 173.63 10.01 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.745 2.418 . . . . 0.0 107.862 161.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 87.7 m -140.73 156.58 46.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -124.73 149.82 46.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 164.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.96 143.02 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.3 110.42 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -77.48 122.26 24.98 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 164.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.536 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -135.78 46.25 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 171.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -138.83 -46.53 0.49 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.101 0.961 . . . . 0.0 110.639 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.68 103.13 15.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -156.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.03 -118.29 7.16 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.884 -1.135 . . . . 0.0 111.123 -170.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -74.82 -5.12 41.78 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 171.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.98 -103.4 0.77 Allowed Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 127.774 2.606 . . . . 0.0 108.232 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 m 97.39 157.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 135.444 5.497 . . . . 0.0 110.147 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.5 t -77.09 157.97 5.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 175.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.9 mt -143.72 84.88 9.58 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 -169.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.1 152.52 76.34 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 N-CA-C 108.202 -1.499 . . . . 0.0 108.202 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.3 23.52 4.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.196 1.398 . . . . 0.0 112.188 170.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -82.65 146.49 29.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.267 -0.896 . . . . 0.0 110.86 -154.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.45 -0.34 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.634 163.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -59.16 139.75 56.6 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.997 1.272 . . . . 0.0 108.061 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -69.43 -176.43 0.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.23 159.59 43.47 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.401 0.68 . . . . 0.0 111.03 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -36.6 65.34 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.354 1.062 . . . . 0.0 111.494 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.21 -177.05 6.07 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.09 1.756 . . . . 0.0 109.018 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 38' ' ' LYS . 24.3 m -133.35 -172.7 3.02 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.494 ' H ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.87 146.64 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 166.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.7 m -103.76 131.08 51.27 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 mtp -137.09 -48.88 0.61 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.83 160.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 129.948 3.299 . . . . 0.0 109.57 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.01 -46.89 71.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.389 1.876 . . . . 0.0 109.693 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 m -62.65 -18.77 62.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 112.281 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -105.97 -37.15 6.74 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.699 0.8 . . . . 0.0 112.143 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 39' ' ' VAL . 10.0 m-85 -65.79 -54.17 30.49 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.687 1.195 . . . . 0.0 110.674 173.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.21 -36.09 80.88 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.76 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -48.22 -38.33 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.541 1.136 . . . . 0.0 112.546 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 88' ' ' MET . 0.1 OUTLIER -57.05 -74.12 0.06 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.698 ' SD ' HG13 ' A' ' 12' ' ' VAL . 16.3 ptp -76.49 52.47 0.79 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.2 p -142.94 2.29 1.33 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.985 1.714 . . . . 0.0 110.173 156.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.51 -3.21 86.47 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 118.324 -1.265 . . . . 0.0 113.951 174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -64.73 -59.4 4.28 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.625 1.713 . . . . 0.0 108.15 166.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.418 ' HA ' HD12 ' A' ' 83' ' ' LEU 0.25 8.2 ptt? 44.34 47.23 7.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.873 2.469 . . . . 0.0 115.719 168.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -60.54 133.7 91.41 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -72.25 124.71 10.18 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.14 2.56 . . . . 0.0 111.999 -162.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 39.34 57.78 2.01 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.924 2.09 . . . . 0.0 110.9 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -33.83 75.57 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.899 1.28 . . . . 0.0 112.274 -167.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -73.41 -21.62 60.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 120.06 1.3 . . . . 0.0 111.626 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -74.68 -42.81 57.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.969 0.908 . . . . 0.0 110.388 166.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.08 -66.27 0.56 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.353 1.061 . . . . 0.0 110.093 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -66.91 -21.7 65.98 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.992 0.917 . . . . 0.0 111.399 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.12 41.06 99.34 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.428 -0.651 . . . . 0.0 113.011 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -64.39 -76.6 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.774 1.287 . . . . 0.0 109.166 -177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.07 52.84 0.09 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.619 1.568 . . . . 0.0 109.931 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.519 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -71.14 162.91 28.64 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.814 -1.179 . . . . 0.0 108.585 -172.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.98 167.84 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.1 p -87.99 171.65 10.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.415 1.086 . . . . 0.0 109.62 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -159.03 -20.12 0.03 OUTLIER Glycine 0 C--N 1.336 0.544 0 CA-C-O 117.615 -1.658 . . . . 0.0 115.689 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 174.79 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.506 1.922 . . . . 0.0 108.299 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 16.9 mtt -158.09 -91.94 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.767 2.427 . . . . 0.0 106.507 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -91.2 36.44 3.63 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 119.408 1.004 . . . . 0.0 113.718 -167.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -52.41 -44.51 65.42 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.683 1.193 . . . . 0.0 111.971 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.69 0.87 13.78 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 32.9 ttm -164.9 47.01 0.1 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.309 1.413 . . . . 0.0 111.315 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -68.35 -50.65 51.71 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.996 -1.065 . . . . 0.0 111.631 -171.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.13 178.07 7.26 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.187 1.395 . . . . 0.0 108.981 174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -71.72 0.06 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 124.629 1.171 . . . . 0.0 111.051 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -67.11 -3.92 8.73 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -168.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.57 -3.55 57.77 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.26 -0.9 . . . . 0.0 110.872 170.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -164.79 48.27 0.1 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.883 1.273 . . . . 0.0 111.76 -164.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 15' ' ' GLU . 6.6 mt 53.85 177.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.362 2.265 . . . . 0.0 114.595 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.36 153.37 85.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -66.65 176.08 4.62 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.46 1.44 . . . . 0.0 110.425 165.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 160.37 58.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -61.95 119.02 8.05 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 35.45 55.39 0.86 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.069 2.148 . . . . 0.0 112.269 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -77.55 70.02 3.88 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.456 -0.777 . . . . 0.0 110.223 -172.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.243 0.748 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 146.731 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.51 168.39 0.58 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.852 1.661 . . . . 0.0 112.102 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 80.81 -10.39 1.24 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.837 2.855 . . . . 0.0 115.033 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.4 m -73.96 -84.88 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 116.994 -1.479 . . . . 0.0 109.203 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.317 0.0 OUTLIER 47.11 24.27 0.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 157.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.48 10.29 33.03 Favored Glycine 0 CA--C 1.538 1.49 0 O-C-N 119.255 -2.153 . . . . 0.0 114.335 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 28.4 m-85 -77.7 171.37 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.576 1.15 . . . . 0.0 112.856 -160.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -57.35 -23.77 51.0 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.727 -1.233 . . . . 0.0 111.62 163.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.17 -20.58 42.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.784 1.174 . . . . 0.0 113.496 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -73.23 -19.16 61.14 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.927 1.691 . . . . 0.0 111.146 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.51 -63.45 1.37 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.167 1.787 . . . . 0.0 106.289 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.702 HG13 ' SD ' ' A' ' 84' ' ' MET . 4.6 t -59.58 -56.87 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 125.085 1.354 . . . . 0.0 112.518 -167.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.49 -21.68 64.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.248 0.931 . . . . 0.0 110.986 -173.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -67.06 -34.01 76.76 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.495 174.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.643 ' HG3' HD21 ' A' ' 116' ' ' LEU . 15.5 mm-40 -59.02 -33.84 71.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 119.642 1.11 . . . . 0.0 112.163 174.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -72.18 -46.75 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -55.6 -49.5 72.62 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.323 1.049 . . . . 0.0 111.48 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.082 0.953 . . . . 0.0 109.388 -174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -70.07 -39.37 75.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.482 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -43.15 79.95 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.645 1.111 . . . . 0.0 113.034 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -63.71 -51.99 62.57 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.278 1.431 . . . . 0.0 110.186 173.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.65 -46.24 87.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.4 -1.438 . . . . 0.0 112.755 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -166.34 62.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.41 1.484 . . . . 0.0 111.976 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.97 -20.19 79.73 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 125.36 1.457 . . . . 0.0 113.528 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -33.79 24.25 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.681 1.24 . . . . 0.0 112.996 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.457 ' OE1' ' HE2' ' A' ' 30' ' ' LYS . 1.1 tm0? -91.71 -35.25 14.27 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.454 1.502 . . . . 0.0 110.702 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.53 -34.77 71.35 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.984 -1.073 . . . . 0.0 108.967 168.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.1 t -57.64 -62.35 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 119.824 1.193 . . . . 0.0 108.612 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.79 -20.06 60.75 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.457 ' HE2' ' OE1' ' A' ' 26' ' ' GLN . 53.1 mttm -67.93 -67.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.905 1.282 . . . . 0.0 111.44 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.6 -60.53 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 109.196 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.05 9.91 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.072 1.796 . . . . 0.0 113.817 -173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.73 176.51 44.19 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 117.955 0.878 . . . . 0.0 111.493 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 mt -102.14 138.16 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 162.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -135.86 157.84 45.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.905 0.383 . . . . 0.0 110.884 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.79 167.19 10.04 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.293 1.037 . . . . 0.0 109.865 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -129.57 105.78 8.3 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 125.917 1.687 . . . . 0.0 108.644 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -74.38 121.57 21.6 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 168.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.483 HG22 ' CE2' ' A' ' 80' ' ' PHE . 5.3 t -119.23 110.69 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 171.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -114.03 174.79 5.76 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t0 61.59 24.8 14.84 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.504 1.522 . . . . 0.0 112.478 173.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 77' ' ' ASP . . . -70.87 -176.81 23.15 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 119.075 -0.847 . . . . 0.0 112.859 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.67 44.3 0.32 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.625 3.55 . . . . 0.0 113.428 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.24 -19.76 0.02 OUTLIER Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.288 2.375 . . . . 0.0 112.698 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.48 -7.71 81.36 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 120.853 2.326 . . . . 0.0 113.351 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -69.19 -173.28 0.51 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.608 157.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -127.22 158.73 36.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.564 1.945 . . . . 0.0 108.697 162.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -119.9 174.69 6.3 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.156 2.182 . . . . 0.0 107.51 166.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.6 m -145.66 150.47 36.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.145 0.978 . . . . 0.0 108.989 161.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -118.73 152.96 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 170.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.1 t -115.62 135.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 171.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.5 t -116.6 120.79 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.63 116.71 28.73 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.0 52.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -145.31 -49.5 0.24 Allowed 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.638 1.175 . . . . 0.0 110.371 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -90.61 139.46 30.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -164.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.83 -135.48 46.33 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -89.79 6.62 40.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.053 1.741 . . . . 0.0 112.056 171.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.24 158.14 27.33 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.2 m -172.13 145.64 1.8 Allowed 'General case' 0 C--O 1.237 0.447 0 C-N-CA 127.006 2.122 . . . . 0.0 105.588 159.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.41 157.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mt -136.28 80.57 39.83 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.34 145.17 87.9 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.234 1.956 . . . . 0.0 109.043 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.91 23.95 3.1 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.582 2.353 . . . . 0.0 112.2 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -89.95 140.5 29.57 Favored 'General case' 0 CA--C 1.524 -0.052 0 O-C-N 120.417 -1.427 . . . . 0.0 109.489 -163.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.8 -22.63 65.16 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.374 0.67 . . . . 0.0 111.345 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -58.27 130.3 46.06 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.235 0.54 . . . . 0.0 110.372 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -60.78 -176.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.235 1.414 . . . . 0.0 111.316 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.26 173.2 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.326 1.45 . . . . 0.0 110.567 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -49.18 19.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 163.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 60.3 m -146.6 -179.43 6.76 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.641 1.576 . . . . 0.0 110.367 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.809 HG22 ' H ' ' A' ' 73' ' ' ILE . 15.0 m -132.51 -165.93 1.67 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.488 1.115 . . . . 0.0 108.194 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.809 ' H ' HG22 ' A' ' 72' ' ' THR . 4.0 tt -150.54 172.75 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.937 -1.102 . . . . 0.0 109.593 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.5 m -122.31 124.07 42.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 163.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.469 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 1.9 mtm -151.73 120.79 6.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 166.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.09 164.07 1.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.426 . . . . 0.0 110.106 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 16.3 t70 -58.9 -54.24 49.34 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.875 0.87 . . . . 0.0 109.405 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -67.59 1.22 2.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.37 1.068 . . . . 0.0 112.691 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.02 -60.85 1.5 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.259 1.824 . . . . 0.0 108.883 168.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.483 ' CE2' HG22 ' A' ' 39' ' ' VAL . 21.4 m-85 -56.18 -41.04 74.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.965 1.306 . . . . 0.0 112.893 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.42 -44.37 62.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.658 0.783 . . . . 0.0 109.417 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -27.77 64.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.546 0.739 . . . . 0.0 112.153 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.2 -78.25 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 C-N-CA 126.365 1.866 . . . . 0.0 109.718 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.702 ' SD ' HG13 ' A' ' 12' ' ' VAL . 6.0 ptp -77.24 51.46 0.84 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.1 p -150.04 14.54 0.81 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.465 1.906 . . . . 0.0 109.857 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.31 1.98 17.33 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.575 1.084 . . . . 0.0 113.883 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -81.31 -32.0 33.29 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 119.556 1.678 . . . . 0.0 110.064 -172.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.8 mmt -114.89 178.21 4.37 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.158 1.383 . . . . 0.0 108.394 166.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -98.26 154.4 37.66 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.217 1.407 . . . . 0.0 110.135 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.79 166.17 25.29 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.525 2.15 . . . . 0.0 109.734 171.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.94 63.07 2.33 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.96 1.362 . . . . 0.0 109.4 -158.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -72.13 -48.74 41.38 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.012 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.736 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -50.22 -33.85 20.92 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 121.01 1.732 . . . . 0.0 114.49 172.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -64.31 -53.14 53.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -56.48 -66.89 0.36 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.873 1.669 . . . . 0.0 112.177 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.573 HE21 ' HA ' ' A' ' 93' ' ' ALA . 0.9 OUTLIER -64.32 -17.02 63.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.143 1.338 . . . . 0.0 112.635 -173.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.98 4.26 54.6 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 121.026 1.739 . . . . 0.0 114.054 172.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -69.16 24.49 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.538 2.735 . . . . 0.0 114.248 -174.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.7 tp 41.7 75.6 0.08 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 127.845 2.458 . . . . 0.0 111.36 177.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.736 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -65.06 145.82 55.82 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -177.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.1 mm -74.78 162.38 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 67.2 p -82.74 -170.31 2.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.454 0.701 . . . . 0.0 109.282 -174.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.75 -57.88 0.23 Allowed Glycine 0 N--CA 1.444 -0.807 0 O-C-N 120.687 -1.258 . . . . 0.0 110.592 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -145.37 151.59 38.53 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 118.923 1.362 . . . . 0.0 111.028 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 11.7 mmt -57.87 -71.59 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.114 1.366 . . . . 0.0 110.948 -165.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.06 25.53 6.06 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.418 1.008 . . . . 0.0 112.187 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -35.72 75.36 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.311 1.556 . . . . 0.0 110.87 177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.04 1.65 23.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.264 1.425 . . . . 0.0 112.42 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.8 ttp -105.86 -37.83 6.56 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.694 1.198 . . . . 0.0 112.556 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -77.4 -58.89 3.02 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.404 -1.435 . . . . 0.0 112.388 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 pt? 38.45 15.88 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.917 1 C-N-CA 131.893 4.077 . . . . 0.0 117.511 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -44.89 -86.01 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 121.725 2.057 . . . . 0.0 112.083 -154.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.58 -6.93 44.48 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 127.334 2.254 . . . . 0.0 113.269 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mp -71.66 -7.07 45.64 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 117.806 -1.092 . . . . 0.0 110.894 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.3 46.92 2.27 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 120.26 1.391 . . . . 0.0 112.938 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.643 HD21 ' HG3' ' A' ' 15' ' ' GLU . 26.4 mt 56.3 -172.45 0.07 Allowed 'General case' 0 C--N 1.347 0.489 0 CA-C-O 123.603 1.668 . . . . 0.0 110.544 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.9 125.9 19.45 Favored Pre-proline 0 N--CA 1.43 -1.444 0 C-N-CA 127.678 2.391 . . . . 0.0 106.206 178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.19 173.39 11.43 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.487 1.458 . . . . 0.0 109.696 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -125.37 -161.57 11.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 123.991 0.805 . . . . 0.0 111.634 -171.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.03 63.31 4.5 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.741 1.216 . . . . 0.0 109.304 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.53 155.47 25.72 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.262 1.425 . . . . 0.0 112.724 -163.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -158.83 131.6 7.01 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.586 1.555 . . . . 0.0 108.257 173.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.247 0.95 0 C-N-CA 127.571 2.348 . . . . 0.0 112.987 173.594 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 119.471 -0.299 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t 64.59 -59.92 0.22 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 129.819 3.247 . . . . 0.0 114.125 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.19 111.15 0.02 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.917 2.087 . . . . 0.0 110.986 -170.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.5 m -143.4 -45.08 0.28 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.72 1.208 . . . . 0.0 109.242 -170.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.92 33.99 23.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.482 0.489 . . . . 0.0 111.63 150.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.63 39.83 0.64 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.936 1.732 . . . . 0.0 109.874 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -85.54 177.87 7.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -66.42 -22.66 66.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.522 -1.362 . . . . 0.0 111.037 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.24 -5.07 1.38 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 169.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -59.37 -47.33 85.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.081 1.31 . . . . 0.0 112.422 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.544 HD22 ' C ' ' A' ' 11' ' ' LEU 0.266 0.0 OUTLIER -68.97 -33.11 73.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.547 0.739 . . . . 0.0 111.53 176.349 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.25 -53.19 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.969 1.708 . . . . 0.0 110.396 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -67.5 -21.91 65.48 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.728 -173.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -75.46 -26.41 58.23 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.494 -1.241 . . . . 0.0 112.768 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -57.09 -41.09 78.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.46 1.482 . . . . 0.0 110.773 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.496 HD11 ' CE ' ' A' ' 84' ' ' MET . 76.6 mt -61.69 -47.72 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.18 -51.32 70.52 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 123.378 0.671 . . . . 0.0 110.775 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -53.0 -50.83 63.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.171 2.188 . . . . 0.0 108.639 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -34.38 73.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.198 . . . . 0.0 111.349 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.09 -32.6 61.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 0.0 112.811 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -63.35 -53.81 46.84 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.834 0.854 . . . . 0.0 109.994 170.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -62.74 -45.82 90.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 110.863 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -159.41 58.0 0.4 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.208 1.004 . . . . 0.0 109.217 -161.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.22 -23.06 66.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.315 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -59.38 -43.11 92.94 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.715 1.757 . . . . 0.0 111.6 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.14 -32.4 73.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.627 -0.671 . . . . 0.0 111.465 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -75.62 -34.35 60.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.863 1.665 . . . . 0.0 108.619 -171.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.37 -48.73 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.704 1.202 . . . . 0.0 109.208 164.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -70.99 -10.68 60.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.805 -1.185 . . . . 0.0 113.437 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -86.02 -30.53 22.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 120.368 1.44 . . . . 0.0 113.603 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.56 -54.11 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.696 1.198 . . . . 0.0 108.772 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.73 57.11 11.72 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.669 2.08 . . . . 0.0 114.786 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.74 -171.18 37.29 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.348 1.574 . . . . 0.0 111.738 -176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.24 124.55 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 158.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -120.93 173.76 7.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.22 142.82 51.05 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.087 0.955 . . . . 0.0 109.411 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -88.27 91.53 8.82 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 124.969 1.308 . . . . 0.0 110.259 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -74.88 89.08 2.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.577 -1.327 . . . . 0.0 112.241 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.576 HG22 ' CD2' ' A' ' 80' ' ' PHE . 51.1 t -93.58 123.41 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -115.78 174.89 5.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.384 1.474 . . . . 0.0 110.357 158.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.53 61.17 2.06 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.803 1.641 . . . . 0.0 114.82 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.8 -152.44 8.85 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 126.329 1.919 . . . . 0.0 111.933 -175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.65 5.9 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 124.185 3.257 . . . . 0.0 114.605 -169.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.45 -49.13 0.21 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 159.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.94 -24.16 4.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.575 1.188 . . . . 0.0 111.402 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -62.16 -175.65 0.08 Allowed 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.087 1.755 . . . . 0.0 111.279 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -127.42 147.65 50.29 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 -172.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.87 170.76 15.4 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.675 1.99 . . . . 0.0 108.087 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -155.9 149.42 24.88 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.62 133.1 55.4 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 166.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.95 142.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.68 113.27 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.54 123.96 30.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 165.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.15 39.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 126.365 1.866 . . . . 0.0 107.76 173.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -124.67 -39.31 2.3 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.574 1.15 . . . . 0.0 109.674 162.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -95.04 115.88 27.99 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -155.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.45 -134.98 49.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -74.81 -2.68 27.76 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.157 -0.925 . . . . 0.0 113.123 173.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.31 157.1 14.11 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 -168.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.2 m -171.46 133.28 0.8 Allowed 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 128.507 2.723 . . . . 0.0 106.137 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.96 147.93 8.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -125.53 93.54 44.52 Favored Pre-proline 0 N--CA 1.446 -0.644 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 -176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.79 150.75 44.98 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.278 1.985 . . . . 0.0 109.381 -172.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.13 22.85 0.16 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.941 2.497 . . . . 0.0 114.507 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.48 147.79 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.419 -155.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.49 -5.09 46.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.96 0.904 . . . . 0.0 111.279 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -44.9 129.12 7.27 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.868 1.667 . . . . 0.0 108.736 170.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -69.06 -176.0 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.919 0.866 . . . . 0.0 109.04 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.2 151.77 37.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.205 1.002 . . . . 0.0 108.956 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -75.82 -31.01 59.19 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 122.932 0.493 . . . . 0.0 112.156 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.1 m -148.37 173.02 13.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.822 2.449 . . . . 0.0 107.689 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -155.48 114.7 3.59 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.129 -1.607 . . . . 0.0 108.063 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.13 146.18 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.0 m -122.55 131.27 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.122 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 26.9 mmm -138.73 -12.56 1.3 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.703 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 67.5 151.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.419 1.888 . . . . 0.0 111.107 -164.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.37 -35.41 79.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.663 1.185 . . . . 0.0 109.578 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.342 -0.837 . . . . 0.0 111.929 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -58.09 2.72 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.73 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.576 ' CD2' HG22 ' A' ' 39' ' ' VAL . 34.6 m-85 -51.21 -55.69 16.76 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.232 1.013 . . . . 0.0 112.139 -173.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -54.14 -58.47 7.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.297 0.953 . . . . 0.0 109.331 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.38 -39.48 73.0 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 123.878 0.736 . . . . 0.0 112.149 -174.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 tt -55.69 -56.61 18.4 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.769 2.428 . . . . 0.0 110.306 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.496 ' CE ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -74.53 -26.92 60.29 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.4 m -74.53 -15.5 60.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.83 -1.169 . . . . 0.0 113.304 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 57.61 3.37 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -168.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.9 tttt -145.21 -32.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.979 1.712 . . . . 0.0 111.034 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 11.6 mtt 58.14 165.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.165 2.586 . . . . 0.0 112.567 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -142.7 158.18 60.34 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 151.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -59.51 125.91 19.21 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.526 2.15 . . . . 0.0 109.387 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -34.74 101.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.207 0 C-N-CA 129.486 3.114 . . . . 0.0 112.518 -167.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -52.6 46.54 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.073 -172.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 100' ' ' LYS . . . -52.09 -19.17 1.76 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -82.49 -74.42 0.35 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.057 0.943 . . . . 0.0 108.49 166.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -61.19 -40.44 93.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.215 1.406 . . . . 0.0 113.961 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.5 -14.23 60.79 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.48 1.112 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.66 -7.97 0.22 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.898 1.714 . . . . 0.0 115.135 -172.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -64.42 -0.93 1.47 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -163.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.7 tp 54.43 90.71 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.233 1.813 . . . . 0.0 110.496 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 93' ' ' ALA . 16.6 pttm -66.65 171.65 4.95 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.513 ' CG2' ' H ' ' A' ' 102' ' ' THR 0.268 2.5 mp -127.96 -162.65 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -176.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.513 ' H ' ' CG2' ' A' ' 101' ' ' ILE . 18.3 p 57.73 -171.21 0.1 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.286 2.234 . . . . 0.0 112.53 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.7 120.11 1.51 Allowed Glycine 0 CA--C 1.527 0.826 0 O-C-N 120.796 -1.19 . . . . 0.0 112.286 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.78 -60.59 1.61 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.086 1.355 . . . . 0.0 111.526 156.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.2 ttm -170.24 74.52 0.07 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.963 2.105 . . . . 0.0 111.072 175.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.39 65.05 1.83 Allowed Glycine 0 CA--C 1.531 1.065 0 O-C-N 120.428 -1.42 . . . . 0.0 113.436 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . 0.274 0.2 OUTLIER -86.92 36.75 0.73 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.73 -80.31 0.21 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.627 1.558 . . . . 0.0 108.787 168.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 68.0 mtm -134.1 27.86 3.83 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.446 1.099 . . . . 0.0 109.857 -169.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -75.17 -43.29 53.08 Favored 'General case' 0 CA--C 1.527 0.061 0 O-C-N 121.187 -0.946 . . . . 0.0 109.726 167.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.27 156.13 29.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.075 2.15 . . . . 0.0 111.917 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.73 -47.96 2.59 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -166.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -98.13 -39.3 8.96 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.771 0.829 . . . . 0.0 112.864 168.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 115.05 7.5 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 70.06 44.9 0.74 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.221 1.008 . . . . 0.0 110.624 -172.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.8 mt 48.35 -173.39 0.01 OUTLIER 'General case' 0 C--N 1.345 0.41 0 C-N-CA 125.497 1.519 . . . . 0.0 111.896 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.92 113.76 62.04 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.348 -177.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.52 174.67 11.28 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.154 1.903 . . . . 0.0 111.025 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.4 95.77 1.29 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -54.22 116.43 2.6 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.366 1.467 . . . . 0.0 112.066 -168.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.49 164.82 15.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.477 2.311 . . . . 0.0 112.326 -161.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.16 139.67 35.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 160.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 C--O 1.25 1.105 0 C-N-CA 128.075 2.55 . . . . 0.0 110.606 -170.585 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 t -152.38 114.54 4.45 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.697 -1.252 . . . . 0.0 109.87 168.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.43 63.12 1.42 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 161.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 t -70.19 -82.5 0.04 OUTLIER 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 124.768 1.227 . . . . 0.0 108.546 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.26 50.04 6.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.392 0.615 . . . . 0.0 111.006 167.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.39 22.39 0.75 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.352 1.453 . . . . 0.0 113.722 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -82.6 177.69 8.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.875 1.337 . . . . 0.0 109.827 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -66.15 -23.42 66.47 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 118.023 -1.471 . . . . 0.0 111.468 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.84 -18.68 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 114.35 169.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 3.5 t-20 -53.09 -44.64 67.73 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.825 0.85 . . . . 0.0 111.024 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . 0.286 0.0 OUTLIER -85.05 -30.22 24.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.573 0.749 . . . . 0.0 111.769 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.55 -54.23 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.593 1.157 . . . . 0.0 110.656 170.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -70.15 -20.9 63.13 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.244 -0.91 . . . . 0.0 111.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 14' ' ' LYS . 22.2 ttmt -75.9 -28.14 57.94 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 118.016 -0.992 . . . . 0.0 113.535 175.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -58.73 -49.91 75.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 119.742 1.155 . . . . 0.0 110.386 163.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -56.6 -43.5 78.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -51.7 68.53 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.229 1.012 . . . . 0.0 111.967 170.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -58.98 -41.02 86.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 -169.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -65.1 -31.71 73.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.704 2.002 . . . . 0.0 111.861 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -29.61 59.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.518 1.054 . . . . 0.0 113.787 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.5 -53.29 54.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 119.45 1.023 . . . . 0.0 109.053 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -45.37 93.9 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -161.49 51.55 0.24 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 123.433 1.587 . . . . 0.0 109.862 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.77 -17.49 14.8 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 117.525 -1.708 . . . . 0.0 114.91 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.77 -51.12 58.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 120.669 2.235 . . . . 0.0 110.852 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -68.08 -28.25 67.19 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.773 -1.205 . . . . 0.0 111.37 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -73.7 -35.75 65.18 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.772 -1.205 . . . . 0.0 108.659 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 54' ' ' VAL . 31.4 t -55.97 -42.03 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.867 1.267 . . . . 0.0 109.459 165.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 4.1 mmpt? -69.31 -29.9 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.55 1.523 . . . . 0.0 113.185 174.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -68.46 -49.33 60.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.591 1.542 . . . . 0.0 111.893 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.06 -48.43 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.003 1.274 . . . . 0.0 109.67 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.08 47.19 84.55 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.646 -1.641 . . . . 0.0 113.935 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.52 171.0 37.41 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.567 1.684 . . . . 0.0 110.728 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.36 131.1 54.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 162.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -129.4 165.57 21.29 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.991 0.424 . . . . 0.0 111.279 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.8 137.62 52.62 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.073 1.749 . . . . 0.0 108.722 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -89.62 109.15 20.13 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.532 1.133 . . . . 0.0 108.668 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HE2' HG21 ' A' ' 72' ' ' THR . 15.4 mttm -87.37 103.32 15.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 121.03 1.741 . . . . 0.0 107.626 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.416 HG22 ' CE2' ' A' ' 80' ' ' PHE . 5.5 t -112.14 94.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.611 -0.681 . . . . 0.0 109.335 -170.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.49 174.43 6.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.383 -1.448 . . . . 0.0 110.294 171.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 59.34 43.81 16.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.205 1.802 . . . . 0.0 112.105 169.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 77' ' ' ASP . . . -78.1 -167.96 31.57 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.082 -1.011 . . . . 0.0 113.862 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.28 -11.5 10.85 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.025 3.15 . . . . 0.0 114.05 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.25 -5.19 8.85 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.535 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.04 74.73 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.21 1.505 . . . . 0.0 112.084 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.7 -175.66 0.2 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.271 1.828 . . . . 0.0 109.768 165.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -135.79 150.71 49.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.145 1.778 . . . . 0.0 109.205 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.87 172.09 13.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.829 2.052 . . . . 0.0 109.065 177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.5 m -145.91 147.3 31.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 108.32 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.403 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -117.59 142.84 46.74 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 163.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.03 143.61 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.4 t -127.31 118.67 50.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.93 110.45 18.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 165.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.461 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -128.44 43.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.308 168.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -132.51 -44.9 0.9 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.377 -0.827 . . . . 0.0 111.611 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -95.84 148.12 22.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 123.734 0.646 . . . . 0.0 109.451 -172.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.95 -130.55 51.04 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 173.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.821 ' H ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.02 4.3 34.32 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.08 1.352 . . . . 0.0 112.383 173.146 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.35 157.73 18.86 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.8 m -172.26 153.01 2.9 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 128.447 2.699 . . . . 0.0 108.028 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 68.0 t -88.09 156.16 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mt -132.79 96.4 18.31 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 -173.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.98 140.32 41.57 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.04 1.827 . . . . 0.0 109.025 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.9 22.79 4.51 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.047 2.139 . . . . 0.0 112.957 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.47 133.95 35.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.419 0.628 . . . . 0.0 110.177 -157.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.36 -7.16 51.93 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.633 1.173 . . . . 0.0 110.594 165.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -52.48 132.92 35.57 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -74.64 -177.09 3.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.085 0.945 . . . . 0.0 109.651 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.62 153.03 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.968 1.707 . . . . 0.0 108.824 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.56 -25.15 56.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.48 -176.22 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.197 0.999 . . . . 0.0 109.47 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.445 HG21 ' HE2' ' A' ' 38' ' ' LYS . 21.4 m -137.66 -175.77 4.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.932 0.893 . . . . 0.0 108.764 -171.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 tt -145.83 142.5 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 154.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.19 146.2 24.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 157.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.454 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 31.4 mtt -134.19 -51.29 0.82 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 157.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.93 161.35 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.143 3.377 . . . . 0.0 107.966 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.464 ' CB ' ' HA2' ' A' ' 42' ' ' GLY . 6.0 t70 -66.72 -47.04 73.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 122.96 0.504 . . . . 0.0 110.863 -171.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.6 m -55.29 -36.25 65.96 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.448 0.699 . . . . 0.0 110.326 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.11 -59.43 2.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.307 1.843 . . . . 0.0 109.849 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 75' ' ' MET . 10.7 m-85 -50.83 -58.75 5.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.39 1.876 . . . . 0.0 111.91 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -42.87 99.87 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.956 0.902 . . . . 0.0 109.81 -172.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -23.24 65.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.87 -173.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mt -67.77 -51.5 48.26 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.496 1.118 . . . . 0.0 110.882 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -49.76 18.32 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.191 0.905 . . . . 0.0 112.556 176.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.1 m -74.53 2.13 10.38 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.594 1.157 . . . . 0.0 112.039 -174.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.53 15.78 64.42 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 120.097 -1.627 . . . . 0.0 113.147 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -72.33 -3.53 24.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.457 1.129 . . . . 0.0 111.552 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 8.5 ttm 85.05 91.18 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.22 2.208 . . . . 0.0 110.914 164.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -139.63 123.34 10.79 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 161.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.76 -173.96 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.314 2.676 . . . . 0.0 111.251 158.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -48.51 143.64 4.8 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.576 -0.703 . . . . 0.0 109.271 161.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.2 m -65.78 -29.74 70.28 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.26 0.552 . . . . 0.0 110.294 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.7 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.456 1.902 . . . . 0.0 111.235 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.66 -143.76 0.31 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.709 1.203 . . . . 0.0 111.886 171.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -1.23 56.78 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.602 1.092 . . . . 0.0 112.471 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -71.8 -60.66 2.12 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.985 1.714 . . . . 0.0 109.645 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.87 61.68 2.36 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 125.7 1.619 . . . . 0.0 111.091 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -64.84 -2.32 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 167.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.5 tp 42.28 70.12 0.31 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.384 1.874 . . . . 0.0 111.821 -163.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -68.69 175.97 3.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.791 160.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.09 172.45 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 166.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.3 p 44.72 -161.53 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.134 2.173 . . . . 0.0 113.816 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.05 27.02 0.03 OUTLIER Glycine 0 C--N 1.338 0.688 0 O-C-N 120.828 -1.17 . . . . 0.0 114.25 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -66.46 148.37 51.97 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.207 1.004 . . . . 0.0 112.001 -166.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 39.8 tpp -60.09 101.07 0.11 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.581 1.952 . . . . 0.0 109.116 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.26 -85.62 0.22 Allowed Glycine 0 C--O 1.224 -0.482 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 pp -51.55 -22.27 3.11 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.82 68.31 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.693 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.43 -22.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.976 1.31 . . . . 0.0 113.225 173.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.99 71.13 2.76 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 119.754 -1.841 . . . . 0.0 111.591 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.39 160.68 37.15 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.064 2.145 . . . . 0.0 108.397 169.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -117.28 -79.88 0.6 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 160.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -54.32 -26.74 31.37 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.515 1.126 . . . . 0.0 113.527 -171.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.85 -10.98 53.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.359 1.064 . . . . 0.0 112.947 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -137.88 54.72 1.8 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.501 1.521 . . . . 0.0 107.106 166.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.343 0.4 OUTLIER 38.49 -173.85 0.0 OUTLIER 'General case' 0 C--N 1.348 0.535 0 C-N-CA 128.752 2.821 . . . . 0.0 113.387 -175.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -104.56 129.46 24.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 120.13 -1.606 . . . . 0.0 107.858 -169.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.56 174.09 13.2 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.059 1.839 . . . . 0.0 111.63 -167.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 171.05 141.98 3.5 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -74.68 119.89 19.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 167.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.37 147.98 34.11 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.013 1.725 . . . . 0.0 109.151 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -93.13 141.5 28.34 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.611 0.641 . . . . 0.0 111.081 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.981 0 C-N-CA 128.413 2.685 . . . . 0.0 110.276 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 121.819 0.819 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 p -95.59 -62.27 1.32 Allowed 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.57 -0.706 . . . . 0.0 109.474 163.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.9 152.03 23.8 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.85 1.26 . . . . 0.0 112.488 -175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 m -176.0 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.241 2.616 . . . . 0.0 106.093 -164.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 67.95 44.48 1.51 Allowed 'General case' 0 C--N 1.347 0.479 0 CA-C-O 121.277 0.561 . . . . 0.0 111.978 165.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.05 42.52 1.27 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.434 1.016 . . . . 0.0 112.535 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -85.1 -176.54 6.22 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.426 1.613 . . . . 0.0 110.583 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -72.36 -17.15 61.86 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.033 -1.042 . . . . 0.0 111.394 164.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.32 -23.98 4.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.2 1.0 . . . . 0.0 112.903 170.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -45.63 77.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.117 1.367 . . . . 0.0 110.32 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.24 -48.77 76.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.171 1.388 . . . . 0.0 109.67 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.3 t -58.65 -54.29 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.725 1.21 . . . . 0.0 111.421 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -64.31 -26.22 68.39 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.911 1.232 . . . . 0.0 111.88 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -75.06 -23.65 58.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.506 -0.746 . . . . 0.0 112.589 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.52 -52.62 53.79 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.434 0.459 . . . . 0.0 109.932 166.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.5 mt -58.64 -48.28 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.186 1.395 . . . . 0.0 107.83 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -55.78 -51.1 68.59 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.759 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -57.99 -47.56 82.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.948 0.795 . . . . 0.0 109.425 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -38.8 88.83 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.559 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.413 HD21 HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.55 -38.99 72.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.816 1.246 . . . . 0.0 113.814 172.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.12 -52.94 56.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.29 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.54 -45.74 90.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.828 1.194 . . . . 0.0 111.58 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -162.73 56.1 0.21 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.138 0.97 . . . . 0.0 111.893 -169.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.51 -16.01 69.04 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 120.905 -1.122 . . . . 0.0 113.103 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.63 -43.3 68.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.764 1.282 . . . . 0.0 112.165 -171.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.77 -32.02 59.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.566 0.746 . . . . 0.0 110.16 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.76 -26.8 60.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -60.31 -28.3 41.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -66.08 -21.91 66.39 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.319 -0.863 . . . . 0.0 111.405 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 9.8 mmpt? -73.0 -70.82 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.266 1.394 . . . . 0.0 111.241 -172.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.65 -59.98 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 56.76 13.05 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.807 1.194 . . . . 0.0 113.146 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.81 42.57 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.38 146.68 7.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 149.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -141.33 177.19 8.27 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 118.969 -1.093 . . . . 0.0 109.581 158.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 72' ' ' THR . . . -124.73 164.15 20.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.502 1.121 . . . . 0.0 108.897 171.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -121.98 106.99 11.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.174 1.79 . . . . 0.0 108.832 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -73.71 110.49 8.04 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 120.282 1.401 . . . . 0.0 112.107 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.07 98.25 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 174.69 7.04 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 166.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 49.75 53.19 13.19 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.982 2.113 . . . . 0.0 113.737 172.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.64 176.54 2.23 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.399 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -59.01 84.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.448 3.432 . . . . 0.0 108.433 158.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.17 -76.46 0.3 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -167.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 139.54 -12.27 3.21 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.506 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -70.18 -171.58 0.47 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.774 1.787 . . . . 0.0 110.978 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -116.1 160.64 20.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.222 1.809 . . . . 0.0 108.772 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.41 166.05 30.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.545 2.338 . . . . 0.0 106.296 173.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 m -150.81 128.88 11.83 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.78 0.832 . . . . 0.0 109.996 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -94.3 127.34 40.1 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 167.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.18 149.59 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.2 119.97 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.26 106.78 18.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 172.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 HD21 ' A' ' 20' ' ' LEU . 1.2 m -138.17 56.78 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 121.611 -0.681 . . . . 0.0 110.474 174.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -139.91 -53.63 0.53 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.307 1.043 . . . . 0.0 109.683 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -78.39 140.9 38.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.942 1.697 . . . . 0.0 108.152 -172.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 -137.57 32.85 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -104.88 8.26 34.64 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.015 1.726 . . . . 0.0 111.724 169.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.44 157.34 29.85 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -173.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.9 m -172.52 161.35 4.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 131.621 3.968 . . . . 0.0 105.991 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -109.96 154.38 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.9 mt -134.25 70.35 73.37 Favored Pre-proline 0 C--O 1.236 0.368 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -158.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.99 142.65 62.82 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.539 2.159 . . . . 0.0 109.28 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 54.88 23.22 4.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.766 2.427 . . . . 0.0 112.437 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 t -87.61 138.32 31.57 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.042 1.292 . . . . 0.0 110.26 -164.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.65 -4.87 58.4 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.48 1.912 . . . . 0.0 111.223 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -60.56 145.18 49.67 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 118.399 -1.32 . . . . 0.0 108.324 170.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -69.6 -173.6 0.61 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.221 1.808 . . . . 0.0 110.378 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.11 133.88 16.79 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.135 -0.353 . . . . 0.0 111.562 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.29 -52.89 4.35 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.933 2.493 . . . . 0.0 111.053 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.3 m -149.42 168.99 21.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.994 2.518 . . . . 0.0 106.767 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 73' ' ' ILE . 87.9 m -121.83 -171.07 2.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.426 ' N ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -143.05 167.61 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 158.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.77 159.68 16.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.748 1.613 . . . . 0.0 106.756 160.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -150.57 -38.86 0.13 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 117.661 -1.162 . . . . 0.0 111.817 158.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 95.57 157.89 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.545 2.338 . . . . 0.0 110.035 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -59.78 -46.77 88.15 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 123.802 0.841 . . . . 0.0 111.134 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -44.01 73.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.574 -1.648 . . . . 0.0 109.338 -175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.03 -65.22 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 128.326 2.65 . . . . 0.0 112.06 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 75' ' ' MET . 43.3 m-85 -51.09 -45.36 61.45 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 110.401 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 tp -60.77 -69.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.616 0.644 . . . . 0.0 109.322 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.37 75.08 Favored 'General case' 0 CA--C 1.524 -0.057 0 C-N-CA 124.244 1.018 . . . . 0.0 113.269 -165.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 tp -52.01 -66.25 0.42 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.677 1.191 . . . . 0.0 109.654 -176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.4 ptm -76.36 -19.48 58.14 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.8 m -77.25 12.35 1.53 Allowed 'General case' 0 CA--C 1.545 0.774 0 O-C-N 120.385 -1.447 . . . . 0.0 111.883 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.46 48.1 86.07 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.102 -1.624 . . . . 0.0 110.477 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -134.28 25.75 3.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.844 1.657 . . . . 0.0 110.153 -177.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 89.0 mtp 71.99 -74.56 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 129.225 3.01 . . . . 0.0 112.223 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.294 0.6 OUTLIER 33.78 89.11 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 127.254 2.222 . . . . 0.0 112.643 -136.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.68 100.86 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.671 2.247 . . . . 0.0 109.893 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 71.26 123.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.532 2.333 . . . . 0.0 110.191 -167.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.9 m -74.36 -103.17 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.58 ' HA ' HE21 ' A' ' 96' ' ' GLN . . . -73.99 -17.77 60.95 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 118.479 -2.638 . . . . 0.0 112.688 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -38.65 91.69 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 117.759 -1.115 . . . . 0.0 109.385 175.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -55.23 -60.54 3.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.969 1.259 . . . . 0.0 110.034 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.58 HE21 ' HA ' ' A' ' 93' ' ' ALA . 6.9 pt20 -69.72 -27.41 64.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.62 24.71 76.11 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 118.852 0.751 . . . . 0.0 113.441 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -76.62 41.22 0.25 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.084 1.442 . . . . 0.0 110.859 175.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 35.2 73.48 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.772 2.429 . . . . 0.0 113.239 168.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.414 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -64.05 138.74 58.6 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.109 -0.995 . . . . 0.0 109.07 -172.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.46 159.23 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.488 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 p -139.7 172.53 12.66 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.287 1.435 . . . . 0.0 109.682 -167.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.15 -56.27 0.71 Allowed Glycine 0 N--CA 1.466 0.685 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -60.93 -17.33 50.55 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.806 0.842 . . . . 0.0 112.37 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 58.2 mtm 47.87 -168.98 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.175 2.19 . . . . 0.0 111.198 -166.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.57 -111.62 2.23 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 124.979 1.276 . . . . 0.0 111.06 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.745 HD23 ' HE3' ' A' ' 110' ' ' LYS . 11.1 mt 63.69 -36.48 0.16 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 129.252 3.021 . . . . 0.0 114.217 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.49 -70.96 0.17 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.923 1.689 . . . . 0.0 110.158 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.7 mtt -76.3 65.8 2.28 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.353 0.978 . . . . 0.0 111.7 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.745 ' HE3' HD23 ' A' ' 107' ' ' LEU . 27.4 mttt -75.72 36.99 0.14 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.004 1.722 . . . . 0.0 112.728 167.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 46.34 -155.19 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.016 1.726 . . . . 0.0 110.683 -175.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.49 -50.48 4.72 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.55 1.068 . . . . 0.0 110.493 164.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -54.82 -28.04 46.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tp -85.08 9.73 13.98 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 122.032 2.197 . . . . 0.0 111.827 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.96 48.81 0.85 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.251 2.22 . . . . 0.0 110.466 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.3 mt 56.41 163.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 129.738 3.215 . . . . 0.0 114.83 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 134.48 88.07 Favored Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.788 163.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.78 173.55 10.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.204 1.269 . . . . 0.0 109.317 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.22 81.99 1.63 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -144.35 -179.39 6.5 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.169 2.187 . . . . 0.0 105.522 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.92 -52.4 0.29 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.219 1.008 . . . . 0.0 109.655 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? 71.16 103.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 128.788 2.835 . . . . 0.0 112.053 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 C--O 1.251 1.135 0 C-N-CA 129.803 3.241 . . . . 0.0 111.948 168.854 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t -153.82 -155.44 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.061 -2.199 . . . . 0.0 105.061 165.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.99 168.99 5.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.23 1.014 . . . . 0.0 110.98 163.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -96.63 -134.13 0.22 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 127.451 2.3 . . . . 0.0 108.755 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 44.29 23.53 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 119.971 3.323 . . . . 0.0 119.971 129.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.75 82.88 0.18 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 126.573 2.035 . . . . 0.0 108.16 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -153.42 160.78 42.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.628 1.571 . . . . 0.0 108.449 -166.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -24.97 50.49 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.3 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.35 -10.69 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.378 1.871 . . . . 0.0 114.624 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 1.5 t-20 -51.35 -44.21 61.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.409 0.684 . . . . 0.0 110.943 172.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -73.39 -38.35 65.68 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.351 178.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' N ' HD13 ' A' ' 11' ' ' LEU . 48.0 t -58.34 -60.78 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 C-N-CA 125.005 1.322 . . . . 0.0 109.969 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 16' ' ' ILE . 39.8 m-85 -66.78 -19.63 65.79 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.746 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -75.56 -28.6 59.07 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.73 ' HG3' HD21 ' A' ' 116' ' ' LEU . 35.7 mm-40 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.533 172.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.784 HD11 ' HE1' ' A' ' 84' ' ' MET . 48.2 mt -68.56 -52.42 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.37 -54.78 12.71 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 125.176 1.39 . . . . 0.0 109.895 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -44.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.214 1.005 . . . . 0.0 110.944 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -44.96 79.12 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.168 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -35.15 66.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 112.635 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.48 -52.9 55.55 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.78 172.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -67.52 -45.69 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.408 -1.433 . . . . 0.0 114.189 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -153.22 64.94 0.76 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.925 1.69 . . . . 0.0 109.461 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.38 -22.41 70.52 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-O 118.333 -1.259 . . . . 0.0 111.177 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -52.48 -38.09 58.65 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.721 1.26 . . . . 0.0 111.429 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.22 -42.97 44.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.735 1.214 . . . . 0.0 109.225 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -20.81 63.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.598 -0.689 . . . . 0.0 111.442 -176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 55' ' ' LYS . 48.3 t -57.27 -38.9 64.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 119.131 0.878 . . . . 0.0 110.213 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -74.84 -5.03 41.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.884 -1.135 . . . . 0.0 113.103 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -69.27 0.68 Allowed 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.936 1.244 . . . . 0.0 110.353 174.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.54 -62.97 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 58.33 9.39 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.728 1.156 . . . . 0.0 113.28 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.97 -169.24 29.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.77 125.89 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 157.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -121.42 172.65 7.9 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' A' ' 72' ' ' THR . . . -128.03 131.32 49.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.994 1.717 . . . . 0.0 108.578 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -82.05 93.86 7.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -74.71 101.13 4.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.252 1.842 . . . . 0.0 109.834 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG22 ' CE2' ' A' ' 80' ' ' PHE . 89.2 t -104.22 121.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -115.77 179.7 3.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.363 1.465 . . . . 0.0 109.421 162.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t70 54.69 53.86 10.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.391 1.091 . . . . 0.0 112.273 164.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.43 -154.91 10.65 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.534 1.54 . . . . 0.0 109.784 168.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -48.74 114.91 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.236 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.9 -8.07 17.58 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.265 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.27 16.49 62.48 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 120.547 2.173 . . . . 0.0 112.083 169.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -61.66 -175.12 0.05 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.18 1.392 . . . . 0.0 111.007 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -150.47 111.58 4.36 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.336 -171.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 174.65 5.86 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.77 2.028 . . . . 0.0 110.416 -175.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 m -147.75 149.43 32.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.354 1.062 . . . . 0.0 109.018 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.434 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -116.7 117.12 28.93 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 166.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.79 128.59 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.517 HG12 HG22 ' A' ' 54' ' ' VAL . 98.2 t -112.07 110.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.63 129.83 34.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -133.16 30.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.603 ' HA ' HG13 ' A' ' 28' ' ' VAL . 3.6 tmtm? -140.09 -25.9 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 120.981 -1.074 . . . . 0.0 112.775 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -84.71 111.67 19.8 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.63 -117.86 7.96 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -85.99 0.34 53.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.157 0.978 . . . . 0.0 112.566 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.23 156.66 3.81 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 -157.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.7 m -172.23 149.59 2.3 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.418 2.287 . . . . 0.0 106.327 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.72 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mt -127.22 81.61 69.68 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 -170.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.12 144.94 65.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.057 1.838 . . . . 0.0 109.728 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 37.47 44.05 0.46 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.308 2.643 . . . . 0.0 111.292 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.7 t -85.8 142.74 28.72 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.693 1.235 . . . . 0.0 109.615 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.26 -17.9 59.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 111.182 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -57.46 133.05 54.87 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -60.96 -175.75 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.998 1.38 . . . . 0.0 109.778 167.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.45 155.49 48.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.152 166.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.41 -27.74 64.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.535 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.7 p -145.62 -175.92 4.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.551 0.74 . . . . 0.0 112.856 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.4 m -136.14 -171.99 3.02 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.474 ' H ' HG22 ' A' ' 72' ' ' THR . 3.6 tt -142.27 175.6 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 161.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.2 m -141.73 137.44 31.66 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 119.335 -2.103 . . . . 0.0 108.373 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.1 ptp -148.65 -28.83 0.29 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 117.528 -1.669 . . . . 0.0 115.217 161.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 97.43 147.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.972 3.309 . . . . 0.0 110.618 -162.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.99 -47.95 84.06 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 127.215 2.206 . . . . 0.0 110.443 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.8 m -66.43 -11.46 52.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.3 -173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.93 -40.24 5.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 168.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.649 ' CE2' HG22 ' A' ' 39' ' ' VAL . 3.3 m-85 -47.42 -54.03 12.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.683 1.193 . . . . 0.0 109.987 171.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.47 -62.26 1.44 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.593 1.957 . . . . 0.0 108.383 176.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.56 -39.94 77.79 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.693 0.797 . . . . 0.0 112.435 -174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -65.75 0.51 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.479 0.712 . . . . 0.0 110.482 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.784 ' HE1' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -76.68 -26.62 54.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -175.019 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.3 m -73.95 -3.65 30.33 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 120.507 -1.371 . . . . 0.0 110.838 -175.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.89 62.85 1.8 Allowed Glycine 0 C--N 1.338 0.67 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -145.76 -9.35 0.54 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.121 1.368 . . . . 0.0 112.195 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 6.2 mtt -151.33 149.94 29.93 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.708 1.14 . . . . 0.0 112.846 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -75.61 160.88 78.27 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.454 0.701 . . . . 0.0 110.087 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.5 165.5 31.55 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.67 1.58 . . . . 0.0 113.014 -165.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.39 97.86 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.182 2.193 . . . . 0.0 110.362 -161.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.3 t -54.55 -61.72 2.13 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 123.887 0.875 . . . . 0.0 109.81 172.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.69 -63.33 1.21 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 116.922 -1.513 . . . . 0.0 111.891 -162.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.2 t80 22.87 -89.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 127.853 2.461 . . . . 0.0 113.91 161.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -62.12 1.51 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.917 1.687 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -64.24 -10.93 26.63 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.67 28.05 62.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.524 1.059 . . . . 0.0 114.667 165.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -65.98 17.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.522 2.329 . . . . 0.0 115.493 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 tp 47.09 61.84 2.67 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.053 1.741 . . . . 0.0 109.063 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.47 142.44 57.55 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 173.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.76 164.62 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.87 131.28 40.61 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.995 -1.065 . . . . 0.0 108.533 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.91 60.87 0.59 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 59.38 -150.71 0.43 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.194 0.998 . . . . 0.0 108.556 -161.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.9 ttp -138.38 148.17 44.22 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.251 1.42 . . . . 0.0 107.563 -168.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.64 8.91 49.46 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.398 0.999 . . . . 0.0 113.699 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.6 -36.18 75.78 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.847 1.259 . . . . 0.0 113.658 -164.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.94 -88.5 0.08 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -170.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.6 mmt 29.1 -83.0 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.26 2.624 . . . . 0.0 114.02 169.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -76.27 33.48 0.13 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.031 1.332 . . . . 0.0 113.225 -175.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.76 102.33 3.97 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -115.79 -55.54 2.42 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -97.6 -23.82 15.81 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 161.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 tp -68.51 -5.62 20.54 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -166.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -136.82 55.6 1.83 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.221 1.408 . . . . 0.0 107.324 167.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 15' ' ' GLU . 13.5 mt 51.05 -174.01 0.02 OUTLIER 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.071 1.348 . . . . 0.0 114.369 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -146.05 129.22 8.21 Favored Pre-proline 0 N--CA 1.452 -0.343 0 O-C-N 121.527 -0.733 . . . . 0.0 111.599 -176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -69.2 173.9 9.8 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.743 1.628 . . . . 0.0 110.291 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.81 62.13 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 107.884 -2.087 . . . . 0.0 107.884 -170.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.63 167.84 22.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.336 1.054 . . . . 0.0 109.446 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.96 15.18 0.41 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -169.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -134.28 151.32 51.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.9 1.227 . . . . 0.0 110.82 -168.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.989 0 C-N-CA 129.536 3.134 . . . . 0.0 111.852 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t -53.58 93.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.487 1.915 . . . . 0.0 112.874 -158.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.43 -22.59 0.33 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.79 1.236 . . . . 0.0 113.164 -171.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.0 m -157.76 -155.48 0.51 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.794 1.238 . . . . 0.0 108.581 -156.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.67 22.91 13.63 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 149.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.2 11.77 0.06 OUTLIER Glycine 0 N--CA 1.466 0.671 0 O-C-N 120.782 -1.199 . . . . 0.0 115.442 -162.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.412 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 1.2 m-30 -80.21 178.51 8.22 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.823 1.249 . . . . 0.0 108.671 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HA ' HD23 ' A' ' 11' ' ' LEU . 23.7 tttm -69.65 -17.92 63.54 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.735 -1.853 . . . . 0.0 111.378 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.37 17.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.265 1.026 . . . . 0.0 112.815 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -58.6 -40.05 82.11 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.516 1.527 . . . . 0.0 110.275 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 8' ' ' LYS . 1.4 mm? -61.53 -51.89 66.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.307 1.843 . . . . 0.0 109.79 175.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.55 -43.61 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.493 2.317 . . . . 0.0 111.943 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.18 -26.94 61.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.168 0.894 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -71.48 -24.77 62.05 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 118.977 0.808 . . . . 0.0 112.619 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -61.13 -46.31 91.09 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 165.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.8 -45.44 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.04 -55.22 33.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.824 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -52.48 -50.51 62.57 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -168.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -65.56 -27.11 68.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.666 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -33.45 66.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.075 0.852 . . . . 0.0 112.006 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.17 -52.3 59.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 170.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -57.58 -45.2 85.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.534 1.134 . . . . 0.0 111.795 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -165.54 62.79 0.11 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.954 0.902 . . . . 0.0 110.897 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.01 -29.18 71.87 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 116.869 -2.073 . . . . 0.0 114.486 -172.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -36.97 3.59 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.99 2.395 . . . . 0.0 112.918 172.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -81.38 -16.84 51.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -93.49 -34.91 13.21 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.088 1.355 . . . . 0.0 108.212 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.2 -46.09 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 126.151 1.78 . . . . 0.0 109.036 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -64.39 -23.94 67.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.562 1.528 . . . . 0.0 113.776 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -74.13 -29.21 61.71 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.411 -0.806 . . . . 0.0 111.828 -166.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mp -117.36 -49.76 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.557 2.343 . . . . 0.0 110.321 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.19 49.26 58.69 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.861 1.696 . . . . 0.0 116.245 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.46 160.55 27.36 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.758 1.779 . . . . 0.0 108.759 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.95 139.14 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 3.6 p90 -127.15 164.55 21.37 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.978 -1.076 . . . . 0.0 109.961 158.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 156.31 21.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.602 1.161 . . . . 0.0 109.342 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 35' ' ' PHE . 6.6 m-85 -114.72 108.34 16.65 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.464 1.506 . . . . 0.0 108.734 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -87.09 95.9 10.11 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -85.09 116.6 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -107.91 176.63 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 119.07 0.85 . . . . 0.0 109.152 162.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t0 46.42 50.79 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.573 1.549 . . . . 0.0 113.776 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 7' ' ' PHE . . . -63.5 165.55 27.94 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.977 167.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -47.46 98.43 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.656 3.571 . . . . 0.0 112.648 172.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.81 -41.3 1.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.237 1.875 . . . . 0.0 111.765 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.59 -8.35 3.39 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.701 -1.61 . . . . 0.0 114.574 163.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -67.61 -175.26 0.5 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.191 1.796 . . . . 0.0 112.782 -174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -125.15 146.23 49.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.935 1.694 . . . . 0.0 111.221 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.93 162.08 34.25 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.716 3.207 . . . . 0.0 106.832 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.7 m -139.25 148.13 42.64 Favored 'General case' 0 C--O 1.228 -0.053 0 CA-C-N 119.082 0.856 . . . . 0.0 110.059 166.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -117.65 156.81 27.54 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 168.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.42 134.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 57.6 t -123.41 112.75 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -91.98 80.28 5.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.43 53.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -146.62 -54.18 0.24 Allowed 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.18 0.992 . . . . 0.0 110.042 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -95.36 140.45 30.23 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.016 0.823 . . . . 0.0 109.586 -164.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.9 -140.9 43.76 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -84.84 -0.1 52.8 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.506 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 157.07 15.97 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 120.795 1.634 . . . . 0.0 111.873 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m -171.77 166.08 6.54 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.913 3.285 . . . . 0.0 108.87 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.33 93.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 127.941 2.496 . . . . 0.0 107.254 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -74.9 101.28 0.48 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 127.231 2.212 . . . . 0.0 107.001 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -70.5 131.22 19.77 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.372 2.714 . . . . 0.0 111.308 -166.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 47.24 24.56 0.44 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.317 2.247 . . . . 0.0 112.591 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.54 143.79 40.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -160.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -73.59 -15.79 61.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.575 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -57.92 145.11 36.76 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 117.708 -1.597 . . . . 0.0 110.429 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.79 -176.18 0.05 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.861 1.315 . . . . 0.0 109.895 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.95 168.06 20.67 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.638 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -37.48 55.6 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.395 0.678 . . . . 0.0 111.391 171.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.9 m -150.93 -173.14 4.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.084 2.153 . . . . 0.0 109.307 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -133.95 -172.92 3.11 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.062 -1.024 . . . . 0.0 108.736 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tt -147.44 165.07 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 155.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -126.48 124.29 39.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 165.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.71 136.62 17.25 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 155.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.15 163.59 1.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 168.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.04 -52.01 62.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.057 1.343 . . . . 0.0 111.005 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.66 -33.77 61.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.3 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.87 -35.26 14.88 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.33 2.252 . . . . 0.0 111.381 -169.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.92 -54.77 33.37 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.482 1.113 . . . . 0.0 108.357 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -31.48 68.59 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.555 0.742 . . . . 0.0 110.361 -175.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.55 -41.76 10.21 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.048 1.339 . . . . 0.0 113.727 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -59.01 -75.51 0.05 Allowed 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -170.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.56 52.22 0.79 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.2 p -152.78 -35.91 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.144 -0.973 . . . . 0.0 110.833 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 132.83 -6.64 5.17 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 118.8 -1.0 . . . . 0.0 115.144 167.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -69.19 -52.81 24.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.124 1.962 . . . . 0.0 109.153 161.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 3.3 mtm 54.55 169.71 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.264 1.825 . . . . 0.0 112.574 -162.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -177.42 53.99 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 127.559 2.344 . . . . 0.0 107.695 160.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -67.48 147.3 76.84 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.89 1.726 . . . . 0.0 109.007 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.48 -25.87 0.06 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.301 1.841 . . . . 0.0 114.907 -173.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 t -50.61 -24.26 3.15 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.029 2.132 . . . . 0.0 112.226 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 100' ' ' LYS . . . -62.09 -26.12 68.1 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.14 -0.975 . . . . 0.0 111.713 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -83.02 -51.99 7.06 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.877 1.217 . . . . 0.0 109.615 164.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -58.09 -51.5 69.44 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.192 1.397 . . . . 0.0 110.863 -161.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -71.28 -70.38 0.32 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.561 1.544 . . . . 0.0 107.652 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 150.06 61.25 0.01 OUTLIER Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -99.79 -6.65 26.6 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.796 163.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.4 tp 49.31 80.56 0.06 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 126.722 2.009 . . . . 0.0 110.565 -168.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -71.19 174.83 5.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.38 168.84 17.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -152.7 -139.51 0.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 130.198 3.399 . . . . 0.0 105.783 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.34 -53.64 0.58 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 120.618 1.554 . . . . 0.0 110.836 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -65.82 -29.28 69.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.901 0.85 . . . . 0.0 111.909 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 57.44 -165.36 0.16 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -160.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.57 -50.49 4.07 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.752 -1.218 . . . . 0.0 113.264 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -48.09 -61.75 1.82 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.001 1.72 . . . . 0.0 111.766 -171.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.0 -0.62 40.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.851 0.861 . . . . 0.0 112.929 -170.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -86.27 -48.42 8.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -75.82 -72.97 0.29 Allowed 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.399 -0.813 . . . . 0.0 112.155 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 34.63 38.84 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 130.799 3.64 . . . . 0.0 115.542 -166.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -106.7 -96.19 0.36 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.121 1.328 . . . . 0.0 108.774 -167.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -19.33 64.34 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.904 1.684 . . . . 0.0 110.223 174.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -13.91 32.76 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 171.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -141.69 62.83 1.44 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.042 0.937 . . . . 0.0 109.514 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . 0.329 0.1 OUTLIER 49.77 -173.48 0.02 OUTLIER 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.421 1.089 . . . . 0.0 113.596 170.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.95 121.84 4.14 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 119.876 -1.765 . . . . 0.0 112.156 170.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.69 173.54 13.75 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.288 1.992 . . . . 0.0 110.289 172.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.33 -175.93 30.12 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 123.71 0.671 . . . . 0.0 111.455 -173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -158.22 123.69 4.47 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.409 1.484 . . . . 0.0 107.776 168.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 50.37 97.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.997 2.919 . . . . 0.0 113.432 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.48 155.03 0.14 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.303 2.241 . . . . 0.0 108.633 -174.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 123' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.397 1.079 . . . . 0.0 109.264 174.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t -143.34 89.57 2.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 171.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.61 179.34 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.469 2.308 . . . . 0.0 112.881 -165.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -177.17 -36.22 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.416 1.087 . . . . 0.0 111.046 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.39 25.95 6.82 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.039 1.4 . . . . 0.0 112.022 154.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.4 84.41 0.36 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 129.349 3.356 . . . . 0.0 108.414 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 34.6 m-85 -152.83 149.74 28.61 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.675 2.39 . . . . 0.0 107.824 -167.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -6.67 51.13 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.846 -1.159 . . . . 0.0 111.782 174.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.28 -16.46 53.97 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.883 0.873 . . . . 0.0 112.975 160.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -59.09 -58.41 8.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.844 1.202 . . . . 0.0 111.019 -168.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 11' ' ' LEU 0.279 0.0 OUTLIER -64.77 -31.37 72.57 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.346 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.36 -55.92 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.813 2.445 . . . . 0.0 110.618 171.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -65.83 -29.34 69.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.683 1.128 . . . . 0.0 111.119 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -70.09 -24.93 63.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 118.043 -0.98 . . . . 0.0 112.771 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.585 ' HG2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.05 -44.17 73.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 176.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -52.02 -54.33 14.23 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -57.33 -48.48 78.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 118.876 -0.583 . . . . 0.0 110.965 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -56.59 -46.85 80.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -66.11 -42.28 89.43 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.69 177.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -32.54 62.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.307 6.5 mm-40 -70.11 -52.31 24.7 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.877 171.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -62.06 -40.69 96.64 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -161.04 60.44 0.29 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.833 1.253 . . . . 0.0 109.858 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.12 -29.69 70.32 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-O 118.185 -1.341 . . . . 0.0 111.47 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.44 -29.5 24.86 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.838 1.319 . . . . 0.0 112.694 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -79.93 -34.98 38.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.911 -1.118 . . . . 0.0 111.678 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -80.31 -19.46 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.643 1.111 . . . . 0.0 108.997 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -53.07 -45.59 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.151 0.887 . . . . 0.0 109.467 169.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.49 -17.67 62.34 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -71.53 -65.17 0.79 Allowed 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.365 -0.834 . . . . 0.0 109.845 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mm -78.32 -56.07 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.0 1.32 . . . . 0.0 108.713 -166.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 50.61 63.29 4.55 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.253 -167.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.47 173.0 39.55 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 119.376 1.588 . . . . 0.0 111.941 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.19 121.36 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 102.936 -2.986 . . . . 0.0 102.936 159.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -130.42 166.01 21.39 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 123.659 0.6 . . . . 0.0 109.724 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB1' ' CG2' ' A' ' 49' ' ' THR . . . -129.12 168.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.889 0.852 . . . . 0.0 112.063 173.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -115.49 98.5 6.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.932 . . . . 0.0 108.529 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -83.9 89.55 7.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.987 0.812 . . . . 0.0 110.904 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.18 124.03 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -115.11 -175.05 2.61 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.899 -1.126 . . . . 0.0 108.728 158.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t0 47.8 58.23 5.23 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 127.236 2.214 . . . . 0.0 111.881 169.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.89 -177.2 4.58 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.393 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -60.23 7.49 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 1 C-N-CA 125.389 4.059 . . . . 0.0 113.188 159.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.71 -31.79 0.3 Allowed Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.282 -1.511 . . . . 0.0 112.075 155.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -2.68 7.61 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 118.805 1.303 . . . . 0.0 114.018 -172.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -62.04 -175.57 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.958 1.379 . . . . 0.0 110.791 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -120.97 165.38 15.33 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 166.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . . . -150.13 164.94 34.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.498 1.919 . . . . 0.0 107.43 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.436 ' CG2' ' HB1' ' A' ' 36' ' ' ALA . 80.0 m -147.07 144.15 28.86 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -115.67 133.05 56.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 103.595 -2.743 . . . . 0.0 103.595 169.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 64.7 t -101.35 136.16 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.69 117.29 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.63 117.07 28.24 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 165.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.65 51.55 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -133.4 -53.61 0.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.123 0.969 . . . . 0.0 108.824 160.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -77.79 111.24 13.39 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.03 -151.93 50.66 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 121.673 0.596 . . . . 0.0 111.648 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -75.02 9.49 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 127.94 2.496 . . . . 0.0 114.205 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.14 157.76 33.9 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.0 m -172.87 158.12 3.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.49 2.316 . . . . 0.0 106.99 152.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.74 160.37 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -141.51 87.57 10.28 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -160.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.53 147.99 18.02 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.012 2.475 . . . . 0.0 109.963 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 52.53 25.8 3.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.995 1.718 . . . . 0.0 111.468 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -92.41 146.84 23.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.524 1.154 . . . . 0.0 109.377 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.84 -26.7 25.54 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.147 1.379 . . . . 0.0 111.909 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -50.33 120.98 5.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.512 1.125 . . . . 0.0 108.648 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -178.04 1.52 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 122.798 1.285 . . . . 0.0 108.804 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.21 156.65 46.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.507 -170.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.2 -32.57 71.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.733 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.76 173.83 15.89 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.101 1.36 . . . . 0.0 110.619 169.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 101' ' ' ILE . 5.0 m -155.23 119.98 4.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -172.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 101' ' ' ILE . 15.8 tt -83.96 155.11 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 118.661 0.664 . . . . 0.0 109.449 -173.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.4 m -100.73 126.32 47.27 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 118.203 -0.904 . . . . 0.0 109.245 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.06 126.74 2.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 157.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.08 166.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 0.0 112.149 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -53.0 63.06 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.817 -1.177 . . . . 0.0 111.457 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t -65.32 -4.53 5.56 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.307 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.23 -53.96 2.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.141 1.776 . . . . 0.0 108.998 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -50.77 -56.72 10.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 121.205 1.82 . . . . 0.0 111.37 171.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 tp -54.16 -51.66 63.6 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.46 1.504 . . . . 0.0 107.852 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -61.4 -23.62 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.33 -66.02 0.88 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.183 0.993 . . . . 0.0 108.965 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -32.52 61.64 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.351 -0.843 . . . . 0.0 112.464 -171.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.81 1.75 11.8 Favored 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.946 -1.096 . . . . 0.0 110.971 169.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.32 45.0 94.64 Favored Glycine 0 C--N 1.341 0.832 0 O-C-N 120.705 -1.247 . . . . 0.0 112.53 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HE2' ' HB1' ' A' ' 82' ' ' ALA . 33.8 ttpt -80.63 -36.46 32.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.702 1.251 . . . . 0.0 110.457 174.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.6 ptp -142.77 -173.73 3.97 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.507 0.594 . . . . 0.0 112.534 -162.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -53.55 116.0 8.96 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.974 1.709 . . . . 0.0 109.978 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -81.46 44.19 1.69 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.828 3.019 . . . . 0.0 112.822 -163.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -156.61 33.67 0.31 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.084 1.353 . . . . 0.0 109.459 170.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.7 t -52.77 -34.03 51.24 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.777 0.717 . . . . 0.0 112.81 -166.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 100' ' ' LYS . . . -55.95 -37.14 68.61 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.58 1.082 . . . . 0.0 111.905 178.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.436 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 34.9 t80 -86.59 -44.66 11.72 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.718 1.607 . . . . 0.0 112.362 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -59.33 -43.58 92.7 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.356 0.662 . . . . 0.0 110.349 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.62 -16.41 58.58 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.607 -0.683 . . . . 0.0 111.371 172.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.79 45.54 95.59 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.583 1.087 . . . . 0.0 111.693 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -84.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.757 0.778 . . . . 0.0 110.64 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -165.78 57.32 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 127.481 2.312 . . . . 0.0 106.949 167.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -72.85 148.8 44.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.746 -1.221 . . . . 0.0 107.954 -177.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -130.27 173.04 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -175.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.8 p -154.91 145.14 21.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.426 1.891 . . . . 0.0 107.24 -169.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.91 -23.96 50.68 Favored Glycine 0 N--CA 1.467 0.709 0 CA-C-N 120.173 1.351 . . . . 0.0 111.452 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -156.46 147.89 22.49 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.572 2.349 . . . . 0.0 105.761 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.6 mtm -62.98 130.16 43.53 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.959 1.254 . . . . 0.0 109.407 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.85 -144.46 15.63 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -168.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 46.32 17.59 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 129.795 3.238 . . . . 0.0 117.25 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.94 -67.95 0.45 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.802 0.728 . . . . 0.0 110.139 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 34.1 ttm -133.65 -3.43 2.95 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.371 -0.83 . . . . 0.0 111.848 -168.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -68.62 -35.24 77.04 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.052 -1.655 . . . . 0.0 112.658 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.74 119.84 25.29 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -110.82 -78.45 0.59 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 123.829 0.851 . . . . 0.0 108.785 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -62.41 -8.74 6.56 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.44 -31.78 73.14 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.847 1.658 . . . . 0.0 109.953 166.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -123.43 47.56 1.99 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.421 1.888 . . . . 0.0 111.244 -166.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.585 HD22 ' HG2' ' A' ' 15' ' ' GLU 0.351 0.2 OUTLIER 49.27 172.17 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.219 2.608 . . . . 0.0 112.051 -175.215 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -105.52 141.96 23.73 Favored Pre-proline 0 CA--C 1.533 0.311 0 O-C-N 119.098 -2.251 . . . . 0.0 111.788 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -79.62 179.54 6.24 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.139 2.559 . . . . 0.0 110.387 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.63 74.57 1.25 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 -171.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -144.29 145.58 32.1 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.19 0.996 . . . . 0.0 109.211 -177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.67 -63.47 0.18 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 43.05 74.98 0.1 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.89 2.076 . . . . 0.0 110.396 -169.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--O 1.244 0.797 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -156.697 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.56 175.09 13.66 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.08 1.352 . . . . 0.0 107.842 155.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.88 145.71 29.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 155.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 t -144.63 -81.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t0 63.49 62.17 0.97 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.304 1.05 . . . . 0.0 111.938 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.57 20.73 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.508 1.051 . . . . 0.0 112.711 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -79.89 171.08 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 120.8 -1.412 . . . . 0.0 108.503 169.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -69.82 -19.36 63.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.879 1.218 . . . . 0.0 110.471 171.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.72 -22.13 3.27 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.146 0.978 . . . . 0.0 112.798 165.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 50' ' ' TRP . 27.7 t-20 -55.58 -47.26 76.74 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.608 0.64 . . . . 0.0 110.725 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.28 -38.97 91.38 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.57 1.148 . . . . 0.0 112.142 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.638 HG13 ' SD ' ' A' ' 84' ' ' MET . 2.6 t -66.15 -57.81 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.192 1.397 . . . . 0.0 109.412 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.95 -23.29 66.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.928 -0.482 . . . . 0.0 111.495 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -70.25 -48.99 54.46 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.534 ' CB ' HD22 ' A' ' 116' ' ' LEU . 8.8 mm-40 -51.34 -39.09 56.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 118.845 0.748 . . . . 0.0 112.885 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.47 -51.66 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 10.4 tp10 -57.27 -54.33 48.02 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 123.973 0.909 . . . . 0.0 111.783 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -57.3 -38.29 73.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.888 1.222 . . . . 0.0 110.135 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.59 -43.89 71.88 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.605 1.162 . . . . 0.0 110.39 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -38.51 69.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.525 1.53 . . . . 0.0 114.071 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.59 -50.7 68.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.287 -0.863 . . . . 0.0 108.682 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.0 -46.99 85.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.593 1.542 . . . . 0.0 114.749 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -153.66 55.44 0.74 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 123.513 1.625 . . . . 0.0 111.089 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.51 -16.1 80.18 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.078 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -60.34 -40.47 90.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.161 1.481 . . . . 0.0 111.485 -168.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -27.49 50.44 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.313 -0.867 . . . . 0.0 110.857 176.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -70.8 -32.99 70.25 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.0 -42.77 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.142 166.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -33.63 74.48 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.957 -1.09 . . . . 0.0 111.267 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -71.92 -41.99 67.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 117.554 -1.212 . . . . 0.0 113.462 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.46 ' CD1' ' HE2' ' A' ' 110' ' ' LYS . 1.3 mp -95.18 -64.21 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 121.911 2.141 . . . . 0.0 107.176 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 77.03 0.28 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.433 1.016 . . . . 0.0 110.671 -169.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.85 145.78 4.2 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 118.312 -1.271 . . . . 0.0 110.636 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -73.37 137.35 23.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -135.28 168.17 19.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 110.155 170.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.57 137.2 52.36 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.534 1.133 . . . . 0.0 109.83 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -88.22 97.2 10.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -74.56 111.94 10.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.532 1.06 . . . . 0.0 109.475 168.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.79 106.79 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.28 177.44 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 159.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.5 t0 55.96 61.45 2.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.065 1.346 . . . . 0.0 111.903 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.55 -160.98 36.19 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.947 1.737 . . . . 0.0 112.442 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.59 4.95 0.39 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 124.567 3.511 . . . . 0.0 114.869 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.74 2.17 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 120.653 -1.279 . . . . 0.0 113.839 164.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.55 5.59 53.87 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 120.515 2.158 . . . . 0.0 113.244 163.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.41 -175.14 0.76 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.174 1.389 . . . . 0.0 109.802 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -118.87 138.0 53.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.098 1.359 . . . . 0.0 108.818 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.56 166.23 12.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.749 1.62 . . . . 0.0 107.64 164.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.0 m -146.35 148.69 32.63 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 160.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 10' ' ' ASN . 1.2 m-90 -119.64 133.77 55.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 101.684 -3.45 . . . . 0.0 101.684 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.88 114.07 40.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.402 HG22 HG13 ' A' ' 61' ' ' VAL . 59.2 t -92.91 105.12 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.28 116.58 18.81 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 163.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.25 52.01 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -144.4 -48.98 0.27 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.609 1.164 . . . . 0.0 109.885 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -80.9 126.01 30.83 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -173.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.17 -142.29 44.72 Favored Glycine 0 N--CA 1.439 -1.112 0 O-C-N 121.391 -0.818 . . . . 0.0 111.632 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -82.74 3.8 27.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.686 -1.15 . . . . 0.0 112.286 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.25 158.02 27.14 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 120.782 1.628 . . . . 0.0 109.512 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -171.72 137.27 1.0 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.551 2.74 . . . . 0.0 106.565 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 17' ' ' GLU . 3.5 t -76.53 111.64 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 166.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -87.0 122.14 71.31 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.78 130.6 10.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 N-CA-C 107.648 -1.712 . . . . 0.0 107.648 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 41.49 45.79 2.85 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.339 1.856 . . . . 0.0 113.465 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.98 137.5 58.03 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -9.07 59.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.404 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -57.72 140.76 50.63 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 166.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HE2' ' H ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -71.89 -177.03 1.85 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.13 157.22 45.86 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 125.085 1.354 . . . . 0.0 108.549 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.04 -33.24 67.85 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 p -153.24 175.72 12.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.454 2.301 . . . . 0.0 109.034 -170.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 73' ' ' ILE . 99.4 m -140.25 -172.73 3.49 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' N ' HG22 ' A' ' 72' ' ' THR . 0.7 OUTLIER -147.25 152.0 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 159.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.5 m -120.47 133.97 55.34 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.4 -38.02 0.14 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.184 1.356 . . . . 0.0 113.439 170.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 96.88 155.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 131.179 3.792 . . . . 0.0 111.516 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -62.72 -44.35 96.46 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.158 0.583 . . . . 0.0 110.571 -173.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -62.97 -21.41 66.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.123 -0.942 . . . . 0.0 111.595 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.28 -67.0 0.82 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 117.884 -1.055 . . . . 0.0 108.537 166.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -49.69 -45.41 48.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.92 1.688 . . . . 0.0 111.97 -168.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tp -59.89 -65.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.96 -36.43 62.84 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.189 0.996 . . . . 0.0 112.34 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.3 tp -48.6 -71.17 0.07 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.507 2.323 . . . . 0.0 109.123 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.638 ' SD ' HG13 ' A' ' 12' ' ' VAL . 10.1 ptp -75.78 -37.16 59.48 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.0 m -75.75 22.78 0.13 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.224 1.374 . . . . 0.0 111.832 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.99 18.1 59.56 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 124.748 1.166 . . . . 0.0 113.614 167.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -100.25 12.86 36.08 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.932 1.366 . . . . 0.0 111.855 -171.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.0 ttt 76.2 79.51 0.09 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 127.188 2.195 . . . . 0.0 112.882 162.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.77 123.86 21.36 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 169.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.11 169.4 4.92 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.142 1.895 . . . . 0.0 110.132 162.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -63.84 104.79 0.73 Allowed 'General case' 0 C--O 1.238 0.475 0 O-C-N 120.663 -1.273 . . . . 0.0 109.329 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.486 ' HB3' HE21 ' A' ' 96' ' ' GLN . 42.3 m -51.23 -38.74 54.21 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 118.423 -0.798 . . . . 0.0 112.739 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 100' ' ' LYS . . . -48.25 -39.29 20.92 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -85.9 -64.99 1.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.417 1.087 . . . . 0.0 109.647 172.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -54.92 -50.74 68.05 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.12 1.368 . . . . 0.0 113.025 -168.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.486 HE21 ' HB3' ' A' ' 92' ' ' SER . 6.7 mt-30 -76.48 -42.88 42.06 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.29 22.78 46.7 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -9.96 22.6 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.247 -1.359 . . . . 0.0 113.615 177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.4 tp 55.83 95.47 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.282 1.833 . . . . 0.0 110.506 -173.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 93' ' ' ALA . 24.3 pttt -66.69 175.56 2.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.998 0.919 . . . . 0.0 108.844 169.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.79 159.66 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 164.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 m 61.24 166.48 0.09 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.332 2.653 . . . . 0.0 114.342 -176.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -133.87 -64.74 0.07 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.765 1.65 . . . . 0.0 109.49 172.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.702 HD22 HD21 ' A' ' 107' ' ' LEU . 53.8 m-20 57.61 -173.18 0.08 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.372 1.869 . . . . 0.0 111.004 -172.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -64.1 6.23 0.19 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.692 1.597 . . . . 0.0 113.813 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.14 89.61 0.86 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 125.358 1.456 . . . . 0.0 109.687 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.702 HD21 HD22 ' A' ' 104' ' ' ASN . 15.8 mt -71.39 -29.81 65.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.929 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.67 -64.03 1.23 Allowed 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 124.002 0.814 . . . . 0.0 109.452 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.04 29.3 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.158 2.583 . . . . 0.0 114.114 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HE2' ' CD1' ' A' ' 31' ' ' ILE . 41.0 tptt -61.67 -72.13 0.13 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.633 2.773 . . . . 0.0 110.715 -169.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -164.23 165.31 22.07 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.111 2.165 . . . . 0.0 106.974 168.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.25 -47.37 86.36 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -72.34 -14.91 61.85 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -165.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.443 HD13 ' CD1' ' A' ' 27' ' ' PHE . 9.0 tp -83.82 3.98 31.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.715 1.143 . . . . 0.0 110.021 169.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -139.42 45.27 1.95 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.529 2.331 . . . . 0.0 108.249 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 84' ' ' MET 0.379 0.1 OUTLIER 57.06 -176.13 0.06 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.617 1.567 . . . . 0.0 113.389 174.153 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.91 135.31 19.44 Favored Pre-proline 0 CA--C 1.538 0.513 0 O-C-N 120.566 -1.334 . . . . 0.0 109.376 170.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.19 -175.68 2.84 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.296 2.664 . . . . 0.0 111.737 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.78 83.67 0.52 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.141 1.353 . . . . 0.0 109.75 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 53.95 157.15 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 130.148 3.379 . . . . 0.0 114.416 -173.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.84 -105.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -145.28 124.12 12.67 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.634 1.106 . . . . 0.0 109.328 174.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.504 -0.794 0 C-N-CA 129.519 3.127 . . . . 0.0 105.771 -162.793 . . . . . . . . 0 0 . 1 stop_ save_